-DOCSTART- X X O

Paradoxically NNP O
, , O
loop NN O
3i NN O
from IN O
the DT O
M1Ach-muscarinic JJ B-NP
receptor NN I-NP
also RB O
maximally RB O
inhibited VBN O
GnRH NNP B-NP
agonist-stimulated JJ O
cAMP JJ O
accumulation NN O
and CC O
PRL NNP B-NP
release NN O
by IN O
40 CD O
% NN O
( -LRB- O
both DT O
effects NNS O
mediated VBN O
through IN O
activation NN O
of IN O
the DT O
Gs JJ B-NP
protein NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Oligomers NNP O
corresponding JJ O
to TO O
the DT O
region NN O
of IN O
the DT O
mlc-1/3 JJ B-NP
enhancer NN I-NP
, , O
which WDT O
encompasses VBZ O
this DT O
conserved JJ O
sequence NN O
, , O
bound VBN O
MEF-2 NN B-NP
and CC O
competed VBN O
for IN O
its PRP$ O
binding NN O
to TO O
the DT O
mck NN B-NP
enhancer NN O
. . O

-DOCSTART- X X O

Overall JJ O
graft NN O
and CC O
patient NN O
survival NN O
after IN O
HAT NNP O
were VBD O
33.3 CD O
% NN O
and CC O
75 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

E2A-HLF-mediated JJ B-NP
cell NN O
transformation NN O
requires VBZ O
both DT O
the DT O
trans-activation NN O
domains NNS O
of IN O
E2A NNP B-NP
and CC O
the DT O
leucine NN O
zipper NN O
dimerization NN O
domain NN O
of IN O
HLF. NNP B-NP

-DOCSTART- X X O

One CD O
patient NN O
exhibited VBD O
a DT O
non-sense JJ O
mutation NN O
( -LRB- O
codon NN O
388 CD O
) -RRB- O
, , O
which WDT O
changed VBD O
a DT O
glutamine NN O
codon NN O
( -LRB- O
CAG NNP O
) -RRB- O
to TO O
a DT O
stop NN O
codon NN O
( -LRB- O
TAG NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
encoded JJ O
ERCC3Dm JJ B-NP
protein NN I-NP
with IN O
the DT O
homologous JJ O
proteins NNS O
of IN O
mouse NN O
and CC O
man NN O
shows VBZ O
a DT O
strong JJ O
amino IN O
acid NN O
conservation NN O
( -LRB- O
71 CD O
% NN O
identity NN O
) -RRB- O
, , O
especially RB O
in IN O
the DT O
postulated JJ O
DNA NNP O
binding NN O
region NN O
and CC O
seven CD O
'helicase JJ B-NP
' '' I-NP
domains NNS I-NP
. . O

-DOCSTART- X X O

Previous JJ O
data NNS O
suggested VBD O
a DT O
subtle JJ O
increase NN O
in IN O
serum NN O
P NNP O
at IN O
the DT O
time NN O
of IN O
hCG NN B-NP
injection NN O
without IN O
LH NNP B-NP
surge NN O
reduces VBZ O
the DT O
PR NN O
of IN O
women NNS O
having VBG O
oocyte NN O
retrievals NNS O
for IN O
IVF NNP O
; : O
this DT O
study NN O
compared VBN O
PRs NNS O
of IN O
recipients NNS O
in IN O
a DT O
shared VBN O
oocyte NN O
program NN O
according VBG O
to TO O
the DT O
donors NNS O
' POS O
pre-hCG JJ B-NP
P NNP O
level NN O
. . O

-DOCSTART- X X O

Scleraxis NNP B-NP
overexpression IN O
enhanced JJ O
expression NN O
of IN O
the DT O
aggrecan JJ B-NP
gene NN I-NP
, , O
which WDT O
is VBZ O
not RB O
normally RB O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
these DT O
osteoblastic JJ O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
29.425 CD O
kb NN O
segment NN O
on IN O
the DT O
left JJ O
arm NN O
of IN O
yeast NN O
chromosome NN O
XV NNP O
contains VBZ O
more RBR O
than IN O
twice RB O
as IN O
many JJ O
unknown JJ O
as IN O
known VBN O
open JJ O
reading NN O
frames NNS O
. . O

-DOCSTART- X X O

Ultimobranchial NNP O
body NN O
and CC O
parathyroid NN O
glands NNS O
of IN O
the DT O
freshwater NN O
snake NN O
Natrix NNP O
piscator NN O
in IN O
response NN O
to TO O
vitamin NN O
D3 IN O
administration NN O
. . O

-DOCSTART- X X O

Given VBN O
a DT O
rapid JJ O
induction NN O
of IN O
Egr-1 NN B-NP
on IN O
stimulation NN O
with IN O
growth NN O
factors NNS O
or CC O
injury NN O
, , O
these DT O
findings NNS O
may MD O
represent VB O
at IN O
least JJS O
one CD O
of IN O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
phenotypic JJ O
modulation NN O
of IN O
smooth JJ O
muscles NNS O
after IN O
vascular JJ O
injury NN O
. . O

-DOCSTART- X X O

Soluble JJ O
recombinant JJ O
RI NNP B-NP
and CC O
soluble JJ O
recombinant JJ O
C NNP B-NP
alpha NN I-NP
can MD O
associate VB O
in IN O
vitro NN O
and CC O
be VB O
activated VBN O
by IN O
cyclic NN O
AMP. . O

-DOCSTART- X X O

A DT O
31-year-old JJ O
man NN O
with IN O
primary JJ O
myelofibrosis NN O
initially RB O
received VBD O
low JJ O
dose NN O
Ara NNP O
C. NNP O

-DOCSTART- X X O

The DT O
factors NNS O
defective JJ O
in IN O
groups NNS O
A DT O
( -LRB- O
CIITA NNP B-NP
) -RRB- O
, , O
C NNP O
( -LRB- O
RFX5 NN B-NP
) -RRB- O
and CC O
D NNP O
( -LRB- O
RFXAP NNP B-NP
) -RRB- O
have VBP O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
are VBP O
consistent JJ O
with IN O
TCOF1 NNP B-NP
mutations NNS I-NP
leading VBG O
to TO O
the DT O
Treacher NNP O
Collins NNP O
syndrome NN O
phenotype NN O
. . O

-DOCSTART- X X O

Acute NNP O
spontaneous JJ O
subdural JJ O
haematoma NN O
. . O

-DOCSTART- X X O

Ultra-energy NNP O
( -LRB- O
UHE NN O
) -RRB- O
imaging NN O
is VBZ O
usually RB O
performed VBN O
in IN O
simultaneous JJ O
F-18 NN O
FDG/Tc-99m NNP O
MIBI NNP O
studies NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
betamethasone NN O
on IN O
duodenal JJ O
calcium NN O
absorption NN O
and CC O
1,25-dihydroxy JJ O
vitamin NN O
D3 IN O
production NN O
in IN O
the DT O
chick NN O
. . O

-DOCSTART- X X O

Fluctuations NNS O
of IN O
the DT O
measured VBN O
ECF NN O
energy-related VBN O
substances NNS O
corresponded VBD O
to TO O
various JJ O
clinical JJ O
events NNS O
presumably RB O
involving VBG O
hypoxia/ischemia NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
demonstrated VBN O
that IN O
a DT O
putative JJ O
HOX NNP B-NP
cofactor NN I-NP
, , O
PBX1A NNP B-NP
, , O
participates NNS O
in IN O
cooperative JJ O
DNA NN O
binding NN O
with IN O
HOXA-1 NN B-NP
and CC O
the DT O
Deformed NNP B-NP
group NN O
protein NN O
HOXD-4. . B-NP

-DOCSTART- X X O

The DT O
effect NN O
of IN O
iron NN O
on IN O
the DT O
toxigenicity NN O
of IN O
Vibrio NNP O
cholerae NNS O
. . O

-DOCSTART- X X O

Although IN O
there EX O
is VBZ O
evidence NN O
that IN O
cone NN O
ratios NNS O
do VBP O
determine VB O
colour NN O
appearance NN O
under IN O
many JJ O
conditions NNS O
, , O
the DT O
site NN O
or CC O
sites NNS O
of IN O
their PRP$ O
computation NN O
is VBZ O
unknown JJ O
. . O

-DOCSTART- X X O

In IN O
an DT O
effort NN O
to TO O
identify VB O
factors NNS O
involved VBN O
in IN O
the DT O
expression NN O
of IN O
this DT O
important JJ O
erythroid-specific JJ O
regulatory JJ O
protein NN O
, , O
we PRP O
have VBP O
isolated VBN O
the DT O
mouse NN B-NP
EKLF NNP I-NP
gene NN I-NP
and CC O
systematically RB O
analyzed VBD O
the DT O
promoter NN O
region NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
All DT O
primary JJ O
tumors NNS O
were VBD O
positive JJ O
for IN O
CAM5.2 NNP B-NP
. . O

-DOCSTART- X X O

Moreover RB O
, , O
since IN O
the DT O
integrated JJ O
transforming NN O
DNA NN O
was VBD O
not RB O
altered VBN O
or CC O
lost VBN O
expression NN O
of IN O
the DT O
RbcS2: NNP B-NP
:aadA NNP O
::RbcS2 NNP O
gene( JJ B-NP
s VBZ I-NP
) -RRB- I-NP
appears VBZ O
to TO O
be VB O
repressed VBN O
. . O

-DOCSTART- X X O

In IN O
one CD O
trial NN O
, , O
116 CD O
subjects NNS O
with IN O
transfusion-related JJ O
chronic JJ O
hepatitis NN O
C NN O
were VBD O
treated VBN O
with IN O
lymphoblastoid JJ B-NP
interferon NN I-NP
( -LRB- O
5 CD O
MU/m2 IN O
three CD O
times NNS O
a DT O
week NN O
for IN O
2 CD O
mo NN O
, , O
then RB O
3 CD O
MU/m2 CD O
three CD O
times NNS O
a DT O
week NN O
for IN O
4 CD O
or CC O
10 CD O
mo NN O
) -RRB- O
. . O

-DOCSTART- X X O

Instead RB O
, , O
the DT O
large JJ O
difference NN O
in IN O
ssDNA-binding JJ O
affinities NNS O
reflects VBZ O
the DT O
loss NN O
of IN O
hexamerization NN O
ability NN O
by IN O
uvsY RB B-NP
, , O
suggesting VBG O
that IN O
a DT O
form NN O
of IN O
intrahexamer NN O
synergism NN O
or CC O
cooperativity NN O
between IN O
binding NN O
sites NNS O
within IN O
the DT O
uvsY JJ B-NP
hexamer NN I-NP
leads VBZ O
to TO O
its PRP$ O
high JJ O
observed JJ O
affinity NN O
for IN O
ssDNA NN O
. . O

-DOCSTART- X X O

Sox8 DT B-NP
maps NNS O
to TO O
the DT O
t NN B-NP
complex NN I-NP
on IN O
mouse NN O
chromosome NN O
17 CD O
and CC O
to TO O
human JJ O
chromosome NN O
16p13.3 CD O
, , O
a DT O
region NN O
associated VBN O
with IN O
the DT O
microphthalmia-cataract JJ O
syndrome NN O
CATM NNP O
and CC O
the DT O
alpha-thalassemia/mental JJ O
retardation NN O
syndrome NN O
ATR-16 NNP O
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
the DT O
effects NNS O
of IN O
chelation NN O
therapy NN O
with IN O
time NN O
following VBG O
strontium JJ O
exposure NN O
to TO O
mice NNS O
. . O

-DOCSTART- X X O

To TO O
better RBR O
understand VB O
the DT O
relationship NN O
between IN O
expression NN O
of IN O
an DT O
oncogene NN O
and CC O
genetic JJ O
instability NN O
, , O
we PRP O
have VBP O
studied VBN O
a DT O
cell NN O
line NN O
expressing VBG O
an DT O
activated JJ B-NP
human JJ I-NP
Ha-ras NNP I-NP
under IN O
the DT O
control NN O
of IN O
bacterial JJ B-NP
lactose NN I-NP
operon NN I-NP
regulatory JJ I-NP
elements NNS I-NP
for IN O
changes NNS O
in IN O
methotrexate NN O
resistance NN O
and CC O
dihydrofolate JJ B-NP
reductase NN I-NP
( -LRB- O
dhfr NN B-NP
) -RRB- O
gene NN O
amplification NN O
following VBG O
mutant JJ B-NP
Ha-ras NNP I-NP
induction NN O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
this DT O
work NN O
was VBD O
to TO O
organize VB O
chemical NN O
data NNS O
in IN O
a DT O
client-server NN O
environment NN O
using VBG O
Database NNP O
Management NNP O
System NNP O
and CC O
Web NNP O
fashion NN O
for IN O
the DT O
client NN O
interface NN O
. . O

-DOCSTART- X X O

The DT O
deduced VBD O
amino IN O
acid NN O
sequence NN O
exhibits NNS O
95.3 CD O
and CC O
76.1 CD O
% NN O
identity NN O
with IN O
the DT O
CAD NNP B-NP
sequences NNS I-NP
of IN I-NP
hamster NN I-NP
and CC I-NP
Squalus NNP I-NP
acanthias NNS I-NP
. . O

-DOCSTART- X X O

The DT O
sulfur NN O
species NNS O
could MD O
be VB O
separated VBN O
within IN O
less JJR O
than IN O
4 CD O
min NN O
by IN O
CZE NNP O
with IN O
a DT O
pyromellitic JJ O
acid NN O
electrolyte NN O
at IN O
pH DT O
3.5 CD O
to TO O
5.0. CD O

-DOCSTART- X X O

Because IN O
of IN O
the DT O
structural JJ O
similarities NNS O
the DT O
new JJ O
gene NN O
will MD O
be VB O
termed VBN O
scERV2 NNS B-NP
from IN O
now RB O
on IN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
DNA NNP O
sequence NN O
upstream RB O
of IN O
the DT O
narQ JJ B-NP
gene NN I-NP
, , O
which WDT O
encodes VBZ O
the DT O
second JJ O
nitrate-responsive JJ O
sensor-transmitter JJ O
protein NN O
in IN O
Escherichia NNP O
coli NNS O
, , O
revealed VBD O
an DT O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORF NN O
) -RRB- O
whose WP$ O
product NN O
shows VBZ O
a DT O
high JJ O
degree NN O
of IN O
similarity NN O
to TO O
a DT O
number NN O
of IN O
iron-sulfur JJ B-NP
proteins NNS I-NP
as RB O
well RB O
as IN O
to TO O
the DT O
beta JJ O
subunit NN O
of IN O
glutamate NN B-NP
synthase NN I-NP
( -LRB- O
gltD NN B-NP
) -RRB- O
of IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

In IN O
CYP7A1 NNP B-NP
transgenic JJ O
mice NNS O
, , O
livers NNS O
contained VBD O
approximately RB O
3-fold JJ O
more RBR O
sterol JJ B-NP
response NN I-NP
element-binding JJ I-NP
protein-2 NN I-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
10,763 CD O
men NNS O
and CC O
3,118 CD O
women NNS O
has VBZ O
been VBN O
studied VBN O
, , O
of IN O
whom WP O
97 CD O
% NN O
and CC O
89 CD O
% NN O
, , O
respectively RB O
, , O
have VBP O
been VBN O
traced VBN O
and CC O
36 CD O
% NN O
and CC O
16 CD O
% NN O
have VBP O
died VBN O
. . O

-DOCSTART- X X O

One CD O
of IN O
them PRP O
is VBZ O
its PRP$ O
limited JJ O
sensitivity NN O
to TO O
weak JJ O
interactions NNS O
, , O
which WDT O
are VBP O
common JJ O
in IN O
the DT O
mammalian JJ O
cerebral NN O
cortex NN O
. . O

-DOCSTART- X X O

Cefminox NN O
shows VBZ O
greater JJR O
in IN O
vivo JJ O
activity NN O
than IN O
that DT O
expected VBN O
for IN O
the DT O
MICs NN O
, , O
excellent JJ O
efficacy NN O
and CC O
safety NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
demonstrated VBN O
that IN O
pyrene NN O
in IN O
diesel-exhaust JJ O
particles NNS O
( -LRB- O
DEP NN O
) -RRB- O
has VBZ O
an DT O
adjuvant JJ O
activity NN O
on IN O
immunoglobulin NN B-NP
E NNP I-NP
( -LRB- O
IgE NN B-NP
) -RRB- O
antibody NN O
production NN O
in IN O
mice NNS O
immunized VBN O
with IN O
Japanese JJ O
cedar NN O
pollen NN O
allergen NN O
(JCPA IN O
) -RRB- O
or CC O
ovalbumin JJ B-NP
( -LRB- O
OA NN B-NP
) -RRB- O
intraperitoneally RB O
. . O

-DOCSTART- X X O

The DT O
corresponding JJ O
tetrapeptide NN O
sequences NNS O
SSPD NNP O
and CC O
SATD NNP O
for IN O
human JJ B-NP
and CC I-NP
mouse NN I-NP
PKC-epsilon NN I-NP
, , O
respectively RB O
, , O
are VBP O
unusual JJ O
for IN O
caspase-3 NN B-NP
. . O

-DOCSTART- X X O

A DT O
poly(ortho NN O
ester NN O
) -RRB- O
designed VBN O
for IN O
combined VBN O
ocular JJ O
delivery NN O
of IN O
dexamethasone NN O
sodium NN O
phosphate NN O
and CC O
5-fluorouracil NN O
: : O
subconjunctival NN O
tolerance NN O
and CC O
in IN O
vitro NN O
release NN O
. . O

-DOCSTART- X X O

Regardless RB O
of IN O
muscle NN O
tensioning NN O
or CC O
marination NN O
treatments NNS O
, , O
aging VBG O
of IN O
the DT O
carcass NN O
for IN O
24 CD O
h NN O
( -LRB- O
T1 NNP O
, , O
T2 NNP O
, , O
and CC O
T3 NNP O
) -RRB- O
produced VBD O
meats NNS O
with IN O
lower JJR O
shear NN O
values NNS O
than IN O
those DT O
from IN O
hot-boned JJ O
carcasses NNS O
( -LRB- O
T4 NNP O
and CC O
T5 DT O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
effect NN O
was VBD O
stronger JJR O
after IN O
multiple JJ O
predoses NNS O
of IN O
sertraline NN O
, , O
when WRB O
imipramine NN O
Cmax NNP O
and CC O
AUC(0-infinity NNP O
) -RRB- O
were VBD O
increased VBN O
by IN O
39 CD O
% NN O
and CC O
68 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
pathogenetically RB O
proved VBN O
to TO O
use VB O
antithrombin JJ B-NP
III NNP I-NP
concentrate NN O
preparations NNS O
with IN O
anti- NNS O
and CC O
dysaggregatory NN O
properties NNS O
, , O
fibronectin VBG B-NP
preparations NNS O
, , O
trasylol NN O
or CC O
its PRP$ O
analogs NNS O
during IN O
complex JJ O
preoperative JJ O
preparation NN O
of IN O
patients NNS O
. . O

-DOCSTART- X X O

LV NNP O
compliance NN O
was VBD O
determined VBN O
from IN O
the DT O
slope NN O
of IN O
the DT O
LV NNP O
end-diastolic JJ O
pressure NN O
( -LRB- O
LVEDP NNP O
) -RRB- O
vs. FW O

-DOCSTART- X X O

The DT O
ARE NN O
is VBZ O
loosely RB O
defined VBN O
as IN O
the DT O
five-nucleotide JJ O
sequence NN O
AUUUA IN O
embedded VBN O
in IN O
a DT O
uracil-rich JJ O
region NN O
. . O

-DOCSTART- X X O

A DT O
regulatory JJ O
element NN O
of IN O
the DT O
empty JJ B-NP
spiracles NNS I-NP
homeobox NN O
gene NN O
is VBZ O
composed VBN O
of IN O
three CD O
distinct JJ O
conserved JJ O
regions NNS O
that WP O
bind VBP O
regulatory JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Together RB O
with IN O
previous JJ O
work NN O
our PRP$ O
results NNS O
suggest VBP O
that IN O
C/EBP NNP B-NP
may MD O
be VB O
a DT O
general JJ O
cooperation NN O
partner NN O
for IN O
v-Myb NN B-NP
in IN O
myelomonocytic JJ O
cells NNS O
. . O

-DOCSTART- X X O

This DT O
bud NN O
morphology NN O
results NNS O
at IN O
least JJS O
in IN O
part NN O
from IN O
a DT O
cell NN O
cycle NN O
delay NN O
imposed VBN O
by IN O
the DT O
Cdc28p-inhibitory JJ B-NP
kinase NN O
Swe1p NN B-NP
. . O

-DOCSTART- X X O

Nonlethal JJ O
sec71-1 NN B-NP
and CC O
sec72-1 NN B-NP
mutations NNS I-NP
eliminate VBP O
proteins NNS O
associated VBN O
with IN O
the DT O
Sec63p-BiP JJ B-NP
complex NN O
from IN O
S. NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

Analytical NNP O
scanning NN O
isoelectrofocusing NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
future NN O
, , O
transoesophageal JJ O
echocardiography NN O
may MD O
be VB O
used VBN O
to TO O
measure VB O
variations NNS O
in IN O
wall NN O
thickness NN O
which WDT O
change VBP O
the DT O
global JJ O
loading NN O
conditions NNS O
in IN O
the DT O
basal NN O
midwall NN O
compartments NNS O
of IN O
the DT O
left JJ O
ventricle NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
d-delta3-carene JJ O
was VBD O
about IN O
four CD O
times NNS O
more RBR O
potent JJ O
as IN O
a DT O
sensory JJ O
irritant JJ O
than IN O
I-beta-pinene NNP O
, , O
whereas IN O
the DT O
difference NN O
with IN O
I-alpha-pinene NN O
was VBD O
more JJR O
marked JJ O
; : O
as IN O
a DT O
sensory JJ O
irritant JJ O
, , O
I-alpha-pinene NNP O
is VBZ O
almost RB O
inactive JJ O
. . O

-DOCSTART- X X O

Sodium NNP O
dodecylsulfate JJ O
polyacrylamide NN O
gel NN O
electrophoresis NN O
( -LRB- O
SDS-PAGE NN O
) -RRB- O
showed VBD O
two CD O
bands NNS O
of IN O
about IN O
the DT O
same JJ O
intensity NN O
with IN O
apparent JJ O
molecular JJ O
masses NNS O
of IN O
24.5 CD O
and CC O
22.5 CD O
kDa NN O
. . O

-DOCSTART- X X O

However RB O
, , O
at IN O
the DT O
time NN O
of IN O
salvage NN O
treatment NN O
, , O
the DT O
mean JJ O
serum NN B-NP
PSA NN I-NP
levels NNS O
were VBD O
9.1 CD O
and CC O
1.1 CD O
ng/mL NN O
for IN O
the DT O
salvage NN O
RP NNP O
and CC O
salvage NN O
RT NNP O
groups NNS O
, , O
respectively RB O
( -LRB- O
P NNP O
= SYM O
0.0001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Uncoupling JJ O
gene NN O
activity NN O
from IN O
chromatin NN O
structure NN O
: : O
promoter NN O
mutations NNS O
can MD O
inactivate VB O
transcription NN O
of IN O
the DT O
yeast NN B-NP
HSP82 NNP I-NP
gene NN I-NP
without IN O
eliminating VBG O
nucleosome-free JJ O
regions NNS O
. . O

-DOCSTART- X X O

Maximal NNP O
exercise NN O
duration NN O
and CC O
peak JJ O
oxygen NN O
consumption NN O
were VBD O
not RB O
changed VBN O
. . O

-DOCSTART- X X O

Real-time JJ O
two-dimensional JJ O
echocardiographic JJ O
studies NNS O
of IN O
the DT O
mitral JJ O
valve NN O
in IN O
short-axis PRP$ O
view NN O
were VBD O
obtained VBN O
from IN O
10 CD O
normal JJ O
subjects NNS O
. . O

-DOCSTART- X X O

More RBR O
important JJ O
, , O
ligand-activated JJ O
insulin NN B-NP
and CC O
IGF-I JJ B-NP
receptors NNS I-NP
phosphorylate VBP O
SHC JJ B-NP
proteins NNS I-NP
in IN O
vitro NN O
, , O
indicating VBG O
that IN O
SHC NNP B-NP
proteins VBZ I-NP
could MD O
be VB O
direct JJ O
substrates NNS O
for IN O
insulin NN B-NP
and CC O
IGF-I JJ B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

To TO O
test VB O
for IN O
progesterone NN B-NP
receptor-mediated JJ I-NP
activation NN O
of IN O
transcription NN O
in IN O
yeast NN O
, , O
reporter NN O
plasmids NNS O
were VBD O
constructed VBN O
to TO O
transform VB O
yeast NN O
cells NNS O
expressing VBG O
PRB NNP B-NP
or CC O
C1C2 NNP B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

TAF-1 JJ B-NP
activates NNS O
transcription NN O
constitutively RB O
and CC O
was VBD O
mapped VBN O
to TO O
the DT O
first JJ O
32 CD O
amino IN O
acids NNS O
of IN O
the DT O
A-region NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
used VBN O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
reporter NN O
gene NN O
system NN O
to TO O
study VB O
the DT O
effect NN O
of IN O
T NNP B-NP
on IN O
the DT O
long JJ O
terminal NN O
repeats NNS O
( -LRB- O
LTRs NNS O
) -RRB- O
of IN O
a DT O
large JJ O
family NN O
of IN O
human JJ O
endogenous JJ O
retrovirus-like JJ O
sequences NNS O
, , O
RTVL-H. . O

-DOCSTART- X X O

They PRP O
contain VBP O
a DT O
large JJ O
( -LRB- O
0.9 CD O
X NNP O
10( JJ O
3 CD O
) -RRB- O
to TO O
1.88 CD O
X NNP O
10( JJ O
3 CD O
) -RRB- O
base-pairs NNS O
) -RRB- O
intron NN O
in IN O
the DT O
middle NN O
of IN O
the DT O
gene NN O
and CC O
are VBP O
further JJ O
interrupted JJ O
close NN O
to TO O
the DT O
5' JJ O
end NN O
of IN O
the DT O
gene NN O
. . O

-DOCSTART- X X O

Primer NNP O
extension NN O
experiments NNS O
using VBG O
dbcAMP-differentiated JJ O
U937 IN O
RNA NNP O
indicated VBD O
a DT O
single JJ O
transcriptional JJ O
initiation NN O
site NN O
. . O

-DOCSTART- X X O

On IN O
a DT O
variety NN O
of IN O
fronts NNS O
, , O
chronic NN O
bacterial JJ O
infection NN O
is VBZ O
being VBG O
found VBN O
to TO O
be VB O
significantly RB O
associated VBN O
with IN O
the DT O
development NN O
of IN O
atherosclerosis NN O
and CC O
the DT O
clinical JJ O
complications NNS O
of IN O
unstable JJ O
angina NN O
, , O
myocardial JJ O
infarction NN O
, , O
and CC O
stroke NN O
. . O

-DOCSTART- X X O

025 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Although IN O
the DT O
energy-based JJ O
DFT NNP O
was VBD O
not RB O
affected VBN O
by IN O
isoproterenol NN O
( -LRB- O
from IN O
6.1 CD O
+/ CD O
- : O
1.5 CD O
to TO O
6.0 CD O
+/ CD O
- : O
1.7 CD O
J) NN O
, , O
it PRP O
was VBD O
decreased VBN O
to TO O
3.7 CD O
+/ CD O
- : O
1.6 CD O
J NN O
in IN O
the DT O
third JJ O
stage NN O
by IN O
infusion NN O
of IN O
E4031 NNP O
and CC O
isoproterenol NN O
( -LRB- O
p NN O
< NN O
0.01 CD O
vs. IN O
baseline NN O
and CC O
vs. JJ O
isoproterenol NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
cases NNS O
of IN O
intracapsular JJ O
prostatic JJ O
cancer NN O
the DT O
level NN O
of IN O
prostatic JJ B-NP
acid NN I-NP
phosphatase NN I-NP
( -LRB- O
PAP NNP B-NP
) -RRB- O
measured VBN O
by IN O
radioimmunoassay NN O
was VBD O
1.4 CD O
+/ CD O
- : O
0.8 CD O
micrograms/l NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
The DT O
number NN O
of IN O
Spanish JJ O
articles NNS O
published VBN O
in IN O
Anesthesiology NNP O
, , O
BJA NNP O
, , O
and CC O
Anesth NNP O
Analg NNP O
is VBZ O
low JJ O
, , O
although IN O
the DT O
comparison NN O
of IN O
our PRP$ O
productivity NN O
with IN O
that DT O
of IN O
other JJ O
EU NNS O
countries NNS O
in IN O
function NN O
of IN O
GNPpc NNP O
places NNS O
us PRP O
in IN O
an DT O
intermediate JJ O
position NN O
. . O

-DOCSTART- X X O

Neonatal JJ O
hyperthyroidism NN O

-DOCSTART- X X O

Serum NN O
prolactin VBP B-NP
rapidly RB O
decreased VBN O
after IN O
institution NN O
of IN O
treatment NN O
, , O
with IN O
actual JJ O
normalization NN O
( -LRB- O
less JJR O
than IN O
20 CD O
ng/ml NN O
) -RRB- O
by IN O
the DT O
3rd JJ O
month NN O
. . O

-DOCSTART- X X O

Three CD O
high-amylose JJ O
rice NN O
varieties NNS O
, , O
IR42 NNP O
, , O
IR36 NNP O
, , O
and CC O
IR62 NNP O
, , O
with IN O
similar JJ O
chemical NN O
composition NN O
including VBG O
amylose JJ O
content NN O
( -LRB- O
26.7-27.0 CD O
% NN O
) -RRB- O
, , O
were VBD O
cooked VBN O
under IN O
the DT O
same JJ O
conditions NNS O
and CC O
tested VBN O
for IN O
in IN O
vitro NN O
digestibility NN O
as RB O
well RB O
as IN O
blood NN O
glucose NN O
and CC O
insulin NN B-NP
responses NNS O
in IN O
healthy JJ O
human JJ O
volunteers NNS O
. . O

-DOCSTART- X X O

This DT O
indicates VBZ O
changes NNS O
in IN O
postvaccination NN O
allergy NN O
to TO O
BCG. NNP O

-DOCSTART- X X O

Between IN O
the DT O
RNA NNP O
initiation NN O
site NN O
and CC O
the DT O
coding NN O
region NN O
is VBZ O
a DT O
GC-rich JJ O
hairpin NN O
structure NN O
followed VBN O
by IN O
8 CD O
T NNP O
residues NNS O
that WDT O
looks VBZ O
like IN O
a DT O
rho-independent JJ B-NP
transcription NN I-NP
terminator NN I-NP
. . O

-DOCSTART- X X O

The DT O
term NN O
Kartagener NNP O
syndrome NN O
applies VBZ O
to TO O
this DT O
syndrome NN O
when WRB O
accompanied VBN O
by IN O
infertility NN O
and CC O
dextrocardia NN O
or CC O
situs NN O
inversus NN O
. . O

-DOCSTART- X X O

The DT O
ferric JJ B-NP
uptake NN I-NP
regulation NN I-NP
( -LRB- O
fur NN B-NP
) -RRB- O
gene NN O
product NN O
participates NNS O
in IN O
regulating JJ O
expression NN O
of IN O
the DT O
manganese JJ O
- : O
and CC O
iron-containing NN O
superoxide NN B-NP
dismutase NN I-NP
genes NNS I-NP
of IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
. . O

-DOCSTART- X X O

On IN O
average JJ O
these DT O
maximum JJ O
potency NN O
estimates NNS O
were VBD O
within IN O
one CD O
order NN O
of IN O
magnitude NN O
of IN O
the DT O
inverse NN O
maximum NN O
dose NN O
tested VBN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
CL100 PRP B-NP
suppresses VBZ O
the DT O
[val12] JJ O
ras-induced JJ B-NP
activation NN O
of IN O
MAP NNP B-NP
kinase NN I-NP
in IN O
a DT O
cell-free JJ O
system NN O
from IN O
Xenopus NNP O
oocytes NNS O
. . O

-DOCSTART- X X O

Static NNP O
and CC O
dynamic JJ O
MRI NNP O
of IN O
the DT O
normal JJ O
and CC O
pathological JJ O
female JJ O
pelvic JJ O
floor NN O

-DOCSTART- X X O

Mutation NN O
of IN O
K14 NNP O
in IN O
H3 NNP B-NP
, , O
which WDT O
serves VBZ O
as IN O
the DT O
major JJ O
target NN O
of IN O
recombinant JJ B-NP
Gcn5p JJ I-NP
acetylation NN O
in IN O
vitro NN O
, , O
confers VBZ O
a DT O
strong JJ O
, , O
synthetic JJ O
growth NN O
defect NN O
in IN O
gcn5 CD B-NP
cells NNS O
. . O

-DOCSTART- X X O

Medical JJ O
management NN O
of IN O
early-stage JJ O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

Upon IN O
incubation NN O
of IN O
the DT O
most RBS O
highly RB O
purified VBN O
fractions NNS O
with IN O
Mn-ATP NNP O
or CC O
Mg-ATP NNP O
, , O
p40 NN B-NP
was VBD O
the DT O
only JJ O
protein NN O
phosphorylated VBN O
on IN O
tyrosine NN O
. . O

-DOCSTART- X X O

CLINICAL NNP O
FEATURES NNP O
: : O
This DT O
30-yr-old JJ O
gravida NN O
V NNP O
para NN O
0 CD O
woman NN O
presented VBN O
to TO O
the DT O
anaesthesia NN O
consultation NN O
clinic NN O
at IN O
37-wk JJ O
gestation NN O
to TO O
discuss VB O
pain NN O
relief NN O
options NNS O
for IN O
labour NN O
and CC O
delivery NN O
. . O

-DOCSTART- X X O

Judge NNP O
Christian NNP O
Byk NNP O
renders VBZ O
service NN O
to TO O
the DT O
Steering NNP O
Committee NNP O
on IN O
Bioethics NNP O
of IN O
the DT O
Council NNP O
of IN O
Europe NNP O
( -LRB- O
CDBI NN O
) -RRB- O
by IN O
proposing VBG O
a DT O
draft NN O
of IN O
the DT O
protocol NN O
destined VBN O
to TO O
fill VB O
in IN O
a DT O
gap NN O
in IN O
international JJ O
law NN O
on IN O
the DT O
status NN O
of IN O
the DT O
human JJ O
embryo NN O
. . O

-DOCSTART- X X O

The DT O
human JJ O
protein NN O
is VBZ O
encoded VBN O
by IN O
a DT O
900-base JJ O
pair-long JJ O
mRNA NN O
that WDT O
is VBZ O
expressed VBN O
in IN O
the DT O
glandular JJ O
epithelial NN O
cells NNS O
of IN O
the DT O
endometrium NN O
in IN O
a DT O
cyclic JJ O
manner NN O
; : O
in IN O
addition NN O
, , O
it PRP O
is VBZ O
found VBN O
in IN O
the DT O
mucosal NN O
epithelial NN O
cells NNS O
of IN O
the DT O
fallopian JJ O
tubes NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
a DT O
0.25 CD O
mg JJ O
dose NN O
of IN O
triazolam NN O
does VBZ O
not RB O
effectively RB O
counteract VB O
a DT O
posture-induced JJ O
sleep NN O
disturbance NN O
, , O
but CC O
induces VBZ O
changes NNS O
in IN O
the DT O
EEG NNP O
spectra NN O
which WDT O
are VBP O
typical JJ O
for IN O
benzodiazepine NN B-NP
receptor NN I-NP
agonists NNS O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
of IN O
liver NN O
, , O
muscle NN O
, , O
fat JJ O
, , O
and CC O
pituitary JJ O
RNA NNP O
from IN O
normal JJ O
( -LRB- O
DwDw NN O
) -RRB- O
chickens NNS O
shows VBZ O
a DT O
major JJ O
transcript NN O
of IN O
4.3 CD O
kilobases NNS O
(kb NN O
) -RRB- O
and CC O
three CD O
minor JJ O
transcripts NNS O
( -LRB- O
0.8 CD O
, , O
1.7 CD O
, , O
and CC O
3.2 CD O
kb NN O
) -RRB- O
, , O
which WDT O
correspond VBP O
to TO O
the DT O
cGHR. NN B-NP

-DOCSTART- X X O

The DT O
procedure NN O
was VBD O
technically RB O
successful JJ O
in IN O
12 CD O
of IN O
14 CD O
(86 CD O
% NN O
) -RRB- O
stenoses VBZ O
in IN O
the DT O
fibromuscular JJ O
dysplasia NN O
subgroup NN O
but CC O
in IN O
only RB O
one CD O
of IN O
five CD O
( -LRB- O
20 CD O
% NN O
) -RRB- O
lesions NNS O
in IN O
the DT O
neurofibromatosis NN O
subgroup NN O
. . O

-DOCSTART- X X O

Amplitude NNP O
of IN O
late JJ O
surface NN O
( -LRB- O
P2 NNP O
and CC O
N2 NNP O
) -RRB- O
and CC O
depth NN O
( -LRB- O
B NNP O
and CC O
C NNP O
) -RRB- O
components NNS O
significantly RB O
decreased VBD O
when WRB O
patients NNS O
shifted VBD O
from IN O
SWS NNP O
IV NNP O
to TO O
PS NNP O
and CC O
increased VBN O
from IN O
PS NNP O
to TO O
W2 NNP O
. . O

-DOCSTART- X X O

We PRP O
then RB O
supplemented VBD O
these DT O
spliceosomes NNS O
with IN O
purified JJ O
proteins NNS O
or CC O
yeast NN O
extract VB O
fractions NNS O
as IN O
a DT O
functional JJ O
assay NN O
for IN O
second-step JJ O
splicing NN O
factors NNS O
. . O

-DOCSTART- X X O

We PRP O
discuss VBP O
the DT O
possibility NN O
that IN O
DNA-protein NNP O
interactions NNS O
at IN O
homologous JJ O
nucleotide JJ O
sequences NNS O
like IN O
those DT O
identified VBN O
in IN O
PII NNP O
are VBP O
part NN O
of IN O
a DT O
regulatory JJ O
gene NN O
cascade NN O
that IN O
participates NNS O
in IN O
timing VBG O
fla NN B-NP
gene NN I-NP
expression NN O
in IN O
the DT O
C. NNP O
crescentus NN O
cell NN O
cycle NN O
. . O

-DOCSTART- X X O

Nramp2 PRP B-NP
contains VBZ O
a DT O
classical JJ O
iron NN O
responsive JJ O
element NN O
in IN O
the DT O
3' JJ O
untranslated JJ O
region NN O
that IN O
confers NNS O
iron NN O
dependent JJ O
mRNA NNS O
stabilization NN O
. . O

-DOCSTART- X X O

When WRB O
a DT O
longer JJR O
-714 NN O
to TO O
+78 CD O
fragment NN O
of IN O
the DT O
PBGD NNP B-NP
promoter NN I-NP
is VBZ O
used VBN O
, , O
the DT O
-70 JJ O
GATA NNP O
mutant NN O
still RB O
displays VBZ O
erythroid-specific JJ O
activity NN O
and CC O
is VBZ O
cis-activated JJ O
by IN O
the DT O
5'HS-2 JJ B-NP
enhancer NN I-NP
, , O
while IN O
the DT O
-100 CD O
CCACC NNP O
mutant NN O
is VBZ O
completely RB O
inactive JJ O
in IN O
the DT O
absence NN O
or CC O
in IN O
the DT O
presence NN O
of IN O
the DT O
5'HS-2 JJ B-NP
enhancer NN I-NP
. . O

-DOCSTART- X X O

The DT O
Robert NNP O
Wood NNP O
Johnson NNP O
Foundation NNP O
: : O
billion CD O
dollar NN O
force NN O
for IN O
health-care NN O
change NN O
. . O

-DOCSTART- X X O

Constant NNP O
slowing VBG O
of IN O
median JJ O
MNCV NNP O
and CC O
SNCV NNP O
and CC O
ulnar JJ O
SNCV NN O
without IN O
changes NNS O
in IN O
morphology NN O
, , O
amplitude NN O
and CC O
duration NN O
of IN O
MAP NNP O
and CC O
SAP NNP O
have VBP O
been VBN O
observed VBN O
in IN O
92 CD O
patients NNS O
, , O
with IN O
persistent JJ O
abnormalities NNS O
in IN O
64 CD O
cases NNS O
after IN O
six CD O
months NNS O
. . O

-DOCSTART- X X O

Studies NNS O
with IN O
and CC O
without IN O
attenuating VBG O
media NNS O
were VBD O
performed VBN O
, , O
and CC O
myocardium-to-defect JJ O
count NN O
ratios NNS O
and CC O
defect VBD O
sizes NNS O
from IN O
dual-isotope JJ O
SPECT JJ O
images NNS O
were VBD O
compared VBN O
to TO O
myocardium-to-defect JJ O
count NN O
ratios NNS O
and CC O
defect VBD O
sizes NNS O
from IN O
single-isotope NN O
( -LRB- O
201Tl JJ O
and CC O
99mTc JJ O
) -RRB- O
SPECT JJ O
images NNS O
. . O

-DOCSTART- X X O

The DT O
N1-P2 JJ O
amplitudes NNS O
of IN O
the DT O
AEP NNP O
decreased VBD O
with IN O
increasing VBG O
strength NN O
of IN O
muscular JJ O
innervation NN O
. . O

-DOCSTART- X X O

Measurements NNS O
in IN O
rats NNS O
given VBN O
a DT O
dose NN O
of IN O
propranolol NN O
that WDT O
partially RB O
inhibited VBD O
the DT O
NA-induced JJ O
increase NN O
in IN O
Q NNP O
to TO O
IBAT NNP O
indicated VBD O
that IN O
the DT O
decline NN O
in IN O
ENAIBAT NNP O
was VBD O
attributable JJ O
primarily RB O
to TO O
the DT O
increase NN O
in IN O
Q NNP O
rather RB O
than IN O
to TO O
increasing VBG O
saturation NN O
of IN O
uptake NN O
mechanisms NNS O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
NUT1 NNP B-NP
and CC O
regulation NN O
of IN O
nitrogen NN O
metabolism NN O
in IN O
the DT O
disease NN O
process NN O
was VBD O
evaluated VBN O
by IN O
pathogenicity NN O
assays IN O
. . O

-DOCSTART- X X O

This DT O
study NN O
tests VBZ O
the DT O
hypothesis NN O
that IN O
O2 NNP O
is VBZ O
a DT O
critical JJ O
component NN O
in IN O
myocardial JJ O
protection NN O
afforded VBN O
by IN O
BCP. NNP O

-DOCSTART- X X O

An DT O
ICU NNP O
length NN O
of IN O
stay NN O
shorter JJR O
than IN O
24 CD O
h NN O
was VBD O
not RB O
related VBN O
to TO O
the DT O
frequency NN O
of IN O
group NN O
C NNP O
errors NNS O
. . O

-DOCSTART- X X O

Injection NN O
of IN O
horseradish NN B-NP
peroxidase NN I-NP
( -LRB- O
HRP NNP B-NP
) -RRB- O
into IN O
the DT O
cerebellar NN O
flocculus NN O
of IN O
the DT O
rat NN O
was VBD O
employed VBN O
to TO O
identify VB O
neurons NNS O
in IN O
the DT O
abducens NNS O
nucleus JJ O
that IN O
project NN O
to TO O
the DT O
flocculus NN O
. . O

-DOCSTART- X X O

The DT O
enzyme NN O
encoded VBN O
by IN O
the DT O
cloned JJ O
fragment NN O
is VBZ O
equally RB O
active JJ O
on IN O
pyruvate JJ O
and CC O
hydroxypyruvate JJ O
, , O
indicating VBG O
that IN O
the DT O
enzyme NN O
has VBZ O
both DT O
D-lactate NNP B-NP
and CC I-NP
D-glycerate JJ I-NP
dehydrogenase NN I-NP
activities NNS O
. . O

-DOCSTART- X X O

In IN O
a DT O
subsequent JJ O
phase-II JJ O
clinical JJ O
trial NN O
safety NN O
and CC O
efficacy NN O
of IN O
transrectal NN O
HIFU NNP O
as IN O
a DT O
novel NN O
minimally , O
invasive JJ O
treatment NN O
modality NN O
for IN O
patients NNS O
with IN O
symptomatic JJ O
benign JJ O
prostatic JJ O
hyperplasia NN O
( -LRB- O
BPH NNP O
; : O
n RB O
= SYM O
102 CD O
) -RRB- O
was VBD O
determined VBN O
. . O

-DOCSTART- X X O

Taking VBG O
into IN O
account NN O
certain JJ O
well RB O
defined VBN O
conditions NNS O
( -LRB- O
frequent JJ O
feedings NNS O
, , O
no DT O
supplementary NN O
feeding VBG O
before IN O
4-6 CD O
months NNS O
, , O
method NN O
only RB O
to TO O
be VB O
used VBN O
in IN O
the DT O
absence NN O
of IN O
menstruation NN O
) -RRB- O
, , O
LAM NNP O
can MD O
be VB O
relied VBN O
on IN O
for IN O
contraceptive JJ O
protection NN O
for IN O
up RB O
to TO O
1 CD O
year NN O
post NN O
partum NN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
ZF-HD NNP B-NP
class NN O
of IN O
homeodomain JJ B-NP
proteins NNS I-NP
may MD O
be VB O
involved VBN O
in IN O
the DT O
establishment NN O
of IN O
the DT O
characteristic JJ O
expression NN O
pattern NN O
of IN O
the DT O
C4 NNP B-NP
PEPCase NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Although IN O
the DT O
only JJ O
authoritative JJ O
way NN O
to TO O
determine VB O
the DT O
effect NN O
of IN O
diet NN O
on IN O
urinary JJ O
pH NN O
is VBZ O
a DT O
feeding VBG O
trial NN O
, , O
there EX O
is VBZ O
no DT O
universally RB O
accepted VBN O
protocol NN O
for IN O
measuring VBG O
urinary JJ O
pH. . O

-DOCSTART- X X O

In IN O
stage NN O
I PRP O
, , O
histochemistry NN O
for IN O
copper NN O
was VBD O
positive JJ O
in IN O
11 CD O
out IN O
of IN O
21 CD O
cases NNS O
: : O
6 CD O
cases NNS O
were VBD O
T+ NNP O
; : O
1 CD O
case NN O
R+ NNP O
and CC O
2 CD O
cases NNS O
O+ VBP O
; : O
2 CD O
cases NNS O
were VBD O
T+ NNP O
, , O
R+ NNP O
, , O
O+ NNP O
. . O

-DOCSTART- X X O

A DT O
24-year-old JJ O
pregnant JJ O
woman NN O
started VBD O
to TO O
have VB O
hyperemesis NN O
gravidarum NN O
6 CD O
weeks NNS O
before IN O
admission NN O
. . O

-DOCSTART- X X O

Biopsy NNP O
of IN O
the DT O
lesion NN O
revealed VBD O
granulomatous JJ O
inflammation NN O
and CC O
numerous JJ O
septate NN O
hyphae NNS O
. . O

-DOCSTART- X X O

Mating JJ O
response NN O
, , O
ovulation NN O
rate NN O
, , O
follicle NN O
and CC O
corpus JJ O
luteum NN O
size NN O
, , O
gestation NN O
length NN O
, , O
pregnancy NN O
rate NN O
, , O
lambing VBG O
rate NN O
, , O
and CC O
lamb NN O
birth NN O
weight NN O
were VBD O
recorded VBN O
. . O

-DOCSTART- X X O

A DT O
biopsy JJ O
specimen NNS O
taken VBN O
from IN O
the DT O
frontal JJ O
branch NN O
of IN O
the DT O
right JJ O
superficial JJ O
artery NN O
revealed VBD O
segmental JJ O
intimal NN O
thickening VBG O
consistent JJ O
with IN O
intimal JJ O
fibroplasia NN O
type NN O
FMD NN O
upon IN O
histological JJ O
examination NN O
. . O

-DOCSTART- X X O

Reduced VBN O
risk NN O
of IN O
upper JJ O
gastrointestinal JJ O
ulcer NN O
complications NNS O
with IN O
celecoxib NN O
, , O
a DT O
novel NN O
COX-2 NNP B-NP
inhibitor VBD O
. . O

-DOCSTART- X X O

The DT O
DW NNP O
directions NNS O
uniformly RB O
sampled VBN O
the DT O
diffusion NN O
ellipsoid JJ O
surface NN O
. . O

-DOCSTART- X X O

Recent JJ O
, , O
highly RB O
visible JJ O
reviews NNS O
on IN O
the DT O
subject NN O
have VBP O
clearly RB O
pointed VBN O
out RP O
that IN O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
cellular JJ O
mechanisms NNS O
through IN O
which WDT O
inhaled VBN O
asbestos NN O
fibers NNS O
cause VBP O
the DT O
well NN O
known VBN O
, , O
debilitating VBG O
lung NN O
disease NN O
- : O
asbestosis NN O
( -LRB- O
i FW O
.e FW O
. . O
interstitial JJ O
pulmonary JJ O
fibrosis NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
Rep78 JJ B-NP
protein NN I-NP
of IN O
adeno-associated JJ O
virus NN O
( -LRB- O
AAV NNP O
) -RRB- O
contains VBZ O
amino JJ O
acid NN O
sequence NN O
motifs NNS O
common JJ O
to TO O
rolling-circle NN B-NP
replication NN I-NP
(RCR NN I-NP
) -RRB- I-NP
initiator NN I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

METHODS NNP O
: : O
Two CD O
patients NNS O
developed VBD O
cervical JJ O
myelopathy NN O
or CC O
radiculopathy NN O
after IN O
spinal JJ O
manipulation NN O
therapy NN O
, , O
and CC O
magnetic JJ O
resonance NN O
imaging NN O
showed VBD O
herniated PRP O
cervical JJ O
discs NNS O
at IN O
C4-C5 NNP O
and CC O
C6-C7 NNP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Isolates NNP O
of IN O
B. NNP O
burgdorferi NN O
from IN O
humans NNS O
, , O
rodents NNS O
, , O
and CC O
I. NN O
dammini NNS O
are VBP O
usually RB O
indistinguishable JJ O
, , O
but CC O
strains NNS O
of IN O
B. NNP O
burgdorferi NN O
with IN O
different JJ O
major JJ O
proteins NNS O
have VBP O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

In IN O
a DT O
pilot NN O
study NN O
in IN O
which WDT O
two CD O
dogs NNS O
were VBD O
given VBN O
parenteral JJ O
rifampin NN O
before IN O
and CC O
after IN O
operation NN O
and CC O
grafts NNS O
were VBD O
preclotted VBN O
with IN O
blood NN O
that WDT O
contained VBD O
rifampin NN O
, , O
it PRP O
was VBD O
suggested VBN O
that IN O
there EX O
was VBD O
a DT O
slight JJ O
increase NN O
in IN O
inhibition NN O
at IN O
24 CD O
hours NNS O
(93 VBP O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
mechanisms NNS O
and CC O
the DT O
signaling VBG O
pathways NNS O
involved VBN O
, , O
IGF-1R DT B-NP
promoter NN I-NP
reporter NN I-NP
constructs NNS I-NP
were VBD O
transiently RB O
transfected VBN O
in IN O
CHO-AT1 JJ O
cells NNS O
that WDT O
overexpress NNP O
angiotensin IN B-NP
AT1 NNP I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Gel NNP O
shift NN O
analysis NN O
of IN O
protein NN O
binding NN O
from IN O
nuclear JJ O
extracts NNS O
to TO O
these DT O
caveolin NN B-NP
promoter NN I-NP
DNA NN I-NP
sequences NNS I-NP
, , O
together RB O
with IN O
DNase NNP B-NP
I PRP I-NP
footprinting VBG O
, , O
confirmed VBD O
nucleoprotein JJ O
binding NN O
to TO O
the DT O
SRE-like JJ O
elements NNS O
as IN O
part NN O
of IN O
the DT O
transcriptional JJ O
response NN O
to TO O
LDL-FC. NNP B-NP

-DOCSTART- X X O

Early RB O
attempts VBZ O
for IN O
modifying VBG O
growth NN O
functions NNS O
to TO O
annual JJ O
variations NNS O
dating VBG O
back RB O
up RB O
to TO O
2 CD O
decades NNS O
are VBP O
recalled VBN O
together RB O
with IN O
examples NNS O
for IN O
their PRP$ O
application NN O
showing VBG O
rather RB O
different JJ O
degrees NNS O
of IN O
approximation NN O
. . O

-DOCSTART- X X O

Indications NNS O
for IN O
therapy NN O
using VBG O
MAO NNP B-NP
inhibitors NNS O

-DOCSTART- X X O

Through IN O
effective JJ O
use NN O
of IN O
laboratory NN O
testing NN O
database NN O
, , O
it PRP O
will MD O
be VB O
possible JJ O
to TO O
shift VB O
away RB O
our PRP$ O
vague JJ O
management NN O
of IN O
pre-analytic JJ O
phase NN O
of IN O
quality NN O
control NN O
so RB O
far RB O
to TO O
its PRP$ O
established VBN O
system NN O
based VBN O
on IN O
objective JJ O
evaluation NN O
. . O

-DOCSTART- X X O

The DT O
melanoma NN B-NP
growth NN I-NP
stimulatory NN I-NP
activity/growth-regulated JJ I-NP
protein NN I-NP
, , O
CXCL1 NNP B-NP
, , O
is VBZ O
constitutively RB O
expressed VBN O
at IN O
high JJ O
levels NNS O
during IN O
inflammation NN O
and CC O
progression NN O
of IN O
melanocytes NNS O
into IN O
malignant JJ O
melanoma NN O
. . O

-DOCSTART- X X O

The DT O
activated JJ O
glucocorticoid NN B-NP
receptor NN I-NP
forms VBZ O
a DT O
complex JJ O
with IN O
Stat5 NNP B-NP
and CC O
enhances VBZ O
Stat5-mediated JJ B-NP
transcriptional JJ O
induction NN O
. . O

-DOCSTART- X X O

The DT O
median JJ O
levels NNS O
of IN O
t-PA DT B-NP
Ag NNP I-NP
and CC O
PAI NNP B-NP
in IN O
plasma NN O
were VBD O
respectively RB O
10.7 CD O
ng/ml NN O
( -LRB- O
interquartile JJ O
range NN O
8.6 CD O
ng/ml NN O
) -RRB- O
and CC O
15.7 CD O
IU/ml NN O
( -LRB- O
interquartile JJ O
range NN O
12.2 CD O
IU/ml NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
rice NN O
gene NN O
consists VBZ O
of IN O
four CD O
exons NNS O
. . O

-DOCSTART- X X O

One CD O
of IN O
the DT O
ORFs NNP O
in IN O
the DT O
Methanococcus NNP O
jannaschii NN O
genome NN O
possesses VBZ O
high JJ O
similarity NN O
to TO O
the DT O
M. NNP B-NP
aeolicus NN I-NP
ilvB NN I-NP
, , O
indicating VBG O
that IN O
it PRP O
is VBZ O
an DT O
authentic JJ O
AHAS. . B-NP

-DOCSTART- X X O

It PRP O
differed VBD O
from IN O
cued JJ O
recall NN O
only RB O
in IN O
the DT O
instructions NNS O
, , O
which WDT O
directed VBD O
subjects NNS O
away RB O
from IN O
the DT O
memory NN O
aspects NNS O
of IN O
the DT O
test NN O
and CC O
asked VBD O
them PRP O
to TO O
complete VB O
each DT O
three-letter JJ O
cue NN O
with IN O
the DT O
first JJ O
word NN O
that WDT O
came VBD O
to TO O
mind VB O
. . O

-DOCSTART- X X O

Samarium-153 JJ O
for IN O
intravascular JJ O
irradiation NN O
therapy NN O
with IN O
liquid-filled JJ O
balloons NNS O
to TO O
prevent VB O
restenosis NN O
: : O
acute JJ O
and CC O
long-term JJ O
results NNS O
in IN O
a DT O
hypercholesterolemic JJ O
rabbit NN O
restenosis NN O
model NN O
. . O

-DOCSTART- X X O

We PRP O
determined VBD O
that IN O
Hop( NNP B-NP
T42 NNP I-NP
) -RRB- I-NP
contains VBZ O
a DT O
glutamic JJ O
acid-to-lysine NN O
substitution NN O
at IN O
amino DT O
acid NN O
residue NN O
695 CD O
( -LRB- O
E695K) NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
suggested VBN O
that IN O
on IN O
presentation NN O
of IN O
tail NN O
tip NN O
necrosis NN O
in IN O
kittens NNS O
a DT O
diagnosis NN O
of IN O
neonatal JJ O
isoerythrolysis NN O
or CC O
isoagglutination NN O
should MD O
be VB O
considered VBN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
cefazolin NN O
, , O
given VBN O
into IN O
the DT O
III NNP O
cerebral NN O
ventricle NN O
at IN O
different JJ O
doses NNS O
were VBD O
studied VBN O
on IN O
GABA NNP O
content NN O
, , O
GAD NNP O
and CC O
GABA-T NNP O
in IN O
the DT O
brain-stem NN O
of IN O
young JJ O
chickens NNS O
( -LRB- O
Gallus JJ O
domesticus NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
amino-terminal JJ B-NP
gag-encoded JJ I-NP
region NN I-NP
of IN O
P140gag-fps NNP B-NP
contains VBZ O
a DT O
phosphotyrosine NN O
residue NN O
in IN O
addition NN O
to TO O
normal JJ O
gag NN B-NP
phosphorylation NN O
sites NNS O
. . O

-DOCSTART- X X O

The DT O
subjects NNS O
' POS O
lungs NNS O
were VBD O
ventilated VBN O
with IN O
N2O NNP O
in IN O
O2 NNP O
( -LRB- O
FIO2 NN O
0.3 CD O
) -RRB- O
to TO O
the DT O
end-tidal JJ O
CO2 NNP O
present NN O
before IN O
anesthesia NN O
, , O
and CC O
then RB O
CBF NNP O
was VBD O
measured VBN O
using VBG O
intravenous JJ O
133Xe CD O
and CC O
ten CD O
scintillation NN O
counters NNS O
, , O
five CD O
over IN O
each DT O
cerebral JJ O
hemisphere NN O
. . O

-DOCSTART- X X O

Six CD O
patients NNS O
( -LRB- O
24 CD O
% NN O
) -RRB- O
developed VBN O
sepsis NN O
and CC O
only RB O
one CD O
survived VBD O
. . O

-DOCSTART- X X O

Diabetic JJ O
osteopenia NN O
, , O
a DT O
known VBN O
chronic NN O
complication NN O
of IN O
diabetes NN O
, , O
has VBZ O
been VBN O
demonstrated VBN O
with IN O
alterations NNS O
in IN O
the DT O
calcium-vitamin NN O
D NNP O
endocrine NN O
system NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
reconstituted JJ O
system NN O
, , O
RNAP NNP B-NP
IIA NNP I-NP
, , O
but CC O
not RB O
RNAP NNP B-NP
IIB NNP I-NP
, , O
can MD O
transcribe VB O
from IN O
the DT O
DHFR NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
data NNS O
suggest VBP O
an DT O
immunological JJ O
non-responsiveness NN O
to TO O
enterotoxin VB B-NP
A DT I-NP
in IN O
a DT O
considerable JJ O
portion NN O
of IN O
the DT O
patients NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
authors NNS O
found VBD O
one CD O
an3 NN B-NP
allele NN I-NP
( -LRB- O
an3-W138A DT B-NP
) -RRB- O
in IN O
which WDT O
a DT O
dTph1 JJ B-NP
element NN I-NP
had VBD O
inserted VBN O
30 CD O
bp NN O
upstream RB O
the DT O
translation NN O
start NN O
, , O
without IN O
inactivating VBG O
the DT O
gene NN O
. . O

-DOCSTART- X X O

The DT O
right JJ O
cornea NN O
of IN O
rats NNS O
was VBD O
cauterized VBN O
by IN O
drops NNS O
of IN O
1.5 CD O
N NNP O
HC1 NN O
over IN O
30 CD O
s PRP O
; : O
the DT O
left NN O
one CD O
served VBD O
as IN O
a DT O
control NN O
. . O

-DOCSTART- X X O

Secretion NNP O
of IN O
cuticle NN O
over IN O
and CC O
between IN O
the DT O
domed JJ O
apical JJ O
surfaces NNS O
of IN O
these DT O
cells NNS O
leads VBZ O
to TO O
a DT O
honeycomb-like JJ O
structure NN O
and CC O
gives VBZ O
the DT O
superficial JJ O
wart-like JJ O
phenotype NN O
of IN O
mitotic JJ O
clones NNS O
on IN O
the DT O
adult NN O
. . O

-DOCSTART- X X O

The DT O
sequences NNS O
of IN O
two CD O
previously RB O
known VBN O
tail NN B-NP
genes NNS I-NP
, , O
R NN B-NP
and CC O
S NNP B-NP
, , O
of IN O
the DT O
temperate JJ O
bacteriophage NN O
P2 NN O
and CC O
the DT O
sequence NN O
of IN O
an DT O
additional JJ O
open JJ O
reading NN O
frame NN O
(orf-30 WDT O
) -RRB- O
located VBN O
between IN O
S NNP B-NP
and CC O
V NNP B-NP
, , O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

After IN O
a DT O
shift NN O
to TO O
37 CD O
degrees NNS O
C NN O
, , O
the DT O
mutant JJ O
Rat7-1p/Nup159-1p NNP B-NP
is VBZ O
lost VBN O
from IN O
the DT O
nuclear JJ O
rim NN O
of IN O
rat7-1 NN O
cells NNS O
and CC O
NPCs NNS O
, , O
which WDT O
are VBP O
clustered VBN O
together RB O
in IN O
these DT O
cells NNS O
grown VBN O
under IN O
permissive JJ O
conditions NNS O
become VBP O
substantially RB O
less JJR O
clustered VBN O
. . O

-DOCSTART- X X O

This DT O
paper NN O
describes VBZ O
a DT O
course NN O
of IN O
therapy NN O
with IN O
an DT O
agoraphobic JJ O
female JJ O
patient NN O
. . O

-DOCSTART- X X O

The DT O
activation NN O
of IN O
NF-kappaB-dependent JJ B-NP
reporter NN O
gene NN O
transcription NN O
by IN O
E1A NNP B-NP
was VBD O
potently RB O
suppressed VBN O
upon IN O
coexpression NN O
of IN O
the DT O
E1B NNP B-NP
19-kDa JJ I-NP
protein NN I-NP
( -LRB- I-NP
19K) CD I-NP
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
transcription NN O
of IN O
both DT O
SCD1 NNP B-NP
and CC O
SCD2 NNP B-NP
genes NNS I-NP
is VBZ O
responsive JJ O
to TO O
cellular JJ O
sterol NN O
levels NNS O
and CC O
to TO O
the DT O
levels NNS O
of IN O
nuclear JJ O
SREBP/ADD1 NNP B-NP
and CC O
that DT O
transcriptional JJ O
induction NN O
requires VBZ O
three CD O
spatially RB O
conserved VBN O
cis NNPS O
elements NNS O
, , O
that DT O
bind NN O
SREBP NNP B-NP
and CC O
NF-Y NNP B-NP
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Recent JJ O
iterative JJ O
methods NNS O
for IN O
sequence NN O
alignment NN O
have VBP O
indicated VBN O
that IN O
the DT O
380 CD O
kDa JJ O
motor NN O
unit NN O
of IN O
dynein NN B-NP
belongs VBZ O
to TO O
the DT O
AAA NNP B-NP
class NN I-NP
of IN O
chaperone-like JJ B-NP
ATPases NNS I-NP
. . O

-DOCSTART- X X O

The DT O
vertebrate JJ B-NP
transcription NN I-NP
factors NNS I-NP
TCF NNP I-NP
( -LRB- O
T NNP B-NP
cell NN I-NP
factor NN I-NP
) -RRB- O
and CC O
LEF NNP B-NP
( -LRB- O
lymphocyte NN B-NP
enhancer NN I-NP
binding JJ I-NP
factor NN I-NP
) -RRB- O
interact NN O
with IN O
beta-catenin JJ B-NP
and CC O
are VBP O
hypothesized VBN O
to TO O
mediate VB O
Wingless/Wnt NNP B-NP
signaling NN O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Activating NN B-NP
protein-1 NN I-NP
( -LRB- O
AP-1 NN B-NP
) -RRB- O
and CC O
Tat-induced NNP B-NP
transcription NN O
were VBD O
assessed VBN O
using VBG O
Jun NNP B-NP
and CC O
hybrid JJ O
Tat/Jun-expression NN B-NP
plasmids NNS O
and CC O
reporter NN O
gene NN O
constructs NNS O
which WDT O
contained VBD O
AP-1 JJ B-NP
binding NN I-NP
sites NNS I-NP
upstream RB O
of IN O
the DT O
rat NN B-NP
prolactin NN I-NP
TATAA NNP I-NP
element NN I-NP
or CC O
an DT O
HIV-1 NN B-NP
LTR NN I-NP
construct VB I-NP
in IN O
which WDT O
AP-1 JJ B-NP
binding NN I-NP
sites NNS I-NP
replaced VBD O
the DT O
TAR JJ O
element NN O
. . O

-DOCSTART- X X O

According VBG O
to TO O
the DT O
penetration NN O
of IN O
Ca-45 NNP O
, , O
the DT O
microleakage NN O
level NN O
was VBD O
scored VBN O
for IN O
each DT O
section NN O
. . O

-DOCSTART- X X O

KatA NNP B-NP
, , O
AhpCF NNP B-NP
, , O
heme NN O
biosynthesis NN O
enzymes NNS O
, , O
and CC O
MrgA NNP B-NP
are VBP O
also RB O
induced VBN O
upon IN O
entry NN O
into IN O
stationary JJ O
phase NN O
under IN O
conditions NNS O
of IN O
iron NN O
and CC O
manganese JJ O
limitation NN O
. . O

-DOCSTART- X X O

Healthy JJ O
preterm JJ O
infants NNS O
of IN O
gestational JJ O
age NN O
26-29 CD O
weeks NNS O
showed VBD O
a DT O
'mature JJ O
' '' O
pattern NN O
of IN O
permeability NN O
at IN O
birth NN O
, , O
followed VBN O
by IN O
a DT O
temporary JJ O
period NN O
of IN O
enhanced JJ O
permeability NN O
after IN O
3-4 CD O
weeks NNS O
of IN O
life NN O
. . O

-DOCSTART- X X O

Reproduction NN O
and CC O
maternal JJ O
response NN O
of IN O
the DT O
rat NN O
when WRB O
thiamine NN O
intake NN O
is VBZ O
limited VBN O
. . O

-DOCSTART- X X O

The DT O
formation NN O
of IN O
tumorlike JJ O
lesions NNS O
in IN O
the DT O
cockroach NN O
leucophaea VBD O
maderae VBN O
after IN O
anal NN O
blockage NN O
. . O

-DOCSTART- X X O

Promoter NNP O
, , O
spliced VBD O
leader NN O
, , O
and CC O
coding VBG O
sequence NN O
for IN O
BICP4 NNP B-NP
, , O
the DT O
largest JJS O
of IN O
the DT O
immediate-early JJ B-NP
proteins NNS I-NP
of IN I-NP
bovine JJ I-NP
herpesvirus NN I-NP
1 CD I-NP
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
prolonged JJ O
inhibition NN O
of IN O
labour NN O
pains NNS O
with IN O
Th DT O
1165a CD O
and CC O
Isoptin NNP O
on IN O
the DT O
heart NN O
, , O
circulation NN O
, , O
organ- NNS O
and CC O
metabolic JJ O
parameters NNS O
of IN O
the DT O
mother NN O

-DOCSTART- X X O

Further JJ O
studies NNS O
are VBP O
warranted VBN O
to TO O
determine VB O
whether IN O
these DT O
findings NNS O
are VBP O
idiosyncratic JJ O
, , O
coincidental JJ O
, , O
or CC O
a DT O
more JJR O
general JJ O
phenomenon NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
In IN O
men NNS O
, , O
weight/height2 NN O
met VBD O
the DT O
criteria NNS O
for IN O
a DT O
satisfactory JJ O
index NN O
in IN O
that IN O
there EX O
was VBD O
a DT O
very RB O
strong JJ O
correlation NN O
with IN O
triceps NNS O
skinfold NN O
, , O
and CC O
a DT O
negligible JJ O
correlation NN O
with IN O
height NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
an DT O
osteocalcin JJ B-NP
gene NN I-NP
promoter NN I-NP
sequence NN I-NP
that WDT O
binds VBZ O
AP1 NNP B-NP
. . O

-DOCSTART- X X O

Sexual JJ O
adventurism NN O
, , O
high-risk JJ O
behavior NN O
, , O
and CC O
human JJ O
immunodeficiency NN O
virus-1 NN O
seroconversion NN O
among IN O
the DT O
Chicago NNP O
MACS-CCS NNP O
cohort NN O
, , O
1984 CD O
to TO O
1992 CD O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
important JJ O
to TO O
understand VB O
the DT O
etiology NN O
of IN O
HITT NNP O
because IN O
of IN O
its PRP$ O
devastating VBG O
clinical JJ O
consequences NNS O
. . O

-DOCSTART- X X O

New NNP O
concepts NNS O
of IN O
condyloma NN O
acuminata NN O
in IN O
children NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
lung NN O
edema NN O
on IN O
pulmonary JJ O
vasoactivity NN O
of IN O
furosemide NN O
. . O

-DOCSTART- X X O

Only RB O
the DT O
native JJ O
structure NN O
of IN O
phosphorylated JJ O
ERK NNP B-NP
was VBD O
recognized VBN O
by IN O
VHR NNP B-NP
and CC O
was VBD O
inactivated VBN O
with IN O
a DT O
second-order NN O
rate NN O
constant JJ O
of IN O
40,000 CD O
M-1 NNP O
s-1 NN O
. . O

-DOCSTART- X X O

The DT O
Xenopus NNP B-NP
homeobox NN I-NP
gene NN I-NP
twin JJ I-NP
mediates NNS O
Wnt IN B-NP
induction NN O
of IN O
goosecoid NN B-NP
in IN O
establishment NN O
of IN O
Spemann NNP O
's POS O
organizer NN O
. . O

-DOCSTART- X X O

Bovine NNP O
anaplasmosis NN O
: : O
susceptibility NN O
of IN O
seronegative JJ O
cows NNS O
from IN O
an DT O
infected JJ O
herd NN O
to TO O
experimental JJ O
infection NN O
with IN O
Anaplasma NNP O
marginale NN O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
TGFbeta1 DT B-NP
expression NN O
is VBZ O
upregulated VBN O
in IN O
mouse NN O
keratinocytes NNS O
infected VBN O
with IN O
a DT O
v-ras JJ B-NP
Ha NNP I-NP
retrovirus NN O
, , O
although IN O
the DT O
functional JJ O
significance NN O
of IN O
this DT O
has VBZ O
not RB O
been VBN O
clear JJ O
. . O

-DOCSTART- X X O

As IN O
a DT O
member NN O
of IN O
the DT O
uncoupling JJ B-NP
protein NN I-NP
family NN I-NP
, , O
UCP2 NNP B-NP
is VBZ O
ubiquitously RB O
expressed VBN O
in IN O
rodents NNS O
and CC O
humans NNS O
, , O
implicating VBG O
a DT O
major JJ O
role NN O
in IN O
thermogenesis NN O
. . O

-DOCSTART- X X O

In IN O
situ FW O
localization NN O
of IN O
PCP-A1 JJ B-NP
transcripts NNS I-NP
revealed VBD O
that IN O
they PRP O
accumulate VBP O
specifically RB O
in IN O
pollen NN O
at IN O
the DT O
late JJ O
binucleate/trinucleate NN O
stage NN O
of IN O
development NN O
rather RB O
than IN O
in IN O
the DT O
tapetum NN O
, , O
which WDT O
previously RB O
was VBD O
taken VBN O
to TO O
be VB O
the DT O
principal JJ O
source NN O
of IN O
the DT O
pollen NN O
coat NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Here RB O
, , O
we PRP O
report VBP O
the DT O
identification NN O
of IN O
two CD O
major JJ O
and CC O
novel JJ O
Shc NNP B-NP
tyrosine NN O
phosphorylation NN O
sites NNS O
, , O
Y239 NNP O
and CC O
Y240 CD O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
our PRP$ O
sequence NN O
data NNS O
, , O
ORF2 NNS O
from IN O
most JJS O
isolates NNS O
excluding VBG O
G1 NNP O
encode VBD O
truncated VBN O
49 CD O
aa JJ O
( -LRB- O
pORF2a NN O
) -RRB- O
because IN O
of IN O
an DT O
in-frame JJ O
stop NN O
codon NN O
, , O
although IN O
ORF2s NNP O
from IN O
most RBS O
G1 JJ O
isolates NNS O
encode JJ O
202 CD O
aa JJ O
( -LRB- O
pORF2ab NN O
) -RRB- O
. . O

-DOCSTART- X X O

Fusions NNS O
between IN O
the DT O
GAL NNP B-NP
DNA NNP I-NP
binding NN I-NP
domain NN I-NP
and CC O
full-length JJ B-NP
mSin3 NNS I-NP
were VBD O
also RB O
capable JJ O
of IN O
repression NN O
. . O

-DOCSTART- X X O

The DT O
method NN O
was VBD O
tested VBN O
on IN O
7 CD O
rats NNS O
with IN O
48-hr-old JJ O
myocardial JJ O
infarction NN O
and CC O
4 CD O
sham-operated JJ O
controls NNS O
. . O

-DOCSTART- X X O

Disruption NN O
and CC O
reconstruction NN O
: : O
narrative JJ O
insights NNS O
into IN O
the DT O
experience NN O
of IN O
family NN O
members NNS O
caring VBG O
for IN O
a DT O
relative JJ O
diagnosed NN O
with IN O
serious JJ O
mental JJ O
illness NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
an DT O
increase NN O
in IN O
lactate NN O
concentration NN O
of IN O
the DT O
magnitude NN O
observed VBD O
during IN O
alkali JJ O
therapy NN O
need NN O
not RB O
indicate VB O
a DT O
worsening VBG O
of IN O
the DT O
metabolic JJ O
picture NN O
in IN O
lactic JJ O
acidosis NN O
. . O

-DOCSTART- X X O

A DT O
wound NN O
model NN O
for IN O
decubitus NN O
and CC O
leg NN O
ulcers NNS O
consisting VBG O
of IN O
human JJ O
dermal NN O
fibroblasts NNS O
in IN O
type NN B-NP
I PRP I-NP
collagen RB I-NP
dermal JJ O
"equivalent JJ O
" `` O
matrix FW O
( -LRB- O
DEM) NN O
was VBD O
exposed VBN O
in IN O
vitro NN O
to TO O
electric JJ O
fields NNS O
similar JJ O
to TO O
postulated JJ O
endogenous JJ O
fields NNS O
in IN O
wounds NNS O
. . O

-DOCSTART- X X O

Lastly RB O
, , O
several JJ O
restriction NN O
length NN O
polymorphisms NNS O
were VBD O
identified VBN O
and CC O
mapped VBN O
within IN O
a DT O
1 CD O
kb JJ O
region NN O
located VBN O
immediately RB O
upstream RB O
from IN O
the DT O
JH NNP B-NP
cluster NN I-NP
. . O

-DOCSTART- X X O

Y1 NNP B-NP
, , O
Y2 NNP B-NP
, , O
and CC O
Y4/PP1 NNP B-NP
. . O

-DOCSTART- X X O

A DT O
case NN O
comparison NN O
of IN O
acquired VBN O
immune JJ O
deficiency NN O
syndrome NN O
( -LRB- O
AIDS NNP O
) -RRB- O
in IN O
homosexual JJ O
males NNS O
with IN O
spindle-endothelial JJ O
cell NN O
abnormalities NNS O
and CC O
with IN O
recrudescent JJ O
melioidosis NN O
. . O

-DOCSTART- X X O

The DT O
significance NN O
of IN O
these DT O
changes NNS O
in IN O
relation NN O
to TO O
the DT O
control NN O
of IN O
phosphorus JJ O
balance NN O
in IN O
ruminants NNS O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

UPR NNP O
elements NNS O
present VBP O
in IN O
other JJ O
ER NNP O
chaperone NN O
genes NNS O
, , O
such JJ O
as IN O
yeast NN B-NP
KAR2 IN I-NP
( -LRB- O
BiP) NNP B-NP
, , O
mammalian JJ B-NP
GRP78 CD I-NP
( -LRB- O
BiP) NNP B-NP
, , O
and CC O
GRP94 NNP B-NP
, , O
function NN O
in IN O
an DT O
analogous JJ O
manner NN O
to TO O
that DT O
in IN O
FKB2 NNP B-NP
. . O

-DOCSTART- X X O

Acceptability NNP O
of IN O
home NN O
monitoring NN O
as IN O
an DT O
aid NN O
to TO O
conception NN O
. . O

-DOCSTART- X X O

The DT O
5-HT3 JJ B-NP
antagonist NN O
ondansetron NNP O
reduced VBD O
alcohol NN O
intake NN O
in IN O
both DT O
the DT O
medium NN O
and CC O
high JJ O
alcohol NN O
preferring VBG O
rats NNS O
at IN O
doses NNS O
between IN O
0.01 CD O
and CC O
0.16 CD O
mg/kg NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
mapped VBD O
a DT O
putative JJ O
hnRNP NN B-NP
A1 IN I-NP
binding JJ I-NP
site NN I-NP
in IN O
U5 DT B-NP
RNA NNP I-NP
and CC O
demonstrated VBD O
that IN O
p40CRS NNS B-NP
( -LRB- O
hnRNP JJ B-NP
A1 NN I-NP
) -RRB- O
binding NN O
to TO O
that DT O
site NN O
correlates VBZ O
with IN O
CRS NNP B-NP
function NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
responsible JJ O
for IN O
multiple JJ O
endocrine NN O
neoplasia NN O
type NN O
1 CD O
( -LRB- O
MEN1 NNP B-NP
) -RRB- O
, , O
a DT O
heritable JJ O
predisposition NN O
to TO O
endocrine VB O
tumours NNS O
in IN O
man NN O
, , O
has VBZ O
recently RB O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

trans-activation NN O
of IN O
the DT O
HIV-1 NN B-NP
LTR NN I-NP
by IN O
the DT O
HIV-1 NN B-NP
Tat NNP I-NP
and CC O
HTLV-I JJ B-NP
Tax NNP I-NP
proteins NNS I-NP
is VBZ O
mediated VBN O
by IN O
different JJ O
cis-acting NN O
sequences NNS O
. . O

-DOCSTART- X X O

Using VBG O
green JJ B-NP
fluorescent NN I-NP
protein NN I-NP
fusions NNS O
we PRP O
demonstrate VBP O
that IN O
the DT O
SYT NNP B-NP
, , O
SSX NNP B-NP
and CC O
the DT O
SYT-SSX JJ B-NP
proteins NNS O
are VBP O
nuclear JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
antisense DT B-NP
TGF-beta JJ I-NP
type NN I-NP
II NNP I-NP
receptor NN I-NP
oligodeoxynucleotides NNS I-NP
( -LRB- I-NP
40 CD I-NP
microM NN I-NP
) -RRB- I-NP
resulted VBD O
in IN O
a DT O
58 CD O
% NN O
increase NN O
in IN O
branching NN O
, , O
compared VBN O
to TO O
scrambled VBD O
and CC O
mismatched VBD O
sequence NN O
controls NNS O
, , O
while IN O
TGF-beta NNP B-NP
, , I-NP
type NN I-NP
II NNP I-NP
receptor NN I-NP
mRNA NNS I-NP
and CC O
its PRP$ O
protein NN O
expression NN O
levels NNS O
were VBD O
suppressed VBN O
by IN O
95 CD O
and CC O
84 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

This DT O
action NN O
could MD O
be VB O
antagonized VBN O
by IN O
aminophylline NN O
, , O
a DT O
competitive JJ O
antagonist NN O
on IN O
P1 NNP B-NP
purinoceptors NNS I-NP
. . O

-DOCSTART- X X O

A DT O
definition NN O
of IN O
bias NN O
founded VBN O
on IN O
the DT O
concept NN O
of IN O
the DT O
study NN O
base NN O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
the DT O
two CD O
pharmacokinetic JJ O
parameters NNS O
, , O
t1/2 CD O
and CC O
Cltp NNP O
, , O
as IN O
indices NNS O
of IN O
drug NN O
elimination NN O
ability NN O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

In IN O
group NN O
1 CD O
, , O
mean JJ O
z-score NN O
for IN O
GFR NNP O
was VBD O
-0.27 JJ O
( -LRB- O
94.6 CD O
% NN O
of IN O
normal JJ O
) -RRB- O
and CC O
in IN O
group NN O
2 CD O
mean JJ O
z-score NN O
was VBD O
-1.51 JJ O
( -LRB- O
72.7 CD O
% NN O
of IN O
normal JJ O
for IN O
two CD O
kidneys NNS O
) -RRB- O
( -LRB- O
P NNP O
= SYM O
0.022 CD O
, , O
Mann-Whitney JJ O
U-test NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
apparent JJ O
binding NN O
constant NN O
of IN O
6 CD O
to TO O
calf NN O
thymus NN O
DNA NN O
is VBZ O
1.68 CD O
X NNP O
10(5 CD O
) -RRB- O
M-1 . O
whereas IN O
netropsin NN B-NP
under IN O
similar JJ O
conditions NNS O
gives VBZ O
a DT O
value NN O
of IN O
1.85 CD O
X NNP O
10(7 CD O
) -RRB- O
M-1 NN O
. . O

-DOCSTART- X X O

Neonatal JJ O
masculinization NN O
affects VBZ O
maternal JJ O
behavior NN O
sensitivity NN O
in IN O
female JJ O
rats NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
there EX O
are VBP O
some DT O
cows NNS O
that WDT O
fail VBP O
to TO O
produce VB O
adequate JJ O
1,25-dihydroxyvitamin NN O
D NN O
at IN O
the DT O
onset NN O
of IN O
lactation NN O
. . O

-DOCSTART- X X O

We PRP O
examined VBD O
the DT O
mechanisms NNS O
by IN O
which WDT O
two CD O
different JJ O
types NNS O
of IN O
photonic JJ O
radiation NN O
, , O
short JJ O
wavelength NN O
UV NN O
( -LRB- O
UV-C) NN O
and CC O
gamma NN O
radiation NN O
, , O
activate JJ O
transcription NN O
factor NN O
NF-kappaB. . B-NP

-DOCSTART- X X O

Prenatal JJ O
diagnosis NN O
of IN O
genetic JJ O
diseases NNS O
. . O

-DOCSTART- X X O

M. NNP O
, , O
Apps NNP O
, , O
D. NNP O

-DOCSTART- X X O

The DT O
three CD O
OAS NNP B-NP
genes NNS I-NP
are VBP O
flanked VBN O
by IN O
markers NNS B-NP
WI-10614 JJ I-NP
(cen NN O
) -RRB- O
and CC O
D12S2293 JJ B-NP
(tel NN O
) -RRB- O
and CC O
are VBP O
contained VBN O
within IN O
three CD O
sets NNS O
of IN O
overlapping VBG O
cosmid JJ O
clones NNS O
. . O

-DOCSTART- X X O

5'-Deletion CD O
of IN O
the DT O
Stat-binding JJ B-NP
sites NNS I-NP
abolished VBD O
all DT O
promoter-reporter JJ O
activity NN O
in IN O
response NN O
to TO O
PRL. NNP B-NP

-DOCSTART- X X O

The DT O
main JJ O
new JJ O
features NNS O
of IN O
this DT O
version NN O
are VBP O
that IN O
end-tidal JJ O
PO2 NNP O
instead RB O
of IN O
inspiratory JJ O
PO2 NNS O
can MD O
be VB O
kept VBN O
constant JJ O
, , O
and CC O
that IN O
the DT O
correcting JJ O
activity NN O
of IN O
both DT O
controllers NNS O
( -LRB- O
capnostat NN O
and CC O
oxystat NN O
) -RRB- O
is VBZ O
proportional JJ O
to TO O
the DT O
magnitude NN O
of IN O
the DT O
difference NN O
between IN O
the DT O
actual JJ O
and CC O
the DT O
adjusted VBN O
end-tidal JJ O
PCO2 NN O
or CC O
PO2 NN O
. . O

-DOCSTART- X X O

The DT O
MAP NNP B-NP
kinase NN I-NP
kinase NN I-NP
kinase NN I-NP
MLK2 IN B-NP
co-localizes NNS O
with IN O
activated JJ O
JNK NNP B-NP
along IN O
microtubules NNS O
and CC O
associates NNS O
with IN O
kinesin NN B-NP
superfamily NN I-NP
motor NN O
KIF3 NNP B-NP
. . O

-DOCSTART- X X O

Materials NNS O
are VBP O
presented VBN O
of IN O
a DT O
comparative JJ O
study NN O
of IN O
morphological JJ O
and CC O
cultural JJ O
properties NNS O
and CC O
virulence NN O
of IN O
liophylized JJ O
cultures NNS O
of IN O
Leishmania NNP O
tropica FW O
major JJ O
after IN O
their PRP$ O
rehydration NN O
or CC O
after IN O
a DT O
long JJ O
passage NN O
on IN O
the DT O
NNN NNP O
medium NN O
. . O

-DOCSTART- X X O

CrkII NNP B-NP
and CC O
CrkL NNP B-NP
constitutively RB O
formed VBD O
complex JJ O
with IN O
the DT O
guanine NNP B-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
C3G NNP B-NP
, , O
in IN O
unstimulated JJ O
as RB O
well RB O
as IN O
PDGF-stimulated JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

DSIP NNP O
was VBD O
found VBN O
to TO O
significantly RB O
increase VB O
slow-waves NNS O
( -LRB- O
delta NN O
sleep) NN O
in IN O
the DT O
sleep NN O
EEG. . O

-DOCSTART- X X O

Two CD O
courses NNS O
of IN O
chemotherapy NN O
( -LRB- O
CBCDA NNP O
+ NN O
VDS NNS O
) -RRB- O
failed VBD O
to TO O
gain VB O
any DT O
improvement NN O
, , O
and CC O
the DT O
pain NN O
resulting VBG O
from IN O
recurrent VBG O
bone NN O
metastases NNS O
was VBD O
managed VBN O
mainly RB O
by IN O
the DT O
administration NN O
of IN O
the DT O
best JJS O
supportive JJ O
care NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
search NN O
for IN O
genetic JJ O
and CC O
acquired VBN O
susceptibility NN O
to TO O
nontuberculous JJ O
mycobacteria NNS O
is VBZ O
also RB O
a DT O
search NN O
for IN O
susceptibility NN O
factors NNS O
for IN O
MTB NNP O
as RB O
well RB O
as IN O
an DT O
opportunity NN O
to TO O
recognize VB O
endogenous JJ O
pathways NNS O
that WDT O
can MD O
be VB O
exploited VBN O
therapeutically RB O
. . O

-DOCSTART- X X O

This DT O
gene NN O
is VBZ O
divided VBN O
into IN O
six CD O
exons NNS O
spanning VBG O
about IN O
3kb CD O
, , O
and CC O
encodes VBZ O
a DT O
175 CD O
amino IN O
acid JJ O
protein NN O
with IN O
40-52 CD O
% NN O
identity NN O
with IN O
the DT O
other JJ O
five CD O
mouse NN B-NP
Reg NN I-NP
( -LRB- O
regenerating VBG B-NP
gene NN I-NP
product NN I-NP
) -RRB- O
proteins VBZ O
. . O

-DOCSTART- X X O

Interconversions NNS O
between IN O
haloperidol NN O
and CC O
reduced VBD O
haloperidol NN O
in IN O
schizophrenic JJ O
patients NNS O
and CC O
guinea NN O
pigs NNS O
: : O
a DT O
steady-state NN O
study NN O
. . O

-DOCSTART- X X O

Bilirubin NNP O
and CC O
red JJ O
cell NN O
metabolism NN O
in IN O
relation NN O
to TO O
neonatal JJ O
jaundice NN O
. . O

-DOCSTART- X X O

Minute NNP B-NP
virus NN I-NP
of IN I-NP
mice NNS I-NP
NS1 NNP I-NP
, , O
an DT O
83-kDa JJ O
mainly RB O
nuclear JJ O
phosphoprotein NN O
, , O
is VBZ O
the DT O
only JJ O
viral NN O
nonstructural JJ O
protein NN O
required VBN O
in IN O
all DT O
cell NN O
types NNS O
and CC O
it PRP O
is VBZ O
involved VBN O
in IN O
multiple JJ O
processes NNS O
necessary JJ O
for IN O
virus NN O
propagation NN O
. . O

-DOCSTART- X X O

Pediatric NNP O
patients--handle NN O
with IN O
care NN O
. . O

-DOCSTART- X X O

K. NNP O

-DOCSTART- X X O

Protection NNP O
levels NNS O
of IN O
33.3 CD O
% NN O
, , O
36.6 CD O
% NN O
and CC O
37.0 CD O
% NN O
were VBD O
achieved VBN O
in IN O
groups NNS O
which WDT O
had VBD O
received VBN O
, , O
respectively RB O
, , O
1000 CD O
20-krad JJ O
cercariae NNS O
, , O
1000 CD O
10-krad JJ O
cercariae NNS O
, , O
2000 CD O
40-krad JJ O
cercariae NNS O
and CC O
2000 CD O
60-krad JJ O
cercariae NNS O
. . O

-DOCSTART- X X O

Interferon-alpha NNP B-NP
inducibility NN O
of IN O
IFI16 NNP B-NP
may MD O
be VB O
regulated VBN O
by IN O
an DT O
interferon-alpha/beta-stimulated JJ B-NP
response NN O
consensus NN O
element NN O
in IN O
the DT O
5' JJ O
UT NNP O
exon NN O
, , O
as IN O
a DT O
similar JJ O
motif NN O
is VBZ O
conserved VBN O
in IN O
the DT O
corresponding JJ O
position NN O
in IN O
the DT O
related JJ O
myeloid JJ B-NP
cell NN I-NP
nuclear JJ I-NP
differentiation NN I-NP
antigen VBN I-NP
gene NN O
.(ABSTRACT . O
TRUNCATED JJ O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

For IN O
the DT O
population NN O
of IN O
patients NNS O
with IN O
melanoma NN O
levels NNS O
III NNP O
and CC O
IV NNP O
significant JJ O
differences NNS O
in IN O
survival NN O
rate NN O
were VBD O
associated VBN O
with IN O
thickness NN O
( -LRB- O
less JJR O
than IN O
2 CD O
mm CD O
or CC O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
2 CD O
mm CD O
; : O
p NN O
less JJR O
than IN O
0,001 CD O
) -RRB- O
, , O
though IN O
not RB O
with IN O
level NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
in IN O
vivo JJ O
attachment NN O
strength NN O
of IN O
the DT O
CSTi-2 NN O
coating NN O
was VBD O
comparable JJ O
both CC O
to TO O
CSTi-1 NNP O
and CC O
to TO O
an DT O
HA-coated JJ O
control NN O
after IN O
8 CD O
weeks NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
negative JJ O
pi NN O
mesons NNS O
on IN O
mouse NN O
bone NN O
marrow NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
( -LRB- O
0 CD O
0 CD O
2 CD O
) -RRB- O
diffraction NN O
of IN O
the DT O
synthesized JJ O
HAp NNP O
crystals NNS O
on IN O
a DT O
Col NNP O
fiber NN O
showed VBD O
an DT O
around RB O
60 CD O
arching NN O
angle NN O
, , O
while IN O
that WDT O
on IN O
a DT O
ChS NNP O
fiber NN O
showed VBD O
just RB O
around IN O
10 CD O
degrees NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
of IN O
SIN4 NNP B-NP
, , O
ROX3 NNP B-NP
, , O
SRB8 CD B-NP
, , O
SRB9 NNP B-NP
, , O
SRB10 NNP B-NP
, , O
SRB11 NNP B-NP
, , O
and CC O
two CD O
novel JJ O
genes NNS O
, , O
NUT1 NNP B-NP
and CC O
NUT2 NNP B-NP
, , O
relieve VB O
the DT O
requirement NN O
of IN O
Swi4p JJ B-NP
for IN O
expression NN O
of IN O
this DT O
reporter NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
case NN O
of IN O
the DT O
pT181 JJ O
plasmid NN O
, , O
inactivation NN O
of IN O
the DT O
initiator NN B-NP
RepC NNP I-NP
protein NN I-NP
occurs VBZ O
by IN O
the DT O
attachment NN O
of IN O
an DT O
oligonucleotide JJ O
to TO O
its PRP$ O
active JJ O
tyrosine NN O
residue NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate VBP O
that IN O
release NN O
of IN O
a DT O
single JJ O
pulley NN O
after IN O
repair NN O
of IN O
the DT O
tendons NNS O
in IN O
this DT O
area NN O
improved VBD O
gliding VBG O
excursions NNS O
of IN O
the DT O
tendons NNS O
and CC O
reduced VBD O
resistance NN O
to TO O
motion NN O
of IN O
the DT O
repaired VBN O
tendons NNS O
, , O
and CC O
provide VB O
support NN O
for IN O
partial JJ O
A2 NNP O
pulley NN O
incision NN O
after IN O
repair NN O
of IN O
the DT O
tendons NNS O
in IN O
the DT O
area NN O
of IN O
the DT O
pulley NN O
. . O

-DOCSTART- X X O

Differential JJ O
transcription NN O
of IN O
plastome-encoded JJ O
genes NNS O
in IN O
the DT O
mesophyll NN O
and CC O
bundle-sheath NN O
chloroplasts NNS O
of IN O
the DT O
monocotyledonous JJ O
NADP-malic JJ O
enzyme-type JJ B-NP
C4 NN O
plants NNS O
maize VBP O
and CC O
Sorghum NNP O
. . O

-DOCSTART- X X O

RESULTS--The DT O
maximal JJ O
early JJ O
asthmatic JJ O
response NN O
after IN O
allergen NN O
with IN O
placebo NN O
treatment NN O
was VBD O
18.4 CD O
% NN O
( -LRB- O
SE NNP O
4.4 CD O
% NN O
) -RRB- O
and CC O
with IN O
WEB NNP O
2086 CD O
18.9 CD O
% NN O
( -LRB- O
4.4 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
64 CD O
uncomplicated JJ O
Type-2 JJ O
diabetic NN O
individuals NNS O
of IN O
higher JJR O
middle JJ O
class NN O
to TO O
rich JJ O
socio-economic JJ O
status NN O
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
role NN O
of IN O
this DT O
domain NN O
in IN O
the DT O
incorporation NN O
of IN O
the DT O
SIV NNP B-NP
Env NNP I-NP
into IN O
virions NNS O
, , O
we PRP O
generated VBD O
a DT O
series NN O
of IN O
SIV NNP B-NP
Env NNP I-NP
mutants NNS I-NP
carrying VBG O
small JJ O
in-frame JJ O
deletions NNS O
within IN O
the DT O
cytoplasmic JJ O
domain NN O
. . O

-DOCSTART- X X O

Ozone NN O
uptake NN O
was VBD O
assessed VBN O
in IN O
awake JJ O
, , O
spontaneously RB O
breathing VBG O
Fischer-344 NNP O
Sprague-Dawley NNP O
, , O
and CC O
Long-Evans NNP O
rats NNS O
and CC O
Hartley NNP O
guinea NN O
pigs NNS O
to TO O
provide VB O
data NNS O
on IN O
the DT O
dosimetry NN O
of IN O
O3 NNS O
in IN O
small JJ O
laboratory NN O
animals NNS O
. . O

-DOCSTART- X X O

On IN O
the DT O
3rd JJ O
day NN O
after IN O
ischemia NN O
of IN O
the DT O
remained VBN O
kidney NN O
for IN O
30 CD O
min NN O
, , O
structural JJ O
components NNS O
of IN O
the DT O
walls NNS O
of IN O
the DT O
glomerular JJ O
arterioles NNS O
and CC O
those DT O
of IN O
the DT O
filtration-reabsorption NN O
barrier NN O
undergo VBP O
certain JJ O
ultrastructural JJ O
changes NNS O
, , O
that IN O
with IN O
time NN O
elapsed VBN O
(7 CD O
, , O
14 CD O
days NNS O
) -RRB- O
gradually RB O
pass VB O
away RB O
, , O
and CC O
amount NN O
of IN O
cells NNS O
with IN O
hypertrophic JJ O
processes NNS O
increases NNS O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
Eales NNS O
' POS O
disease NN O
, , O
chorioretinitis NN O
, , O
central JJ O
serous JJ O
retinopathy NN O
, , O
or CC O
malignant JJ O
choroidal NN O
melanoma NN O
were VBD O
tested VBN O
for IN O
HLA NNP B-NP
antigen JJ O
deviation NN O
. . O

-DOCSTART- X X O

Of IN O
all DT O
YASR NNP O
syndromes NNS O
, , O
the DT O
highest JJS O
stability NN O
was VBD O
for IN O
the DT O
Anxious/Depressed VBN O
scale NN O
. . O

-DOCSTART- X X O

Significant JJ O
differences NNS O
were VBD O
observed VBN O
in IN O
the DT O
composition NN O
of IN O
nuclear JJ O
transcription NN O
factors NNS O
bound VBD O
to TO O
cis-elements NNS O
within IN O
the DT O
LDH/C NNP B-NP
proximal NN I-NP
promoter NN I-NP
region NN I-NP
in IN O
somatic JJ O
versus JJ O
germ NN O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
although IN O
the DT O
G3 JJ O
sequence NN O
contains VBZ O
two CD O
protein-binding JJ O
motifs NNS O
, , O
the DT O
organization NN O
of IN O
the DT O
G3 JJ O
enhancer-like JJ O
element NN O
is VBZ O
not RB O
bipartite JJ O
. . O

-DOCSTART- X X O

A DT O
preterm JJ O
formula NN O
with IN O
a DT O
traditional JJ O
corn NN O
oil/MCT NN O
blend NN O
containing VBG O
38 CD O
% NN O
MCTs IN O
(MCT JJ O
group NN O
) -RRB- O
was VBD O
compared VBN O
to TO O
a DT O
new JJ O
fat JJ O
blend NN O
, , O
designed VBN O
to TO O
resemble VB O
human JJ O
milk NN O
more RBR O
, , O
containing VBG O
6 CD O
% NN O
MCTs NNP O
(LC NNP O
T NNP O
group NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
existence NN O
of IN O
a DT O
TFIIIB NN B-NP
assembly NN O
pathway NN O
leading VBG O
to TO O
the DT O
faithful NN O
transcription NN O
of IN O
natural JJ O
eukaryotic JJ O
tRNA NN O
genes NNS O
in IN O
the DT O
absence NN O
of IN O
TFIIIC NNP B-NP
provides VBZ O
novel JJ O
insights NNS O
into IN O
the DT O
functional JJ O
flexibility NN O
of IN O
the DT O
eukaryotic JJ O
tRNA NN O
gene NN O
transcription NN O
machinery NN O
and CC O
on IN O
its PRP$ O
evolution NN O
from IN O
an DT O
ancestral JJ O
RNA NNP B-NP
polymerase NN I-NP
III NNP I-NP
system NN O
relying VBG O
on IN O
upstream RB O
, , O
TATA NNP O
- : O
centered VBN O
control NN O
elements NNS O
. . O

-DOCSTART- X X O

Reasons NNS O
are VBP O
presented VBN O
to TO O
support VB O
the DT O
contention NN O
that IN O
this DT O
increase NN O
is VBZ O
in IN O
part NN O
real JJ O
. . O

-DOCSTART- X X O

Hypocalcemia NNP O
is VBZ O
usually RB O
due JJ O
to TO O
either DT O
a DT O
disturbance NN O
in IN O
the DT O
parathyroid NN B-NP
hormone-adenylate JJ I-NP
cyclase NN B-NP
system NN O
or CC O
a DT O
disturbance NN O
in IN O
vitamin NN O
D NNP O
metabolism NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
with IN O
GPR37 DT B-NP
probes NNS O
revealed VBD O
a DT O
main JJ O
3.8-kb NN O
mRNA NN O
and CC O
a DT O
less RBR O
abundant JJ O
8-kb JJ O
mRNA NN O
, , O
both DT O
expressed VBD O
in IN O
human JJ O
brain NN O
tissues NNS O
, , O
particularly RB O
in IN O
corpus JJ O
callosum NN O
, , O
medulla NN O
, , O
putamen VBN O
, , O
and CC O
caudate VB O
nucleus JJ O
. . O

-DOCSTART- X X O

TNF-alpha NNP B-NP
effect NN O
was VBD O
eliminated VBN O
by IN O
a DT O
2-bp JJ O
substitution NN O
mutation NN O
in IN O
the DT O
NF-kappa NNP B-NP
B1 NNP I-NP
binding JJ I-NP
half NN I-NP
site NN I-NP
of IN O
the DT O
NF-kappa NNP B-NP
B NNP I-NP
cis NNPS I-NP
element NN I-NP
. . O

-DOCSTART- X X O

The DT O
tam IN B-NP
A DT I-NP
gene NN I-NP
of IN I-NP
Aspergillus NNP I-NP
nidulans NNS I-NP
encodes VBZ O
a DT O
739-amino JJ O
acid NN O
protein NN O
with IN O
similarity NN O
to TO O
Uga35p/Dal81p/DurLp NNP B-NP
of IN O
Saccharomyces NNP O
cerevisiae NNS O
. . O

-DOCSTART- X X O

Glutathione NN B-NP
reductase NN I-NP
( -LRB- O
GR CD B-NP
) -RRB- O
was VBD O
purified VBN O
from IN O
the DT O
cyanobacterium NN O
Anabaena NNP O
PCC NNP O
7120 CD O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
inoculum NN O
size NN O
, , O
medium NN O
, , O
temperature NN O
, , O
and CC O
duration NN O
of IN O
growth NN O
on IN O
the DT O
in IN O
vitro NN O
susceptibility NN O
testing NN O
of IN O
Aspergillus DT O
fumigatus NN O
were VBD O
investigated VBN O
using VBG O
broth NN O
micro- NNS O
and CC O
macro-dilution NN O
techniques NNS O
. . O

-DOCSTART- X X O

This DT O
dynamic JJ O
nature NN O
may MD O
be VB O
relevant JJ O
to TO O
the DT O
ability NN O
of IN O
E47 NNP B-NP
both CC O
to TO O
homodimerize VB O
and CC O
to TO O
heterodimerize VB O
with IN O
MyoD NNP B-NP
, , O
Id NN B-NP
, , O
and CC O
Tal1 NNP B-NP
. . O

-DOCSTART- X X O

In IN O
spite NN O
of IN O
the DT O
variability NN O
of IN O
DD95 NNP O
with IN O
regard NN O
to TO O
body NN O
weight NN O
, , O
the DT O
recovery NN O
of IN O
neuromuscular JJ O
transmission NN O
in IN O
the DT O
patients NNS O
of IN O
the DT O
three CD O
groups NNS O
is VBZ O
comparable JJ O
. . O

-DOCSTART- X X O

Kerstin NNP O
takes VBZ O
the DT O
abbreviated JJ O
medical JJ O
education NN O
. . O

-DOCSTART- X X O

An DT O
atypical JJ O
form NN O
of IN O
juvenile JJ O
myasthenia NN O
gravis NN O
associated VBN O
with IN O
severe JJ O
emaciation NN O
, , O
muscle NN O
atrophy NN O
, , O
ophthalmoplegia NNP O
, , O
bulbar NN O
signs NNS O
and CC O
joint JJ O
contracture NN O

-DOCSTART- X X O

Autophosphorylation NNP O
on IN O
the DT O
major JJ O
phosphorylation NN O
site NN O
Y1235 IN O
upregulates NNS O
the DT O
kinase NN O
activity NN O
of IN O
the DT O
receptor NN O
, , O
increasing VBG O
the DT O
Vmax NNP O
of IN O
the DT O
phosphotransfer NN O
reaction NN O
. . O

-DOCSTART- X X O

Two CD O
pharmacokinetic JJ O
models NNS O
were VBD O
compared VBN O
. . O

-DOCSTART- X X O

The DT O
cats NNS O
with IN O
stage-2 JJ O
lymphomas NNS O
that WDT O
were VBD O
FeLV-test NNP O
negative NN O
had VBD O
the DT O
best JJS O
response NN O
to TO O
treatment NN O
. . O

-DOCSTART- X X O

Reality NN O
and CC O
clinical JJ O
application NN O
of IN O
immunoglobulin NN B-NP
preparations NNS O

-DOCSTART- X X O

Our PRP$ O
case NN O
, , O
however RB O
, , O
had VBD O
no DT O
histologic NN O
evidence NN O
of IN O
malignancy NN O
, , O
no DT O
serum NN B-NP
alpha NN I-NP
fetoprotein NN I-NP
at IN O
7 CD O
months NNS O
of IN O
age NN O
, , O
and CC O
no DT O
recurrence NN O
at IN O
1 CD O
years NNS O
. . O

-DOCSTART- X X O

We PRP O
evaluated VBZ O
99mTc-ECD JJ O
SPECT NNP O
comparing NN O
with IN O
rCBF DT O
images NNS O
obtained VBN O
by IN O
PET NN O
in IN O
12 CD O
patients NNS O
with IN O
spinocerebellar JJ O
degeneration NN O
(SCD NN O
) -RRB- O
. . O

-DOCSTART- X X O

Outlook NNP O
in IN O
oral JJ O
and CC O
cutaneous JJ O
Kaposi NNP O
's POS O
sarcoma NN O
. . O

-DOCSTART- X X O

The DT O
concepts NNS O
were VBD O
developed VBN O
by IN O
Mines NNS O
and CC O
Garrey NNP O
during IN O
the DT O
next JJ O
10 CD O
years NNS O
. . O

-DOCSTART- X X O

Maximum NNP O
overexpression IN O
of IN O
holoenzyme NN O
activity NN O
was VBD O
achieved VBN O
by IN O
the DT O
inclusion NN O
in IN O
such JJ O
plasmids NNS O
of IN O
Salmonella NNP O
typhimurium NN O
cysG NN O
, , O
which WDT O
encodes VBZ O
a DT O
uroporphyrinogen NN B-NP
III NNP I-NP
methyltransferase NN I-NP
required VBN O
for IN O
the DT O
synthesis NN O
of IN O
siroheme NN O
, , O
a DT O
cofactor NN O
for IN O
the DT O
hemoprotein NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Precision NNP O
and CC O
accuracy NN O
were VBD O
measured VBN O
using VBG O
controls NNS O
and CC O
method NN O
comparison NN O
studies NNS O
. . O

-DOCSTART- X X O

Residues NNS O
crucial JJ O
for IN O
Ras NNP B-NP
interaction NN O
with IN O
GDP-GTP NNP B-NP
exchangers NNS I-NP
. . O

-DOCSTART- X X O

Expression NN O
of IN O
human JJ B-NP
complement NN I-NP
receptor NN I-NP
type NN I-NP
2 CD I-NP
( -LRB- O
CR2/CD21 NN B-NP
) -RRB- O
is VBZ O
primarily RB O
restricted VBN O
to TO O
mature VB O
B NNP O
cells NNS O
and CC O
follicular JJ O
dendritic NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
AtNMT1 NNP B-NP
expression NN O
profile NN O
indicated VBD O
ubiquity NN O
in IN O
roots NNS O
, , O
stem NN O
, , O
leaves NNS O
, , O
flowers NNS O
, , O
and CC O
siliques NNS O
( -LRB- O
approximately RB O
1.7 CD O
kb NN O
transcript NN O
and CC O
approximately RB O
50 CD O
kDa NN O
immunoreactive JJ O
polypeptide NN O
) -RRB- O
but CC O
a DT O
greater JJR O
level NN O
in IN O
the DT O
younger JJR O
tissue NN O
, , O
which WDT O
are VBP O
developmentally RB O
very RB O
active JJ O
. . O

-DOCSTART- X X O

Studies NNS O
in IN O
26 CD O
patients NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
mutations NNS O
within IN O
the DT O
Ubx NNP B-NP
unit NN I-NP
exons NNS I-NP
are VBP O
known VBN O
and CC O
most RBS O
of IN O
these DT O
behave VB O
as IN O
null JJ O
alleles NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
molecular JJ O
mechanisms NNS O
by IN O
which WDT O
specific JJ O
cis NNPS O
- : O
and CC O
trans-acting JJ O
factors NNS O
control VBP O
activity NN O
of IN O
the DT O
prodynorphin NN B-NP
promoter NN I-NP
are VBP O
not RB O
as RB O
clearly RB O
defined VBN O
. . O

-DOCSTART- X X O

Sesame NNP O
seed NN O
should MD O
also RB O
be VB O
considered VBN O
a DT O
cause NN O
of IN O
allergic JJ O
reactions NNS O
to TO O
drug NN O
products NNS O
and CC O
cosmetics NNS O
. . O

-DOCSTART- X X O

In IN O
absence NN O
of IN O
i.m JJ O
. . O
medication NN O
, , O
levels NNS O
over IN O
1,000 CD O
U NNP O
must MD O
be VB O
carefully RB O
screened VBN O
in IN O
order NN O
to TO O
rule VB O
out RP O
SNM NNP O
or CC O
organic JJ O
pathology NN O
associated VBN O
. . O

-DOCSTART- X X O

This DT O
latter JJ O
complex JJ O
reacts NNS O
with IN O
an DT O
antibody NN O
to TO O
serum VB B-NP
response NN I-NP
factor NN I-NP
( -LRB- O
SRF NN B-NP
) -RRB- O
and CC O
exhibits VBZ O
the DT O
same JJ O
binding NN O
characteristics NNS O
as IN O
purified VBN O
SRF. . B-NP

-DOCSTART- X X O

After IN O
cumulative JJ O
occlusions NNS O
of IN O
15 CD O
, , O
30 CD O
, , O
45 CD O
, , O
and CC O
90 CD O
min NN O
, , O
transmural JJ O
needle NN O
biopsies NNS O
were VBD O
taken VBN O
from IN O
the DT O
ischemic JJ O
area NN O
to TO O
be VB O
analyzed VBN O
for IN O
adenine DT O
nucleotides NNS O
, , O
nucleosides NNS O
, , O
creatine JJ O
phosphate NN O
, , O
and CC O
ultrastructural JJ O
changes NNS O
. . O

-DOCSTART- X X O

Although IN O
indomethacin NN O
is VBZ O
useful JJ O
for IN O
examining VBG O
the DT O
role NN O
of IN O
cyclooxygenase NN B-NP
products NNS I-NP
in IN O
asthmatic JJ O
responses NNS O
, , O
it PRP O
should MD O
not RB O
be VB O
considered VBN O
in IN O
the DT O
treatment NN O
of IN O
asthma NN O
. . O

-DOCSTART- X X O

Therapeutic JJ O
iodine NN O
125 CD O
for IN O
hyperthyroidism NN O
: : O
evidence NN O
for IN O
a DT O
special JJ O
radiobiological JJ O
effect NN O
on IN O
the DT O
follicular JJ O
cell NN O
. . O

-DOCSTART- X X O

The DT O
biological JJ O
activity NN O
of IN O
these DT O
mutants NNS O
was VBD O
tested VBN O
by IN O
determining VBG O
their PRP$ O
capacity NN O
to TO O
( -LRB- O
i NN O
) -RRB- O
reconstitute VBP O
RNA NNP B-NP
polymerase NN I-NP
activity NN O
in IN O
vivo NN O
by IN O
cotransfection NN O
with IN O
proteins NNS O
NP NNP B-NP
, , O
PB1 NNP B-NP
, , O
and CC O
PA NNP B-NP
and CC O
a DT O
virion-like JJ O
RNA NNP O
encoding VBG O
the DT O
cat NN B-NP
gene NN O
into IN O
vaccinia NN O
virus NN O
T7-infected DT O
COS-1 JJ O
cells NNS O
and CC O
( -LRB- O
ii NNS O
) -RRB- O
complete JJ O
with IN O
the DT O
wild-type JJ B-NP
PB2 NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Menstrual NNP O
and CC O
lunar JJ O
cycles NNS O
. . O

-DOCSTART- X X O

A DT O
nationwide JJ O
record NN O
linkage NN O
of IN O
the DT O
Finnish JJ O
Twin NNP O
Cohort NNP O
Study NNP O
(FTCS) NNP O
with IN O
the DT O
Hospital NNP O
Discharge NNP O
Registry NNP O
and CC O
the DT O
Registry NNP O
of IN O
Rights NNP O
for IN O
Free NNP O
medication NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

Western JJ O
blot NN O
experiments NNS O
detected VBD O
SMBP NNP B-NP
as IN O
a DT O
70 CD O
kDa JJ O
protein NN O
that WDT O
may MD O
be VB O
further JJ O
cleaved VBN O
into IN O
an DT O
active JJ O
34 CD O
kDa JJ O
N-terminal JJ O
polypeptide NN O
. . O

-DOCSTART- X X O

On IN O
Western NNP O
blots NNS O
, , O
the DT O
same JJ O
antibodies NNS O
recognized VBD O
the DT O
recombinant JJ O
protein NN O
migrating VBG O
slightly RB O
slower JJR O
on IN O
SDS/PAGE NN O
than IN O
chicken NN B-NP
axonin-1 NN I-NP
. . O

-DOCSTART- X X O

Denaturing VBG O
gradient JJ O
gel NN O
electrophoresis NN O
( -LRB- O
DGGE NNP O
) -RRB- O
with IN O
sequence NN O
analysis NN O
showed VBD O
that IN O
PGCL4 NNP B-NP
is VBZ O
a DT O
major JJ O
member NN O
in IN O
the DT O
female JJ O
mammary JJ O
gland NN O
, , O
and CC O
in IN O
the DT O
submaxillary NN O
and CC O
lachrymal JJ O
glands NNS O
of IN O
both DT O
sexes NNS O
, , O
while IN O
the DT O
counterpart NN O
in IN O
male JJ O
liver NN O
and CC O
the DT O
coagulate JJ O
glands NNS O
was VBD O
found VBN O
to TO O
be VB O
PGCL1 NNP B-NP
. . O

-DOCSTART- X X O

ATF NNP O
is VBZ O
formulated VBN O
from IN O
the DT O
prothrombin NN B-NP
time NN O
( -LRB- O
PT NNP O
) -RRB- O
, , O
fibrinogen VBN B-NP
transformation NN O
rate NN O
(FTR NN O
) -RRB- O
( -LRB- O
a DT O
representation NN O
of IN O
thrombin NN B-NP
activity NN O
) -RRB- O
, , O
and CC O
a DT O
consideration NN O
of IN O
the DT O
fibrinogen NN B-NP
( -LRB- O
FBG NNP B-NP
) -RRB- O
content NN O
of IN O
blood NN O
plasma NN O
. . O

-DOCSTART- X X O

Protein NNP O
binding NN O
to TO O
UAS1MLS1 NNP B-NP
was VBD O
observed VBN O
with IN O
extracts NNS O
from IN O
derepressed VBN O
but CC O
not RB O
from IN O
repressed JJ O
cells NNS O
, , O
and CC O
could MD O
be VB O
competed VBN O
for IN O
by IN O
an DT O
excess NN O
of IN O
the DT O
unlabelled JJ O
CSRE NNP O
( -LRB- O
ICL1 NN B-NP
) -RRB- O
sequence NN O
. . O

-DOCSTART- X X O

Recently RB O
we PRP O
have VBP O
performed VBN O
a DT O
detailed JJ O
analysis NN O
of IN O
specific JJ O
neuronal JJ O
populations NNS O
affected VBN O
by IN O
the DT O
mutation NN O
which WDT O
shed VBD O
new JJ O
light NN O
on IN O
the DT O
role NN O
of IN O
Krox-20 NNP B-NP
in IN O
the DT O
segmentation NN O
and CC O
on IN O
the DT O
physiological JJ O
consequences NNS O
of IN O
its PRP$ O
inactivation NN O
. . O

-DOCSTART- X X O

Further JJ O
comparative JJ O
analysis NN O
identified VBN O
an DT O
ADNP NNP B-NP
paralog NN O
( -LRB- O
33 CD O
% NN O
identity NN O
and CC O
46 CD O
% NN O
similarity NN O
) -RRB- O
, , O
indicating VBG O
that IN O
these DT O
genes NNS O
belong VBP O
to TO O
a DT O
novel JJ O
protein NN O
family NN O
with IN O
a DT O
nine-zinc JJ O
finger NN O
motif NN O
followed VBN O
by IN O
a DT O
homeobox NN O
domain NN O
. . O

-DOCSTART- X X O

Nature NN O
and CC O
incidence NN O
of IN O
conditioned JJ O
responses NNS O
in IN O
a DT O
methadone CD O
population NN O
: : O
a DT O
comparison NN O
of IN O
laboratory NN O
, , O
clinic NN O
, , O
and CC O
naturalistic JJ O
settings NNS O
. . O

-DOCSTART- X X O

Fourteen NNP O
Centers NNPS O
participated VBD O
in IN O
this DT O
trial NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
identified VBN O
retina-specific JJ O
transcripts NNS O
of IN O
3.0 CD O
kb NN O
for IN O
rod NN B-NP
G NNP I-NP
alpha NN I-NP
t NN I-NP
and CC O
2.6 CD O
kb NN O
for IN O
cone NN B-NP
G NNP I-NP
alpha NN I-NP
t NN I-NP
. . O

-DOCSTART- X X O

This DT O
interesting JJ O
exon NN O
junction NN O
resulted VBD O
in IN O
novel NN O
deduced VBN O
amino IN O
terminal NN O
open JJ O
reading NN O
frames NNS O
, , O
which WDT O
are VBP O
completely RB O
in-frame JJ O
with IN O
sequences NNS O
located VBN O
further RB O
downstream RB O
. . O

-DOCSTART- X X O

We PRP O
investigated VBD O
the DT O
pattern NN O
of IN O
evolution NN O
of IN O
bronchial JJ O
albumin NN B-NP
, , O
IgA NNP B-NP
, , O
and CC O
IgG NNP B-NP
levels NNS O
in IN O
ventilated VBN O
ICU NNP O
patients NNS O
in IN O
relation NN O
to TO O
nosocomial JJ O
pneumonia NN O
. . O

-DOCSTART- X X O

Membrane NNP O
depolarization NN O
is VBZ O
a DT O
critical JJ O
element NN O
of IN O
neuronal JJ O
signaling NN O
. . O

-DOCSTART- X X O

Humoral NNP O
immunity NN O
is VBZ O
altered VBN O
with IN O
the DT O
drop NN O
in IN O
IgG NNP B-NP
levels NNS O
. . O

-DOCSTART- X X O

( -LRB- O
control NN O
hearts NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Although IN O
several JJ O
other JJ O
signal NN O
transduction NN O
molecules NNS O
also RB O
contain VBP O
tandemly NN O
occurring VBG O
SH3 NNP B-NP
and CC O
SH2 NNP B-NP
domains VBZ I-NP
, , O
the DT O
function NN O
of IN O
these DT O
closely RB O
spaced JJ O
domains NNS O
is VBZ O
not RB O
well RB O
understood VBN O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
this DT O
possibility NN O
, , O
we PRP O
conducted VBD O
split-visual-field JJ O
studies NNS O
in IN O
which WDT O
we PRP O
manipulated VBD O
stimulus NN O
sets NNS O
, , O
recognition NN O
task NN O
, , O
and CC O
exposure NN O
duration NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
changes NNS O
in IN O
the DT O
patient NN O
's POS O
thyroid JJ O
scan NN O
and CC O
RAIU NNP O
were VBD O
attributable JJ O
to TO O
the DT O
presence NN O
of IN O
TSAb NNP O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
revealed VBN O
that IN O
Hv-p68 CD B-NP
belongs VBZ O
to TO O
the DT O
large JJ O
family NN O
of IN O
FAD-dependent JJ B-NP
glucose NN I-NP
methanol NN I-NP
choline NN I-NP
oxidoreductases NNS I-NP
and CC O
that IN O
it PRP O
shares VBZ O
significant JJ O
sequence NN O
identity NN O
( -LRB- O
>67 CD O
% NN O
) -RRB- O
with IN O
the DT O
alcohol NN B-NP
oxidases NNS I-NP
of IN O
the DT O
methylotrophic JJ O
yeasts NNS O
. . O

-DOCSTART- X X O

Coronatine NN B-NP
( -LRB- O
COR JJ B-NP
) -RRB- O
is VBZ O
a DT O
plasmid-encoded JJ O
phytotoxin NN O
synthesized VBN O
by IN O
several JJ O
pathovars NNS O
of IN O
phytopathogenic JJ O
Pseudomonas NNP O
syringae NN O
. . O

-DOCSTART- X X O

Radioactively RB O
labeled VBN O
microspheres NNS O
were VBD O
used VBN O
to TO O
determine VB O
and CC O
compare VB O
the DT O
hemodynamic JJ O
effects NNS O
of IN O
sodium NN O
nitroprusside NN O
( -LRB- O
SNP NNP O
) -RRB- O
, , O
nitroglycerin JJ O
(NTG) NN O
, , O
and CC O
deep JJ O
enflurane NN O
anesthesia NN O
on IN O
oral JJ O
tissues NNS O
during IN O
controlled VBN O
hypotension NN O
when WRB O
compared VBN O
with IN O
controls NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
no DT O
consensus NN O
on IN O
indications NNS O
exists VBZ O
and CC O
, , O
according VBG O
to TO O
the DT O
literature NN O
, , O
results NNS O
are VBP O
contradictory JJ O
. . O

-DOCSTART- X X O

However RB O
, , O
studies NNS O
using VBG O
the DT O
A20 NNP B-NP
promoter NN I-NP
demonstrated VBD O
that IN O
LMP1 NNP B-NP
transcriptionally RB O
activates VBZ O
the DT O
A20 NNP B-NP
gene NN I-NP
through IN O
cis-acting JJ O
kappa NN B-NP
B NNP I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
tested VBD O
whether IN O
activation NN O
by IN O
either DT O
of IN O
these DT O
factors NNS O
is VBZ O
dependent JJ O
on IN O
components NNS O
of IN O
the DT O
SAGA NNP B-NP
complex NN I-NP
. . O

-DOCSTART- X X O

Recombinant NNP O
propeptides NNS O
containing VBG O
mutations NNS O
of IN O
one CD O
of IN O
the DT O
three CD O
tryptophan IN O
residues NNS O
were VBD O
three CD O
orders NNS O
of IN O
magnitude NN O
less RBR O
effective JJ O
as IN O
inhibitors NNS O
of IN O
mature JJ B-NP
cathepsin NN I-NP
S NNP I-NP
than IN O
the DT O
wild-type JJ O
propeptide NN O
. . O

-DOCSTART- X X O

AU-rich JJ O
elements NNS O
in IN O
the DT O
3'-untranslated JJ O
region NN O
of IN O
a DT O
new JJ O
mucin-type JJ B-NP
gene NN I-NP
family NN O
of IN O
Trypanosoma NNP O
cruzi VBD O
confers NNS O
mRNA NNS O
instability NN O
and CC O
modulates NNS O
translation NN O
efficiency NN O
. . O

-DOCSTART- X X O

The DT O
repeats NNS O
are VBP O
highly RB O
conserved VBN O
both DT O
within IN O
a DT O
given VBN O
element NN O
as RB O
well RB O
as IN O
between IN O
different JJ O
members NNS O
of IN O
the DT O
family NN O
( -LRB- O
less RBR O
than IN O
10 CD O
% NN O
divergence NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
Polycomb NNP B-NP
group NN I-NP
proteins NNS I-NP
are VBP O
involved VBN O
in IN O
maintenance NN O
of IN O
the DT O
silenced JJ O
state NN O
of IN O
several JJ O
developmentally NN O
regulated VBN O
genes NNS O
. . O

-DOCSTART- X X O

Alterations NNP O
in IN O
TCR-MHC JJ B-NP
contacts NNS O
subsequent JJ O
to TO O
cross-recognition NN O
of IN O
class NN B-NP
I PRP I-NP
MHC RB I-NP
and CC O
singly RB O
substituted VBN O
peptide NN O
variants NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
that IN O
the DT O
products NNS O
of IN O
both DT O
the DT O
GIY-YIG NNP B-NP
ORF NNP O
and CC O
the DT O
non-canonical JJ O
LAGLI-DADG-GIY-YIG NNP B-NP
ORF NNP O
, , O
which WDT O
is VBZ O
generated VBN O
by IN O
its PRP$ O
integration NN O
, , O
have VBP O
endonuclease NN O
activities NNS O
which WDT O
recognize VBP O
and CC O
cut VBD O
the DT O
insertion NN O
site NN O
of IN O
the DT O
optional JJ O
sequence NN O
. . O

-DOCSTART- X X O

The DT O
pharmacokinetics NNS O
were VBD O
best RB O
described VBN O
by IN O
a DT O
two-compartment JJ O
open JJ O
model NN O
giving VBG O
distribution NN O
half-lives NNS O
of IN O
0.31 CD O
h NN O
and CC O
1.53 CD O
h NN O
, , O
and CC O
elimination NN O
half-lives NNS O
of IN O
69.7 CD O
h NN O
and CC O
60.3 CD O
h NN O
for IN O
oxolinic JJ O
acid NN O
and CC O
oxytetracycline NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Inhibitory NN O
receptors NNS O
are VBP O
characterized VBN O
by IN O
the DT O
presence NN O
of IN O
a DT O
characteristic JJ O
sequence NN O
known VBN O
as IN O
an DT O
immunoreceptor NN O
tyrosine-based JJ O
inhibitory JJ O
motif NN O
( -LRB- O
ITIM NNP O
) -RRB- O
in IN O
their PRP$ O
cytoplasmic JJ O
tail NN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
some DT O
defects NNS O
observed VBD O
in IN O
BS NNP O
, , O
WS NNP O
or CC O
RTS NNP O
are VBP O
the DT O
consequence NN O
of IN O
unrestrained JJ O
recombination NN O
. . O

-DOCSTART- X X O

Alternative JJ O
splicing NN O
of IN O
the DT O
human JJ B-NP
serotonin NN I-NP
transporter NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Nuclear NNP O
proteins VBZ O
bound VBN O
the DT O
cad JJ B-NP
+55/+75 CD I-NP
element NN I-NP
in IN O
a DT O
cell NN O
cycle-dependent JJ O
manner NN O
in IN O
electromobility NN O
shift NN O
assays VBZ O
; : O
antibodies NNS O
specific JJ O
to TO O
USF NNP B-NP
and CC O
Max NNP B-NP
blocked VBD O
the DT O
DNA-binding JJ O
activity NN O
of IN O
different JJ O
growth-regulated JJ O
protein-DNA NN O
complexes NNS O
. . O

-DOCSTART- X X O

The DT O
carboxy-proximal JJ O
regions NNS O
of IN O
the DT O
VP1 NNP B-NP
, , O
which WDT O
contain VBP O
very RB O
low JJ O
amino IN O
acid NN O
homology NN O
, , O
displayed VBD O
evidence NN O
of IN O
conservation NN O
in IN O
structural JJ O
features NNS O
such JJ O
as IN O
a DT O
hydrophilic JJ O
, , O
highly RB O
basic JJ O
domain NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that DT O
inhibition NN O
occurs VBZ O
with IN O
a DT O
NS1-Rev NNP B-NP
chimera NN O
in IN O
which WDT O
the DT O
78 CD O
amino-terminal JJ O
amino IN O
acids NNS O
of IN O
the DT O
NS1A JJ B-NP
protein NN I-NP
comprising VBG O
its PRP$ O
entire JJ O
RNA-binding JJ O
domain NN O
is VBZ O
deleted VBN O
, , O
thereby RB O
establishing VBG O
that IN O
this DT O
carboxyl NN O
portion NN O
of IN O
the DT O
NS1A JJ B-NP
protein NN I-NP
can MD O
function VB O
as IN O
an DT O
independent JJ O
effector NN O
domain NN O
. . O

-DOCSTART- X X O

Thus RB O
integration NN B-NP
host NN I-NP
factor NN I-NP
is VBZ O
required VBN O
for IN O
normal JJ O
type NN B-NP
1 CD I-NP
fimbriae NN I-NP
phase NN O
variation NN O
in IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

Salts NNS O
of IN O
these DT O
four CD O
metal NN O
ions NNS O
may MD O
be VB O
added VBN O
to TO O
the DT O
growth NN O
medium NN O
to TO O
facilitate VB O
selective JJ O
isolation NN O
of IN O
Acinetobacter NNP O
. . O

-DOCSTART- X X O

To TO O
examine VB O
the DT O
effect NN O
of IN O
the DT O
cAMP JJ O
signal NN O
transduction NN O
pathway NN O
on IN O
transcription NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
catalytic JJ O
subunit NN O
of IN O
glucose-6-phosphatase JJ B-NP
( -LRB- O
G6Pase NN B-NP
) -RRB- O
, , O
G6Pase-chloramphenicol JJ B-NP
acetyltransferase NN B-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
fusion NN O
genes NNS O
were VBD O
transiently RB O
transfected VBN O
into IN O
either CC O
the DT O
liver-derived JJ O
HepG2 CD O
or CC O
kidney-derived VBN O
LLC-PK JJ O
cell NN O
line NN O
. . O

-DOCSTART- X X O

Two CD O
plasmids NNS O
, , O
one CD O
containing VBG O
the DT O
amino JJ O
terminus NN O
of IN O
P NNP O
fused VBD O
to TO O
the DT O
DNA-binding JJ O
domain NN O
of IN O
the DT O
yeast NN O
transactivator NN O
, , O
GAL4 NNP B-NP
, , O
and CC O
the DT O
other JJ O
containing VBG O
the DT O
amino JJ O
terminus NN O
of IN O
NP NNP B-NP
fused VBD O
to TO O
the DT O
herpesvirus NN O
transactivator NN O
, , O
VP16 CD B-NP
, , O
were VBD O
transfected VBN O
in IN O
COS-1 JJ O
cells NNS O
along IN O
with IN O
a DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
reporter NN O
plasmid NN O
containing VBG O
GAL4 NNP B-NP
DNA-binding NNP O
sites NNS O
. . O

-DOCSTART- X X O

Ultrastructure NNP O
and CC O
toxin NN O
formation NN O
of IN O
Cor NNP O
. . O
diphtheriae NNS O
PW-8 DT O
cultured JJ O
in IN O
the DT O
presence NN O
of IN O
penicillin VBG O

-DOCSTART- X X O

Ras NNP B-NP
involvement NN O
in IN O
signal NN O
transduction NN O
by IN O
the DT O
serotonin NN B-NP
5-HT2B NN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

The DT O
nine CD O
subjects NNS O
were VBD O
treated VBN O
in IN O
random JJ O
sequence NN O
with IN O
cimetidine JJ O
0-8-1-0 JJ O
g NN O
on IN O
one CD O
day NN O
and CC O
placebo NN O
capsules NNS O
on IN O
the DT O
other JJ O
. . O

-DOCSTART- X X O

The DT O
detection NN O
limits VBZ O
obtained VBN O
by IN O
using VBG O
the DT O
mixed JJ O
eluent NN O
were VBD O
0.05-0.13 CD O
mg/L NNS O
, , O
several JJ O
times NNS O
lower JJR O
than IN O
those DT O
obtained VBN O
by IN O
using VBG O
single JJ O
KHPh NNP O
eluent VBD O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
buthionine NN O
sulfoximine NN O
( -LRB- O
BSO NNP O
) -RRB- O
and CC O
disulfiram NN O
( -LRB- O
DSF NNP O
) -RRB- O
on IN O
the DT O
urotoxicity NN O
induced VBN O
by IN O
cyclophosphamide NN O
( -LRB- O
CPA NNP O
) -RRB- O
was VBD O
examined VBN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
clones NNS O
encodes VBZ O
Xenopus NNP B-NP
N-ras NNP I-NP
. . O

-DOCSTART- X X O

Psoriasis NN O
on IN O
tumor NN O
. . O

-DOCSTART- X X O

Flicker NNP O
thresholds NNS O
were VBD O
measured VBN O
from IN O
1 CD O
to TO O
40 CD O
Hz NN O
with IN O
a DT O
vertical-line NN O
target NN O
used VBN O
for IN O
the DT O
asynchrony NN O
thresholds NNS O
. . O

-DOCSTART- X X O

Buserelin NNP O
offers VBZ O
an DT O
effective JJ O
alternative JJ O
medical JJ O
treatment NN O
of IN O
carcinoma NN O
of IN O
the DT O
prostate NN O
and CC O
, , O
apart RB O
from IN O
impotence NN O
, , O
does VBZ O
not RB O
have VB O
the DT O
side NN O
effects NNS O
of IN O
oestrogens NNS O
. . O

-DOCSTART- X X O

Cell NNP O
sloughing NN O
with IN O
proparacaine NN O
. . O

-DOCSTART- X X O

One CD O
hundred CD O
cDNA NN O
clones NNS O
were VBD O
sequenced VBN O
and CC O
8 CD O
RTKs JJ B-NP
were VBD O
identified VBN O
, , O
as RB O
well RB O
as IN O
12 CD O
non-RTKs JJ O
and CC O
2 CD O
serine/threonine NN B-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

A DT O
model NN O
for IN O
oligomerization-dependent JJ O
subunit NN O
folding NN O
. . O

-DOCSTART- X X O

The DT O
reporter NN O
gene NN O
with IN O
two CD O
copies NNS O
of IN O
the DT O
wild-type JJ O
Repeat NN O
2 CD O
+ NN O
3 CD O
sequence NN O
was VBD O
transcribed VBN O
actively RB O
in IN O
sterol-deprived JJ O
cells NNS O
and CC O
was VBD O
repressed VBN O
by IN O
more JJR O
than IN O
80 CD O
% NN O
when WRB O
sterols NNS O
were VBD O
present JJ O
. . O

-DOCSTART- X X O

This DT O
review NN O
chronicles VBZ O
the DT O
characteristics NNS O
of IN O
deliberate JJ O
and CC O
accidental JJ O
mass NN O
poisonings NNS O
that WDT O
occurred VBD O
in IN O
World NNP O
Wars NNPS O
I PRP O
and CC O
II NNP O
, , O
in IN O
Bhopal NNP O
, , O
and CC O
in IN O
other JJ O
historical JJ O
cases NNS O
up IN O
to TO O
and CC O
including VBG O
modern JJ O
wars NNS O
. . O

-DOCSTART- X X O

Similar JJ O
to TO O
what WP O
was VBD O
observed VBN O
for IN O
P. NNP O
putida VBD O
, , O
a DT O
psrA NN B-NP
null JJ O
mutant NN O
of IN O
P. NNP O
aeruginosa NN O
also RB O
showed VBD O
a DT O
90 CD O
% NN O
reduction NN O
in IN O
rpoS NNP B-NP
promoter NN I-NP
activity NN O
; : O
both DT O
mutants NNS O
could MD O
be VB O
complemented VBN O
for IN O
rpoS NNP B-NP
promoter NN I-NP
activity NN O
when WRB O
the DT O
psrA NN B-NP
gene NN I-NP
was VBD O
provided VBN O
in IN O
trans NNS O
. . O
psrA NN B-NP
mutants NNS I-NP
of IN O
both DT O
Pseudomonas NNP O
species NNS O
lost VBD O
the DT O
ability NN O
to TO O
induce VB O
rpoS NNS B-NP
expression NN O
at IN O
stationary JJ O
phase NN O
, , O
but CC O
they PRP O
retained VBD O
the DT O
ability NN O
to TO O
produce VB O
quorum-sensing NN O
autoinducer NN O
molecules NNS O
. . O

-DOCSTART- X X O

Extracellular JJ B-NP
protein NN I-NP
kinase NN I-NP
A DT I-NP
as IN O
a DT O
cancer NN O
biomarker NN O
: : O
its PRP$ O
expression NN O
by IN O
tumor NN O
cells NNS O
and CC O
reversal NN O
by IN O
a DT O
myristate-lacking JJ O
Calpha NNP O
and CC O
RIIbeta NNP O
subunit NN O
overexpression NN O
. . O

-DOCSTART- X X O

The DT O
KEMAR NN O
measurements NNS O
show VBP O
that IN O
the DT O
two CD O
models NNS O
give VBP O
an DT O
improvement NN O
of IN O
the DT O
signal-to-noise JJ O
ratio NN O
of IN O
approximately RB O
7.5 CD O
dB NN O
in IN O
a DT O
diffuse JJ O
sound NN O
field NN O
. . O

-DOCSTART- X X O

Mutations NNS O
that IN O
extend VBP O
the DT O
specificity NN O
of IN O
the DT O
endonuclease NN O
activity NN O
of IN O
lambda NN B-NP
terminase NN I-NP
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
new JJ O
class NN O
of IN O
competitive JJ O
NMDA NN B-NP
receptor NN I-NP
antagonists NNS O
, , O
exemplified VBN O
by IN O
CGP NNP O
37849 CD O
, , O
is VBZ O
the DT O
most RBS O
promising JJ O
candidate NN O
for IN O
clinical JJ O
trials NNS O
in IN O
anxiety NN O
disorders NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
fungus NN O
Neurospora NNP O
crassa VBD O
, , O
nit-2 JJ B-NP
, , O
the DT O
major JJ O
nitrogen NN O
regulatory JJ O
gene NN O
, , O
activates VBZ O
the DT O
expression NN O
of IN O
unlinked JJ O
structural JJ O
genes NNS O
that WDT O
specify VB O
nitrogen-catabolic JJ O
enzymes NNS O
during IN O
conditions NNS O
of IN O
nitrogen NN O
limitation NN O
. . O

-DOCSTART- X X O

Tetrazepam NNP O
: : O
a DT O
benzodiazepine NN O
which WDT O
dissociates VBZ O
sedation NN O
from IN O
other JJ O
benzodiazepine NN O
activities NNS O
. . O

-DOCSTART- X X O

An DT O
hcr1 JJ B-NP
null NN O
mutant NN O
was VBD O
viable JJ O
, , O
but CC O
showed VBD O
slight JJ O
reduction NN O
of IN O
growth NN O
when WRB O
compared VBN O
with IN O
the DT O
wild-type JJ O
strain NN O
. . O

-DOCSTART- X X O

The DT O
women NNS O
in IN O
the DT O
intermediate JJ O
calcium NN O
group NN O
had VBD O
approximately RB O
the DT O
same JJ O
mean JJ O
BMD NNP O
values NNS O
as IN O
those DT O
in IN O
the DT O
low JJ O
calcium NN O
group NN O
. . O

-DOCSTART- X X O

Serum NN B-NP
amyloid JJ I-NP
A DT I-NP
( -LRB- O
SAA NNP B-NP
) -RRB- O
is VBZ O
a DT O
plasma NN O
protein NN O
which WDT O
has VBZ O
been VBN O
associated VBN O
with IN O
several JJ O
diseases NNS O
, , O
including VBG O
amyloidosis NN O
, , O
arthritis NN O
, , O
and CC O
atherosclerosis NN O
, , O
and CC O
its PRP$ O
abnormal JJ O
expression NN O
, , O
particularly RB O
in IN O
nonhepatic JJ O
cells NNS O
, , O
is VBZ O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
these DT O
diseases NNS O
. . O

-DOCSTART- X X O

Convergence NN O
of IN O
trigeminal JJ O
input NN O
with IN O
visceral JJ O
and CC O
phrenic JJ O
inputs NNS O
on IN O
primate JJ O
C1-C2 JJ O
spinothalamic JJ O
tract NN O
neurons NNS O
. . O

-DOCSTART- X X O

A DT O
Frank NNP O
vectorcardiogram NN O
was VBD O
recorded VBN O
before IN O
and CC O
every DT O
15-30 CD O
minutes NNS O
for IN O
10 CD O
hours NNS O
after IN O
the DT O
occlusion NN O
. . O

-DOCSTART- X X O

When WRB O
O-2A/c-myc JJ O
cells NNS O
underwent JJ O
terminal NN O
differentiation NN O
APprog NNP B-NP
complexes NNS I-NP
were VBD O
lost VBN O
and CC O
conventional JJ O
AP-1 JJ B-NP
DNA-binding NN O
activity NN O
became VBD O
evident JJ O
, , O
particularly RB O
in IN O
astrocytes NNS O
. . O

-DOCSTART- X X O

( -LRB- O
i NN O
) -RRB- O
The DT O
chimeric JJ O
gene NN O
consisting VBG O
of IN O
the DT O
coding NN O
and CC O
5' JJ O
nontranslated JJ O
leader NN O
regions NNS O
of IN O
the DT O
TK NNP B-NP
gene NN I-NP
fused VBD O
to TO O
portions NNS O
of IN O
the DT O
domain NN O
of IN O
alpha NN B-NP
gene NN I-NP
0 CD I-NP
extending VBG O
largely RB O
upstream RB O
from IN O
the DT O
site NN O
of IN O
initiation NN O
of IN O
transcription NN O
of IN O
alpha NN B-NP
gene NN I-NP
0 CD I-NP
was VBD O
regulated VBN O
in IN O
the DT O
same JJ O
fashion NN O
as IN O
the DT O
alpha NN B-NP
4- . I-NP
and CC I-NP
alpha NN I-NP
27-TK JJ I-NP
chimeras NNS O
. . O

-DOCSTART- X X O

Torsion NNP O
of IN O
the DT O
contralateral JJ O
testis NN O
5 CD O
years NNS O
after IN O
orchiopexy NN O
. . O

-DOCSTART- X X O

Legionella NNP B-NP
antibodies NNS I-NP
in IN O
domestic JJ O
animals NNS O

-DOCSTART- X X O

When WRB O
transfected VBN O
into IN O
HepG2 CD O
cells NNS O
, , O
which WDT O
lack VBP O
C/EBP JJ B-NP
alpha NN I-NP
, , O
the DT O
mouse NN B-NP
ob NN I-NP
promoter NN I-NP
was VBD O
only RB O
weakly RB O
active JJ O
. . O

-DOCSTART- X X O

When WRB O
translated VBN O
in-frame JJ O
with IN O
PKC NNP B-NP
zeta NNP I-NP
, , O
a DT O
stop NN O
codon NN O
is VBZ O
located VBN O
28 CD O
amino IN O
acids NNS O
towards IN O
the DT O
N-terminus NNP O
of IN O
the DT O
divergence NN O
point NN O
and CC O
the DT O
intervening NN O
sequence NN O
lacks VBZ O
an DT O
expected VBN O
initiating NN O
methionine NN O
. . O
psi NNS B-NP
PKC NNP I-NP
zeta NN I-NP
is VBZ O
non-functional JJ O
in IN O
terms NNS O
of IN O
protein NN O
synthesis NN O
since IN O
Western NNP O
blotting VBG O
with IN O
an DT O
antibody NN O
directed VBN O
against IN O
the DT O
C-terminus NN O
of IN O
PKC NNP B-NP
zeta NNP I-NP
failed VBD O
to TO O
reveal VB O
a DT O
protein NN O
smaller JJR O
than IN O
PKC NNP B-NP
zeta NN I-NP
, , O
and CC O
synthetic JJ O
psi NNS B-NP
PKC . I-NP
zeta NN I-NP
RNA NNP I-NP
failed VBD O
to TO O
support VB O
protein NN O
synthesis NN O
in IN O
a DT O
translation NN O
system NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Comparative JJ O
ultrafiltration NN O
( -LRB- O
UF) NNP O
studies NNS O
with IN O
BiGG NNP O
and CC O
standard JJ O
lactate NN O
( -LRB- O
La NNP O
) -RRB- O
solutions NNS O
in IN O
rabbits NNS O
showed VBD O
that IN O
net JJ O
UF NNS O
with IN O
La NNP O
solution NN O
peaked VBD O
at IN O
2 CD O
h NN O
and CC O
decreased VBD O
significantly RB O
at IN O
4 CD O
h NN O
and CC O
6 CD O
h NN O
. . O

-DOCSTART- X X O

JCAHO NNP O
moves VBZ O
to TO O
rewrite VB O
many JJ O
rules NNS O
to TO O
lessen VB O
hospitals NNS O
' POS O
regulatory JJ O
burden NN O
. . O

-DOCSTART- X X O

However RB O
, , O
it PRP O
is VBZ O
not RB O
easy JJ O
to TO O
establish VB O
the DT O
diagnosis NN O
of IN O
thoracic JJ O
MFH. . O

-DOCSTART- X X O

IGF-I JJ B-NP
levels NNS O
were VBD O
measured VBN O
in IN O
the DT O
CSF NNP O
of IN O
11 CD O
children NNS O
with IN O
autism NN O
( -LRB- O
4 CD O
females NNS O
, , O
7 CD O
males NNS O
; : O
mean JJ O
age NN O
3.8 CD O
years NNS O
, , O
SD NNP O
1.1 CD O
) -RRB- O
using VBG O
a DT O
sensitive JJ O
radioimmunoassay NN O
method NN O
and CC O
compared VBN O
with IN O
levels NNS O
in IN O
11 CD O
control NN O
participants NNS O
( -LRB- O
6 CD O
females NNS O
, , O
5 CD O
males NNS O
; : O
mean JJ O
age NN O
3.8 CD O
years NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Forty-five CD O
patients NNS O
with IN O
recent-onset JJ O
hyperthyroidism NN O
( -LRB- O
<12 JJ O
weeks NNS O
) -RRB- O
were VBD O
sex NN O
and CC O
menopause NN O
stratified VBN O
and CC O
randomly RB O
allocated VBN O
to TO O
treatment NN O
with IN O
carbimazole NN O
( -LRB- O
Neotomizol NNP O
) -RRB- O
, , O
carbimazole NN O
plus CC O
low JJ O
dose NN O
CT NN O
( -LRB- O
Calsynar NNP O
; : O
100 CD O
IU/day NNP O
, , O
2 CD O
days/week NN O
) -RRB- O
, , O
or CC O
carbimazole NN O
plus CC O
high JJ O
dose NN O
CT NN O
( -LRB- O
Calsynar NNP O
; : O
100 CD O
IU/day NNP O
, , O
14 CD O
days/month NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
that IN O
psbH NNS B-NP
and CC O
psbT NN B-NP
are VBP O
transcribed VBN O
from IN O
the DT O
upstream JJ O
psbB NN B-NP
gene NN I-NP
promoter NN I-NP
, , O
and CC O
that IN O
the DT O
psbH NN B-NP
mRNA NN I-NP
has VBZ O
its PRP$ O
own JJ O
target NN O
sequence NN O
for IN O
Mbb1 NNP B-NP
function NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Men NN O
presenting VBG O
with IN O
urethritis NN O
and CC O
women NNS O
presenting VBG O
with IN O
PID NNP O
both CC O
have VBP O
significantly RB O
greater JJR O
peripheral JJ O
blood NN O
mononuclear NN O
cell NN O
proliferative JJ O
responses NNS O
to TO O
the DT O
DK20 NNP O
strain NN O
of IN O
C NNP O
trachomatis NN O
than IN O
controls NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
provide VBP O
the DT O
first JJ O
evidence NN O
that IN O
differential JJ O
splicing NN O
in IN O
the DT O
extracellular JJ O
region NN O
of IN O
a DT O
receptor NN O
gene NN O
generates VBZ O
receptor NN O
variants NNS O
with IN O
different JJ O
ligand-binding NN O
specificities NNS O
. . O

-DOCSTART- X X O

Intrathecal NNP O
injections NNS O
of IN O
small JJ O
volumes NNS O
of IN O
the DT O
alpha NN B-NP
2-adrenoceptor JJ I-NP
agonists NNS O
, , O
xylazine NN O
and CC O
clonidine NN O
, , O
into IN O
the DT O
cervical JJ O
region NN O
of IN O
the DT O
spinal JJ O
cord NN O
of IN O
conscious JJ O
unrestrained JJ O
sheep NN O
produced VBD O
a DT O
dose-dependent JJ O
analgesia NN O
of IN O
the DT O
forelimbs NNS O
as IN O
measured VBN O
using VBG O
a DT O
mechanical JJ O
pressure NN O
device NN O
. . O

-DOCSTART- X X O

Estrogen NN O
has VBZ O
positive JJ O
effects NNS O
on IN O
mood NN O
, , O
sexual JJ O
function NN O
, , O
target NN O
end NN O
organs NNS O
and CC O
cognitive JJ O
function NN O
, , O
and CC O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
etiology NN O
of IN O
Alzheimer NNP O
's POS O
Disease NN O
by IN O
acting VBG O
to TO O
prevent VB O
amyloid JJ O
plaque NN O
formation NN O
, , O
oxidative JJ O
stress NN O
, , O
or CC O
deterioration NN O
of IN O
the DT O
cholinergic JJ O
neurotransmitter NN O
system NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
gentamycin NN O
on IN O
the DT O
kidney NN O
functional JJ O
state NN O
in IN O
experimental JJ O
pyelonephritis NN O

-DOCSTART- X X O

Nucleocapsid NNP O
structure NN O
and CC O
thermostability NN O
of IN O
the DT O
virion NN O
, , O
nucleocapsid JJ O
and CC O
polymerase NN O
complex NN O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
recurrences NNS O
in IN O
gingival NN O
hyperplasia NN O

-DOCSTART- X X O

Measurement NN O
of IN O
protein NN O
in IN O
natural JJ O
rubber NN O
latex RB O
. . O

-DOCSTART- X X O

Maximum NNP O
likelihood NN O
estimation NN O
in IN O
covariance NN O
structure NN O
analysis NN O
with IN O
truncated JJ O
data NNS O
. . O

-DOCSTART- X X O

The DT O
arterial JJ O
blood NN O
pressure NN O
was VBD O
measured VBN O
by IN O
using VBG O
bloody JJ O
method NN O
in IN O
anesthizied DT O
animals NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
the DT O
subcellular JJ O
location NN O
, , O
domain NN O
structure NN O
, , O
and CC O
biochemical JJ O
function NN O
of IN O
metaxin NN B-NP
were VBD O
investigated VBN O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
, , O
however RB O
, , O
uncertainty NN O
as IN O
to TO O
how WRB O
results NNS O
obtained VBD O
in IN O
recent JJ O
experiments NNS O
scale NN O
up IN O
to TO O
landscape NN O
and CC O
regional JJ O
levels NNS O
and CC O
generalize NN O
across IN O
ecosystem NN O
types NNS O
and CC O
processes NNS O
. . O

-DOCSTART- X X O

Chest NNP O
X-P NNP O
revealed VBD O
an DT O
abnormal JJ O
shadow NN O
in IN O
the DT O
left JJ O
upper JJ O
lobe NN O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
the DT O
size NN O
and CC O
organisation NN O
of IN O
the DT O
brain NN O
in IN O
man NN O
and CC O
his PRP$ O
ancestors NNS O
. . O

-DOCSTART- X X O

K562 IN O
erythroleukemia NN O
cells NNS O
stably RB O
transfected VBN O
with IN O
constructs NNS O
containing VBG O
the DT O
human JJ B-NP
Agamma-globin NNP I-NP
promoter NN I-NP
linked VBN O
to TO O
an DT O
enhanced JJ B-NP
green JJ I-NP
fluorescent NN I-NP
protein NN I-NP
( -LRB- O
EGFP NNP B-NP
) -RRB- O
reporter NN O
, , O
with IN O
or CC O
without IN O
HS2 NNP O
, , O
were VBD O
analyzed VBN O
for IN O
EGFP NNP B-NP
expression NN O
by IN O
flow NN O
cytometry NN O
. . O

-DOCSTART- X X O

Some DT O
may MD O
affect VB O
the DT O
folding JJ O
pathway NN O
or CC O
the DT O
affinity NN O
for IN O
chaperonins NNS B-NP
. . O

-DOCSTART- X X O

VBP NNP B-NP
and CC O
a1/EBP DT B-NP
could MD O
mediate VB O
the DT O
high JJ O
rates NNS O
of IN O
ALV NNP O
and CC O
RSV NNP B-NP
LTR-enhanced NNP I-NP
transcription NN O
in IN O
bursal JJ O
lymphoma NN O
cells NNS O
and CC O
many JJ O
other JJ O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

The DT O
BCL-6 NNP B-NP
POZ NNP O
domain NN O
and CC O
other JJ O
POZ NN O
domains VBZ O
interact NN O
with IN O
the DT O
co-repressors NNS O
N-CoR NNP B-NP
and CC O
SMRT. NNP B-NP

-DOCSTART- X X O

The DT O
traW JJ B-NP
gene NN I-NP
of IN I-NP
the DT I-NP
Escherichia NNP I-NP
coli NNS I-NP
K-12 . I-NP
sex NN I-NP
factor NN I-NP
, , O
F NNP O
, , O
encodes VBZ O
one CD O
of IN O
the DT O
numerous JJ O
proteins NNS O
required VBN O
for IN O
conjugative JJ O
transfer NN O
of IN O
this DT O
plasmid NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
these DT O
chemokines NNS O
is VBZ O
similar JJ O
in IN O
that DT O
both DT O
require VBP O
the DT O
NF-kappa NNP B-NP
B NNP I-NP
element NN I-NP
and CC O
additional JJ O
regions NNS O
such JJ O
as IN O
the DT O
CAAT/enhancer NNP B-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
C/EBP NN B-NP
) -RRB- O
element NN O
of IN O
the DT O
IL-8 NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
toxicity NN O
of IN O
copper NN O
to TO O
the DT O
collembolan NN O
Folsomia NNP O
fimetaria VBD O
L. NNP O
was VBD O
studied VBN O
in IN O
soil NN O
incubated VBN O
with IN O
copper NN O
sulfate NN O
for IN O
different JJ O
periods NNS O
before IN O
the DT O
introduction NN O
of IN O
collembolans NNS O
, , O
to TO O
assess VB O
the DT O
effect NN O
of IN O
aging VBG O
of IN O
contamination NN O
on IN O
the DT O
toxicity NN O
of IN O
copper NN O
. . O

-DOCSTART- X X O

Using VBG O
probes NNS O
containing VBG O
C/EBP-binding JJ B-NP
sites NNS I-NP
from IN O
the DT O
iNOS NNS B-NP
gene NN I-NP
revealed VBD O
further JJ O
binding NN O
of IN O
different JJ O
complexes NNS O
, , O
all DT O
of IN O
which WDT O
were VBD O
strongly RB O
inducible JJ O
by IN O
cAMP NNS O
and CC O
to TO O
a DT O
lower JJR O
extent NN O
also RB O
by IN O
IL-1beta NNP B-NP
. . O

-DOCSTART- X X O

The DT O
duration NN O
of IN O
PGE2 NNP O
and CC O
PGF2 NNP O
alpha NN O
elevations NNS O
as RB O
well RB O
as IN O
the DT O
peak NN O
values NNS O
were VBD O
influenced VBN O
by IN O
day NN O
of IN O
the DT O
cycle NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Lateral JJ O
PF NNP O
OA NNP O
was VBD O
more RBR O
common JJ O
than IN O
medial JJ O
PF NN O
OA NN O
( -LRB- O
P<0.0001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
we PRP O
show VBP O
that IN O
GATA-1 JJ B-NP
and CC O
Sp1 JJ B-NP
synergize NN O
from IN O
a DT O
distance NN O
in IN O
constructs NNS O
designed VBN O
to TO O
mimic VB O
the DT O
architecture NN O
of IN O
globin NN B-NP
locus NN I-NP
control NN I-NP
regions NNS I-NP
and CC O
downstream NN O
globin JJ B-NP
promoters NNS I-NP
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
space NN O
radiation NN O
are VBP O
partially RB O
known VBN O
on IN O
astronauts NNS O
, , O
but CC O
much RB O
remains VBZ O
to TO O
be VB O
discovered VBN O
. . O

-DOCSTART- X X O

First RB O
, , O
the DT O
amino-terminal JJ O
regulatory JJ O
arm NN O
of IN O
the DT O
GDI NNP B-NP
binds NNS O
to TO O
the DT O
switch NN O
I PRP O
and CC O
II NNP O
domains NNS O
of IN O
Cdc42 NNP B-NP
leading VBG O
to TO O
the DT O
inhibition NN O
of IN O
both DT O
GDP NNP O
dissociation NN O
and CC O
GTP NNP O
hydrolysis NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
virus-infected JJ O
cells NNS O
, , O
translation NN O
of IN O
the DT O
M1 JJ B-NP
protein NN I-NP
was VBD O
reduced VBN O
to TO O
10 CD O
to TO O
20 CD O
% NN O
of IN O
that DT O
of IN O
the DT O
wild-type JJ O
virus NN O
; : O
however RB O
, , O
the DT O
translation NN O
of IN O
neither DT O
the DT O
nucleoprotein JJ O
nor CC O
NS1 NNP B-NP
was VBD O
significantly RB O
interfered VBN O
with IN O
, , O
indicating VBG O
the DT O
important JJ O
role NN O
of IN O
NS1 NNP B-NP
in IN O
translational JJ O
stimulation NN O
of IN O
the DT O
M1 JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
show VBP O
that IN O
while IN O
a DT O
larger JJR O
polypeptide NN O
substrate NN O
carrying VBG O
the DT O
HD1/3C NNP B-NP
site NN I-NP
was VBD O
processed VBN O
more RBR O
efficiently RB O
than IN O
a DT O
polypeptide NN O
substrate NN O
carrying VBG O
the DT O
POL/Zn NNP B-NP
site NN I-NP
, , O
cleavage NN O
of IN O
the DT O
synthetic JJ O
peptide NN O
substrates NNS O
containing VBG O
these DT O
two CD O
cleavage JJ O
sites NNS O
occurred VBD O
at IN O
similar JJ O
efficiencies NNS O
. . O

-DOCSTART- X X O

The DT O
GST-CBL-LZIP JJ B-NP
fusion NN O
protein NN O
contains VBZ O
a DT O
binding JJ O
site NN O
for IN O
the DT O
SH2 NNP B-NP
domain NN I-NP
of IN O
the DT O
p85 NN B-NP
subunit NN I-NP
of IN O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
, , O
which WDT O
mapped VBD O
to TO O
Tyr731 NNP O
, , O
which WDT O
is VBZ O
present JJ O
in IN O
the DT O
sequence NN O
YEAM. . O

-DOCSTART- X X O

The DT O
level NN O
of IN O
transcription NN O
generated VBN O
by IN O
all DT O
of IN O
these DT O
activators NNS O
is VBZ O
greater JJR O
than IN O
the DT O
sum NN O
of IN O
the DT O
levels NNS O
generated VBN O
by IN O
individual JJ O
factors NNS O
, , O
a DT O
phenomenon NN O
designated VBN O
transcriptional JJ O
synergy NN O
. . O

-DOCSTART- X X O

Growth NN B-NP
hormone NN I-NP
exerts VBZ O
its PRP$ O
effects NNS O
on IN O
the DT O
ovarian JJ O
follicular JJ O
cycle NN O
directly RB O
or CC O
by IN O
local JJ O
production NN O
of IN O
insulin-like JJ B-NP
growth NN I-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
IGF-1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
posterior JJ O
wall NN O
is VBZ O
more RBR O
compliant JJ O
than IN O
the DT O
anterior JJ O
wall NN O
( -LRB- O
that DT O
is VBZ O
, , O
for IN O
a DT O
given VBN O
difference NN O
in IN O
transmural JJ O
pressure NN O
, , O
the DT O
local JJ O
segment NN O
length NN O
change NN O
of IN O
the DT O
posterior JJ O
wall NN O
was VBD O
greater JJR O
) -RRB- O
. . O

-DOCSTART- X X O

No DT O
consensus NN O
binding NN O
sequence NN O
could MD O
be VB O
discerned VBN O
in IN O
these DT O
fragments NNS O
and CC O
bound JJ O
factor NN O
is VBZ O
in IN O
rapid JJ O
equilibrium NN O
with IN O
unbound JJ O
. . O

-DOCSTART- X X O

Sixteen CD O
patients NNS O
( -LRB- O
25.4 CD O
% NN O
) -RRB- O
encountered VBN O
rejection NN O
while IN O
weaning VBG O
at IN O
median JJ O
period NN O
of IN O
9.5 CD O
months NNS O
( -LRB- O
range NN O
, , O
1-63 JJ O
months NNS O
) -RRB- O
from IN O
the DT O
start NN O
of IN O
weaning NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
in IN O
the DT O
untreated JJ O
patients NNS O
demonstrate VBP O
the DT O
primary JJ O
importance NN O
of IN O
bulk JJ O
reduction NN O
at IN O
initial JJ O
laparotomy NN O
. . O

-DOCSTART- X X O

Vertebrate JJ O
U6 IN B-NP
small JJ I-NP
nuclear JJ I-NP
RNA NN I-NP
( -LRB- O
snRNA NN O
) -RRB- O
loci NNS O
exemplify VBP O
a DT O
novel JJ O
class NN O
of IN O
polymerase NN B-NP
III-transcribed JJ I-NP
genes NNS O
that WDT O
lack VBP O
an DT O
intragenic JJ O
control NN O
region NN O
( -LRB- O
ICR NN O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
article NN O
focuses VBZ O
on IN O
a DT O
general JJ O
approach NN O
to TO O
the DT O
use NN O
of IN O
ARV NNP O
agents NNS O
. . O

-DOCSTART- X X O

Finally RB O
, , O
there EX O
is VBZ O
now RB O
appropriate JJ O
recognition NN O
of IN O
the DT O
pivotal JJ O
role NN O
of IN O
BP NNP O
reduction NN O
in IN O
forestalling JJ O
pressure-related JJ O
cardiovascular JJ O
complications NNS O
, , O
even RB O
among IN O
high-risk JJ O
persons NNS O
with IN O
diabetes NNS O
mellitus JJ O
and CC O
renal JJ O
insufficiency NN O
. . O

-DOCSTART- X X O

Most JJS O
other JJ O
differences NNS O
between IN O
these DT O
two CD O
Leporipoxviruses NNS O
are VBP O
located VBN O
in IN O
the DT O
telomeres NNS O
. . O

-DOCSTART- X X O

The DT O
Tat NNPS B-NP
protein NN I-NP
coded VBN O
by IN O
human JJ O
immunodeficiency NN O
virus NN O
( -LRB- O
HIV NNP O
) -RRB- O
is VBZ O
a DT O
strong JJ O
activator NN O
of IN O
viral JJ O
gene NN O
expression NN O
from IN O
the DT O
long JJ O
terminal NN O
repeat NN O
( -LRB- O
LTR NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Type JJ O
C NNP O
units NNS O
summate VBP O
the DT O
responses NNS O
to TO O
the DT O
two-tone JJ O
stimulus NN O
, , O
and CC O
show VB O
little JJ O
or CC O
no DT O
inhibitory JJ O
influences NNS O
. . O

-DOCSTART- X X O

19 CD O
, , O
4967-4973 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
gel NNP O
retardation NN O
analysis NN O
, , O
four CD O
binding JJ O
sites NNS O
for IN O
Rap1p NNP B-NP
have VBP O
been VBN O
identified VBN O
within IN O
the DT O
promoter NN O
of IN O
the DT O
RAP1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Unlike IN O
CSK NNP B-NP
, , O
the DT O
SH3 NNP B-NP
domain NN I-NP
of IN O
HYL NNP B-NP
was VBD O
unique JJ O
since IN O
the DT O
ALYDY NNP O
motif NN O
was VBD O
absent JJ O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Although IN O
low JJ O
levels NNS O
of IN O
vIRF-2 JJ B-NP
mRNAs NNS I-NP
can MD O
be VB O
detected VBN O
in IN O
the DT O
HHV-8-positive JJ O
BCBL-1 JJ O
tumor NN O
cell NN O
line NN O
, , O
12-0-tetradecanoylphorbol-13-acetate JJ O
( -LRB- O
TPA NNP O
) -RRB- O
treatment NN O
does VBZ O
not RB O
stimulate VB O
expression NN O
of IN O
vIRF-2 JJ B-NP
gene NN I-NP
together RB O
with IN O
primary JJ O
lytic JJ O
cycle NN O
genes NNS O
. . O

-DOCSTART- X X O

As IN O
anticipated VBN O
, , O
both DT O
intracellular JJ O
p54-SAPKbeta JJ B-NP
activation NN O
and CC O
Bcl-2 JJ B-NP
phosphorylation NN O
are VBP O
blocked VBN O
by IN O
co-transfection NN O
with IN O
the DT O
MAP NNP B-NP
kinase NN I-NP
specific JJ O
phosphatase NN O
MKP3/PYST1 NNP B-NP
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
In IN O
76 CD O
trials NNS O
, , O
5,351 CC O
patients NNS O
received VBD O
24 CD O
different JJ O
regimens NNS O
of IN O
droperidol NN O
. . O

-DOCSTART- X X O

One CD O
new JJ O
ORF NNP O
, , O
YBR0224 NNP B-NP
, , O
was VBD O
detected VBN O
, , O
coding VBG O
for IN O
a DT O
protein NN O
with IN O
918 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

This DT O
suggests VBZ O
that IN O
the DT O
duration NN O
of IN O
varicocele JJ O
per IN O
se NN O
could MD O
affect VB O
DHT NNP O
seminal JJ O
plasma NN O
levels NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
cognitive JJ O
performance NN O
of IN O
elderly JJ O
subjects NNS O
could MD O
be VB O
trained VBN O
to TO O
a DT O
large JJ O
extent NN O
. . O

-DOCSTART- X X O

Two CD O
genes NNS O
from IN O
the DT O
family NN O
encoding NN O
mouse NN B-NP
ribosomal JJ I-NP
protein NN I-NP
S16 . I-NP
were VBD O
cloned VBN O
, , O
sequenced VBN O
, , O
and CC O
analyzed VBD O
. . O

-DOCSTART- X X O

Replacement NNP O
of IN O
a DT O
valine NN O
( -LRB- O
V68 CD O
) -RRB- O
in IN O
the DT O
ETS NNP B-NP
domain NN O
of IN O
SAP1a NNP B-NP
by IN O
aspartic JJ O
acid NN O
( -LRB- O
as IN O
found VBN O
in IN O
c-Ets-1 NN B-NP
, , O
Elk-1 NNP B-NP
, , O
and CC O
Net JJ B-NP
) -RRB- O
enhanced JJ O
ternary JJ O
complex NN O
formation NN O
by IN O
more JJR O
than IN O
60-fold JJ O
. . O

-DOCSTART- X X O

Tissue-specific NNP O
gene NN O
regulation NN O
of IN O
eukaryotic JJ O
organisms NNS O
is VBZ O
to TO O
a DT O
large JJ O
extent NN O
mediated VBN O
by IN O
transcription NN O
factors NNS O
that WDT O
interact NN O
with IN O
genomic JJ O
DNA NNP O
sequences NNS O
in IN O
a DT O
sequence-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

As IN O
exogenously RB O
expressed VBN O
PKR NN B-NP
can MD O
form VB O
heterodimers NNS O
with IN O
endogenous JJ B-NP
PKR NNP I-NP
, , O
the DT O
results NNS O
obtained VBD O
on IN O
the DT O
functional JJ O
characterization NN O
of IN O
mutant JJ O
forms NNS O
of IN O
PKR NNP B-NP
have VBP O
been VBN O
taken VBN O
with IN O
caution NN O
. . O

-DOCSTART- X X O

Experimental JJ O
exposure NN O
of IN O
poults NNS O
with IN O
each DT O
of IN O
two CD O
strains NNS O
representing VBG O
the DT O
rarely RB O
reported VBN O
capsular JJ O
group NN O
B NNP O
indicated VBD O
that IN O
both DT O
were VBD O
virulent JJ O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
the DT O
reaction NN O
of IN O
cytochrome NN B-NP
c NNS I-NP
with IN O
corticosteroids NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
can MD O
be VB O
summarized VBN O
as RB O
follows VBZ O
. . O

-DOCSTART- X X O

The DT O
level NN O
of IN O
expression NN O
of IN O
the DT O
PDE NNP B-NP
protein NN I-NP
was VBD O
monitored VBN O
by IN O
immunoblot NN O
analysis NN O
using VBG O
two CD O
specific JJ O
cAMP-PDE JJ B-NP
polyclonal JJ I-NP
antibodies NNS I-NP
and CC O
by IN O
measuring VBG O
the DT O
PDE NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

In IN O
response NN O
to TO O
phosphorus NN O
limitation NN O
, , O
the DT O
fungus NN O
Neurospora NNP O
crassa VBD O
synthesizes NNS O
a DT O
number NN O
of IN O
enzymes NNS O
that WDT O
function VBP O
to TO O
bring VB O
more JJR O
phosphate NN O
into IN O
the DT O
cell NN O
. . O

-DOCSTART- X X O

The DT O
Cryotherapy NNP O
for IN O
Retinopathy NNP O
of IN O
Prematurity NNP O
Study NNP O
has VBZ O
shown VBN O
that IN O
this DT O
number NN O
can MD O
be VB O
halved VBN O
with IN O
treatment NN O
. . O

-DOCSTART- X X O

Many JJ O
of IN O
the DT O
metabolic JJ O
effects NNS O
induced VBN O
by IN O
thiazide DT O
diuretics NNS O
, , O
however RB O
, , O
can MD O
be VB O
limited VBN O
by IN O
the DT O
use NN O
of IN O
low JJ O
doses NNS O
. . O

-DOCSTART- X X O

This DT O
paper NN O
describes VBZ O
a DT O
longitudinal JJ O
study NN O
in IN O
which WDT O
clinical JJ O
parameters NNS O
and CC O
aspartate NN B-NP
aminotransferase NN I-NP
( -LRB- O
AST NN B-NP
) -RRB- O
in IN O
gingival NN O
crevicular JJ O
fluid NN O
( -LRB- O
GCF NN O
) -RRB- O
were VBD O
monitored VBN O
bimonthly RB O
over IN O
a DT O
6-12 JJ O
months NNS O
period NN O
in IN O
970 CD O
sites NNS O
from IN O
7 CD O
treated VBN O
periodontitis NN O
patients NNS O
. . O

-DOCSTART- X X O

Penicillamine-induced JJ O
myasthenia NN O
gravis NN O
associated VBN O
with IN O
antibodies NNS O
to TO O
acetylcholine NN B-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

A DT O
mutated JJ B-NP
ABF1 NNP I-NP
site NN I-NP
that WDT O
displays VBZ O
a DT O
very RB O
low JJ O
affinity NN O
for IN O
ABF1 NNP B-NP
does VBZ O
not RB O
functionally RB O
replace VB O
the DT O
ILV1 NNP B-NP
REB1 NNP B-NP
site NN I-NP
. . O

-DOCSTART- X X O

1.23 CD O
) -RRB- O
as IN O
a DT O
PPARalpha-interacting JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

RESULT( NNP O
S) NNP O
: : O
A DT O
prospective JJ O
study NN O
was VBD O
conducted VBN O
with IN O
44 CD O
cycles NNS O
for IN O
34 CD O
couples NNS O
with IN O
nafarelin NN O
acetate NN O
( -LRB- O
group NN O
1 CD O
) -RRB- O
and CC O
47 CD O
cycles NNS O
for IN O
40 CD O
couples NNS O
with IN O
buserelin NN O
acetate NN O
( -LRB- O
group NN O
2 CD O
) -RRB- O
with IN O
a DT O
long JJ O
IVF NN O
protocol NN O
; : O
68 CD O
cycles NNS O
for IN O
46 CD O
couples NNS O
with IN O
nafarelin NN O
acetate NN O
( -LRB- O
group NN O
3 CD O
) -RRB- O
and CC O
56 CD O
cycles NNS O
for IN O
39 CD O
couples NNS O
with IN O
buserelin NN O
acetate NN O
( -LRB- O
group NN O
4 CD O
) -RRB- O
with IN O
a DT O
short JJ O
IVF NNP O
protocol NN O
; : O
39 CD O
cycles NNS O
for IN O
32 CD O
couples NNS O
with IN O
nafarelin NN O
acetate NN O
( -LRB- O
group NN O
5 CD O
) -RRB- O
and CC O
50 CD O
cycles NNS O
for IN O
30 CD O
couples NNS O
with IN O
buserelin NN O
acetate NN O
( -LRB- O
group NN O
6 CD O
) -RRB- O
with IN O
a DT O
long JJ O
ICSI NNP O
protocol NN O
; : O
and CC O
87 CD O
cycles NNS O
for IN O
60 CD O
couples NNS O
with IN O
nafarelin NN O
acetate NN O
( -LRB- O
group NN O
7 CD O
) -RRB- O
and CC O
81 CD O
cycles NNS O
for IN O
61 CD O
couples NNS O
with IN O
buserelin NN O
acetate NN O
( -LRB- O
group NN O
8 CD O
) -RRB- O
with IN O
a DT O
short JJ O
ICSI NNP O
protocol NN O
. . O

-DOCSTART- X X O

They PRP O
are VBP O
both DT O
insensitive JJ O
to TO O
inhibitors NNS O
of IN O
serine NN B-NP
and CC I-NP
aspartyl NN I-NP
proteinases NNS I-NP
but CC O
are VBP O
sensitive JJ O
to TO O
sulfhydryl VB O
reagents NNS O
and CC O
0.5 CD O
mM JJ O
ZnCl2 NNP O
. . O

-DOCSTART- X X O

Association NNP O
between IN O
diaphragm JJ O
use NN O
and CC O
asymptomatic JJ O
bacteriuria NNS O
. . O

-DOCSTART- X X O

We PRP O
compared VBD O
these DT O
responses NNS O
for IN O
six CD O
hatchling NN O
and CC O
eight CD O
adult NN O
Chrysemys NNP O
picta NN O
from IN O
an DT O
Ohio NNP O
population NN O
. . O

-DOCSTART- X X O

INTERNET NN O
is VBZ O
literally RB O
a DT O
world NN O
of IN O
data NNS O
, , O
dialogue NN O
, , O
and CC O
discourse NN O
on IN O
any DT O
topic NN O
imaginable NN O
, , O
right RB O
at IN O
your PRP$ O
fingertips NNS O
. . O

-DOCSTART- X X O

We PRP O
established VBD O
that IN O
, , O
in IN O
unstimulated JJ O
lymphocytes NNS O
, , O
the DT O
Src NNP B-NP
homology NN I-NP
2 CD I-NP
( -LRB- O
SH2 NN B-NP
) -RRB- O
and CC O
SH3 VB B-NP
domain-containing JJ I-NP
protein NN I-NP
Grb2 NNP B-NP
and CC O
the DT O
p85 NN B-NP
subunit NN O
of IN O
phosphatidylinositol NN B-NP
3-kinase CD I-NP
, , O
associate JJ O
constitutively RB O
with IN O
Cbl JJ B-NP
via IN O
their PRP$ O
SH3 JJ B-NP
domains NNS I-NP
. . O

-DOCSTART- X X O

Indirect JJ O
determination NN O
of IN O
maximal JJ O
O2 NNP O
consumption NN O
in IN O
man NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
ICSBP NNP B-NP
and CC O
PU.1 NNP B-NP
are VBP O
critical JJ O
elements NNS O
for IN O
IL-18 NN B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

Sequence NNP O
divergence NN O
of IN O
approximately RB O
16 CD O
% NN O
reduced VBN O
transformation NN O
frequencies NNS O
by IN O
at IN O
least JJS O
10-fold JJ O
. . O

-DOCSTART- X X O

During IN O
subsequent JJ O
CS-alone JJ O
trials NNS O
, , O
the DT O
responses NNS O
of IN O
( -LRB- O
+)MK-801-injected JJ O
mice NNS O
were VBD O
extinguished VBN O
as RB O
easily RB O
as IN O
those DT O
of IN O
saline-injected JJ O
mice NNS O
. . O

-DOCSTART- X X O

The DT O
kinetics NNS O
of IN O
[14C]NG NN O
in IN O
the DT O
blood NN O
of IN O
the DT O
dosed JJ O
animals NNS O
was VBD O
followed VBN O
. . O

-DOCSTART- X X O

The DT O
data NNS O
show VBP O
that IN O
processing NN O
time NN O
as IN O
a DT O
function NN O
of IN O
intensity NN O
is VBZ O
modified VBN O
not RB O
only RB O
at IN O
the DT O
retina NN O
but CC O
also RB O
at IN O
later JJ O
processing NN O
sites NNS O
. . O

-DOCSTART- X X O

Salt NNP O
wars NNS O
. . O

-DOCSTART- X X O

Analysis NNP O
of IN O
domain NN O
deletion NN O
mutants NNS O
demonstrated VBD O
strong JJ O
synergy NN O
between IN O
the DT O
RRM NN O
and CC O
a DT O
central JJ O
degenerate NN O
RRM NN O
repeat NN O
in IN O
binding NN O
to TO O
RNA NNP O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
an DT O
immobilized JJ O
template-based JJ O
assay NN O
to TO O
examine VB O
transcription NN O
termination NN O
by IN O
VA1 NNP B-NP
, , O
7SL NNP B-NP
, , O
and CC O
Alu NNP B-NP
class NN I-NP
III NNP I-NP
templates NNS O
and CC O
the DT O
role NN O
of IN O
transcript NN O
release NN O
in IN O
the DT O
pol NN B-NP
III NNP I-NP
terminator-dependent NN O
inhibition NN O
of IN O
processing NN O
of IN O
B1-Alu JJ B-NP
transcripts NNS O
. . O

-DOCSTART- X X O

Conservation NNP O
of IN O
this DT O
zinc NN O
finger NN O
motif NN O
from IN O
yeast NN O
to TO O
mouse NN O
and CC O
human JJ O
implies VBZ O
functional JJ O
importance NN O
. . O

-DOCSTART- X X O

The DT O
terminal NN O
a DT O
sequence NN O
of IN O
the DT O
herpes NNS O
simplex JJ O
virus NN O
genome NN O
contains VBZ O
the DT O
promoter NN O
of IN O
a DT O
gene NN O
located VBN O
in IN O
the DT O
repeat NN O
sequences NNS O
of IN O
the DT O
L NNP O
component NN O
. . O

-DOCSTART- X X O

A DT O
simple JJ O
algorithm NN O
fitting VBG O
the DT O
data NNS O
for IN O
the DT O
moving VBG O
192Ir IN O
source NN O
is VBZ O
proposed VBN O
. . O

-DOCSTART- X X O

Preventing VBG O
the DT O
heterosexual JJ O
spread NN O
of IN O
HIV NNP O
into IN O
this DT O
vulnerable JJ O
population NN O
is VBZ O
a DT O
formidable JJ O
public JJ O
health NN O
challenge NN O
. . O

-DOCSTART- X X O

Several JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
corticotropin-releasing JJ B-NP
factor NN I-NP
test NN O
( -LRB- O
CRF NN B-NP
) -RRB- O
is VBZ O
useful JJ O
for IN O
the DT O
aetiological JJ O
diagnosis NN O
of IN O
Cushing NNP O
's POS O
syndrome NN O
: : O
in IN O
Cushing NNP O
's POS O
disease NN O
, , O
as IN O
opposed VBN O
to TO O
ectopic JJ O
ACTH NNP B-NP
secretion NN O
syndrome NN O
, , O
the DT O
hypothalamus-pituitary-adrenal JJ O
( -LRB- O
HPA NN O
) -RRB- O
axis NN O
can MD O
still RB O
be VB O
stimulated VBN O
by IN O
CRF. NNP B-NP

-DOCSTART- X X O

The DT O
psi NNS B-NP
zeta NN I-NP
gene NN I-NP
has VBZ O
a DT O
nonsense NN O
mutation NN O
in IN O
exon NN O
1 CD O
but CC O
has VBZ O
identical JJ O
promoter NN O
sequence NN O
and CC O
RNA NNP O
processing VBG O
sites NNS O
to TO O
the DT O
zeta NN B-NP
gene NN I-NP
, , O
raising VBG O
the DT O
possibility NN O
that IN O
both DT O
psi NNS B-NP
zeta NN I-NP
and CC O
zeta NN B-NP
are VBP O
transcriptionally RB O
active JJ O
. . O

-DOCSTART- X X O

Tax NNP B-NP
and CC O
the DT O
active JJ O
Tax NNP B-NP
mutants NNS I-NP
were VBD O
able JJ O
to TO O
abrogate VB O
the DT O
G1 NNP O
arrest NN O
and CC O
apoptosis NN O
induced VBN O
by IN O
p53 NN B-NP
, , O
and CC O
this DT O
effect NN O
does VBZ O
not RB O
correlate VB O
with IN O
an DT O
altered JJ O
localization NN O
of IN O
nuclear JJ B-NP
p53 NN I-NP
or CC O
with IN O
the DT O
disruption NN O
of IN O
p53-DNA NN B-NP
complexes NNS I-NP
. . O

-DOCSTART- X X O

Chronic NNP O
, , O
recurrent JJ O
multifocal JJ O
osteomyelitis NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
The DT O
extract VB O
of IN O
medicinal JJ O
plants NNS O
containing VBG O
curcumin NN O
is VBZ O
traditionally RB O
believed VBN O
to TO O
have VB O
a DT O
positive JJ O
contraction NN O
effect NN O
on IN O
the DT O
human JJ O
gall-bladder NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
the DT O
formation NN O
of IN O
the DT O
complex NN O
between IN O
IclR NNP B-NP
and CC O
the DT O
operator/promoter NN O
region NN O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
impaired VBN O
by IN O
phosphoenol NN O
pyruvate JJ O
but CC O
insensitive JJ O
to TO O
acetate VB O
, , O
acetyl-CoA NNS O
, , O
pyruvate JJ O
, , O
and CC O
oxaloacetate NN O
. . O

-DOCSTART- X X O

Also RB O
, , O
the DT O
RVW NNP O
hypertrophy NN O
, , O
the DT O
IVS NNP O
hypertrophy NN O
, , O
and CC O
the DT O
RV NN O
high JJ O
pressure NN O
load NN O
to TO O
the DT O
LV NNP O
through IN O
the DT O
IVS NNP O
may MD O
be VB O
related VBN O
to TO O
the DT O
small JJ O
LV NNP O
, , O
high JJ O
EF NN O
, , O
and CC O
abnormal JJ O
two CD O
chamber NN O
inflow NN O
in IN O
the DT O
PS NNP O
group NN O
before IN O
BV. NNP O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
Respiratory-related JJ O
electromyographic JJ O
( -LRB- O
EMG) NN O
activity NN O
of IN O
the DT O
superior JJ O
pharyngeal NN O
constrictor NN O
( -LRB- O
SPC NNP O
) -RRB- O
muscle NN O
was VBD O
analyzed VBN O
during IN O
the DT O
early JJ O
stage NN O
of IN O
forced JJ O
breathing NN O
. . O

-DOCSTART- X X O

Expression NNP O
, , O
characterization NN O
, , O
and CC O
genomic JJ O
structure NN O
of IN O
carp JJ B-NP
JAK1 NNP I-NP
kinase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Cough-CPR NNP O
, , O
a DT O
deep JJ O
rhythmic JJ O
forceful JJ O
cough NN O
repeated VBD O
30-60 CD O
times NNS O
per IN O
minute NN O
, , O
can MD O
be VB O
an DT O
effective JJ O
resuscitative NN O
technique NN O
during IN O
emergencies NNS O
occurring VBG O
in IN O
the DT O
cardiac NN O
catheterization NN O
laboratory NN O
. . O

-DOCSTART- X X O

The DT O
cause NN O
for IN O
the DT O
increase NN O
in IN O
plasma NN B-NP
ANP NNP I-NP
levels NNS O
in IN O
the DT O
active JJ O
phase NN O
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

-DOCSTART- X X O

Further JJ O
interventions NNS O
were VBD O
: : O
nephrectomy NN O
( -LRB- O
2x CD O
) -RRB- O
, , O
resection NN O
and CC O
ligation NN O
of IN O
the DT O
inferior JJ O
vena NN O
cava NN O
( -LRB- O
1x CD O
) -RRB- O
, , O
resection NN O
and CC O
replacement NN O
of IN O
the DT O
left JJ O
renal JJ O
vein NN O
( -LRB- O
1x CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
clones NNS O
contain VBP O
most JJS O
of IN O
the DT O
exon NN O
of IN O
cyclin NN B-NP
D2 IN I-NP
except IN O
exon NN O
5 CD O
. . O

-DOCSTART- X X O

The DT O
odds NNS O
of IN O
atopy NN O
( -LRB- O
defined VBN O
as IN O
a DT O
positive JJ O
test NN O
for IN O
at IN O
least JJS O
one CD O
of IN O
the DT O
antigens NNS O
) -RRB- O
were VBD O
5 CD O
times NNS O
higher JJR O
( -LRB- O
odds NNS O
ratio NN O
= SYM O
7.0 CD O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
= SYM O
1.6-31.1 CD O
% NN O
; : O
p NN O
= SYM O
0.01 CD O
) -RRB- O
in IN O
the DT O
uninfected JJ O
group NN O
, , O
after IN O
taking VBG O
into IN O
account NN O
the DT O
potential JJ O
influence NN O
of IN O
gender NN O
and CC O
age NN O
. . O

-DOCSTART- X X O

Similar JJ O
immunological JJ O
disturbances NNS O
were VBD O
observed VBN O
in IN O
SCI NNP O
but CC O
not RB O
in IN O
the DT O
PC2 NNP O
subgroup NN O
, , O
i IN O
.e JJ O
. . O
patients NNS O
examined VBD O
later RB O
than IN O
6 CD O
months NNS O
after IN O
injury NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
remaining VBG O
91 CD O
patients NNS O
( -LRB- O
group NN O
2 CD O
) -RRB- O
, , O
Pseudomonas NNP O
( -LRB- O
18 CD O
) -RRB- O
, , O
coagulase-negative JJ B-NP
Staphylococci NNS O
( -LRB- O
15 CD O
) -RRB- O
, , O
Staphylococcus NNP O
epidermidis NN O
( -LRB- O
23 CD O
) -RRB- O
, , O
Staphylococcus NNP O
aureus FW O
( -LRB- O
16 CD O
) -RRB- O
, , O
Corynebacterium NNP O
species NNS O
( -LRB- O
12 CD O
) -RRB- O
, , O
and CC O
others NNS O
( -LRB- O
seven CD O
) -RRB- O
were VBD O
isolated VBN O
. . O

-DOCSTART- X X O

Serum NNP O
concentrations NNS O
of IN O
hormones NNS O
in IN O
patients NNS O
classified VBD O
as IN O
C NNP O
were VBD O
characteristically NNS O
and CC O
inclined VBN O
to TO O
be VB O
hypergonadotropic JJ O
and CC O
hypoestrogenic JJ O
. . O

-DOCSTART- X X O

We PRP O
generated VBD O
" `` O
signature NN O
" '' O
oligonucleotides NNS O
from IN O
these DT O
CDR3s NNS B-NP
and CC O
probed JJ O
PCR NN O
amplified VBN O
V NNP B-NP
kappa NN I-NP
products NNS I-NP
from IN O
the DT O
synovium NN O
and CC O
PBLs NNS O
of IN O
the DT O
same JJ O
patient NN O
, , O
and CC O
from IN O
PBLs NNP O
and CC O
spleen VBN O
of IN O
individuals NNS O
without IN O
rheumatic JJ O
disease NN O
. . O

-DOCSTART- X X O

Structure NN O
and CC O
regulation NN O
of IN O
KGD2 NNP B-NP
, , O
the DT O
structural JJ O
gene NN O
for IN O
yeast NN B-NP
dihydrolipoyl NN I-NP
transsuccinylase NN I-NP
. . O

-DOCSTART- X X O

Above IN O
this DT O
transition NN O
temperature NN O
the DT O
calcium NN O
antagonist NN O
lowers NNS O
fm VBP O
more RBR O
pronouncedly RB O
than IN O
below RB O
. . O

-DOCSTART- X X O

Solution NN O
of IN O
the DT O
Boltzmann NNP O
equation NN O
in IN O
a DT O
random JJ O
magnetic JJ O
field NN O
. . O

-DOCSTART- X X O

These DT O
include VBP O
the DT O
genes NNS O
, , O
undefined JJ B-NP
1 CD I-NP
( -LRB- O
UD1 NN B-NP
) -RRB- O
, , O
UD2 NNP B-NP
, , O
and CC O
UD3 NNP B-NP
, , O
each DT O
coding NN O
for IN O
proteins NNS O
of IN O
unknown JJ O
function NN O
, , O
the DT O
ken JJ B-NP
gene NN I-NP
encoding VBG O
a DT O
new JJ O
Kruppel-like JJ B-NP
putative JJ I-NP
transcription NN I-NP
factor NN I-NP
, , O
the DT O
fly NN O
homologues NNS O
of IN O
the DT O
mammalian JJ B-NP
mitochondrial JJ I-NP
trifunctional JJ I-NP
enzyme NN I-NP
( -LRB- O
thiolase NN B-NP
) -RRB- O
, , O
and CC O
the DT O
TAR NN B-NP
DNA-binding NN I-NP
protein-43 NN I-NP
( -LRB- O
TBPH) NNP B-NP
, , O
the DT O
first JJ O
nonvertebrate JJ O
member NN O
of IN O
the DT O
transmembrane NN B-NP
4 CD I-NP
superfamily NN I-NP
( -LRB- O
TM4SF NN B-NP
) -RRB- O
gene NN O
, , O
a DT O
new JJ O
homeodomain NN B-NP
gene NN I-NP
, , O
and CC O
a DT O
gene NN O
coding NN O
for IN O
a DT O
putative JJ O
nuclear JJ O
binding JJ O
protein NN O
( -LRB- O
PNBP NN O
) -RRB- O
that WDT O
is VBZ O
homologous JJ O
to TO O
maleless JJ B-NP
, , O
and CC O
a DT O
Copia-like JJ B-NP
element NN I-NP
. . O

-DOCSTART- X X O

We PRP O
recently RB O
described VBD O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
nontoxic JJ O
PAP NNP B-NP
mutants NNS I-NP
, , O
NT123-2 NNP O
, , O
which WDT O
has VBZ O
a DT O
point NN O
mutation NN O
( -LRB- O
E176V NN O
) -RRB- O
in IN O
the DT O
active JJ O
site NN O
that IN O
abolishes NNS O
enzymatic JJ O
activity NN O
, , O
and CC O
NT124-3 NN O
, , O
which WDT O
has VBZ O
a DT O
nonsense NN O
mutation NN O
that IN O
results NNS O
in IN O
deletion NN O
of IN O
the DT O
C-terminal JJ O
25 CD O
aa JJ O
( -LRB- O
W237Stop NN O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
ligand-independent JJ O
pathway NN O
can MD O
function VB O
through IN O
another DT O
androgen-regulated JJ O
promoter NN O
as IN O
shown VBN O
by IN O
the DT O
use NN O
of IN O
the DT O
mouse NN B-NP
mammary NN I-NP
tumor NN I-NP
virus NN I-NP
MMTV-CAT JJ I-NP
reporter NN I-NP
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
low-dose JJ O
oral JJ O
contraceptives NNS O
: : O
cervical JJ O
mucus NN O
and CC O
plasma NN O
hormone NN O
changes NNS O
in IN O
relation NN O
to TO O
circulating VBG O
D-norgestrel NNP O
and CC O
17alpha CD O
ethynyl-estradiol JJ O
concentrations NNS O
. . O

-DOCSTART- X X O

On IN O
the DT O
pharmacology NN O
of IN O
9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol JJ O
( -LRB- O
WA VB O
335 CD O
) -RRB- O
, , O
a DT O
histamine NN O
and CC O
serotonin NN O
antagonist NN O

-DOCSTART- X X O

This DT O
incompatibility NN O
phenotype NN O
requires VBZ O
the DT O
global JJ O
transcriptional JJ O
repressor NN O
, , O
KorB NNP B-NP
, , O
and CC O
the DT O
target NN O
for IN O
incC-mediated JJ B-NP
incompatibility NN O
is VBZ O
a DT O
KorB-binding JJ B-NP
site NN I-NP
( -LRB- I-NP
O( JJ I-NP
B) NN I-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

A DT O
mean JJ O
value NN O
for IN O
HbA1 NNP B-NP
greater JJR O
than IN O
10 CD O
% NN O
was VBD O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
progression NN O
of IN O
retinopathy NN O
and CC O
a DT O
mean JJ O
value NN O
less JJR O
than IN O
8.7 CD O
% NN O
was VBD O
associated VBN O
with IN O
a DT O
diminished JJ O
risk NN O
. . O

-DOCSTART- X X O

Threefold JJ O
risks NNS O
were VBD O
observed VBN O
for IN O
men NNS O
with IN O
the DT O
highest JJS O
level NN O
of IN O
intensity NN O
and CC O
for IN O
those DT O
with IN O
the DT O
highest JJS O
probability NN O
of IN O
EMF NN O
exposure NN O
, , O
although IN O
women NNS O
with IN O
heavy JJ O
EMF NN O
exposure NN O
did VBD O
not RB O
experience VB O
increased VBN O
risk NN O
. . O

-DOCSTART- X X O

Early JJ O
complement NN O
components NNS O
, , O
C1q JJ B-NP
and CC O
C4 NNP B-NP
, , O
and CC O
IgA NNP B-NP
secretory NN O
piece NN O
were VBD O
absent JJ O
. . O

-DOCSTART- X X O

Erdheim-Chester NNP O
disease NN O
: : O
a DT O
distinct JJ O
lipoidosis NN O
or CC O
part NN O
of IN O
the DT O
spectrum NN O
of IN O
histiocytosis NN O
? . O
Erdheim-Chester NNP O
disease NN O
has VBZ O
always RB O
been VBN O
considered VBN O
a DT O
distinct JJ O
lipoidosis NN O
based VBN O
on IN O
clinical JJ O
and CC O
radiographic JJ O
criteria NNS O
. . O

-DOCSTART- X X O

The DT O
leader NN O
peptide NN O
was VBD O
hypothesized VBN O
to TO O
inhibit VB O
ribosome DT O
release NN O
at IN O
the DT O
tnaC JJ B-NP
stop NN I-NP
codon NN I-NP
, , O
thereby RB O
blocking VBG O
Rho NNP B-NP
's POS O
access NN O
to TO O
the DT O
transcript NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
presence NN O
of IN O
high JJ O
concentrations NNS O
( -LRB- O
propofol NN O
100 CD O
microg NN O
mL-1 NN O
, , O
thiopental JJ O
50 CD O
microg NN O
mL-1 NN O
) -RRB- O
marked VBN O
relaxation NN O
was VBD O
observed VBN O
( -LRB- O
propofol JJ O
-32 NN O
% NN O
up IN O
to TO O
-49 DT O
% NN O
, , O
P NNP O
< VBD O
0,05 CD O
; : O
thiopental JJ O
-23 CC O
% NN O
up IN O
to TO O
-67 DT O
% NN O
, , O
P NNP O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Specifically RB O
, , O
we PRP O
demonstrate VBP O
that IN O
this DT O
25-base JJ O
pair NN O
region NN O
mediates NNS O
the DT O
up-regulatory JJ O
effect NN O
of IN O
TGF-beta NNP B-NP
on IN O
COL1A2 NNP B-NP
promoter NN I-NP
activity NN O
and CC O
allows VBZ O
antagonistic JJ O
activity NN O
of IN O
TNF-alpha NNP B-NP
on IN O
the DT O
TGF-beta JJ B-NP
effect NN O
. . O

-DOCSTART- X X O

The DT O
mouse NN O
lactoferrin VBG B-NP
gene NN O
promoter NN O
was VBD O
active JJ O
in IN O
human JJ O
endometrium NN O
carcinoma NN O
RL NNP O
95-2 CD O
cells NNS O
and CC O
in IN O
rat NN O
glioma NN O
C6 IN O
cells NNS O
. . O

-DOCSTART- X X O

Computer NN O
analysis NN O
revealed VBN O
that IN O
the DT O
human JJ B-NP
protein NN I-NP
P1 DT I-NP
sequence NN I-NP
corresponding JJ O
to TO O
amino VB O
acid NN O
residues NNS O
within IN O
the DT O
N-terminal JJ O
RNA NNP O
binding NN O
domain NN O
displays VBZ O
high JJ O
homology NN O
( -LRB- O
greater JJR O
than IN O
54 CD O
% NN O
identity NN O
; : O
61 CD O
to TO O
94 CD O
% NN O
similarity NN O
) -RRB- O
with IN O
two CD O
animal NN O
virus NN O
proteins VBZ O
which WDT O
possess VBP O
RNA NNP O
binding JJ O
activity NN O
(vaccinia NNP O
virus NN B-NP
E3L NNP I-NP
; : O
rotavirus JJ B-NP
VP2 NN I-NP
) -RRB- O
and CC O
two CD O
proteins NNS O
of IN O
unknown JJ O
function NN O
( -LRB- O
murine NN B-NP
TIK NN I-NP
; : O
rotavirus NN B-NP
NS34) NN I-NP
, , O
but CC O
which WDT O
are VBP O
likely JJ O
RNA NNP O
binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Conversely RB O
the DT O
rate NN O
of IN O
bioavailability NN O
was VBD O
significantly RB O
different JJ O
, , O
because IN O
from IN O
the DT O
Reference NN O
patch NN O
the DT O
release NN O
rate NN O
is VBZ O
fast RB O
in IN O
the DT O
first JJ O
24 CD O
h NN O
, , O
leading VBG O
to TO O
an DT O
E2 JJ O
peak NN O
at IN O
8 CD O
h NN O
and CC O
to TO O
a DT O
Cmax NN O
in IN O
average NN O
at IN O
23 CD O
h NN O
. . O

-DOCSTART- X X O

A DT O
silica-based JJ O
, , O
fluoride-free JJ O
placebo NN O
containing VBG O
NaTPP NNP O
, , O
and CC O
a DT O
NaF-containing JJ O
silica-based JJ O
USP NNP O
reference NN O
standard NN O
toothpaste NN O
were VBD O
used VBN O
as IN O
negative JJ O
and CC O
positive JJ O
control NN O
toothpastes NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
cost NN O
and CC O
effectiveness NN O
of IN O
nurse NN O
education--1 NN O
. . O

-DOCSTART- X X O

No DT O
significant JJ O
difference NN O
in IN O
plasma NN O
ET NNP B-NP
levels NNS O
was VBD O
found VBN O
between IN O
cardiac JJ O
and CC O
peripheral JJ O
sampling NN O
sites NNS O
( -LRB- O
pulmonary JJ O
artery NN O
; : O
1.07 CD O
+/ CD O
- : O
0.28 CD O
, , O
right RB O
atrium NN O
; : O
1.02 CD O
+/ CD O
- : O
0.28 CD O
, , O
peripheral JJ O
artery NN O
; : O
1.12 CD O
+/ NN O
- : O
0.23 CD O
, , O
peripheral JJ O
vein NN O
; : O
1.14 CD O
+/ CD O
- : O
0.38 CD O
fmol/ml NN O
: : O
N.S. NNP O
) -RRB- O
, , O
or CC O
among IN O
patients NNS O
with IN O
uncomplicated JJ O
MI NNP O
, , O
unstable JJ O
angina NN O
( -LRB- O
1.00 CD O
+/ NN O
- : O
0.32 CD O
fmol/ml NN O
) -RRB- O
, , O
and CC O
healthy JJ O
subjects NNS O
( -LRB- O
1.01 CD O
+/ NN O
- : O
0.29 CD O
fmol/ml NN O
) -RRB- O
. . O

-DOCSTART- X X O

Transfer NN O
of IN O
health NN O
care NN O
to TO O
natives NNS O
holds VBZ O
much JJ O
promise NN O
, , O
lecturers NNS O
say VBP O
. . O

-DOCSTART- X X O

S. NNP O
aureus NN O
leakage NN O
into IN O
the DT O
totally RB O
submerged JJ O
test NN O
specimens NNS O
was VBD O
detected VBN O
in IN O
1 CD O
of IN O
5 CD O
samples NNS O
incubated VBN O
for IN O
4 CD O
weeks NNS O
, , O
while IN O
no DT O
leakage NN O
was VBD O
detected VBN O
in IN O
specimens NNS O
incubated VBN O
for IN O
3 CD O
, , O
5 CD O
, , O
6 CD O
, , O
7 CD O
, , O
and CC O
8 CD O
weeks NNS O
. . O

-DOCSTART- X X O

The DT O
Prompt NNP O
and CC O
Praise NNP O
condition NN O
was VBD O
superior JJ O
to TO O
the DT O
other JJ O
two CD O
conditions NNS O
in IN O
encouraging JJ O
participation NN O
in IN O
low-interest JJ O
recreational JJ O
activities NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
promoters NNS O
of IN O
many JJ O
immediate JJ B-NP
early JJ I-NP
genes NNS I-NP
, , O
including VBG O
c-fos NNS B-NP
, , O
CArG NNP O
DNA NNP O
regulatory JJ O
elements NNS O
mediate JJ O
basal NN O
constituitive JJ O
expression NN O
and CC O
rapid JJ O
and CC O
transient JJ O
serum NN O
induction NN O
. . O

-DOCSTART- X X O

Strains NNS O
lacking VBG O
a DT O
functional JJ B-NP
RPL16A NNP I-NP
gene NN I-NP
grow VBP O
as RB O
rapidly RB O
as IN O
wild JJ O
type NN O
, , O
whereas IN O
those DT O
containing VBG O
a DT O
null JJ O
allele NN O
of IN O
RPL16B NNP B-NP
grow VB O
more RBR O
slowly RB O
than IN O
wild JJ O
type NN O
. . O

-DOCSTART- X X O

DIC NNP O
and CC O
low JJ O
grade NN O
fibrinolysis NN O
may MD O
account VB O
for IN O
the DT O
coagulation NN O
abnormalities NNS O
of IN O
the DT O
syndrome NN O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
wild JJ O
type NN O
and CC O
SeCys/Cys NNP O
mutant NN O
of IN O
human JJ B-NP
thioredoxin NN I-NP
reductase NN I-NP
in IN O
E. NNP O
coli NNS O
: : O
the DT O
role NN O
of IN O
selenocysteine NN O
in IN O
the DT O
catalytic JJ O
activity NN O
. . O

-DOCSTART- X X O

A DT O
Meis1 NNP B-NP
cDNA NN I-NP
clone NN O
that WDT O
encoded VBD O
a DT O
novel NN O
member NN O
of IN O
the DT O
homeobox NN B-NP
gene NN I-NP
family NN I-NP
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

Cellular NNP O
lysates NNS O
were VBD O
analyzed VBN O
for IN O
luciferase NN B-NP
and CC O
beta-galactosidase JJ B-NP
activities NNS O
. . O

-DOCSTART- X X O

The DT O
protein NN O
contains VBZ O
a DT O
SHAQKYF NNP O
amino IN O
acid NN O
signature NN O
motif NN O
in IN O
the DT O
second JJ O
myb-like JJ B-NP
repeat NN I-NP
, , O
which WDT O
is VBZ O
highly RB O
conserved VBN O
in IN O
a DT O
number NN O
of IN O
recently RB O
identified VBN O
plant NN B-NP
myb-related JJ I-NP
genes NNS I-NP
, , O
thus RB O
defining VBG O
a DT O
new JJ O
class NN O
of IN O
plant NN O
DNA-binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
aluminum NN O
hydroxide NN O
was VBD O
associated VBN O
with IN O
an DT O
increase NN O
in IN O
fecal JJ O
fluoride NN O
excretion NN O
and CC O
a DT O
decrease NN O
in IN O
net JJ O
absorption NN O
of IN O
fluoride NN O
regardless RB O
of IN O
the DT O
intake JJ O
fluoride NN O
, , O
calcium NN O
, , O
phosphorus NN O
, , O
or CC O
magnesium NN O
. . O

-DOCSTART- X X O

First RB O
aid NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
and CC O
determined VBN O
the DT O
complete JJ O
nucleotide JJ O
sequence NN O
of IN O
another DT O
operon NN O
, , O
cpeCD NN B-NP
, , O
that WDT O
encodes VBZ O
the DT O
linker NN O
proteins VBZ O
associated VBN O
with IN O
phycoerythrin NN B-NP
hexamers NNS I-NP
in IN O
the DT O
phycobilisome JJ B-NP
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
results NNS O
of IN O
a DT O
detailed JJ O
study NN O
aimed VBN O
at IN O
identifying VBG O
the DT O
gene NN O
or CC O
genes NNS O
responsible JJ O
for IN O
the DT O
rapid JJ O
growth-arrest NN O
response NN O
obtained VBN O
with IN O
human JJ O
chromosome-9. NN O

-DOCSTART- X X O

A DT O
novel NN O
Cdc42Hs NNP B-NP
mutant NN I-NP
induces VBZ O
cellular JJ O
transformation NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
mechanism NN O
of IN O
ribosomal JJ O
frameshifting NN O
at IN O
the DT O
PVM NNP O
signal NN O
is VBZ O
different JJ O
from IN O
the DT O
one CD O
described VBN O
by IN O
the DT O
'simultaneous JJ O
slippage NN O
' POS O
model NN O
in IN O
that DT O
only RB O
the DT O
string NN O
of IN O
four CD O
adenosine NN O
nucleotides NNS O
represents VBZ O
the DT O
slippery JJ O
sequence NN O
involved VBN O
in IN O
a DT O
-1 NN O
P-site JJ O
slippage NN O
. . O

-DOCSTART- X X O

Kluyveromyces NNP O
lactis NN O
, , O
a DT O
budding VBG O
yeast NN O
related VBN O
to TO O
Saccharomyces NNP O
cerevisiae NNS O
, , O
can MD O
grow VB O
on IN O
a DT O
wider JJR O
variety NN O
of IN O
substrates NNS O
and CC O
shows VBZ O
less JJR O
sensitivity NN O
to TO O
glucose VB O
repression NN O
than IN O
does VBZ O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
Fc NNP I-NP
gamma NN I-NP
receptor NN I-NP
gene NN I-NP
Fc JJ B-NP
gamma NN I-NP
RIIA NNP I-NP
is VBZ O
expressed VBN O
in IN O
platelets NNS O
, , O
neutrophils NNS O
, , O
monocytes NNS O
and CC O
macrophages NNS O
. . O

-DOCSTART- X X O

Hence RB O
, , O
it PRP O
is VBZ O
perhaps RB O
not RB O
necessary JJ O
to TO O
perform VB O
spinal JJ O
puncture NN O
if IN O
the DT O
only JJ O
purpose NN O
is VBZ O
to TO O
determine VB O
the DT O
CSF/serum NNP O
ratio NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
VDR NNP B-NP
was VBD O
able JJ O
to TO O
bind NN O
to TO O
VDREs NNP O
with IN O
high JJ O
affinity NN O
and CC O
to TO O
fully RB O
activate JJ O
transcription NN O
in IN O
intact JJ O
yeast NN O
cells NNS O
in IN O
the DT O
presence NN O
of IN O
the DT O
retinoid JJ B-NP
X NNP I-NP
receptor NN I-NP
( -LRB- O
RXR NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
sequences NNS O
essential JJ O
for IN O
the DT O
transcription NN O
of IN O
EFT1 NNP B-NP
were VBD O
localized VBN O
to TO O
the DT O
region NN O
between IN O
the DT O
start NN O
ATG NNP O
and CC O
the DT O
stop NN O
codon NN O
of IN O
the DT O
VPS17 NNP B-NP
gene NN I-NP
that WDT O
terminates VBZ O
267 CD O
nt NN O
upstream RB O
on IN O
the DT O
same JJ O
strand NN O
. . O

-DOCSTART- X X O

Foreign JJ O
DNA NNP O
inserts NNS O
contained VBD O
within IN O
the DT O
fowlpox NN O
virus NN O
sequence NN O
were VBD O
transferred VBN O
to TO O
the DT O
viral JJ O
genome NN O
by IN O
homologous JJ O
recombination NN O
occurring VBG O
in IN O
cells NNS O
infected VBN O
with IN O
a DT O
fowlpox NN O
virus NN O
temperature-sensitive JJ O
mutant JJ O
and CC O
transfected VBN O
with IN O
both DT O
wild-type JJ O
viral JJ O
DNA NN O
and CC O
plasmid JJ O
DNA NN O
. . O

-DOCSTART- X X O

The DT O
LT-beta NNP B-NP
gene NN I-NP
is VBZ O
expressed VBN O
in IN O
lymphoid NN O
cells NNS O
and CC O
organs NNS O
, , O
but CC O
little RB O
is VBZ O
known VBN O
about IN O
its PRP$ O
inducible JJ O
regulation NN O
. . O

-DOCSTART- X X O

Genomic JJ O
organization NN O
of IN O
the DT O
human JJ B-NP
multidrug NN I-NP
resistance NN I-NP
( -LRB- I-NP
MDR1 NNP I-NP
) -RRB- I-NP
gene NN I-NP
and CC O
origin NN O
of IN O
P-glycoproteins NNS B-NP
. . O

-DOCSTART- X X O

Yet RB O
IL-2 JJ B-NP
and CC O
IFN-gamma NNP B-NP
production NN O
are VBP O
independently RB O
regulated VBN O
, , O
as IN O
demonstrated VBN O
by IN O
their PRP$ O
differential JJ O
expression NN O
in IN O
certain JJ O
T NNP O
cell NN O
subsets NNS O
, , O
suggesting VBG O
that IN O
the DT O
regulatory JJ O
elements NNS O
in IN O
these DT O
two CD O
genes NNS O
must MD O
differ VB O
. . O

-DOCSTART- X X O

Using VBG O
beta JJ B-NP
1-AR-luciferase JJ I-NP
reporter NN O
recombinants NNS O
, , O
we PRP O
have VBP O
previously RB O
determined VBN O
that IN O
important JJ O
beta NN B-NP
1-AR JJ I-NP
genetic JJ O
elements NNS O
controlling VBG O
expression NN O
within IN O
the DT O
C6 NNP O
glioma NNP O
cell NN O
line NN O
are VBP O
contained VBN O
within IN O
the DT O
region NN O
-396 . O
to TO O
-299 CD O
, , O
relative JJ O
to TO O
the DT O
translational JJ O
start NN O
site NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
is VBZ O
predicted VBN O
to TO O
encode VB O
an DT O
880-amino-acid JJ O
protein NN O
which WDT O
contains VBZ O
two CD O
C2H2 JJ O
zinc NN O
fingers NNS O
, , O
a DT O
nuclear JJ O
localization NN O
sequence NN O
and CC O
two CD O
transcriptional JJ O
activation NN O
domains NNS O
. . O

-DOCSTART- X X O

Pathogenesis NN O
of IN O
fever NN O
. . O

-DOCSTART- X X O

In IN O
many JJ O
other JJ O
contractile JJ O
protein NN O
gene NN O
families NNS O
, , O
genes NNS O
encoding VBG O
cardiac JJ O
isoforms NNS O
are VBP O
expressed VBN O
early JJ O
in IN O
skeletal NN O
muscle NN O
development NN O
and CC O
are VBP O
later RB O
repressed VBN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
clinical JJ O
case NN O
report NN O
of IN O
NIHF NNP O
due JJ O
to TO O
fetal JJ O
Kasabach-Merritt NNP O
syndrome NN O
that WDT O
was VBD O
prenatally RB O
diagnosed VBN O
by IN O
sonography NN O
, , O
computerized JJ O
tomography NN O
, , O
and CC O
percutaneous JJ O
umbilical JJ O
blood NN O
sampling NN O
. . O

-DOCSTART- X X O

Growth NN O
factors NNS O
promote VBP O
cell NN O
survival NN O
through IN O
phosphorylation NN O
of IN O
Bad NNP B-NP
, , O
resulting VBG O
in IN O
its PRP$ O
dissociation NN O
from IN O
Bcl-2 JJ B-NP
and CC O
Bcl-x( JJ B-NP
L NNP I-NP
) -RRB- I-NP
and CC O
its PRP$ O
association NN O
with IN O
14-3-3tau JJ B-NP
. . O

-DOCSTART- X X O

Developmental NNP O
regulation NN O
of IN O
expression NN O
of IN O
the DT O
malate NN B-NP
synthase NN I-NP
gene NN I-NP
in IN O
transgenic JJ O
plants NNS O
. . O

-DOCSTART- X X O

Of IN O
3841 CD O
serum NN O
samples NNS O
from IN O
sows NNS O
received VBN O
from IN O
the DT O
Tennessee NNP O
State NNP O
Diagnostic NNP O
Laboratory NNP O
in IN O
1991-1992 CD O
, , O
1130 CD O
were VBD O
positive JJ O
for IN O
Toxoplasma NNP B-NP
gondii NNP I-NP
antibody NN I-NP
. . O

-DOCSTART- X X O

An DT O
insertion NN O
sequence NN O
element NN O
( -LRB- O
IS1170 NNP O
) -RRB- O
was VBD O
identified VBN O
upstream RB O
of IN O
the DT O
nimC JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
the DT O
upstream JJ O
region NN O
of IN O
the DT O
beta NN B-NP
-MyHC JJ I-NP
gene NN I-NP
(-5518 . O
to TO O
-2490 DT O
relative JJ O
to TO O
the DT O
transcriptional JJ O
start NN O
site NN O
) -RRB- O
directed VBN O
high JJ O
levels NNS O
of IN O
transcriptional JJ O
activity NN O
only RB O
when WRB O
stably RB O
integrated VBN O
, , O
but CC O
not RB O
when WRB O
expressed VBN O
extrachromosomally RB O
in IN O
transient JJ O
assays NNS O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
TAM-67 JJ B-NP
reverted VBD O
the DT O
morphology NN O
of IN O
the DT O
AdoMetDC-antisense NNP B-NP
expressors NNS I-NP
. . O

-DOCSTART- X X O

Immune NNP O
and CC O
clinical JJ O
impact NN O
of IN O
Lactobacillus JJ O
acidophilus NN O
on IN O
asthma NN O
. . O

-DOCSTART- X X O

To TO O
examine VB O
the DT O
functional JJ O
relationship NN O
between IN O
distinct JJ O
cis-active JJ O
elements NNS O
within IN O
the DT O
distal JJ O
enhancer NN O
region NN O
of IN O
the DT O
rat NN B-NP
PRL NNP I-NP
gene NN I-NP
, , O
we PRP O
have VBP O
used VBN O
deletional JJ O
and CC O
mutational JJ O
analysis NN O
of IN O
that DT O
region NN O
in IN O
transient NN O
transfection NN O
studies NNS O
in IN O
GH3 DT O
pituitary JJ O
tumor NN O
cells NNS O
. . O

-DOCSTART- X X O

While IN O
there EX O
is VBZ O
growing VBG O
evidence NN O
that IN O
perception NN O
and CC O
imagery NN O
share NN O
common JJ O
neural JJ O
substrates NNS O
, , O
the DT O
fact NN O
that IN O
D.F. NNP O
shows VBZ O
intact JJ O
visual JJ O
imagery NN O
in IN O
the DT O
face NN O
of IN O
a DT O
massive JJ O
perceptual JJ O
deficit NN O
in IN O
form NN O
vision NN O
challenges NNS O
recent JJ O
suggestions NNS O
that IN O
these DT O
two CD O
psychological JJ O
processes NNS O
share VBP O
common JJ O
input NN O
pathways NNS O
in IN O
early JJ O
vision NN O
. . O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
of IN O
the DT O
conserved VBN O
cysteine NN O
residue NN O
( -LRB- O
tom1C3235A NN B-NP
) -RRB- O
in IN O
the DT O
hect-domain JJ B-NP
, , O
supposed VBN O
to TO O
be VB O
necessary JJ O
for IN O
thioester-bond JJ O
formation NN O
with IN O
ubiquitin JJ B-NP
, , O
abolished VBD O
the DT O
gene NN O
function NN O
. . O

-DOCSTART- X X O

The DT O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
protein NN O
encoded VBN O
by IN O
MSK1 NNP B-NP
is VBZ O
homologous JJ O
to TO O
yeast NN B-NP
cytoplasmic JJ I-NP
lysyl-tRNA NNS I-NP
synthetase NN I-NP
and CC O
to TO O
the DT O
product NN O
of IN O
the DT O
herC JJ B-NP
gene NN I-NP
, , O
which WDT O
has VBZ O
recently RB O
been VBN O
suggested VBN O
to TO O
code VB O
for IN O
the DT O
Escherichia NNP O
coli NNS O
enzyme NN O
. . O

-DOCSTART- X X O

Joint NNP O
ultrasonography NN O
demonstrating VBG O
thickening NN O
of IN O
synoviae NNS O
and CC O
tendons NNS O
has VBZ O
become VBN O
a DT O
useful JJ O
non-invasive JJ O
diagnostic JJ O
tool NN O
, , O
although IN O
it PRP O
is VBZ O
not RB O
specific JJ O
for IN O
beta JJ B-NP
2-M JJ I-NP
amyloidosis NN O
, , O
and CC O
results NNS O
depend VBP O
on IN O
observer JJ O
experience NN O
. . O

-DOCSTART- X X O

Videoanalysis NNP O
confirms VBZ O
the DT O
ballistic JJ O
character NN O
of IN O
the DT O
initial JJ O
phase NN O
of IN O
the DT O
reaching VBG O
movement NN O
. . O

-DOCSTART- X X O

Toward IN O
this DT O
end NN O
, , O
we PRP O
used VBD O
two CD O
cultured JJ O
colon NN O
cancer NN O
cell NN O
lines NNS O
; : O
one CD O
( -LRB- O
RKO NN O
) -RRB- O
has VBZ O
a DT O
transcriptionally RB O
activated VBN O
u-PAR NNP B-NP
gene NN I-NP
, , O
and CC O
the DT O
other JJ O
( -LRB- O
GEO NN O
) -RRB- O
overexpresses VBZ O
the DT O
receptor NN O
only RB O
after IN O
phorbol NN O
ester NN O
treatment NN O
. . O

-DOCSTART- X X O

Mortality NNP O
among IN O
patients NNS O
with IN O
CAVB NNP O
is VBZ O
still RB O
high JJ O
and CC O
has VBZ O
not RB O
declined VBN O
within IN O
the DT O
last JJ O
decade NN O
. . O

-DOCSTART- X X O

Serum NN O
triglycerides VBZ O
also RB O
showed VBD O
an DT O
increase NN O
from IN O
birth NN O
to TO O
6 CD O
months NNS O
of IN O
age NN O
, , O
but CC O
a DT O
decrease NN O
from IN O
6 CD O
months NNS O
to TO O
1 CD O
years NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
SF NNP B-NP
, , O
but CC O
not RB O
GM-CSF JJ B-NP
or CC O
IL-3 JJ B-NP
, , O
induced JJ O
tyrosine NN O
phosphorylation NN O
of IN O
phospholipase NN B-NP
C-gamma NN I-NP
( -LRB- O
PLC-gamma NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
oxalate-containing NN O
products NNS O
on IN O
the DT O
exposed JJ O
dentine NN O
surface NN O
: : O
an DT O
SEM NNP O
investigation NN O
. . O

-DOCSTART- X X O

Up IN O
to TO O
1988 CD O
, , O
145 CD O
cases NNS O
had VBD O
been VBN O
reported VBN O
in IN O
literature NN O
and CC O
32 CD O
cases NNS O
in IN O
our PRP$ O
country NN O
. . O

-DOCSTART- X X O

Disorganization NNP O
scores NNS O
of IN O
the DT O
hypertrophy NN O
zone NN O
and CC O
trabecular JJ O
bone NN O
were VBD O
low JJ O
, , O
approaching VBG O
normal JJ O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
, , O
for IN O
turkey NN O
poults NNS O
fed VBN O
on IN O
diets NNS O
with IN O
phytase NN B-NP
supplementation NN O
, , O
and CC O
tibial JJ O
abnormality NN O
scores NNS O
were VBD O
linearly RB O
decreased VBN O
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
as IN O
nP JJ O
levels NNS O
increased VBD O
(zero CD O
score NN O
is VBZ O
considered VBN O
normal JJ O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
1a CD B-NP
, , O
which WDT O
also RB O
interacts VBZ O
independently RB O
with IN O
the DT O
ER NNP O
and CC O
viral JJ O
RNA NNP O
, , O
is VBZ O
a DT O
key JJ O
organizer NN O
of IN O
RNA NNP O
replication NN O
complex JJ O
assembly NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
examine VBP O
the DT O
population NN O
of IN O
gammaS NNS B-NP
transcripts NNS I-NP
in IN O
adult NN O
human JJ O
lens NN O
and CC O
the DT O
structure NN O
of IN O
the DT O
human JJ B-NP
CRYGS NNP I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Functional JJ O
importance NN O
of IN O
a DT O
properly RB O
folded VBN O
surface NN O
loop NN O
covering VBG O
the DT O
catalytic JJ O
center NN O
. . O

-DOCSTART- X X O

This DT O
mechanism NN O
seems VBZ O
to TO O
be VB O
involved VBN O
in IN O
VIP-induced NNP B-NP
PRL NNP B-NP
gene NN I-NP
regulation NN O
. . O

-DOCSTART- X X O

A DT O
Brassica NNP O
cDNA NN O
clone NN O
encoding VBG O
a DT O
bifunctional JJ O
hydroxymethylpyrimidine NN B-NP
kinase/thiamin-phosphate NN I-NP
pyrophosphorylase NN B-NP
involved VBN O
in IN O
thiamin NN O
biosynthesis NN O
. . O

-DOCSTART- X X O

When WRB O
CSF NNP O
[HCO3-] NNP O
is VBZ O
shown VBN O
as IN O
a DT O
function NN O
of IN O
CSF NNP O
PCO2 NNP O
the DT O
data NNS O
of IN O
K-depleted JJ O
rats NNS O
are VBP O
no RB O
longer RB O
displaced VBN O
when WRB O
compared VBN O
to TO O
controls NNS O
but CC O
still RB O
have VBP O
a DT O
significantly RB O
greater JJR O
slope NN O
( -LRB- O
1.21 CD O
+/ NN O
- : O
0.23 CD O
vs. NN O

-DOCSTART- X X O

In IN O
the DT O
matched VBN O
control NN O
group NN O
the DT O
acquisition-rate NN O
of IN O
both DT O
symptomatic JJ O
and CC O
asymptomatic JJ O
0acteriuria NN O
was VBD O
over IN O
12 CD O
% NN O
, , O
a DT O
figure NN O
similar JJ O
to TO O
the DT O
percentage NN O
of IN O
women NNS O
present JJ O
in IN O
the DT O
practice NN O
population NN O
during IN O
one CD O
year NN O
with IN O
transient NN O
, , O
symptomatic JJ O
, , O
and CC O
persistent JJ O
A.B. . O

-DOCSTART- X X O

In IN O
2 CD O
subjects NNS O
the DT O
phytomitogen NN O
reactivity NN O
of IN O
the DT O
lymphocytes NNS O
was VBD O
improved VBN O
after IN O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
maintenance NN O
of IN O
increased VBN O
myocardial JJ O
capillary NN O
density NN O
required VBD O
a DT O
similar JJ O
amount NN O
of IN O
exercise NN O
, , O
and CC O
at IN O
least JJS O
1 CD O
h NN O
of IN O
exercise NN O
once RB O
a DT O
week NN O
was VBD O
necessary JJ O
to TO O
maintain VB O
the DT O
enlargement NN O
of IN O
ECA.20 CD O

-DOCSTART- X X O

These DT O
observations NNS O
have VBP O
led VBN O
us PRP O
to TO O
conclude VB O
that IN O
an DT O
elevated JJ O
VIII-ratio NN O
is VBZ O
a DT O
very RB O
sensitive JJ O
indicator NN O
of IN O
intravascular JJ O
coagulation NN O
. . O

-DOCSTART- X X O

The DT O
inner JJ O
ears NNS O
were VBD O
exposed VBN O
by IN O
microdissection NN O
, , O
and CC O
the DT O
vestibular JJ O
sensory JJ O
regions NNS O
were VBD O
either RB O
sectioned VBN O
and CC O
studied VBN O
with IN O
light NN O
or CC O
electron NN O
microscopy NN O
, , O
or CC O
prepared VBN O
and CC O
studied VBN O
with IN O
the DT O
surface NN O
specimen VBN O
technique NN O
. . O

-DOCSTART- X X O

The DT O
matrix NN O
surrounding VBG O
the DT O
clusters NNS O
either CC O
showed VBD O
a DT O
normal JJ O
morphology NN O
or CC O
a DT O
homogeneous JJ O
appearance NN O
, , O
within IN O
which WDT O
faint JJ O
cross NN O
striations NNS O
but CC O
no DT O
distinctly RB O
fibrillar JJ O
outlines NNS O
could MD O
be VB O
identified VBN O
. . O

-DOCSTART- X X O

The DT O
incidence NN O
of IN O
DNCB NNP O
reactions NNS O
was VBD O
78 CD O
per IN O
cent NN O
for IN O
Stage NN O
I PRP O
and CC O
II NNP O
cancers NNS O
( -LRB- O
37 CD O
patinets NNS O
) -RRB- O
, , O
73 CD O
per IN O
cent NN O
for IN O
resectable JJ O
Stage NNP O
III NNP O
cancer NN O
( -LRB- O
22 CD O
patients NNS O
) -RRB- O
, , O
and CC O
66 CD O
per IN O
cent NN O
in IN O
patients NNS O
with IN O
unresectable JJ O
or CC O
inoperable JJ O
Stage NN O
III NNP O
cancer NN O
. . O

-DOCSTART- X X O

Workers NNS O
with IN O
" `` O
sensitivity NN O
" '' O
to TO O
toluene DT O
diisocyanate NN O
( -LRB- O
TDI) NNP O
studied VBD O
in IN O
depth NN O
in IN O
an DT O
attempt NN O
to TO O
determine VB O
mechanisms NNS O
of IN O
bronchial JJ O
hyperreactivity NN O
. . O

-DOCSTART- X X O

Bertioga NNP O
( -LRB- O
Guama NNP O
group NN O
) -RRB- O
and CC O
Anhembi NNP O
( -LRB- O
Bunyamwera NN O
group NN O
) -RRB- O
, , O
two CD O
new JJ O
arboviruses NNS O
isolated VBN O
in IN O
Sao NNP O
Paulo NNP O
, , O
Brazil NNP O
. . O

-DOCSTART- X X O

The DT O
'field JJ O
of IN O
stress NN O
' '' O
of IN O
the DT O
supervisory JJ O
nurse NN O

-DOCSTART- X X O

Williams NNP O
, , O
2 CD O
August NNP O
1977 CD O
. . O

-DOCSTART- X X O

Disrupted VBN O
vaccines NNS O
and CC O
whole-virus NN O
vaccines NNS O
containing VBG O
type NN B-NP
B NNP I-NP
antigen NN I-NP
only RB O
did VBD O
not RB O
cause VB O
significant JJ O
reactivity NN O
. . O

-DOCSTART- X X O

255-61 CD O
. . O

-DOCSTART- X X O

The DT O
maximum JJ O
period NN O
of IN O
treatment NN O
was VBD O
73 CD O
(oral JJ O
) -RRB- O
, , O
73 CD O
( -LRB- O
intraperitoneal NN O
) -RRB- O
or CC O
75 CD O
( -LRB- O
dermal JJ O
) -RRB- O
weeks NNS O
. . O

-DOCSTART- X X O

Bone NNP O
marrow NN O
transplantation-1979 NN O
. . O

-DOCSTART- X X O

Inherent JJ O
hematology NN O
of IN O
old JJ O
age NN O

-DOCSTART- X X O

Immunologic NNP O
mechanisms NNS O
in IN O
chronic JJ O
brucellosis NN O
in IN O
humans NNS O
. . O

-DOCSTART- X X O

This DT O
expression NN O
assumes VBZ O
: : O
( -LRB- O
1 CD O
) -RRB- O
a DT O
laminar NN O
flow NN O
regimen RB O
during IN O
expiration NN O
, , O
and CC O
( -LRB- O
2 CD O
) -RRB- O
a DT O
constant JJ O
CT NN O
value NN O
over IN O
the DT O
range NN O
of IN O
VT. NNP O

-DOCSTART- X X O

In IN O
addition NN O
a DT O
significant JJ O
Treatment NNP O
X NNP O
Strain NNP O
interaction NN O
was VBD O
due JJ O
to TO O
the DT O
larger JJR O
defecation NN O
numbers NNS O
displayed VBN O
by IN O
the DT O
taurine-injected JJ O
MR NNP O
rats NNS O
relative JJ O
to TO O
the DT O
saline-injected JJ O
MR NNP O
rats NNS O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
come VBN O
out RP O
that IN O
CAEC NNP O
is VBZ O
between IN O
CC NNP O
and CC O
CIEC NNP O
and CC O
that DT O
attacks NNS O
of IN O
biliary NN O
fever NN O
and CC O
high JJ O
levels NNS O
of IN O
alkaline NN B-NP
phosphatase NN I-NP
and CC O
transaminases NNS O
in IN O
the DT O
serum NN O
are VBP O
the DT O
helpful JJ O
findings NNS O
for IN O
preoperative JJ O
diagnosis NN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
examined VBD O
the DT O
dependence NN O
of IN O
difference NN O
tone NN O
level NN O
[ JJ O
L(f2-f1 JJ O
) -RRB- O
] SYM O
on IN O
the DT O
following VBG O
parameters NNS O
of IN O
the DT O
two-tone JJ O
input NN O
: : O
f1 CD O
, , O
f2/f1 FW O
( -LRB- O
f2 NN O
greater JJR O
than IN O
f1 CD O
) -RRB- O
, , O
L1 NNP O
, , O
L2 NNP O
, , O
and CC O
L1 NNP O
= SYM O
L2 CD O
. . O

-DOCSTART- X X O

All DT O
13 CD O
patients NNS O
showed VBD O
endoscopic JJ O
evidence NN O
of IN O
oesophagitis NN O
, , O
moderate JJ O
in IN O
4 CD O
and CC O
severe JJ O
in IN O
9 CD O
. . O

-DOCSTART- X X O

Urinary JJ O
excretion NN O
of IN O
oestrone JJ O
, , O
oestradiol-17 JJ O
beta NN O
and CC O
oestriol NN O
in IN O
pregnancies NNS O
complicated VBN O
by IN O
steroid JJ B-NP
sulphatase NN I-NP
deficiency NN O
. . O

-DOCSTART- X X O

When WRB O
two CD O
determinations NNS O
were VBD O
performed VBN O
on IN O
12 CD O
samples NNS O
of IN O
plasma NN O
taken VBN O
from IN O
normal JJ O
adults NNS O
in IN O
October NNP O
, , O
the DT O
values NNS O
were VBD O
22.6 CD O
+/ JJ O
- : O
4.8 CD O
and CC O
21.0 CD O
+/ NNS O
- : O
3.6 CD O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NN O
) -RRB- O
ng/ml NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

None NN O
of IN O
the DT O
cystometrograms NNS O
showed VBD O
uninhibited JJ O
detrusor NN O
contractions NNS O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
Graves NNP O
' POS O
disease NN O
. . O

-DOCSTART- X X O

A DT O
highly RB O
significant JJ O
correlation NN O
was VBD O
found VBN O
between IN O
the DT O
presence NN O
of IN O
fibrinolytic JJ O
degradation NN O
products NNS O
( -LRB- O
FDP NNP O
) -RRB- O
and CC O
the DT O
incidence NN O
of IN O
nephropathy NN O
and CC O
renal JJ O
insufficiency NN O
, , O
as RB O
well RB O
as IN O
between IN O
the DT O
presence NN O
of IN O
fibrin NN B-NP
monomers NNS I-NP
( -LRB- O
Godal NNP O
's POS O
ethanol-gelification JJ O
test NN O
) -RRB- O
and CC O
the DT O
evolutive JJ O
signs NNS O
of IN O
the DT O
primary JJ O
disease NN O
( -LRB- O
fever NN O
, , O
accelerated VBN O
ESR NNP O
) -RRB- O
. . O

-DOCSTART- X X O

2 CD O
cases NNS O
of IN O
toxic JJ O
lymphomononucleosis NN O

-DOCSTART- X X O

A DT O
one-week JJ O
ulcer NN O
therapy NN O
with IN O
atropine NN O
and CC O
Vikalin NNP O
( -LRB- O
Roter NNP O
) -RRB- O
led VBD O
to TO O
a DT O
significant JJ O
( -LRB- O
p NN O
less JJR O
than IN O
0.01 CD O
) -RRB- O
reduction NN O
of IN O
the DT O
nocturnal JJ O
proteolytic JJ O
activity NN O
. . O

-DOCSTART- X X O

Action NNP O
of IN O
strontium-90 JJ O
and CC O
metaphos NNS O
on IN O
Cyprinus NNP O
carpio NN O

-DOCSTART- X X O

Escherichia NNP O
of IN O
a DT O
single JJ O
sero-anzymatic JJ O
type NN O
( -LRB- O
06a6b NN O
: : O
K13 `` O
: : O
H1 CD O
) -RRB- O
were VBD O
isolated VBN O
in IN O
a DT O
group NN O
affection NN O
. . O

-DOCSTART- X X O

A DT O
one-way JJ O
analysis NN O
of IN O
variance NN O
, , O
performed VBN O
separately RB O
for IN O
men NNS O
and CC O
women NNS O
for IN O
differences NNS O
among IN O
the DT O
three CD O
phobic JJ O
groups NNS O
on IN O
field NN O
dependence NN O
, , O
showed VBD O
significance NN O
( -LRB- O
rho RB O
less JJR O
than IN O
.05 CD O
) -RRB- O
for IN O
the DT O
females NNS O
, , O
with IN O
the DT O
famale NN O
agoraphobic IN O
being VBG O
more RBR O
field NN O
dependent JJ O
than IN O
the DT O
female JJ O
simple JJ O
phobic JJ O
groups NNS O
, , O
but CC O
not RB O
for IN O
the DT O
males NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
a DT O
quantitative JJ O
study NN O
of IN O
vasculosyncytial JJ O
membranes NNS O
in IN O
123 CD O
placentas NNS O
are VBP O
presented VBN O
. . O

-DOCSTART- X X O

Platelet NN O
serotonin NN O
(5-HT) JJ O
and CC O
5-HT JJ B-NP
releasing VBG I-NP
factor NN I-NP
in IN O
plasma NN O
of IN O
migrainous JJ O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
vigilance NN O
task NN O
and CC O
the DT O
measurement NN O
of IN O
attentional JJ O
deficits NNS O
. . O

-DOCSTART- X X O

Absorption NN O
varied VBN O
between IN O
65 CD O
and CC O
95 CD O
per IN O
cent NN O
, , O
with IN O
a DT O
mean JJ O
absorption NN O
of IN O
80 CD O
per IN O
cent NN O
, , O
in IN O
both DT O
pregnant JJ O
and CC O
non-pregnant JJ O
subjects NNS O
. . O

-DOCSTART- X X O

A DT O
diagnosis NN O
of IN O
MS NNP O
was VBD O
made VBN O
based VBN O
on IN O
subtle JJ O
neurologic NN O
signs NNS O
, , O
spinal JJ O
fluid NN O
gamma NN B-NP
globulin NN I-NP
elevations NNS O
, , O
and CC O
abnormalities NNS O
in IN O
neuropsychological JJ O
testing NN O
. . O

-DOCSTART- X X O

The DT O
elevated JJ O
Viso NNP O
V NNP O
in IN O
the DT O
RDS NNP O
group NN O
suggests VBZ O
an DT O
increase NN O
in IN O
small JJ O
airway NN O
resistance NN O
secondary JJ O
to TO O
the DT O
disease NN O
or CC O
to TO O
its PRP$ O
therapy NN O
. . O

-DOCSTART- X X O

The DT O
psychological JJ O
tests NNS O
consisted VBD O
of IN O
a DT O
free-recall JJ O
task NN O
, , O
a DT O
test NN O
for IN O
visuomotor NN O
coordination NN O
and CC O
a DT O
recognition NN O
task NN O
. . O

-DOCSTART- X X O

Eleven NNP O
strains NNS O
of IN O
Fusarium NNP O
poae NNS O
and CC O
F. NNP O
sporotrichioides NNS O
from IN O
the DT O
U.S.S.R. NNP O
and CC O
7 CD O
strains NNS O
of IN O
these DT O
species NNS O
and CC O
one CD O
of IN O
F. NNP O
sporotrichioides NNS O
var NN O
. . O
tricinctum NN O
from IN O
U.S.A. NNP O
and CC O
France NNP O
have VBP O
been VBN O
compared VBN O
as IN O
to TO O
their PRP$ O
capacity NN O
to TO O
yield VB O
T-2 JJ B-NP
toxin NN I-NP
. . O

-DOCSTART- X X O

Amikacin NNP O
was VBD O
used VBN O
in IN O
the DT O
treatment NN O
of IN O
56 CD O
serious JJ O
gram-negative JJ O
infections NNS O
in IN O
54 CD O
patients NNS O
of IN O
whom WP O
47 CD O
survived VBD O
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
the DT O
new JJ O
Gravigard NNP O
IUCD NNP O
inserter NN O
. . O

-DOCSTART- X X O

Well-visualised JJ O
arteriograms NNS O
of IN O
the DT O
limbs NNS O
can MD O
be VB O
obtained VBN O
by IN O
xeroradiography NN O
after IN O
rapid JJ O
manual NN O
injection NN O
of IN O
contrast-medium NN O
into IN O
an DT O
arm NN O
vein NN O
, , O
as IN O
demonstrated VBN O
in IN O
28 CD O
patients NNS O
. . O

-DOCSTART- X X O

Possibility NN O
of IN O
a DT O
TSH-Screening JJ B-NP
method NN O
for IN O
detection NN O
of IN O
hypothyroidism NN O
in IN O
the DT O
newborn JJ O

-DOCSTART- X X O

Thus RB O
analysis NN O
indicated VBD O
no DT O
reliable JJ O
evidence NN O
that IN O
conscious JJ O
presleep NN O
suggestions NNS O
become VBP O
incorporated JJ O
into IN O
dream NN O
content NN O
. . O

-DOCSTART- X X O

Batch NNP O
cultures NNS O
of IN O
S. NNP O
mutans NNS O
serotype VBP O
a DT O
demonstrated VBD O
no DT O
growth NN O
on IN O
MSB NNP O
agar NN O
. . O

-DOCSTART- X X O

Pregnant JJ O
women NNS O
at IN O
term NN O
had VBD O
the DT O
lowest JJS O
levels NNS O
of IN O
antithrombin JJ B-NP
III NNP I-NP
. . O

-DOCSTART- X X O

The DT O
recovered VBD O
calves NNS O
were VBD O
tested VBN O
for IN O
immunity NN O
to TO O
homologous JJ O
severe JJ O
challenge NN O
, , O
50 CD O
or CC O
73 CD O
days NNS O
after IN O
the DT O
first JJ O
infection NN O
. . O

-DOCSTART- X X O

Preflight NNP O
, , O
inflight NN O
, , O
and CC O
postflight JJ O
exercise NN O
response NN O
tests NNS O
were VBD O
conducted VBN O
on IN O
the DT O
astronauts NNS O
of IN O
the DT O
second JJ O
Skylab NNP O
mission NN O
(Skylab NN O
3 CD O
) -RRB- O
as IN O
part NN O
of IN O
an DT O
evaluation NN O
of IN O
physiological JJ O
adaptation NN O
to TO O
long-term JJ O
weightlessness NN O
. . O

-DOCSTART- X X O

E NNP O
50 CD O
, , O
843 CD O
( -LRB- O
1994 CD O
)] NN O
. . O

-DOCSTART- X X O

With IN O
the DT O
help NN O
of IN O
a DT O
nomogram NN O
one NN O
can MD O
read VB O
off IN O
the DT O
refraction NN O
, , O
when WRB O
axis DT O
length NN O
and CC O
corneal NN O
curvature NN O
are VBP O
known VBN O
. . O

-DOCSTART- X X O

Potscoital JJ O
test NN O

-DOCSTART- X X O

Since IN O
1968 CD O
, , O
a DT O
steep JJ O
decrease NN O
in IN O
the DT O
number NN O
of IN O
strains NNS O
resistant JJ O
to TO O
three CD O
or CC O
more JJR O
antibiotics NNS O
( -LRB- O
multiple-resistant JJ O
) -RRB- O
and CC O
in IN O
strains NNS O
of IN O
the DT O
83A NN O
complex NN O
was VBD O
noticed VBN O
. . O

-DOCSTART- X X O

Alpha-1 NNP B-NP
antitrypsin NN I-NP
and CC O
Indian JJ O
childhood NN O
cirrhosis NN O
. . O

-DOCSTART- X X O

Two CD O
patients NNS O
were VBD O
treated VBN O
with IN O
both DT O
regimens NNS O
. . O

-DOCSTART- X X O

IgG NNP B-NP
levels NNS O
of IN O
1/100 CD O
were VBD O
present JJ O
in IN O
only RB O
four CD O
out IN O
of IN O
ten CD O
samples NNS O
obtained VBN O
150 CD O
days NNS O
after IN O
the DT O
clinical JJ O
onset NN O
. . O

-DOCSTART- X X O

Letter NNP O
: : O
Perspectives NNS O
in IN O
bone NN O
marrow NN O
transplantation NN O
. . O

-DOCSTART- X X O

A DT O
clinically RB O
useful JJ O
diagnostic JJ O
method NN O
has VBZ O
been VBN O
developed VBN O
for IN O
detecting VBG O
and CC O
quantitating VBG O
periods NNS O
of IN O
apnea NN O
in IN O
pediatric JJ O
patients NNS O
. . O

-DOCSTART- X X O

Before IN O
this DT O
date NN O
, , O
the DT O
drug NN O
directly RB O
inhibits VBZ O
fetal NN O
weight NN O
gain NN O
, , O
whereas IN O
the DT O
sensitivity NN O
of IN O
the DT O
placenta NN O
is VBZ O
only RB O
transient JJ O
at IN O
day NN O
16 CD O
resulting VBG O
in IN O
maximum NN O
weight NN O
decrease NN O
of IN O
this DT O
organ NN O
24 CD O
h NN O
later RB O
. . O

-DOCSTART- X X O

The DT O
interpretation NN O
of IN O
antibiotic JJ O
disc NN O
sensitivities NNS O
. . O

-DOCSTART- X X O

Her PRP$ O
serum NN O
FT3 IN O
concentration NN O
was VBD O
, , O
however RB O
, , O
much RB O
higher JJR O
than IN O
the DT O
ranges NNS O
in IN O
normal JJ O
pregnancy NN O
or CC O
in IN O
GTD NNP O
patients NNS O
without IN O
clinical JJ O
hyperthyroidism NN O
. . O

-DOCSTART- X X O

Hypertonic NNP O
glucose NN O
administered VBN O
intrajejunally RB O
in IN O
Heidenhain NNP O
pouch NN O
dogs VBZ O
resulted VBN O
in IN O
an DT O
equal JJ O
inhibition NN O
of IN O
pentagastrin-induced JJ O
acid NN O
secretion NN O
from IN O
the DT O
pouch NN O
and CC O
the DT O
main JJ O
stomach NN O
, , O
whereas IN O
hypertonic JJ O
saline NN O
had VBD O
no DT O
effect NN O
. . O

-DOCSTART- X X O

The DT O
study NN O
of IN O
calcium NN O
metabolism NN O
in IN O
ten CD O
thalassaemic IN O
children NNS O
comperatively RB O
with IN O
controls NNS O
after IN O
oral JJ O
administration NN O
of IN O
47Ca DT O
has VBZ O
shown VBN O
diminished VBN O
intestinal JJ O
absorption NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
insulin NN B-NP
response NN O
had VBD O
returned VBN O
to TO O
the DT O
non-pregnant JJ O
value NN O
by IN O
the DT O
second JJ O
day NN O
of IN O
the DT O
puerperium NN O
. . O

-DOCSTART- X X O

The DT O
apparent JJ O
Kd NNP O
of IN O
the DT O
MetRS/CAU NNP B-NP
operator NN I-NP
complex NN I-NP
is VBZ O
one CD O
order NN O
magnitude NN O
higher JJR O
than IN O
that DT O
of IN O
the DT O
ThrRS/CGU NNP B-NP
operator NN I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
human JJ B-NP
gene NN I-NP
encoding NN I-NP
cytokeratin NN I-NP
17 CD I-NP
and CC O
its PRP$ O
expression NN O
pattern NN O
. . O

-DOCSTART- X X O

For IN O
the DT O
first JJ O
group NN O
, , O
the DT O
maximal JJ O
decrease NN O
in IN O
plasma NN O
potassium NN O
elicited VBN O
by IN O
salbutamol NN O
was VBD O
0.80 CD O
+/ CD O
- : O
0.19 CD O
, , O
0.48 CD O
+/ NNS O
- : O
0.22 CD O
, , O
and CC O
0.78 CD O
+/ NNS O
- : O
0.46 CD O
mmol/l NN O
, , O
and CC O
for IN O
the DT O
second JJ O
group NN O
, , O
maximal JJ O
decrement NN O
was VBD O
1.31 CD O
+/ CD O
- : O
0.37 CD O
, , O
0.70 CD O
+/ NNS O
- : O
0.24 CD O
, , O
and CC O
0.84 CD O
+/ NNS O
- : O
0.17 CD O
mmol/l NN O
for IN O
the DT O
iv NN O
, , O
po NN O
, , O
and CC O
it PRP O
routes NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
two CD O
drugs NNS O
increase VBP O
the DT O
rate NN O
of IN O
early JJ O
diastolic JJ O
filling NN O
. . O

-DOCSTART- X X O

100 CD O
years NNS O
of IN O
dentistry NN O
at IN O
the DT O
Friedrich NNP O
Schiller NNP O
University NNP O
in IN O
Jena NNP O

-DOCSTART- X X O

These DT O
studies NNS O
show VBP O
that IN O
UCRBP NNP B-NP
binds NNS O
to TO O
various JJ O
target NN O
motifs NNS O
that WDT O
are VBP O
distinct JJ O
from IN O
the DT O
UCR NNP O
motif NN O
: : O
the DT O
adeno-associated JJ B-NP
virus NN I-NP
P5 DT I-NP
promoter NN I-NP
and CC O
elements NNS O
in IN O
the DT O
immunoglobulin NN B-NP
light NN I-NP
- : I-NP
and CC I-NP
heavy-chain JJ I-NP
genes NNS O
, , O
as RB O
well RB O
as IN O
elements NNS O
in IN O
ribosomal JJ B-NP
protein NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
receptor NN O
structure NN O
includes VBZ O
a DT O
cysteine-rich JJ O
extracellular JJ O
domain NN O
, , O
a DT O
single JJ O
hydrophobic JJ O
transmembrane NN O
domain NN O
, , O
and CC O
a DT O
predicted VBD O
cytoplasmic JJ B-NP
serine/threonine NN I-NP
kinase NN I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
gel NN O
mobility NN O
shift NN O
experiments NNS O
have VBP O
failed VBN O
to TO O
reveal VB O
that IN O
HAP2 NNP B-NP
or CC O
HAP3 NNP B-NP
binds NNS O
to TO O
domain NN O
1 CD O
or CC O
that DT O
hap3 JJ B-NP
mutations NNS O
affect VBP O
the DT O
complexes NNS O
bound VBD O
to TO O
it PRP O
. . O

-DOCSTART- X X O

Two CD O
points NNS O
are VBP O
indicated VBN O
: : O
first JJ O
, , O
the DT O
photosensitized JJ O
damage NN O
of IN O
YHPD NNP O
is VBZ O
interrelated VBN O
to TO O
not RB O
only RB O
1O2 VB O
, , O
but CC O
also RB O
free JJ O
radicals NNS O
( -LRB- O
O2-. DT O
.OH NNP O
and CC O
YHPD-. NNP O
) -RRB- O
; : O
second JJ O
, , O
although IN O
the DT O
photosensitized JJ O
damage NN O
of IN O
YHPD NN O
is VBZ O
stronger JJR O
than IN O
that DT O
of IN O
BHPD NNP O
, , O
yet RB O
the DT O
photosensitized JJ O
damage NN O
is VBZ O
negatively RB O
correlated VBN O
to TO O
the DT O
yield NN O
of IN O
1O2 JJ O
but CC O
positively RB O
correlated JJ O
to TO O
those DT O
of IN O
O2-. NNP O
and CC O
OH. NNP O

-DOCSTART- X X O

Fructokinase NNP B-NP
activity NN O
is VBZ O
elevated VBN O
up RP O
to TO O
twofold RB O
when WRB O
Z. NNP O
mobilis VBD O
was VBD O
grown VBN O
on IN O
fructose NN O
instead RB O
of IN O
glucose NN O
, , O
and CC O
there EX O
was VBD O
a DT O
parallel JJ O
increase NN O
in IN O
frk JJ B-NP
mRNA NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
IgG NNP B-NP
antibodies NNS I-NP
vs JJ O
HHV-6 NN O
( -LRB- O
anti-HHV-6-IgG JJ B-NP
) -RRB- O
were VBD O
determined VBN O
by IN O
indirect JJ O
immunofluorescence NN O
in IN O
100 CD O
IVDA NNP O
( -LRB- O
29 CD O
seronegative NN O
and CC O
71 CD O
seropositive JJ O
for IN O
HIV-1 NN O
of IN O
which WDT O
45 CD O
were VBD O
in IN O
stage NN O
II NNP O
and CC O
26 CD O
in IN O
IV-C1 NNP O
of IN O
CDC NNP O
) -RRB- O
as RB O
well RB O
as IN O
in IN O
100 CD O
healthy JJ O
subjects NNS O
of IN O
a DT O
similar JJ O
age NN O
( -LRB- O
control NN O
group NN O
) -RRB- O
. . O

-DOCSTART- X X O

Possible JJ O
roles NNS O
of IN O
RAD5 DT B-NP
putative JJ O
ATPase/DNA NNP B-NP
helicase NN B-NP
activity NN O
in IN O
DNA NNP O
repair NN O
and CC O
in IN O
the DT O
maintenance NN O
of IN O
wild-type JJ O
rates NNS O
of IN O
instability NN O
of IN O
simple JJ O
repetitive JJ O
sequences NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Replication NNP O
of IN O
bovine NN O
papillomavirus-1 NN O
( -LRB- O
BPV-1 JJ O
) -RRB- O
DNA NN O
requires VBZ O
two CD O
viral JJ O
gene NN O
products NNS O
, , O
the DT O
E1 JJ B-NP
protein NN I-NP
and CC O
the DT O
full-length JJ B-NP
E2 JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Insertional NNP O
inactivation NN O
of IN O
sms NNS B-NP
led VBN O
to TO O
increased VBN O
sensitivity NN O
to TO O
the DT O
alkylating NN O
agent NN O
methylmethane NN O
sulfonate NN O
, , O
but CC O
not RB O
to TO O
a DT O
requirement NN O
for IN O
serine NN O
or CC O
other JJ O
metabolites NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
MAP NNP B-NP
kinase NN I-NP
activator/MAP NN I-NP
kinase NN B-NP
system NN O
may MD O
be VB O
the DT O
downstream JJ O
components NNS O
of IN O
ras JJ B-NP
signal NN O
transduction NN O
pathways NNS O
. . O

-DOCSTART- X X O

T-cell NN B-NP
receptor NN I-NP
beta JJ I-NP
(TCR NN O
beta NN B-NP
) -RRB- O
gene NN O
rearrangements NNS O
occur VBP O
in IN O
a DT O
third JJ O
of IN O
early RB O
B-cell JJ O
acute JJ O
lymphoblastic JJ O
leukemias NNS O
( -LRB- O
ALLs NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
minimal JJ O
promoter NN O
of IN O
the DT O
RII NNP B-NP
beta NN I-NP
gene NN I-NP
was VBD O
composed VBN O
of IN O
two CD O
adjacent JJ O
functional JJ O
elements NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that IN O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
or CC O
platelet-derived VBN B-NP
growth NN I-NP
factor NN I-NP
stimulation NN O
of IN O
intact JJ O
human JJ O
or CC O
murine JJ O
cells NNS O
leads VBZ O
to TO O
phosphorylation NN O
of IN O
Nck JJ B-NP
protein NN I-NP
on IN O
tyrosine NN O
, , O
serine NN O
, , O
and CC O
threonine CD O
residues NNS O
. . O

-DOCSTART- X X O

Structure NN O
and CC O
expression NN O
of IN O
a DT O
gene NN O
from IN O
Arabidopsis NNP O
thaliana , O
encoding VBG O
a DT O
protein NN O
related VBN O
to TO O
SNF1 JJ B-NP
protein NN O
kinase NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
dioxins NNS O
on IN O
thyroid DT O
function NN O
in IN O
newborn JJ O
babies NNS O
. . O

-DOCSTART- X X O

cDNA NN O
clones NNS O
encoding VBG O
Arabidopsis NNP O
thaliana . O
and CC O
Zea NNP B-NP
mays VBZ I-NP
mitochondrial JJ I-NP
chaperonin NN I-NP
HSP60 . B-NP
and CC O
gene NN O
expression NN O
during IN O
seed NN O
germination NN O
and CC O
heat NN O
shock NN O
. . O

-DOCSTART- X X O

Gestational JJ O
trophoblastic JJ O
diseases NNS O
: : O
recent JJ O
advances NNS O
in IN O
the DT O
understanding NN O
of IN O
cytogenetics NNS O
, , O
histopathology NN O
, , O
and CC O
natural JJ O
history NN O
. . O

-DOCSTART- X X O

These DT O
sites NNS O
are VBP O
also RB O
potential JJ O
keratan NN O
sulfate NN O
attachment NN O
sites NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
hGCSFR NN B-NP
gene NN I-NP
was VBD O
chromosomally RB O
localized VBN O
by IN O
Southern JJ O
blot NN O
analysis NN O
of IN O
its PRP$ O
segregation NN O
pattern NN O
in IN O
a DT O
panel NN O
of IN O
rodent-human JJ O
hybrid JJ O
DNAs NN O
using VBG O
the DT O
radiolabeled VBN O
cDNA NN O
probe NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
cibenzoline NN O
is VBZ O
an DT O
effective JJ O
antiarrhythmic JJ O
agent NN O
with IN O
a DT O
favourable JJ O
pharmacokinetic JJ O
profile NN O
that WDT O
may MD O
be VB O
considered VBN O
with IN O
other JJ O
class NN O
I PRP O
drugs NNS O
in IN O
patients NNS O
requiring VBG O
therapy NN O
for IN O
high JJ O
risk NN O
arrhythmias NNS O
. . O

-DOCSTART- X X O

T NNP B-NP
antigen NN I-NP
contains VBZ O
four CD O
H-2Db-restricted JJ O
cytotoxic JJ O
T NNP O
lymphocyte NN O
( -LRB- O
CTL NNP O
) -RRB- O
recognition NN O
epitopes NNS O
that WDT O
are VBP O
targets NNS O
for IN O
CTL NNP O
clones NNS O
Y-1 JJ O
, , O
Y-2 JJ O
, , O
Y-3 JJ O
, , O
and CC O
Y-5 NNP O
. . O

-DOCSTART- X X O

The DT O
treatment NN O
group NN O
also RB O
showed VBD O
in IN O
vivo JJ O
T-cell NN O
activation NN O
with IN O
an DT O
initial JJ O
lymphopenia NN O
followed VBN O
by IN O
a DT O
rebound NN O
lymphocytosis NN O
and CC O
upregulation NN O
of IN O
the DT O
subset NN O
markers NNS O
CD25 IN B-NP
( -LRB- O
interleukin NN B-NP
2 CD I-NP
receptor NN I-NP
) -RRB- O
and CC O
CD45RO NNP B-NP
(T-memory JJ O
cells NNS O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
lumenal JJ O
domains NNS O
of IN O
Sec12p NNP B-NP
, , O
Stl1p NNP B-NP
and CC O
Stl2p NNP B-NP
are VBP O
very RB O
different JJ O
in IN O
size NN O
and CC O
do VBP O
not RB O
show VB O
any DT O
appreciable JJ O
homology NN O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
was VBD O
stimulated VBN O
8-20-fold JJ O
by IN O
phorbol NN O
esters NNS O
accounting VBG O
for IN O
the DT O
previously RB O
observed VBN O
transcriptional JJ O
activation NN O
of IN O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
beta NN I-NP
. . O

-DOCSTART- X X O

PaO2 DT O
threshold NN O
was VBD O
determined VBN O
through IN O
an DT O
indwelling NN O
O2 IN O
sensor NN O
catheter NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
both DT O
the DT O
E26 NNP O
virus-encoded JJ O
v-ets NNS B-NP
and CC O
the DT O
myeloid/B-cell-specific JJ B-NP
factor NN I-NP
PU.1 . I-NP
bind NN O
efficiently RB O
to TO O
this DT O
site NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

The DT O
IgG NNP B-NP
subclass NN O
profile NN O
of IN O
untreated JJ O
coeliac JJ O
disease NN O
was VBD O
found VBN O
to TO O
be VB O
the DT O
same JJ O
as IN O
in IN O
healthy JJ O
controls NNS O
( -LRB- O
IgG1 IN B-NP
approximately RB O
IgG2 JJ B-NP
> NN O
IgG3 IN B-NP
> JJ O
IgG4 NNP B-NP
) -RRB- O
, , O
with IN O
only RB O
the DT O
magnitude NN O
of IN O
the DT O
individual JJ O
subclass NN O
responses NNS O
being VBG O
increased VBN O
in IN O
coeliac NN O
patients NNS O
. . O

-DOCSTART- X X O

Subcutaneous JJ O
administration NN O
of IN O
the DT O
somatostatin NN B-NP
analogue NN O
, , O
octreotide NN O
, , O
100 CD O
micrograms NNS O
thrice NN O
daily RB O
, , O
resulted VBD O
in IN O
a DT O
sustained JJ O
improvement NN O
in IN O
diarrhoea NN O
and CC O
disappearance NN O
of IN O
faecal JJ O
incontinence NN O
without IN O
reducing VBG O
calcitonin NN B-NP
levels NNS O
. . O

-DOCSTART- X X O

GAL4-VP16-mediated JJ B-NP
antirepression NN O
required VBD O
an DT O
auxiliary JJ O
factor NN O
, , O
denoted VBN O
as IN O
a DT O
co-antirepressor NN O
, , O
which WDT O
was VBD O
partially RB O
purified VBN O
from IN O
Drosophila NNP O
embryos NNS O
. . O

-DOCSTART- X X O

One CD O
phage NN O
clone NN O
contains VBZ O
a DT O
junction NN O
between IN O
alpha NN O
satellite NN O
DNA NN O
and CC O
a DT O
novel NN O
low-copy JJ O
repeated VBD O
sequence NN O
. . O

-DOCSTART- X X O

Dopamine NNP O
neurons NNS O
in IN O
subjects NNS O
that IN O
received VBN O
6-OHDA NNS O
were VBD O
protected VBN O
by IN O
pre-treatment JJ O
with IN O
GBR-12909 NNP O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
blood NN O
flow NN O
in IN O
the DT O
penile NN O
foreskin NN O
was VBD O
estimated VBN O
to TO O
be VB O
15 CD O
ml/min/100 CD O
g NN O
and CC O
it PRP O
increased VBD O
to TO O
150-200 CD O
% NN O
after IN O
the DT O
induction NN O
of IN O
anesthesia NN O
, , O
and CC O
then RB O
decreased VBD O
to TO O
72 CD O
% NN O
at IN O
the DT O
tip NN O
of IN O
the DT O
created VBN O
parameatal NN O
foreskin IN O
flap NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
, , O
neither DT O
phosphate NN O
buffered VBN O
saline NN O
injection NN O
into IN O
the DT O
ES NNPS O
nor CC O
primary JJ O
KLH NNP B-NP
challenges NNS O
of IN O
the DT O
ES NNPS O
were VBD O
capable JJ O
of IN O
elevating VBG O
the DT O
threshold NN O
level NN O
and CC O
changing VBG O
the DT O
latency NN O
. . O

-DOCSTART- X X O

Model NNP O
predictions NNS O
were VBD O
in IN O
accord NN O
with IN O
the DT O
nine-year JJ O
survival NN O
experience NN O
of IN O
women NNS O
in IN O
the DT O
HIP NNP O
trial NN O
, , O
and CC O
, , O
with IN O
the DT O
exception NN O
of IN O
women NNS O
40-44 CD O
years NNS O
old JJ O
, , O
with IN O
HIP NNP O
data NNS O
on IN O
18-year JJ O
survival NN O
. . O

-DOCSTART- X X O

Exon-intron NNP O
junctions NNS O
in IN O
the DT O
human JJ O
and CC O
rat NN B-NP
AdoMet NNP I-NP
decarboxylase NN I-NP
genes NNS I-NP
were VBD O
in IN O
identical JJ O
positions NNS O
except IN O
that IN O
exons NNS O
6 CD O
and CC O
7 CD O
of IN O
the DT O
human JJ O
gene NN O
formed VBD O
a DT O
single JJ O
exon NN O
in IN O
the DT O
rat NN O
gene NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
encoding JJ O
TRP-2 JJ B-NP
maps NNS O
to TO O
mouse NN O
chromosome NN O
14 CD O
, , O
in IN O
the DT O
region NN O
of IN O
the DT O
coat NN B-NP
colour NN I-NP
mutation NN I-NP
slaty NN I-NP
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
genomic JJ O
DNA NNP O
sequence NN O
with IN O
that DT O
of IN O
the DT O
four CD O
different JJ O
mRNAs NNS O
indicates VBZ O
that IN O
these DT O
transcripts NNS O
are VBP O
produced VBN O
by IN O
alternative JJ O
splicing NN O
of IN O
the DT O
murine NN O
pre-mRNA JJ O
according VBG O
to TO O
a DT O
cassette NN O
model NN O
. . O

-DOCSTART- X X O

Probable JJ O
progressive JJ O
multifocal JJ O
leukoencephalopathy NN O
( -LRB- O
PML) NNP O
was VBD O
diagnosed VBN O
on IN O
the DT O
basis NN O
of IN O
clinical JJ O
picture NN O
and CC O
magnetic JJ O
resonance NN O
imaging NN O
in IN O
a DT O
63-year-old JJ O
man NN O
with IN O
a DT O
complete JJ O
remission NN O
of IN O
a DT O
non-Hodgkin NN O
's POS O
lymphoma NN O
. . O

-DOCSTART- X X O

Marker NNP O
rescue NN O
analysis NN O
has VBZ O
localized VBN O
ts8 CD B-NP
to TO O
a DT O
910-bp JJ O
internal JJ O
segment NN O
of IN O
rpoB NN B-NP
that IN O
encodes VBZ O
the DT O
Rif NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

Competition NN O
analysis NN O
by IN O
gel NNP O
mobility NN O
shift NN O
electrophoresis NN O
indicates VBZ O
that IN O
this DT O
DNA-protein NNP O
interaction NN O
is VBZ O
novel JJ O
and CC O
not RB O
related VBN O
to TO O
many JJ O
transcription NN O
factors NNS O
previously RB O
reported VBD O
. . O

-DOCSTART- X X O

The DT O
1.7 CD O
kb JJ O
cloned JJ O
fragment NN O
was VBD O
sequenced VBN O
and CC O
shown VBN O
to TO O
contain VB O
the DT O
entire JJ O
fliA NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
SEN1 NNP B-NP
gene NN I-NP
corresponds NNS O
to TO O
a DT O
6,336-bp JJ O
open JJ O
reading NN O
frame NN O
coding NN O
for IN O
a DT O
2,112-amino-acid JJ O
protein NN O
( -LRB- O
molecular JJ O
mass NN O
, , O
239 CD O
kDa NN O
) -RRB- O
. . O

-DOCSTART- X X O

At IN O
the DT O
C-terminus NN O
of IN O
the DT O
protein NN O
is VBZ O
a DT O
domain NN O
that WDT O
contains VBZ O
sequences NNS O
very RB O
similar JJ O
to TO O
those DT O
found VBN O
in IN O
the DT O
breakpoint NN O
cluster NN O
region NN O
gene NN O
product NN O
, , O
n-chimerin JJ B-NP
, , O
and CC O
rho NNP B-NP
GAP NNP I-NP
, , O
all DT O
of IN O
which WDT O
have VBP O
been VBN O
shown VBN O
to TO O
possess VB O
intrinsic JJ O
GAP JJ B-NP
activity NN O
on IN O
small JJ B-NP
GTPases NNS I-NP
. . O

-DOCSTART- X X O

Neural-specific JJ O
expression NN O
, , O
genomic JJ O
structure NN O
, , O
and CC O
chromosomal NN O
localization NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
zinc-finger NN B-NP
transcription NN I-NP
factor NN I-NP
NGFI-C. . I-NP

-DOCSTART- X X O

These DT O
results NNS O
support VBP O
the DT O
diagnostic JJ O
validity NN O
of IN O
NFPD NNP O
in IN O
CP/NCA NNP O
patients NNS O
, , O
because IN O
such JJ O
patients NNS O
had VBD O
a DT O
family NN O
history NN O
of IN O
panic NN O
disorder NN O
similar JJ O
to TO O
patients NNS O
with IN O
a DT O
more JJR O
classical JJ O
panic NN O
disorder NN O
presentation NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
no DT O
transcripts NNS O
of IN O
the DT O
same JJ O
size NN O
and CC O
having VBG O
the DT O
same JJ O
developmental JJ O
profile NN O
as IN O
those DT O
generated VBN O
by IN O
the DT O
wild-type JJ B-NP
E10 JJ I-NP
fragment NN I-NP
were VBD O
identified VBN O
by IN O
probes NNS O
covering VBG O
the DT O
remainder NN O
of IN O
the DT O
cloned JJ O
region NN O
. . O

-DOCSTART- X X O

Both DT O
parents NNS O
are VBP O
clinically RB O
normal JJ O
and CC O
unrelated JJ O
. . O

-DOCSTART- X X O

The DT O
sequence-specific JJ O
interaction NN O
of IN O
nuclear JJ B-NP
factor NN I-NP
HiNF-D NNP I-NP
with IN O
this DT O
key JJ O
proximal JJ O
promoter NN O
element NN O
of IN O
the DT O
H4-FO108 CD B-NP
gene NN I-NP
is VBZ O
cell NN O
cycle NN O
regulated VBN O
in IN O
normal JJ O
diploid JJ O
cells NNS O
( -LRB- O
J. NNP O

-DOCSTART- X X O

While IN O
blood NN O
pressure NN O
and CC O
noradrenergic JJ O
activity NN O
, , O
assessed VBN O
as IN O
changes NNS O
in IN O
the DT O
plasma NN O
levels NNS O
and CC O
urinary JJ O
excretion NN O
of IN O
norepinephrine NN O
, , O
remained VBD O
unaffected JJ O
in IN O
the DT O
Pl NNP O
group NN O
, , O
a DT O
significant JJ O
drop NN O
in IN O
the DT O
supine NN O
systolic JJ O
and CC O
diastolic JJ O
blood NN O
pressures NNS O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
resting VBG O
venous JJ O
norepinephrine JJ O
level NN O
and CC O
in IN O
urinary JJ O
norepinephrine NN O
excretion NN O
was VBD O
found VBN O
after IN O
the DT O
first JJ O
month NN O
of IN O
dF JJ O
administration NN O
. . O

-DOCSTART- X X O

The DT O
homologies NNS O
between IN O
RAD16 NNP B-NP
, , O
RAD54 NNP B-NP
and CC O
SNF2 NNP B-NP
are VBP O
also RB O
shared VBN O
by IN O
several JJ O
additional JJ O
, , O
recently RB O
isolated VBN O
yeast NN O
and CC O
Drosophila NNP O
genes NNS O
. . O

-DOCSTART- X X O

Two CD O
cDNAs NNS O
encoding VBG O
casein NN B-NP
kinase-1 NN I-NP
have VBP O
been VBN O
isolated VBN O
from IN O
a DT O
yeast NN O
cDNA NN O
library NN O
and CC O
termed VBD O
CKI1 NNP B-NP
and CC O
CKI2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
observed JJ O
sequence NN O
variation NN O
disrupts VBZ O
the DT O
first JJ O
ORF NN O
in IN O
many JJ O
Y NNP B-NP
's POS O
while IN O
most JJS O
of IN O
the DT O
second JJ O
ORF NN O
including VBG O
the DT O
putative JJ O
helicase NN B-NP
region NN I-NP
is VBZ O
unaffected JJ O
. . O

-DOCSTART- X X O

The DT O
final JJ O
screening NN O
yielded VBD O
a DT O
clone NN O
containing VBG O
a DT O
2 CD O
kilobase NN O
(kb NN O
) -RRB- O
insert NN O
. . O

-DOCSTART- X X O

Lesions NNS O
were VBD O
made VBN O
by IN O
pressure NN O
injection NN O
of IN O
kainic JJ O
acid NN O
into IN O
the DT O
SOC NNP O
through IN O
a DT O
stereotaxically RB O
positioned VBN O
glass NN O
micropipette NN O
. . O

-DOCSTART- X X O

Cardiovascular NNP O
risk NN O
factors NNS O
were VBD O
measured VBN O
by IN O
standardized VBN O
techniques NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
carbon-perfused JJ O
areas NNS O
and CC O
MBF NNP O
in IN O
the DT O
liver NN O
, , O
renal JJ O
cortex NN O
, , O
spleen JJ O
, , O
and CC O
small JJ O
intestinal JJ O
serosa NN O
( -LRB- O
only JJ O
MBF NN O
) -RRB- O
increased VBN O
significantly RB O
5 CD O
h NN O
after IN O
CLP. NN O

-DOCSTART- X X O

Lewis NNP O
, , O
N. NNP O

-DOCSTART- X X O

This DT O
accurate JJ O
and CC O
rapid JJ O
method NN O
makes VBZ O
the DT O
MLPA NNP O
test NN O
logistically RB O
feasible JJ O
for IN O
large-scale JJ O
screening NN O
. . O

-DOCSTART- X X O

The DT O
modalities NNS O
for IN O
using VBG O
reference NN O
values NNS O
for IN O
individual JJ O
subjects NNS O
as RB O
well RB O
as IN O
for IN O
groups NNS O
are VBP O
then RB O
discussed VBN O
and CC O
the DT O
main JJ O
points NNS O
of IN O
research NN O
which WDT O
must MD O
be VB O
faced VBN O
in IN O
the DT O
near JJ O
future NN O
regarding VBG O
reference NN O
values NNS O
are VBP O
highlighted VBN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
the DT O
previously RB O
identified VBN O
and CC O
characterized VBN O
attenuator NN B-NP
1 CD I-NP
situated VBN O
93 CD O
nucleotides NNS O
downstream RB O
from IN O
the DT O
major JJ O
late JJ O
transcription NN O
start NN O
site NN O
, , O
a DT O
second JJ O
attenuator NN O
, , O
attenuator NN B-NP
2 CD I-NP
, , O
situated VBN O
55 CD O
nucleotides NNS O
downstream RB O
from IN O
it PRP O
, , O
has VBZ O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

These DT O
experiments NNS O
delineate VBP O
a DT O
186-bp JJ O
, , O
EBNA-2-responsive JJ B-NP
cell NN O
DNA NN O
fragment NN O
and CC O
provide VB O
firm JJ O
evidence NN O
that IN O
EBNA-2 JJ B-NP
transactivates NNS O
transcription NN O
of IN O
cell NN O
genes NNS O
. . O

-DOCSTART- X X O

This DT O
repression NN O
was VBD O
mediated VBN O
through IN O
binding NN O
to TO O
the DT O
E2 NNP B-NP
DNA-binding NNP I-NP
site NN I-NP
immediately RB O
upstream RB O
of IN O
the DT O
P105 CD B-NP
promoter NN O
TATA NNP O
box NN O
and CC O
could MD O
be VB O
abrogated VBN O
by IN O
preincubation NN O
of IN O
the DT O
HPV-18 NN B-NP
P105 . I-NP
promoter NN I-NP
template NN O
with IN O
the DT O
nuclear JJ O
extract VB O
allowing VBG O
the DT O
formation NN O
of IN O
the DT O
preinitiation NN O
complex NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
determined VBN O
that IN O
the DT O
mutants NNS O
define VB O
two CD O
complementation NN O
groups NNS O
, , O
designated VBN O
cgs NNS B-NP
1+ VBG I-NP
and CC O
cgs NNS B-NP
2+ IN I-NP
( -LRB- O
continues VBZ O
to TO O
grow VB O
in IN O
stationary NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
strategy NN O
has VBZ O
been VBN O
used VBN O
to TO O
determine VB O
2.6 CD O
kilobases NNS O
of IN O
nucleotide JJ O
sequence NN O
in IN O
the DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
ADE NNP I-NP
1 CD I-NP
locus NN I-NP
. . O

-DOCSTART- X X O

Its PRP$ O
neuromuscular JJ O
effects NNS O
are VBP O
similar JJ O
to TO O
a DT O
single JJ O
ED90 JJ O
dose NN O
of IN O
vecuronium NN O
. . O

-DOCSTART- X X O

Wnt-1 NN B-NP
( -LRB- O
int-1 NN B-NP
) -RRB- O
is VBZ O
a DT O
cellular JJ O
oncogene NN O
often RB O
activated VBN O
by IN O
insertion NN O
of IN O
proviral JJ O
DNA NN O
of IN O
the DT O
mouse NN O
mammary NN O
tumor NN O
virus NN O
. . O

-DOCSTART- X X O

We PRP O
speculate VBP O
that IN O
these DT O
tumors NNS O
may MD O
represent VB O
congenital JJ O
hamartomatous JJ O
growths NNS O
. . O

-DOCSTART- X X O

Identification NN O
and CC O
characterization NN O
of IN O
the DT O
promoter NN O
for IN O
the DT O
cytotactin NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

2:121-133 CD O
, , O
1988 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Although IN O
the DT O
N13-N20 JJ O
interpeak JJ O
interval NN O
remained VBD O
stable JJ O
because IN O
of IN O
the DT O
parallel JJ O
shift NN O
of IN O
the DT O
2 CD O
peaks NNS O
, , O
the DT O
central JJ O
conduction NN O
time NN O
measured VBN O
from IN O
onset NN O
latencies NNS O
of IN O
N11 NNP O
and CC O
N20 NNP O
significantly RB O
increased VBD O
. . O

-DOCSTART- X X O

The DT O
murine NN B-NP
mutation NN I-NP
dominant JJ I-NP
white JJ I-NP
spotting NN I-NP
( -LRB- O
W NNP B-NP
) -RRB- O
is VBZ O
in IN O
the DT O
proto-oncogene NN O
, , O
c-kit NN B-NP
. . O

-DOCSTART- X X O

A DT O
full-length JJ B-NP
human JJ I-NP
pim-1 NN I-NP
cDNA NN I-NP
was VBD O
subcloned VBN O
into IN O
the DT O
bacterial JJ O
vector NN O
pGEX-2T NN O
and CC O
the DT O
Pim-1 JJ B-NP
protein NN I-NP
expressed VBN O
as IN O
a DT O
fusion NN O
product NN O
with IN O
bacterial JJ B-NP
glutathione NN I-NP
S-transferase NN I-NP
( -LRB- O
GST NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
characterized VBD O
cDNA NN O
clones NNS O
specific JJ O
for IN O
the DT O
extracellular JJ O
matrix NN O
glycoprotein NN O
undulin NN B-NP
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
the DT O
alpha NN B-NP
inhibin IN I-NP
gene NN I-NP
by IN O
cyclic JJ O
adenosine NN O
3', IN O
5'-monophosphate JJ O
after IN O
transfection NN O
into IN O
rat NN O
granulosa NN O
cells NNS O
. . O

-DOCSTART- X X O

E. NNP O
, , O
Hession NNP O
, , O
C. NNP O
, , O
Goff NNP O
, , O
D. NNP O
, , O
Griffiths NNP O
, , O
B. NNP O
, , O
Tizard NNP O
, , O
R. NNP O
, , O
Newman NNP O
, , O
B. NNP O
, , O
Chi-Rosso NNP O
, , O
G. NNP O
, , O
and CC O
Lobb NNP O
, , O
R. NNP O
, , O
( -LRB- O
1990 CD O
) -RRB- O
Cell NNP O
63 CD O
, , O
1349-1356 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
sulfhydryl NN O
group NN O
of IN O
certain JJ O
angiotensin NN B-NP
converting VBG I-NP
enzyme JJ I-NP
inhibitors NNS O
can MD O
potentiate VB O
their PRP$ O
effect NN O
on IN O
the DT O
endogenous JJ O
nitrovasodilator NN O
EDRF. . B-NP

-DOCSTART- X X O

They PRP O
were VBD O
checked VBN O
for IN O
anti-HCV JJ B-NP
( -LRB- O
anti-C100-3 JJ B-NP
) -RRB- O
with IN O
HCV NNP O
EIA NNP O
kit NN O
( -LRB- O
Abbott NNP O
Lab. NNP O
, , O
North NNP O
Chicago NNP O
, , O
IL NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Diltiazem NNP O
resulted VBD O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
epicardial JJ O
diameter NN O
( -LRB- O
+10 CD O
% NN O
; : O
p NN O
= SYM O
0.001 CD O
) -RRB- O
and CC O
in IN O
coronary JJ O
blood NN O
flow NN O
( -LRB- O
CBF NN O
) -RRB- O
( -LRB- O
+30 CD O
% NN O
; : O
p NN O
= SYM O
0.0001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
risk NN O
factors NNS O
can MD O
be VB O
divided VBN O
into IN O
2 CD O
groups NNS O
: : O
local JJ O
vessel NN O
wall-related JJ O
factors NNS O
, , O
and CC O
local JJ O
( -LRB- O
focal JJ O
action NN O
) -RRB- O
systemic JJ O
factors NNS O
. . O

-DOCSTART- X X O

Vaccinia NNP O
virus NN O
( -LRB- O
VV NN O
) -RRB- O
is VBZ O
a DT O
potent JJ O
immunogen NN O
, , O
but CC O
the DT O
nature NN O
of IN O
VV NNP O
proteins VBZ O
involved VBN O
in IN O
the DT O
activation NN O
of IN O
the DT O
immune JJ O
response NN O
of IN O
the DT O
host NN O
is VBZ O
not RB O
yet RB O
known VBN O
. . O

-DOCSTART- X X O

The DT O
tissue NN O
specificity NN O
of IN O
gene NN O
expression NN O
was VBD O
identical JJ O
to TO O
that DT O
described VBN O
previously RB O
for IN O
the DT O
CaMV NNP B-NP
35S NNP I-NP
domain NN I-NP
B NNP I-NP
enhancer NN I-NP
element NN I-NP
. . O

-DOCSTART- X X O

The DT O
size NN O
of IN O
the DT O
mutant JJ O
molecule NN O
corresponds NNS O
to TO O
the DT O
unprocessed JJ O
cytoplasmic JJ O
precursor NN O
( -LRB- O
pre-super-pro-PrB JJ B-NP
) -RRB- O
, , O
as IN O
detected VBN O
in IN O
sec61 JJ B-NP
mutants NNS I-NP
, , O
when WRB O
translocation NN O
into IN O
the DT O
endoplasmic JJ O
reticulum NN O
is VBZ O
blocked VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
active-site JJ O
mutation NN O
prevents VBZ O
the DT O
wild-type JJ O
processing NN O
of IN O
the DT O
N-glycosylated JJ O
73-kDa JJ O
precursor NN O
of IN O
PrB NNP B-NP
to TO O
the DT O
41.5 CD B-NP
kDa NN I-NP
pro-PrB NNS I-NP
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
. . O

-DOCSTART- X X O

Bone NN O
and CC O
bones NNS O
. . O

-DOCSTART- X X O

To TO O
overcome VB O
this DT O
problem NN O
, , O
we PRP O
have VBP O
overexpressed VBN O
Kex2p IN B-NP
using VBG O
the DT O
baculovirus/insect NN O
cell NN O
expression NN O
system NN O
. . O

-DOCSTART- X X O

J. NNP O

-DOCSTART- X X O

The DT O
major JJ B-NP
49-kDa JJ I-NP
core NN I-NP
protein NN I-NP
in IN O
the DT O
liver NN O
HSPG NN B-NP
preparation NN O
was VBD O
found VBN O
to TO O
be VB O
reactive JJ O
to TO O
an DT O
antibody NN O
that WDT O
specifically RB O
recognizes VBZ O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
fibroglycan JJ B-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
cDNAs NNS O
for IN O
a DT O
gene NN O
coding NN O
for IN O
a DT O
G NNP B-NP
protein NN I-NP
alpha NN I-NP
subunit NN I-NP
from IN I-NP
tomato NN I-NP
( -LRB- O
Lycopersicon NNP O
esculentum NN O
, , O
cv. . O

-DOCSTART- X X O

Substituting VBG O
a DT O
Ser NN O
for IN O
Gly69 NNP O
or CC O
a DT O
Glu NNP O
for IN O
Lys NNP O
71 CD O
in IN O
the DT O
conserved JJ O
TGEK NNP B-NP
tetrapeptide NN I-NP
in IN O
finger NN O
II NNP O
of IN O
TFIIIA NNP B-NP
resulted VBD O
in IN O
the DT O
loss NN O
of IN O
DNA NNP O
binding NN O
. . O

-DOCSTART- X X O

The DT O
model NN O
is VBZ O
able JJ O
to TO O
anticipate VB O
why WRB O
the DT O
effect NN O
of IN O
water NN O
fluoridation NN O
on IN O
caries NNS O
prevalence NN O
is VBZ O
most RBS O
pronounced JJ O
when WRB O
caries NNS O
is VBZ O
diagnosed VBN O
at IN O
cavity NN O
level NN O
. . O

-DOCSTART- X X O

Auditory NNP O
threshold NN O
shifts NNS O
, , O
as IN O
measured VBN O
by IN O
the DT O
auditory JJ O
evoked JJ O
brainstem NN O
response NN O
, , O
were VBD O
measured VBN O
at IN O
2,4,8,12,16 CD O
, , O
20 CD O
and CC O
24 CD O
kHz NN O
. . O

-DOCSTART- X X O

Fundamental NNP O
and CC O
clinical JJ O
evaluation NN O
of IN O
equilibrium NN O
dialysis--radioimmunoassay NN O
system NN O
for IN O
measurement NN O
of IN O
serum NN O
free JJ O
thyroxine NN O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
TA VBZ O
caused VBN O
a DT O
specific JJ O
decrease NN O
in IN O
AGD NNP O
on IN O
GD NNP O
20 CD O
that DT O
was VBD O
largely RB O
reversed VBN O
by IN O
PCD NNP O
23 CD O
. . O

-DOCSTART- X X O

When WRB O
examined VBN O
as IN O
adults NNS O
( -LRB- O
8 CD O
weeks NNS O
old JJ O
) -RRB- O
, , O
the DT O
external JJ O
genitalia NNS O
of IN O
TA-exposed JJ O
offspring NN O
were VBD O
normal JJ O
. . O

-DOCSTART- X X O

A DT O
330-kb JJ O
YAC NNP O
, , O
A148A7 NNP O
, , O
spanned VBD O
from IN O
the DT O
HLA-DQA1 JJ B-NP
locus NN O
through IN O
the DT O
Y3/Ring JJ B-NP
4 CD B-NP
locus NN O
and CC O
extended VBD O
at IN O
least JJS O
130 CD O
kb NN O
centromeric NN O
of IN O
YAC NNP O
B1D12 NNP O
. . O

-DOCSTART- X X O

We PRP O
examined VBD O
behavioral JJ O
alterations NNS O
in IN O
the DT O
brown JJ O
cockroach NN O
, , O
Periplaneta NNP O
brunnea NN O
, , O
infected VBN O
with IN O
the DT O
acanthocephalan NN O
, , O
Moniliformis NNP O
moniliformis NN O
. . O

-DOCSTART- X X O

The DT O
existence NN O
of IN O
threshold NN O
concentrations NNS O
, , O
above IN O
which WDT O
certain JJ O
phenomena NNS O
may MD O
occur VB O
, , O
strengthens VBZ O
the DT O
role NN O
of IN O
sentinels NNS O
. . O

-DOCSTART- X X O

These DT O
changes NNS O
were VBD O
n't RB O
so RB O
significant JJ O
in IN O
the DT O
group NN O
of IN O
obese JJ O
children NNS O
who WP O
did VBD O
n't RB O
lose VB O
weight NN O
. . O

-DOCSTART- X X O

Magnetotherapy JJ O
of IN O
hepatitis NN O
A NNP O
and CC O
B NNP O
in IN O
children NNS O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
local JJ O
abnormalities NNS O
in IN O
both DT O
patients NNS O
can MD O
support VB O
the DT O
hypothesis NN O
that IN O
the DT O
cortex NN O
, , O
especially RB O
of IN O
the DT O
temporal JJ O
anterior JJ O
lobe NN O
, , O
is VBZ O
involved VBN O
in IN O
the DT O
origin NN O
of IN O
the DT O
laughing VBG O
seizures NNS O
. . O

-DOCSTART- X X O

TPTA NNP O
produced VBD O
brain NN O
congestion NN O
, , O
and CC O
hepatic JJ O
and CC O
pulmonary JJ O
petechial JJ O
and CC O
generalized JJ O
hemorrhages NNS O
. . O

-DOCSTART- X X O

Resolution NNP O
of IN O
thermographic DT O
asymmetry NN O
and/or CC O
decrease NN O
in IN O
Delta NNP O
T NNP O
was VBD O
demonstrated VBN O
in IN O
approximately RB O
81 CD O
% NN O
of IN O
the DT O
post-treatment JJ O
population NN O
. . O

-DOCSTART- X X O

The DT O
ED30 NN O
values NNS O
were VBD O
2.4 CD O
and CC O
2.2 CD O
mg/kg NN O
and CC O
similar JJ O
to TO O
the DT O
respective JJ O
values NNS O
of IN O
nifedipine NN O
( -LRB- O
ED VBN O
30 CD O
:2.4,2.1 JJ O
mg/kg NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
abundance NN O
of IN O
transcripts NNS O
from IN O
several JJ O
unrelated JJ O
genes NNS O
is VBZ O
decreased VBN O
in IN O
cdc68-1 JJ B-NP
mutant JJ I-NP
cells NNS O
after IN O
transfer NN O
to TO O
the DT O
restrictive JJ O
temperature NN O
, , O
while IN O
at IN O
least JJS O
one CD O
transcript NN O
, , O
from IN O
the DT O
HSP82 NNP B-NP
gene NN I-NP
, , O
persists NNS O
in IN O
an DT O
aberrant JJ O
fashion NN O
. . O

-DOCSTART- X X O

The DT O
spectrum NN O
of IN O
histologically PRP O
diagnosed VBD O
malignant JJ O
neoplasms NNS O
in IN O
Sabah NNP O
, , O
1983-1988 CD O
. . O

-DOCSTART- X X O

When WRB O
transfected VBN O
into IN O
Drosophila NNP O
SL-2 NNP O
cells NNS O
, , O
pCAT NN O
plasmid NN O
containing VBG O
2,090 CD O
bp NN O
of IN O
5'-flanking JJ O
region NN O
shows VBZ O
a DT O
3.0- CD O
to TO O
3.5-fold JJ O
increase NN O
in IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
activity NN O
after IN O
induction NN O
with IN O
retinoic JJ O
acid NN O
and/or NN O
8-bromo-cAMP. . O

-DOCSTART- X X O

The DT O
N-terminus NNP O
of IN O
another DT O
open JJ O
reading NN O
frame NN O
was VBD O
found VBN O
3' CD O
from IN O
nifA NNS B-NP
and CC O
tentatively RB O
identified VBN O
as IN O
nifB NNS B-NP
by IN O
amino DT O
acid NN O
sequence NN O
comparison NN O
. . O

-DOCSTART- X X O

A DT O
novel NN O
cDNA NN O
clone NN O
termed VBD O
R2 PRP O
was VBD O
isolated VBN O
by IN O
subtractive JJ O
hybridization NN O
of IN O
a DT O
cDNA JJ O
library NN O
of IN O
phytohemagglutinin FW B-NP
( -LRB- O
PHA NN B-NP
)/phorbol NN O
myristate NN O
acetate-stimulated JJ O
Jurkat NNP O
cells NNS O
and CC O
by IN O
rescreening VBG O
a DT O
cDNA JJ O
library NN O
of IN O
PHA-stimulated JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

-DOCSTART- X X O

Suggestive JJ O
evidence NN O
was VBD O
obtained VBN O
that IN O
cstA DT B-NP
is VBZ O
involved VBN O
in IN O
peptide NN O
utilization NN O
. . O

-DOCSTART- X X O

Identification NN O
and CC O
nucleotide JJ O
sequence NN O
of IN O
Rhizobium NNP B-NP
meliloti , I-NP
insertion NN I-NP
sequence NN I-NP
ISRm3 VBZ I-NP
: : O
similarity NN O
between IN O
the DT O
putative JJ O
transposase NN B-NP
encoded VBN O
by IN O
ISRm3 NNP B-NP
and CC O
those DT O
encoded VBN O
by IN O
Staphylococcus NNP B-NP
aureus NN I-NP
IS256 NNP I-NP
and CC O
Thiobacillus NNP B-NP
ferrooxidans NNS I-NP
IST2 NNP I-NP
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
relationship NN O
of IN O
these DT O
viruses NNS O
, , O
the DT O
complete JJ O
DNA NN O
sequence NN O
of IN O
KV NNP O
consisting VBG O
of IN O
4754 CD O
bp NN O
was VBD O
determined VBN O
. . O

-DOCSTART- X X O

Heterodimers NNP O
of IN O
myogenin NN B-NP
and CC O
E12 NN B-NP
( -LRB- O
or CC O
MyoD NNP B-NP
and CC O
E12 NNP B-NP
) -RRB- O
specifically RB O
bound VBD O
a DT O
restriction NN O
fragment NN O
extending VBG O
from IN O
-200 CD O
to TO O
-103 JJ O
relative JJ O
to TO O
the DT O
start NN O
of IN O
cardiac JJ B-NP
alpha-actin NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

The DT O
Italian NNP O
Lung NNP O
Cancer NNP O
Task NNP O
Force NNP O
( -LRB- O
FONICAP NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
region NN O
shows VBZ O
strong JJ O
sequence NN O
similarity NN O
to TO O
Escherichia NNP O
coli NNS O
consensus NN O
promoters NNS O
and CC O
ribosome-binding JJ O
sequences NNS O
and CC O
allows VBZ O
high JJ O
levels NNS O
of IN O
expression NN O
in IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

Young NNP O
CD-1 NNP O
mice NNS O
, , O
4 CD O
days NNS O
old JJ O
, , O
exposed JJ O
to TO O
0.1 CD O
% NN O
nicotine JJ O
sulfate NN O
on IN O
gestational JJ O
days NNS O
6-20 . O
were VBD O
compared VBN O
with IN O
untreated JJ O
pups NNS O
of IN O
the DT O
same JJ O
age NN O
to TO O
determine VB O
its PRP$ O
effect NN O
on IN O
the DT O
development NN O
of IN O
mandibular JJ O
first JJ O
molars NNS O
. . O

-DOCSTART- X X O

USF NNP B-NP
synthesized VBD O
in IN O
an DT O
in IN O
vitro NN O
transcription NN O
and CC O
translation NN O
system NN O
also RB O
binds VBZ O
to TO O
the DT O
ADH NNP B-NP
promoter NN I-NP
as RB O
well RB O
as IN O
to TO O
the DT O
MLP. NNP O

-DOCSTART- X X O

Arterial NNP O
radioactivity NN O
content NN O
after IN O
the DT O
intravenous JJ O
administration NN O
of IN O
HMPAO NNP O
in IN O
seven CD O
human JJ O
subjects NNS O
was VBD O
analyzed VBN O
. . O

-DOCSTART- X X O

Experimentally RB O
in IN O
green JJ O
monkeys NNS O
, , O
Syrian JJ O
hamsters NNS O
and CC O
white JJ O
mice NNS O
the DT O
authors NNS O
studied VBD O
the DT O
pathogenic JJ O
properties NNS O
of IN O
a DT O
new JJ O
virus NN O
Issyk-Kul NNP O
. . O

-DOCSTART- X X O

Limits NNS O
of IN O
energy NN O
turnover NN O
in IN O
relation NN O
to TO O
physical JJ O
performance NN O
were VBD O
addressed VBN O
in IN O
terms NNS O
of IN O
upper JJ O
and CC O
lower JJR O
limit NN O
, , O
changes NNS O
during IN O
a DT O
training NN O
programme NN O
and CC O
how WRB O
to TO O
regulate VB O
energy NN O
balance NN O
at IN O
a DT O
changing VBG O
energy NN O
turnover NN O
. . O

-DOCSTART- X X O

The DT O
smaller JJR O
uptake NN O
rate NN O
and CC O
faster JJR O
clearance NN O
rate NN O
resulted VBD O
in IN O
the DT O
lower JJR O
BCF NN O
for IN O
SWA NNP O
killifish NN O
. . O

-DOCSTART- X X O

Determinants NNS O
of IN O
recurrent JJ O
ischaemia NN O
and CC O
revascularisation NN O
procedures NNS O
after IN O
thrombolysis VBG O
with IN O
recombinant JJ O
tissue NN B-NP
plasminogen NN I-NP
activator NN I-NP
in IN O
primary JJ O
coronary JJ O
occlusion NN O
. . O

-DOCSTART- X X O

Bronchial NNP O
mucosa NN O
tattooing VBG O
in IN O
persons NNS O
exposed VBN O
to TO O
different JJ O
industrial JJ O
aerosols NNS O
did VBD O
not RB O
depend VB O
on IN O
the DT O
forms NNS O
of IN O
PC NN O
, , O
DB NNP O
and CC O
the DT O
diseases NNS O
' POS O
stages NNS O
. . O

-DOCSTART- X X O

Lipoprotein NNP B-NP
lipase NN I-NP
( -LRB- O
LPL) NNP B-NP
, , O
a DT O
key JJ O
enzyme NN O
in IN O
normal JJ O
lipoprotein NN O
metabolism NN O
, , O
has VBZ O
a DT O
complex JJ O
pattern NN O
of IN O
regulation NN O
and CC O
tissue-specific JJ O
expression NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
cDNA-predicted JJ O
avian NN B-NP
TnIcardiac NNP I-NP
amino IN I-NP
acid NN I-NP
sequences NNS I-NP
with IN O
known VBN O
TnI NNP B-NP
sequences NNS I-NP
indicated VBD O
1 CD O
) -RRB- O
that IN O
the DT O
presence NN O
of IN O
an DT O
N-terminal JJ O
extension NN O
sequence NN O
carrying VBG O
a DT O
dual JJ O
protein NN B-NP
kinase NN I-NP
A DT I-NP
phosphorylation NN O
target NN O
site NN O
and CC O
an DT O
adjacent JJ O
proline-rich JJ O
segment NN O
is VBZ O
an DT O
ancient JJ O
cardiac-specific JJ O
feature NN O
of IN O
TnI NNP B-NP
which WDT O
has VBZ O
been VBN O
conserved VBN O
since IN O
the DT O
bird/mammal JJ O
divergence NN O
, , O
2 CD O
) -RRB- O
that IN O
features NNS O
of IN O
the DT O
near-N-terminal JJ O
troponin NN B-NP
C NNP I-NP
( -LRB- O
TnC)-binding NN B-NP
site NN O
sequence NN O
suggest VBP O
isoform-specific JJ O
adaptation NN O
of IN O
TnI NNP B-NP
and CC O
TnC NNP B-NP
, , O
and CC O
3 CD O
) -RRB- O
that IN O
the DT O
avian JJ O
TnIcardiac NNP B-NP
internal JJ O
actin/TnC-binding NN B-NP
, , I-NP
actomyosin-inhibitory NN I-NP
, , I-NP
domain NN I-NP
shows VBZ O
significant JJ O
sequence NN O
divergence NN O
from IN O
mammalian JJ B-NP
TnIcardiac NNP I-NP
sequences NNS I-NP
, , O
including VBG O
the DT O
absence NN O
of IN O
a DT O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
target NN O
site NN O
which WDT O
is VBZ O
a DT O
cardiac-specific JJ O
feature NN O
of IN O
TnI NNP B-NP
in IN O
mammals NNS O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
ROSP NNP O
undergoes VBZ O
a DT O
number NN O
of IN O
fluctuations NNS O
in IN O
the DT O
negative JJ O
and CC O
positive JJ O
directions NNS O
with IN O
a DT O
gradually RB O
decreasing VBG O
amplitude NN O
in IN O
the DT O
course NN O
of IN O
5-25 CD O
days NNS O
following VBG O
the DT O
operation NN O
, , O
after IN O
which WDT O
relatively RB O
stable JJ O
negative JJ O
values NNS O
of IN O
the DT O
ROSP NNP O
are VBP O
established VBN O
on IN O
the DT O
average NN O
in IN O
electrodes NNS O
implanted VBN O
to TO O
the DT O
level NN O
of IN O
the DT O
dura NN O
mater NN O
, , O
and CC O
positive JJ O
values NNS O
in IN O
electrodes NNS O
implanted VBN O
to TO O
the DT O
level NN O
of IN O
the DT O
pia NN O
mater NN O
. . O

-DOCSTART- X X O

Blood NN O
flow NN O
velocity NN O
waveforms NNS O
were VBD O
recorded VBN O
by IN O
pulsed JJ O
Doppler NNP O
examination NN O
of IN O
the DT O
fetal NN O
internal JJ O
carotid NN O
and CC O
middle NN O
cerebral NN O
arteries NNS O
using VBG O
the DT O
established VBN O
transabdominal JJ O
route NN O
as RB O
well RB O
as IN O
a DT O
new JJ O
transvaginal JJ O
approach NN O
. . O

-DOCSTART- X X O

Twenty-four CD O
hours NNS O
later RB O
, , O
the DT O
animals NNS O
were VBD O
randomized VBN O
to TO O
subretinal JJ O
treatment NN O
with IN O
2.5 CD O
micrograms NNS O
of IN O
tissue NN B-NP
plasminogen NN I-NP
activator NN I-NP
or CC O
a DT O
similar JJ O
volume NN O
of IN O
physiologic NN O
saline NN O
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
antiepileptic JJ O
drug NN O
effect NN O
on IN O
membrane NN O
fluidity NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
solidification NN O
could MD O
occur VB O
in IN O
all DT O
feeds VBZ O
containing VBG O
casein NN B-NP
and CC O
that DT O
alternative NN O
feeds VBZ O
should MD O
be VB O
considered VBN O
in IN O
patients NNS O
with IN O
increased JJ O
gastric JJ O
acidity NN O
. . O

-DOCSTART- X X O

Determination NNP O
of IN O
an DT O
RNA NNP O
structure NN O
involved VBN O
in IN O
splicing VBG O
inhibition NN O
of IN O
a DT O
muscle-specific JJ O
exon NN O
. . O

-DOCSTART- X X O

The DT O
antihypertensive JJ O
effect NN O
of IN O
Estulic NNP O
has VBZ O
been VBN O
examined VBN O
over IN O
a DT O
12-month JJ O
period NN O
in IN O
101 CD O
hypertensive JJ O
patients NNS O
. . O

-DOCSTART- X X O

Monitoring NN O
patients NNS O
with IN O
acute JJ O
leukemia NN O
for IN O
IL-1 NN B-NP
and CC O
TNF NN B-NP
levels NNS O
throughout IN O
the DT O
clinical JJ O
course NN O
of IN O
disease NN O
may MD O
help VB O
clarify VB O
the DT O
causes NNS O
of IN O
febrile JJ O
episodes NNS O
. . O

-DOCSTART- X X O

The DT O
1489-base JJ O
pair NN O
EFIA NNP B-NP
cDNA NN O
encodes VBZ O
a DT O
322-amino JJ O
acid NN O
protein NN O
which WDT O
is VBZ O
nearly RB O
identical JJ O
to TO O
two CD O
previously RB O
described VBN O
human JJ O
DNA NN O
binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Translational NNP O
fusions NNS O
of IN O
the DT O
aroF JJ B-NP
regulatory JJ I-NP
regions NNS I-NP
to TO O
lacZ NN B-NP
were VBD O
constructed VBN O
and CC O
then RB O
introduced VBD O
in IN O
single JJ O
copy NN O
into IN O
the DT O
E. NNP O
coli NNS O
chromosome NN O
. . O
beta-Galactosidase NN B-NP
assays VBZ O
for IN O
tyrR-mediated JJ O
regulation NN O
of IN O
aroF-lacZ JJ B-NP
expression NN O
revealed VBD O
that IN O
the DT O
E. NNP B-NP
coli NNS I-NP
TyrR NNP I-NP
repressor NN I-NP
apparently RB O
recognizes VBZ O
the DT O
operators NNS O
of IN O
both DT O
organisms NNS O
with IN O
about RB O
equal JJ O
efficiency NN O
. . O

-DOCSTART- X X O

We PRP O
reviewed VBN O
the DT O
records NNS O
of IN O
151 CD O
patients NNS O
with IN O
optic JJ O
neuritis NN O
examined VBN O
over IN O
an DT O
eight-year JJ O
period NN O
. . O

-DOCSTART- X X O

The DT O
long JJ O
terminal NN O
repeat NN O
( -LRB- O
LTR NNP O
) -RRB- O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
( -LRB- O
HIV NNP O
) -RRB- O
contains VBZ O
three CD O
binding NN O
sites NNS O
for IN O
the DT O
transcriptional JJ O
factor NN O
Sp1 NNP B-NP
. . O

-DOCSTART- X X O

Differences NNS O
in IN O
the DT O
clinical JJ O
presentation NN O
and CC O
the DT O
gross JJ O
appearance NN O
of IN O
the DT O
two CD O
cases NNS O
are VBP O
described VBN O
, , O
and CC O
similarities NNS O
in IN O
the DT O
microscopic NN O
features NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Using VBG O
an DT O
ELISA NNP O
, , O
we PRP O
found VBD O
that IN O
surfactant JJ B-NP
protein NN I-NP
A DT I-NP
( -LRB- O
SP-A NNP B-NP
) -RRB- O
was VBD O
markedly RB O
elevated VBN O
in IN O
the DT O
pneumonia NN O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
prevalence NN O
of IN O
opportunistic JJ O
infection NN O
among IN O
surviving VBG O
AIDS NNP O
patients NNS O
and CC O
the DT O
probability NN O
of IN O
being VBG O
in IN O
tumour JJ O
response NN O
following VBG O
cancer NN O
therapy NN O
conditional JJ O
on IN O
being VBG O
alive JJ O
are VBP O
two CD O
examples NNS O
of IN O
such JJ O
functions NNS O
. . O

-DOCSTART- X X O

To TO O
test VB O
promotor NN O
function NN O
, , O
chimeric JJ O
genes NNS O
were VBD O
constructed VBN O
linking VBG O
fragments NNS O
of IN O
chicken NN O
IGF-I JJ B-NP
5'-flanking JJ O
DNA NN O
to TO O
a DT O
promoterless JJ O
reporter NN O
plasmid NN O
. . O

-DOCSTART- X X O

The DT O
alpha NN B-NP
4 CD I-NP
gene NN I-NP
5' JJ O
flanking VBG O
region NN O
acted VBD O
as IN O
a DT O
promoter NN O
in IN O
transfection NN O
assays VBZ O
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
alpha NN B-NP
4 CD I-NP
integrin NN I-NP
gene NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
similar JJ O
rates NNS O
of IN O
B. NNP O
sphaericus NN O
products NNS O
, , O
ABG-6184 DT O
technical JJ O
powder NN O
and CC O
BSP-2 JJ O
flowable JJ O
concentrate NN O
, , O
produced VBD O
no DT O
significant JJ O
reduction NN O
. . O

-DOCSTART- X X O

Some DT O
of IN O
the DT O
PCR NN O
products NNS O
contained VBN O
mutations NNS O
in IN O
ATG1 NNP B-NP
and/or CC O
ATG2 NNP B-NP
. . O

-DOCSTART- X X O

An DT O
RME1-independent JJ B-NP
pathway NN O
for IN O
sporulation NN O
control NN O
in IN O
Saccharomyces NNP O
cerevisiae NNS O
acts VBZ O
through IN O
IME1 NNP B-NP
transcript NN I-NP
accumulation NN O
. . O

-DOCSTART- X X O

Its PRP$ O
application NN O
in IN O
Madagascar NNP O
: : O
advantages NNS O
and CC O
disadvantages NNS O

-DOCSTART- X X O

ARPIA NNP O
has VBZ O
been VBN O
implemented VBN O
by IN O
using VBG O
a DT O
relational JJ O
DBMS NNP O
, , O
very RB O
cheap JJ O
and CC O
highly RB O
diffused VBD O
on IN O
personal JJ O
computers NNS O
. . O

-DOCSTART- X X O

Immuno-cytochemistry NNP O
, , O
using VBG O
antisera DT O
against IN O
Campylobacter NNP O
jejuni NNP O
, , O
showed VBD O
that IN O
the DT O
positive JJ O
staining NN O
in IN O
altered JJ O
epithelial NN O
cells NNS O
were VBD O
restricted VBN O
to TO O
intracellular JJ O
organisms NNS O
having VBG O
a DT O
structure NN O
resembling VBG O
Campylobacter NNP O
spp NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
discovered VBD O
a DT O
V NNP B-NP
lambda NN I-NP
pseudogene NN I-NP
, , O
called VBD O
psi NNS B-NP
V NNP I-NP
lambda VBD I-NP
1 CD I-NP
, , O
3 CD O
kb NN O
upstream RB O
of IN O
the DT O
U266 NNP B-NP
lambda NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Like IN O
other JJ O
members NNS O
of IN O
this DT O
family NN O
, , O
the DT O
AP-4 NNP B-NP
HLH NNP O
motif NN O
and CC O
the DT O
adjacent JJ O
basic JJ O
domain NN O
are VBP O
necessary JJ O
and CC O
sufficient JJ O
to TO O
confer VB O
site-specific JJ O
DNA NNP O
binding NN O
. . O

-DOCSTART- X X O

A DT O
bacteriological JJ O
relapse NN O
requiring VBG O
treatment NN O
occurred VBN O
by IN O
5 CD O
years NNS O
in IN O
16.8 CD O
% NN O
of IN O
113 CD O
R3 NNS O
, , O
5.2 CD O
% NN O
of IN O
97 CD O
R5 CD O
, , O
and CC O
20.0 CD O
% NN O
of IN O
115 CD O
Z5 CD O
patients NNS O
with IN O
organisms NNS O
sensitive JJ O
to TO O
streptomycin VB O
and CC O
isoniazid VB O
initially RB O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
indicates VBZ O
that IN O
AHA2 DT B-NP
mRNA NN I-NP
relative JJ O
to TO O
total JJ O
cellular JJ O
RNA NNP O
is VBZ O
expressed VBN O
at IN O
significantly RB O
higher JJR O
levels NNS O
in IN O
root NN O
tissue NN O
as IN O
compared VBN O
with IN O
shoot NN O
tissue NN O
. . O

-DOCSTART- X X O

A DT O
4.8-kilobase JJ O
BamHI-HindII NNP B-NP
I PRP B-NP
fragment NN O
encoding VBG O
the DT O
entire JJ B-NP
Neurospora NNP I-NP
crassa NN I-NP
CuZn NNP I-NP
superoxide NN I-NP
dismutase NN I-NP
gene NN I-NP
( -LRB- O
herein RB O
designated VBN O
sod-1 NN B-NP
) -RRB- O
was VBD O
isolated VBN O
from IN O
a DT O
genomic JJ O
library NN O
using VBG O
two CD O
60-base JJ O
deoxyoligonucleotide NN O
probes NNS O
corresponding JJ O
to TO O
the DT O
published VBN O
N. NNP O
crassa VBD O
amino IN O
acid NN O
sequence NN O
. . O

-DOCSTART- X X O

The DT O
nmr JJ B-NP
gene NN I-NP
is VBZ O
the DT O
major JJ O
negative JJ O
regulatory JJ O
gene NN O
in IN O
the DT O
nitrogen NN O
control NN O
circuit NN O
of IN O
Neurospora NNP O
crassa NN O
, , O
which WDT O
, , O
together RB O
with IN O
positive JJ O
regulatory JJ O
genes NNS O
, , O
governs VBZ O
the DT O
expression NN O
of IN O
multiple JJ O
unlinked JJ O
structural JJ O
genes NNS O
of IN O
the DT O
circuit NN O
. . O

-DOCSTART- X X O

This DT O
result NN O
indicates VBZ O
that IN O
separate JJ O
complexes NNS O
exist VBP O
containing VBG O
ankyrin NN B-NP
and CC O
fodrin NN B-NP
with IN O
either DT O
uvomorulin NNP B-NP
or CC O
Na+, NNP B-NP
K+-ATPase NNP I-NP
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
the DT O
human JJ O
homolog NN O
of IN O
the DT O
mouse NN B-NP
Mx NNP I-NP
protein NN I-NP
involved VBN O
in IN O
resistance NN O
to TO O
influenza NN O
virus NN O
. . O

-DOCSTART- X X O

Summers NNP O
, , O
Virology NNP O
89:517-527 CD O
, , O
1978 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Various JJ O
mutant JJ B-NP
HN NNP I-NP
genes NNS I-NP
were VBD O
constructed VBN O
to TO O
examine VB O
the DT O
role NN O
of IN O
residues NNS O
flanking VBG O
the DT O
signal-anchor NN O
domain NN O
, , O
including VBG O
the DT O
cytoplasmic JJ O
tail NN O
, , O
on IN O
assembly NN O
and CC O
intracellular JJ O
transport NN O
of IN O
the DT O
HN NNP B-NP
glycoprotein NN I-NP
. . O

-DOCSTART- X X O

A DT O
DNA NN O
motif NN O
related VBN O
to TO O
the DT O
cAMP-responsive JJ O
element NN O
and CC O
an DT O
exon-located JJ B-NP
activator NN I-NP
protein-2 NN I-NP
binding NN I-NP
site NN I-NP
in IN O
the DT O
human JJ B-NP
tissue-type NN I-NP
plasminogen NN I-NP
activator NN I-NP
gene NN I-NP
promoter NN I-NP
cooperate VBP O
in IN O
basal JJ O
expression NN O
and CC O
convey VB O
activation NN O
by IN O
phorbol NN O
ester NN O
and CC O
cAMP. NN O

-DOCSTART- X X O

The DT O
recombinant NN O
contains VBZ O
the DT O
normal JJ O
beta NN B-NP
A-globin NNP I-NP
gene NN I-NP
, , O
the DT O
mutant JJ O
gene NN O
and CC O
Ylp NN O
vector NN O
sequences NNS O
between IN O
the DT O
two CD O
copies NNS O
. . O

-DOCSTART- X X O

Some DT O
of IN O
the DT O
mutations NNS O
obtained VBN O
do VBP O
not RB O
contain VB O
a DT O
copy NN O
of IN O
the DT O
Ulysses NNP B-NP
element NN I-NP
at IN O
the DT O
mutant JJ O
locus NN O
, , O
suggesting VBG O
that IN O
a DT O
different JJ O
transposable JJ O
element NN O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
mutation NN O
. . O

-DOCSTART- X X O

Kinetic JJ O
experiments NNS O
revealed VBD O
that IN O
within IN O
10 CD O
min NN O
this DT O
radiolabeled JJ O
precursor JJ O
protein NN O
was VBD O
converted VBN O
in IN O
HL-60 JJ O
cells NNS O
into IN O
an DT O
Mr NNP O
approximately RB O
150,000 CD O
chondroitin NN O
sulfate NN O
proteoglycan JJ O
intermediate JJ O
. . O

-DOCSTART- X X O

The DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
14DM NNP I-NP
gene NN I-NP
, , O
encoding VBG O
cytochrome NN B-NP
P450 . I-NP
lanosterol NN I-NP
14 CD I-NP
alpha-demethylase NN I-NP
( -LRB- O
14DM) JJ B-NP
, , O
was VBD O
overexpressed VBN O
in IN O
various JJ O
S. NNP O
cerevisiae NNS O
strains NNS O
under IN O
the DT O
control NN O
of IN O
three CD O
strong JJ O
heterologous JJ O
yeast NN O
transcription NN O
promoters NNS O
(pADC1 VBP O
, , O
pGPD RB B-NP
, , O
pPHO5 DT B-NP
) -RRB- O
and CC O
under IN O
the DT O
control NN O
of IN O
its PRP$ O
own JJ O
promoter NN O
. . O

-DOCSTART- X X O

Serum NN B-NP
beta JJ I-NP
2-microglobulin JJ I-NP
levels NNS O
( -LRB- O
beta-2-M) NN B-NP
were VBD O
studied VBN O
in IN O
150 CD O
drug NN O
addicts NNS O
, , O
50 CD O
of IN O
them PRP O
asymptomatic JJ O
carriers NNS O
of IN O
anti NNS B-NP
HIV-1 JJ I-NP
antibodies NNS I-NP
, , O
50 CD O
symptomatic JJ O
carriers NNS O
with IN O
persistent JJ O
generalized JJ O
lymphadenopathy NN O
( -LRB- O
P.G.L. NNP O
) -RRB- O
and CC O
50 CD O
serum NN O
negative JJ O
patients NNS O
who WP O
had VBD O
been VBN O
living VBG O
in IN O
a DT O
closed JJ O
community NN O
for IN O
at IN O
least JJS O
2 CD O
years NNS O
. . O

-DOCSTART- X X O

This DT O
emancipation NN O
of IN O
the DT O
ability NN O
to TO O
copulate VB O
from IN O
hormonal JJ O
influence NN O
makes VBZ O
female JJ O
sexual JJ O
motivation NN O
the DT O
primary JJ O
regulator NN O
of IN O
mating NN O
in IN O
primates NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
various JJ O
deletion NN O
mutants NNS O
indicates VBZ O
that IN O
the DT O
sequence NN O
requirements NNS O
for IN O
binding NN O
by IN O
QBP NNP B-NP
in IN O
vitro NN O
are VBP O
indistinguishable JJ O
from IN O
those DT O
necessary JJ O
for IN O
Q NNP O
activity NN O
in IN O
vivo NN O
, , O
strongly RB O
suggesting VBG O
that IN O
QBP NNP B-NP
is VBZ O
required VBN O
for IN O
the DT O
function NN O
of IN O
this DT O
TATA-independent JJ O
promoter NN O
. . O

-DOCSTART- X X O

The DT O
two CD O
larger JJR O
peptides NNS O
, , O
one CD O
containing VBG O
amino IN O
acids NNS O
1-228 WDT O
and CC O
the DT O
other JJ O
containing VBG O
amino IN O
acids NNS O
85-228 CD O
, , O
formed VBD O
dimers NNS O
in IN O
solution NN O
and CC O
bound VBD O
DNA NN O
specifically RB O
as IN O
a DT O
dimer NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
transcription NN O
extracts NNS O
from IN O
ret1-1 NN B-NP
cells NNS O
terminate VBP O
less RBR O
efficiently RB O
at IN O
weak JJ O
transcription NN O
termination NN O
signals NNS O
than IN O
those DT O
from IN O
RET1 NNP B-NP
cells NNS O
, , O
using VBG O
a DT O
variety NN O
of IN O
tRNA DT O
templates NNS O
. . O

-DOCSTART- X X O

These DT O
latter JJ O
results NNS O
showed VBD O
that IN O
the DT O
ABFI NNP B-NP
protein NN I-NP
, , O
like IN O
the DT O
RAP1 JJ B-NP
protein NN I-NP
, , O
bound VBN O
sequences NNS O
required VBD O
for IN O
positive JJ O
as RB O
well RB O
as IN O
negative JJ O
regulation NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Homozygous JJ O
protein NN B-NP
C NN I-NP
(PC NN O
) -RRB- O
deficiency NN O
is VBZ O
reported VBN O
in IN O
two CD O
siblings NNS O
( -LRB- O
girl NN O
and CC O
boy NN O
) -RRB- O
who WP O
received VBD O
their PRP$ O
proper JJ O
diagnoses NNS O
at IN O
the DT O
ages NNS O
of IN O
7 CD O
4/12 CD O
and CC O
1 CD O
3/12 CD O
years NNS O
respectively RB O
. . O

-DOCSTART- X X O

Horseradish NNP B-NP
peroxidase NN I-NP
as IN O
a DT O
permeability NN O
marker NN O
in IN O
injured JJ O
rat NN O
caudal NN O
and CC O
iliac JJ O
arteries NNS O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
coenzyme NN O
Q10 IN O
( -LRB- O
CoQ NN O
) -RRB- O
and CC O
captopril NN O
on IN O
functional JJ O
capacity NN O
, , O
hemodynamics NNS O
and CC O
survival NN O
were VBD O
studied VBN O
in IN O
154 CD O
rats NNS O
that IN O
recovered VBN O
after IN O
experimental JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

Some DT O
mutations NNS O
affected VBD O
Dhfr NNP B-NP
in IN O
a DT O
qualitative JJ O
manner NN O
, , O
such JJ O
as IN O
by IN O
changing VBG O
the DT O
startpoint NN O
of IN O
one CD O
of IN O
the DT O
major JJ O
Dhfr NNP B-NP
transcripts NNS I-NP
or CC O
changing VBG O
the DT O
relative JJ O
abundance NN O
of IN O
the DT O
two CD O
major JJ O
Dhfr NNP B-NP
transcripts NNS I-NP
. . O

-DOCSTART- X X O

Modification NNP O
by IN O
this DT O
latter JJ O
compound NN O
was VBD O
so RB O
extensive JJ O
that IN O
the DT O
amount NN O
of IN O
membrane-associated JJ O
N-myristoylated JJ O
protein NN O
was VBD O
decreased VBN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
human JJ O
T NNP B-NP
cell NN I-NP
receptor NN I-NP
(TCR NN I-NP
) -RRB- I-NP
alpha NN I-NP
gene NN I-NP
is VBZ O
regulated VBN O
by IN O
a DT O
T NNP O
cell-specific JJ O
transcriptional JJ O
enhancer NN O
that WDT O
is VBZ O
located VBN O
4.5 CD O
kilobases NNS O
(kb IN O
) -RRB- O
3' CD O
to TO O
the DT O
C NNP B-NP
alpha NN I-NP
gene NN I-NP
segment NN I-NP
. . O

-DOCSTART- X X O

Cerebral NN O
flow NN O
and CC O
resistance NN O
showed VBD O
minor JJ O
reductions NNS O
with IN O
HD. NNP O

-DOCSTART- X X O

Auditory-visual JJ O
interaction NN O
in IN O
the DT O
generation NN O
of IN O
saccades NNS O
in IN O
man NN O
. . O

-DOCSTART- X X O

The DT O
upstream JJ O
promoter NN O
is VBZ O
located VBN O
within IN O
the DT O
coding NN O
sequence NN O
of IN O
a DT O
divergent JJ O
gene NN O
expressing VBG O
a DT O
protein NN O
of IN O
Mr NNP O
39 CD O
kDa NN O
of IN O
unknown JJ O
function NN O
. . O

-DOCSTART- X X O

Coenzyme NNP O
Q10 CD O
: : O
blood NN O
levels NNS O
and CC O
metabolic JJ O
demand NN O
. . O

-DOCSTART- X X O

Serum NNP O
Fibrin NNP B-NP
Degradation NNP I-NP
Products NNPS I-NP
( -LRB- O
FDP NNP B-NP
) -RRB- O
were VBD O
determined VBN O
in IN O
50 CD O
oral JJ O
cancer NN O
patients NNS O
and CC O
50 CD O
normal JJ O
individuals NNS O
prior RB O
to TO O
any DT O
kind NN O
of IN O
treatment NN O
. . O

-DOCSTART- X X O

Staining VBG O
with IN O
IF IN O
MoAB NNP O
alone RB O
of IN O
BAL NNP O
fluid NN O
only RB O
seemed VBD O
to TO O
be VB O
even RB O
more RBR O
sensitive JJ O
than IN O
silver NN O
methenamine NN O
staining NN O
of IN O
BAL NNP O
, , O
TBB NNP O
and CC O
brushing VBG O
material NN O
. . O

-DOCSTART- X X O

By IN O
introducing VBG O
a DT O
series NN O
of IN O
deletions NNS O
in IN O
the DT O
vimentin NN B-NP
promoter NN O
, , O
we PRP O
further RB O
restrict VBP O
these DT O
sequences NNS O
to TO O
30 CD O
base NN O
pairs NNS O
, , O
located VBN O
between IN O
241 CD O
and CC O
210 CD O
base NN O
pairs NNS O
upstream RB O
of IN O
the DT O
mRNA NN O
cap NN O
site NN O
. . O

-DOCSTART- X X O

The DT O
beta JJ O
chain NN O
contains VBZ O
five CD O
potential JJ O
N-linked JJ O
glycosylation NN O
sites NNS O
, , O
and CC O
endoglycosidase NN B-NP
digestion NN O
suggested VBD O
that IN O
the DT O
beta JJ O
chain NN O
contained VBD O
multiple JJ O
complex NN O
carbohydrate NN O
side NN O
chains NNS O
. . O

-DOCSTART- X X O

Thyrotropin-induced JJ B-NP
expression NN O
of IN O
a DT O
gene NN O
for IN O
a DT O
ribosomal JJ B-NP
protein NN I-NP
related VBN O
to TO O
the DT O
trk NN B-NP
oncogene NN I-NP
. . O

-DOCSTART- X X O

The DT O
BAL-to-plasma NNP O
specific JJ O
activity NN O
of IN O
urea NN O
was VBD O
about IN O
twice RB O
that DT O
of IN O
Na+ NNP O
, , O
indicating VBG O
that IN O
urea NN O
diffused VBD O
into IN O
the DT O
ELF NN O
more RBR O
rapidly RB O
than IN O
Na+ NNP O
during IN O
the DT O
70 CD O
s VBZ O
that IN O
elapsed VBN O
between IN O
the DT O
time NN O
the DT O
radioactive JJ O
urea NN O
and CC O
Na+ NNP O
were VBD O
injected VBN O
into IN O
the DT O
circulation NN O
and CC O
the DT O
time NN O
when WRB O
lavage NN O
was VBD O
complete JJ O
. . O

-DOCSTART- X X O

Intron NNP O
1 CD O
is VBZ O
6.5 CD O
kb NN O
long JJ O
, , O
and CC O
the DT O
minimal JJ O
sizes NNS O
of IN O
introns NNS O
2 CD O
and CC O
3 CD O
are VBP O
estimated VBN O
to TO O
be VB O
32 CD O
kb IN O
each DT O
. . O

-DOCSTART- X X O

Approximately RB O
65 CD O
% NN O
of IN O
the DT O
total JJ O
cAMP-dependent JJ B-NP
phosphotransferase NN I-NP
activity NN O
is VBZ O
recovered VBN O
in IN O
particulate JJ O
fractions NNS O
of IN O
homogenates NNS O
prepared VBN O
from IN O
asynchronous JJ O
populations NNS O
of IN O
C. NNP O
elegans NNS O
. . O

-DOCSTART- X X O

High JJ O
levels NNS O
of IN O
C NNP B-NP
subunits NNS I-NP
are VBP O
observed VBN O
in IN O
several JJ O
subsequent JJ O
larval NN O
and CC O
adult NN O
stages NNS O
of IN O
development NN O
. . O

-DOCSTART- X X O

French NNP O
, , O
M. NNP O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
gradual JJ O
increase NN O
in IN O
the DT O
myocyte NN O
diameter NN O
according VBG O
to TO O
age NN O
in IN O
the DT O
biopsy NN O
and CC O
autopsy NN O
specimens NNS O
. . O

-DOCSTART- X X O

Despite IN O
the DT O
absence NN O
of IN O
exercise-induced JJ O
asthma NN O
( -LRB- O
EIA NNP O
) -RRB- O
while IN O
breathing VBG O
WH WDT O
air NN O
, , O
asthmatic JJ O
patients NNS O
still RB O
had VBD O
significantly RB O
higher JJR O
mean JJ O
GH NNP O
increments NNS O
than IN O
normal JJ O
subjects NNS O
( -LRB- O
9.2 CD O
vs IN O
2.3 CD O
ng/ml NN O
, , O
P NNP O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
these DT O
genes NNS O
and CC O
their PRP$ O
surrounding VBG O
sequences NNS O
are VBP O
presented VBN O
and CC O
compared VBN O
with IN O
other JJ O
known VBN O
tRNA IN O
genes NNS O
from IN O
plant NN O
mitochondria NN O
. . O

-DOCSTART- X X O

Basing VBG O
on IN O
experimental JJ O
toxicity NN O
research NN O
it PRP O
was VBD O
established VBN O
that IN O
, , O
out IN O
of IN O
50 CD O
atmosphere NN O
metal NN O
corrosion NN O
inhibitors NNS O
, , O
some DT O
14 CD O
per IN O
cent NN O
were VBD O
found VBN O
extremely RB O
hazardous JJ O
, , O
42 CD O
per IN O
cent--of JJ O
high JJ O
level NN O
hazardous JJ O
, , O
33 CD O
percent--of , O
moderate JJ O
and CC O
11 CD O
per IN O
cent--of NN O
low JJ O
hazardous JJ O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
prognosis NN O
of IN O
twin JJ O
births NNS O
over IN O
20 CD O
years NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
2,397 CD O
( -LRB- O
74 CD O
% NN O
) -RRB- O
had VBD O
one CD O
or CC O
more JJR O
risk NN O
factors NNS O
( -LRB- O
not RB O
low JJ O
risk NN O
) -RRB- O
; : O
of IN O
these DT O
, , O
5.3 CD O
% NN O
died VBD O
in IN O
6 CD O
weeks NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
6 CD O
of IN O
24 CD O
infants NNS O
studied VBN O
( -LRB- O
27th-40th JJ O
weeks NNS O
of IN O
gestation NN O
) -RRB- O
, , O
acquired VBN O
and CC O
congenital JJ O
structural JJ O
anomalies NNS O
of IN O
the DT O
airways NNS O
were VBD O
detected VBN O
with IN O
an DT O
ultrathin JJ O
flexible JJ O
fiberscope NN O
( -LRB- O
Olympus NNP O
PF18 CD O
S NNP O
, , O
1.8 CD O
mm CD O
) -RRB- O
. . O

-DOCSTART- X X O

Sprague-Dawley NNP O
newborn JJ O
rats NNS O
( -LRB- O
n NN O
= SYM O
85 CD O
) -RRB- O
breathed VBD O
100 CD O
% NN O
oxygen NN O
( -LRB- O
O2 IN O
) -RRB- O
or CC O
room NN O
air NN O
(RA NN O
) -RRB- O
during IN O
the DT O
first JJ O
8 CD O
days NNS O
of IN O
life NN O
, , O
and CC O
then RB O
RA. . O

-DOCSTART- X X O

The DT O
Lm NNP O
increased VBD O
and CC O
the DT O
alveoli/mm2 NN O
and CC O
elastic JJ O
recoil NN O
pressure NN O
decreased VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
this DT O
reading NN O
frame NN O
was VBD O
concluded VBN O
to TO O
encode VB O
the DT O
precursor NN O
of IN O
mitochondrial JJ B-NP
fumarase NN I-NP
. . O

-DOCSTART- X X O

Role NNP O
of IN O
superoxide NN B-NP
dismutase NN I-NP
in IN O
cellular JJ O
oxidative JJ O
processes NNS O
and CC O
method NN O
of IN O
its PRP$ O
determination NN O
in IN O
biological JJ O
materials NNS O

-DOCSTART- X X O

A. NN O

-DOCSTART- X X O

The DT O
levels NNS O
of IN O
both DT O
MAP1-specific JJ B-NP
and CC I-NP
MAP2-specific JJ I-NP
mRNAs JJ I-NP
decline NN O
in IN O
the DT O
postnatal JJ O
developing VBG O
brain NN O
; : O
the DT O
level NN O
of IN O
MAP1-specific JJ B-NP
mRNA NN I-NP
also RB O
increases VBZ O
slightly RB O
in IN O
rat NN O
PC12 NN O
cells NNS O
upon IN O
exposure NN O
to TO O
nerve NN B-NP
growth NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

Prognosis NN O
of IN O
asymptomatic JJ O
multiple JJ O
myeloma NN O
. . O

-DOCSTART- X X O

The DT O
size NN O
discrepancy NN O
is VBZ O
not RB O
due JJ O
to TO O
glycosylation NN O
or CC O
phosphorylation NN O
of IN O
Ag35 DT B-NP
but CC O
may MD O
result VB O
from IN O
a DT O
proline-rich JJ O
sequence NN O
which WDT O
occurs VBZ O
in IN O
this DT O
polypeptide NN O
. . O

-DOCSTART- X X O

Serum NN O
prostatic JJ B-NP
acid NN I-NP
phosphatase NN I-NP
levels NNS O
showed VBD O
a DT O
significantly RB O
weaker JJR O
correlation NN O
with IN O
cancer NN O
volume NN O
( -LRB- O
r NN O
equals NNS O
0.51 CD O
) -RRB- O
and CC O
every DT O
other JJ O
pathological JJ O
parameter NN O
. . O

-DOCSTART- X X O

Their PRP$ O
studies NNS O
have VBP O
revealed VBN O
a DT O
considerable JJ O
increase NN O
of IN O
CSF NNP B-NP
AP NNP I-NP
activity NN O
in IN O
purulent JJ O
meningitides NNS O
whereas IN O
in IN O
serous JJ O
meningitides NNS O
it PRP O
grows VBZ O
negligibly RB O
. . O

-DOCSTART- X X O

Dopamine NNP O
caused VBD O
a DT O
prominent JJ O
potassium NN O
efflux NN O
measured VBN O
as IN O
86Rb+ JJ O
efflux NN O
from IN O
control NN O
glands NNS O
, , O
but CC O
was VBD O
without IN O
effect NN O
in IN O
denervated JJ O
glands NNS O
. . O

-DOCSTART- X X O

The DT O
ratio NN O
of IN O
radioactivity NN O
in IN O
tumour NN O
compared VBN O
with IN O
normal JJ O
tissue NN O
( -LRB- O
T:N JJ O
ratio NN O
) -RRB- O
was VBD O
determined VBN O
after IN O
simultaneously RB O
injecting VBG O
microspheres NNS O
into IN O
the DT O
portal JJ O
and CC O
arterial JJ O
circulation NN O
of IN O
each DT O
animal NN O
. . O

-DOCSTART- X X O

The DT O
mRNA NN O
was VBD O
converted VBN O
to TO O
cDNA VB O
and CC O
amplified VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
technique NN O
. . O

-DOCSTART- X X O

Cotransfection NN O
of IN O
either DT O
construct VB O
with IN O
plasmids NNS O
encoding JJ O
PKI(1-31 . B-NP
) -RRB- I-NP
inhibits VBZ O
cAMP-stimulated JJ O
but CC O
not RB O
basal- , O
or CC O
phorbol NN O
ester-stimulated JJ O
expression NN O
. . O

-DOCSTART- X X O

Structural JJ O
organization NN O
and CC O
expression NN O
of IN O
the DT O
mouse NN B-NP
estrogen NN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

Muscle NNP O
action NN O
potential JJ O
and CC O
masticatory JJ O
rhythm NN O
of IN O
anterior JJ O
temporal JJ O
and CC O
masseter JJ O
muscles NNS O
in IN O
children NNS O
and CC O
adults NNS O

-DOCSTART- X X O

Growth NN O
of IN O
tracheal NN O
anastomoses NNS O
in IN O
growing VBG O
animals NNS O

-DOCSTART- X X O

The DT O
other JJ O
patients NNS O
continued VBD O
the DT O
trial NN O
with IN O
single JJ O
daily JJ O
doses NNS O
of IN O
monotherapy NN O
. . O

-DOCSTART- X X O

Using VBG O
mutated JJ B-NP
IL2R NNP I-NP
alpha NN I-NP
promoter NN I-NP
constructs NNS I-NP
in IN O
transient NN O
transfection NN O
and CC O
DNA NN O
binding NN O
assays VBZ O
, , O
we PRP O
now RB O
demonstrate VBP O
that IN O
sequences NNS O
located VBN O
immediately RB O
upstream RB O
and CC O
downstream RB O
of IN O
the DT O
kappa NN B-NP
B NNP I-NP
enhancer NN I-NP
also RB O
contribute VBP O
to TO O
the DT O
regulation NN O
of IN O
IL2R NNP B-NP
alpha NN I-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
overall JJ O
prevalence NN O
of IN O
HBV NNP O
markers NNS O
was VBD O
higher JJR O
among IN O
staff NN O
members NNS O
than IN O
in IN O
the DT O
blood NN O
donors NNS O
of IN O
our PRP$ O
area NN O
. . O

-DOCSTART- X X O

Plasma NNP O
concentrations NNS O
of IN O
ANF NNP B-NP
(pANF) NNP O
, , O
aldosterone NN O
( -LRB- O
PAC NNP O
) -RRB- O
and CC O
renin NN B-NP
( -LRB- O
PRC NNP B-NP
) -RRB- O
were VBD O
measured VBN O
daily RB O
, , O
as RB O
were VBD O
hemodynamic JJ O
parameters NNS O
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
dexamethasone NN O
was VBD O
associated VBN O
with IN O
progressive JJ O
rises NNS O
in IN O
plasma NN O
17 CD O
alpha NN O
OH NNP O
progesterone NN O
, , O
11 CD O
beta-desoxycortisol JJ O
, , O
DHEA NNP O
sulphate NN O
, , O
androstenedione NN O
and CC O
testosterone NN O
, , O
together RB O
with IN O
increased VBN O
urinary JJ O
excretion NN O
of IN O
androsterone NN O
, , O
11 CD O
beta JJ O
OH NNP O
androsterone NN O
, , O
etiocholanolone NN O
, , O
DHEA NNP O
, , O
and CC O
16 CD O
alpha NN O
OH NNP O
DHEA. . O

-DOCSTART- X X O

In IN O
HeLa NNP O
cells NNS O
, , O
it PRP O
activated VBD O
transcription NN O
from IN O
the DT O
herpes NNS B-NP
simplex JJ I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
thymidine NN I-NP
kinase NN I-NP
promoter NN I-NP
linked VBN O
to TO O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
gene NN I-NP
when WRB O
located VBN O
in IN O
inverted JJ O
orientation NN O
upstream RB O
of IN O
the DT O
thymidine NN B-NP
kinase NN I-NP
promoter NN I-NP
or CC O
downstream NN O
of IN O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
gene NN I-NP
coding VBG I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

The DT O
mustard NN B-NP
chloroplast NN I-NP
gene NN I-NP
rps16 WDT I-NP
is VBZ O
split VBN O
by IN O
an DT O
887 CD O
bp JJ O
group NN O
II NNP O
( -LRB- O
or CC O
III NNP O
) -RRB- O
intron NN O
. . O

-DOCSTART- X X O

A DT O
brief JJ O
account NN O
of IN O
the DT O
1988 CD O
seminar NN O
in IN O
Shanghai NNP O
on IN O
viral JJ O
hepatitis NN O
A NNP O

-DOCSTART- X X O

Restriction NNP O
maps NNS O
of IN O
the DT O
cloned JJ O
plasmids NNS O
revealed VBD O
that IN O
their PRP$ O
chromosomal NN O
inserts NNS O
consisted VBD O
of IN O
overlapping VBG O
fragments NNS O
. . O

-DOCSTART- X X O

Insert2 PRP O
contains VBZ O
repetitive JJ O
non-Ig-related JJ O
sequences NNS O
and CC O
a DT O
small JJ B-NP
Ig-related JJ I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

In IN O
patients NNS O
resistant JJ O
to TO O
VAD NN O
, , O
high-dose JJ O
therapies NNS O
with IN O
intravenous JJ O
melphalan NN O
, , O
a DT O
CBV NN O
combination NN O
( -LRB- O
cyclophosphamide-BCNU-VP-16 NN O
) -RRB- O
or CC O
an DT O
EDAP NNP O
regimen NN O
(VP-16 NN O
-platinum NN O
) -RRB- O
produced VBN O
responses NNS O
in IN O
about IN O
40 CD O
% NN O
of IN O
patients NNS O
. . O

-DOCSTART- X X O

Most JJS O
of IN O
them PRP O
were VBD O
situated VBN O
at IN O
Sylvius NNP O
fissure NN O
( -LRB- O
13 CD O
cases NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Specifically RB O
, , O
they PRP O
were VBD O
performed VBN O
to TO O
determine VB O
whether IN O
detection NN O
of IN O
envelope NN O
phase NN O
disparity NN O
was VBD O
consistent JJ O
with IN O
processing NN O
within IN O
a DT O
single JJ O
channel NN O
in IN O
which WDT O
the DT O
AM VBP O
tones NNS O
were VBD O
simply RB O
added VBN O
. . O

-DOCSTART- X X O

Gel NNP O
retardation NN O
assays VBZ O
combined VBN O
with IN O
DNase NNP B-NP
I PRP I-NP
footprinting VBG O
and CC O
diethyl NN O
pyrocarbonate JJ O
interference NN O
showed VBD O
that IN O
a DT O
nuclear JJ O
factor NN O
from IN O
differentiated JJ O
C2 NNP O
myotubes NNS O
and CC O
BC3H1 NNP O
myocytes VBZ O
recognized VBN O
a DT O
conserved VBN O
A DT O
+ JJ O
T-rich JJ O
sequence NN O
within IN O
the DT O
peripheral JJ O
activating JJ O
region NN O
. . O

-DOCSTART- X X O

No DT O
changes NNS O
were VBD O
evident JJ O
in IN O
the DT O
FR-task JJ O
performance NN O
of IN O
controls NNS O
that IN O
received VBN O
daily JJ O
saline NN O
injections NNS O
. . O

-DOCSTART- X X O

Collaborative JJ O
study NN O
of IN O
Japanese JJ O
Pharmacopoeia NNP O
Heparin NNP O
Sodium NNP O
Reference NNP O
Standard NNP O

-DOCSTART- X X O

In IN O
Rat-1a NNP O
cells NNS O
the DT O
expression NN O
of IN O
human JJ B-NP
c-jun NN I-NP
mRNA NN I-NP
was VBD O
associated VBN O
with IN O
the DT O
ability NN O
to TO O
clone VB O
in IN O
soft JJ O
agarose NN O
and CC O
form NN O
tumors NNS O
in IN O
nude JJ O
mice NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
formation NN O
of IN O
foci NNS O
of IN O
transformed VBN O
RECs NNS O
by IN O
the DT O
c-jun/ras JJ B-NP
combination NN O
was VBD O
augmented VBN O
3-fold JJ O
by IN O
the DT O
tumor NN O
promoter NN O
phorbol NN O
12-tetradecanoate JJ O
13-acetate JJ O
. . O

-DOCSTART- X X O

US-Doppler NNP O
has VBZ O
recently RB O
gained VBN O
attention NN O
as IN O
a DT O
noninvasive JJ O
method NN O
for IN O
the DT O
functional JJ O
evaluation NN O
of IN O
arteriovenous JJ O
fistulas NNS O
( -LRB- O
FAV NN O
) -RRB- O
. . O

-DOCSTART- X X O

Doppler NNP O
echo VBP O
in IN O
evaluating VBG O
arteriovenous JJ O
fistulae NNS O
for IN O
dialysis NN O

-DOCSTART- X X O

Improved VBN O
cosmesis NN O
, , O
extension NN O
of IN O
the DT O
scope NN O
of IN O
the DT O
problems NNS O
that WDT O
can MD O
be VB O
addressed VBN O
with IN O
this DT O
repair NN O
( -LRB- O
including VBG O
treatment NN O
of IN O
a DT O
distal JJ O
urethrocutaneous JJ O
fistula NN O
) -RRB- O
and CC O
the DT O
ease NN O
with IN O
which WDT O
the DT O
Arap NNP O
procedure NN O
can MD O
be VB O
performed VBN O
are VBP O
the DT O
advantages NNS O
that IN O
this DT O
operation NN O
has VBZ O
over IN O
other JJ O
1-stage JJ O
distal JJ O
hypospadias NNS O
repairs NNS O
. . O

-DOCSTART- X X O

Following VBG O
the DT O
patients NNS O
during IN O
a DT O
course NN O
of IN O
therapy NN O
with IN O
a DT O
selective JJ O
vasodilator NN O
calcium NN O
antagonist NN O
, , O
the DT O
beta-adrenergic JJ O
reflex NN O
vasodilation NN O
became VBD O
substantially RB O
attenuated VBN O
but CC O
was VBD O
preserved VBN O
during IN O
a DT O
placebo NN O
course NN O
of IN O
therapy NN O
. . O

-DOCSTART- X X O

Psychiatry NNP O
and CC O
the DT O
skin NN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
data NNS O
also RB O
suggest VBP O
that IN O
when WRB O
compared VBN O
to TO O
the DT O
systemic JJ O
vascular JJ O
bed NN O
, , O
the DT O
pulmonary JJ O
vascular JJ O
bed NN O
is VBZ O
less RBR O
responsive JJ O
to TO O
bolus JJ O
administration NN O
of IN O
ET-1 NNP B-NP
. . O

-DOCSTART- X X O

A DT O
significant JJ O
relationship NN O
existed VBD O
during IN O
the DT O
evolution NN O
of IN O
the DT O
disease NN O
between IN O
CRS/BW NNP O
and CC O
gas NN O
exchange NN O
parameters NNS O
( -LRB- O
FIO2 CD O
and CC O
a/AO2 JJ O
ratio NN O
) -RRB- O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
, , O
but CC O
gas NN O
exchange NN O
improved VBD O
earlier JJR O
than IN O
lung NN O
mechanics NNS O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
molecular JJ O
weight NN O
of IN O
the DT O
polyprotein NN O
encoded VBN O
by IN O
ORF1 NNP O
is VBZ O
33 CD O
kilodaltons NNS O
(kDa DT O
) -RRB- O
. . O

-DOCSTART- X X O

Allelic NNP O
variation NN O
in IN O
HLA-B NNP B-NP
and CC O
HLA-C NNP B-NP
sequences NNS I-NP
and CC O
the DT O
evolution NN O
of IN O
the DT O
HLA-B NNP B-NP
alleles NNS I-NP
. . O

-DOCSTART- X X O

Similarly RB O
, , O
the DT O
sequence NN O
of IN O
the DT O
U2 NNP B-NP
RNA NNP I-NP
region NN I-NP
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
pre-mRNA JJ O
branchpoint NN O
recognition NN O
in IN O
yeast NN O
, , O
and CC O
exactly RB O
conserved VBN O
in IN O
metazoan NN B-NP
U2 IN I-NP
RNAs NNP I-NP
, , O
was VBD O
totally RB O
divergent JJ O
in IN O
trypanosomes NNS O
. . O

-DOCSTART- X X O

A DT O
raised VBN O
amplitude NN O
of IN O
the DT O
aggregation NN O
of IN O
plates NNS O
and CC O
a DT O
decrease NN O
in IN O
the DT O
threshold NN O
of IN O
their PRP$ O
sensitivity NN O
to TO O
ADP NNP O
were VBD O
established VBN O
in IN O
the DT O
persons NNS O
with IN O
types NNS O
IIa NNP O
and CC O
IIb NNP O
HLP NNP O
and CC O
in IN O
CHD NNP O
without IN O
HLP. NNP O

-DOCSTART- X X O

Significant JJ O
intergroup NN O
differences NNS O
are VBP O
highlighted JJ O
for IN O
both DT O
selected VBN O
dentoskeletal NN O
and CC O
soft JJ O
tissue NN O
profile NN O
variables NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
and CC O
characterisation NN O
of IN O
the DT O
two CD O
homologous JJ O
genes NNS O
coding VBG O
for IN O
nitrate JJ B-NP
reductase NN I-NP
in IN I-NP
tobacco NN I-NP
. . O

-DOCSTART- X X O

COUP NNP B-NP
transcription NN I-NP
factor NN I-NP
is VBZ O
a DT O
member NN O
of IN O
the DT O
steroid NN B-NP
receptor NN I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

Qualitatively RB O
, , O
the DT O
results NNS O
are VBP O
similar JJ O
for IN O
the DT O
two CD O
species NNS O
: : O
Both DT O
rhesus NN O
monkey NN O
and CC O
man NN O
have VBP O
photopic JJ O
and CC O
scotopic JJ O
branches NNS O
, , O
which WDT O
cross VBP O
at IN O
approximately RB O
the DT O
same JJ O
time NN O
in IN O
the DT O
dark JJ O
and CC O
at IN O
approximately RB O
the DT O
same JJ O
background NN O
luminance NN O
. . O

-DOCSTART- X X O

Endometrial NNP O
biopsies NNS O
and CC O
plasma NN O
oestradiol FW O
( -LRB- O
E2 NN O
) -RRB- O
and CC O
progesterone NN O
( -LRB- O
P4 NN O
) -RRB- O
levels NNS O
in IN O
23 CD O
patients NNS O
were VBD O
evaluated VBN O
during IN O
26 CD O
replacement NN O
therapy NN O
cycles NNS O
for IN O
premature JJ O
ovarian JJ O
failure NN O
. . O

-DOCSTART- X X O

Behaviorally RB O
, , O
a DT O
pain-tolerant JJ O
group NN O
( -LRB- O
PT NNP O
= SYM O
29 CD O
Ss NN O
) -RRB- O
tolerated VBD O
the DT O
entire JJ O
3-min JJ O
test NN O
( -LRB- O
means VBZ O
= SYM O
180 CD O
+/ CD O
- : O
0 CD O
sec) NN O
, , O
while IN O
a DT O
pain-sensitive JJ O
group NN O
( -LRB- O
PS NNP O
= SYM O
13 CD O
Ss NN O
) -RRB- O
averaged VBD O
only RB O
50.31 CD O
+/ NNS O
- : O
20.81 CD O
sec NN O
of IN O
the DT O
cold-pressor NN O
test NN O
( -LRB- O
t NN O
= SYM O
16.75 CD O
, , O
P NNP O
less JJR O
than IN O
0.0001 CD O
) -RRB- O
, , O
replicating VBG O
our PRP$ O
earlier JJR O
studies NNS O
. . O

-DOCSTART- X X O

Initial JJ O
experience NN O
with IN O
a DT O
microprocessor NN O
controlled VBN O
current JJ O
based VBN O
defibrillator NN O
. . O

-DOCSTART- X X O

The DT O
values NNS O
were VBD O
consistently RB O
lower JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
during IN O
summer NN O
( -LRB- O
3.79 CD O
+/ NN O
- : O
0.13 CD O
micrograms/100 CD O
ml NN O
) -RRB- O
, , O
as IN O
compared VBN O
to TO O
winter NN O
( -LRB- O
5.06 CD O
+/ NN O
- : O
0.27 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
xanthine NN B-NP
oxidase NN I-NP
activity NN O
in IN O
patients NNS O
with IN O
circulatory JJ O
failure NN O

-DOCSTART- X X O

The DT O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( -LRB- O
HIV-1 NN O
) -RRB- O
preferentially RB O
infects VBZ O
CD4+ NNP B-NP
T NNP O
lymphocytes NNS O
and CC O
may MD O
exist VB O
as IN O
a DT O
latent JJ O
provirus NN O
within IN O
these DT O
cells NNS O
for IN O
extended VBN O
periods NNS O
. . O

-DOCSTART- X X O

The DT O
subepicardial JJ O
lymphatic JJ O
capillaries NNS O
were VBD O
ramified VBN O
and CC O
anastomosed VBN O
with IN O
each DT O
other JJ O
to TO O
form VB O
a DT O
relatively RB O
dense JJ O
network NN O
which WDT O
extended VBD O
over IN O
the DT O
entire JJ O
surface NN O
of IN O
both DT O
ventricles NNS O
. . O

-DOCSTART- X X O

During IN O
sub-maximal JJ O
exercise NN O
, , O
DCR NN O
in IN O
the DT O
UT JJ O
dogs NNS O
decreased VBD O
from IN O
a DT O
resting VBG O
value NN O
of IN O
4.08 CD O
+/ NNS O
- : O
0.18 CD O
mm CD O
Hg NNP O
X NNP O
ml-1 NN O
X NNP O
min-1 CD O
to TO O
1.91 CD O
+/ CD O
- : O
0.17 CD O
mm CD O
Hg NNP O
X NNP O
ml-1 NN O
X NNP O
min-1 NN O
at IN O
a DT O
workload NN O
of IN O
6.4 CD O
kph NN O
( -LRB- O
speed NN O
)/16 CD O
% NN O
( -LRB- O
grade NN O
) -RRB- O
. . O

-DOCSTART- X X O

An DT O
analysis NN O
of IN O
the DT O
steady JJ O
state NN O
RNA NN O
levels NNS O
in IN O
T-lymphoid JJ O
cell NN O
lines NNS O
showed VBD O
that IN O
at IN O
least JJS O
three CD O
different JJ O
incomplete JJ O
proviral NN O
transcripts NNS O
and CC O
their PRP$ O
spliced JJ O
products NNS O
made VBN O
up RP O
the DT O
majority NN O
of IN O
expressed VBN O
RD-114 NNP B-NP
mRNA NN I-NP
, , O
and CC O
further RB O
demonstrated VBD O
that IN O
partially RB O
deleted VBN O
proviral NN O
loci NNS O
have VBP O
the DT O
potential JJ O
to TO O
be VB O
transcriptionally RB O
vigorous JJ O
in IN O
certain JJ O
feline NN O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

Sodium NNP O
dodecyl JJ O
sulphate-induced JJ O
cleavage NN O
by IN O
eukaryotic JJ B-NP
topoisomerase NN I-NP
I PRP I-NP
is VBZ O
known VBN O
to TO O
yield VB O
enzyme VBG O
covalently RB O
attached VBN O
to TO O
the DT O
3' JJ O
cut NN O
end NN O
of IN O
the DT O
DNA NNP O
. . O

-DOCSTART- X X O

RVEF NN O
and CC O
LVEF NNP O
both DT O
increased VBN O
by IN O
about RB O
14 CD O
% NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
and CC O
p VB O
less JJR O
than IN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Quantitative JJ O
assays IN O
in IN O
which WDT O
the DT O
activity NN O
of IN O
the DT O
synthetic JJ B-NP
alpha NN I-NP
s-1 NN I-NP
was VBD O
compared VBN O
to TO O
that DT O
of IN O
native JJ O
purified VBN O
human JJ B-NP
erythrocyte NN I-NP
type-1 NN I-NP
Gs NNP I-NP
, , O
indicated VBD O
that IN O
the DT O
two CD O
products NNS O
are VBP O
equipotent NN O
within IN O
a DT O
2-fold JJ O
margin NN O
of IN O
error NN O
. . O

-DOCSTART- X X O

Most JJS O
patients NNS O
with IN O
high JJ O
blood NN O
pressure NN O
( -LRB- O
BP NNP O
) -RRB- O
can MD O
be VB O
managed VBN O
by IN O
using VBG O
one CD O
of IN O
4 CD O
classes NNS O
of IN O
compounds NNS O
: : O
a DT O
diuretic JJ O
, , O
beta JJ O
blocker NN O
, , O
converting VBG O
enzyme JJ O
inhibitor NN O
or CC O
calcium NN O
antagonist NN O
. . O

-DOCSTART- X X O

Seventy-one JJ O
supplementary JJ O
doses NNS O
of IN O
vecuronium NN O
were VBD O
used VBN O
for IN O
muscle NN O
relaxation NN O
during IN O
a DT O
22-h-long JJ O
NLA NNP O
II NNP O
anaesthesia NN O
. . O

-DOCSTART- X X O

The DT O
East JJ O
African JJ O
dik-dik NN O
antelope NN O
represents VBZ O
a DT O
miniature JJ O
model NN O
ruminant NN O
for IN O
comparative JJ O
studies NNS O
. . O

-DOCSTART- X X O

2 CD O
cases NNS O
of IN O
type NN O
II NNP O
tyrosinosis NN O
( -LRB- O
Richner-Hanhart JJ O
syndrome NN O
) -RRB- O

-DOCSTART- X X O

Effects NNS O
of IN O
aging VBG O
and CC O
beta-adrenergic-blockade NN O
on IN O
standing-induced JJ O
QT/QS2 JJ O
changes NNS O
. . O

-DOCSTART- X X O

Hemodynamic NNP O
assessment NN O
was VBD O
obtained VBN O
before IN O
and CC O
following VBG O
administration NN O
of IN O
digoxin NN O
10 CD O
micrograms/kg NN O
IV NNP O
or CC O
dopamine NN O
, , O
5 CD O
to TO O
12 CD O
micrograms/kg/min NN O
IV. . O

-DOCSTART- X X O

For IN O
the DT O
present JJ O
work NN O
we PRP O
used VBD O
water NN O
saturated VBD O
with IN O
a DT O
50/50 CD O
mixture NN O
of IN O
H2 NNP O
and CC O
O2 NNP O
gases NNS O
, , O
for IN O
which WDT O
the DT O
heat NN O
defect NN O
is VBZ O
calculated VBN O
to TO O
be VB O
-2.1 DT O
% NN O
. . O

-DOCSTART- X X O

During IN O
flexion NN O
whiplash NN O
, , O
the DT O
torque NN O
at IN O
the DT O
occipital NN O
condyle NN O
reverses VBZ O
its PRP$ O
direction NN O
at IN O
about RB O
25 CD O
ms NNS O
after IN O
impact NN O
. . O

-DOCSTART- X X O

Functional JJ O
flow NN O
was VBD O
evaluated VBN O
using VBG O
laser NN O
Doppler NNP O
flowmetry NN O
( -LRB- O
LDF) NNP O
, , O
for IN O
which WDT O
the DT O
output NN O
signal NN O
, , O
blood NN O
cell NN O
flux NN O
(BCF) NN O
, , O
is VBZ O
expressed VBN O
in IN O
terms NNS O
of IN O
volts NNS O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
picture NN O
and CC O
laboratory NN O
parameters NNS O
were VBD O
consistent JJ O
with IN O
a DT O
serum NN O
sickness NN O
reaction NN O
. . O

-DOCSTART- X X O

The DT O
seco-steroid JJ O
hormone NN O
1,25-dihydroxyvitamin CD O
D3 NNP O
is VBZ O
known VBN O
to TO O
induce VB O
the DT O
expression NN O
of IN O
a DT O
calcium NN O
binding JJ O
protein NN O
termed VBD O
calbindin-D28K JJ B-NP
in IN O
a DT O
variety NN O
of IN O
target NN O
tissues NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
calbindin-D28K JJ B-NP
promoter NN I-NP
is VBZ O
composed VBN O
of IN O
a DT O
variety NN O
of IN O
simple JJ O
repeated VBN O
sequences NNS O
, , O
some DT O
of IN O
which WDT O
are VBP O
components NNS O
of IN O
putative JJ O
regulatory JJ O
signals NNS O
. . O

-DOCSTART- X X O

Organ NNP O
transplantation NN O
in IN O
Denmark NNP O
. . O

-DOCSTART- X X O

Those DT O
dosages NNS O
that WDT O
inhibited VBD O
mean JJ O
NTE NN B-NP
activity NN O
in IN O
spinal NN O
cord NN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
72 CD O
% NN O
and CC O
brain NN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
66 CD O
% NN O
of IN O
control NN O
values NNS O
within IN O
44 CD O
hr NN O
postexposure NN O
produced VBD O
marked VBN O
spinal JJ O
cord NN O
pathology NN O
14 CD O
days NNS O
postexposure NN O
in IN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
90 CD O
% NN O
of IN O
similarly RB O
dosed VBN O
animals NNS O
. . O

-DOCSTART- X X O

Thirty CD O
of IN O
the DT O
clones NNS O
contained VBD O
a DT O
complete JJ O
340 CD O
base-pair NN O
dimer JJ O
unit NN O
of IN O
the DT O
repeat NN O
. . O

-DOCSTART- X X O

Cattaneo NNP O
, , O
and CC O
J. NNP O

-DOCSTART- X X O

Next JJ O
, , O
with IN O
carcinoma NN O
presenting VBG O
a DT O
leather NN O
bottle NN O
( -LRB- O
linitis NN O
plastica NN O
type NN O
) -RRB- O
of IN O
the DT O
stomach NN O
itself PRP O
, , O
the DT O
II NNP O
c NN O
portion NN O
of IN O
the DT O
stomach NN O
consisted VBD O
of IN O
fundic JJ O
glands NNS O
(undifferentiated JJ O
carcinoma NN O
) -RRB- O
shall MD O
become VB O
the DT O
primary JJ O
focus NN O
supporting VBG O
Nakamura NNP O
's POS O
theory NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
DNAs NN O
of IN O
all DT O
Ph1-positive JJ O
chronic NN O
myelocytic JJ O
leukemia NN O
patients NNS O
studied VBD O
to TO O
date NN O
, , O
a DT O
breakpoint NN O
on IN O
chromosome NN O
22 CD O
( -LRB- O
the DT O
Ph1 JJ O
chromosome NN O
) -RRB- O
can MD O
be VB O
demonstrated VBN O
with IN O
a DT O
probe NN O
from IN O
the DT O
bcr NN B-NP
( -LRB- O
breakpoint NN B-NP
cluster NN I-NP
region NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
5'-nontranslated JJ O
sequences NNS O
and CC O
parts NNS O
of IN O
the DT O
coding NN O
sequences NNS O
of IN O
various JJ O
yeast NN O
genes NNS O
have VBP O
been VBN O
cloned VBN O
into IN O
representative JJ O
lacZ JJ B-NP
fusion NN O
vectors NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
suppression NN O
of IN O
elevated JJ O
prolactin NN B-NP
levels NNS O
in IN O
progressive JJ O
metastatic JJ O
breast NN O
cancer NN O
patients NNS O
is VBZ O
not RB O
effective JJ O
in IN O
restoring VBG O
tumor NN O
sensitivity NN O
to TO O
chemotherapy NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
found VBD O
an DT O
eIF-4A JJ B-NP
intronless JJ O
retroposon NN O
which WDT O
, , O
when WRB O
compared VBN O
to TO O
the DT O
cDNA NN O
, , O
contains VBZ O
a DT O
single JJ O
nucleotide JJ O
difference NN O
. . O

-DOCSTART- X X O

In IN O
view NN O
of IN O
these DT O
results NNS O
, , O
simultaneous JJ O
pancreas-kidney NN O
transplantation NN O
appears VBZ O
to TO O
be VB O
the DT O
treatment NN O
of IN O
choice NN O
for IN O
Type NNP O
I PRP O
diabetic VBD O
patients NNS O
. . O

-DOCSTART- X X O

Factors NNS O
influencing VBG O
the DT O
bond NN O
strength NN O
between IN O
glass NN O
polyalkenoate NN O
( -LRB- O
ionomer NN O
) -RRB- O
cements NNS O
and CC O
dentine NN O
. . O

-DOCSTART- X X O

Research NNP O
on IN O
ethylene NN O
glycol NN O
and CC O
diethylene NN O
glycol NN O
for IN O
carcinogenic JJ O
effects NNS O

-DOCSTART- X X O

Isolation NNP O
and CC O
characterization NN O
of IN O
a DT O
vinculin NN B-NP
cDNA NN I-NP
from IN I-NP
chick-embryo NN I-NP
fibroblasts NNS I-NP
. . O

-DOCSTART- X X O

A DT O
complementary JJ O
study NN O
, , O
showing VBG O
a DT O
good JJ O
agreement NN O
between IN O
surface NN O
and CC O
oesophageal JJ O
EMGd NN O
seems VBZ O
to TO O
confirm VB O
that DT O
surface NN O
EMGd NN O
is VBZ O
a DT O
useful JJ O
and CC O
promising JJ O
tool NN O
for IN O
clinical JJ O
investigation NN O
. . O

-DOCSTART- X X O

No DT O
differences NNS O
in IN O
fixation NN O
quality NN O
were VBD O
observed VBN O
between IN O
cochleas NNS O
fixed VBN O
by IN O
intravascular JJ O
perfusion NN O
and CC O
cochleas NNS O
fixed VBN O
by IN O
intralabyrinthine NN O
perfusion NN O
. . O

-DOCSTART- X X O

The DT O
requirement NN O
of IN O
different JJ O
essential JJ O
fatty NN O
acids NNS O
in IN O
patients NNS O
with IN O
total JJ O
parenteral JJ O
nutrition NN O
after IN O
heavy JJ O
injury NN O
is VBZ O
of IN O
special JJ O
interest NN O
with IN O
respect NN O
to TO O
the DT O
development NN O
and CC O
prognosis NN O
of IN O
shock NN O
, , O
sepsis NN O
or CC O
adult NN O
respiratory NN O
distress NN O
syndrome NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
mixtures NNS O
of IN O
sesame JJ O
flour NN O
and CC O
soybean NN O
flour NN O
were VBD O
well RB O
accepted VBN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
end NN O
of IN O
the DT O
coding NN O
region NN O
was VBD O
located VBN O
precisely RB O
by IN O
comparing VBG O
the DT O
deduced JJ O
amino JJ O
acid NN O
sequence NN O
to TO O
the DT O
actual JJ O
N-terminal JJ O
amino DT O
acid NN O
sequence NN O
of IN O
IHF. NNP B-NP

-DOCSTART- X X O

Conservative JJ O
treatment NN O
of IN O
bladder NN O
carcinoma NN O
by IN O
partial JJ O
cystectomy NN O
and CC O
interstitial JJ O
iridium NN O
192 CD O
. . O

-DOCSTART- X X O

Existence NN O
and CC O
uniqueness NN O
of IN O
solutions NNS O
of IN O
the DT O
appropriate JJ O
boundary NN O
value NN O
problems NNS O
are VBP O
established VBN O
, , O
in IN O
the DT O
case NN O
of IN O
small JJ O
permeability NN O
coefficients NNS O
and CC O
transport NN O
rates NNS O
, , O
or CC O
large JJ O
diffusion NN O
coefficients NNS O
and CC O
small JJ O
resistance NN O
to TO O
flow VB O
constants NNS O
. . O

-DOCSTART- X X O

Neuromyelitis NN O
optica NN O
( -LRB- O
Devic NNP O
's POS O
syndrome NN O
) -RRB- O
: : O
not RB O
always RB O
multiple JJ O
sclerosis NN O
. . O

-DOCSTART- X X O

None NN O
had VBD O
a DT O
past JJ O
history NN O
of IN O
opportunistic JJ O
infections NNS O
; : O
neither CC O
did VBD O
any DT O
have VB O
lymphopenia NN O
. . O

-DOCSTART- X X O

Post-transcriptional JJ O
regulation NN O
of IN O
ribosomal JJ B-NP
protein NN I-NP
gene NN I-NP
expression NN O
during IN O
development NN O
in IN O
Dictyostelium NNP O
discoideum NN O
. . O

-DOCSTART- X X O

The DT O
temporal JJ O
and CC O
static JJ O
plasma NN O
concentration-effect NN O
relationships NNS O
were VBD O
evaluated VBN O
by IN O
pharmacodynamic JJ O
modeling JJ O
and CC O
linear JJ O
regression NN O
. . O

-DOCSTART- X X O

Many JJ O
children NNS O
with IN O
BGC NNP O
are VBP O
delayed VBN O
in IN O
their PRP$ O
development NN O
, , O
but CC O
calcifications NNS O
are VBP O
not RB O
directly RB O
related VBN O
to TO O
specific JJ O
forms NNS O
of IN O
neurologic NN O
dysfunction NN O
. . O

-DOCSTART- X X O

R-wave JJ O
voltage NN O
in IN O
the DT O
right JJ O
precordial JJ O
leads NNS O
in IN O
anthracycline NN O
cardiomyopathy NN O
: : O
a DT O
clinical JJ O
study NN O
. . O

-DOCSTART- X X O

Secretory NNP O
function NN O
of IN O
the DT O
prostate NN O
gland NN O
. . O

-DOCSTART- X X O

Minor NNP O
differences NNS O
were VBD O
noted VBN O
with IN O
latamoxef JJ O
producing VBG O
mild JJ O
persistant JJ O
elevation NN O
of IN O
prothrombin NN B-NP
time NN O
( -LRB- O
0.7 CD O
second NN O
) -RRB- O
associated VBN O
with IN O
depression NN O
of IN O
factor NN B-NP
II NNP I-NP
and CC O
factor NN B-NP
VII NNP I-NP
. . O

-DOCSTART- X X O

The DT O
size NN O
of IN O
the DT O
group NN O
allocated VBN O
to TO O
the DT O
good JJ O
compliance NN O
category NN O
by IN O
the DT O
use NN O
of IN O
the DT O
digoxin NN O
marker NN O
was VBD O
equivalent JJ O
in IN O
size NN O
to TO O
a DT O
group NN O
of IN O
patients NNS O
who WP O
had VBD O
returned VBN O
less RBR O
than IN O
15 CD O
% NN O
of IN O
their PRP$ O
prescribed JJ O
dose NN O
or CC O
reported VBD O
a DT O
deviation NN O
of IN O
less JJR O
than IN O
6 CD O
% NN O
from IN O
their PRP$ O
prescription NN O
. . O

-DOCSTART- X X O

Bullous JJ O
keratopathy NN O
was VBD O
usually RB O
aphakic JJ O
in IN O
origin NN O
in IN O
1982 CD O
, , O
but CC O
after IN O
1983 CD O
pseudophakic NN O
bullous JJ O
keratopathy NN O
( -LRB- O
PBK) NNP O
was VBD O
the DT O
most RBS O
common JJ O
cause NN O
of IN O
bullous JJ O
keratopathy NN O
. . O

-DOCSTART- X X O

The DT O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- I-NP
EGF NN I-NP
) -RRB- I-NP
receptor NN I-NP
, , O
which WDT O
exhibits VBZ O
intrinsic JJ O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
activity NN O
, , O
undergoes VBZ O
a DT O
rapid JJ O
, , O
intramolecular JJ O
self-phosphorylation NN O
reaction NN O
following VBG O
EGF NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

The DT O
glomerular JJ O
filtration NN O
rate NN O
and CC O
effective JJ O
renal JJ O
plasma NN O
flow NN O
were VBD O
determined VBN O
by IN O
a DT O
standard JJ O
clearance NN O
method NN O
, , O
employing VBG O
continuous JJ O
infusion NN O
of IN O
inulin NN O
and CC O
para-aminohippuric JJ O
acid NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
MAN NNP O
showed VBD O
a DT O
unimodal JJ O
, , O
skewed JJ O
distribution NN O
, , O
with IN O
a DT O
range NN O
from IN O
approximately RB O
1 CD O
to TO O
14 CD O
micron NN O
and CC O
a DT O
maximum NN O
at IN O
3-4 CD O
micron NN O
. . O

-DOCSTART- X X O

Abnormal JJ O
technetium NN O
Tc NN O
99m IN O
medronate JJ O
scans NNS O
in IN O
patients NNS O
with IN O
previously RB O
undiagnosed JJ O
polyarthralgias NNS O
suggested VBD O
inflammatory JJ O
arthropathy NN O
and CC O
influenced VBD O
management NN O
decisions NNS O
with IN O
favorable JJ O
therapeutic JJ O
outcomes NNS O
. . O

-DOCSTART- X X O

The DT O
state NN O
of IN O
the DT O
liver NN O
in IN O
generalized JJ O
forms NNS O
of IN O
meningococcal JJ O
infection NN O

-DOCSTART- X X O

The DT O
actuarial JJ O
local JJ O
control NN O
rates NNS O
at IN O
10 CD O
years NNS O
for IN O
the DT O
three CD O
treatment NN O
groups NNS O
were VBD O
as IN O
follows VBZ O
: : O
subtotal JJ O
excision NN O
alone RB O
, , O
18 CD O
% NN O
; : O
subtotal JJ O
excision NN O
plus CC O
postoperative JJ O
radiation NN O
therapy NN O
, , O
82 CD O
% NN O
; : O
and CC O
total JJ O
excision NN O
alone RB O
, , O
77 CD O
% NN O
. . O

-DOCSTART- X X O

Ischemic NNP O
heart NN O
disease NN O
, , O
age NN O
of IN O
more JJR O
than IN O
75 CD O
years NNS O
, , O
and CC O
the DT O
fact NN O
that IN O
the DT O
patient NN O
was VBD O
a DT O
woman NN O
were VBD O
independent JJ O
predictors NNS O
of IN O
poor JJ O
cardiac JJ O
function NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
indicate VBP O
that IN O
autophosphorylation NN O
of IN O
Thr286 DT O
( -LRB- O
alpha NN O
subunit NN O
) -RRB- O
and CC O
Thr287 CD O
( -LRB- O
beta JJ O
subunit NN O
) -RRB- O
is VBZ O
responsible JJ O
for IN O
transition NN O
of IN O
CaM-kinase JJ B-NP
II NNP I-NP
to TO O
the DT O
Ca2+-independent JJ O
form NN O
. . O

-DOCSTART- X X O

This DT O
rapid JJ O
and CC O
extensive JJ O
penetration NN O
of IN O
intrathecally RB O
administered VBN O
chemotherapy NN O
may MD O
offer VB O
insight NN O
into IN O
the DT O
myelopathy NN O
observed VBD O
with IN O
these DT O
treatments NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
unlike IN O
control NN O
rats NNS O
operated VBD O
animals NNS O
did VBD O
not RB O
show VB O
aversion NN O
to TO O
the DT O
highest JJS O
concentrations NNS O
of IN O
saccharin JJ O
solutions NNS O
. . O

-DOCSTART- X X O

Two CD O
scintigraphic JJ O
methods NNS O
, , O
resting VBG O
dipyridamole NN O
and CC O
exercise NN O
thallium-201 DT O
myocardial JJ O
perfusion NN O
imaging NN O
, , O
to TO O
detect VB O
and CC O
localize VB O
coronary JJ O
artery NN O
stenosis NN O
were VBD O
compared VBN O
in IN O
32 CD O
patients NNS O
suffering VBG O
from IN O
coronary JJ O
artery NN O
disease NN O
. . O

-DOCSTART- X X O

X2 DT O
test NN O
, , O
with IN O
Yates NNP O
correction NN O
if IN O
need NN O
, , O
was VBD O
used VBN O
as IN O
statistical JJ O
. . O
method NN O
. . O

-DOCSTART- X X O

Mean JJ O
fluorosis NN O
scores NNS O
, , O
however RB O
, , O
were VBD O
similar JJ O
. . O

-DOCSTART- X X O

Pharmacologic NNP O
properties NNS O
of IN O
serotonergic JJ O
agents NNS O
and CC O
antidepressant JJ O
drugs NNS O
. . O

-DOCSTART- X X O

The DT O
incidence NN O
of IN O
second JJ O
malignant JJ O
neoplasms NNS O
was VBD O
lower JJR O
( -LRB- O
1.3 CD O
% NN O
) -RRB- O
in IN O
the DT O
group NN O
treated VBN O
with IN O
5-fluorouracil CD O
, , O
doxorubicin RB O
, , O
and CC O
cyclophosphamide NN O
than IN O
in IN O
the DT O
historical JJ O
control NN O
group NN O
( -LRB- O
4.8 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
our PRP$ O
observations NNS O
, , O
we PRP O
propose VBP O
a DT O
model NN O
whereby WRB O
inactive JJ O
precursor NN O
molecules NNS O
produced VBN O
from IN O
the DT O
PEP4 NNP B-NP
gene NN I-NP
self-activate JJ O
within IN O
the DT O
yeast NN O
vacuole NN O
and CC O
subsequently RB O
activate VB O
other JJ O
vacuolar JJ B-NP
hydrolases NNS I-NP
. . O

-DOCSTART- X X O

Several JJ O
new JJ O
techniques NNS O
are VBP O
available JJ O
for IN O
monitoring VBG O
control NN O
of IN O
diabetes NNS O
. . O

-DOCSTART- X X O

Postglucose NNP O
serum NN B-NP
insulin NN I-NP
levels NNS O
showed VBD O
no DT O
significant JJ O
correlations NNS O
with IN O
systolic JJ O
or CC O
diastolic JJ O
blood NN O
pressure NN O
levels NNS O
in IN O
men NNS O
, , O
but CC O
in IN O
female JJ O
diabetic NN O
and CC O
non-diabetic JJ O
subjects NNS O
significant JJ O
correlations NNS O
were VBD O
found VBN O
in IN O
particular JJ O
with IN O
systolic JJ O
blood NN O
pressure NN O
level NN O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
oligonucleotide-directed JJ O
mutagenesis NN O
to TO O
alter VB O
a DT O
site NN O
in IN O
MucA NNP B-NP
homologous JJ O
to TO O
the DT O
Ala-Gly NNP O
cleavage NN O
site NN O
of IN O
LexA. NNP B-NP

-DOCSTART- X X O

The DT O
latter NN O
was VBD O
determined VBN O
as IN O
follows VBZ O
: : O
Type JJ O
I-solid JJ O
tumor NN O
tissue NN O
without IN O
significant JJ O
peripheral JJ O
isolated JJ O
tumor NN O
cells NNS O
; : O
Type JJ O
II-solid JJ O
tumor NN O
tissue NN O
associated VBN O
with IN O
peripheral JJ O
isolated JJ O
tumor NN O
cells NNS O
; : O
Type NNP O
III-isolated NNP O
tumor NN O
cells NNS O
only RB O
. . O

-DOCSTART- X X O

Rabbits NNS O
developed VBD O
profound JJ O
hypocalcemia NN O
, , O
with IN O
levels NNS O
falling VBG O
from IN O
15.5 CD O
+/ NNS O
- : O
0.2 CD O
to TO O
7.6 CD O
+/ NNS O
- : O
0.4 CD O
mg/dl NN O
under IN O
the DT O
influence NN O
of IN O
TSST-1 NN B-NP
. . O

-DOCSTART- X X O

Dorsal NNP O
foot NN O
TcpO2 . O
was VBD O
measured VBN O
by IN O
using VBG O
oxygen-sensing NN O
electrodes NNS O
with IN O
surface NN O
temperatures NNS O
of IN O
42 CD O
degrees NNS O
C NN O
and CC O
45 CD O
degrees NNS O
C NN O
; : O
in IN O
theory NN O
, , O
changes NNS O
in IN O
sympathetic JJ O
activity NN O
should MD O
affect VB O
vasomotor JJ O
tone NN O
and CC O
TcpO2 NN O
in IN O
skin NN O
beneath IN O
an DT O
electrode NN O
at IN O
42 CD O
degrees NNS O
C NN O
( -LRB- O
submaximal JJ O
vasodilation NN O
) -RRB- O
, , O
but CC O
not RB O
at IN O
45 CD O
degrees NNS O
C NN O
( -LRB- O
maximal JJ O
vasodilation NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequences NNS O
of IN O
the DT O
human JJ B-NP
and CC I-NP
murine JJ I-NP
ornithine NN I-NP
decarboxylase NN I-NP
mRNAs NN I-NP
share NN O
an DT O
85 CD O
% NN O
homology NN O
, , O
even RB O
in IN O
their PRP$ O
3'-noncoding JJ O
regions NNS O
. . O

-DOCSTART- X X O

In IN O
cases NNS O
of IN O
1 CD O
degrees NNS O
HPT NN O
, , O
the DT O
plasma NN O
1,25-(OH)2D JJ O
level NN O
rose VBD O
significantly RB O
in IN O
all DT O
cases NNS O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
, , O
although IN O
the DT O
pattern NN O
of IN O
the DT O
increase NN O
was VBD O
not RB O
uniform JJ O
. . O

-DOCSTART- X X O

Data NNP O
from IN O
119 CD O
men NNS O
and CC O
40 CD O
women NNS O
undergoing VBG O
coronary JJ O
angiography NN O
provide VBP O
an DT O
opportunity NN O
to TO O
compare VB O
these DT O
associations NNS O
in IN O
relation NN O
to TO O
a DT O
direct JJ O
and CC O
continuous JJ O
measure NN O
of IN O
atherosclerosis NN O
while IN O
controlling VBG O
for IN O
age NN O
, , O
sex NN O
, , O
income NN O
, , O
hypertension NN O
, , O
serum NN O
cholesterol NN O
, , O
smoking NN O
, , O
angina NN O
, , O
diabetes NNS O
, , O
family NN O
history NN O
of IN O
heart NN O
disease NN O
, , O
Type JJ O
A DT O
behavior NN O
pattern NN O
, , O
and CC O
hostility NN O
. . O

-DOCSTART- X X O

Immobilization NN O
of IN O
the DT O
fracture NN O
in IN O
a DT O
collar NN O
and CC O
cuff NN O
sling NN O
was VBD O
as RB O
effective JJ O
as IN O
more JJR O
elaborate JJ O
methods NNS O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
patients NNS O
receiving VBG O
phenytoin NNS O
and CC O
those DT O
who WP O
were VBD O
not RB O
showed VBN O
significantly RB O
lower JJR O
serum NN O
folate NN O
in IN O
the DT O
sub-group NN O
receiving VBG O
phenytoin NN O
, , O
but CC O
there EX O
was VBD O
no DT O
significant JJ O
difference NN O
between IN O
the DT O
sub-groups NNS O
with IN O
respect NN O
to TO O
vitamin NN O
B12 CD O
or CC O
behaviour CD O
problem NN O
rating NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
a DT O
low-energy JJ O
laser NN O
beam NN O
on IN O
the DT O
cells NNS O
of IN O
the DT O
newt JJ O
embryo NN O

-DOCSTART- X X O

Separate JJ O
experiments NNS O
measured VBN O
AIB NNP O
and CC O
86RbCl JJ O
uptake NN O
in IN O
36B-10 JJ O
cells NNS O
in IN O
vitro NN O
1 CD O
and CC O
2 CD O
days NNS O
following VBG O
20 CD O
Gy NNP O
irradiation NN O
to TO O
assess VB O
whether IN O
this DT O
radiation NN O
dose NN O
reduced VBD O
the DT O
capacity NN O
of IN O
tumor NN O
cells NNS O
to TO O
trap NN O
AIB NNP O
or CC O
Rb+ NNP O
. . O

-DOCSTART- X X O

Hyperthyroidism NN O

-DOCSTART- X X O

These DT O
changes NNS O
at IN O
the DT O
site NN O
of IN O
injection NN O
consist VBP O
of IN O
a DT O
focal JJ O
abnormality NN O
characterized VBN O
by IN O
a DT O
slight JJ O
increase NN O
in IN O
signal NN O
intensity NN O
on IN O
T1 DT O
weighted JJ O
images NNS O
and CC O
markedly RB O
increased JJ O
signal NN O
intensity NN O
on IN O
T2 DT O
weighted JJ O
images NNS O
. . O

-DOCSTART- X X O

References NNS O
for IN O
occupational JJ O
fitness NN O
of IN O
adolescents NNS O
with IN O
diseases NNS O
of IN O
the DT O
respiratory JJ O
tract NN O
and CC O
lungs NNS O

-DOCSTART- X X O

Salzburg NNP O
, , O
9-12 CD O
September NNP O
1987 CD O
. . O

-DOCSTART- X X O

The DT O
selenium NN O
level NN O
and CC O
glutathione NN B-NP
peroxidase NN I-NP
activity NN O
in IN O
the DT O
blood NN O
, , O
liver NN O
, , O
and CC O
stomach NN O
mucosa NN O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
high-selenium JJ O
diet NN O
group NN O
than IN O
in IN O
the DT O
low-selenium NN O
diet NN O
group NN O
. . O

-DOCSTART- X X O

Oxygen NNP O
delivery NN O
and CC O
consumption NN O
and CC O
P50 CD O
in IN O
patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
primary JJ O
visual JJ O
cortex NN O
of IN O
the DT O
rat NN O
is VBZ O
asymmetrical JJ O
in IN O
volume NN O
, , O
and CC O
that IN O
the DT O
asymmetry NN O
reflects VBZ O
side NN O
differences NNS O
in IN O
the DT O
number NN O
of IN O
neurons NNS O
. . O

-DOCSTART- X X O

Estimated VBN O
nucleic JJ O
acid NN O
N NNP O
absorption NN O
is VBZ O
7-8 CD O
% NN O
of IN O
N NNP O
intake NN O
. . O

-DOCSTART- X X O

However RB O
, , O
further JJ O
analyses NNS O
of IN O
the DT O
data NNS O
indicate VBP O
that IN O
increasing VBG O
VO2 NN O
AT WDT O
( -LRB- O
r NN O
= SYM O
-0.63 FW O
, , O
P NNP O
less JJR O
than IN O
0.05 CD O
) -RRB- O
rather RB O
than IN O
VO2max NNP O
( -LRB- O
r NN O
= SYM O
-0.15 FW O
) -RRB- O
could MD O
result VB O
in IN O
improving VBG O
the DT O
10,000 CD O
m NN O
race NN O
performance NN O
to TO O
a DT O
larger JJR O
extent NN O
, , O
and CC O
that IN O
the DT O
absolute JJ O
amount NN O
of IN O
change NN O
( -LRB- O
delta NN O
) -RRB- O
in IN O
the DT O
10,000 CD O
m NN O
run VBN O
time NN O
is VBZ O
best RB O
accounted VBN O
for IN O
by IN O
a DT O
combination NN O
of IN O
delta JJ O
VO2 NN O
AT WDT O
and CC O
delta JJ O
5,000 CD O
m NN O
run VBN O
time NN O
. . O

-DOCSTART- X X O

Liver NN O
TG NNP O
and CC O
serum NN O
NEFA NN O
concentrations NNS O
were VBD O
positively RB O
correlated JJ O
. . O

-DOCSTART- X X O

Pharmacological JJ O
action NN O
of IN O
eptazocine NN O
(l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz JJ O
azonine NN O
) -RRB- O
. . O

-DOCSTART- X X O

Failures NNS O
of IN O
colorimetric JJ O
additivity NN O
under IN O
these DT O
experimental JJ O
conditions NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Further JJ O
investigations NNS O
are VBP O
necessary JJ O
to TO O
elucidate VB O
the DT O
biochemical JJ O
and CC O
physiological JJ O
properties NNS O
of IN O
DLIS. NNP O

-DOCSTART- X X O

Renal JJ O
clearance NN O
fell VBD O
from IN O
19.0 CD O
+/ CD O
- : O
4.9 CD O
ml/min/1.73 CD O
m2 NNS O
( -LRB- O
group NN O
I PRP O
) -RRB- O
to TO O
1.0 CD O
+/ NNS O
- : O
0.4 CD O
ml/min/1.73 CD O
m2 NN O
( -LRB- O
group NN O
IV NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
mechanism NN O
of IN O
action NN O
is VBZ O
explored VBN O
in IN O
some DT O
detail NN O
, , O
specifically RB O
as IN O
it PRP O
relates VBZ O
to TO O
reticuloendothelial JJ O
system NN O
( -LRB- O
RES NNP O
) -RRB- O
Fc NNP B-NP
receptor NN I-NP
blockade NN O
and CC O
suppression NN O
of IN O
antiplatelet NN O
antibody NN O
synthesis NN O
. . O

-DOCSTART- X X O

We PRP O
analyzed VBD O
data NNS O
from IN O
56 CD O
patients NNS O
with IN O
Systemic NNP O
Lupus NNP O
Erythematosus NNP O
( -LRB- O
SLE NN O
) -RRB- O
in IN O
whom WP O
renal JJ O
biopsies NNS O
were VBD O
done VBN O
systematically RB O
. . O

-DOCSTART- X X O

The DT O
possibility NN O
of IN O
a DT O
hereditary JJ O
disorder NN O
leading VBG O
to TO O
a DT O
minor JJ O
defect NN O
in IN O
elastic JJ O
fibre JJ O
structure NN O
which WDT O
could MD O
be VB O
responsible JJ O
for IN O
the DT O
spontaneous JJ O
lesions NNS O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

Seventeen CD O
of IN O
them PRP O
were VBD O
on IN O
treatment NN O
with IN O
systemic JJ O
steroids NNS O
. . O

-DOCSTART- X X O

This DT O
lack NN O
of IN O
correlation NN O
may MD O
be VB O
due JJ O
to TO O
variations NNS O
in IN O
the DT O
metabolic JJ O
activity NN O
of IN O
the DT O
endometriotic JJ O
implants NNS O
present VBP O
at IN O
different JJ O
stages NNS O
of IN O
the DT O
disease NN O
. . O

-DOCSTART- X X O

Human NNP O
and CC O
Chinese JJ B-NP
hamster NN I-NP
S14 IN I-NP
protein NN I-NP
sequences NNS I-NP
deduced VBD O
from IN O
the DT O
cDNAs NNS O
are VBP O
identical JJ O
. . O

-DOCSTART- X X O

These DT O
fusion NN O
proteins VBZ O
also RB O
allowed VBN O
the DT O
localization NN O
of IN O
the DT O
transcriptional JJ O
activation NN O
and CC O
DNA NN O
binding NN O
domains NNS O
of IN O
the DT O
ToxR NNP B-NP
protein NN I-NP
to TO O
its PRP$ O
cytoplasmically RB O
located VBN O
N-terminal JJ O
portion NN O
. . O

-DOCSTART- X X O

The DT O
risk NN O
for IN O
these DT O
complications NNS O
is VBZ O
increased VBN O
by IN O
the DT O
following JJ O
factors NNS O
: : O
multiple JJ O
gestation NN O
, , O
the DT O
combination NN O
of IN O
magnesium NN O
sulfate NN O
and CC O
beta-adrenergic JJ O
agonist NN O
, , O
and CC O
the DT O
use NN O
of IN O
adrenocortico-steroids NNS O
to TO O
hasten VB O
fetal NN O
pulmonary JJ O
maturity NN O
. . O

-DOCSTART- X X O

II NNP O
. . O

-DOCSTART- X X O

In IN O
19 CD O
patients NNS O
vagotomy RB O
not RB O
only RB O
curbed VBD O
the DT O
bleeding NN O
but CC O
provided VBD O
definitive JJ O
therapy NN O
( -LRB- O
Visick JJ O
I-II NN O
) -RRB- O
; : O
4 CD O
patients NNS O
died VBD O
( -LRB- O
mortality NN O
rate NN O
16 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
retrospective JJ O
study NN O
of IN O
banked JJ O
sera NN O
from IN O
19 CD O
cats NNS O
with IN O
the DT O
eosinophilic JJ O
granuloma NN O
complex NN O
revealed VBD O
that IN O
68 CD O
% NN O
of IN O
affected JJ O
cats NNS O
had VBD O
circulating VBG O
antibodies NNS O
to TO O
components NNS O
of IN O
normal JJ O
cat NN O
epithelium NN O
. . O

-DOCSTART- X X O

In IN O
memory NN O
of IN O
Magdelaine NNP O
Comtesse NNP O

-DOCSTART- X X O

All DT O
patients NNS O
had VBD O
elevated VBN O
levels NNS O
of IN O
serum NN B-NP
IgE NNP I-NP
antibodies NNS I-NP
to TO O
the DT O
crude NN O
soybean NN O
extract VB O
; : O
binding NN O
values NNS O
ranged VBD O
from IN O
2.3 CD O
to TO O
28.1 CD O
times NNS O
that IN O
of IN O
a DT O
negative JJ O
control NN O
serum NN O
. . O

-DOCSTART- X X O

Dual JJ O
radionuclide NN O
subtraction NN O
imaging NN O
of IN O
the DT O
spleen JJ O
using VBG O
67Ga DT O
citrate NN O
and CC O
99mTc NNP O
is VBZ O
useful JJ O
in IN O
further JJ O
delineating NN O
lesions NNS O
that WDT O
are VBP O
identified VBN O
on IN O
either CC O
a DT O
routine JJ O
radiogallium NN O
survey NN O
or CC O
on IN O
a DT O
conventional JJ O
sulfur NN O
colloid NN O
liver-spleen JJ O
image NN O
. . O

-DOCSTART- X X O

The DT O
volume NN O
of IN O
blood NN O
to TO O
the DT O
flap NN O
ranges VBZ O
from IN O
1 CD O
to TO O
2 CD O
ml/min NN O
, , O
collateral NN O
circulation NN O
to TO O
the DT O
flap NN O
exists VBZ O
, , O
but CC O
is VBZ O
negligible JJ O
, , O
and CC O
there EX O
is VBZ O
little JJ O
change NN O
in IN O
the DT O
capillary NN O
blood NN O
flow NN O
as IN O
the DT O
flap JJ O
ages NNS O
. . O

-DOCSTART- X X O

Laboratory NNP O
pyrolyses NNS O
have VBP O
indeed RB O
shown VBN O
that IN O
PCBs NNS O
give VBP O
significant JJ O
yields NNS O
of IN O
PCDFs NNS O
, , O
and CC O
chlorobenzenes NNS O
give VBP O
both DT O
PCDFs NNS O
and CC O
PCDDs NNS O
. . O

-DOCSTART- X X O

No DT O
consistent JJ O
correlation NN O
between IN O
blood NN O
pressure NN O
change NN O
and CC O
SCR-change NN O
was VBD O
seen VBN O
. . O

-DOCSTART- X X O

Piroxicam NNP O
produced VBD O
a DT O
lower JJR O
incidence NN O
of IN O
gastric JJ O
ulcers NNS O
than IN O
equivalent JJ O
doses NNS O
of IN O
indomethacin NN O
. . O

-DOCSTART- X X O

Since IN O
1970 CD O
the DT O
frequency NN O
of IN O
potassium-induced JJ O
ulceration NN O
has VBZ O
been VBN O
low--3 JJ O
cases NNS O
per IN O
100 CD O
000 CD O
patient-years NNS O
of IN O
slow-release NN O
tablet NN O
use NN O
. . O

-DOCSTART- X X O

Ultrastructure NNP O
of IN O
the DT O
heart NN O
muscle NN O
in IN O
experimental JJ O
myocardial JJ O
infarct NN O
following VBG O
physical JJ O
training NN O

-DOCSTART- X X O

Pharmacological NNP O
desympathization NN O
leads VBZ O
to TO O
the DT O
development NN O
of IN O
hyper-reactivity NN O
of IN O
the DT O
true JJ O
pacemakers NNS O
to TO O
noradrenaline NN O
and CC O
dopamine NN O
and CC O
triggers VBZ O
off RP O
changes NNS O
in IN O
the DT O
regulation NN O
of IN O
the DT O
electric JJ O
activity NN O
of IN O
these DT O
cells NNS O
by IN O
catecholamines NNS O
. . O

-DOCSTART- X X O

Vitiligo NNP O
in IN O
diabetes NN O
mellitus NN O
. . O

-DOCSTART- X X O

The DT O
pharmacokinetics NNS O
of IN O
each DT O
tetracycline NN O
in IN O
serum NN O
and CC O
dermal JJ O
, , O
suction NN O
blister NN O
fluid NN O
were VBD O
determined VBN O
after IN O
oral JJ O
doses NNS O
of IN O
300 CD O
mg NN O
lymecycline NN O
or CC O
100 CD O
mg JJ O
doxycycline NN O
on IN O
the DT O
3rd JJ O
day NN O
. . O

-DOCSTART- X X O

Either CC O
a DT O
UV NN O
detector NN O
set VBN O
at IN O
268 CD O
nm NN O
or CC O
an DT O
electrochemical JJ O
(EC NN O
) -RRB- O
detector NN O
set VBN O
at IN O
a DT O
potential NN O
of IN O
+0.9 CD O
V NNP O
(versus NNP O
Ag/AgCl/3 NNP O
M NNP O
NaCl NNP O
) -RRB- O
was VBD O
used VBN O
to TO O
monitor VB O
the DT O
drug NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
transfer NN O
ratios NNS O
of IN O
the DT O
drug NN O
into IN O
the DT O
genital NN O
tissues NNS O
to TO O
the DT O
concentration NN O
in IN O
the DT O
uterine NN O
arterial NN O
blood NN O
were VBD O
such JJ O
that IN O
the DT O
transfer NN O
ratio NN O
into IN O
the DT O
portio NN O
vaginalis NN O
was VBD O
the DT O
highest JJS O
, , O
followed VBN O
by IN O
the DT O
uterine NN O
cervix NN O
and CC O
the DT O
myometrium NN O
, , O
and CC O
that IN O
into IN O
the DT O
oviduct NN O
was VBD O
the DT O
lowest JJS O
with IN O
about IN O
1/2 CD O
that IN O
into IN O
the DT O
portio NN O
vaginalis NN O
. . O

-DOCSTART- X X O

Lower NNP O
extremity NN O
weight NN O
bearing VBG O
under IN O
various JJ O
standing VBG O
conditions NNS O
in IN O
independently RB O
ambulatory JJ O
patients NNS O
with IN O
hemiparesis NN O
. . O

-DOCSTART- X X O

On IN O
d NN O
112 CD O
, , O
progesterone NN O
was VBD O
higher JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
.05 CD O
) -RRB- O
in IN O
hysterectomized JJ O
heifers NNS O
than IN O
in IN O
other JJ O
treatment NN O
groups NNS O
. . O

-DOCSTART- X X O

Supraventricular NNP O
arrhythmias--digoxin NN O
and CC O
quinidine JJ O
revisited VBN O
. . O

-DOCSTART- X X O

Visidex NNP O
I PRP O
is VBZ O
unsuitable JJ O
for IN O
storage NN O
and CC O
re-reading NN O
. . O

-DOCSTART- X X O

The DT O
transit NN O
time NN O
was VBD O
significantly RB O
shortened VBN O
. . O

-DOCSTART- X X O

Relations NNP O
between IN O
cellular JJ O
electrical JJ O
activity NN O
and CC O
cardiac JJ O
mechanical JJ O
activity NN O
in IN O
man NN O
, , O
the DT O
dog NN O
and CC O
the DT O
rabbit NN O

-DOCSTART- X X O

Ultraviolet NNP O
light-induced JJ O
kinin NN B-NP
formation NN O
in IN O
human JJ O
skin NN O
. . O

-DOCSTART- X X O

Prevention NNP O
of IN O
maternal JJ O
Rh NNP O
sensitization NN O
: : O
anti-Rh JJ B-NP
immune JJ I-NP
globulin NN I-NP
. . O

-DOCSTART- X X O

Enzyme PRP O
histochemical JJ O
findings NNS O
in IN O
the DT O
ultimobranchial JJ O
body NN O
of IN O
the DT O
horse NN O

-DOCSTART- X X O

Pre-beta-1 JJ B-NP
lipoprotein NN I-NP
and CC O
early JJ O
detection NN O
of IN O
risk NN O
factors NNS O
for IN O
coronary JJ O
heart NN O
disease NN O
. . O

-DOCSTART- X X O

Absence NN O
of IN O
action NN O
potentials NNS O
in IN O
frog NN O
slow JJ O
muscle NN O
fibres NNS O
paralysed VBN O
by IN O
botulinum NN B-NP
toxin NN I-NP
. . O

-DOCSTART- X X O

I. NN O

-DOCSTART- X X O

Particles NNS O
resembling VBG O
microbodies NNS O
in IN O
normal JJ O
and CC O
neoplastic JJ O
perianal JJ O
glands NNS O
of IN O
dogs NNS O
. . O

-DOCSTART- X X O

Problems NNP O
common JJ O
to TO O
pediatrics NNS O
and CC O
anesthesiology NN O

-DOCSTART- X X O

Junctions NNP O
between IN O
cells NNS O
of IN O
the DT O
human JJ O
enamel NN O
organ NN O
. . O

-DOCSTART- X X O

Taxonomically RB O
significant JJ O
colour NN O
changes NNS O
in IN O
Brevibacterium NNP O
linens NNS O
probably RB O
associated VBN O
with IN O
a DT O
carotenoid-like JJ O
pigment NN O
. . O

-DOCSTART- X X O

A DT O
short JJ O
history NN O
of IN O
dermatology NN O
in IN O
Lagos NNP O
, , O
Nigeria NNP O
. . O

-DOCSTART- X X O

Glucose JJ O
disappearance NN O
rate NN O
and CC O
changes NNS O
in IN O
plasma NN O
nutrients NNS O
after IN O
intravenouly JJ O
injected JJ O
glucose NN O
in IN O
normoglycaemic JJ O
and CC O
hypoglycaemic JJ O
underweight JJ O
newborns NNS O
. . O

-DOCSTART- X X O

Normal JJ O
values NNS O
for IN O
the DT O
peripheral JJ O
blood NN O
and CC O
bone NN O
marrow NN O
of IN O
the DT O
grey NN O
( -LRB- O
Armenian JJ O
) -RRB- O
hamster NN O

-DOCSTART- X X O

Methyl NNP O
mercury NN O
intoxication NN O
in IN O
rat NN O
kidneys NNS O
. . O

-DOCSTART- X X O

Suppression NN O
of IN O
food NN O
intake NN O
in IN O
the DT O
rat NN O
by IN O
tung JJ O
oil NN O
. . O

-DOCSTART- X X O

Change NNP O
in IN O
the DT O
makeup NN O
of IN O
the DT O
blood NN O
following VBG O
a DT O
short-term JJ O
local JJ O
action NN O
of IN O
a DT O
permanent JJ O
magnetic JJ O
field NN O
on RP O
the DT O
human JJ O
body NN O

-DOCSTART- X X O

Observations NNS O
on IN O
saccules NNS O
of IN O
rats NNS O
exposed VBN O
to TO O
long-term JJ O
hypergravity NN O
. . O

-DOCSTART- X X O

The DT O
levels NNS O
of IN O
galactosyltransferase NN B-NP
activity NN O
in IN O
sera NN O
from IN O
normal JJ O
children NNS O
and CC O
patients NNS O
with IN O
cystic JJ O
fibrosis NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
ionizing VBG O
radiation NN O
in IN O
the DT O
human JJ O
oral JJ O
cavity NN O
and CC O
oropharynx NN O
: : O
results NNS O
of IN O
a DT O
survey NN O
. . O

-DOCSTART- X X O

Isolation NNP O
of IN O
Proteus NNP O
vulgaris NN O
MC-63 . O
from IN O
carcinoma NN O
63 CD O
and CC O
its PRP$ O
antitumor JJ O
effect NN O
on IN O
Crocker NNP O
sarcoma NN O
180 CD O
and CC O
Ehrlich NNP O
carcinoma NN O
. . O

-DOCSTART- X X O

Heterogeneity NNP O
of IN O
human JJ B-NP
serum NN I-NP
albumin NN I-NP
. . O

-DOCSTART- X X O

Reactivities NNS O
to TO O
horse NN B-NP
anti-lymphocyte JJ I-NP
globulin NN I-NP
. . O

-DOCSTART- X X O

Relation NN O
between IN O
mixing JJ O
ratio NN O
of IN O
raw JJ O
materials NNS O
and CC O
composition NN O
of IN O
products NNS O
in IN O
the DT O
synthesis NN O
of IN O
aluminosilicates NNS O

-DOCSTART- X X O

Sinusoidal JJ O
oscillations NNS O
of IN O
a DT O
gas NN O
dilution NN O
indicator NN O

-DOCSTART- X X O

Studies NNS O
on IN O
the DT O
hereditary JJ O
nature NN O
of IN O
sole JJ O
prints--with NN O
special JJ O
reference NN O
to TO O
interdigital NN O
and CC O
triradii NNS O

-DOCSTART- X X O

Successive JJ O
abdominal NN O
scintillation NN O
with IN O
131-I-tagged JJ O
BSP--description NN O
of IN O
the DT O
thyroid NN O
gland NN O
, , O
kidney NN O
and CC O
spleen JJ O
( -LRB- O
comparison NN O
with IN O
131-I-RB CD O
) -RRB- O

-DOCSTART- X X O

Osteosarcoma NNP O
caused VBD O
by IN O
3,4-benzopyrene JJ O

-DOCSTART- X X O

The DT O
content NN O
of IN O
glucosamine NN O
and CC O
galactosamine NN O
in IN O
tartar NN O

-DOCSTART- X X O

Relapse VB O
of IN O
leukemia NN O
after IN O
prolonged JJ O
remission NN O
. . O

-DOCSTART- X X O

Influence NN O
of IN O
cigarette NN O
smoking NN O
on IN O
some DT O
blood NN O
coagulation NN O
tests NNS O
. . O

-DOCSTART- X X O

SAM-TR-68-54 NNP O
. . O

-DOCSTART- X X O

Spinal JJ O
cord NN O
representation NN O
of IN O
the DT O
micturition NN O
reflex NN O
. . O

-DOCSTART- X X O

Pitfalls NNS O
in IN O
the DT O
use NN O
of IN O
chromosome NN O
aberration NN O
analysis NN O
for IN O
biological JJ O
radiation NN O
dosimetry NN O
. . O

-DOCSTART- X X O

Midge NN O
control NN O
in IN O
flood NN O
channels NNS O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
taloximine NN O
and CC O
aminophylline VB O
on IN O
isolated VBN O
human JJ O
smooth JJ O
muscle NN O
. . O

-DOCSTART- X X O

The DT O
exploratory JJ O
behaviour NN O
in IN O
normal JJ O
and CC O
aggressive JJ O
mice NNS O
. . O

-DOCSTART- X X O

18F JJ O
and CC O
85Sr JJ O
scintimetry NN O
in IN O
the DT O
study NN O
of IN O
primary JJ O
arthropathies NNS O
. . O

-DOCSTART- X X O

Endocardial NNP O
fibro-elastosis NN O
, , O
mitral JJ O
incompetence NN O
, , O
and CC O
coarctation NN O
of IN O
abdominal JJ O
aorta NN O
. . O

-DOCSTART- X X O

The DT O
significance NN O
of IN O
structural JJ O
integrity NN O
of IN O
lymphoid JJ O
tissue NN O
for IN O
antibody NN O
production NN O
in IN O
culture NN O
in IN O
vivo NN O

-DOCSTART- X X O

Hemodynamics NNP O
changes NNS O
in IN O
man NN O
during IN O
flight NN O

-DOCSTART- X X O

Automatic NNP O
view NN O
box NN O
. . O

-DOCSTART- X X O

I. NN O

-DOCSTART- X X O

Experience NN O
with IN O
the DT O
restoration NN O
of IN O
agglutination NN O
properties NNS O
of IN O
non-agglutinating JJ O
dysenterial JJ O
cultures NNS O
with IN O
the DT O
use NN O
of IN O
Rzhaninov NNP O
's POS O
method NN O

-DOCSTART- X X O

Study VB O
on IN O
the DT O
evagination NN O
of IN O
Cysticercus NNP O
pisiformis NN O
. . O

-DOCSTART- X X O

Compensatory NNP O
renal JJ O
hypertrophy NN O
in IN O
parabiotic JJ O
rats NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
evaluation NN O
of IN O
the DT O
mucolytic JJ O
action NN O
of IN O
urea NN O
. . O

-DOCSTART- X X O

Histogenetic JJ O
aspects NNS O
of IN O
mesoblastic JJ O
nephroma NN O
. . O

-DOCSTART- X X O

Upstream NNP O
activation NN O
sites NNS O
of IN O
the DT O
CYC1 NNP B-NP
gene NN I-NP
of IN O
Saccharomyces NNS O
cerevisiae NNS O
are VBP O
active JJ O
when WRB O
inverted VBN O
but CC O
not RB O
when WRB O
placed VBN O
downstream NN O
of IN O
the DT O
"TATA NNP O
box" NN O
. . O

-DOCSTART- X X O

Cardiac NNP O
taurine NN O
levels NNS O
and CC O
sarcolemmal JJ O
calcium NN O
binding NN O
activity NN O
in IN O
furazolidone-induced JJ O
cardiomyopathy NN O
. . O

-DOCSTART- X X O

Separation NNP O
of IN O
malaria-infected JJ O
erythrocytes NNS O
from IN O
whole JJ O
blood NN O
: : O
use NN O
of IN O
a DT O
selective JJ O
high-gradient JJ O
magnetic JJ O
separation NN O
technique NN O
. . O

-DOCSTART- X X O

Brief JJ O
report NN O
. . O

-DOCSTART- X X O

In IN O
several JJ O
cases NNS O
of IN O
definite JJ O
SjS NNS O
, , O
labial JJ O
salivary NN O
gland NN O
examinations NNS O
after IN O
more RBR O
than IN O
a DT O
one CD O
year NN O
interval NN O
were VBD O
performed VBN O
on IN O
two CD O
occasions NNS O
, , O
and CC O
the DT O
clinical JJ O
and CC O
histopathological JJ O
changes NNS O
were VBD O
investigated VBN O
. . O

-DOCSTART- X X O

In IN O
most JJS O
cases NNS O
of IN O
acute JJ O
transmural JJ O
infarction NN O
, , O
the DT O
reciprocal JJ O
ST NNP O
segment NN O
depressions NNS O
observed VBD O
in IN O
contralateral JJ O
leads NNS O
are VBP O
less RBR O
marked JJ O
than IN O
the DT O
primary JJ O
ST NNP O
segment NN O
elevations NNS O
. . O

-DOCSTART- X X O

No DT O
direct JJ O
repeats NNS O
flank VBD O
the DT O
pseudogene NN O
in IN O
the DT O
U2/4 NNP B-NP
locus NN I-NP
. . O

-DOCSTART- X X O

Radioimmunoassay NNP O
of IN O
serum NN O
creatine NN B-NP
kinase NN I-NP
B NNP I-NP
isoenzyme NN I-NP
in IN O
the DT O
diagnosis NN O
of IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

Selective JJ O
macrophage NN O
inhibition IN O
abolishes NNS O
warfarin-induced VBN O
reduction NN O
of IN O
metastasis NN O
. . O

-DOCSTART- X X O

A DT O
haemolytic JJ O
enterotoxigenic JJ O
strain NN O
of IN O
E. NNP O
coli NNS O
( -LRB- O
O149:K88:H10 CD O
) -RRB- O
was VBD O
regularly RB O
recovered VBN O
from IN O
piglets NNS O
with IN O
PWD NNP O
while IN O
rotavirus NN O
was VBD O
demonstrated VBN O
on IN O
a DT O
number NN O
of IN O
occasions NNS O
. . O

-DOCSTART- X X O

Restoration NN O
of IN O
impaired VBN O
immune JJ O
functions NNS O
in IN O
aging VBG O
animals NNS O
. . O

-DOCSTART- X X O

Another DT O
sequence NN O
, , O
GGGXGGAG NNP O
, , O
which WDT O
is VBZ O
repeated VBN O
several JJ O
times NNS O
in IN O
many JJ O
polyomaviruses NNS O
and CC O
adenoviruses NNS O
, , O
and CC O
which WDT O
is VBZ O
thought VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
DNA NNP O
replication NN O
and/or CC O
transcription NN O
, , O
is VBZ O
not RB O
found VBN O
in IN O
the DT O
JCV NNP O
sequence NN O
presented VBD O
. . O

-DOCSTART- X X O

I. NN O

-DOCSTART- X X O

USA NNP O
80 CD O
, , O
802-806 CD O
] SYM O
was VBD O
used VBN O
to TO O
isolate VB O
a DT O
genomic JJ O
clone NN O
lambda NN O
PGK-1 NN B-NP
containing VBG O
a DT O
portion NN O
of IN O
an DT O
autosomal JJ O
locus NN O
for IN O
phosphoglycerate NN B-NP
kinase NN I-NP
( -LRB- O
PGK) NNP B-NP
. . O

-DOCSTART- X X O

A. NN O

-DOCSTART- X X O

Frog NNP O
type NN O
I PRP O
( -LRB- O
Ft NN O
I PRP O
) -RRB- O
and CC O
frog JJ O
type NN O
II NNP O
( -LRB- O
Ft NN O
II NNP O
) -RRB- O
slowly RB O
adapting VBG O
( -LRB- O
SA NNP O
) -RRB- O
units NNS O
produced VBD O
spikes NNS O
only RB O
at IN O
the DT O
indentation NN O
phase NN O
, , O
and CC O
the DT O
threshold NN O
response NN O
phase NN O
( -LRB- O
TRP NNP O
) -RRB- O
, , O
i FW O
.e FW O
. . O
. . O
the DT O
phase NN O
of IN O
the DT O
first JJ O
spike NN O
was VBD O
for IN O
ca MD O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
efficacy NN O
rates NNS O
evaluated VBN O
in IN O
151 CD O
cases NNS O
( -LRB- O
KS-R1 DT O
group NN O
in IN O
77 CD O
cases NNS O
, , O
oral JJ O
group NN O
in IN O
74 CD O
cases NNS O
) -RRB- O
on IN O
standard JJ O
criteria NNS O
of IN O
committee NN O
members NNS O
were VBD O
88.3 CD O
% NN O
for IN O
the DT O
KS-R1 JJ O
group NN O
and CC O
86.5 CD O
% NN O
for IN O
the DT O
oral JJ O
group NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Martin NNP O
Luther NNP O
and CC O
his PRP$ O
physicians NNS O
. . O

-DOCSTART- X X O

Renal JJ O
response NN O
to TO O
captopril VB O
in IN O
severe JJ O
heart NN O
failure NN O
: : O
role NN O
of IN O
furosemide NN O
in IN O
natriuresis NN O
and CC O
reversal NN O
of IN O
hyponatremia NN O
. . O

-DOCSTART- X X O

EGV NNP O
had VBD O
no DT O
detectable JJ O
effect NN O
on IN O
PP NNP B-NP
secretion NN O
under IN O
basal NN O
or CC O
stimulated VBN O
conditions NNS O
. . O

-DOCSTART- X X O

Lung NNP O
prostacyclin NN O
production NN O
may MD O
be VB O
related VBN O
to TO O
flow NN O
. . O

-DOCSTART- X X O

For IN O
the DT O
first JJ O
30 CD O
min NN O
following JJ O
insulin NN B-NP
administration NN O
, , O
the DT O
rate NN O
of IN O
change NN O
in IN O
glucose NN O
levels NNS O
was VBD O
significantly RB O
less JJR O
among IN O
the DT O
patients NNS O
with IN O
major JJ O
depressive JJ O
disorder NN O
than IN O
among IN O
either CC O
the DT O
patients NNS O
with IN O
dysthymic JJ O
disorder NN O
or CC O
the DT O
normal JJ O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

Urease NN B-NP
activity NN O
of IN O
97 CD O
% NN O
of IN O
these DT O
organisms NNS O
became VBD O
evident JJ O
within IN O
30 CD O
min NN O
. . O

-DOCSTART- X X O

Regional NNP O
CBF NNP O
was VBD O
determined VBN O
by IN O
clearance NN O
of IN O
xenon NNP O
133 CD O
in IN O
67 CD O
patients NNS O
undergoing VBG O
coronary JJ O
bypass IN O
grafting VBG O
procedures NNS O
. . O

-DOCSTART- X X O

Cardiovascular NNP O
and CC O
adrenal JJ O
medullo-sympathetic JJ O
reactions NNS O
to TO O
acute JJ O
tobacco NN O
poisoning NN O

-DOCSTART- X X O

Exposure NN O
of IN O
endothelium NN O
to TO O
pulsatile NN O
shear NN O
stresses VBZ O
that IN O
followed VBD O
a DT O
tape NN O
recording NN O
of IN O
physiological JJ O
flow NN O
waveforms NNS O
(electromagnetic JJ O
flowmeter NN O
) -RRB- O
did VBD O
not RB O
cause VB O
gross JJ O
injury NN O
or CC O
denudation NN O
even RB O
when WRB O
peak NN O
shear NN O
exceeded VBD O
1500 CD O
dyne/cm2 NN O
. . O

-DOCSTART- X X O

Hydrocortisone NNP O
seems VBZ O
to TO O
be VB O
unable JJ O
to TO O
hinder VB O
the DT O
postdenervation NN O
changes NNS O
in IN O
the DT O
muscle NN O
membrane NN O
whereas IN O
high JJ O
doses NNS O
of IN O
the DT O
hormone NN O
are VBP O
able JJ O
to TO O
induce VB O
changes NNS O
in IN O
the DT O
muscle NN O
membrane NN O
. . O

-DOCSTART- X X O

Salivary NNP O
estradiol NN O
17 CD O
beta NN O
( -LRB- O
E2-17 JJ O
beta NN O
) -RRB- O
and CC O
progesterone NN O
( -LRB- O
P NNP O
) -RRB- O
were VBD O
determined VBN O
by IN O
using VBG O
radioimmunoassay NN O
techniques NNS O
in IN O
30 CD O
pregnant JJ O
females NNS O
in IN O
the DT O
first JJ O
, , O
second JJ O
and CC O
third JJ O
trimesters NNS O
as RB O
well RB O
as IN O
in IN O
10 CD O
non-pregnant JJ O
controls NNS O
during IN O
the DT O
luteal JJ O
phase NN O
of IN O
the DT O
menstrual JJ O
cycle NN O
. . O

-DOCSTART- X X O

Variable JJ O
FHR NNP O
decelerations NNS O
or CC O
bradycardias NNS O
were VBD O
encountered VBN O
on IN O
95 CD O
nonstress NN O
tests NNS O
( -LRB- O
18.8 CD O
% NN O
) -RRB- O
in IN O
80 CD O
( -LRB- O
33.5 CD O
% NN O
) -RRB- O
postdate NN O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
response NN O
chain NN O
in IN O
each DT O
component NN O
was VBD O
maintained VBN O
by IN O
food NN O
presentation NN O
under IN O
a DT O
fixed-ratio JJ O
schedule NN O
. . O

-DOCSTART- X X O

This DT O
machine NN O
drift NN O
, , O
which WDT O
was VBD O
not RB O
associated VBN O
with IN O
a DT O
rise NN O
in IN O
water NN O
phantom NN O
temperature NN O
and CC O
did VBD O
not RB O
consistently RB O
correlate VB O
with IN O
estimated JJ O
x-ray JJ O
tube NN O
heat NN O
, , O
could MD O
result VB O
in IN O
a DT O
significant JJ O
overestimation NN O
of IN O
regional JJ O
cerebral JJ O
blood NN O
flow NN O
(rCBF NNS O
) -RRB- O
for IN O
a DT O
xenon/CT NN O
rCBF NN O
protocol NN O
involving VBG O
5-7 CD O
sequential JJ O
scans NNS O
obtained VBN O
at IN O
1-min JJ O
interscan NN O
intervals NNS O
. . O

-DOCSTART- X X O

Reaction NN O
of IN O
human JJ O
organism NN O
to TO O
exercise VB O
. . O

-DOCSTART- X X O

HA NNP O
resulted VBD O
in IN O
decreased VBN O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
Tre NNP O
( -LRB- O
0.4 CD O
degrees NNS O
C NN O
) -RRB- O
and CC O
HR NNP O
( -LRB- O
17 CD O
b NN O
X NNP O
min-1 NN O
) -RRB- O
, , O
and CC O
increased VBD O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
Msw NN O
( -LRB- O
16 CD O
g NN O
X NNP O
m-2 CD O
X NNP O
h-1 NN O
) -RRB- O
during IN O
the DT O
saline NN O
experiments NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that DT O
administration NN O
of IN O
the DT O
calcium NN O
antagonist NN O
Verapamil NNP O
is VBZ O
of IN O
no DT O
additional JJ O
value NN O
in IN O
tocolytic JJ O
treatment NN O
with IN O
beta-mimetics NNS O
. . O

-DOCSTART- X X O

During IN O
a DT O
single JJ O
LAD NN O
occlusion NN O
lasting VBG O
35 CD O
minutes NNS O
( -LRB- O
series NN O
I PRP O
, , O
n RB O
= SYM O
10 CD O
) -RRB- O
9 CD O
microns NNS O
TMs NNS O
were VBD O
infused VBN O
immediately RB O
and CC O
30 CD O
minutes NNS O
after IN O
ligation NN O
, , O
15 CD O
microns NNS O
TMs NNS O
being VBG O
infused VBN O
after IN O
15-20 CD O
minutes NNS O
. . O

-DOCSTART- X X O

Brain NN O
pH RB O
following VBG O
3 CD O
h NN O
of IN O
cerebral JJ O
focal JJ O
ischemia NN O
changed VBN O
from IN O
a DT O
normal JJ O
value NN O
of IN O
7.0 CD O
to TO O
6.5 CD O
and CC O
6.2 CD O
in IN O
animals NNS O
studied VBN O
under IN O
barbiturate NN O
and CC O
halothane NN O
anesthesia NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

After IN O
clofelin DT O
administration NN O
the DT O
autoregulation NN O
borders NNS O
shifted VBD O
to TO O
the DT O
right JJ O
i NN O
. . O
e NN O
. . O
towards IN O
higher JJR O
AP NNP O
levels NNS O
. . O

-DOCSTART- X X O

Angionephroscintigraphy NNP O
in IN O
the DT O
diagnosis NN O
of IN O
diseases NNS O
of IN O
the DT O
kidney NN O

-DOCSTART- X X O

Serum NN O
lipids NNS O
and CC O
lipoproteins NNS O
of IN O
29 CD O
insulin NN B-NP
dependent JJ O
diabetic JJ O
children NNS O
have VBP O
been VBN O
determined VBN O
and CC O
related VBN O
to TO O
the DT O
metabolic JJ O
status NN O
of IN O
the DT O
patients NNS O
. . O

-DOCSTART- X X O

Out IN O
of IN O
these DT O
families NNS O
74,3 VBP O
% NN O
planned VBN O
next JJ O
pregnancy NN O
( -LRB- O
table NN O
IX NNP O
) -RRB- O
, , O
57,6 CD O
% NN O
wanted VBD O
to TO O
have VB O
prenatal JJ O
diagnosis NN O
( -LRB- O
table NN O
VI NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Dipetalonema NNP O
( -LRB- O
Alafilaria NNP O
) -RRB- O
hydrochoerus NN O
subgen NN O
. . O
et FW O
sp. VBD O
n RB O
. . O

-DOCSTART- X X O

Despite IN O
total JJ O
tumor NN O
resection NN O
, , O
multiple JJ O
intraperitoneal JJ O
tumor NN O
nodules NNS O
of IN O
varying VBG O
sizes NNS O
were VBD O
found VBN O
and CC O
resected VBN O
six CD O
months NNS O
and CC O
one CD O
year NN O
later RB O
. . O

-DOCSTART- X X O

Additionally RB O
, , O
observations NNS O
that IN O
patients NNS O
with IN O
mitral JJ O
versus JJ O
aortic JJ O
regurgitation NN O
respond VBP O
differently RB O
to TO O
valve VB O
replacement NN O
suggest VBP O
that IN O
differences NNS O
exist VBP O
preoperatively RB O
between IN O
these DT O
two CD O
types NNS O
of IN O
volume NN O
overload NN O
. . O

-DOCSTART- X X O

Is VBZ O
nisoldipine NN O
capable JJ O
of IN O
reducing VBG O
left VBN O
ventricular JJ O
preload NN O
? . O
In IN O
ten CD O
anesthetized DT O
pigs NNS O
, , O
nisoldipine JJ O
(2-4 NN O
micrograms NNS O
X NNP O
kg-1 NN O
X NNP O
min-1 NN O
) -RRB- O
, , O
a DT O
calcium NN O
channel NN O
blocker NN O
structurally RB O
related VBN O
to TO O
nifedipine NN O
, , O
reduced VBD O
left VBN O
ventricular JJ O
systolic JJ O
pressure NN O
( -LRB- O
40 CD O
% NN O
) -RRB- O
and CC O
systemic JJ O
vascular JJ O
resistance NN O
( -LRB- O
35 CD O
% NN O
) -RRB- O
, , O
whereas IN O
maxLVdP/dt JJ O
decreased VBN O
by IN O
20 CD O
% NN O
and CC O
cardiac JJ O
output NN O
was VBD O
unchanged JJ O
. . O

-DOCSTART- X X O

The DT O
importance NN O
of IN O
selective JJ O
renal JJ O
vein NN O
phlebography NN O
in IN O
the DT O
evaluation NN O
of IN O
unexplained JJ O
hematuria NN O
and CC O
filing NN O
defects NNS O
in IN O
the DT O
excretory NN O
urogram NN O
is VBZ O
illustrated VBN O
. . O

-DOCSTART- X X O

The DT O
pyramidal JJ O
tract NN O
and CC O
Mesencephalic NNP O
Reticular NNP O
Formation NNP O
( -LRB- O
MRF NN O
) -RRB- O
were VBD O
stimulated VBN O
before IN O
and CC O
after IN O
the DT O
transection NN O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
now RB O
a DT O
significative JJ O
difference NN O
between IN O
age NN O
group NN O
1-5 WDT O
and CC O
the DT O
others NNS O
( -LRB- O
p NN O
Less RBR O
Than JJ O
0,02 NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
sympathetic JJ O
neuroeffector NN O
influence NN O
on IN O
the DT O
myocardium NN O
with IN O
ATCI NNP O
depends VBZ O
to TO O
a DT O
large JJ O
measure NN O
on IN O
the DT O
intensity NN O
of IN O
the DT O
neurotransmitter NN O
biosynthesis NN O
and CC O
function NN O
of IN O
cardiomyocyte NN O
adrenoreceptors NNS O
. . O

-DOCSTART- X X O

In IN O
silicosis NN O
, , O
significant JJ O
relationships NNS O
between IN O
patients NNS O
and CC O
sons NNS O
were VBD O
not RB O
seen VBN O
with IN O
respect NN O
to TO O
arterial JJ O
blood NN O
gas NN O
determinations NNS O
and CC O
ventilatory NN O
responses NNS O
except IN O
for IN O
Paco2 NNP O
of IN O
patients NNS O
and CC O
hypercapnic JJ O
ventilatory NN O
responses NNS O
of IN O
sons NNS O
. . O

-DOCSTART- X X O

This DT O
study NN O
was VBD O
designed VBN O
to TO O
assess VB O
and CC O
compare VB O
the DT O
ability NN O
of IN O
three CD O
different JJ O
forms NNS O
of IN O
DSG NNP O
to TO O
block VB O
EIB NNP O
. . O

-DOCSTART- X X O

Many JJ O
of IN O
these DT O
landfill NN O
operations NNS O
were VBD O
undertaken VBN O
in IN O
the DT O
early JJ O
1950s NNS O
and CC O
1960s NNS O
, , O
when WRB O
knowledge NN O
regarding VBG O
the DT O
safe JJ O
and CC O
prolonged JJ O
containment NN O
of IN O
the DT O
waste NN O
buried VBN O
was VBD O
nonexistent JJ O
or CC O
minimal JJ O
at IN O
best JJS O
. . O

-DOCSTART- X X O

Acute NNP O
type NN O
A DT O
hepatitis NN O
in IN O
three CD O
patients NNS O
with IN O
chronic JJ O
HBV NNP O
infection NN O
. . O

-DOCSTART- X X O

Echosismography NNP O
enables VBZ O
to TO O
improve VB O
the DT O
diagnosis NN O
when WRB O
compared VBN O
with IN O
classical JJ O
sonography NN O
in IN O
about IN O
20 CD O
% NN O
of IN O
cases NNS O
. . O

-DOCSTART- X X O

A DT O
reassessment NN O
of IN O
the DT O
prevalence NN O
data NNS O
was VBD O
carried VBN O
out RP O
in IN O
the DT O
southern JJ O
province NN O
of IN O
Uusimaa NNP O
and CC O
in IN O
the DT O
western JJ O
province NN O
of IN O
Vaasa NNP O
, , O
the DT O
prevalence NN O
day NN O
being VBG O
January NNP O
1 CD O
, , O
1979 CD O
. . O

-DOCSTART- X X O

In IN O
visible JJ O
tumours NNS O
the DT O
best JJS O
results NNS O
were VBD O
obtained VBN O
with IN O
FB NNP O
( -LRB- O
85 CD O
% NN O
) -RRB- O
while IN O
TBN NNP O
was VBD O
positive JJ O
in IN O
65 CD O
% NN O
. . O

-DOCSTART- X X O

Alveolar NNP O
growth NN O
, , O
contemporary JJ O
with IN O
dental JJ O
eruption NN O
, , O
is VBZ O
sufficient JJ O
to TO O
compensate VB O
possible JJ O
hypotrophy NN O
of IN O
maxillary NN O
bone NN O
bases NNS O
. . O

-DOCSTART- X X O

Correlation NN O
between IN O
intraocular JJ O
involvement NN O
and CC O
systemic JJ O
outcome NN O
was VBD O
poor JJ O
. . O

-DOCSTART- X X O

At IN O
necropsy JJ O
28 CD O
days NNS O
post-inoculation NN O
, , O
F344 NNP O
rats NNS O
had VBD O
no DT O
gross JJ O
lung NN O
lesions NNS O
, , O
even RB O
those DT O
given VBN O
the DT O
maximum JJ O
dose NN O
of IN O
1.4 CD O
X NNP O
10(9 CD O
) -RRB- O
colony-forming JJ O
units NNS O
of IN O
M. NNP O
pulmonis NNS O
. . O

-DOCSTART- X X O

Aneurysmectomy NN O
and CC O
the DT O
performance NN O
of IN O
CABG NNP O
were VBD O
not RB O
significantly RB O
associated VBN O
with IN O
postoperative JJ O
ECG JJ O
changes NNS O
, , O
but CC O
more RBR O
bypass IN O
grafts NNS O
per IN O
patient NN O
grafted VBD O
appeared VBN O
in IN O
the DT O
group NN O
with IN O
postoperative JJ O
ECG JJ O
changes NNS O
, , O
suggesting VBG O
that IN O
coronary JJ O
artery NN O
disease NN O
may MD O
be VB O
more RBR O
severe JJ O
in IN O
that DT O
group NN O
. . O

-DOCSTART- X X O

Contractile JJ O
responses NNS O
to TO O
norepinephrine JJ O
, , O
serotonin NN O
and CC O
potassium NN O
( -LRB- O
K+ NNP O
) -RRB- O
and CC O
relaxant JJ O
responses NNS O
to TO O
isoproterenol JJ O
and CC O
papaverine NN O
were VBD O
studied VBN O
in IN O
vitro NN O
with IN O
spirally RB O
cut VBN O
thoracic JJ O
aortic JJ O
strips NNS O
from IN O
aortic JJ O
coarcted JJ O
hypertensive JJ O
rats NNS O
( -LRB- O
AHR)2 NN O
, , O
6 CD O
, , O
14 CD O
and CC O
28 CD O
days NNS O
postoperatively RB O
and CC O
compared VBN O
to TO O
time-matched JJ O
, , O
sham-operated JJ O
normotensive JJ O
controls NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
diabetics NNS O
, , O
Ca2+ NNP O
infusions NNS O
induced VBD O
a DT O
rise NN O
of IN O
plasma NN O
Ca2+ NNP O
up IN O
to TO O
3.2 CD O
+/ NNS O
- : O
0.1 CD O
mmol/1 NN O
and CC O
a DT O
fall NN O
of IN O
circulating VBG O
glucagon NN B-NP
(-26.4 CC O
+/ NNS O
- : O
5.7 CD O
% NN O
; : O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
and CC O
glucose NN O
(-23.3 JJ O
+/ NNS O
- : O
3.6 CD O
% NN O
; : O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Rats NNS O
underwent IN O
either CC O
a DT O
90-95 CD O
% NN O
JIB NN O
or CC O
a DT O
sham NN O
operation NN O
. . O

-DOCSTART- X X O

Large JJ O
and CC O
small JJ O
medullary NN O
lesions NNS O
inhibited VBD O
the DT O
occurrence NN O
of IN O
target NN O
fibres NNS O
in IN O
the DT O
tenotomized JJ O
muscles NNS O
, , O
the DT O
smallest JJS O
one CD O
being VBG O
neurolysis NN O
of IN O
the DT O
dorsal JJ O
roots NNS O
. . O

-DOCSTART- X X O

Selenium NN O
status NN O
of IN O
thoroughbreds NNS O
in IN O
the DT O
United NNP O
Kingdom NNP O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggested VBD O
the DT O
possibility NN O
that IN O
the DT O
fetus NN O
played VBD O
some DT O
role NN O
in IN O
the DT O
production NN O
of IN O
E3-16-G NNP O
in IN O
early JJ O
pregnancy NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
demonstrates VBZ O
secretion NN O
of IN O
bicarbonate NN O
by IN O
the DT O
human JJ O
stomach NN O
in IN O
vivo NN O
at IN O
a DT O
rate NN O
equivalent NN O
to TO O
10--20 CD O
% NN O
of IN O
basal JJ O
acid NN O
secretion NN O
. . O

-DOCSTART- X X O

The DT O
tetraphasic JJ O
action NN O
of IN O
lidocaine NN O
on IN O
CNS NNP O
electrical JJ O
activity NN O
and CC O
behavior NN O
in IN O
cats NNS O
. . O

-DOCSTART- X X O

The DT O
favourable JJ O
effect NN O
of IN O
thymic JJ O
shielding NN O
was VBD O
also RB O
reflected VBN O
in IN O
a DT O
significant JJ O
increase NN O
of IN O
LD50/30 NNP O
, , O
and CC O
the DT O
dose NN O
reduction NN O
factor NN O
was VBD O
equal JJ O
to TO O
2. MD O

-DOCSTART- X X O

Mastocytosis NNP O
. . O

-DOCSTART- X X O

TCZ NNP O
provides VBZ O
quick RB O
, , O
inexpensive JJ O
, , O
noninvasive JJ O
indication NN O
of IN O
tissue NN O
necrosis NN O
, , O
moderate-to-severe JJ O
intracranial JJ O
hemorrhage NN O
, , O
and CC O
delayed VBD O
brain NN O
maturation NN O
. . O

-DOCSTART- X X O

Adverse JJ O
reaction NN O
of IN O
the DT O
apparently RB O
healthy JJ O
partner NN O
in IN O
response NN O
to TO O
improvement NN O
in IN O
the DT O
overtly RB O
dysfunctional JJ O
partner NN O
. . O

-DOCSTART- X X O

Since IN O
only RB O
58 CD O
% NN O
of IN O
our PRP$ O
sample NN O
could MD O
be VB O
adequately RB O
classified VBN O
with IN O
one CD O
diagnosis NN O
, , O
we PRP O
expect VBP O
that IN O
the DT O
ASDC NNP O
nosology NN O
will MD O
need VB O
to TO O
evolve VB O
further RB O
. . O

-DOCSTART- X X O

Static NNP O
lung NN O
function NN O
in IN O
puppies NNS O
after IN O
pneumonectomy NN O
. . O

-DOCSTART- X X O

Current JJ O
status NN O
of IN O
chemotherapy NN O
for IN O
Hodgkin NNP O
's POS O
disease NN O

-DOCSTART- X X O

In IN O
Group NNP O
V NNP O
, , O
the DT O
salvaged JJ O
tissue NN O
was VBD O
primarily RB O
subepicardial JJ O
with IN O
virtually RB O
no DT O
lateral JJ O
zone NN O
of IN O
salvaged JJ O
tissue NN O
( -LRB- O
ratio NN O
of IN O
salvaged JJ O
subepicardium NN O
to TO O
salvaged VB O
subendocardium NN O
14.8 CD O
+/ NN O
- : O
1.9 CD O
to TO O
1 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Responses NNS O
to TO O
brainstem NN O
of IN O
nuclei JJ O
medialis NNS O
dorsalis NNS O
, , O
lateralis NNS O
posterior JJ O
were VBD O
of IN O
considerably RB O
longer RBR O
latency RB O
. . O

-DOCSTART- X X O

A DT O
simplified JJ O
thin-layer NN O
chromatographic JJ O
determination NN O
of IN O
hippuric JJ O
acid NN O
and CC O
methylhippuric NN O
acids NNS O
. . O

-DOCSTART- X X O

MSMS NNP O
Council NNP O
hears VBZ O
new JJ O
public JJ O
health NN O
director NN O
. . O

-DOCSTART- X X O

Twenty CD O
patients NNS O
aged VBN O
45 CD O
or CC O
older JJR O
with IN O
the DT O
diagnosis NN O
of IN O
endogenous JJ O
depression NN O
were VBD O
evaluated VBN O
in IN O
terms NNS O
of IN O
safety NN O
and CC O
efficacy NN O
in IN O
their PRP$ O
response NN O
to TO O
multiple JJ O
monitored JJ O
electroconvulsive JJ O
therapy NN O
( -LRB- O
MMECT) NNP O
versus IN O
single JJ O
electroconvulsive JJ O
therapy NN O
( -LRB- O
SECT) NNP O
. . O

-DOCSTART- X X O

Tests NNS O
of IN O
the DT O
method NN O
indicate VBP O
( -LRB- O
1 CD O
) -RRB- O
the DT O
Mossbauer NNP O
source NN O
can MD O
be VB O
placed VBN O
on IN O
the DT O
basilar NN O
membrane NN O
without IN O
altering VBG O
the DT O
signal-transmission NN O
properties NNS O
of IN O
the DT O
cochlea NN O
, , O
and CC O
( -LRB- O
2 CD O
) -RRB- O
the DT O
source NN O
adheres VBZ O
to TO O
the DT O
basilar JJ O
membrane NN O
. . O

-DOCSTART- X X O

Importance NN O
of IN O
determining VBG O
the DT O
blood NN O
sulfhydryl NN O
groups NNS O
in IN O
fractures NNS O
of IN O
the DT O
long JJ O
tubular JJ O
bones NNS O
complicated VBN O
by IN O
infection NN O

-DOCSTART- X X O

The DT O
ability NN O
of IN O
sodium NN O
phenobarbital NN O
( -LRB- O
60 CD O
mg/kg NN O
) -RRB- O
and CC O
sodium NN O
barbital NN O
( -LRB- O
80 CD O
mg/kg NN O
) -RRB- O
to TO O
produce VB O
a DT O
taste NN O
aversion NN O
in IN O
23 CD O
hr NN O
fluid NN O
deprived VBD O
rats NNS O
was VBD O
examined VBN O
using VBG O
a DT O
discrimination NN O
or CC O
two CD O
bottle NN O
taste NN O
aversion NN O
task NN O
( -LRB- O
0.125 CD O
% NN O
sodium NN O
saccharin NN O
solution NN O
or CC O
water NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
spite NN O
of IN O
this DT O
and CC O
other JJ O
complications NNS O
of IN O
corticosteroids NNS O
, , O
she PRP O
made VBD O
a DT O
full JJ O
recovery NN O
from IN O
the DT O
fungal JJ O
infection NN O
following VBG O
treatment NN O
with IN O
amphotericin JJ O
B NNP O
and CC O
surgical JJ O
excision NN O
of IN O
the DT O
lung NN O
abscess NN O
. . O

-DOCSTART- X X O

Marked NNP O
sedative JJ O
activity NN O
was VBD O
observed VBN O
with IN O
9-methoxy-5-phenylpyrrolo[2,1-d][1,5]benzothiazepin-6,6-dioxide JJ O
( -LRB- O
NF19 NNP O
) -RRB- O
and CC O
9-chloro-5-p-nitrophenylpyrrolo[2,1-d][1,5]benzothiazepin-6,6-dioxide JJ O
( -LRB- O
NF20 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
potentially RB O
SLE-inducing JJ O
drugs NNS O
are VBP O
reviewed VBN O
. . O

-DOCSTART- X X O

EUK-8 NNS O
is VBZ O
a DT O
novel NN O
, , O
synthetic NN O
, , O
low-molecular-weight JJ O
salen-manganese NN O
complex NN O
that WDT O
exhibits VBZ O
both DT O
superoxide NN B-NP
dismutase NN I-NP
and CC O
catalase NN B-NP
activities NNS O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
psychotropic JJ O
drugs NNS O
showed VBD O
significantly RB O
higher JJR O
PRL NNP B-NP
levels NNS O
. . O

-DOCSTART- X X O

BSE NNP O
and CC O
farmworkers NNS O
. . O

-DOCSTART- X X O

Considerably RB O
high JJ O
levels NNS O
of IN O
IgE NNP B-NP
antibodies NNS I-NP
was VBD O
also RB O
established VBN O
while IN O
other JJ O
pollens NNS O
did VBD O
not RB O
show VB O
such JJ O
correspondence NN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
particularly RB O
intriguing JJ O
because IN O
SKUT-1B-20 JJ O
cells NNS O
lack VBP O
the DT O
transcription NN O
factor NN O
Pit-1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
number NN O
of IN O
lactotropes NNS O
, , O
somatotropes NNS O
, , O
thyrotropes NNS O
, , O
and CC O
gonadotropes NNS O
was VBD O
not RB O
altered VBN O
compared VBN O
with IN O
controls NNS O
, , O
indicating VBG O
that IN O
in IN O
the DT O
adult NN O
pituitary NN O
, , O
POMC NNP B-NP
products NNS I-NP
are VBP O
not RB O
required VBN O
to TO O
maintain VB O
the DT O
distribution NN O
of IN O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

Correlation NN O
coefficients NNS O
between IN O
the DT O
reference NN O
methods NNS O
and CC O
NIT NNP O
were VBD O
> VBN O
or CC O
= SYM O
0.95 CD O
for IN O
water NN O
, , O
fat JJ O
, , O
crude JJ O
protein NN O
and CC O
connective-tissue-protein NN O
frei NN O
meat NN O
protein NN O
, , O
and CC O
> NNP O
or CC O
= SYM O
0.86 CD O
for IN O
connective-tissue-protein NN O
. . O

-DOCSTART- X X O

Histopathologic NN O
observations NNS O
showed VBD O
that IN O
both DT O
somatostatin NN B-NP
and CC O
triamcinolone NN O
acetonide NN O
reduced VBD O
the DT O
inflammatory NN O
signs NNS O
in IN O
the DT O
joint JJ O
structures NNS O
, , O
although IN O
triamcinolone NN O
acetonide NN O
appeared VBD O
to TO O
be VB O
more RBR O
effective JJ O
. . O

-DOCSTART- X X O

Preferential JJ O
heterodimeric JJ O
parallel JJ O
coiled-coil NN O
formation NN O
by IN O
synthetic JJ B-NP
Max NNP I-NP
and CC O
c-Myc JJ B-NP
leucine NN I-NP
zippers NNS I-NP
: : O
a DT O
description NN O
of IN O
putative JJ O
electrostatic JJ O
interactions NNS O
responsible JJ O
for IN O
the DT O
specificity NN O
of IN O
heterodimerization NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
tip NN B-NP
acts VBZ O
at IN O
an DT O
early JJ O
stage NN O
of IN O
the DT O
T-cell JJ O
signal NN O
transduction NN O
cascade NN O
by IN O
associating VBG O
with IN O
Lck NNP B-NP
and CC O
downregulating VBG O
Lck-mediated JJ O
activation NN O
. . O

-DOCSTART- X X O

As IN O
hGM-CSF NN B-NP
receptor NN I-NP
( -LRB- O
hGMR NN B-NP
) -RRB- O
does VBZ O
not RB O
contain VB O
a DT O
consensus NN O
sequence NN O
for IN O
binding NN O
of IN O
PI NNP B-NP
3-kinase CD I-NP
, , O
hGMR NN B-NP
must MD O
use VB O
a DT O
distinct JJ O
mechanism NN O
for IN O
its PRP$ O
association NN O
with IN O
and CC O
activation NN O
of IN O
PI NNP B-NP
3-kinase CD I-NP
. . O

-DOCSTART- X X O

Therefore RB O
, , O
we PRP O
studied VBD O
ninety CD O
coagulopathic JJ O
patients NNS O
with IN O
the DT O
aim NN O
of IN O
determining VBG O
the DT O
prevalence NN O
of IN O
hepatitis NN B-NP
C NNP I-NP
virus NN I-NP
( -LRB- I-NP
HCV NN I-NP
) -RRB- I-NP
antibodies NNS I-NP
using VBG O
the DT O
ELISA NNP O
and CC O
RIBA NNP O
methods NNS O
. . O

-DOCSTART- X X O

Hepatitis NNP B-NP
B NNP I-NP
surface NN I-NP
antigen NN I-NP
was VBD O
detected VBN O
in IN O
2 CD O
patients NNS O
, , O
with IN O
negative JJ O
hepatitis NN B-NP
C NNP I-NP
virus NN I-NP
antibody NN I-NP
. . O

-DOCSTART- X X O

Liver NN O
transplantation NN O
in IN O
one CD O
patient NN O
resolved VBN O
metabolic JJ O
complications NNS O
but CC O
did VBD O
not RB O
improve VB O
PMN NNP O
count NN O
or CC O
the DT O
infectious JJ O
status NN O
, , O
while IN O
neutropenia NN O
was VBD O
corrected VBN O
by IN O
G-CSF. NNP B-NP

-DOCSTART- X X O

Activation NN O
of IN O
the DT O
SH2-containing JJ B-NP
protein NN I-NP
tyrosine NN I-NP
phosphatase NN I-NP
, , O
SH-PTP2 NNP B-NP
, , O
by IN O
phosphotyrosine-containing NN O
peptides NNS O
derived VBD O
from IN O
insulin NN B-NP
receptor NN I-NP
substrate-1 NN I-NP
. . O

-DOCSTART- X X O

Tyrosine NNP O
phosphorylation NN O
of IN O
cellular JJ O
proteins NNS O
is VBZ O
the DT O
earliest JJS O
identifiable JJ O
event NN O
following VBG O
T-cell DT B-NP
antigen NN I-NP
receptor NN I-NP
(TCR NN O
) -RRB- O
stimulation NN O
and CC O
is VBZ O
essential JJ O
for IN O
activating VBG O
downstream NN O
signaling VBG O
machinery NN O
. . O

-DOCSTART- X X O

Microvessels NNS O
were VBD O
counted VBN O
in IN O
a DT O
x200 CD O
field NN O
( -LRB- O
0.754 CD O
mm2 NN O
) -RRB- O
in IN O
the DT O
area NN O
of IN O
maximal JJ O
angiogenesis NN O
. . O

-DOCSTART- X X O

Pharmacological NNP O
and CC O
pharmacokinetic JJ O
characteristics NNS O
of IN O
the DT O
non-ionic JJ O
monomeric JJ O
X-ray NN O
contrast NN O
agent NN O
iopromide VBP O
( -LRB- O
Ultravist NN O
, , O
CAS NNP O
73334-07-3 CD O
) -RRB- O
were VBD O
evaluated VBN O
in IN O
preclinical JJ O
studies NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
we PRP O
report VBP O
that IN O
ligand NN O
binding NN O
induced VBN O
tyrosine NN O
phosphorylation NN O
in IN O
BaF3 CD O
cells NNS O
engineered VBN O
to TO O
express VB O
the DT O
murine NN B-NP
Mpl NN I-NP
receptor NN I-NP
( -LRB- O
BaF3/mMpl NNP O
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
identify VB O
critical JJ O
regions NNS O
mediating VBG O
growth NN O
signal NN O
transduction NN O
by IN O
hG-CSFR NN B-NP
, , O
deletions NNS O
or CC O
site-directed JJ O
amino IN O
acid NN O
substitutions NNS O
were VBD O
introduced VBN O
into IN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
hG-CSFR NN B-NP
, , O
and CC O
the DT O
mutant JJ O
cDNAs NNS O
were VBD O
transfected VBN O
into IN O
the DT O
murine NN B-NP
interleukin-3 NN I-NP
( -LRB- O
IL-3)-dependent JJ B-NP
Ba/F3 . O
and CC O
FDCP JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

The DT O
fusion NN O
proteins NNS O
were VBD O
tested VBN O
by IN O
ELISA NNP O
for IN O
reactivity NN O
with IN O
a DT O
panel NN O
of IN O
human JJ B-NP
anti-La CC I-NP
sera NN I-NP
in IN O
order NN O
to TO O
define VB O
the DT O
nature NN O
of IN O
the DT O
epitopes NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
protein NN O
binding NN O
to TO O
the DT O
E2F-like JJ B-NP
sequences NNS I-NP
may MD O
act VB O
to TO O
reduce VB O
expression NN O
. . O

-DOCSTART- X X O

The DT O
optimal JJ O
care NN O
of IN O
CHF NNP O
patient NN O
includes VBZ O
the DT O
recognition NN O
and CC O
management NN O
of IN O
these DT O
electrolyte JJ O
disturbances NNS O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
rHb1.1 CD B-NP
or CC O
human JJ B-NP
serum NN I-NP
albumin NN I-NP
was VBD O
administered VBN O
intravenously RB O
to TO O
fasting VBG O
male JJ O
volunteers NNS O
. . O

-DOCSTART- X X O

Several JJ O
different JJ O
oncogenes NNS O
and CC O
growth NN O
factors NNS O
promote VBP O
G1 DT O
phase NN O
progression NN O
. . O

-DOCSTART- X X O

The DT O
chloramphenicol-resistance NN B-NP
transposon NN I-NP
Tn4451 NNP B-NP
undergoes VBZ O
precise JJ O
conjugative JJ O
deletion NN O
from IN O
its PRP$ O
parent NN O
plasmid NN O
plP401 NN O
in IN O
Clostridium NNP O
perfringens NNS O
and CC O
precise JJ O
spontaneous JJ O
excision NN O
from IN O
multicopy JJ O
plasmids NNS O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Deletions NNS O
were VBD O
examined VBN O
in IN O
the DT O
LYS2 NNP B-NP
gene NN I-NP
, , O
using VBG O
a DT O
set NN O
of IN O
31 CD O
- : O
to TO O
156-bp JJ O
inserts NNS O
that WDT O
included VBD O
inserts NNS O
with IN O
no DT O
apparent JJ O
potential NN O
for IN O
secondary JJ O
structure NN O
as RB O
well RB O
as IN O
two CD O
quasipalindromes NNS O
. . O

-DOCSTART- X X O

The DT O
hydropathy NN O
plot NN O
revealed VBD O
a DT O
rather RB O
hydrophilic JJ O
N-terminal JJ O
region NN O
and CC O
the DT O
absence NN O
of IN O
a DT O
hydrophobic JJ O
signal NN O
peptide NN O
. . O

-DOCSTART- X X O

All DT O
carcasses NNS O
resulted VBD O
in IN O
contamination NN O
with IN O
aerobic JJ O
mesophilic NN O
bacteria NNS O
in IN O
the DT O
range NN O
from IN O
6 CD O
x NN O
10( JJ O
3 CD O
) -RRB- O
to TO O
1.2 CD O
x NN O
10(6 CD O
) -RRB- O
CFU/ml NNP O
liquid NN O
washed VBD O
, , O
and CC O
94 CD O
% NN O
them PRP O
with IN O
sporulate JJ O
bacteria NNS O
, , O
the DT O
threshold NN O
being VBG O
under IN O
100 CD O
CFU/ml NNP O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
debate NN O
over IN O
electives--1899 CD O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
Codonopsis NNP O
pilosula NN O
oral JJ O
liquor NN O
( -LRB- O
CPOL NNP O
) -RRB- O
on IN O
tissue-type NN B-NP
plasminogen NN I-NP
activator NN I-NP
(t-PA NN O
) -RRB- O
and CC O
plasminogen NN B-NP
activator NN I-NP
inhibitor NN I-NP
( -LRB- O
PAI NN B-NP
) -RRB- O
in IN O
the DT O
plasma NN O
of IN O
25 CD O
patients NNS O
of IN O
coronary JJ O
heart NN O
disease NN O
with IN O
blood NN O
stasis NN O
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
isolated VBD O
two CD O
alternatively JJ O
spliced JJ O
forms NNS O
of IN O
human JJ B-NP
CD6 NN I-NP
cDNA NN I-NP
lacking VBG O
sequences NNS O
encoding VBG O
membrane-proximal JJ O
regions NNS O
of IN O
the DT O
cytoplasmic JJ O
domain NN O
which WDT O
maintain VBP O
the DT O
same JJ O
reading NN O
frame NN O
as IN O
CD6-PB1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
average JJ O
values NNS O
were VBD O
199 CD O
and CC O
424 CD O
revertants/g NN O
for IN O
the DT O
hamburgers NNS O
and CC O
hot JJ O
dogs NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Another DT O
common JJ O
mutation NN O
involved VBN O
amino IN O
acids NNS O
that WDT O
are VBP O
thought VBN O
to TO O
make VB O
specific JJ O
contacts NNS O
with IN O
DNA NNP O
. . O

-DOCSTART- X X O

Altogether RB O
our PRP$ O
data NNS O
indicate VBP O
that IN O
PEDF NN B-NP
belongs VBZ O
to TO O
the DT O
subgroup NN O
of IN O
noninhibitory JJ O
serpins NNS B-NP
and CC O
that IN O
its PRP$ O
N-terminal JJ O
region NN O
confers VBZ O
a DT O
neurite-promoting JJ O
activity NN O
to TO O
the DT O
protein NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
this DT O
new JJ O
measurement NN O
technique NN O
provides VBZ O
an DT O
easy JJ O
and CC O
accurate JJ O
P0.1 NNP O
measurement NN O
using VBG O
standard JJ O
respiratory NN O
equipment NN O
when WRB O
tested VBN O
in IN O
a DT O
lung NN O
model NN O
. . O

-DOCSTART- X X O

After IN O
cells NNS O
were VBD O
stably RB O
transfected VBN O
with IN O
CIITA NNP B-NP
, , O
endogenous JJ O
MHC NNP B-NP
class NN I-NP
II NNP I-NP
genes NNS I-NP
were VBD O
constitutively RB O
expressed VBN O
, , O
and CC O
MHC NNP B-NP
class NN I-NP
II NNP I-NP
promoters NNS I-NP
, , O
delivered VBN O
by IN O
transfection NN O
, , O
were VBD O
actively RB O
transcribed VBN O
in IN O
CIITA-expressing JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

Mean JJ O
growth NN O
changes NNS O
in IN O
this DT O
Class NNP O
II NNP O
sample NN O
were VBD O
comparable JJ O
to TO O
those DT O
previously RB O
reported VBN O
for IN O
male JJ O
subjects NNS O
with IN O
Class NN O
I PRP O
malocclusions VBD O
over IN O
the DT O
same JJ O
age NN O
period NN O
, , O
suggesting VBG O
a DT O
similarity NN O
in IN O
postpubertal JJ O
development NN O
between IN O
these DT O
two CD O
groups NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
describe VBP O
the DT O
characterization NN O
of IN O
two CD O
early JJ O
class NN B-NP
II NNP I-NP
flagellar NN I-NP
genes NNS I-NP
contained VBN O
in IN O
the DT O
orfX-fliP JJ O
locus NN O
. . O

-DOCSTART- X X O

To TO O
discern VB O
whether IN O
these DT O
disorders NNS O
of IN O
GnRH NNP B-NP
deficiency NN O
are VBP O
associated VBN O
with IN O
altered JJ O
melatonin NN O
secretion NN O
profiles NNS O
, , O
we PRP O
compared VBD O
untreated JJ O
young JJ O
males NNS O
IGD VBN O
( -LRB- O
n RB O
= SYM O
7 CD O
) -RRB- O
and CC O
DP NNP O
( -LRB- O
n NN O
= SYM O
7 CD O
) -RRB- O
to TO O
normal JJ O
pubertal JJ O
male NN O
controls NNS O
( -LRB- O
n NN O
= SYM O
6 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Oncological NNP O
, , O
clinical JJ O
and CC O
psychological JJ O
aspects NNS O
are VBP O
evaluated VBN O
according VBG O
to TO O
experience VB O
accumulated VBN O
in IN O
recent JJ O
years NNS O
, , O
with IN O
immediate JJ O
and CC O
delayed VBN O
reconstruction NN O
, , O
carried VBD O
out RP O
in IN O
the DT O
most RBS O
diverse JJ O
specialized JJ O
centers NNS O
. . O

-DOCSTART- X X O

Basal NNP O
promoter NN O
activity NN O
is VBZ O
enhanced VBN O
by IN O
a DT O
functional JJ O
M1 NNP O
domain NN O
in IN O
LHR-expressing JJ B-NP
mouse NN O
Leydig NNP O
tumor NN O
cells NNS O
( -LRB- O
MLTC NNP O
) -RRB- O
but CC O
not RB O
in IN O
non-expressing JJ O
CHO NNP O
cells NNS O
. . O

-DOCSTART- X X O

CCAAT/enhancer-binding JJ B-NP
protein NN I-NP
isoforms VBZ I-NP
beta JJ I-NP
and CC I-NP
delta JJ I-NP
are VBP O
expressed VBN O
in IN O
mammary NN O
epithelial NN O
cells NNS O
and CC O
bind NN O
to TO O
multiple JJ O
sites NNS O
in IN O
the DT O
beta-casein JJ B-NP
gene NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

To TO O
explore VB O
the DT O
mechanism NN O
of IN O
RSK NNP B-NP
activation NN O
, , O
a DT O
cloned JJ O
human JJ O
RSK NN B-NP
cDNA NN O
( -LRB- O
RSK3 NN B-NP
) -RRB- O
was VBD O
used VBN O
to TO O
generate VB O
and CC O
characterize VB O
several JJ O
site-directed JJ O
RSK NN B-NP
mutants NNS I-NP
; : O
K91A NNP O
(N-Lys NNP O
, , O
NH2-terminal JJ O
ATP-binding JJ O
mutant NN O
) -RRB- O
, , O
K444A NNP O
(C-Lys NNP O
, , O
COOH-terminal JJ O
ATP-binding JJ O
mutant NN O
) -RRB- O
, , O
N/C-Lys NNP O
( -LRB- O
double JJ O
ATP-binding NN O
mutant NN O
) -RRB- O
T570A DT O
(C-Thr NN O
, , O
mutant NN O
of IN O
the DT O
putative JJ O
MAPK NNP B-NP
phosphorylation NN O
site NN O
in IN O
subdomain JJ O
VIII NNP O
of IN O
the DT O
C-domain NN O
) -RRB- O
, , O
S218A NNP O
(N-Ser NNP O
, , O
mutant NN O
of IN O
the DT O
corresponding JJ O
NH2-terminal JJ O
residue NN O
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
microinjection NN O
of IN O
dominant JJ O
negative JJ O
forms NNS O
of IN O
Rac NNP B-NP
and CC O
Cdc42 NNP B-NP
or CC O
of IN O
the DT O
Rho NNP B-NP
inhibitor NN O
C3 IN B-NP
transferase NN I-NP
blocked VBD O
serum-induced JJ O
DNA NN O
synthesis NN O
. . O

-DOCSTART- X X O

The DT O
yeast NN O
enzyme NN O
was VBD O
6-fold JJ O
slower JJR O
than IN O
the DT O
mammalian JJ O
enzymes NNS O
, , O
which WDT O
made VBD O
it PRP O
amenable JJ O
to TO O
pre-steady-state VB O
stopped-flow JJ O
spectroscopic JJ O
kinetic JJ O
analysis NN O
at IN O
30 CD O
degrees NNS O
C NN O
and CC O
pH NNS O
6.0. . O

-DOCSTART- X X O

The DT O
CVA16.4 NNP B-NP
proteolipid VBD I-NP
transcript NN I-NP
is VBZ O
the DT O
most RBS O
prevalent JJ O
of IN O
the DT O
two CD O
proteolipid JJ O
messages NNS O
in IN O
expanding VBG O
ovules NNS O
harvested VBN O
10 CD O
d JJ O
post-anthesis NN O
. . O

-DOCSTART- X X O

IgE NN B-NP
levels NNS O
showed VBD O
higher JJR O
values NNS O
compared VBN O
to TO O
normal JJ O
individuals NNS O
and CC O
IgE NN B-NP
levels NNS O
were VBD O
higher JJR O
in IN O
children NNS O
groups NNS O
than IN O
in IN O
adults NNS O
regardless RB O
of IN O
the DT O
intensity NN O
of IN O
infection NN O
. . O

-DOCSTART- X X O

In IN O
one CD O
glioblastoma NN O
cell NN O
line NN O
, , O
a DT O
Shc-associated JJ B-NP
p190 NN B-NP
was VBD O
identified VBN O
as IN O
the DT O
activated JJ O
PDGFR. . B-NP

-DOCSTART- X X O

Using VBG O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
Whipple-specific JJ O
DNA NN O
fragments NNS O
of IN O
284 CD O
base NN O
pairs NNS O
from IN O
the DT O
genome NN O
of IN O
the DT O
Whipple NNP O
bacterium NN O
( -LRB- O
Tropheryma NNP O
whippelii NN O
) -RRB- O
were VBD O
demonstrated VBN O
. . O

-DOCSTART- X X O

The DT O
immunosuppressant JJ O
FK506 NNP O
inhibits VBZ O
amino IN O
acid NN O
import NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

This DT O
300 CD O
bp NN O
5'-upstream JJ O
sequence NN O
of IN O
K3 DT B-NP
keratin NN I-NP
gene NN I-NP
, , O
which WDT O
can MD O
function VB O
in IN O
vitro NN O
as IN O
a DT O
keratinocyte-specific JJ O
promoter NN O
, , O
contains VBZ O
two CD O
clusters NNS O
of IN O
partially RB O
overlapping JJ O
motifs NNS O
, , O
one CD O
with IN O
an DT O
NFkB NNP B-NP
consensus NN O
sequence NN O
and CC O
another DT O
with IN O
a DT O
GC NNP O
box NN O
. . O

-DOCSTART- X X O

Here RB O
the DT O
cloning NN O
and CC O
molecular JJ O
analysis NN O
of IN O
the DT O
Zm-ERabp1 NNP B-NP
, , O
Zm-ERabp4 NNP B-NP
, , O
and CC O
Zm-ERabp5 DT B-NP
genes NNS I-NP
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
the DT O
RV NN O
5'( VBZ O
+)SL JJ O
sequence NN O
had VBD O
the DT O
primary JJ O
enhancing VBG O
effect NN O
on IN O
translation NN O
. . O

-DOCSTART- X X O

Solitary NNP O
thyroid VBD O
nodule NN O
. . O

-DOCSTART- X X O

The DT O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
protein NN O
in IN O
the DT O
region NN O
of IN O
the DT O
specificity NN O
pocket NN O
is VBZ O
similar JJ O
to TO O
that DT O
of IN O
S. NNP B-NP
griseus NN I-NP
proteases VBZ I-NP
A DT I-NP
, , I-NP
B NNP I-NP
, , I-NP
and CC I-NP
C. NNP I-NP

-DOCSTART- X X O

Binding NNP O
of IN O
meAda NN B-NP
is VBZ O
necessary JJ O
to TO O
activate VB O
transcription NN O
of IN O
the DT O
adaptive JJ O
response NN O
genes NNS O
; : O
accordingly RB O
, , O
in IN O
vitro NN O
transcription NN O
of IN O
aidB NN B-NP
is VBZ O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
meAda NN B-NP
. . O

-DOCSTART- X X O

Vascular JJ O
endothelial JJ O
cells NNS O
undergo VBP O
profound JJ O
changes NNS O
upon IN O
cellular JJ O
activation NN O
including VBG O
expression NN O
of IN O
a DT O
spectrum NN O
of IN O
cell NN O
activation-associated JJ O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
MPS1 NNS B-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
has VBZ O
been VBN O
fused VBN O
to TO O
those DT O
that WDT O
encode VBP O
the DT O
LexA NNP B-NP
protein NN I-NP
or CC O
the DT O
GST JJ B-NP
protein NN I-NP
and CC O
both DT O
of IN O
these DT O
constructs NNS O
function VBP O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

Restriction NNP O
mapping NN O
analysis NN O
localized VBN O
this DT O
cDNA NN O
to TO O
the DT O
HHV-6A( JJ B-NP
U1102 NN I-NP
) -RRB- I-NP
genomic JJ I-NP
BamHI NNP I-NP
G NNP I-NP
fragment NN I-NP
, , O
at IN O
the DT O
right JJ O
end NN O
of IN O
the DT O
unique JJ O
long JJ O
segment NN O
of IN O
the DT O
genome NN O
and CC O
to TO O
the DT O
SalI NNP B-NP
L NNP I-NP
and CC O
SalI NNP B-NP
O NNP I-NP
fragments NNS I-NP
within IN O
the DT O
left JJ O
and CC O
right JJ O
terminal NN O
direct JJ O
repeat NN O
regions NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Sequence NNP O
comparisons NNS O
of IN O
prokaryotic JJ B-NP
RCR NN I-NP
initiators NNS I-NP
has VBZ O
revealed VBN O
a DT O
set NN O
of IN O
three CD O
common JJ O
motifs NNS O
, , O
two CD O
of IN O
which WDT O
, , O
a DT O
putative JJ O
metal NN O
coordination NN O
site NN O
and CC O
a DT O
downstream NN O
active-site JJ O
tyrosine NN O
motif NN O
, , O
could MD O
be VB O
tentatively RB O
identified VBN O
in IN O
parvoviral JJ B-NP
replicator NN I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
2 CD O
kb NN O
of IN O
5'-flanking JJ O
region NN O
and CC O
the DT O
1.1 CD O
kb NN O
of IN O
the DT O
entire JJ O
sGTH NN B-NP
alpha NN I-NP
subunit NN I-NP
coding VBG O
region NN O
were VBD O
sequenced VBN O
from IN O
the DT O
genomic JJ O
clone NN O
, , O
sGTH DT B-NP
alpha-G1 NN I-NP
. . O

-DOCSTART- X X O

His PRP$ O
carnitine NN B-NP
palmitoyltransferase NN I-NP
( -LRB- I-NP
CPT NNP I-NP
) -RRB- I-NP
I PRP I-NP
and CC I-NP
II NNP I-NP
activities NNS O
were VBD O
0.06 CD O
and CC O
0.12 CD O
nmol/min/mg JJ O
protein NN O
, , O
as IN O
compared VBN O
with IN O
a DT O
mean JJ O
value NN O
of IN O
0.22 CD O
+/ NNS O
- : O
0.14 CD O
and CC O
0.27 CD O
+/ NNS O
- : O
0.07 CD O
nmol/min/mg JJ O
protein NN O
, , O
respectively RB O
, , O
in IN O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
two CD O
approaches NNS O
to TO O
ascertain VB O
whether IN O
CDP/cut NNP B-NP
serves VBZ O
as IN O
a DT O
repressor NN O
of IN O
gp91-phox JJ B-NP
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Despite IN O
the DT O
activation NN O
of IN O
these DT O
intracellular JJ O
signaling NN O
molecules NNS O
, , O
PDGF NNP B-NP
beta NN I-NP
receptor NN I-NP
activation NN O
elicited VBD O
no DT O
detectable JJ O
effect NN O
on IN O
cell NN O
proliferation NN O
or CC O
differentiation NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
45Ca-binding JJ O
assays IN O
revealed VBN O
that IN O
CCaMK NNP B-NP
directly RB O
binds VBZ O
Ca2+ NNP O
. . O

-DOCSTART- X X O

Primer NNP O
extension NN O
experiments NNS O
revealed VBD O
a DT O
strong JJ O
transcription NN O
initiation NN O
site NN O
102 CD O
bp , O
upstream RB O
of IN O
the DT O
translational JJ O
start NN O
site NN O
. . O

-DOCSTART- X X O

The DT O
bHLH JJ B-NP
proteins NNS I-NP
function VBP O
as IN O
potent JJ O
transcriptional JJ O
activators NNS O
of IN O
tissue-specific JJ O
genes NNS O
by IN O
forming VBG O
heterodimers NNS O
between IN O
ubiquitous JJ O
and CC O
cell-restricted JJ O
family NN O
members NNS O
. . O

-DOCSTART- X X O

The DT O
other JJ O
two CD O
clones NNS O
, , O
Ash-m NNP B-NP
and CC I-NP
-s NNP I-NP
, , O
had VBD O
nucleotide JJ O
sequences NNS O
identical JJ O
with IN O
Ash-l JJ B-NP
cDNA NN O
in IN O
the DT O
amino-terminal JJ O
region NN O
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
here RB O
that IN O
the DT O
-DEDDDL JJ O
sequence NN O
stabilizes VBZ O
GDP NNP O
binding NN O
to TO O
Ran NNP B-NP
, , O
and CC O
that IN O
the DT O
domain NN O
is VBZ O
required VBN O
for IN O
high JJ O
affinity NN O
interaction NN O
with IN O
a DT O
Ran-binding JJ B-NP
protein NN I-NP
, , O
HTF9A/RanBP1 NNP B-NP
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
investigate VB O
the DT O
incidence NN O
and CC O
presentation NN O
of IN O
acute JJ O
pernicious JJ O
or CC O
fulminating JJ O
beriberi NN O
in IN O
a DT O
general JJ O
district NN O
hospital NN O
. . O

-DOCSTART- X X O

CPT-11 NN O
was VBD O
administered VBN O
as IN O
a DT O
30-minute JJ O
i NN O
.v. , O
infusion NN O
at IN O
a DT O
dose NN O
of IN O
350 CD O
mg/m2 CD O
diluted VBN O
in IN O
250 CD O
ml JJ O
normal JJ O
saline NN O
every DT O
3 CD O
weeks NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
Western NNP O
blots NNS O
demonstrated VBD O
at IN O
least JJS O
six CD O
types NNS O
of IN O
Ypt NN B-NP
in IN O
both DT O
Cr NNP O
and CC O
Vc NNP O
, , O
suggesting VBG O
that IN O
these DT O
Ypt NN B-NP
are VBP O
used VBN O
for IN O
household NN O
functions NNS O
responsible JJ O
for IN O
vesicle NN O
transport NN O
rather RB O
than IN O
for IN O
cellular JJ O
differentiation NN O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
a DT O
national JJ O
effort NN O
to TO O
begin VB O
to TO O
ask VB O
all DT O
female NN O
patients NNS O
about IN O
family NN O
violence NN O
. . O

-DOCSTART- X X O

SRY-related JJ B-NP
cDNA NN I-NP
encoding VBG O
a DT O
protein NN O
with IN O
a DT O
high-mobility-group NN B-NP
( -LRB- O
HMG) NNP B-NP
box NN O
and CC O
a DT O
leucine NN O
zipper NN O
motif NN O
, , O
which WDT O
was VBD O
designated VBN O
SOX-LZ JJ B-NP
, , O
was VBD O
isolated VBN O
from IN O
a DT O
rainbow NN O
trout NN O
testis NN O
cDNA NN O
library NN O
. . O

-DOCSTART- X X O

We PRP O
compared VBD O
the DT O
inhibitory JJ O
effect NN O
of IN O
naturally RB O
occurring VBG O
mutant JJ B-NP
hTR NN I-NP
beta NN I-NP
1 CD I-NP
, , O
artificially RB O
created VBN O
hTR NN B-NP
alpha NN I-NP
1 CD I-NP
mutants NNS I-NP
, , O
c-erbA DT B-NP
alpha NN I-NP
2 CD I-NP
and CC O
the DT O
human JJ B-NP
peroxisome JJ I-NP
proliferator-activated JJ I-NP
receptor NN I-NP
( -LRB- O
hPPAR NN B-NP
) -RRB- O
on IN O
three CD O
prototypic JJ O
T3-response NN O
elements NNS O
( -LRB- O
TREs NN O
) -RRB- O
, , O
TRE-PAL NNP O
, , O
DR NN O
+ NN O
4 CD O
and CC O
TRE-LAP. NNP O

-DOCSTART- X X O

The DT O
27-base JJ O
element NN O
interacts VBZ O
with IN O
a DT O
PDGF-activated JJ B-NP
serine/threonine NN O
phosphoprotein NN O
that WDT O
is VBZ O
detected VBN O
only RB O
within IN O
the DT O
nucleus NN O
of IN O
PDGF-treated JJ O
3T3 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
promoter NN O
for IN O
the DT O
human JJ B-NP
85 CD I-NP
kDa NN I-NP
cytosolic JJ I-NP
phospholipase NN I-NP
A2 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
FIII/YY1 NNP B-NP
, , O
a DT O
Xenopus NNP B-NP
laevis NN I-NP
conserved VBD I-NP
zinc-finger JJ I-NP
protein NN I-NP
binding NN O
to TO O
the DT O
first JJ O
exon NN O
of IN O
L1 NNP B-NP
and CC O
L14 NNP B-NP
ribosomal JJ I-NP
protein NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

This DT O
structure NN O
of IN O
cucumisin NN B-NP
suggests VBZ O
that IN O
it PRP O
is VBZ O
probably RB O
synthesized VBN O
as IN O
an DT O
inactive JJ O
precursor NN O
. . O

-DOCSTART- X X O

A DT O
unique JJ O
leucine-proline NN O
repeat NN O
element NN O
found VBD O
N-terminal JJ O
to TO O
the DT O
DNA-binding JJ O
domain NN O
of IN O
EmBP-1 NNP B-NP
does VBZ O
not RB O
appear VB O
to TO O
play VB O
a DT O
role NN O
in IN O
DNA-binding NN O
or CC O
dimerization NN O
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
both DT O
prfA NNS B-NP
and CC O
ponA NN B-NP
resulted VBD O
in IN O
extremely RB O
slow JJ O
growth NN O
and CC O
a DT O
reduction NN O
in IN O
sporulation NN O
efficiency NN O
. . O

-DOCSTART- X X O

In IN O
broken VBN O
L-cell NNP O
membranes NNS O
expressing VBG O
wild JJ O
type NN O
or CC O
mutant JJ B-NP
M6P/IGF NNP I-NP
II NNP I-NP
receptors NNS I-NP
, , O
30 CD O
nM JJ O
IGF NNP B-NP
II NNP I-NP
also RB O
failed VBD O
to TO O
affect VB O
the DT O
pertussis NN B-NP
toxin NN I-NP
substrate NN O
activity NN O
. . O

-DOCSTART- X X O

For IN O
the DT O
first JJ O
time NN O
we PRP O
describe VBP O
deletion NN O
and CC O
point NN O
mutations NNS O
within IN O
the DT O
plasma NN B-NP
membrane NN I-NP
family NN I-NP
of IN I-NP
guanylyl NN I-NP
cyclase NN I-NP
receptors NNS I-NP
that WDT O
result VBP O
in IN O
the DT O
formation NN O
of IN O
effective JJ O
dominant JJ O
negative JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Similarly RB O
approximately RB O
300 CD O
bp NN O
of IN O
sequence NN O
downstream NN O
of IN O
the DT O
translation NN O
terminator NN O
TGA NNP O
of IN O
the DT O
beta-tubulin NN B-NP
2 CD I-NP
( -LRB- O
BTU2 NN B-NP
) -RRB- O
gene NN O
could MD O
substitute VB O
for IN O
the DT O
3' JJ O
region NN O
of IN O
the DT O
H4-I JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
introduction NN O
of IN O
an DT O
acidic NN O
residue NN O
at IN O
the DT O
second JJ O
site NN O
was VBD O
essential JJ O
for IN O
suppression NN O
of IN O
the DT O
Asn-285 NNP O
mutation NN O
because IN O
Lys-220 NNP O
and CC O
Gln-220 NNP O
second-site JJ O
mutants NNS O
of IN O
the DT O
Asn-285 NNP O
mutant NN O
showed VBD O
very RB O
low JJ O
tetracycline NN O
resistance NN O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

One CD O
complex NN O
appears VBZ O
to TO O
be VB O
ubiquitous JJ O
but CC O
enriched VBD O
in IN O
lymphoid JJ O
cells NNS O
and CC O
represents VBZ O
the DT O
binding NN O
of IN O
a DT O
potentially RB O
novel JJ O
factor NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
approximately RB O
50 CD O
kDa NN O
. . O

-DOCSTART- X X O

Each DT O
type NN O
was VBD O
divided VBN O
into IN O
two CD O
subgroups NNS O
on IN O
the DT O
basis NN O
of IN O
whether IN O
the DT O
body NN O
and CC O
tail NN O
of IN O
the DT O
pancreas NNS O
showed VBD O
intense JJ O
fatty JJ O
replacement NN O
( -LRB- O
type NN O
a DT O
= SYM O
negative JJ O
for IN O
intense JJ O
fatty JJ O
replacement NN O
, , O
type NN O
b NN O
= SYM O
positive JJ O
for IN O
intense JJ O
fatty JJ O
replacement NN O
) -RRB- O
. . O

-DOCSTART- X X O

Between IN O
the DT O
subgroups NNS O
of IN O
dementia NN O
disorders NNS O
there EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
basal JJ O
cortisol NN O
levels NNS O
. . O

-DOCSTART- X X O

The DT O
region NN O
between IN O
DXS52 NNP B-NP
and CC O
Factor NNP B-NP
VIII NNP I-NP
gene NN I-NP
in IN O
the DT O
human JJ O
Xq28 CD O
chromosomal NN O
band NN O
contains VBZ O
a DT O
G+C-rich JJ O
isochore NN O
to TO O
which WDT O
many JJ O
genes NNS O
have VBP O
been VBN O
mapped VBN O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
and CC O
transcriptional JJ O
analysis NN O
of IN O
the DT O
DNA NNP B-NP
polymerase NN I-NP
gene NN I-NP
of IN I-NP
Bombyx NNP I-NP
mori , I-NP
nuclear JJ I-NP
polyhedrosis NN I-NP
virus NN I-NP
. . O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
the DT O
Flavobacterium NNP O
glycosylasparaginase NN B-NP
with IN O
a DT O
mammalian JJ O
glycosylasparaginase NN B-NP
revealed VBD O
30 CD O
% NN O
structural JJ O
identity NN O
and CC O
60 CD O
% NN O
overall JJ O
similarity NN O
between IN O
the DT O
prokaryotic JJ O
and CC O
eukaryotic JJ O
forms NNS O
of IN O
the DT O
enzyme NN O
. . O

-DOCSTART- X X O

To TO O
understand VB O
the DT O
function NN O
of IN O
receptor-linked JJ B-NP
tyrosine NN I-NP
phosphatases NNS I-NP
in IN O
neural JJ O
development NN O
, , O
we PRP O
sought VBD O
to TO O
identify VB O
LAR NNP B-NP
isoforms VBZ I-NP
preferentially RB O
expressed VBN O
in IN O
the DT O
nervous JJ O
system NN O
and CC O
cellular JJ O
processes NNS O
regulating VBG O
LAR NN B-NP
alternative NN O
splicing NN O
. . O

-DOCSTART- X X O

135 CD O
students NNS O
had VBD O
a DT O
count NN O
of IN O
less JJR O
than IN O
50 CD O
eggs/10 CD O
ml NN O
. . O
urine NN O
and CC O
56 CD O
had VBD O
more JJR O
than IN O
50 CD O
eggs/10ml NN O
. . O

-DOCSTART- X X O

Physical JJ O
analysis NN O
maps NNS O
SAL6 VBG B-NP
to TO O
chromosome NN O
XVI NNS O
between IN O
TPK2 NNP B-NP
and CC O
spt14 CD B-NP
. . O

-DOCSTART- X X O

Rho NNP B-NP
GDP/GTP NNP I-NP
exchange NN I-NP
inhibitor NN I-NP
, , O
Rho NNP B-NP
GDI NNP I-NP
, , O
comigrated VBN O
with IN O
Rac2 NNP B-NP
and CC O
RhoA NNP B-NP
, , O
but CC O
not RB O
Rac1 NNP B-NP
. . O

-DOCSTART- X X O

Schnell NNP O
, , O
J. NNP O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
this DT O
clone NN O
in IN O
a DT O
wee1/mik1-deficient JJ B-NP
mutant NN O
causes VBZ O
an DT O
elongated JJ O
cell NN O
phenotype NN O
under IN O
non-permissive JJ O
growth NN O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
jitter NN O
and CC O
the DT O
fiber NN O
density NN O
did VBD O
not RB O
change VB O
significantly RB O
from IN O
day NN O
0 CD O
( -LRB- O
30.1 CD O
+/ RB O
- : O
3.6 CD O
microseconds NNS O
; : O
1.4 CD O
+/ CD O
- : O
0.07 CD O
) -RRB- O
to TO O
day NN O
30 CD O
( -LRB- O
34.5 CD O
+/ NN O
- : O
2.7 CD O
microseconds NNS O
; : O
1.6 CD O
+/ CD O
- : O
0.13 CD O
) -RRB- O
. . O

-DOCSTART- X X O

One CD O
member NN O
of IN O
this DT O
family NN O
, , O
RFX1 NNP B-NP
, , O
is VBZ O
a DT O
transcription NN O
factor NN O
for IN O
a DT O
variety NN O
of IN O
viral JJ O
and CC O
cellular JJ O
genes NNS O
. . O

-DOCSTART- X X O

During IN O
ISO+AT NNP O
infusion NN O
, , O
abdominal JJ O
fat JJ O
blood NN O
flow NN O
was VBD O
still RB O
significantly RB O
increased VBN O
as IN O
compared VBN O
with IN O
control NN O
values NNS O
in IN O
lean JJ O
and CC O
obese JJ O
subjects NNS O
. . O

-DOCSTART- X X O

The DT O
first JJ O
open JJ O
reading NN O
frame NN O
of IN O
the DT O
blueberry NN O
scorch NN O
carlavirus NN O
( -LRB- O
BBScV NNP O
) -RRB- O
genome NN O
encodes VBZ O
a DT O
putative JJ O
replication-associated JJ O
protein NN O
of IN O
223 JJ O
kDa FW O
( -LRB- O
p223 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

From IN O
sequence NN O
alignments NNS O
with IN O
phylogenetically RB O
related VBN O
viruses NNS O
, , O
including VBG O
tymoviruses NNS O
, , O
we PRP O
predicted VBD O
that IN O
p223 PRP B-NP
contained VBD O
a DT O
papain-like JJ B-NP
proteinase NN I-NP
domain NN I-NP
with IN O
a DT O
putative JJ O
catalytic JJ O
cysteine994 NN O
and CC O
histidine1075 NN O
. . O

-DOCSTART- X X O

The DT O
regions NNS O
of IN O
the DT O
tooth NN O
fracture NN O
are VBP O
determined VBN O
. . O

-DOCSTART- X X O

Like IN O
humans NNS O
, , O
the DT O
PITSLRE NNP B-NP
PK NNP I-NP
genes NNS I-NP
in IN I-NP
chickens NNS I-NP
must MD O
be VB O
closely RB O
linked VBN O
, , O
based VBN O
on IN O
fluorescent NN O
in IN O
situ NN O
hybridization NN O
( -LRB- O
FISH) NNP O
localization NN O
of IN O
these DT O
genes NNS O
to TO O
a DT O
single JJ O
chicken NN O
microchromosome JJ O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
the DT O
P450BM-3 JJ B-NP
Barbie NNP I-NP
box NN I-NP
significantly RB O
increased VBD O
the DT O
expression NN O
of IN O
both DT O
P450BM-3 JJ B-NP
and CC O
Bm3P1 NNP B-NP
( -LRB- O
another DT O
small JJ O
gene NN O
located VBN O
upstream RB O
of IN O
the DT O
P450BM-3 JJ B-NP
gene NN I-NP
that WDT O
encodes VBZ O
a DT O
second JJ O
putative JJ O
regulatory JJ O
protein NN O
) -RRB- O
in IN O
response NN O
to TO O
pentobarbital JJ O
induction NN O
but CC O
left VBD O
the DT O
basal NN O
levels NNS O
unaffected JJ O
. . O

-DOCSTART- X X O

When WRB O
combined VBN O
with IN O
serum NN O
ferritin NN B-NP
and CC O
hemoglobin NN B-NP
determinations NNS O
, , O
the DT O
serum NN O
transferrin NN B-NP
receptor NN I-NP
assay NN O
is VBZ O
a DT O
valuable JJ O
addition NN O
in IN O
epidemiologic NN O
surveys NNS O
because IN O
it PRP O
provides VBZ O
a DT O
quantitative JJ O
measure NN O
of IN O
functional JJ O
iron NN O
deficiency NN O
and CC O
it PRP O
distinguishes VBZ O
true JJ O
IDA NNP O
from IN O
the DT O
anemia NN O
of IN O
chronic JJ O
disease NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
screened VBN O
the DT O
mouse NN O
cDNA NN O
library NN O
of IN O
an DT O
MIN6 NNP O
cell NN O
line NN O
, , O
derived VBN O
from IN O
pancreatic JJ O
beta JJ O
cells NNS O
, , O
for IN O
its PRP$ O
novel NN O
isoform NN O
and CC O
have VBP O
identified VBN O
a DT O
cDNA NN O
encoding VBG O
a DT O
593-amino JJ O
acid NN O
protein NN O
having VBG O
63 CD O
, , O
53 CD O
, , O
and CC O
30 CD O
% NN O
identity NN O
with IN O
munc-18/n-Sec1/rbSec1 JJ B-NP
, , O
Caenorhabditis NNP B-NP
elegans NNS I-NP
unc18 CD I-NP
, , O
and CC O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
Sec1p NNP I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
the DT O
hypoxia-induced JJ O
expression NN O
of IN O
the DT O
endogenous JJ O
Epo NNP B-NP
gene NN I-NP
was VBD O
significantly RB O
inhibited VBN O
in IN O
Hep3B NNP O
cells NNS O
stably RB O
transfected VBN O
with IN O
HNF-4 JJ B-NP
delta NN I-NP
C. NNP I-NP

-DOCSTART- X X O

Small JJ B-NP
Maf NNP I-NP
proteins NNS I-NP
heterodimerize VBP O
with IN O
Fos NNP B-NP
and CC O
may MD O
act VB O
as IN O
competitive JJ O
repressors NNS O
of IN O
the DT O
NF-E2 JJ B-NP
transcription NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

Glomerular JJ O
hemodynamics NNS O
during IN O
abortion NN O
induced VBN O
by IN O
RU NNP O
486 CD O
and CC O
sepsis VBZ O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

Alternatively RB O
processed VBN O
isoforms NNS O
of IN O
cellular JJ B-NP
nucleic JJ I-NP
acid-binding NN I-NP
protein NN I-NP
interact NN O
with IN O
a DT O
suppressor NN O
region NN O
of IN O
the DT O
human JJ B-NP
beta-myosin NN I-NP
heavy NN I-NP
chain NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Erythrocyte NNP B-NP
delta-aminolevulinic JJ I-NP
acid NN I-NP
dehydratase NN I-NP
( -LRB- O
ALAD NN B-NP
) -RRB- O
activity NN O
, , O
erythrocyte NN O
zinc NN O
protoporphyrin NN O
( -LRB- O
ZPP)/heme NNP O
ratio NN O
, , O
and CC O
urinary JJ O
coproporphyrin NN O
(UC) IN O
concentration NN O
have VBP O
been VBN O
employed VBN O
as IN O
biological JJ O
indicators NNS O
of IN O
moderate-to JJ O
high-level JJ O
lead NN O
exposure NN O
, , O
corresponding JJ O
to TO O
blood NN O
levels NNS O
in IN O
excess NN O
of IN O
50 CD O
micrograms/dl NN O
, , O
in IN O
human JJ O
subjects NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
disassociation NN O
rates NNS O
indicates VBZ O
that IN O
the DT O
Grf10-Swi5-DNA NNP B-NP
complex NN O
has VBZ O
a DT O
longer JJR O
half-life NN O
than IN O
protein-DNA NN O
complexes NNS O
that WDT O
contain VBP O
only RB O
Swi5 VB B-NP
or CC O
Grf10 VB B-NP
. . O

-DOCSTART- X X O

Results NNS O
from IN O
in IN O
vitro NN O
transcription-translation NN O
analysis NN O
and CC O
maxicell NN O
experiments NNS O
suggested VBD O
that IN O
the DT O
447-bp JJ O
ORF NN O
was VBD O
the DT O
one CD O
being VBG O
actively RB O
expressed VBN O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
specific JJ O
antibodies NNS O
allowed VBD O
the DT O
identification NN O
of IN O
at IN O
least JJS O
RAR NN B-NP
beta NN I-NP
in IN O
some DT O
of IN O
the DT O
DNA-protein NNP O
complexes NNS O
, , O
although IN O
the DT O
four CD O
sequences NNS O
bind VBP O
single JJ O
RARs NNS B-NP
transfected VBN O
in IN O
COS NNP O
cells NNS O
much RB O
less RBR O
efficiently RB O
, , O
or CC O
not RB O
at IN O
all DT O
, , O
when WRB O
compared VBN O
to TO O
a DT O
canonical JJ O
RAR NN B-NP
responsive JJ I-NP
element NN I-NP
. . O

-DOCSTART- X X O

A DT O
decanucleotide NN O
promoter NN O
sequence NN O
homologous JJ O
to TO O
those DT O
found VBN O
in IN O
humans NNS O
and CC O
mice NNS O
was VBD O
located VBN O
in IN O
the DT O
5' JJ O
untranslated JJ O
region NN O
of IN O
one CD O
horse NN O
gene NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
We PRP O
conducted VBD O
a DT O
phase NN O
I PRP O
study VBP O
with IN O
MDL NNP O
73,147EF NNP O
, , O
a DT O
new JJ O
5 CD B-NP
hydroxytryptamine NN I-NP
3 CD I-NP
(5-HT3 . I-NP
) -RRB- I-NP
receptor NN I-NP
antagonist NN O
, , O
in IN O
25 CD O
patients NNS O
requiring VBG O
emetogenic JJ O
chemotherapy NN O
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
sequence NN O
adjacent JJ O
to TO O
the DT O
lacZ NN B-NP
gene NN I-NP
has VBZ O
been VBN O
determined VBN O
for IN O
91 CD O
vegetative NN O
fusion NN O
genes NNS O
whose WP$ O
products NNS O
have VBP O
been VBN O
localized VBN O
and CC O
for IN O
43 CD O
meiotically RB O
induced VBN O
fusions NNS O
. . O

-DOCSTART- X X O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
One CD O
hundred CD O
eighty-four CD O
chemotherapy-naive JJ O
patients NNS O
receiving VBG O
high-dose JJ O
cisplatin NN O
(81 VBD O
to TO O
120 CD O
mg/m2 NN O
) -RRB- O
were VBD O
randomized VBN O
to TO O
receive VB O
one CD O
of IN O
four CD O
granisetron NN O
doses NNS O
(5 VBP O
, , O
10 CD O
, , O
20 CD O
, , O
or CC O
40 CD O
micrograms/kg NN O
) -RRB- O
administered VBN O
before IN O
chemotherapy NN O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
showed VBD O
that IN O
v-Rel NN B-NP
, , O
the DT O
oncoprotein NNP O
of IN O
the DT O
avian JJ O
retrovirus NN O
Rev-T NN O
, , O
can MD O
increase VB O
expression NN O
from IN O
promoters NNS O
containing VBG O
binding JJ O
sites NNS O
for IN O
the DT O
cellular JJ O
transcription NN O
factor NN O
Sp1 NNP B-NP
in IN O
chicken NN O
embryo NN O
fibroblasts NNS O
( -LRB- O
S. NNP O

-DOCSTART- X X O

Treatment NNP O
with IN O
amphotericin NN O
B NNP O
and CC O
flucytosine NN O
led VBD O
to TO O
improvement NN O
of IN O
the DT O
symptoms NNS O
but CC O
did VBD O
not RB O
eradicate VB O
the DT O
micro-organisms NNS O
from IN O
the DT O
cerebrospinal JJ O
fluid NN O
( -LRB- O
CSF) NNP O
. . O

-DOCSTART- X X O

Consequently RB O
functional JJ O
mRNAs NN O
can MD O
be VB O
produced VBN O
by IN O
endogenous JJ B-NP
RNA NNP I-NP
polymerase NN I-NP
I. NN O

-DOCSTART- X X O

Univariate NNP O
statistical JJ O
analysis NN O
based VBN O
on IN O
Kaplan-Meier-estimates NNP O
and CC O
Log-Rank-Test NNP O
showed VBD O
the DT O
following VBG O
prognostically RB O
beneficial JJ O
factors NNS O
: : O
Limited JJ O
disease NN O
stage NN O
( -LRB- O
p NN O
= SYM O
0.009 CD O
) -RRB- O
, , O
NSE NNP B-NP
serum NN O
level NN O
less JJR O
than IN O
25 CD O
micrograms/l NN O
( -LRB- O
p NN O
= SYM O
0.016 CD O
) -RRB- O
, , O
serum NN O
alkaline NN B-NP
phosphatase NN I-NP
less JJR O
than IN O
200 CD O
U/l NNP O
( -LRB- O
p NN O
= SYM O
0.035 CD O
) -RRB- O
, , O
normal JJ O
serum NN O
albumin NN B-NP
( -LRB- O
p NN O
= SYM O
0.003 CD O
) -RRB- O
and CC O
activity NN O
index NN O
of IN O
minimum NN O
of IN O
70 CD O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Of IN O
419 CD O
persons NNS O
surveyed VBN O
, , O
207 CD O
( -LRB- O
49.4 CD O
% NN O
) -RRB- O
were VBD O
antigen-positive JJ O
with IN O
the DT O
Og4C3 NNP B-NP
assay NN O
. . O

-DOCSTART- X X O

Ten CD O
volunteers NNS O
were VBD O
tested VBN O
at IN O
18,000 CD O
ft NN O
(5,486 CD O
m NN O
) -RRB- O
, , O
and CC O
through IN O
12,000 CD O
, , O
8,000 CD O
, , O
and CC O
5,000 CD O
ft NN O
( -LRB- O
3,657 CD O
, , O
2,438 CD O
, , O
and CC O
1,524 CD O
m NN O
) -RRB- O
with IN O
directional JJ O
sounds NNS O
recorded VBN O
via IN O
a DT O
dummy JJ O
head NN O
microphone NN O
and CC O
presented VBD O
binaurally RB O
. . O

-DOCSTART- X X O

Upon IN O
differentiation NN O
with IN O
retinoic JJ O
acid NN O
(RA NN O
) -RRB- O
, , O
transcription NN O
of IN O
the DT O
Rex-1 NNP B-NP
gene NN I-NP
decreases VBZ O
rapidly RB O
. . O

-DOCSTART- X X O

Rat NNP B-NP
kidney NN I-NP
carboxylesterase NN I-NP
. . O

-DOCSTART- X X O

Infect NN O
. . O

-DOCSTART- X X O

The DT O
Nur77 JJ B-NP
protein NN I-NP
can MD O
act VB O
as IN O
a DT O
potent JJ O
transcription NN O
activator NN O
and CC O
may MD O
function VB O
to TO O
regulate VB O
the DT O
expression NN O
of IN O
downstream NN O
genes NNS O
in IN O
response NN O
to TO O
extracellular JJ O
stimuli NNS O
. . O

-DOCSTART- X X O

KRN2391 NNP O
and CC O
cromakalim NN O
produced VBD O
a DT O
dose-dependent JJ O
increase NN O
in IN O
aortic JJ O
and CC O
coronary JJ O
blood NN O
flow NN O
. . O

-DOCSTART- X X O

Basal NNP O
plasma NN O
AVP IN B-NP
levels NNS O
and CC O
AVP NNP B-NP
release NN O
after IN O
postural JJ O
change NN O
were VBD O
assessed VBN O
, , O
and CC O
plasma NN O
NPY NN B-NP
levels NNS O
were VBD O
measured VBN O
in IN O
the DT O
same JJ O
samples NNS O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
nuclear JJ O
forms NNS O
of IN O
IE110 PRP B-NP
were VBD O
found VBN O
to TO O
move VB O
a DT O
cytoplasmic JJ O
form NN O
of IN O
IE175 PRP B-NP
into IN O
nuclear JJ O
punctate NN O
structures NNS O
, , O
and CC O
a DT O
cytoplasmic JJ O
form NN O
of IN O
IE110 NNP B-NP
was VBD O
able JJ O
to TO O
retain VB O
nuclear JJ O
forms NNS O
of IN O
IE175 NNP B-NP
in IN O
cytoplasmic JJ O
punctate NN O
structures NNS O
. . O

-DOCSTART- X X O

The DT O
inflation NN O
hub NN O
of IN O
the DT O
probe NN O
is VBZ O
recreated VBN O
by IN O
modifying VBG O
a DT O
standard JJ O
USCI NNP O
Tuohy-Borst NNP O
Y NNP O
adaptor NN O
and CC O
attaching VBG O
this DT O
to TO O
the DT O
transected VBN O
probe NN O
hypotube NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
yeast NN B-NP
CEG1 IN I-NP
demonstrated VBN O
that IN O
four CD O
of IN O
the DT O
five CD O
conserved JJ O
motifs NNS O
are VBP O
essential JJ O
for IN O
capping VBG B-NP
enzyme JJ I-NP
function NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

A DT O
sequence NN O
representing VBG O
about RB O
50 CD O
% NN O
of IN O
the DT O
expected JJ O
complete JJ O
sequence NN O
was VBD O
obtained VBN O
by IN O
translation NN O
of IN O
the DT O
two CD O
open JJ O
reading NN O
frames NNS O
present VB O
on IN O
a DT O
1.6 CD O
kb NN O
DNA NN O
genomic JJ O
fragment NN O
. . O

-DOCSTART- X X O

METHODS--16 CD O
volunteered VBD O
for IN O
spirometry NN O
with IN O
methacholine NN O
provocation NN O
test NN O
including VBG O
a DT O
test NN O
for IN O
small JJ O
airways NNS O
function NN O
by IN O
volume NN O
of IN O
trapped JJ O
gas NN O
(VTG) NN O
. . O

-DOCSTART- X X O

Relationship NN O
of IN O
CDK-activating JJ B-NP
kinase NN I-NP
and CC O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
CTD NNP O
kinase NN O
TFIIH/TFIIK. . B-NP

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
social JJ O
isolation NN O
on IN O
morphine-induced JJ O
locomotor NN O
activity NN O
were VBD O
compared VBN O
in IN O
: : O
( -LRB- O
i NN O
) -RRB- O
animals NNS O
with IN O
an DT O
intact JJ O
hypothalamo-pituitary-adrenal JJ O
( -LRB- O
HPA NN O
) -RRB- O
axis NN O
; : O
( -LRB- O
ii NNS O
) -RRB- O
animals NNS O
in IN O
which WDT O
stress-induced JJ O
corticosterone NN O
secretion NN O
was VBD O
blocked VBN O
by IN O
adrenalectomy NN O
. . O

-DOCSTART- X X O

Standard JJ O
curve NN O
correlation NN O
coefficients NNS O
of IN O
0.995 CD O
or CC O
greater JJR O
were VBD O
obtained VBN O
during IN O
validation NN O
experiments NNS O
and CC O
analysis NN O
of IN O
study NN O
samples NNS O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
difference NN O
in IN O
plasma NN O
concentrations NNS O
of IN O
PGI2 NNP O
( -LRB- O
figure NN O
4 CD O
) -RRB- O
and CC O
TxA2 NNP O
in IN O
patients NNS O
with IN O
normal JJ O
blood NN O
pressure NN O
, , O
mild JJ O
preeclampsia NN O
and CC O
hypotension NN O
, , O
whereas IN O
in IN O
severe JJ O
preeclampsia NN O
, , O
the DT O
plasma NN O
concentration NN O
of IN O
PGI2 CD O
was VBD O
significantly RB O
lower JJR O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
and CC O
of IN O
TxA2 DT O
significantly RB O
higher JJR O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Under IN O
resting VBG O
conditions NNS O
, , O
activity NN O
levels NNS O
of IN O
cardiac NN O
vagal NN O
and CC O
sympathetic JJ O
outflows NNS O
are VBP O
not RB O
related VBN O
across IN O
young JJ O
, , O
healthy JJ O
human JJ O
subjects NNS O
and CC O
peripheral JJ O
interaction NN O
is VBZ O
not RB O
manifest JJ O
between IN O
the DT O
autonomic JJ O
divisions NNS O
. . O

-DOCSTART- X X O

Both DT O
proprioceptive JJ O
and CC O
electroreceptive JJ O
units NNS O
showed VBD O
a DT O
progression NN O
of IN O
receptive JJ O
fields NNS O
from IN O
anterior JJ O
to TO O
posterior JJ O
body NN O
in IN O
the DT O
rostral NN O
to TO O
caudal VB O
direction NN O
along IN O
the DT O
length NN O
of IN O
DGR NNP O
. . O

-DOCSTART- X X O

Granisetron NNP O
, , O
but CC O
not RB O
saline JJ O
, , O
abolished VBD O
vomiting NN O
and CC O
nausea NN O
when WRB O
given VBN O
as IN O
intervention NN O
after IN O
this DT O
combined VBN O
emetic JJ O
regimen NNS O
. . O

-DOCSTART- X X O

This DT O
was VBD O
obtained VBN O
with IN O
the DT O
thermal JJ O
neutron NN O
fluency NN O
2.0 CD O
x NN O
10( JJ O
10 CD O
) -RRB- O
n/cm2 NN O
. . O

-DOCSTART- X X O

Endotoxemia NNP O
induced VBN O
by IN O
gram-negative JJ O
bacteria NNS O
leads VBZ O
to TO O
endotoxic JJ O
shock NN O
pathogenetically RB O
stemming VBG O
from IN O
the DT O
integral JJ O
component NN O
of IN O
the DT O
bacterial JJ O
wall--lipid JJ O
A. NN O

-DOCSTART- X X O

The DT O
study NN O
made VBD O
to TO O
define VB O
the DT O
ability NN O
of IN O
lipid JJ B-NP
A DT I-NP
monoclonal JJ I-NP
antibodies NNS I-NP
to TO O
correct VB O
hemodynamic JJ O
disturbances NNS O
due JJ O
to TO O
endotoxemia NN O
in IN O
dog NN O
experiments NNS O
showed VBD O
the DT O
efficacy NN O
of IN O
the DT O
antibodies NNS O
administration NN O
. . O

-DOCSTART- X X O

This DT O
sequenced VBD O
region NN O
of IN O
the DT O
V NNP O
beta NN O
locus NN O
contains VBZ O
an DT O
average JJ O
number NN O
of IN O
repetitive JJ O
DNA NN O
elements NNS O
( -LRB- O
21 CD O
Alu NNP B-NP
, , O
three CD O
L1 CD B-NP
, , O
three CD O
MER NN O
, , O
and CC O
three CD O
retrovirus-related JJ O
elements NNS O
. . O

-DOCSTART- X X O

In IN O
an DT O
in IN O
vitro NN O
study NN O
, , O
10/0 CD O
nylon NN O
was VBD O
found VBN O
to TO O
require VB O
a DT O
significantly RB O
lower JJR O
laser NN O
energy NN O
density NN O
to TO O
produce VB O
suture NN O
lysis NN O
following VBG O
a DT O
single JJ O
shot NN O
than IN O
either DT O
10/0 CD O
Dacron NNP O
or CC O
10/0 CD O
prolene NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
that IN O
microinjection NN O
of IN O
an DT O
anti-CBP JJ B-NP
antiserum NN I-NP
into IN O
fibroblasts NNS O
can MD O
inhibit VB O
transcription NN O
from IN O
a DT O
cAMP JJ O
responsive JJ O
promoter NN O
. . O

-DOCSTART- X X O

Ketamine NNP O
in IN O
the DT O
treatment NN O
of IN O
bronchospasm NN O
during IN O
mechanical JJ O
ventilation NN O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
the DT O
disposition NN O
of IN O
venlafaxine NN O
and CC O
O-desmethylvenlafaxine NNP O
is VBZ O
markedly RB O
altered VBN O
in IN O
renal JJ O
disease NN O
; : O
therefore RB O
dosage NN O
adjustment NN O
is VBZ O
warranted VBN O
for IN O
patients NNS O
with IN O
creatinine JJ O
clearance NN O
values NNS O
below IN O
30 CD O
ml/min NN O
. . O

-DOCSTART- X X O

M. NNP O
, , O
and CC O
D. NNP O

-DOCSTART- X X O

At IN O
least JJS O
some DT O
of IN O
the DT O
difference NN O
in IN O
stability NN O
of IN O
the DT O
two CD O
kinds NNS O
of IN O
complexes NNS O
was VBD O
due JJ O
to TO O
the DT O
fact NN O
that IN O
the DT O
dissociation NN O
rate NN O
of IN O
the DT O
A NNP O
stem NN O
substrate NN O
from IN O
the DT O
protein-DNA NN O
complexes NNS O
was VBD O
approximately RB O
fourfold RB O
faster JJR O
than IN O
that DT O
of IN O
the DT O
complete JJ O
TR. NN B-NP

-DOCSTART- X X O

Number NN O
and CC O
size NN O
of IN O
silver-stained JJ O
nucleoli NNS O
( -LRB- O
Ag-NOR JJ O
clusters NNS O
) -RRB- O
in IN O
canine CD O
seminomas NNS O
: : O
correlation NN O
with IN O
histological JJ O
features NNS O
and CC O
tumour NN O
behaviour NN O
. . O

-DOCSTART- X X O

The DT O
tumor NN O
suppressor NN O
and CC O
transcriptional JJ O
factor NN O
p53 NN B-NP
is VBZ O
a DT O
phosphorylated JJ O
protein NN O
. . O

-DOCSTART- X X O

The DT O
acfD NN B-NP
gene NN I-NP
encompasses VBZ O
254 CD O
nt NN O
that WDT O
are VBP O
predicted VBN O
to TO O
encode VB O
an DT O
88-amino-acid JJ O
( -LRB- O
aa JJ O
) -RRB- O
protein NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
KRAB NNP B-NP
domain NN I-NP
present NN O
in IN O
the DT O
non-finger JJ O
region NN O
of IN O
many JJ O
ZFP NNP B-NP
genes NNS I-NP
quenches NNS O
transcription NN O
possibly RB O
due JJ O
to TO O
specific JJ O
protein-protein NN O
interactions NNS O
between IN O
the DT O
KRAB-A NNP B-NP
domain NN I-NP
and CC O
components NNS O
of IN O
the DT O
proximal JJ O
transcriptional JJ O
apparatus NN O
. . O

-DOCSTART- X X O

The DT O
newly RB O
recognised VBN O
skeletogenital JJ O
syndrome NN O
. . O

-DOCSTART- X X O

The DT O
immune JJ O
response NN O
of IN O
past-infection NN O
of IN O
cytomegalovirus NN O
in IN O
the DT O
patients NNS O
of IN O
RTID NNP O
is VBZ O
rather RB O
remarkable JJ O
. . O

-DOCSTART- X X O

Reduced VBN O
NK NNP O
activity NN O
correlates VBZ O
with IN O
active JJ O
disease NN O
in IN O
HIV- PRP$ O
patients NNS O
with IN O
multidrug-resistant JJ O
pulmonary JJ O
tuberculosis NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
leader-mRNA JJ O
fusion NN O
in IN O
coronavirus NN O
transcription NN O
does VBZ O
not RB O
require VB O
direct JJ O
RNA-RNA JJ O
interaction NN O
between IN O
complementary JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Comparison NN O
with IN O
the DT O
bovine JJ O
gene NN O
showed VBD O
that IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
hATP1 JJ B-NP
gene NN I-NP
has VBZ O
an DT O
unconserved JJ O
guanine-cytosine FW O
( -LRB- O
GC NN O
) -RRB- O
rich JJ O
region NN O
, , O
including VBG O
several JJ O
binding JJ O
motifs NNS O
of IN O
transcriptional JJ O
factors NNS O
, , O
such JJ O
as IN O
Sp1 NNP B-NP
, , O
AP-2 NNP B-NP
, , O
and CC O
GCF. NNP B-NP

-DOCSTART- X X O

Here RB O
, , O
we PRP O
present VBP O
genetic JJ O
evidence NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
for IN O
a DT O
functional JJ O
interaction NN O
between IN O
the DT O
DEAH NNP B-NP
protein NN I-NP
Prp16 NNP B-NP
, , O
and CC O
the DT O
U6 NNP B-NP
and CC O
U2 NNP B-NP
spliceosomal JJ I-NP
snRNAs NNS I-NP
. . O

-DOCSTART- X X O

These DT O
mutants NNS O
had VBD O
deletions NNS O
of IN O
the DT O
extreme JJ O
amino-terminal JJ O
residues NNS O
as RB O
far RB O
as IN O
amino IN O
acid NN O
residue JJ O
30 CD O
. . O

-DOCSTART- X X O

Through IN O
a DT O
stretch NN O
of IN O
56 CD O
amino IN O
acids NNS O
, , O
constituting VBG O
the DT O
MADS NNP B-NP
domain NN I-NP
, , O
the DT O
two CD O
proteins NNS O
are VBP O
identical JJ O
except IN O
for IN O
two CD O
conservative JJ O
amino JJ O
acid NN O
substitutions NNS O
. . O

-DOCSTART- X X O

Clinical NNP O
aspects NNS O
of IN O
early JJ O
increase NN O
in IN O
serum NN O
gamma-glutamyl NN B-NP
transferase NN I-NP
in IN O
cerebral JJ O
infarction NN O
. . O

-DOCSTART- X X O

The DT O
indoor JJ O
radon NN O
concentration NN O
in IN O
the DT O
summer NN O
( -LRB- O
1990 CD O
) -RRB- O
period NN O
ranged VBD O
between IN O
8 CD O
and CC O
81 CD O
Bq NNP O
m-3 NN O
, , O
while IN O
in IN O
the DT O
winter NN O
( -LRB- O
1989-1990 CD O
) -RRB- O
it PRP O
ranged VBD O
between IN O
20 CD O
and CC O
143 CD O
Bq NNP O
m-3 NN O
for IN O
the DT O
first JJ O
year NN O
of IN O
measurements NNS O
or CC O
between IN O
8 CD O
and CC O
92 CD O
Bq NNP O
m-3 NN O
in IN O
the DT O
summer NN O
( -LRB- O
1991 CD O
) -RRB- O
period NN O
and CC O
between IN O
12 CD O
and CC O
119 CD O
Bq NNP O
m-3 NN O
in IN O
the DT O
winter NN O
( -LRB- O
1990-1991 CD O
) -RRB- O
for IN O
the DT O
second JJ O
year NN O
of IN O
measurements NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
hrpRS NNS B-NP
and CC O
hrpL NNS B-NP
are VBP O
part NN O
of IN O
a DT O
regulatory JJ O
cascade NN O
in IN O
which WDT O
HrpR NNP B-NP
and CC O
HrpS NNP B-NP
activate JJ O
expression NN O
of IN O
hrpL NN B-NP
and CC O
HrpL NNP B-NP
, , O
a DT O
putative JJ O
sigma NN B-NP
factor NN I-NP
, , O
induces VBZ O
expression NN O
of IN O
HrpL-responsive JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

DtxR NN B-NP
is VBZ O
an DT O
iron-dependent JJ O
sequence-specific JJ O
DNA-binding JJ O
protein NN O
that IN O
binds NNS O
to TO O
the DT O
tox NN B-NP
operator NN I-NP
, , O
an DT O
inverted-repeat NN O
nucleotide JJ O
sequence NN O
located VBN O
upstream RB O
from IN O
the DT O
diphtheria NN B-NP
toxin NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
LBP-1 JJ B-NP
represses NNS O
HIV-1 NN O
transcription NN O
by IN O
inhibiting VBG O
the DT O
binding NN O
of IN O
TFIID NNP B-NP
to TO O
the DT O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

Sodium-taurocholate-induced JJ O
acute JJ O
necrotizing JJ O
pancreatitis NN O
does VBZ O
not RB O
affect VB O
jejunal JJ O
oxygenation NN O
in IN O
pigs NNS O
. . O

-DOCSTART- X X O

The DT O
epidemic JJ O
occurred VBD O
in IN O
a DT O
group NN O
of IN O
26 CD O
community NN O
members NNS O
( -LRB- O
23 CD O
men NNS O
and CC O
3 CD O
women NNS O
, , O
mean JJ O
age NN O
, , O
28.9--3 JJ O
years NNS O
) -RRB- O
living VBG O
and CC O
working VBG O
together RB O
, , O
who WP O
underwent VBD O
acute JJ O
and CC O
convalescent JJ O
serologic NN O
tests NNS O
for IN O
Mycoplasma NNP O
pneumoniae NNS O
, , O
Legionella NNP O
pneumophila VBD O
, , O
cytomegalovirus NN O
, , O
adenovirus NN O
, , O
Coxiella NNP O
burnetii NNS O
, , O
and CC O
Chlamydia NNP O
pneumoniae NNS O
. . O

-DOCSTART- X X O

Genomic JJ O
DNA NN O
clones NNS O
containing VBG O
the DT O
T-cell-specific JJ B-NP
human NN I-NP
MAL NNP I-NP
gene NN I-NP
were VBD O
isolated VBN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
dibasic JJ O
proprotein NN O
processing NN O
enzyme NN O
furin NN B-NP
is VBZ O
directed VBN O
by IN O
multiple JJ O
promoters NNS O
. . O

-DOCSTART- X X O

Genetic JJ O
and CC O
phenotypic JJ O
analysis NN O
indicates VBZ O
that IN O
NHP6A NNP B-NP
and CC O
NHP6B NNP B-NP
function NN O
downstream NN O
of IN O
SLT2 NNP B-NP
. . O

-DOCSTART- X X O

Rather RB O
, , O
complete VB O
skipping VBG O
of IN O
exon NN O
V NNP O
and CC O
subsequent JJ O
joining VBG O
of IN O
exon NN O
IV NNP O
to TO O
exon VB O
VI NNP O
caused VBD O
a DT O
shift NN O
in IN O
the DT O
open JJ O
reading NN O
frame NN O
, , O
which WDT O
remodeled VBD O
GPHe( JJ B-NP
P2 NN I-NP
) -RRB- I-NP
with IN O
an DT O
elongated JJ O
new JJ O
hydrophobic JJ O
sequence NN O
for IN O
membrane NN O
anchoring NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
the DT O
foreign JJ O
gene NN O
was VBD O
confirmed VBN O
by IN O
Southern JJ O
analysis NN O
. . O

-DOCSTART- X X O

Functional JJ O
postnatal JJ O
development NN O
of IN O
the DT O
rat NN O
primary JJ O
visual JJ O
cortex NN O
and CC O
the DT O
role NN O
of IN O
visual JJ O
experience NN O
: : O
dark JJ O
rearing NN O
and CC O
monocular JJ O
deprivation NN O
. . O

-DOCSTART- X X O

Altogether RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
Ypt51p NNP B-NP
, , O
Ypt52p NNP B-NP
, , O
and CC O
Ypt53p NNP B-NP
are VBP O
required VBN O
for IN O
transport NN O
in IN O
the DT O
endocytic JJ O
pathway NN O
and CC O
for IN O
correct JJ O
sorting NN O
of IN O
vacuolar NN B-NP
hydrolases NNS I-NP
suggesting VBG O
a DT O
possible JJ O
intersection NN O
of IN O
the DT O
endocytic JJ O
with IN O
the DT O
vacuolar JJ O
sorting NN O
pathway NN O
. . O

-DOCSTART- X X O

The DT O
variable JJ O
regions NNS O
of IN O
vertebrate JJ O
striated JJ O
TnT JJ B-NP
isoforms NNS I-NP
reflect VBP O
the DT O
subsequent JJ O
addition NN O
and CC O
modification NN O
of IN O
genomic JJ O
sequences NNS O
to TO O
give VB O
rise NN O
to TO O
members NNS O
of IN O
the DT O
TnT NNP B-NP
multigene NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

These DT O
viruses NNS O
depend VBP O
on IN O
the DT O
host NN O
cell NN O
machinery NN O
for IN O
their PRP$ O
existence NN O
, , O
and CC O
interference NN O
with IN O
these DT O
processes NNS O
typically RB O
interferes VBZ O
with IN O
other JJ O
important JJ O
host NN O
physiology NN O
. . O

-DOCSTART- X X O

The DT O
experiment NN O
included VBD O
6 CD O
male NN O
and CC O
4 CD O
female NN O
healthy JJ O
subjects NNS O
who WP O
, , O
during IN O
a DT O
24-hour JJ O
stay NN O
in IN O
the DT O
respiration NN O
chambers NNS O
, , O
performed VBN O
, , O
in IN O
the DT O
morning NN O
and CC O
afternoon NN O
, , O
15 CD O
min NN O
cycling NN O
with IN O
the DT O
total JJ O
work NN O
of IN O
6,750 CD O
kg NN O
m NN O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
sequence NN O
data NNS O
obtained VBN O
from IN O
the DT O
human JJ O
TCRAC/TCRDC NNP B-NP
region NN O
, , O
we PRP O
have VBP O
extended VBN O
a DT O
polymerase NN O
chain NN O
reaction-based VBD O
assay NN O
to TO O
test VB O
for IN O
the DT O
expression NN O
of IN O
the DT O
individual JJ O
TCRAJ NNP B-NP
gene NN I-NP
segments NNS I-NP
. . O

-DOCSTART- X X O

The DT O
baroreflex NN O
latency RB O
( -LRB- O
from IN O
the DT O
ECG NNP O
R-wave NNP O
to TO O
the DT O
integrated JJ O
MSNA NNP O
burst NN O
peak NN O
) -RRB- O
was VBD O
constant JJ O
at IN O
approximately RB O
1.20 CD O
s VBZ O
during IN O
sleep NN O
, , O
suggesting VBG O
that IN O
pulse-synchronicity NN O
was VBD O
maintained VBN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
unlike IN O
the DT O
case NN O
for IN O
HIS3 PRP$ B-NP
where WRB O
only RB O
a DT O
limited JJ O
subset NN O
of IN O
TATA-like JJ O
sequences NNS O
can MD O
activate VB O
transcription NN O
in IN O
conjunction NN O
with IN O
GCN4p NNP B-NP
, , O
many JJ O
divergent JJ O
TATA-like JJ O
sequences NNS O
allowed VBN O
GCN4p IN B-NP
activation NN O
of IN O
TRP3 NNP B-NP
. . O

-DOCSTART- X X O

This DT O
strategy NN O
was VBD O
used VBN O
to TO O
place VB O
both DT O
the DT O
Tn903 NNP B-NP
neo NN I-NP
gene NN I-NP
and CC O
the DT O
Rhodosporidium NNP B-NP
toruloides NNS I-NP
phenylalanine VBP I-NP
ammonia NN I-NP
lyase NN I-NP
( -LRB- O
PAL)-encoding JJ B-NP
gene NN O
under IN O
the DT O
transcriptional JJ O
control NN O
of IN O
pPGK::REP2 NN B-NP
. . O

-DOCSTART- X X O

A-69-year-old JJ O
patient NN O
with IN O
postoperative JJ O
small-bowel JJ O
obstruction NN O
underwent IN O
laparotomy NN O
three CD O
times NNS O
. . O

-DOCSTART- X X O

VP-16 CD O
, , O
ifosfamide RB O
and CC O
cisplatin JJ O
(VIP NN O
) -RRB- O
for IN O
extensive JJ O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

-DOCSTART- X X O

To TO O
identify VB O
the DT O
precise JJ O
location NN O
of IN O
the DT O
phosphorylation NN O
site NN O
on IN O
the DT O
64-kDa JJ O
protein NN O
, , O
a DT O
step-by-step NN O
mutagenesis NN O
procedures NNS O
was VBD O
followed VBN O
. . O

-DOCSTART- X X O

Measurement NN O
of IN O
SaO2 NNP O
at IN O
moderate JJ O
altitude NN O
can MD O
be VB O
helpful JJ O
in IN O
the DT O
care NN O
of IN O
both DT O
healthy JJ O
and CC O
ill JJ O
newborns NNS O
or CC O
infants NNS O
. . O

-DOCSTART- X X O

TATA NNP O
and CC O
CCAAT NN O
boxes NNS O
are VBP O
located VBN O
34-bp JJ O
and CC O
68-bp JJ O
, , O
respectively RB O
, , O
upstream RB O
of IN O
the DT O
transcription NN O
start NN O
site NN O
, , O
the DT O
5'-untranslated JJ O
leader NN O
is VBZ O
78 CD O
nucleotides NNS O
long RB O
, , O
and CC O
the DT O
intronless JJ O
gene NN O
has VBZ O
at IN O
least JJS O
two CD O
different JJ O
polyadenylation NN O
sites NNS O
. . O

-DOCSTART- X X O

GGS1 NNP B-NP
is VBZ O
the DT O
same JJ O
gene NN O
as IN O
TPS1 NNP B-NP
which WDT O
was VBD O
identified VBN O
as IN O
encoding VBG O
a DT O
subunit NN O
of IN O
the DT O
trehalose-6-phosphate JJ B-NP
synthase/phosphatase NN I-NP
complex NN I-NP
and CC O
it PRP O
is VBZ O
allelic JJ O
to TO O
the DT O
fdp1 CD B-NP
, , O
byp1 CD B-NP
, , O
glc6 CD B-NP
and CC O
cif1 CD O
mutations NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
The DT O
study NN O
demonstrates VBZ O
that IN O
transvaginal JJ O
ultrasonography NN O
has VBZ O
an DT O
efficiency NN O
of IN O
88 CD O
% NN O
in IN O
differentiating VBG O
endometriomas NNS O
from IN O
other JJ O
ovarian JJ O
masses NNS O
with IN O
a DT O
specificity NN O
of IN O
90 CD O
% NN O
. . O

-DOCSTART- X X O

A DT O
series NN O
of IN O
5'-deletions NNS O
revealed VBD O
that IN O
the DT O
fragment NN O
-218 . O
to TO O
+4 VB O
from IN O
the DT O
TSS NNP O
had VBD O
the DT O
highest JJS O
promoter NN O
activity NN O
, , O
nearly RB O
1000-fold JJ O
greater JJR O
than IN O
the DT O
promoterless JJ O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
construct VB I-NP
. . O

-DOCSTART- X X O

The DT O
bioavailability NN O
of IN O
etodolac NN O
from IN O
capsules NNS O
exposed VBN O
to TO O
stressed VBN O
conditions NNS O
was VBD O
compared VBN O
in IN O
both DT O
dogs NNS O
and CC O
humans NNS O
to TO O
capsules NNS O
stored VBN O
at IN O
RT NNP O
conditions NNS O
. . O

-DOCSTART- X X O

Four CD O
forms NNS O
of IN O
salmonellosis NN O
were VBD O
recognised VBN O
in IN O
feedlots NNS O
and CC O
during IN O
transport NN O
by IN O
sea NN O
: : O
septicaemic JJ O
, , O
and CC O
acute JJ O
, , O
subacute JJ O
and CC O
chronic JJ O
enteric NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
the DT O
protein-tyrosine NN B-NP
kinase NN I-NP
domain NN I-NP
, , O
p56lck JJ B-NP
possesses NNS O
Src NNP B-NP
homology NN I-NP
2 CD I-NP
and CC I-NP
3 CD I-NP
( -LRB- O
SH2 NNP B-NP
and CC O
SH3 NNP B-NP
) -RRB- O
domains VBZ O
as RB O
well RB O
as IN O
a DT O
unique JJ O
N-terminal JJ O
region NN O
. . O

-DOCSTART- X X O

The DT O
fourth JJ O
dose NN O
produced VBD O
favorable JJ O
results NNS O
( -LRB- O
66.7 CD O
% NN O
) -RRB- O
in IN O
individuals NNS O
with IN O
HB NNP B-NP
antibodies NNS I-NP
between IN O
10 CD O
and CC O
100 CD O
IU/ml NNP O
and CC O
unfavorable JJ O
ones NNS O
( -LRB- O
3.8 CD O
% NN O
) -RRB- O
where WRB O
the DT O
HB NNP B-NP
antibodies NNS I-NP
were VBD O
below IN O
10 CD O
IU/ml NN O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
the DT O
N-terminal JJ O
cytoplasmic JJ O
domain NN O
of IN O
the DT O
latent JJ B-NP
membrane NN I-NP
protein NN I-NP
2A DT I-NP
( -LRB- O
LMP2A NN B-NP
) -RRB- O
of IN O
the DT O
Epstein-Barr NNP O
virus NN O
( -LRB- O
EBV NNP O
) -RRB- O
contains VBZ O
a DT O
single JJ O
copy NN O
of IN O
the DT O
Tyr-X-X-Leu/Ile-containing JJ O
motif NN O
which WDT O
could MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
B NNP O
cell NN O
transformation NN O
. . O

-DOCSTART- X X O

The DT O
cloning NN O
of IN O
PTR2 NNP B-NP
represents VBZ O
the DT O
first JJ O
example NN O
of IN O
the DT O
molecular JJ O
genetic JJ O
characterization NN O
of IN O
a DT O
eucaryotic JJ O
peptide NN O
transport NN O
gene NN O
. . O

-DOCSTART- X X O

TGF NNP B-NP
beta NN I-NP
1 CD I-NP
expression NN O
is VBZ O
largely RB O
governed VBN O
by IN O
three CD O
AP-1 JJ B-NP
binding JJ I-NP
sites NNS I-NP
located VBN O
in IN O
two CD O
different JJ O
promoters NNS O
of IN O
this DT O
gene NN O
. . O

-DOCSTART- X X O

Strategic NNP O
change NN O
in IN O
the DT O
NHS. NNP O

-DOCSTART- X X O

A DT O
favourable JJ O
response NN O
was VBD O
achieved VBN O
with IN O
a DT O
combination NN O
of IN O
amphotericin NN O
B NNP O
and CC O
cotrimoxazole NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
At IN O
the DT O
beginning NN O
of IN O
the DT O
QA/Q NN O
I PRP O
process VBP O
, , O
monitoring VBG O
of IN O
blood NN O
administration NN O
practices NNS O
revealed VBD O
that IN O
a DT O
variance NN O
from IN O
institutional JJ O
blood NN O
administration NN O
policy NN O
occurred VBD O
during IN O
50 CD O
percent NN O
of IN O
blood NN O
and CC O
component NN O
transfusions NNS O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
Pay4p NNP B-NP
sequence NN I-NP
contains VBZ O
two CD O
putative JJ O
ATP-binding JJ O
domains NNS O
and CC O
shows NNS O
structural JJ O
relationships NNS O
to TO O
other JJ O
potential JJ O
ATP-binding JJ B-NP
proteins NNS I-NP
involved VBN O
in IN O
biological JJ O
processes NNS O
as RB O
diverse JJ O
as IN O
peroxisome JJ O
biogenesis NN O
, , O
vesicle-mediated JJ O
protein NN O
transport NN O
, , O
cell NN O
cycle NN O
control NN O
, , O
and CC O
transcriptional JJ O
regulation NN O
. . O

-DOCSTART- X X O

Peripheral JJ O
vitreochorioretinal JJ O
dystrophies NNS O
in IN O
myopia NN O
patients NNS O

-DOCSTART- X X O

Thomas NNP O
' POS O
Hospital NN O
solution NN O
( -LRB- O
with IN O
95 CD O
% NN O
O2:5 CD O
% NN O
CO2 NN O
) -RRB- O
can MD O
meet VB O
the DT O
metabolic JJ O
demand NN O
of IN O
the DT O
ischaemic JJ O
myocardium NN O
and CC O
thus RB O
increase VB O
the DT O
safe JJ O
duration NN O
of IN O
cardiac JJ O
arrest NN O
. . O

-DOCSTART- X X O

Animal JJ O
age NN O
and CC O
sex NN O
had VBD O
no DT O
significant JJ O
effects NNS O
on IN O
CSF NNP O
composition NN O
, , O
but CC O
serum NN O
IgG NNP B-NP
concentration NN O
increased VBN O
with IN O
age NN O
. . O

-DOCSTART- X X O

A DT O
randomized JJ O
, , O
multicenter JJ O
study NN O
comparing VBG O
the DT O
efficacy NN O
and CC O
tolerability NN O
of IN O
tropisetron NN O
, , O
a DT O
new JJ O
5-HT3 JJ B-NP
receptor NN I-NP
antagonist NN O
, , O
with IN O
a DT O
metoclopramide-containing NN O
antiemetic JJ O
cocktail NN O
in IN O
the DT O
prevention NN O
of IN O
cisplatin-induced JJ O
emesis NN O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid JJ O
sequence NN O
of IN O
the DT O
SAP-1 JJ B-NP
cDNA NN I-NP
showed VBD O
that IN O
mature JJ B-NP
SAP-1 NNP I-NP
consisted VBD O
of IN O
1093 CD O
amino IN O
acids NNS O
and CC O
a DT O
transmembrane-type JJ B-NP
PTP NNP I-NP
, , O
which WDT O
possessed VBD O
a DT O
single JJ O
PTP-conserved JJ B-NP
domain NN I-NP
in IN O
the DT O
cytoplasmic JJ O
region NN O
. . O

-DOCSTART- X X O

Several JJ O
features NNS O
of IN O
10.24.6 CD O
cells NNS O
suggest VBP O
that IN O
the DT O
mutation NN O
disrupts VBZ O
normal JJ O
intracellular JJ O
formation NN O
of IN O
peptide/DR NN B-NP
complexes NNS I-NP
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
elements NNS O
, , O
the DT O
homeodomain-binding JJ B-NP
element NN I-NP
, , O
was VBD O
identified VBN O
to TO O
mediate VB O
negative JJ O
regulation NN O
. . O

-DOCSTART- X X O

Twenty-three CD O
sequence-tagged JJ O
sites NNS O
(STSs NNS O
) -RRB- O
were VBD O
mapped VBN O
within IN O
the DT O
contig NN O
, , O
a DT O
density NN O
of IN O
approximately RB O
1 CD O
per IN O
200 CD O
kb NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
dopamine NN B-NP
receptor NN I-NP
stimulation NN O
by IN O
different JJ O
dopamine NN O
agonists NNS O
produces VBZ O
a DT O
different JJ O
pattern NN O
of IN O
effects NNS O
on IN O
the DT O
characteristics NNS O
of IN O
the DT O
reaction NN O
time NN O
response NN O
. . O

-DOCSTART- X X O

The DT O
first JJ O
group NN O
of IN O
sequential JJ O
BMB NNP O
showed VBD O
a DT O
significant JJ O
progress NN O
to TO O
myelofibrosis NN O
in IN O
so-called JJ O
" `` O
Chronic NNP O
Megakaryocytic-Granulocytic NNP O
Myelosis"--CMGM-, NNP O
which WDT O
corresponds VBZ O
to TO O
Agnogenic NNP O
Myeloid NNP O
Metaplasia-AMM-in NNP O
72.4 CD O
% NN O
( -LRB- O
21/29 CD O
patients NNS O
) -RRB- O
, , O
as RB O
well RB O
as IN O
in IN O
CML NNP O
with IN O
megakaryocytic JJ O
increase-CML.MI-in JJ O
39.2 CD O
% NN O
( -LRB- O
20/51 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Chicken NN O
sterol NN B-NP
carrier NN I-NP
protein NN I-NP
2/sterol CD I-NP
carrier NN B-NP
protein NN I-NP
x NN I-NP
: : O
cDNA NN O
cloning NN O
reveals VBZ O
evolutionary JJ O
conservation NN O
of IN O
structure NN O
and CC O
regulated JJ O
expression NN O
. . O

-DOCSTART- X X O

A DT O
single JJ O
five CD O
minute JJ O
period NN O
of IN O
rapid JJ O
atrial JJ O
pacing NN O
fails VBZ O
to TO O
limit VB O
infarct NN O
size NN O
in IN O
the DT O
in IN O
situ FW O
rabbit NN O
heart NN O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
indicated VBD O
that IN O
the DT O
20S JJ B-NP
proteasome NN I-NP
is VBZ O
a DT O
catalytic JJ O
core NN O
of IN O
the DT O
26S CD B-NP
proteolytic JJ I-NP
complex NN I-NP
that IN O
possesses NNS O
a DT O
latent JJ O
multicatalytic JJ O
proteinase NN O
activity NN O
and CC O
catalyzes VBZ O
an DT O
ATP-dependent JJ O
, , O
selective JJ O
breakdown NN O
of IN O
proteins NNS O
ligated VBN O
to TO O
ubiquitin NNP B-NP
. . O

-DOCSTART- X X O

The DT O
phosphorylation NN O
efficiency NN O
is VBZ O
improved VBN O
by IN O
increasing VBG O
the DT O
number NN O
of IN O
N-terminal JJ O
arginine NN O
residues NNS O
and CC O
by IN O
moving VBG O
the DT O
arginyl NN O
cluster NN O
one CD O
residue NN O
further RB O
away RB O
from IN O
the DT O
serine NN O
, , O
the DT O
nonapeptide NN O
( -LRB- O
Arg NNP O
)4-Ala-Ala-Ser-Val-Ala NNP O
being VBG O
the DT O
best JJS O
substrate NN O
among IN O
all PDT O
the DT O
short JJ O
peptides NNS O
tested VBD O
( -LRB- O
Km NNP O
= SYM O
15 CD O
microM NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
UV NN O
induction NN O
of IN O
c-jun NN B-NP
is VBZ O
mediated VBN O
by IN O
two CD O
UV JJ O
response NN O
elements NNS O
consisting VBG O
of IN O
AP-1-like JJ B-NP
sequences NNS I-NP
within IN O
its PRP$ O
5' JJ O
control NN O
region NN O
. . O

-DOCSTART- X X O

When WRB O
comparing VBG O
the DT O
barley NN B-NP
PSI-K NNP I-NP
and CC O
PSI-G NNP B-NP
with IN O
the DT O
reported VBN O
PSI-K JJ B-NP
sequence NN I-NP
from IN I-NP
Synechococcus NNP I-NP
vulcanus NN I-NP
, , O
the DT O
degree NN O
of IN O
similarity NN O
is VBZ O
equal JJ O
, , O
suggesting VBG O
that IN O
an DT O
ancestral JJ O
gene NN O
has VBZ O
been VBN O
duplicated VBN O
in IN O
a DT O
chloroplast NN O
progenitor NN O
but CC O
not RB O
in IN O
a DT O
cyanobacterial NN O
. . O

-DOCSTART- X X O

The DT O
simultaneous JJ O
recording NN O
of IN O
electrical JJ O
activity NN O
from IN O
the DT O
surface NN O
electrocardiogram NN O
, , O
right JJ O
ventricular NN O
apex NN O
, , O
His PRP$ O
bundle NN O
, , O
high RB O
right JJ O
atrium NN O
, , O
coronary JJ O
sinus NN O
, , O
with IN O
or CC O
without IN O
a DT O
roving NN O
mapping NN O
catheter NN O
, , O
enables VBZ O
us PRP O
to TO O
precisely RB O
map VBP O
the DT O
electrical JJ O
activation NN O
sequence NN O
in IN O
the DT O
heart NN O
. . O

-DOCSTART- X X O

Differences NNS O
in IN O
profiles NNS O
of IN O
viscosity NN O
variables NNS O
between IN O
subgroups NNS O
of IN O
EAD NN O
in IN O
RA NNP O
patients NNS O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

Since IN O
the DT O
-172/-148 NNS O
element NN O
also RB O
conferred VBD O
estrogen NN O
and CC O
thyroid NN O
hormone NN O
responsiveness NN O
, , O
it PRP O
can MD O
be VB O
considered VBN O
a DT O
composite JJ O
hormone NN O
response NN O
element NN O
. . O

-DOCSTART- X X O

Together RB O
with IN O
a DT O
considerably RB O
shortened VBN O
and CC O
interrupted VBN O
aromatic JJ O
aa JJ O
stretch NN O
in IN O
this DT O
region NN O
, , O
these DT O
differences NNS O
are VBP O
discussed VBN O
in IN O
terms NNS O
of IN O
the DT O
peculiar JJ O
affinity NN O
of IN O
cyanobacterial JJ B-NP
cytochrome NN I-NP
oxidases NNS I-NP
for IN O
acidic JJ O
c-type JJ B-NP
cytochromes NNS I-NP
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
the DT O
presumptive JJ O
phosphorylated JJ O
tyrosine NN O
and CC O
threonine CD O
residues NNS O
of IN O
Mpk1p NNP B-NP
individually RB O
to TO O
phenylalanine VB O
and CC O
alanine VB O
, , O
respectively RB O
, , O
severely RB O
impaired VBN O
Mpk1p IN B-NP
function NN O
. . O

-DOCSTART- X X O

16 CD O
, , O
99-104 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
focus VBP O
on IN O
the DT O
genetics NNS O
of IN O
the DT O
region NN O
of IN O
the DT O
17 CD B-NP
hep NN I-NP
syn NN I-NP
gB NNP I-NP
gene NN I-NP
that WDT O
conferred VBD O
both DT O
the DT O
syncytial JJ O
and CC O
pathogenic JJ O
phenotypes NNS O
to TO O
17 CD B-NP
syn+ NN I-NP
. . O

-DOCSTART- X X O

Drugs NNS O
suppressed VBD O
> VBN O
or CC O
= SYM O
75 CD O
% NN O
of IN O
the DT O
total JJ O
premature JJ O
ventricular NN O
contractions NNS O
in IN O
all DT O
patients NNS O
who WP O
had VBD O
both DT O
use-dependent JJ O
QRS NNP O
prolongation NN O
and CC O
reverse VB O
use-dependent JJ O
QT NNP O
prolongation NN O
, , O
in IN O
79 CD O
% NN O
of IN O
patients NNS O
with IN O
use-dependent JJ O
QRS NNP O
prolongation NN O
alone RB O
, , O
in IN O
70 CD O
% NN O
with IN O
reverse NN O
use-dependent NN O
QT NNP O
prolongation NN O
alone RB O
, , O
and CC O
in IN O
11 CD O
% NN O
with IN O
neither DT O
use-dependent JJ O
QRS NNP O
prolongation NN O
nor CC O
reverse VB O
use-dependent NN O
QT NNP O
prolongation NN O
. . O

-DOCSTART- X X O

Genetic JJ O
interactions NNS O
between IN O
BCK2 NNP B-NP
and CC O
other JJ O
pathway NN O
components NNS O
suggested VBD O
that IN O
BCK2 JJ B-NP
functions NNS O
on IN O
a DT O
common JJ O
pathway NN O
branch NN O
with IN O
PPZ1 NNP B-NP
and CC O
PPZ2 NNP B-NP
. . O

-DOCSTART- X X O

These DT O
experiments NNS O
confirm VBP O
that IN O
the DT O
6-S JJ O
liganded JJ O
form NN O
of IN O
the DT O
receptor NN O
identified VBN O
in IN O
nuclear JJ O
extracts NNS O
of IN O
cells NNS O
treated VBN O
with IN O
2,3,7,8-tetrachlorodibenzo-p-dioxin JJ O
(TCDD NNP O
) -RRB- O
contains VBZ O
the DT O
Ah UH B-NP
receptor NN I-NP
protein NN I-NP
and CC O
ARNT NN B-NP
but CC O
not RB O
the DT O
90-kDa JJ B-NP
heat NN I-NP
shock NN I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Regulated JJ O
activity NN O
of IN O
the DT O
distal JJ O
promoter-like JJ O
element NN O
of IN O
the DT O
human JJ B-NP
corticotropin-releasing NN I-NP
hormone NN I-NP
gene NN I-NP
and CC O
secondary JJ O
structural JJ O
features NNS O
of IN O
its PRP$ O
corresponding JJ O
transcripts NNS O
. . O

-DOCSTART- X X O

We PRP O
linked VBD O
hypersensitivity NN O
site NN O
2 CD O
( -LRB- O
HS2 NN O
) -RRB- O
from IN O
the DT O
locus NN O
control NN O
region NN O
(LCR NN O
) -RRB- O
to TO O
a DT O
A DT B-NP
gamma-globin NN I-NP
gene NN O
( -LRB- O
A DT B-NP
gamma* NN I-NP
) -RRB- O
mutationally RB O
marked VBD O
to TO O
allow VB O
its PRP$ O
transcript NN O
to TO O
be VB O
distinguished VBN O
from IN O
endogenous JJ O
gamma-globin NN B-NP
mRNA NN O
. . O

-DOCSTART- X X O

Skin NNP O
and CC O
bowel NN O
TPO2 NN O
varied VBN O
with IN O
DO2 NNP O
and CC O
each DT O
other JJ O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Transgenic NNP O
mice NNS O
harboring VBG O
the DT O
rat NN O
TnI-CAT JJ B-NP
fusion NN O
gene NN O
expressed VBD O
the DT O
reporter NN O
specifically RB O
in IN O
the DT O
skeletal JJ O
muscle NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Fifty-one CD O
healthy JJ O
eyes NNS O
, , O
169 CD O
ocular JJ O
hypertensive JJ O
eyes NNS O
with IN O
normal JJ O
visual JJ O
fields NNS O
, , O
and CC O
132 CD O
glaucomatous JJ O
eyes NNS O
with IN O
early JJ O
visual JJ O
field NN O
defects NNS O
were VBD O
evaluated VBN O
with IN O
qualitative JJ O
and CC O
quantitative JJ O
measures NNS O
of IN O
structural JJ O
damage NN O
to TO O
the DT O
optic JJ O
nerve NN O
and CC O
nerve NN O
fiber NN O
layer NN O
. . O

-DOCSTART- X X O

To TO O
identify VB O
factors NNS O
that WDT O
may MD O
modify VB O
the DT O
heterosexual JJ O
transmission NN O
of IN O
human JJ O
T NNP O
cell NN O
leukemia/lymphoma NN O
virus NN O
type NN O
I PRP O
( -LRB- O
HTLV-I) NNP O
, , O
534 CD O
married VBN O
couples NNS O
enrolled VBD O
in IN O
the DT O
Miyazaki NNP O
Cohort NNP O
Study NNP O
between IN O
November NNP O
1984 CD O
and CC O
April NNP O
1989 CD O
were VBD O
studied VBN O
: : O
95 CD O
husband NN O
HTLV-I-seropositive JJ O
( -LRB- O
H+ RB O
)/wife NN O
seropositive JJ O
( -LRB- O
W+ NN O
) -RRB- O
, , O
33 CD O
H+/W-, NNP O
64 CD O
H-/W+ NNP O
, , O
and CC O
342 CD O
H-/W-. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
gene NN O
predicts VBZ O
a DT O
polypeptide NN O
of IN O
215 CD O
amino IN O
acids NNS O
( -LRB- O
25.2 CD O
kDa NN O
) -RRB- O
with IN O
two CD O
putative JJ O
membrane-spanning NN O
domains NNS O
. . O

-DOCSTART- X X O

An DT O
extensive JJ O
inverted JJ O
repeat NN O
is VBZ O
present JJ O
3' IN O
of IN O
rpeA NN B-NP
; : O
inverted VBN O
repeats NNS O
are VBP O
found VBN O
downstream NN O
of IN O
all DT O
PE NN B-NP
operons NNS I-NP
sequenced VBD O
to TO O
date NN O
, , O
although IN O
the DT O
sequence NN O
is VBZ O
not RB O
conserved VBN O
. . O

-DOCSTART- X X O

Localization NN O
of IN O
the DT O
intronless JJ O
gene NN O
coding NN O
for IN O
calmodulin-like JJ B-NP
protein NN I-NP
CLP NN B-NP
to TO O
human JJ O
chromosome NN O
10p13-ter JJ O
. . O

-DOCSTART- X X O

In IN O
wandering VBG O
stage NN O
larvae NNS O
, , O
the DT O
OBP NNP B-NP
transcript NN I-NP
appeared VBD O
to TO O
be VB O
at IN O
least JJS O
250-fold JJ O
less RBR O
abundant JJ O
than IN O
ribosomal JJ O
RNA NNP O
. . O

-DOCSTART- X X O

However RB O
, , O
L-plastin NNP B-NP
has VBZ O
been VBN O
found VBN O
in IN O
many JJ O
types NNS O
of IN O
malignant JJ O
human JJ O
cells NNS O
of IN O
non-hemopoietic JJ O
origin NN O
suggesting VBG O
that IN O
its PRP$ O
expression NN O
is VBZ O
induced VBN O
accompanying VBG O
tumorigenesis NN O
in IN O
solid JJ O
tissues NNS O
. . O

-DOCSTART- X X O

The DT O
DNase NN B-NP
I PRP I-NP
footprint VBP O
extended VBN O
5' CD O
in IN O
the DT O
silencer NN O
region NN O
to TO O
include VB O
an DT O
inverted JJ O
repeat NN O
of IN O
a DT O
six-nucleotide JJ O
motif NN O
(epsilon NN O
-267 . O
to TO O
-278 JJ O
bp NN O
) -RRB- O
which WDT O
shares NNS O
5 CD O
of IN O
6 CD O
bases NNS O
with IN O
the DT O
GATA-1 JJ B-NP
consensus NN I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

This DT O
report NN O
describes VBZ O
the DT O
identification NN O
of IN O
a DT O
gene NN O
of IN O
related JJ O
function NN O
, , O
SMD1 NNP B-NP
, , O
located VBN O
immediately RB O
3' CD O
to TO O
PRP38. . B-NP

-DOCSTART- X X O

This DT O
short JJ O
communication NN O
compares VBZ O
a DT O
novel NN O
fluorimetric JJ O
microplate NN O
enzyme NN O
immunoassay NN O
( -LRB- O
FEIA NNP O
) -RRB- O
with IN O
a DT O
commercial JJ O
time-resolved JJ O
fluoroimmunoassay NN O
for IN O
the DT O
determination NN O
of IN O
thyrotropin NN B-NP
in IN O
dried JJ O
blood NN O
spots NNS O
. . O

-DOCSTART- X X O

Constructs NNS O
containing VBG O
the DT O
full-length JJ B-NP
PfCPK NNP I-NP
cDNA NN I-NP
have VBP O
been VBN O
expressed VBN O
in IN O
Escherichia NNP O
coli NNS O
at IN O
a DT O
high JJ O
level NN O
to TO O
generate VB O
a DT O
60-kDa JJ O
recombinant JJ O
protein NN O
. . O

-DOCSTART- X X O

Endosonography NNP O
accurately RB O
assessed VBD O
tumor NN O
extension NN O
in IN O
two CD O
T2 JJ O
tumors NNS O
, , O
14 CD O
T3 CD O
tumors NNS O
, , O
and CC O
seven CD O
T4 NNS O
tumors NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
cell NN O
cycle NN O
regulation NN O
in IN O
the DT O
budding VBG O
yeast NN O
Saccharomyces NNS O
cerevisiae NNS O
has VBZ O
shown VBN O
that IN O
a DT O
central JJ O
regulatory JJ O
protein NN O
kinase NN O
, , O
Cdc28 '' B-NP
, , O
undergoes VBZ O
changes NNS O
in IN O
activity NN O
through IN O
the DT O
cell NN O
cycle NN O
by IN O
associating VBG O
with IN O
distinct JJ O
groups NNS O
of IN O
cyclins NNS B-NP
that WDT O
accumulate VBP O
at IN O
different JJ O
times NNS O
. . O

-DOCSTART- X X O

Ig-alpha NNP B-NP
and CC O
Ig-beta NNP B-NP
contain VBP O
extended VBN O
cytoplasmic JJ O
structure NN O
(61 CD O
and CC O
48 CD O
amino IN O
acids NNS O
, , O
respectively RB O
) -RRB- O
and CC O
associate JJ O
with IN O
cytoplasmic JJ O
effectors NNS O
indicating VBG O
that IN O
they PRP O
are VBP O
directly RB O
involved VBN O
in IN O
signal NN O
transduction NN O
. . O

-DOCSTART- X X O

Internal NNP O
amino IN O
acid NN O
sequence NN O
has VBZ O
now RB O
been VBN O
obtained VBN O
from IN O
this DT O
protein NN O
which WDT O
shares VBZ O
50-100 CD O
% NN O
sequence NN O
identity NN O
with IN O
sequences NNS O
encoded VBN O
by IN O
mammalian JJ B-NP
G NNP I-NP
alpha NN I-NP
11 CD I-NP
and CC O
G NNP B-NP
alpha NN I-NP
q NN I-NP
cDNAs NNS I-NP
. . O

-DOCSTART- X X O

Nitric JJ O
oxide NN O
inhalation NN O
selectively RB O
reduces VBZ O
pulmonary JJ O
hypertension NN O
in IN O
porcine NN O
endotoxin NN O
shock NN O
and CC O
improves VBZ O
arterial JJ O
oxygenation NN O
and CC O
pH VB O
with IN O
a DT O
marked JJ O
attenuation NN O
of IN O
sympathetic JJ O
activation NN O
. . O

-DOCSTART- X X O

The DT O
fission NN B-NP
yeast NN I-NP
dsk1+ JJ I-NP
gene NN I-NP
, , O
a DT O
multicopy JJ O
suppressor NN O
for IN O
cold-sensitive JJ O
dis1 NN B-NP
mutants NNS I-NP
, , O
encodes VBZ O
a DT O
novel NN O
61-kd JJ O
protein NN O
kinase NN O
. . O

-DOCSTART- X X O

The DT O
strategies NNS O
by IN O
which WDT O
hepatitis NN O
B NNP O
and CC O
hepatitis NN O
D NNP O
can MD O
be VB O
diminished VBN O
and CC O
eventually RB O
eliminated VBN O
are VBP O
: : O
immunization NN O
, , O
measures NNS O
to TO O
prevent VB O
exposure NN O
to TO O
infective JJ O
blood NN O
or CC O
blood NN O
derivatives NNS O
and CC O
education NN O
( -LRB- O
in IN O
particular JJ O
awareness NN O
that IN O
hepatitis NN O
B NNP O
is VBZ O
a DT O
sexually RB O
transmitted JJ O
disease NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
gene NN O
encoding VBG O
the DT O
receptor NN O
for IN O
macrophage NN B-NP
colony-stimulating JJ I-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
CSF-1 NN B-NP
) -RRB- O
, , O
the DT O
c-fms NNS B-NP
protooncogene NN I-NP
, , O
is VBZ O
selectively RB O
expressed VBN O
in IN O
immature JJ O
and CC O
mature JJ O
mononuclear NN O
phagocytes NNS O
and CC O
trophoblasts NNS O
. . O

-DOCSTART- X X O

This DT O
sequence NN O
similarity NN O
raises VBZ O
the DT O
possibility NN O
that IN O
GCN1 DT B-NP
interacts NNS O
with IN O
ribosomes NNS O
or CC O
tRNA DT O
molecules NNS O
and CC O
functions NNS O
in IN O
conjunction NN O
with IN O
GCN2 NNP B-NP
in IN O
monitoring VBG O
uncharged JJ O
tRNA NN O
levels NNS O
during IN O
the DT O
process NN O
of IN O
translation NN O
elongation NN O
. . O

-DOCSTART- X X O

However RB O
, , O
study NN O
of IN O
the DT O
productive JJ O
gamma NN O
gene NN O
showed VBD O
that IN O
the DT O
skipped VBN O
variable JJ O
exon NN O
was VBD O
bounded VBN O
by IN O
normal JJ O
splicing NN O
signals NNS O
and CC O
that IN O
the DT O
adjacent JJ O
intron NN O
organization NN O
was VBD O
not RB O
altered VBN O
. . O

-DOCSTART- X X O

Patient NNP O
characteristics NNS O
associated VBN O
with IN O
deep JJ O
wounds NNS O
as RB O
well RB O
as IN O
patient NN O
and CC O
wound NN O
characteristics NNS O
predictive VBP O
of IN O
the DT O
extent NN O
of IN O
healing NN O
and CC O
time NN O
required VBN O
for IN O
healing NN O
were VBD O
identified VBN O
. . O

-DOCSTART- X X O

The DT O
remaining VBG O
RAD+ NNP B-NP
cells NNS O
progressed VBD O
to TO O
form VB O
microcolonies NNS O
( -LRB- O
< JJ O
30 CD O
cells NNS O
) -RRB- O
containing VBG O
aberrantly RB O
shaped JJ O
inviable JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
gp39 CD I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

There EX O
is VBZ O
no DT O
TATA NNP O
box NN O
around IN O
the DT O
transcriptional JJ O
start NN O
points NNS O
(tsp) RB O
, , O
as IN O
determined VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
the DT O
efficacies NNS O
of IN O
adjuvant JJ O
carboplatin NN O
and CC O
of IN O
abdominal JJ O
radiotherapy NN O
seem VBP O
to TO O
be VB O
identical JJ O
. . O

-DOCSTART- X X O

Thus RB O
, , O
SPECT NNP O
was VBD O
not RB O
as RB O
sensitive JJ O
as IN O
PET NN O
in IN O
this DT O
activation NN O
task NN O
. . O

-DOCSTART- X X O

Transcriptional NNP O
activation NN O
of IN O
the DT O
chicken NN B-NP
lysozyme NN I-NP
gene NN I-NP
by IN O
NF-kappa NNP B-NP
Bp65 NNP I-NP
( -LRB- O
RelA NNP B-NP
) -RRB- O
and CC O
c-Rel JJ B-NP
, , O
but CC O
not RB O
by IN O
NF-kappa NNP B-NP
Bp50 NNP I-NP
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
a DT O
possible JJ O
role NN O
in IN O
transcription NN O
, , O
Paf1p NNP B-NP
is VBZ O
localized VBN O
to TO O
the DT O
nucleus NN O
. . O

-DOCSTART- X X O

Hb NN B-NP
levels NNS O
remained VBD O
adequate JJ O
( -LRB- O
Hb NN B-NP
= SYM O
10.68 CD O
+/ CD O
- : O
0.77 CD O
g/dl NN O
) -RRB- O
after IN O
14.6 CD O
+/ CD O
- : O
7.64 CD O
months NNS O
. . O

-DOCSTART- X X O

SBF NN B-NP
binds NNS O
to TO O
the DT O
promoter NN O
prior RB O
to TO O
the DT O
activation NN O
of IN O
transcription NN O
in IN O
late JJ O
G1 NNP O
, , O
suggesting VBG O
that IN O
Cln/Cdc28 DT B-NP
kinase NN O
regulates VBZ O
the DT O
ability NN O
of IN O
previously RB O
bound VBN O
SBF NN B-NP
to TO O
activate VB O
transcription NN O
. . O

-DOCSTART- X X O

This DT O
analysis NN O
revealed VBD O
that IN O
SAP NNP B-NP
145 CD I-NP
, , O
together RB O
with IN O
four CD O
other JJ O
SF3a/SF3b NNP B-NP
subunits NNS O
, , O
UV NN O
cross-links NNS O
to TO O
pre-mRNA VB O
in IN O
a DT O
20-nucleotide JJ O
region NN O
upstream RB O
of IN O
the DT O
BPS. NNP O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
, , O
expression NN O
pattern NN O
, , O
and CC O
chromosomal NN O
localization NN O
of IN O
human JJ O
CDKN2D/INK4d NNP B-NP
, , O
an DT O
inhibitor NN O
of IN O
cyclin NN B-NP
D-dependent JJ I-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

The DT O
IL-8 NN B-NP
receptor NN I-NP
is VBZ O
a DT O
seven-transmembrane JJ O
spanning NN O
receptor NN O
coupled VBN O
to TO O
specific JJ O
heterotrimeric JJ B-NP
G NNP I-NP
proteins VBZ I-NP
including VBG O
Gi NNP B-NP
and CC O
G16 NNP B-NP
. . O

-DOCSTART- X X O

During IN O
the DT O
following JJ O
pregnancy NN O
ultrasonographic JJ O
studies NNS O
of IN O
the DT O
male JJ O
fetus NN O
in IN O
the DT O
16th JJ O
week NN O
of IN O
gestation NN O
revealed VBD O
severe JJ O
micrognathia NN O
, , O
short JJ O
and CC O
wide JJ O
thumbs NNS O
, , O
and CC O
big JJ O
toes NNS O
, , O
and CC O
bowed VBD O
tibiae NNS O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
body NN O
mass NN O
index NN O
( -LRB- O
BMI NNP O
) -RRB- O
was VBD O
31.8 CD O
+/ JJ O
- : O
6.3 CD O
kg/m2 NN O
and CC O
28.5 CD O
+/ JJ O
- : O
6.3 CD O
kg/m2 CD O
in IN O
women NNS O
and CC O
men NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
RPF-1 NN B-NP
is VBZ O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
early JJ O
steps NNS O
in IN O
the DT O
differentiation NN O
of IN O
amacrine NN O
and CC O
ganglion NN O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
point NN O
mutant NN O
we PRP O
observed VBD O
normal JJ O
repair NN O
of IN O
endonuclease NN B-NP
III NNP I-NP
site NN I-NP
( -LRB- O
i FW O
.e FW O
. . O
as IN O
wild JJ O
type NN O
) -RRB- O
, , O
but CC O
no DT O
removal NN O
of IN O
CPDs NNS O
at IN O
the DT O
MAT NN B-NP
alpha NN I-NP
and CC O
HML NNP B-NP
alpha NN I-NP
loci NNS I-NP
. . O

-DOCSTART- X X O

Carboxy-terminal NNP O
Spc110p NNP B-NP
truncations NNS O
lacking VBG O
the DT O
calmodulin NN B-NP
binding NN O
site NN O
can MD O
support VB O
growth NN O
and CC O
are VBP O
also RB O
phosphorylated VBN O
in IN O
a DT O
cell NN O
cycle-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

Ongoing NNP O
and CC O
future JJ O
investigations NNS O
may MD O
better RB O
define VB O
the DT O
optimal JJ O
approach NN O
for IN O
local JJ O
control NN O
, , O
the DT O
optimal JJ O
duration NN O
of IN O
maintenance NN O
chemotherapy NN O
, , O
and CC O
the DT O
possible JJ O
role NN O
of IN O
biologic JJ O
response NN O
modifiers NNS O
and CC O
growth NN O
factors NNS O
in IN O
further JJ O
improving VBG O
the DT O
outcome NN O
for IN O
patients NNS O
with IN O
this DT O
disease NN O
. . O

-DOCSTART- X X O

SUMMARY NN O
OF IN O
REVIEW NNP O
: : O
We PRP O
discuss VBP O
the DT O
criteria NNS O
that WDT O
make VBP O
such JJ O
studies NNS O
comparable JJ O
, , O
drawing VBG O
on IN O
the DT O
experiences NNS O
of IN O
recent JJ O
studies NNS O
performed VBN O
around IN O
the DT O
world NN O
. . O

-DOCSTART- X X O

Left VBN O
atrial JJ O
volumes NNS O
were VBD O
greater JJR O
in IN O
old JJ O
compared VBN O
with IN O
young JJ O
subjects NNS O
( -LRB- O
maximal NN O
: : O
31 CD O
+/ CD O
- : O
10 CD O
cm3/m2 NN O
vs IN O
24 CD O
+/ NNS O
- : O
8 CD O
cm3/m2 NN O
, , O
p NN O
= SYM O
0.02 CD O
; : O
at IN O
onset NN O
of IN O
atrial JJ O
systole NN O
: : O
23 CD O
+/ CD O
- : O
8 CD O
cm3/m2 CD O
vs IN O
15 CD O
+/ NNS O
- : O
5 CD O
cm3/m2 NN O
, , O
p NN O
= SYM O
0.0002 CD O
; : O
minimal JJ O
: : O
13 CD O
+/ NN O
- : O
5 CD O
cm3/m2 CD O
vs IN O
9 CD O
+/ CD O
- : O
4 CD O
cm3/m2 CD O
, , O
p NN O
= SYM O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
observed VBD O
abundant JJ O
levels NNS O
of IN O
Rev-erbA NNP B-NP
alpha NN B-NP
mRNA NN O
in IN O
dividing NN O
C2C12 IN O
myoblasts NNS O
, , O
which WDT O
were VBD O
suppressed VBN O
when WRB O
the DT O
cells NNS O
differentiated JJ O
into IN O
postmitotic JJ O
multinucleated JJ O
myotubes NNS O
. . O

-DOCSTART- X X O

As IN O
expected VBN O
, , O
glycosylation NN O
of IN O
Env NNP B-NP
produced VBD O
from IN O
mutants NNS O
was VBD O
affected VBN O
but CC O
, , O
irrespective JJ O
of IN O
the DT O
glycosylation NN O
phenotype NN O
, , O
( -LRB- O
i NN O
) -RRB- O
similar JJ O
quantities NNS O
of IN O
Env NNP B-NP
were VBD O
synthesized VBN O
, , O
( -LRB- O
ii NNS O
) -RRB- O
the DT O
immunoreactivity NN O
of IN O
V3 NNP B-NP
was VBD O
similar JJ O
, , O
( -LRB- O
iii NNS O
) -RRB- O
gp160 CD B-NP
was VBD O
efficiently RB O
cleaved VBN O
into IN O
gp120 CD B-NP
and CC O
gp41 CD B-NP
, , O
(vi NNP O
) -RRB- O
Env NNP B-NP
was VBD O
exposed VBN O
at IN O
the DT O
cell NN O
membrane NN O
, , O
( -LRB- O
v NN O
) -RRB- O
secreted VBN O
gp120 CD B-NP
bound VBN O
CD4 NN B-NP
, , O
and CC O
(vi NNP O
) -RRB- O
membrane NN O
gp41 NN B-NP
was VBD O
able JJ O
to TO O
induce VB O
membrane NN O
fusion NN O
with IN O
CD4+ JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

On IN O
the DT O
trail NN O
of IN O
Dr. NNP O

-DOCSTART- X X O

Analysis NN O
of IN O
RAR NN B-NP
alpha NN I-NP
mutants NNS I-NP
in IN O
transfection NN O
studies NNS O
reveals VBZ O
that IN O
the DT O
DNA NNP O
binding NN O
domain NN O
is VBZ O
sufficient JJ O
for IN O
inhibition NN O
of IN O
BZLF1 NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

We PRP O
measured VBD O
serum NN B-NP
hepatocyte NN I-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
HGF NN B-NP
) -RRB- O
in IN O
patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
, , O
angina DT O
pectoris NN O
, , O
and CC O
other JJ O
heart NN O
diseases NNS O
. . O

-DOCSTART- X X O

No DT O
significant JJ O
differences NNS O
existed VBN O
between IN O
the DT O
two CD O
age NN O
groups NNS O
in IN O
baseline NN O
characteristics NNS O
, , O
including VBG O
treatment NN O
protocol NN O
, , O
performance NN O
status NN O
, , O
and CC O
serum NN B-NP
lactate NN I-NP
dehydrogenase NN I-NP
( -LRB- O
LDH) NNP B-NP
level NN O
. . O

-DOCSTART- X X O

In IN O
agreement NN O
with IN O
previous JJ O
in IN O
vitro NN O
data NNS O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
UmuD NNP B-NP
and CC O
UmuD' NNP B-NP
are VBP O
able JJ O
to TO O
form VB O
both DT O
homodimers NNS O
( -LRB- O
UmuD-UmuD NNP B-NP
and CC O
UmuD'-UmuD' NNP B-NP
) -RRB- O
and CC O
a DT O
heterodimer NN O
( -LRB- O
UmuD-UmuD' JJ B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays IN O
using VBG O
crude JJ O
extracts NNS O
from IN O
FREJ4 NNP O
cells NNS O
revealed VBD O
the DT O
binding NN O
of IN O
a DT O
member( NN O
s VBZ O
) -RRB- O
of IN O
the DT O
Ets NNP B-NP
family NN I-NP
of IN I-NP
transcription NN I-NP
factors NNS I-NP
to TO O
the DT O
P4 NNP B-NP
EBS NNP I-NP
, , O
as RB O
well RB O
as IN O
the DT O
interaction NN O
of IN O
two CD O
members NNS O
of IN O
the DT O
Sp1 NNP B-NP
family NN I-NP
, , O
Sp1 NNP B-NP
and CC O
Sp3 NNP B-NP
, , O
with IN O
the DT O
adjacent JJ O
GC NNP O
box NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
thrombin-stimulated DT B-NP
vascular JJ O
smooth JJ O
muscle NN O
proliferation NN O
is VBZ O
delayed VBN O
and CC O
requires VBZ O
the DT O
de FW O
novo FW O
expression NN O
of IN O
one CD O
or CC O
more JJR O
autocrine NN O
mitogens NNS O
. . O

-DOCSTART- X X O

Adduction NN O
of IN O
the DT O
human JJ B-NP
N-ras NNP I-NP
codon NN I-NP
61 CD I-NP
sequence NN I-NP
with IN O
(-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a DT O
] JJ O
pyrene NN O
: : O
structural JJ O
refinement NN O
of IN O
the DT O
intercalated JJ O
SRS NNP O
R(61,2 NNP O
) -RRB- O
(-)-(7S,8R,9S,10R)-N6-[10-(7,8,9,10- : O
tetrahydrobenzo[a]pyrenyl JJ O
)]-2'-deoxyadenosyl JJ O
adduct NN O
from IN O
1H CD O
NMR. . O

-DOCSTART- X X O

Menstrual-cycle NNP O
phase NN O
did VBD O
not RB O
significantly RB O
affect VB O
personality NN O
variables NNS O
in IN O
either DT O
group NN O
. . O

-DOCSTART- X X O

Ca2+ NNP O
decreased VBD O
Zn2+ JJ O
binding NN O
in IN O
S100 DT B-NP
beta NN I-NP
but CC O
it PRP O
did VBD O
not RB O
influence NN O
binding NN O
to TO O
MRP14 NNP B-NP
, , O
suggesting VBG O
that IN O
the DT O
Zn2+ NNP O
binding NN O
site NN O
was VBD O
distinct JJ O
from IN O
and CC O
independent JJ O
of IN O
the DT O
two CD O
Ca2+ JJ O
binding JJ O
domains NNS O
. . O

-DOCSTART- X X O

A DT O
direct JJ O
role NN O
for IN O
sterol JJ B-NP
regulatory JJ I-NP
element NN I-NP
binding JJ I-NP
protein NN I-NP
in IN O
activation NN O
of IN O
3-hydroxy-3-methylglutaryl JJ B-NP
coenzyme NN I-NP
A DT I-NP
reductase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

An DT O
inactive JJ O
analog NN O
of IN O
wortmannin NN O
, , O
WM12 NNP O
, , O
did VBD O
not RB O
affect VB O
TCR/CD3-induced JJ B-NP
Erk2 DT B-NP
activation NN O
, , O
and CC O
wortmannin NN O
had VBD O
no DT O
effect NN O
on IN O
the DT O
activity NN O
of IN O
Erk2 NNP B-NP
when WRB O
added VBN O
directly RB O
to TO O
the DT O
in IN O
vitro NN O
assays VBZ O
. . O

-DOCSTART- X X O

The DT O
transcription NN O
start NN O
point NN O
of IN O
the DT O
proximal JJ O
promoter NN O
aligns NNS O
to TO O
that DT O
of IN O
mouse NN O
promoter NN O
P3 NN O
and CC O
lies VBZ O
within IN O
a DT O
conserved JJ O
region NN O
of IN O
sequence NN O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
signal NN B-NP
recognition NN I-NP
particle NN I-NP
( -LRB- O
SRP)-SRP NN B-NP
receptor NN B-NP
( -LRB- O
Srb NNP B-NP
) -RRB- O
system NN O
in IN O
Bacillus NN O
subtilis NNS O
( -LRB- O
Bs NNS O
) -RRB- O
, , O
we PRP O
cloned VBD O
the DT O
Bs NNP B-NP
srb NN I-NP
gene NN I-NP
, , O
which WDT O
encodes VBZ O
a DT O
homologue NN O
of IN O
the DT O
mammalian JJ B-NP
SRP NNP I-NP
receptor NN I-NP
alpha-subunit NN I-NP
[Oguro NNP O
et NNP O
al NN O
. . O
, , O
DNA NNP O
Res NNP O
. . O

-DOCSTART- X X O

An DT O
apparent JJ O
ufo NN B-NP
mRNA NN I-NP
overexpression NN O
was VBD O
not RB O
found VBN O
in IN O
any DT O
of IN O
the DT O
positive JJ O
leukemia NN O
cell NN O
lines NNS O
, , O
but CC O
was VBD O
identified VBN O
in IN O
the DT O
drug-resistant JJ O
subclones NNS O
of IN O
the DT O
cervix NN O
carcinoma NN O
cell NN O
line NN O
HeLa NNP O
. . O

-DOCSTART- X X O

Reproducing NN O
populations NNS O
of IN O
this DT O
aphid NN O
were VBD O
first RB O
detected VBN O
in IN O
Puerto NNP O
Rico NNP O
in IN O
April NNP O
1992 CD O
. . O

-DOCSTART- X X O

At IN O
cuticular JJ O
positions NNS O
exhibiting VBG O
the DT O
Brd JJ B-NP
bristle JJ I-NP
loss NN I-NP
phenotype NN I-NP
, , O
we PRP O
have VBP O
found VBN O
that IN O
the DT O
progeny NN O
of IN O
the DT O
multiplied JJ O
SOPs NNS O
develop VBP O
aberrantly RB O
, , O
in IN O
that DT O
neurons NNS O
and CC O
thecogen NN O
( -LRB- O
sheath NN O
) -RRB- O
cells NNS O
appear VBP O
but CC O
not RB O
trichogen NN O
( -LRB- O
shaft NN O
) -RRB- O
and CC O
tormogen NN O
( -LRB- O
socket NN O
) -RRB- O
cells NNS O
. . O

-DOCSTART- X X O

Transcriptional NNP O
blockade NN O
was VBD O
reversed VBN O
by IN O
co-transfections NNS O
of IN O
a DT O
wild-type JJ B-NP
SRF NN I-NP
expression NN O
vector NN O
, , O
but CC O
was VBD O
not RB O
rescued VBN O
by IN O
the DT O
expression NN O
of IN O
other JJ O
myogenic JJ O
factors NNS O
, , O
such JJ O
as IN O
MyoD NNP B-NP
and CC O
Mef-2C. NNP B-NP

-DOCSTART- X X O

The DT O
mMIWC1 JJ B-NP
promoter NN I-NP
was VBD O
identified VBN O
and CC O
contained VBN O
TATA NNP O
, , O
CAAT NNP O
, , O
GATA NNP O
, , O
and CC O
AP-2 JJ B-NP
elements NNS I-NP
; : O
primer NN O
extension NN O
revealed VBD O
mMIWC JJ B-NP
transcription NN O
initiation NN O
at IN O
621 CD O
bp NN O
upstream RB O
from IN O
the DT O
mMIWC1 JJ B-NP
translational JJ O
initiation NN O
site NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
obtained VBN O
the DT O
human JJ B-NP
EP4 NN I-NP
receptor NN I-NP
gene NN I-NP
sequence NN I-NP
and CC O
determined VBD O
its PRP$ O
structure NN O
relative JJ O
to TO O
EP4R NNP B-NP
cDNA NN I-NP
synthesized VBN O
from IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

-DOCSTART- X X O

Specifically RB O
, , O
the DT O
deduced JJ O
FR-19 JJ B-NP
amino JJ I-NP
acid NN I-NP
sequence NN I-NP
has VBZ O
approximately89 RB O
, , O
77 CD O
, , O
and CC O
68 CD O
% NN O
overall JJ O
identity NN O
to TO O
chicken NN B-NP
TEF-1A NNS I-NP
, , O
mouse NN B-NP
TEF-1 NN I-NP
, , O
and CC O
mouse NN B-NP
embryonic JJ I-NP
TEA NNP I-NP
domain-containing NN I-NP
factor NN I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
cloned VBN O
the DT O
human JJ B-NP
DSG3 NNP I-NP
gene NN I-NP
and CC O
examined VBD O
the DT O
transcriptional JJ O
regulation NN O
of IN O
its PRP$ O
expression NN O
. . O

-DOCSTART- X X O

ZIOS NNP O
was VBD O
significantly RB O
more RBR O
sensitive JJ O
than IN O
all DT O
subsequent JJ O
methods NNS O
, , O
and CC O
Ptc,O2 NNP O
was VBD O
significantly RB O
more RBR O
sensitive JJ O
than IN O
FEV1 NNP O
. . O

-DOCSTART- X X O

Vacuolar NNP O
membrane NN O
vesicles NNS O
from IN O
hum1 JJ B-NP
mutants NNS I-NP
lack VBP O
all DT O
Ca2+/H+ JJ O
antiport NN O
activity NN O
, , O
demonstrating NN O
that IN O
Hum1p NNP B-NP
catalyzes VBZ O
the DT O
exchange NN O
of IN O
Ca2+ NNP O
for IN O
H+ NNP O
across IN O
the DT O
yeast NN O
vacuolar JJ O
membrane NN O
. . O

-DOCSTART- X X O

However RB O
, , O
one CD O
3' IN O
splice NN O
site NN O
, , O
located VBN O
at IN O
nucleotide JJ O
( -LRB- O
nt NN O
) -RRB- O
3225 CD O
, , O
is VBZ O
used VBN O
for IN O
the DT O
processing NN O
of IN O
most JJS O
BPV-1 JJ O
pre-mRNAs JJ O
in IN O
BPV-1-transformed JJ O
C127 NN O
cells NNS O
and CC O
at IN O
early JJ O
to TO O
intermediate JJ O
times NNS O
in IN O
productively NN O
infected VBD O
warts NNS O
. . O

-DOCSTART- X X O

HS NNP O
inducibility NN O
required VBD O
the DT O
HSE NNP O
which WDT O
was VBD O
bound VBN O
by IN O
HS NNP B-NP
transcription NN I-NP
factor-1( JJ I-NP
HSF-1 NN B-NP
) -RRB- O
present NN O
in IN O
extracts NNS O
prepared VBN O
from IN O
cells NNS O
exposed VBN O
to TO O
HS. NNP O

-DOCSTART- X X O

The DT O
logistic JJ O
regression NN O
analysis NN O
of IN O
the DT O
manual NN O
method NN O
( -LRB- O
percentage NN O
normal JJ O
morphology NN O
) -RRB- O
and CC O
IVOS NNP O
indicated VBD O
that IN O
both DT O
were VBD O
predictors NNS O
of IN O
fertilization NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
general JJ O
broadening NN O
of IN O
proton NN O
resonances NNS O
for IN O
a DT O
three-nucleotide JJ O
segment NN O
centered VBD O
about IN O
the DT O
lesion NN O
site NN O
which WDT O
resulted VBD O
in IN O
a DT O
tentative JJ O
assignment NN O
for IN O
the DT O
sugar NN O
protons NNS O
of IN O
the DT O
C7 NNP O
residue NN O
in IN O
the DT O
spectrum NN O
of IN O
the DT O
adduct NN O
duplex NN O
. . O

-DOCSTART- X X O

Cbl NNP B-NP
constitutively RB O
interacts VBZ O
with IN O
the DT O
SH3 JJ B-NP
domains NNS I-NP
of IN O
Grb2 NNP B-NP
, , O
with IN O
a DT O
preference NN O
for IN O
the DT O
amino-terminal JJ O
domain NN O
, , O
and CC O
is VBZ O
in IN O
this DT O
way NN O
recruited VBD O
to TO O
Shc NNP B-NP
upon IN O
BCR NNP B-NP
stimulation NN O
. . O

-DOCSTART- X X O

Activation NN O
mediated VBN O
by IN O
Cat8p NNP B-NP
was VBD O
no RB O
longer RB O
detectable VB O
in IN O
a DT O
cat1 NN B-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
DSF NNP O
was VBD O
instilled VBN O
in IN O
one CD O
eye NN O
chosen VBN O
at IN O
random JJ O
and CC O
CF NNP O
in IN O
the DT O
fellow JJ O
eye NN O
of IN O
13 CD O
normal JJ O
subjects NNS O
and CC O
in IN O
13 CD O
patients NNS O
with IN O
KCS. NNP O

-DOCSTART- X X O

In IN O
addition NN O
, , O
they PRP O
display VBP O
common JJ O
features NNS O
that WDT O
make VBP O
them PRP O
strikingly RB O
related VBD O
to TO O
snoRNA VB B-NP
U14 NNP I-NP
. . O

-DOCSTART- X X O

The DT O
relative JJ O
tumor NN O
FDG-uptake NN O
(Q-MRGlu NN O
) -RRB- O
( -LRB- O
tumor/contralateral JJ O
cortex NN O
) -RRB- O
of IN O
all DT O
meningiomas NNS O
was VBD O
calculated VBN O
with IN O
0.73 CD O
+/ NNS O
- : O
0.37 CD O
( -LRB- O
0.24-1.79 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
most RBS O
frequent JJ O
causes NNS O
of IN O
the DT O
meningitis NN O
was VBD O
the DT O
external JJ O
ventricular JJ O
drainage NN O
( -LRB- O
14.8 CD O
% NN O
) -RRB- O
, , O
post-neurosurgical JJ O
( -LRB- O
0.8 CD O
% NN O
) -RRB- O
and CC O
head NN O
injury NN O
( -LRB- O
0.0007 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Fifty-one CD O
patients NNS O
with IN O
primary JJ O
refractory JJ O
or CC O
relapsed VBN O
malignant JJ O
lymphoma NNS O
( -LRB- O
47 CD O
non-Hodgkin NN O
's POS O
lymphoma NN O
and CC O
four CD O
Hodgkin NNP O
's POS O
disease NN O
) -RRB- O
were VBD O
treated VBN O
with IN O
a DT O
new JJ O
chemotherapeutic NN O
regimen NNS O
( -LRB- O
cisplatinum NN O
, , O
methyl NN O
GAG NNP O
, , O
bleomocyin NN O
, , O
methyl NN O
prednisolon NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
3 CD O
treatments NNS O
the DT O
diet NN O
was VBD O
supplemented VBN O
with IN O
0, CD O
100 CD O
and CC O
150 CD O
mg NN O
probiotic/kg JJ O
food NN O
. . O

-DOCSTART- X X O

This DT O
caused VBD O
severe JJ O
cortical JJ O
damage NN O
and CC O
neuronal JJ O
loss NN O
in IN O
hippocampus NN O
subfields NNS O
CA1 NNP O
, , O
CA3 NNP O
, , O
and CC O
hilus NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
characterization NN O
of IN O
the DT O
promoter NN O
region NN O
should MD O
help VB O
to TO O
define VB O
regulatory JJ O
elements NNS O
that WDT O
control NN O
neuron-specific JJ O
and CC O
developmental JJ O
expression NN O
of IN O
the DT O
MAP1B NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Mutants NNS O
lacking VBG O
the DT O
3' JJ O
stem-loop NN O
exhibited VBD O
a DT O
75 CD O
% NN O
reduction NN O
in IN O
the DT O
level NN O
of IN O
psaB NN B-NP
mRNA NN O
. . O

-DOCSTART- X X O

The DT O
deduced VBD O
amino IN O
acid NN O
sequence NN O
was VBD O
highly RB O
conserved VBN O
across IN O
the DT O
wide JJ O
range NN O
of IN O
eukaryotes NNS O
(vertebrates NNS O
, , O
invertebrates NNS O
, , O
fungi NNS O
, , O
plants NNS O
and CC O
protozoa NNS O
) -RRB- O
in IN O
which WDT O
this DT O
gene NN O
has VBZ O
now RB O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

Semidominant NN O
mutations NNS O
in IN O
the DT O
yeast NN B-NP
Rad51 NNP I-NP
protein NN I-NP
and CC O
their PRP$ O
relationships NNS O
with IN O
the DT O
Srs2 NNP B-NP
helicase NN I-NP
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
clone NN O
was VBD O
used VBN O
as IN O
a DT O
homologous JJ O
probe NN O
to TO O
isolate VB O
a DT O
truncated JJ O
genomic JJ O
clone NN O
encoding VBG O
H2A1 NNP B-NP
. . O

-DOCSTART- X X O

Subsequent JJ O
to TO O
their PRP$ O
secretion NN O
, , O
the DT O
IGF-II NNP B-NP
in IN O
xz97 CD O
and CC O
G11 NNP O
cells NNS O
accumulated VBN O
in IN O
the DT O
conditioned JJ O
medium NN O
mostly RB O
as IN O
two CD O
partially RB O
processed VBN O
species NNS O
with IN O
appMr, NN O
of IN O
17K JJ O
and CC O
14K JJ O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Stably RB O
transfected VBN O
human JJ O
kidney NN O
293 CD O
cells NNS O
expressing VBG O
the DT O
wild JJ B-NP
type NN I-NP
rat NN I-NP
LH/CG NN I-NP
receptor NN I-NP
(rLHR NN O
) -RRB- O
or CC O
receptors NNS O
with IN O
C-terminal JJ O
tails NNS O
truncated VBD O
at IN O
residues NNS O
653 CD O
, , O
631 CD O
, , O
or CC O
628 CD O
( -LRB- O
designated VBN O
rLHR-t653 NN B-NP
, , O
rLHR-t631 JJ B-NP
, , O
and CC O
rLHR-t628 NNS B-NP
) -RRB- O
were VBD O
used VBN O
to TO O
probe VB O
the DT O
importance NN O
of IN O
this DT O
region NN O
on IN O
the DT O
regulation NN O
of IN O
hormonal JJ O
responsiveness NN O
. . O

-DOCSTART- X X O

Sleep NN O
was VBD O
determined VBN O
again RB O
for IN O
an DT O
additional JJ O
3 CD O
days NNS O
and CC O
6 CD O
hours NNS O
. . O

-DOCSTART- X X O

A DT O
neuropsychological JJ O
test NN O
battery NN O
was VBD O
used VBN O
that IN O
contained VBN O
the DT O
Wisconsin NNP O
card NN O
sorting VBG O
test NN O
, , O
Street NNP O
completion NN O
test NN O
, , O
Stroop NNP O
test NN O
, , O
a DT O
dichotic JJ O
memory NN O
listening VBG O
test NN O
, , O
and CC O
a DT O
facial JJ O
recognition NN O
test NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
CPET NNP O
is VBZ O
a DT O
useful JJ O
investigation NN O
in IN O
the DT O
management NN O
of IN O
patients NNS O
with IN O
cardiopulmonary JJ O
disease NN O
and CC O
complements VBZ O
the DT O
various JJ O
other JJ O
investigations NNS O
offered VBN O
by IN O
a DT O
pulmonary JJ O
function NN O
laboratory NN O
. . O

-DOCSTART- X X O

Update NN O
: : O
diphtheria NN O
epidemic NN O
in IN O
the DT O
newly RB O
independent JJ O
states NNS O
of IN O
the DT O
former JJ O
USSR NNP O
, , O
January NNP O
1995-March JJ O
1996 CD O
. . O

-DOCSTART- X X O

A DT O
novel NN O
phosphotyrosine-binding NN O
domain NN O
in IN O
the DT O
N-terminal JJ O
transforming JJ O
region NN O
of IN O
Cbl NNP B-NP
interacts NNS O
directly RB O
and CC O
selectively RB O
with IN O
ZAP-70 CD B-NP
in IN O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

Myelomatous JJ O
pleural JJ O
effusion NN O
as IN O
presentation NN O
form NN O
of IN O
multiple JJ O
myeloma NN O

-DOCSTART- X X O

METHODS NNS O
AND CC O
RESULTS NNS O
: : O
A DT O
64-year-old JJ O
woman NN O
with IN O
confirmed JJ O
AV NN O
nodal NN O
reentrant NN O
tachycardia NN O
underwent IN O
a DT O
successful JJ O
" `` O
slow JJ O
pathway NN O
" '' O
AV IN O
modification NN O
with IN O
a DT O
single JJ O
radiofrequency NN O
application NN O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
three CD O
loci NNS O
( -LRB- O
SIC1 NNP B-NP
, , O
SWI5 NNP B-NP
, , O
and CC O
RIC3 JJ B-NP
) -RRB- O
were VBD O
identified VBN O
. . O

-DOCSTART- X X O

Almost RB O
complete JJ O
sequence NN O
identity NN O
was VBD O
found VBN O
between IN O
the DT O
3' JJ O
end NN O
of IN O
the DT O
DXS6673E NNP B-NP
gene NN I-NP
and CC O
two CD O
expressed VBD O
sequence NN O
tags NNS O
( -LRB- O
ESTs NNP O
) -RRB- O
and CC O
between IN O
the DT O
5' JJ O
end NN O
of IN O
the DT O
DXS6673E NNP B-NP
gene NN I-NP
and CC O
a DT O
third JJ O
EST. NNP O

-DOCSTART- X X O

Sequencing NN O
of IN O
the DT O
16p JJ O
11.1/Xq28 CD O
duplication NN O
breakpoints NNS O
has VBZ O
revealed VBN O
the DT O
presence NN O
of IN O
repetitive JJ O
immunoglobulin-like JJ B-NP
CAGGG NNP I-NP
pentamer NN I-NP
sequences NNS I-NP
at IN O
or CC O
near IN O
the DT O
paralogy NN O
boundaries NNS O
. . O

-DOCSTART- X X O

Chernoff NNP O
, , O
submitted VBD O
for IN O
publication NN O
) -RRB- O
. . O

-DOCSTART- X X O

Neither DT O
CES1 NNP B-NP
nor CC O
CES4 NNP B-NP
is VBZ O
essential JJ O
for IN O
cell NN O
growth NN O
, , O
and CC O
a DT O
double JJ O
deletion NN O
mutant NN O
is VBZ O
viable JJ O
. . O

-DOCSTART- X X O

Constitutive JJ O
phosphorylation NN O
of IN O
the DT O
CD30v NNP B-NP
protein NN I-NP
was VBD O
demonstrated VBN O
by IN O
in IN O
vitro NN O
labeling NN O
with IN O
[32P] NNP O
. . O

-DOCSTART- X X O

A DT O
system NN O
is VBZ O
described VBN O
in IN O
which WDT O
the DT O
volume NN O
flow NN O
rate NN O
of IN O
blood NN O
in IN O
a DT O
vessel NN O
is VBZ O
determined VBN O
using VBG O
transverse NN O
colour NN O
Doppler NNP O
ultrasound JJ O
imaging NN O
. . O

-DOCSTART- X X O

This DT O
paper NN O
gives VBZ O
an DT O
overview NN O
of IN O
the DT O
global JJ O
pattern NN O
of IN O
casualties NNS O
in IN O
earthquakes NNS O
which WDT O
occurred VBD O
during IN O
the DT O
30-month JJ O
period NN O
from IN O
1 CD O
September NNP O
1993 CD O
to TO O
29 CD O
February NNP O
1996 CD O
. . O

-DOCSTART- X X O

Transcription NNP O
factor NN O
recognition NN O
surface NN O
on IN O
the DT O
RNA NNP B-NP
polymerase NN I-NP
alpha NN I-NP
subunit NN I-NP
is VBZ O
involved VBN O
in IN O
contact NN O
with IN O
the DT O
DNA NNP O
enhancer NN O
element NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
it PRP O
also RB O
discusses VBZ O
the DT O
effects NNS O
of IN O
antihypertensive JJ O
drugs NNS O
currently RB O
regarded VBN O
as IN O
first-choice JJ O
agents NNS O
, , O
i IN O
.e NN O
. . O
calcium NN O
antagonists NNS O
and CC O
the DT O
angiotensin NN B-NP
converting VBG I-NP
enzyme JJ I-NP
inhibitors NNS O
, , O
on IN O
intrarenal JJ O
hemodynamics NNS O
. . O

-DOCSTART- X X O

B NNP B-NP
cell NN I-NP
antigen NN I-NP
receptor NN I-NP
(BCR)-induced JJ O
apoptosis NN O
in IN O
the DT O
WEHI-231 NNP O
B NNP O
lymphoma NN O
cell NN O
line NN O
can MD O
be VB O
prevented VBN O
by IN O
engaging VBG O
CD40 NNP B-NP
. . O

-DOCSTART- X X O

An DT O
InlC NNP B-NP
deletion NN I-NP
mutant NN I-NP
shows VBZ O
reduced VBN O
virulence NN O
when WRB O
tested VBN O
in IN O
an DT O
intravenous JJ O
mouse NN O
model NN O
, , O
but CC O
intracellular JJ O
replication NN O
of IN O
the DT O
mutant JJ O
in IN O
Caco-2 NNP O
and CC O
J774 CD O
cells NNS O
appears VBZ O
to TO O
be VB O
comparable JJ O
with IN O
that DT O
of IN O
the DT O
wild-type JJ O
strain NN O
. . O

-DOCSTART- X X O

Mutations NNS O
at IN O
two CD O
neighboring VBG O
sites NNS O
, , O
serine NN O
242 CD O
and CC O
threonine CD O
255 CD O
, , O
exacerbated VBD O
the DT O
effect NN O
. . O

-DOCSTART- X X O

In IN O
both DT O
settings NNS O
, , O
it PRP O
can MD O
be VB O
phosphorylated VBN O
by IN O
cyclin NN B-NP
D-dependent JJ I-NP
kinases NNS I-NP
, , O
suggesting VBG O
that IN O
its PRP$ O
transcriptional JJ O
activity NN O
may MD O
normally RB O
be VB O
regulated VBN O
through IN O
such JJ O
mechanisms NNS O
. . O

-DOCSTART- X X O

Individuals NNS O
attending VBG O
the DT O
GUM NNP O
Department NNP O
in IN O
the DT O
Royal NNP O
Infirmary NNP O
of IN O
Edinburgh NNP O
between IN O
1990 CD O
and CC O
1994 CD O
with IN O
the DT O
diagnosis NN O
of IN O
HIV NNP O
infection NN O
, , O
genital NN O
warts NNS O
, , O
genital JJ O
herpes NNS O
, , O
non-specific JJ O
genital NN O
infection NN O
( -LRB- O
NSGI) NNP O
, , O
gonorrhoea NNP O
and CC O
syphilis NNS O
were VBD O
included VBN O
in IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

Rss1p NNP B-NP
encodes VBZ O
a DT O
novel NN O
essential JJ O
protein NN O
of IN O
538 CD O
amino IN O
acids NNS O
, , O
which WDT O
contains VBZ O
an DT O
extended JJ O
predicted VBN O
coiled-coil NN O
domain NN O
and CC O
is VBZ O
located VBN O
both DT O
at IN O
nuclear JJ O
pore NN O
complexes NNS O
( -LRB- O
NPCs NNS O
) -RRB- O
and CC O
in IN O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

In IN O
spite NN O
of IN O
much JJ O
effort NN O
, , O
no DT O
one NN O
has VBZ O
succeeded VBN O
in IN O
isolating VBG O
and CC O
characterizing VBG O
the DT O
enzyme( NN O
s VBZ O
) -RRB- O
responsible JJ O
for IN O
synthesis NN O
of IN O
cellulose NN O
, , O
the DT O
major JJ O
cell NN O
wall NN O
polymer NN O
of IN O
plants NNS O
. . O

-DOCSTART- X X O

Factor NNP O
V NNP O
Leiden NNP O
is VBZ O
a DT O
genetic JJ O
disorder NN O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
DNase NN B-NP
I PRP I-NP
footprinting MD O
showed VBD O
that IN O
OxyR-C199S NNP B-NP
protected VBD O
Pmom NNP B-NP
from IN O
-104 CD O
to TO O
-46 VB O
on IN O
the DT O
top JJ O
strand NN O
and CC O
produced VBD O
a DT O
protection NN O
pattern NN O
characteristic NN O
of IN O
reduced JJ B-NP
wild-type JJ I-NP
OxyR NN I-NP
. . O

-DOCSTART- X X O

These DT O
data NNS O
provide VBP O
strong JJ O
evidence NN O
that IN O
E2F NNP B-NP
or CC O
an DT O
E2F-related JJ B-NP
transcription NN I-NP
factor NN I-NP
is VBZ O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
nonmuscle NN B-NP
myosin NN I-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequence NN O
alignment NN O
between IN O
mouse NN O
and CC O
human JJ B-NP
CA NNP I-NP
IV NNP I-NP
shows VBZ O
69 CD O
% NN O
identity NN O
in IN O
the DT O
coding NN O
region NN O
and CC O
all DT O
of IN O
the DT O
exon-intron NN O
boundaries NNS O
are VBP O
conserved VBN O
, , O
as RB O
are VBP O
the DT O
sizes NNS O
of IN O
the DT O
introns NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
fodrin NN B-NP
proteolysis NN O
in IN O
vivo NN O
may MD O
reflect VB O
the DT O
activity NN O
of IN O
multiple JJ O
ICE/Ced-3 JJ B-NP
proteases NNS O
whose WP$ O
partial JJ O
sensitivity NN O
to TO O
DEVD-CHO NNP O
reflects VBZ O
a DT O
limited VBN O
contribution NN O
from IN O
CPP32 CD B-NP
, , O
or CC O
an DT O
ICE/Ced-3 JJ B-NP
protease NN O
less RBR O
sensitive JJ O
than IN O
CPP32 CD B-NP
to TO O
DEVD-CHO NNP O
inhibition NN O
. . O

-DOCSTART- X X O

Recurrent JJ O
G-to-A NNP O
substitution NN O
in IN O
a DT O
single JJ O
codon NN O
of IN O
SREBP NNP B-NP
cleavage-activating JJ I-NP
protein NN I-NP
causes VBZ O
sterol JJ O
resistance NN O
in IN O
three CD O
mutant JJ O
Chinese JJ O
hamster NN O
ovary JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

The DT O
Escherichia NNP B-NP
coli NNS I-NP
tet-repressor NN I-NP
( -LRB- O
TetR NN B-NP
) -RRB- O
operator NN O
system NN O
was VBD O
used VBN O
to TO O
develop VB O
a DT O
variation NN O
of IN O
the DT O
yeast NN O
two-hybrid JJ O
assay NN O
in IN O
which WDT O
disruptions NNS O
of IN O
protein-protein NN O
interactions NNS O
can MD O
be VB O
identified VBN O
by IN O
a DT O
positive JJ O
selection NN O
. . O

-DOCSTART- X X O

FK506 NNP O
is VBZ O
10- CD O
to TO O
100-fold CD O
more RBR O
potent JJ O
than IN O
cyclosporin NN O
A DT O
in IN O
preventing VBG O
organ NN O
rejection NN O
and CC O
in IN O
toxicity NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
the DT O
promoter NN O
and CC O
enhancer NN O
regions NNS O
identified VBN O
here RB O
are VBP O
essential JJ O
for IN O
maintaining VBG O
the DT O
efficient JJ O
promoter NN O
activity NN O
of IN O
the DT O
human JJ B-NP
activin NN I-NP
betaA IN I-NP
subunit NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Northern NNP O
( -LRB- O
RNA NN O
) -RRB- O
blot NN O
analyses NNS O
indicated VBD O
that IN O
the DT O
cdh JJ B-NP
genes NNS I-NP
encoding VBG O
the DT O
five CD O
subunits NNS O
and CC O
an DT O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORF1 NNP O
) -RRB- O
with IN O
unknown JJ O
function NN O
are VBP O
cotranscribed VBN O
during IN O
growth NN O
on IN O
acetate NN O
. . O

-DOCSTART- X X O

Damage NN O
to TO O
the DT O
BBB NNP O
was VBD O
judged VBN O
by IN O
extravasation NN O
of IN O
Evans NNP O
Blue NNP O
( -LRB- O
EB NN O
) -RRB- O
dye NN O
, , O
which WDT O
was VBD O
administered VBN O
either CC O
2 CD O
, , O
3 CD O
, , O
24 CD O
or CC O
48 CD O
h NN O
after IN O
onset NN O
of IN O
MCAo NNP O
. . O

-DOCSTART- X X O

The DT O
determination NN O
of IN O
immunoglobulin NN B-NP
E NNP I-NP
( -LRB- O
IgE NN B-NP
) -RRB- O
antibodies NNS O
by IN O
one CD O
of IN O
several JJ O
laboratory NN O
tests NNS O
, , O
by IN O
skin-prick NN O
tests NNS O
or CC O
by IN O
appropriate JJ O
challenge NN O
procedures NNS O
is VBZ O
useful JJ O
either CC O
to TO O
identify VB O
atopic IN O
individuals NNS O
or CC O
as IN O
outcome NN O
predictors NNS O
in IN O
wheezy JJ O
children NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
extracts NNS O
of IN O
the DT O
mutant JJ O
virions NNS O
catalyze VBP O
the DT O
wild-type JJ O
level NN O
of IN O
transcription NN O
from IN O
an DT O
exogenous JJ O
template NN O
containing VBG O
an DT O
early JJ O
promoter NN O
. . O

-DOCSTART- X X O

In IN O
Group NNP O
IV NNP O
dogs VBZ O
that IN O
received VBD O
alpha-MSH NNS B-NP
only RB O
during IN O
reperfusion NN O
, , O
BAEPs NNS O
were VBD O
increased VBN O
approximately RB O
10 CD O
to TO O
14 CD O
% NN O
more JJR O
than IN O
in IN O
Group NNP O
II NNP O
during IN O
the DT O
late JJ O
reperfusion NN O
period NN O
. . O

-DOCSTART- X X O

Complementary NNP O
DNAs NNP O
encompassing VBG O
the DT O
coat NN B-NP
protein NN I-NP
coding NN O
and CC O
adjacent JJ O
regions NNS O
of IN O
Agropyron NNP O
mosaic NN O
virus NN O
( -LRB- O
AgMV) NNP O
and CC O
Hordeum NNP O
mosaic NN O
virus NN O
( -LRB- O
HoMV) NNP O
were VBD O
cloned VBN O
and CC O
sequenced VBN O
. . O

-DOCSTART- X X O

In IN O
some DT O
cases NNS O
, , O
factor-induced JJ O
Rac NNP B-NP
activation NN O
results NNS O
in IN O
Rho NNP B-NP
activation NN O
, , O
and CC O
factor-induced JJ O
Cdc42 NNP B-NP
activation NN O
leads VBZ O
to TO O
Rac NNP B-NP
activation NN O
, , O
as IN O
determined VBN O
by IN O
specific JJ O
morphological JJ O
changes NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
we PRP O
did VBD O
not RB O
observe VB O
a DT O
correlation NN O
between IN O
serum NN O
and CC O
seminal JJ B-NP
plasma NN I-NP
PSA NNP I-NP
levels NNS O
. . O

-DOCSTART- X X O

This DT O
establishes VBZ O
Rad3/Mec1 NNP B-NP
as IN O
the DT O
only JJ O
conserved JJ O
protein NN O
which WDT O
is VBZ O
required VBN O
for IN O
all DT O
the DT O
DNA NNP O
structure NN O
checkpoints NNS O
in IN O
both DT O
yeast NN O
model NN O
systems NNS O
. . O

-DOCSTART- X X O

The DT O
P13 NN O
and CC O
N22 NN O
of IN O
ppSEPs NNS O
had VBD O
phase NN O
reversal NN O
relationship NN O
with IN O
the DT O
P2 NNP O
and CC O
N2 NNP O
recorded VBD O
from IN O
the DT O
PES NNP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
region NN O
( -LRB- O
P1 NNP O
) -RRB- O
corresponding JJ O
to TO O
the DT O
main JJ O
group NN O
of IN O
transcription NN O
initiation NN O
sites NNS O
is VBZ O
devoid JJ O
of IN O
TATA NNP O
and CC O
CAAT NNP O
boxes NNS O
but CC O
has VBZ O
putative JJ O
binding NN O
sites NNS O
for IN O
the DT O
transcription NN B-NP
factor NN I-NP
SP1 NNP I-NP
and CC O
is VBZ O
embedded VBN O
in IN O
a DT O
large JJ O
G NNP O
+ NNP O
C-rich NNP O
domain NN O
of IN O
a DT O
CpG NNP O
island NN O
, , O
features NNS O
shared VBN O
by IN O
the DT O
promoters NNS O
of IN O
constitutively RB O
expressed VBN O
housekeeping NN O
genes NNS O
. . O

-DOCSTART- X X O

Children NNS O
born VBN O
from IN O
chronic JJ O
alcoholic JJ O
mothers NNS O
have VBP O
shown VBN O
behavioral JJ O
teratogenic JJ O
effects NNS O
more RBR O
frequently RB O
than IN O
morphological JJ O
malformations NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report NN O
that WDT O
expression NN O
of IN O
the DT O
I-POU/tI-POU JJ B-NP
message NN O
is VBZ O
maximal JJ O
late RB O
in IN O
the DT O
embryonic JJ O
phase NN O
of IN O
Drosophila NNP O
development NN O
, , O
and CC O
I-POU NNP B-NP
is VBZ O
the DT O
preferred JJ O
splice NN O
variant NN O
. . O

-DOCSTART- X X O

Although IN O
p48 VBG B-NP
gene NN I-NP
induction NN O
is VBZ O
dependent JJ O
on IN O
STAT1 NNP B-NP
and CC O
JAK1 NNP B-NP
, , O
activated VBN O
STAT1 NNP B-NP
does VBZ O
not RB O
bind NN O
to TO O
GATE. NNP B-NP

-DOCSTART- X X O

Differential JJ O
signaling NN O
and CC O
immediate-early JJ B-NP
gene NN I-NP
activation NN O
by IN O
four CD O
splice NN O
variants NNS O
of IN O
the DT O
human JJ B-NP
pituitary NN I-NP
adenylate JJ I-NP
cyclase-activating NN I-NP
polypeptide NN I-NP
receptor NN I-NP
( -LRB- O
hPACAP-R NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Fourth JJ O
, , O
the DT O
3'-region JJ O
splice NN O
junctions NNS O
of IN O
the DT O
MSRs NNS B-NP
during IN O
latent JJ O
and CC O
productive JJ O
infection NN O
were VBD O
determined VBN O
by IN O
sequencing VBG O
RNA-PCR NNP O
products NNS O
generated VBD O
with IN O
primers NNS O
that WDT O
flank VBD O
the DT O
3' JJ O
splice NN O
region NN O
. . O

-DOCSTART- X X O

In IN O
all DT O
cases NNS O
the DT O
antigenemia NN O
was VBD O
transient JJ O
and CC O
cleared VBN O
by IN O
28th JJ O
day NN O
post-vaccination NN O
. . O

-DOCSTART- X X O

However RB O
, , O
five CD O
new JJ O
mutation NN O
sites NNS O
( -LRB- O
S61 NNP B-NP
, , O
SL1 NNP B-NP
, , O
S29 NNP B-NP
, , O
SL11 NNP B-NP
, , O
SL196 NNP B-NP
and CC O
SL126 NNP B-NP
) -RRB- O
are VBP O
unique JJ O
to TO O
the DT O
nrdB NN B-NP
intron NN O
and CC O
disrupt VB O
self-splicing NN O
. . O

-DOCSTART- X X O

Serotonin NNP O
concentration NN O
in IN O
the DT O
blood NN O
of IN O
patients NNS O
with IN O
hemorrhagic JJ O
fever NN O
with IN O
renal JJ O
syndrome NN O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Some DT O
Gulf NNP O
War NNP O
veterans NNS O
may MD O
have VB O
delayed VBN O
, , O
chronic JJ O
neurotoxic JJ O
syndromes NNS O
from IN O
wartime NN O
exposure NN O
to TO O
combinations NNS O
of IN O
chemicals NNS O
that WDT O
inhibit VBP O
butyrylcholinesterase NN B-NP
and CC O
neuropathy NN B-NP
target NN I-NP
esterase NN I-NP
. . O

-DOCSTART- X X O

No DT O
correlation NN O
between IN O
the DT O
age NN O
of IN O
the DT O
horses NNS O
and CC O
the DT O
antibody NN O
level NN O
could MD O
be VB O
found VBN O
. . O

-DOCSTART- X X O

The DT O
Y-type JJ O
structural JJ O
motif NN O
is VBZ O
also RB O
conserved VBN O
among IN O
a DT O
number NN O
of IN O
divergent JJ O
BiP NNP B-NP
mRNAs NNS I-NP
. . O

-DOCSTART- X X O

SIM1 NNP B-NP
and CC O
SIM2 NNP B-NP
do VBP O
not RB O
form VB O
homodimers NNS O
, , O
and CC O
they PRP O
do VBP O
not RB O
interact VB O
with IN O
AHR. NNP B-NP

-DOCSTART- X X O

A DT O
heterologous JJ O
promoter NN O
construct VB O
containing VBG O
three CD O
repeats NNS O
of IN O
a DT O
consensus NN O
Sp1 IN B-NP
site NN I-NP
, , O
cloned VBD O
upstream RB O
of IN O
a DT O
single JJ O
copy NN O
of IN O
the DT O
ZII NNP B-NP
( -LRB- O
CREB/ JJ B-NP
AP1 NN I-NP
) -RRB- O
element NN O
from IN O
the DT O
BZLF1 JJ B-NP
promoter NN I-NP
linked VBN O
to TO O
the DT O
beta-globin NN B-NP
TATA NNP O
box NN O
, , O
exhibited VBD O
phorbol NN O
ester NN O
inducibility NN O
. . O

-DOCSTART- X X O

Together RB O
, , O
the DT O
data NNS O
suggest VBP O
that IN O
cAMP-dependent JJ O
control NN O
of IN O
the DT O
amounts NNS O
of IN O
the DT O
activator NN O
SF-1 NN B-NP
vs. IN O
the DT O
repressor NN O
COUP-TF NN B-NP
could MD O
influence VB O
CRS2-dependent JJ O
transcription NN O
. . O

-DOCSTART- X X O

Interaction NNP O
of IN O
Ets-1 NNP B-NP
and CC O
the DT O
POU-homeodomain JJ B-NP
protein NN I-NP
GHF-1/Pit-1 NN B-NP
reconstitutes VBZ O
pituitary-specific JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Enhanced JJ O
period-peak JJ O
analysis NN O
of IN O
electro-encephalograms NNS O
using VBG O
a DT O
fast JJ O
sinc IN O
function NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
measured VBN O
the DT O
MBF NN O
on IN O
incisors NNS O
and CC O
its PRP$ O
direction NN O
in IN O
three CD O
dimensions NNS O
for IN O
different JJ O
jaw NN O
openings NNS O
in IN O
ten CD O
subjects NNS O
. . O

-DOCSTART- X X O

The DT O
neuroprotective JJ O
efficacy NN O
of IN O
the DT O
selective JJ O
N-type NN O
voltage-sensitive JJ O
calcium NN O
channel NN O
blocker NN O
, , O
SNX-111 NNP O
, , O
was VBD O
evaluated VBN O
in IN O
spontaneously RB O
hypertensive JJ O
rats NNS O
subjected VBN O
to TO O
60 CD O
min NN O
of IN O
focal JJ O
cerebral NN O
ischemia NN O
by IN O
permanent JJ O
ligation NN O
of IN O
the DT O
right JJ O
common JJ O
carotid NN O
artery NN O
and CC O
temporary JJ O
occlusion NN O
of IN O
the DT O
right JJ O
middle NN O
cerebral NN O
artery NN O
. . O

-DOCSTART- X X O

The DT O
HBP NNP B-NP
gene NN I-NP
is VBZ O
composed VBN O
of IN O
eight CD O
exons NNS O
covering VBG O
19.5 CD O
kb NN O
on IN O
the DT O
short JJ O
arm NN O
of IN O
chromosome NN O
4 CD O
. . O

-DOCSTART- X X O

The DT O
intensity NN O
of IN O
the DT O
SSTEs NNP O
is VBZ O
an DT O
order NN O
of IN O
magnitude NN O
larger JJR O
than IN O
that DT O
of IN O
the DT O
MSEs NNP O
and CC O
determines VBZ O
the DT O
signal NN O
contrast NN O
if IN O
both DT O
effects NNS O
are VBP O
selected VBN O
simultaneously RB O
. . O

-DOCSTART- X X O

In IN O
eukaryotic JJ O
cells NNS O
, , O
premature JJ O
termination NN O
of IN O
translation NN O
at IN O
nonsense NN O
codons NNS O
has VBZ O
been VBN O
implicated VBN O
as IN O
the DT O
cause NN O
of IN O
a DT O
variety NN O
of IN O
posttranscriptional JJ O
events NNS O
, , O
including VBG O
rapid JJ O
mRNA RB O
decay NN O
in IN O
the DT O
cytoplasm NN O
or CC O
the DT O
nucleus JJ O
, , O
altered VBN O
splice NN O
site NN O
selection NN O
, , O
and CC O
exon NN O
skipping VBG O
. . O

-DOCSTART- X X O

A DT O
miracle NN O
cure NN O
and CC O
its PRP$ O
solution NN O

-DOCSTART- X X O

Ume6p NNP B-NP
, , O
which WDT O
also RB O
controls VBZ O
the DT O
expression NN O
of IN O
early JJ O
meiotic JJ O
genes NNS O
, , O
represses VBZ O
CAR1 NNP B-NP
expression NN O
through IN O
a DT O
sequence NN O
called VBN O
URS NNP O
, , O
as IN O
a DT O
function NN O
of IN O
nitrogen NN O
availability NN O
. . O

-DOCSTART- X X O

None NN O
of IN O
these DT O
organic JJ O
manifestations NNS O
was VBD O
discovered VBN O
by IN O
scintigraphic JJ O
means NNS O
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
U1 NNP B-NP
snRNP NN I-NP
is VBZ O
recruited VBN O
to TO O
the DT O
5' JJ O
splice NN O
site NN O
by IN O
protein/protein NN O
interactions NNS O
involving VBG O
the DT O
SR NNP B-NP
domains NNS O
of IN O
the DT O
U1-70K JJ B-NP
protein NN I-NP
and CC O
SF2/ASF. NN B-NP

-DOCSTART- X X O

An DT O
aromatic JJ O
stacking NN O
interaction NN O
between IN O
subunits NNS O
helps VBZ O
mediate JJ O
DNA NN O
sequence NN O
specificity NN O
: : O
operator NN O
site NN O
discrimination NN O
by IN O
phage JJ B-NP
lambda NN I-NP
cI NN I-NP
repressor NN I-NP
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
the DT O
purification NN O
of IN O
this DT O
larger JJR O
form NN O
as IN O
an DT O
approximately RB O
320-kDa JJ O
particle NN O
that WDT O
contains VBZ O
mRNP3+4 CD B-NP
and CC O
nine CD O
additional JJ O
polypeptides NNS O
, , O
including VBG O
mRNA-binding JJ O
polypeptides NNS O
of IN O
34 CD O
and CC O
36 CD O
kDa NN O
and CC O
a DT O
doublet NN O
of IN O
110/105 CD O
kDa NNS O
that DT O
proved VBD O
to TO O
be VB O
nucleolin NNS B-NP
. . O

-DOCSTART- X X O

The DT O
perioperative JJ O
mortality NN O
of IN O
all DT O
patients NNS O
was VBD O
1.9 CD O
% NN O
, , O
the DT O
mortality NN O
of IN O
patients NNS O
older JJR O
than IN O
70 CD O
years NNS O
was VBD O
4.3 CD O
% NN O
. . O

-DOCSTART- X X O

Having VBG O
an DT O
LRR NNP B-NP
domain NN I-NP
and CC O
an DT O
SH3-binding JJ B-NP
domain NN I-NP
, , O
Acan125 NNP B-NP
and CC O
the DT O
C. NNP O
elegans NNS O
homologue NN O
define VB O
a DT O
novel JJ O
family NN O
of IN O
bifunctional JJ O
binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

The DT O
capacity NN O
to TO O
repair VB O
8-OxoG JJ O
has VBZ O
been VBN O
measured VBN O
in IN O
cell-free JJ O
extracts NNS O
of IN O
wild-type JJ O
and CC O
ogg1 JJ B-NP
strains NNS O
using VBG O
a DT O
34mer JJ O
DNA NN O
fragment NN O
containing VBG O
a DT O
single JJ O
8-OxoG JJ O
residue JJ O
paired VBN O
with IN O
a DT O
cytosine JJ O
(8-OxoG/C JJ O
) -RRB- O
as IN O
a DT O
substrate NN O
. . O

-DOCSTART- X X O

The DT O
likelihood NN O
that IN O
a DT O
common JJ O
region NN O
of IN O
deletions NNS O
would MD O
contain VB O
a DT O
tumor NN O
suppressor NN O
is VBZ O
strongly RB O
enhanced VBN O
by IN O
coincidence NN O
of IN O
that DT O
region NN O
with IN O
a DT O
chromosome NN O
fragment NN O
suppressing VBG O
tumorigenicity NN O
upon IN O
introduction NN O
in IN O
tumor NN O
cells NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
in IN O
some DT O
of IN O
them PRP O
either DT O
pattern NN O
may MD O
predominate VB O
or CC O
be VB O
exclusively RB O
present JJ O
. . O

-DOCSTART- X X O

The DT O
carboxyl-terminal JJ O
CCCC NNP O
module NN O
is VBZ O
structurally RB O
related VBN O
to TO O
the DT O
DNA-binding JJ O
domain NN O
of IN O
the DT O
erythroid JJ B-NP
transcription NN I-NP
factor NN I-NP
GATA-1 NN I-NP
. . O

-DOCSTART- X X O

A DT O
polypeptide NN O
encoded VBN O
by IN O
the DT O
NTS NNS O
16 CD O
open JJ O
reading NN O
frame NN O
has VBZ O
sequence NN O
similarity NN O
to TO O
the DT O
catalytic JJ O
domain NN O
of IN O
several JJ O
receptor NN B-NP
protein NN I-NP
kinases NNS I-NP
from IN I-NP
plants NNS I-NP
including VBG O
the DT O
S-receptor NN B-NP
kinases NNS I-NP
implicated VBN O
in IN O
the DT O
rejection NN O
of IN O
self-pollen JJ O
in IN O
Brassica NNP O
species NNS O
and CC O
the DT O
Pto NNP B-NP
gene NN I-NP
product NN I-NP
of IN I-NP
tomato NN I-NP
which WDT O
confers VBZ O
resistance NN O
to TO O
a DT O
bacterial JJ O
pathogen NN O
. . O

-DOCSTART- X X O

In IN O
gel NNP O
mobility NN O
shift NN O
assays VBZ O
, , O
factors NNS O
present JJ O
in IN O
nuclear JJ O
extracts NNS O
derived VBN O
from IN O
differentiated JJ O
osteoblast NN O
bound VBN O
to TO O
oligonucleotide VB O
probes NNS O
containing VBG O
the DT O
E-box NNP O
1 CD O
and CC O
E-box NNP O
2 CD O
elements NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Surprisingly RB O
, , O
PAF NNP B-NP
blockade NN O
increased VBD O
mortality NN O
after IN O
trauma NN O
( -LRB- O
5 CD O
of IN O
11 CD O
WEB-2086 CD O
animals NNS O
versus IN O
1 CD O
of IN O
9 CD O
vehicle NN O
animals NNS O
; : O
p NN O
= SYM O
0.15 CD O
) -RRB- O
and CC O
depressed VBD O
cardiac JJ O
index NN O
and CC O
O2 CD O
delivery NN O
at IN O
72 CD O
hours NNS O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
thus RB O
conclude VBP O
that IN O
the DT O
NFAT NNP B-NP
RIR NNP I-NP
plays VBZ O
an DT O
essential JJ O
dual JJ O
role NN O
in IN O
DNA NNP O
recognition NN O
and CC O
cooperative JJ O
binding NN O
to TO O
AP-1 NNP B-NP
family NN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
association NN O
of IN O
PS1 NNP B-NP
fragments NNS I-NP
may MD O
be VB O
maintained VBN O
during IN O
cycles NNS O
of IN O
phosphorylation/dephosphorylation NN O
of IN O
the DT O
PS1 NNP B-NP
CTF. . I-NP

-DOCSTART- X X O

A DT O
patient NN O
of IN O
Group NNP O
B NNP O
had VBD O
severe JJ O
athetoid NN O
CP CD O
with IN O
spasticity NN O
, , O
being VBG O
unable JJ O
to TO O
right JJ O
his PRP$ O
trunk NN O
and CC O
neck NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
our PRP$ O
studies NNS O
suggest VBP O
that IN O
pV-mediated JJ O
activation NN O
of IN O
HIV-1 PRP$ B-NP
LTR NNP I-NP
activity NN O
is VBZ O
controlled VBN O
by IN O
the DT O
nuclear JJ O
translocation NN O
of IN O
the DT O
NF-kappaB NNP B-NP
transcription NN I-NP
factor NN I-NP
, , O
which WDT O
is VBZ O
mediated VBN O
by IN O
IkappaBalpha NNP B-NP
serine NN O
phosphorylation NN O
and CC O
degradation NN O
, , O
but CC O
also RB O
by IN O
a DT O
still RB O
undefined JJ O
NF-kappaB-independent JJ B-NP
pathway NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
review VB O
the DT O
role NN O
of IN O
grains NNS O
in IN O
the DT O
formation NN O
of IN O
complex JJ O
molecules NNS O
in IN O
interstellar JJ O
molecular JJ O
clouds NNS O
. . O

-DOCSTART- X X O

Like IN O
the DT O
elicitors NNS O
of IN O
the DT O
hypersensitive JJ O
reaction NN O
( -LRB- O
HR NN O
) -RRB- O
produced VBN O
by IN O
E. NNP O
chrysanthemi NN O
( -LRB- O
HarpinEch NNP O
) -RRB- O
and CC O
E. NNP O
amylovora NN O
( -LRB- O
HarpinEa NNP O
) -RRB- O
, , O
the DT O
deduced JJ O
36-kDa JJ O
protein NN O
does VBZ O
not RB O
possess VB O
a DT O
typical JJ O
signal NN O
sequence NN O
, , O
but CC O
it PRP O
contains VBZ O
a DT O
putative JJ O
membrane-spanning NN O
domain NN O
. . O

-DOCSTART- X X O

Rep-Rep JJ B-NP
protein NN O
interaction NN O
was VBD O
confirmed VBN O
in IN O
vitro NN O
through IN O
coimmunoprecipitation NN O
experiments NNS O
with IN O
a DT O
bacterially RB O
expressed VBN O
maltose-binding JJ B-NP
protein-Rep78 NNS I-NP
fusion NN O
protein NN O
in IN O
combination NN O
with IN O
[35S]methionine-labeled JJ O
Rep78 NNS B-NP
synthesized VBN O
in IN O
a DT O
coupled VBN O
in IN O
vitro NN O
transcription-translation NN O
system NN O
. . O

-DOCSTART- X X O

Fourteen CD O
patients NNS O
with IN O
New NNP O
York NNP O
Heart NNP O
Association NNP O
class NN O
II NNP O
congestive JJ O
heart NN O
failure NN O
were VBD O
enrolled VBN O
in IN O
a DT O
double-blind JJ O
, , O
cross-over JJ O
study NN O
. . O

-DOCSTART- X X O

The DT O
main JJ O
advantages NNS O
of IN O
Multi-MUP JJ O
analysis NN O
are VBP O
: : O
( -LRB- O
1 CD O
) -RRB- O
quick JJ O
acquisition NN O
of IN O
many JJ O
MUPs NNS O
; : O
( -LRB- O
2 CD O
) -RRB- O
simultaneous JJ O
collection NN O
of IN O
several JJ O
MUPs NNS O
at IN O
one CD O
recording NN O
site NN O
; : O
( -LRB- O
3 CD O
) -RRB- O
possibility NN O
to TO O
analyze VB O
not RB O
only RB O
low JJ O
threshold NN O
MUPs NNS O
; : O
( -LRB- O
4 CD O
) -RRB- O
less JJR O
bias NN O
in IN O
the DT O
selection NN O
of IN O
MUPs NNS O
and CC O
( -LRB- O
5 CD O
) -RRB- O
the DT O
reproducibility NN O
of IN O
the DT O
results NNS O
that WDT O
allow VBP O
the DT O
same JJ O
reference NN O
values NNS O
to TO O
be VB O
used VBN O
in IN O
different JJ O
laboratories NNS O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
have VBP O
indicated VBN O
that IN O
a DT O
hamster NN O
cell NN O
line NN O
(ts13 VBZ O
) -RRB- O
with IN O
a DT O
point NN O
mutation NN O
in IN O
the DT O
TAF(II)250/CCG1 NNP B-NP
( -LRB- O
TAF(II)250 NN B-NP
) -RRB- O
gene NN O
shows VBZ O
temperature-sensitive JJ O
expression NN O
of IN O
a DT O
subset NN O
of IN O
genes NNS O
and CC O
arrests NNS O
in IN O
late JJ O
G1 NNP O
at IN O
39.5 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

METHODS NNP O
: : O
The DT O
responses NNS O
of IN O
a DT O
31-year-old JJ O
woman NN O
with IN O
complex JJ O
regional JJ O
pain NN O
syndrome NN O
type NN O
I PRP O
( -LRB- O
reflex NN O
sympathetic JJ O
dystrophy NN O
) -RRB- O
to TO O
a DT O
thermal JJ O
grill NN O
were VBD O
evaluated VBN O
before IN O
and CC O
after IN O
stellate JJ O
ganglion NN O
block NN O
. . O

-DOCSTART- X X O

More RBR O
recently RB O
, , O
however RB O
, , O
a DT O
number NN O
of IN O
developments NNS O
such JJ O
as IN O
the DT O
successful JJ O
use NN O
of IN O
the DT O
inhaled VBN O
steroid NN O
budesonide NN O
and CC O
oral JJ O
dexamethasone NN O
have VBP O
reinforced VBN O
the DT O
argument NN O
for IN O
using VBG O
steroids NNS O
. . O

-DOCSTART- X X O

In IN O
ciliates NNS O
, , O
both DT O
mechanisms NNS O
are VBP O
readily RB O
observed VBN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
the DT O
occurrence NN O
of IN O
several JJ O
transcription NN O
signals NNS O
in IN O
the DT O
Thermus NNP B-NP
pyr NN I-NP
promoter NN I-NP
region NN I-NP
and CC O
strong JJ O
amino JJ O
acid NN O
sequence NN O
identities NNS O
( -LRB- O
about IN O
60 CD O
% NN O
) -RRB- O
between IN O
Thermus NNP B-NP
PyrR NNP I-NP
and CC O
the DT O
PyrR NNP B-NP
attenuation IN I-NP
proteins NNS I-NP
of IN O
two CD O
Bacillus NNP O
sp. NN O
, , O
we PRP O
propose VBP O
a DT O
regulatory JJ O
mechanism NN O
involving VBG O
transcriptional JJ O
attenuation NN O
to TO O
control VB O
pyr JJ B-NP
gene NN I-NP
expression NN O
in IN O
Thermus NNP O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
B-S NNP O
mutant NN O
does VBZ O
not RB O
mimic VB O
efficiently RB O
the DT O
chloroplastic JJ B-NP
GAPDHs NNP I-NP
, , O
and CC O
long-range JJ O
and/or CC O
second-layer JJ O
effects NNS O
, , O
not RB O
easily RB O
predictable JJ O
from IN O
visual JJ O
inspection NN O
of IN O
three-dimensional JJ O
structures NNS O
, , O
need NN O
to TO O
be VB O
taken VBN O
into IN O
account NN O
for IN O
designing VBG O
a DT O
true JJ O
" `` O
chloroplastic-like JJ O
" `` O
mutant JJ O
of IN O
cytosolic JJ B-NP
GAPDH. . I-NP

-DOCSTART- X X O

Evaluation NN O
of IN O
myocardial JJ O
perfusion NN O
by IN O
99mTc-tetrofosmin NNP O
SPECT NNP O
before IN O
and CC O
after IN O
emergent JJ O
percutaneous JJ O
transluminal JJ O
coronary JJ O
angioplasty NN O
for IN O
acute JJ O
myocardial JJ O
infarction NN O

-DOCSTART- X X O

The DT O
1.1- CD O
and CC O
1.3-kb CD O
mRNA JJ O
species NNS O
were VBD O
found VBN O
only RB O
in IN O
the DT O
heart NN O
, , O
and CC O
the DT O
2.6-kb JJ O
species NNS O
was VBD O
found VBN O
in IN O
the DT O
heart NN O
, , O
kidney NN O
and CC O
brain NN O
, , O
but CC O
not RB O
in IN O
skeletal JJ O
muscle NN O
or CC O
liver NN O
. . O

-DOCSTART- X X O

This DT O
investigation NN O
was VBD O
undertaken VBN O
to TO O
determine VB O
whether IN O
consuming VBG O
several JJ O
small JJ O
feedings NNS O
of IN O
preexercise NN O
carbohydrate NN O
( -LRB- O
CHO NNP O
) -RRB- O
, , O
rather RB O
than IN O
a DT O
single JJ O
bolus NN O
, , O
would MD O
affect VB O
blood NN O
glucose NN O
and CC O
insulin NN B-NP
responses NNS O
during IN O
rest NN O
and CC O
exercise NN O
. . O

-DOCSTART- X X O

Whereas IN O
the DT O
mutant JJ O
enzymes NNS O
terminate VBP O
normally RB O
at IN O
the DT O
late JJ O
terminator NN O
in IN O
T7 CD O
DNA NN O
( -LRB- O
T(phi) NN O
) -RRB- O
and CC O
rrnB NNP B-NP
T2 NNP O
, , O
they PRP O
fail VBP O
to TO O
terminate VB O
at IN O
one CD O
of IN O
the DT O
termination NN O
sites NNS O
of IN O
rrnB NNP B-NP
T1 NNP O
, , O
and CC O
also RB O
fail VB O
to TO O
recognize VB O
the DT O
PTH NNP B-NP
and CC O
CJ NNP O
signals NNS O
. . O

-DOCSTART- X X O

Cytological JJ O
data NNS O
suggest VBP O
that IN O
the DT O
transgenes NNS O
associate NN O
with IN O
a DT O
nucleolus JJ O
. . O

-DOCSTART- X X O

Strikingly RB O
, , O
stoichiometric JJ O
association NN O
of IN O
p107 NNS B-NP
or CC O
p130 VB B-NP
with IN O
either DT O
cyclin NN B-NP
E-cdk2 NN I-NP
or CC O
cyclin NN B-NP
A-cdk2 NN I-NP
negated VBN O
the DT O
activities NNS O
of IN O
these DT O
kinases NNS O
. . O

-DOCSTART- X X O

Clinical NNP O
and CC O
haematological JJ O
signs NNS O
are VBP O
not RB O
specific JJ O
in IN O
this DT O
setting NN O
, , O
and CC O
the DT O
diagnosis NN O
relies VBZ O
on IN O
histological JJ O
features NNS O
, , O
mainly RB O
bone NN O
marrow NN O
examination NN O
. . O

-DOCSTART- X X O

A DT O
striking JJ O
feature NN O
of IN O
the DT O
recombinant JJ B-NP
H19 CD I-NP
allele NN I-NP
is VBZ O
the DT O
occurrence NN O
of IN O
a DT O
parental JJ O
imprint NN O
set VBN O
on IN O
the DT O
neo NN B-NP
replacement NN I-NP
cassette NN I-NP
. . O

-DOCSTART- X X O

Identification NN O
of IN O
five CD O
new JJ O
genes NNS O
, , O
closely RB O
related VBN O
to TO O
the DT O
interleukin-1beta JJ B-NP
converting VBG I-NP
enzyme JJ I-NP
gene NN I-NP
, , O
that WDT O
do VBP O
not RB O
encode VB O
functional JJ O
proteases NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
we PRP O
could MD O
not RB O
find VB O
the DT O
homologous JJ O
regions NNS O
with IN O
guanine NNP B-NP
nucleotide JJ I-NP
exchange NN I-NP
factors NNS I-NP
or CC O
GTPase-activating JJ B-NP
proteins NNS I-NP
in IN O
the DT O
c-cbl JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Serum NN B-NP
response NN I-NP
factor NN I-NP
( -LRB- O
SRF) NNP B-NP
, , O
a DT O
member NN O
of IN O
an DT O
ancient JJ O
family NN O
of IN O
DNA-binding JJ O
proteins NNS O
, , O
is VBZ O
generally RB O
assumed VBN O
to TO O
be VB O
a DT O
ubiquitous JJ O
transcription NN O
factor NN O
involved VBN O
in IN O
regulating VBG O
growth NN O
factor-responsive JJ O
genes NNS O
. . O

-DOCSTART- X X O

Activity NN O
of IN O
palgD NN B-NP
in IN O
the DT O
cysB NN B-NP
mutant NN I-NP
, , O
in IN O
CHA NNP O
and CC O
in IN O
the DT O
non-mucoid JJ O
strain NN O
PAO NNP O
was VBD O
assessed VBN O
by IN O
the DT O
use NN O
of IN O
a DT O
transcriptional JJ O
algD-xylE JJ B-NP
fusion NN O
. . O

-DOCSTART- X X O

The DT O
Man9-mannosidase JJ B-NP
specificity NN O
of IN O
the DT O
cDNA NN O
construct VB O
was VBD O
verified VBN O
by IN O
the DT O
observation NN O
that IN O
all DT O
peptide NN O
sequences NNS O
derived VBN O
from IN O
a DT O
previously RB O
purified VBN O
, , O
catalytically RB O
active JJ O
49-kDa JJ O
fragment NN O
were VBD O
found VBN O
within IN O
the DT O
coding NN O
region NN O
. . O

-DOCSTART- X X O

ORF NNP O
M1 NNP O
has VBZ O
striking JJ O
homology NN O
to TO O
poxvirus NN O
serpins NNS B-NP
, , O
while IN O
ORF NNP O
M11 NNP O
encodes VBZ O
a DT O
potential JJ O
homolog NN O
of IN O
Bcl-2-like JJ B-NP
molecules NNS I-NP
encoded VBN O
by IN O
other JJ O
gammaherpesviruses NNS O
( -LRB- O
gene NN B-NP
16 CD I-NP
of IN O
HVS NNP O
and CC O
KSHV NNP O
and CC O
the DT O
BHRF1 NNP B-NP
gene NN I-NP
of IN O
EBV NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Stereotactic NNP O
radiofrequency NN O
lesioning NN O
of IN O
the DT O
hamartoma NN O
resulted VBD O
in IN O
seizure NN O
remission NN O
without IN O
complications NNS O
20 CD O
months NNS O
after IN O
surgery NN O
. . O

-DOCSTART- X X O

However RB O
, , O
mean JJ O
food NN O
intake NN O
in IN O
the DT O
40 CD O
% NN O
group NN O
was VBD O
half JJ O
that IN O
of IN O
the DT O
ACT NNP O
group NN O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
and CC O
significantly RB O
less JJR O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
than IN O
the DT O
SEP NNP O
group NN O
, , O
which WDT O
consumed VBD O
amounts NNS O
equivalent JJ O
to TO O
65 CD O
% NN O
of IN O
daily JJ O
requirement NN O
. . O

-DOCSTART- X X O

The DT O
following VBG O
technique NN O
describes VBZ O
a DT O
modification NN O
to TO O
a DT O
bar NN O
superstructure NN O
that WDT O
provided VBD O
the DT O
advantages NNS O
of IN O
convenience NN O
, , O
security NN O
, , O
and CC O
consistent JJ O
positioning NN O
even RB O
though IN O
one CD O
implant NN O
was VBD O
lost VBN O
and CC O
the DT O
angulation NN O
of IN O
implants NNS O
limited JJ O
accuracy NN O
. . O

-DOCSTART- X X O

Its PRP$ O
potential JJ O
as IN O
a DT O
diagnostic JJ O
tool NN O
for IN O
epidemiological JJ O
surveillance NN O
was VBD O
assessed VBN O
in IN O
comparison NN O
with IN O
three CD O
other JJ O
diagnostic JJ O
tests NNS O
: : O
stool NN O
examination NN O
, , O
ELISA NNP O
with IN O
soluble JJ B-NP
egg NN I-NP
antigen NN I-NP
( -LRB- O
SEA NN B-NP
) -RRB- O
and CC O
the DT O
circumoval NN O
precipitin NN B-NP
test NN O
( -LRB- O
COPT NN O
) -RRB- O
. . O

-DOCSTART- X X O

Human JJ B-NP
thymine-DNA JJ I-NP
glycosylase NN I-NP
maps NNS O
at IN O
chromosome NN O
12q22-q24.1 CD O
: : O
a DT O
region NN O
of IN O
high JJ O
loss NN O
of IN O
heterozygosity NN O
in IN O
gastric JJ O
cancer NN O
. . O

-DOCSTART- X X O

FOG NN B-NP
is VBZ O
coexpressed VBN O
with IN O
GATA-1 NNP B-NP
during IN O
embryonic JJ O
development NN O
and CC O
in IN O
erythroid NN O
and CC O
megakaryocytic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Autoimmune NNP O
neutropenia NN O
( -LRB- O
AIN NNP O
) -RRB- O
is VBZ O
a DT O
frequent JJ O
cause NN O
of IN O
chronic NN O
neutropenia NN O
especially RB O
in IN O
youngest JJS O
children NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
have VBP O
tested VBN O
the DT O
hypothesis NN O
that IN O
the DT O
short JJ O
transcripts NNS O
, , O
or CC O
proteins VBZ O
translated VBN O
from IN O
the DT O
short JJ O
transcripts NNS O
, , O
are VBP O
also RB O
required VBN O
for IN O
respiration NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
tested VBD O
this DT O
notion NN O
by IN O
using VBG O
ligation-mediated JJ O
PCR NN O
to TO O
assess VB O
the DT O
formation NN O
of IN O
recombination-activating JJ B-NP
gene NN I-NP
(RAG)-dependent JJ O
double-strand NN O
breaks NNS O
( -LRB- O
DSBs NNS O
) -RRB- O
at IN O
RSSs NNP O
3' CD O
of IN O
Ddelta3 CD B-NP
and CC O
5' CD O
of IN O
Jdelta1 NNP B-NP
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
Cbl NNP B-NP
, , O
the DT O
120-kDa JJ O
protein NN O
product NN O
of IN O
the DT O
c-cbl JJ B-NP
proto-oncogene NN I-NP
, , O
serves VBZ O
as IN O
a DT O
substrate NN O
of IN O
a DT O
number NN O
of IN O
receptor-coupled JJ B-NP
tyrosine NN I-NP
kinases NNS I-NP
and CC O
forms NNS O
complexes NNS O
with IN O
SH3 NNP B-NP
and CC O
SH2 NNP B-NP
domain-containing JJ O
proteins NNS O
, , O
pointing VBG O
to TO O
its PRP$ O
role NN O
in IN O
signal NN O
transduction NN O
. . O

-DOCSTART- X X O

Volunteers NNS O
were VBD O
irradiated VBN O
on IN O
their PRP$ O
backs NNS O
with IN O
suberythemal JJ O
UV NN O
daily RB O
for IN O
5 CD O
d NN O
after IN O
application NN O
of IN O
the DT O
sunscreens NNS O
and CC O
their PRP$ O
base NN O
lotion NN O
to TO O
different JJ O
sites NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
thus RB O
one CD O
of IN O
the DT O
key JJ O
enzymes NNS O
involved VBN O
in IN O
the DT O
triiodothyronine-mediated JJ O
control NN O
of IN O
growth NN O
, , O
differentiation NN O
and CC O
basal NN O
metabolism NN O
in IN O
vertebrates NNS O
. . O

-DOCSTART- X X O

Patients NNS O
received VBD O
either DT O
diltiazem JJ O
CD NN O
180 CD O
mg NN O
or CC O
placebo NN O
once/day RB O
in IN O
combination NN O
with IN O
existing VBG O
antianginal JJ O
therapy NN O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
B NNP O
cell NN O
apoptosis NN O
by IN O
co-cross-linking NN O
CD23 NNS B-NP
and CC O
sIg NN B-NP
involves VBZ O
aberrant JJ O
regulation NN O
of IN O
c-myc JJ B-NP
and CC O
is VBZ O
inhibited VBN O
by IN O
bcl-2 NN B-NP
. . O

-DOCSTART- X X O

Because IN O
the DT O
biosynthetic JJ O
pathway NN O
to TO O
the DT O
vacuole NN O
intersects VBZ O
with IN O
the DT O
endocytic JJ O
pathway NN O
, , O
internalization NN O
of IN O
a DT O
bulk NN O
membrane NN O
endocytic JJ O
marker NN O
FM NNP O
4-64 CD O
was VBD O
assayed VBN O
in IN O
the DT O
sop NN B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

Genes NNP O
belonging VBG O
to TO O
the DT O
ras NNS B-NP
superfamily NN I-NP
encode JJ O
low-molecular-weight JJ B-NP
GTP/GDP-binding JJ I-NP
proteins NNS I-NP
that WDT O
are VBP O
highly RB O
conserved VBN O
in IN O
wide JJ O
variety NN O
of IN O
organisms NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
identify VBP O
and CC O
characterize VBP O
two CD O
overlapping JJ O
ELL NNP B-NP
functional JJ I-NP
domains NNS I-NP
that WDT O
govern VBP O
its PRP$ O
interaction NN O
with IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
and CC O
the DT O
ternary JJ O
elongation NN O
complex NN O
. . O

-DOCSTART- X X O

The DT O
position NN O
, , O
transcription NN O
orientation NN O
, , O
and CC O
imprinted JJ O
status NN O
of IN O
the DT O
genes NNS O
immediately RB O
flanking VBG O
Igf2r NNP B-NP
have VBP O
been VBN O
assessed VBN O
. . O

-DOCSTART- X X O

The DT O
MCAD NNP B-NP
nuclear JJ I-NP
receptor NN I-NP
response NN I-NP
element NN I-NP
1 CD I-NP
( -LRB- O
NRRE-1 NN B-NP
) -RRB- O
interacts VBZ O
in IN O
vitro NN O
with IN O
ERR NNP B-NP
alpha NN I-NP
expressed VBD O
in IN O
COS-7 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
gene NN O
also RB O
revealed VBD O
the DT O
presence NN O
of IN O
multiple JJ O
TATA NNP O
and CC O
CAAT NNP O
sequences NNS O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays POS O
and CC O
competition NN O
experiments NNS O
showed VBD O
that IN O
site NN O
A DT O
is VBZ O
recognized VBN O
by IN O
an DT O
NF1 JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

A DT O
specific JJ O
distal JJ O
promoter NN O
controls VBZ O
gamma-glutamyl NN B-NP
transpeptidase NN I-NP
gene NN I-NP
expression NN O
in IN O
undifferentiated JJ O
rat NN O
transformed VBN O
liver NN O
cells NNS O
. . O

-DOCSTART- X X O

Proteasomes NNS O
are VBP O
the DT O
multisubunit JJ O
protease NN O
involved VBN O
in IN O
the DT O
generation NN O
of IN O
peptides NNS O
presented VBN O
by IN O
MHC NNP B-NP
class NN I-NP
I PRP I-NP
molecules NNS I-NP
. . O

-DOCSTART- X X O

These DT O
discoloration NN O
's POS O
can MD O
be VB O
treated VBN O
in IN O
several JJ O
ways NNS O
but CC O
up RB O
to TO O
lately RB O
tooth NN O
structure NN O
had VBD O
to TO O
be VB O
removed VBN O
in IN O
an DT O
irreversible JJ O
manner NN O
in IN O
order NN O
to TO O
provide VB O
sufficient JJ O
bulk NN O
for IN O
the DT O
new JJ O
restorative JJ O
material NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
preliminary JJ O
biochemical JJ O
characterization NN O
of IN O
the DT O
T NNP B-NP
antigens NNS I-NP
encoded VBN O
by IN O
three CD O
SV40 CD O
mutants NNS O
, , O
5030 CD O
, , O
5031 CD O
, , O
and CC O
5061 CD O
, , O
each DT O
of IN O
which WDT O
have VBP O
altered VBN O
residues NNS O
within IN O
or CC O
near IN O
the DT O
ATP NNP O
binding NN O
pocket NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
RXRalphaF318A NNP B-NP
constitutive NN O
activity NN O
generated VBD O
within IN O
heterodimers NNS O
in IN O
the DT O
presence NN O
of IN O
BMS614 NNP O
requires VBZ O
the DT O
integrity NN O
of IN O
both DT O
RXR NNP B-NP
and CC O
RAR NNP B-NP
AF-2 NNP O
domains VBZ O
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
the DT O
Src NNP B-NP
homology-2 NN I-NP
( -LRB- O
SH2 NNP B-NP
) -RRB- O
domain-containing NN O
protein-tyrosine NN B-NP
phosphatase NN I-NP
, , O
SHP-2 NNP B-NP
, , O
associates NNS O
with IN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
PECAM-1 NN B-NP
as IN O
it PRP O
becomes VBZ O
tyrosine-phosphorylated JJ O
during IN O
platelet NN O
aggregation NN O
: : O
a DT O
process NN O
that WDT O
can MD O
be VB O
mimicked VBN O
in IN O
part NN O
by IN O
small JJ O
synthetic JJ O
phosphopeptides NNS O
corresponding JJ O
to TO O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
PECAM-1 NN B-NP
encompassing VBG O
tyrosine FW O
residues NNS O
Tyr-663 JJ O
or CC O
Tyr-686 NNP O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
multiple JJ O
tumor NN O
suppressor NN O
genes NNS O
( -LRB- O
e NN O
.g. NN O
, , O
p53 NN B-NP
, , O
DCC NNP B-NP
, , O
APC NNP B-NP
, , O
MCC NNP B-NP
, , O
BRCA1 NNP B-NP
, , O
and CC O
WAF1/CIP1 NNP B-NP
) -RRB- O
were VBD O
inactivated VBN O
at IN O
different JJ O
frequencies NNS O
via IN O
various JJ O
mechanisms NNS O
[e IN O
.g. NNP O
, , O
loss NN O
of IN O
heterozygosity NN O
( -LRB- O
LOH) NNP O
, , O
loss NN O
of IN O
expression NN O
( -LRB- O
LOE) NNP O
, , O
mutation NN O
, , O
and CC O
inactivation NN O
by IN O
cellular JJ O
binding JJ O
protein] NN O
. . O

-DOCSTART- X X O

Because IN O
the DT O
deletion NN O
included VBD O
the DT O
TK NNP B-NP
gene NN I-NP
, , O
selection NN O
with IN O
gancyclovir NN O
against IN O
cells NNS O
not RB O
having VBG O
undergone VBN O
recombination NN O
was VBD O
possible JJ O
. . O

-DOCSTART- X X O

Fermentation NNP O
process NN O
after IN O
supplementation NN O
of IN O
nitrate JJ O
, , O
nitrite JJ O
, , O
lactic JJ O
acid NN O
bacteria NNS O
and CC O
formic JJ O
acid NN O

-DOCSTART- X X O

The DT O
Trx-CT NNP B-NP
fusion NN O
protein NN O
was VBD O
produced VBN O
less RBR O
efficiently RB O
( -LRB- O
20 CD O
% NN O
of IN O
total JJ O
soluble JJ O
cellular JJ O
protein NN O
) -RRB- O
. . O

-DOCSTART- X X O

U4/U6 DT B-NP
snRNP NN O
is VBZ O
one CD O
of IN O
four CD O
essential JJ O
small JJ O
nuclear JJ O
ribonucleoprotein NN O
( -LRB- O
snRNP NN O
) -RRB- O
particles NNS O
( -LRB- O
U1 NNP B-NP
, , O
U2 NNP B-NP
, , O
U5 . B-NP
and CC O
U4/U6) JJ B-NP
present NN O
in IN O
the DT O
spliceosome JJ O
. . O

-DOCSTART- X X O

We PRP O
cloned VBD O
a DT O
complete JJ O
cDNA NN O
( -LRB- O
2.9 CD O
kb NN O
) -RRB- O
for IN O
HET NNP B-NP
from IN O
an DT O
MCF-7 JJ O
cDNA NN O
library NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
ZNF74 NNP B-NP
sublocalization NN O
in IN O
nuclear JJ O
domains NNS O
enriched VBN O
in IN O
pre-mRNA JJ O
maturating NN O
factors NNS O
, , O
its PRP$ O
RNA NNP O
binding NN O
activity NN O
, , O
and CC O
its PRP$ O
direct JJ O
phosphodependent NN O
interaction NN O
with IN O
the DT O
pol NN B-NP
IIo NNP I-NP
, , O
a DT O
form NN O
of IN O
the DT O
RNA NNP B-NP
polymerase NN I-NP
functionally RB O
associated VBN O
with IN O
pre NN O
- : O
mRNA NN O
processing NN O
, , O
suggest VBP O
a DT O
role NN O
for IN O
this DT O
member NN O
of IN O
the DT O
KRAB NNP B-NP
multifinger JJ I-NP
protein NN I-NP
family NN I-NP
in IN O
RNA NNP O
processing NN O
. . O

-DOCSTART- X X O

Modulation NNP O
of IN O
AUUUA DT O
response NN O
element NN O
binding NN O
by IN O
heterogeneous JJ B-NP
nuclear JJ I-NP
ribonucleoprotein NN I-NP
A1 . I-NP
in IN O
human JJ O
T NNP O
lymphocytes NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
mutation NN O
of IN O
the DT O
Sp1 NNP B-NP
site NN I-NP
also RB O
significantly RB O
reduced VBN O
promoter NN O
activity NN O
. . O

-DOCSTART- X X O

These DT O
residues NNS O
, , O
Ile244 NNP O
at IN O
the DT O
extracellular JJ O
end NN O
of IN O
transmembrane NN O
helix NN O
3 CD O
, , O
and CC O
Tyr318 CD O
at IN O
the DT O
COOH-terminal JJ O
portion NN O
of IN O
extracellular JJ O
loop NN O
2 CD O
, , O
are VBP O
replaced VBN O
by IN O
Leu NNP O
and CC O
Ile NNP O
in IN O
the DT O
PTH-1 NN B-NP
receptor NN I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Together RB O
, , O
our PRP$ O
results NNS O
show VBP O
that IN O
tinman NN B-NP
is VBZ O
controlled VBN O
by IN O
an DT O
array NN O
of IN O
discrete JJ O
enhancer NN O
elements NNS O
that WDT O
are VBP O
activated VBN O
successively RB O
by IN O
differential JJ O
genetic JJ O
inputs NNS O
, , O
as RB O
well RB O
as IN O
by IN O
closely RB O
linked VBN O
activator NN O
and CC O
repressor NN O
binding NN O
sites NNS O
within IN O
an DT O
early-acting JJ O
enhancer NN O
, , O
which WDT O
restrict VBP O
twist NN B-NP
activity NN O
to TO O
specific JJ O
areas NNS O
within IN O
the DT O
twist NN B-NP
expression NN I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

The DT O
Fis NNP B-NP
protein NN I-NP
regulates VBZ O
site-specific JJ O
DNA NN O
inversion NN O
catalyzed VBN O
by IN O
a DT O
family NN O
of IN O
DNA NNP B-NP
invertases NNS I-NP
when WRB O
bound VBN O
to TO O
a DT O
cis-acting JJ O
recombinational JJ O
enhancer NN O
. . O

-DOCSTART- X X O

These DT O
studies NNS O
serve VBP O
as IN O
the DT O
basis NN O
for IN O
the DT O
further JJ O
characterization NN O
of IN O
the DT O
regulatory JJ O
mechanism NN O
of IN O
aromatase JJ B-NP
expression NN O
in IN O
human JJ O
breast NN O
cancer NN O
and CC O
ASCs NNP O
. . O

-DOCSTART- X X O

A DT O
second JJ O
aim NN O
was VBD O
to TO O
determine VB O
whether IN O
the DT O
decrease NN O
in IN O
muscle-tendon JJ O
unit NN O
rest NN O
length NN O
produced VBN O
by IN O
prolonged JJ O
immobilisation NN O
in IN O
a DT O
shortened JJ O
position NN O
is VBZ O
mediated VBN O
primarily RB O
by IN O
adaptations NNS O
of IN O
the DT O
muscle NN O
or CC O
tendon VB O
. . O

-DOCSTART- X X O

The DT O
lysozyme NN B-NP
FEF NNP B-NP
site NN O
is VBZ O
immediately RB O
5' VB O
to TO O
a DT O
PU. NN B-NP

-DOCSTART- X X O

Expression NN O
of IN O
thiamin NN O
biosynthetic JJ O
genes NNS O
( -LRB- O
thiCOGE NNS B-NP
) -RRB- O
and CC O
production NN O
of IN O
symbiotic JJ B-NP
terminal NN I-NP
oxidase NN I-NP
cbb3 VBD I-NP
in IN O
Rhizobium NNP O
etli NNS O
. . O

-DOCSTART- X X O

Chimeras NNS O
containing VBG O
IE1 NNP B-NP
peptides NNS I-NP
dramatically RB O
activated VBD O
transcription NN O
of IN O
the DT O
basal NN O
promoter NN O
only RB O
when WRB O
lac NN B-NP
operator NN I-NP
sequences NNS I-NP
were VBD O
present JJ O
. . O

-DOCSTART- X X O

Transfection NN O
of IN O
HepG2 NNP O
and CC O
SK-N-MC JJ O
cells NNS O
with IN O
constructs NNS O
deleted VBN O
of IN O
additional JJ O
5'-flanking JJ O
fragments NNS O
permitted VBD O
the DT O
definition NN O
of IN O
a DT O
minimal JJ O
200 CD O
bp NN O
promoter NN O
fragment NN O
containing VBG O
the DT O
pseudo-TATA JJ O
box NN O
and CC O
two CD O
putative JJ O
SP1-binding JJ B-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Epitopes NNP O
of IN O
adhesion-perturbing JJ O
monoclonal JJ O
antibodies NNS O
map NN O
within IN O
a DT O
predicted VBN O
alpha-helical JJ O
domain NN O
of IN O
the DT O
integrin NN B-NP
beta NN I-NP
1 CD I-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

Radiation NN O
decreased VBD O
the DT O
levels NNS O
of IN O
T4 NNP O
and CC O
T3 NNP O
6 CD O
h NN O
and CC O
72 CD O
h NN O
in IN O
group NN O
C NNP O
, , O
in IN O
group NN O
A DT O
at IN O
72 CD O
h NN O
, , O
in IN O
group NN O
B NN O
at IN O
24 CD O
h NN O
postexposure NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
DNA-bound NNP O
LAZ3/BCL6 NNP B-NP
recruits VBZ O
SMRT NNP B-NP
in IN O
vivo RB O
, , O
and CC O
both DT O
overexpressed JJ O
proteins NNS O
completely RB O
colocalize VBP O
in IN O
nuclear JJ O
dots NNS O
. . O

-DOCSTART- X X O

All DT O
pigs NNS O
had VBD O
significant JJ O
regional JJ O
LV NN O
dysfunction NN O
and CC O
reduced VBD O
LV NNP O
ejection NN O
fraction NN O
( -LRB- O
41+/-11 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

4 CD O
) -RRB- O
PU NNP B-NP
and CC O
PD NNP B-NP
lacked VBD O
the DT O
canonical JJ O
TATA NNP O
or CC O
CAAT NNP O
motifs NNS O
, , O
and CC O
are VBP O
AT-rich JJ O
. . O

-DOCSTART- X X O

The DT O
prescription NN O
for IN O
apoplexy NN O
includes VBZ O
C1-7 NNP O
, , O
T1-9 NNP O
and CC O
L2-4. PRP$ O

-DOCSTART- X X O

Interleukin-1 NN B-NP
levels NNS O
remained VBD O
low JJ O
throughout IN O
the DT O
course NN O
. . O

-DOCSTART- X X O

Sequences NNS O
required VBN O
for IN O
interaction NN O
of IN O
mu2 NN B-NP
and CC O
CTLA-4 NN B-NP
were VBD O
localized VBN O
to TO O
residues NNS O
, , O
161TTGVY CD O
in IN O
CTLA-4 NN B-NP
; : O
this DT O
sequence NN O
is VBZ O
N-terminal JJ O
to TO O
, , O
but CC O
overlaps RB O
with IN O
, , O
a DT O
previously RB O
identified VBN O
SH2 NNP B-NP
binding JJ I-NP
motif NN I-NP
, , O
165YVKM CD O
, , O
involved VBN O
in IN O
CTLA-4 JJ B-NP
signaling NN O
. . O

-DOCSTART- X X O

During IN O
the DT O
conditioning NN O
procedure NN O
, , O
the DT O
C-fiber NN O
reflex NN O
was VBD O
facilitated VBN O
( -LRB- O
wind-up NN O
) -RRB- O
in IN O
a DT O
stimulus-dependent JJ O
fashion NN O
in IN O
intact JJ O
, , O
anesthetized JJ O
animals NNS O
during IN O
the DT O
application NN O
of IN O
the DT O
first JJ O
seven CD O
conditioning NN O
stimuli NNS O
; : O
thereafter RB O
, , O
the DT O
magnitude NN O
of IN O
the DT O
responses NNS O
reached VBD O
a DT O
plateau NN O
and CC O
then RB O
decreased VBD O
. . O

-DOCSTART- X X O

Multiple JJ O
regression NN O
analyses NNS O
revealed VBD O
that DT O
WAIS-R JJ O
factor NN O
scores NNS O
Verbal JJ O
Comprehension NNP O
and CC O
Freedom NNP O
from IN O
Distractibility NNP O
accounted VBD O
for IN O
up RB O
to TO O
42 CD O
% NN O
of IN O
the DT O
variance NN O
in IN O
WMS-R NNP O
and CC O
CVLT NNP O
indices NNS O
. . O

-DOCSTART- X X O

In IN O
ICU NNP O
patients NNS O
, , O
the DT O
LIS NNP O
related VBN O
to TO O
the DT O
postoperative JJ O
rise NN O
in IN O
IL-6 DT B-NP
level NN O
only RB O
, , O
even RB O
though IN O
the DT O
rise NN O
in IN O
plasma NN O
concentrations NNS O
of IN O
cytokines NNS O
interrelated VBN O
. . O

-DOCSTART- X X O

The DT O
SR NNP B-NP
protein NN I-NP
family NN I-NP
is VBZ O
involved VBN O
in IN O
constitutive JJ O
and CC O
regulated JJ O
pre-mRNA JJ O
splicing NN O
and CC O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
evolutionarily RB O
conserved VBN O
in IN O
metazoan NN O
organisms NNS O
. . O

-DOCSTART- X X O

Holliday NNP B-NP
junction NN I-NP
resolvase NN I-NP
in IN O
Schizosaccharomyces NNP O
pombe NN O
has VBZ O
identical JJ O
endonuclease NN O
activity NN O
to TO O
the DT O
CCE1 NNP B-NP
homologue NN O
YDC2 NN B-NP
. . O

-DOCSTART- X X O

In IN O
Xenopus NNP O
embryos NNS O
, , O
the DT O
engineered VBN B-NP
PDGF NN I-NP
receptor NN I-NP
protein NN I-NP
induced VBD O
the DT O
formation NN O
of IN O
mesoderm NN O
from IN O
animal-pole JJ O
explants NNS O
in IN O
an DT O
FK1012-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

A DT O
genomic JJ O
clone NN O
was VBD O
isolated VBN O
that IN O
contained VBN O
12.5 CD O
kb NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
and CC O
the DT O
first JJ O
exon NN O
of IN O
the DT O
p69/71 JJ B-NP
2-5A JJ I-NP
synthetase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
clinical JJ O
study NN O
, , O
the DT O
defect NN O
size NN O
shown VBN O
by IN O
BMIPP NNP O
imaging NN O
was VBD O
greater JJR O
in IN O
anterior JJ O
than IN O
in IN O
inferior JJ O
infarcts NNS O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
and CC O
correlated VBD O
well RB O
with IN O
the DT O
risk NN O
area NN O
revealed VBN O
by IN O
contrast NN O
ventriculography NN O
( -LRB- O
r NN O
= SYM O
0.80 CD O
, , O
p NN O
< NN O
0.0001 CD O
) -RRB- O
CONCLUSION NN O
: : O
The DT O
above IN O
preliminary JJ O
data NNS O
, , O
admittedly RB O
from IN O
a DT O
small JJ O
group NN O
of IN O
patients NNS O
, , O
suggest VBP O
that IN O
tomographic JJ O
BMIPP NNP O
imaging NN O
provides VBZ O
an DT O
accurate JJ O
quantification NN O
of IN O
defect NN O
size NN O
by IN O
means NNS O
of IN O
a DT O
simple JJ O
threshold NN O
technique NN O
and CC O
, , O
in IN O
the DT O
subacute JJ O
phase NN O
, , O
permits VBZ O
determination NN O
of IN O
the DT O
amount NN O
of IN O
myocardium NN O
at IN O
risk NN O
after IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

This DT O
information NN O
, , O
together RB O
with IN O
estimation NN O
of IN O
the DT O
size NN O
of IN O
the DT O
deglycosylated JJ O
A DT O
subunit NN O
relative JJ O
to TO O
a DT O
series NN O
of IN O
C-terminal JJ B-NP
truncated JJ I-NP
TSHR NN I-NP
ectodomain NN I-NP
variants NNS I-NP
, , O
places NNS O
cleavage JJ O
Site NNP O
1 CD O
in IN O
the DT O
vicinity NN O
of IN O
, , O
or CC O
closely RB O
upstream RB O
to TO O
, , O
residue JJ O
317 CD O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
that IN O
in IN O
cultured JJ O
cells NNS O
from IN O
Drosophila NNP O
melanogaster NN O
human NN B-NP
Sp1 NNP I-NP
efficiently RB O
activates VBZ O
transcription NN O
from IN O
synthetic JJ O
promoters NNS O
containing VBG O
TATA NNP O
boxes NNS O
, , O
but CC O
not RB O
from IN O
promoters NNS O
that WDT O
contain VBP O
an DT O
initiator NN O
instead RB O
of IN O
a DT O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

No DT O
apparent JJ O
clinical JJ O
signs NNS O
indicative NN O
of IN O
systemic JJ O
toxicity NN O
were VBD O
observed VBN O
in IN O
the DT O
F0 NNP O
and CC O
F1 NNP O
animals NNS O
of IN O
either DT O
sex NN O
. . O

-DOCSTART- X X O

Such JJ O
mutations NNS O
are VBP O
thought VBN O
to TO O
exert VB O
their PRP$ O
dominant JJ O
phenotype NN O
by IN O
sequestration NN O
of IN O
the DT O
guanine NNP B-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
( -LRB- O
GNEF NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Upon IN O
analysis NN O
of IN O
various JJ O
deletion NN O
and CC O
point-mutated JJ O
variants NNS O
of IN O
the DT O
human JJ B-NP
IL-6 NN I-NP
gene NN I-NP
promoter NN I-NP
coupled VBN O
to TO O
a DT O
reporter NN O
gene NN O
, , O
we PRP O
screened VBD O
for IN O
possible JJ O
cooperating VBG O
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
purpose NN O
was VBD O
to TO O
determine VB O
if IN O
intact JJ O
perianal NN O
( -LRB- O
S4-5 '' O
) -RRB- O
pin NN O
sensation NN O
( -LRB- O
PPS) NNP O
and CC O
bulbocavernosus NN O
( -LRB- O
S2-4 NN O
) -RRB- O
reflex NN O
(BCR NN O
) -RRB- O
shortly RB O
after IN O
spinal JJ O
cord NN O
injury NN O
(SCI) NNS O
are VBP O
predictive JJ O
of IN O
bladder NN O
function NN O
recovery NN O
. . O

-DOCSTART- X X O

Platelet NNP O
aggregation NN O
in IN O
response NN O
to TO O
10 CD O
micrograms NNS O
collagen/ml NN B-NP
was VBD O
decreased VBN O
in IN O
parallel JJ O
after IN O
treatment NN O
with IN O
ASA NNP O
. . O

-DOCSTART- X X O

The DT O
inhibition NN O
of IN O
focus NN O
formation NN O
observed VBD O
in IN O
the DT O
presence NN O
of IN O
C3G NNP B-NP
was VBD O
not RB O
due JJ O
to TO O
toxic JJ O
effects NNS O
on IN O
cell NN O
viability NN O
, , O
since IN O
transfected VBN O
C3G NNP B-NP
cells NNS O
exhibited VBD O
the DT O
same JJ O
survival NN O
and CC O
growth NN O
rates NNS O
as IN O
untransfected JJ O
NIH3T3 NNP O
cells NNS O
or CC O
cells NNS O
transfected VBN O
with IN O
plasmid NN O
vector NN O
alone RB O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
direct JJ O
association NN O
with IN O
D3 DT O
phosphatidylinositides NNS O
seems VBZ O
to TO O
be VB O
essential JJ O
for IN O
activation NN O
of IN O
PKB/Akt NNP B-NP
. . O

-DOCSTART- X X O

The DT O
FMN NNP O
moiety NN O
but CC O
not RB O
the DT O
[3Fe-4S] JJ O
cluster NN O
of IN O
the DT O
subunit NN O
appears VBZ O
to TO O
participate VB O
in IN O
this DT O
reaction NN O
. . O

-DOCSTART- X X O

However RB O
, , O
laparoscopy NN O
failed VBD O
to TO O
establish VB O
inoperability NN O
in IN O
any DT O
cases NNS O
of IN O
carcinoma NN O
spread VBD O
to TO O
areas NNS O
not RB O
accessible JJ O
to TO O
laparoscopic JJ O
visualization NN O
. . O

-DOCSTART- X X O

Molecular JJ O
characterization NN O
of IN O
the DT O
50- CD O
and CC O
57-kDa JJ O
subunits NNS O
of IN O
the DT O
bovine NN B-NP
vacuolar NN I-NP
proton NN I-NP
pump NN I-NP
. . O

-DOCSTART- X X O

In IN O
C. NNP O
albicans NNS O
, , O
HST6 NNP B-NP
is VBZ O
expressed VBN O
constitutively RB O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
different JJ O
cell NN O
types NNS O
analysed CC O
(yeast NN O
, , O
hyphae NN O
, , O
white JJ O
and CC O
opaque JJ O
) -RRB- O
, , O
demonstrating VBG O
that IN O
HST6 NNP B-NP
transcription NN O
is VBZ O
not RB O
repressed VBN O
in IN O
this DT O
diploid JJ O
yeast NN O
, , O
unlike IN O
in IN O
diploid JJ O
S. NNP O
cerevisiae NN O
, , O
and CC O
suggesting VBG O
a DT O
basic JJ O
biological JJ O
function NN O
for IN O
the DT O
Hst6p JJ B-NP
transporter NN O
in IN O
C. NNP O
albicans NNS O
. . O

-DOCSTART- X X O

No DT O
TATA NNP O
box NN O
was VBD O
found VBN O
in IN O
the DT O
putative JJ O
promoter NN O
region NN O
, , O
but CC O
multiple JJ O
GC NN O
boxes NNS O
were VBD O
found VBN O
around IN O
the DT O
cap NN O
sites NNS O
, , O
supporting VBG O
the DT O
previously RB O
inferred VBN O
housekeeping NN O
nature NN O
of IN O
CYP51 NNP B-NP
gene NN I-NP
and CC O
the DT O
existence NN O
of IN O
the DT O
multiple JJ O
transcription NN O
initiation NN O
sites NNS O
. . O

-DOCSTART- X X O

Cis-regulation NNP O
downstream NN O
of IN O
cell NN O
type NN O
specification NN O
: : O
a DT O
single JJ O
compact JJ O
element NN O
controls VBZ O
the DT O
complex JJ O
expression NN O
of IN O
the DT O
CyIIa NNP B-NP
gene NN I-NP
in IN O
sea NN O
urchin IN O
embryos NNS O
. . O

-DOCSTART- X X O

Randomised VBN O
comparison NN O
of IN O
addition NN O
of IN O
autologous JJ O
bone-marrow NN O
transplantation NN O
to TO O
intensive JJ O
chemotherapy NN O
for IN O
acute JJ O
myeloid JJ O
leukaemia NN O
in IN O
first JJ O
remission NN O
: : O
results NNS O
of IN O
MRC NNP O
AML NNP O
10 CD O
trial NN O
. . O

-DOCSTART- X X O

In IN O
ferrets NNS O
naturally RB O
infected VBN O
with IN O
H. NNP O
mustelae NNS O
, , O
a DT O
single JJ O
dose NN O
( -LRB- O
50 CD O
mg/kg NN O
, , O
per IN O
os NNS O
) -RRB- O
of IN O
fluorofamide NN O
completely RB O
inhibited VBD O
bacterial JJ B-NP
urease NN I-NP
. . O

-DOCSTART- X X O

The DT O
risk NN O
factors NNS O
for IN O
hematuria NN O
in IN O
patients NNS O
with IN O
renal JJ O
hypouricemia NN O
are VBP O
the DT O
elevation NN O
of IN O
urinary JJ O
urate JJ O
concentration NN O
and CC O
the DT O
subtypes NNS O
of IN O
Post NNP O
and CC O
Secretion NNP O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Using VBG O
information NN O
in IN O
the DT O
dbEST NN O
database NN O
of IN O
expressed VBN O
sequence NN O
tags NNS O
, , O
we PRP O
isolated VBD O
an DT O
Arabidopsis NNP O
thaliana NN O
gene NN O
( -LRB- O
GCR1 NNP B-NP
) -RRB- O
that WDT O
encodes VBZ O
a DT O
protein NN O
with IN O
seven CD O
predicted VBD O
membrane-spanning NN O
domains NNS O
and CC O
other JJ O
features NNS O
characteristic JJ O
of IN O
7TM JJ B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Purification NNP O
of IN O
MvaT NNP B-NP
enriched VBD O
for IN O
two CD O
polypeptides NNS O
of IN O
approximate JJ O
molecular JJ O
mass NN O
15 CD O
kDa NN O
and CC O
16 CD O
kDa NN O
, , O
designated VBN O
P15 NNP B-NP
and CC O
P16 NNP B-NP
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Defensins NNS B-NP
, , O
also RB O
known VBN O
as IN O
human JJ B-NP
neutrophil NN I-NP
peptides NNS I-NP
, , O
are VBP O
antimicrobial JJ O
peptides NNS O
present JJ O
in IN O
the DT O
azurophil JJ O
granules NNS O
of IN O
neutrophils NNS O
. . O

-DOCSTART- X X O

The DT O
PDH NNP B-NP
complex-encoding NN I-NP
genes NNS I-NP
were VBD O
identified VBN O
by IN O
hybridization NN O
experiments NNS O
and CC O
sequence NN O
analysis NN O
in IN O
two CD O
separate JJ O
gene NN O
regions NNS O
in IN O
the DT O
genome NN O
of IN O
Z. NNP O
mobilis VBD O
. . O

-DOCSTART- X X O

Cervicovaginal JJ O
foetal NN B-NP
fibronectin NN I-NP
in IN O
the DT O
prediction NN O
of IN O
preterm JJ O
labour NN O
in IN O
a DT O
low-risk JJ O
population NN O
. . O

-DOCSTART- X X O

The DT O
RAS-cyclic JJ B-NP
AMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
cAPK NN B-NP
pathway NN O
prevents VBZ O
the DT O
UAS NNP O
activity NN O
of IN O
IREu NNP B-NP
in IN O
the DT O
presence NN O
of IN O
glucose NN O
as IN O
the DT O
sole JJ O
carbon NN O
source NN O
, , O
while IN O
the DT O
transcriptional JJ O
activators NNS O
Msn2p . B-NP
and CC O
Msn4p JJ B-NP
promote VBP O
the DT O
UAS NNP O
activity NN O
of IN O
this DT O
repeat NN O
in IN O
the DT O
presence NN O
of IN O
acetate NN O
. . O

-DOCSTART- X X O

Cytochrome NNP B-NP
b NN I-NP
in IN O
human JJ B-NP
complex NN I-NP
II NNP I-NP
( -LRB- O
succinate-ubiquinone NN B-NP
oxidoreductase NN I-NP
) -RRB- O
: : O
cDNA JJ O
cloning NN O
of IN O
the DT O
components NNS O
in IN O
liver NN O
mitochondria NN O
and CC O
chromosome NN O
assignment NN O
of IN O
the DT O
genes NNS O
for IN O
the DT O
large JJ O
( -LRB- O
SDHC NN B-NP
) -RRB- O
and CC O
small JJ O
( -LRB- O
SDHD NN B-NP
) -RRB- O
subunits NNS O
to TO O
1q21 CD O
and CC O
11q23 CD O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
promoter NN O
and CC O
androgen NN O
regulatory JJ O
sequences NNS O
required VBN O
for IN O
optimal JJ O
transcription NN O
of IN O
the DT O
rat NN O
androgen-binding CC B-NP
protein NN I-NP
gene NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
Sir NNP B-NP
proteins VBZ I-NP
from IN O
K. NNP O
lactis NN O
have VBP O
roles NNS O
in IN O
both DT O
silencing NN O
and CC O
telomere JJ O
length NN O
maintenance NN O
, , O
reflecting VBG O
conserved VBN O
functional JJ O
themes NNS O
. . O

-DOCSTART- X X O

We PRP O
recently RB O
characterized VBD O
a DT O
single JJ O
yeast NN B-NP
hnRNP NN I-NP
methyltransferase NN I-NP
( -LRB- O
HMT1 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Serum NN O
levels NNS O
of IN O
testosterone NN O
also RB O
showed VBD O
no DT O
significant JJ O
changes NNS O
by IN O
exposure NN O
to TO O
p VB O
,p'-DDE NNP O
under IN O
the DT O
conditions NNS O
of IN O
this DT O
study NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
the DT O
current JJ O
literature NN O
, , O
the DT O
mechanisms NNS O
involved VBN O
in IN O
the DT O
toxicity NN O
of IN O
OA NNP B-NP
indicate VBP O
three CD O
major JJ O
effects NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
inhibition NN O
of IN O
mitochondrial JJ O
respiration NN O
correlated VBN O
with IN O
a DT O
depletion NN O
of IN O
ATP NNP O
; : O
( -LRB- O
2 CD O
) -RRB- O
inhibition NN O
of IN O
tRNA-synthetase JJ B-NP
accompanied VBN O
by IN O
a DT O
reduced JJ O
protein NN O
synthesis NN O
; : O
and CC O
( -LRB- O
3 CD O
) -RRB- O
enhanced VBN O
lipid JJ O
peroxidation NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
restoring VBG O
checkpoint NN O
control NN O
, , O
overexpression IN O
of IN O
sum1+ NN B-NP
inhibits VBZ O
the DT O
normal JJ O
cell NN O
cycle NN O
response NN O
to TO O
osmotic JJ O
stress NN O
. . O

-DOCSTART- X X O

Decreased JJ O
levels NNS O
of IN O
alpha2-antiplasmin NN B-NP
were VBD O
also RB O
observed VBN O
in IN O
the DT O
mediastinum NN O
( -LRB- O
0.50 CD O
versus NN O
0.61 CD O
U/mL NNP O
; : O
p NN O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
the DT O
effect NN O
of IN O
acute JJ O
administration NN O
of IN O
various JJ O
doses NNS O
of IN O
malathion NN O
via IN O
oral JJ O
and CC O
dermal JJ O
routes NNS O
to TO O
mice NNS O
and CC O
rats NNS O
on IN O
serum NN O
levels NNS O
of IN O
histamine NN O
was VBD O
evaluated VBN O
. . O

-DOCSTART- X X O

Using VBG O
Southern JJ O
blot NN O
analysis NN O
and CC O
restriction NN O
mapping NN O
of IN O
genomic JJ O
YAC NNP O
(yeast JJS O
artificial JJ O
chromosome NN O
) -RRB- O
and CC O
cosmid JJ O
clones NNS O
, , O
we PRP O
located VBD O
the DT O
human JJ B-NP
RIL NNP I-NP
gene NN I-NP
240-260 CD O
kb NNS O
telomeric JJ O
to TO O
the DT O
IRF1 NNP B-NP
gene NN I-NP
and CC O
characterized VBD O
its PRP$ O
genomic JJ O
structure NN O
. . O

-DOCSTART- X X O

However RB O
, , O
mandibular JJ O
position NN O
(S-N-B NNP O
and CC O
S-N-Pog NNP O
) -RRB- O
was VBD O
found VBN O
to TO O
be VB O
significantly RB O
more JJR O
retrusive JJ O
in IN O
Class NNP O
II NNP O
when WRB O
compared VBN O
with IN O
Class NN O
I PRP O
subjects NNS O
. . O

-DOCSTART- X X O

Echinostomiasis NNP O
is VBZ O
aggravated VBN O
by IN O
socioeconomic JJ O
factors NNS O
such JJ O
as IN O
poverty NN O
, , O
malnutrition NN O
, , O
an DT O
explosively RB O
growing VBG O
free-food JJ O
market NN O
, , O
a DT O
lack NN O
of IN O
supervised JJ O
food NN O
inspection NN O
, , O
poor JJ O
or CC O
insufficient JJ O
sanitation NN O
, , O
other JJ O
helminthiases NNS O
, , O
and CC O
declining VBG O
economic JJ O
conditions NNS O
. . O

-DOCSTART- X X O

To TO O
clarify VB O
whether IN O
seizure-offset NN O
patterns NNS O
are VBP O
reliable JJ O
in IN O
predicting VBG O
seizure NN O
outcome NN O
, , O
we PRP O
studied VBD O
SEEG/ECoG NNP O
in IN O
a DT O
similar JJ O
group NN O
of IN O
patients NNS O
with IN O
temporal JJ O
lobe NN O
epilepsy NN O
( -LRB- O
TLE) NNP O
. . O

-DOCSTART- X X O

These DT O
modifications NNS O
may MD O
improve VB O
the DT O
interlaboratory JJ O
reproducibility NN O
of IN O
CD34 NNP B-NP
determinations NNS O
due JJ O
to TO O
the DT O
reduction NN O
in IN O
sample NN O
handling NN O
and CC O
calculation NN O
of IN O
results NNS O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid NN O
sequence NN O
is VBZ O
78.0 CD O
% NN O
identical JJ O
to TO O
the DT O
cytoplasmic JJ B-NP
dynein NN I-NP
heavy JJ I-NP
chain NN I-NP
of IN I-NP
Neurospora NNP I-NP
crassa NN I-NP
, , O
70.2 CD O
% NN O
identical JJ O
to TO O
that DT O
of IN O
Aspergillus NNP O
nidulans NNS O
and CC O
24.8 CD O
% NN O
identical JJ O
to TO O
that DT O
of IN O
Saccharomyces NNP O
cerevisiae NNS O
. . O

-DOCSTART- X X O

The DT O
5'-flanking JJ O
region NN O
, , O
from IN O
nucleotide JJ O
-837 NNS O
to TO O
-336 CD O
, , O
contains VBZ O
TATA NNP O
and CC O
inverted VBN O
CAAT NN O
boxes NNS O
as RB O
well RB O
as IN O
GATA-1/SP1 NNP B-NP
erythroid-specific JJ O
cis-acting JJ O
regulatory JJ O
elements NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Horses NNS O
with IN O
colic NN O
had VBD O
significantly RB O
higher JJR O
fibrinogen NN B-NP
concentration NN O
, , O
greater JJR O
alpha NN B-NP
2AP VBP I-NP
and CC O
protein NN B-NP
C NNP I-NP
activities NNS O
, , O
and CC O
longer RB O
PT NNP O
and CC O
APTT NNP O
than IN O
did VBD O
healthy JJ O
horses NNS O
. . O

-DOCSTART- X X O

The DT O
same JJ O
IL-4-inducible JJ B-NP
reporter NN O
gene NN O
is VBZ O
also RB O
synergistically RB O
activated VBN O
by IN O
the DT O
endogenous JJ B-NP
Stat6 NNP I-NP
and CC O
NF-kappaB NNP B-NP
proteins VBZ I-NP
in IN O
IL-4-stimulated JJ B-NP
I.29mu NNP O
B NNP O
lymphoma NN O
cells NNS O
. . O

-DOCSTART- X X O

Convulsive JJ O
seizure NN O
during IN O
a DT O
treatment NN O
with IN O
interferon NN B-NP
alpha NN I-NP
for IN O
chronic JJ O
viral JJ O
hepatitis NN O
C NNP O

-DOCSTART- X X O

A DT O
stratified JJ O
random JJ O
sample NN O
of IN O
20 CD O
active JJ O
employees NNS O
from IN O
a DT O
cohort NN O
of IN O
phenoxy JJ O
herbicide NN O
workers NNS O
was VBD O
selected VBN O
in IN O
1995 CD O
for IN O
determining VBG O
PCDD NNP O
and CC O
PCDF NNP O
congeners NNS O
in IN O
blood NN O
lipids NNS O
to TO O
assess VB O
the DT O
extent NN O
of IN O
past JJ O
PCDD NN O
and CC O
PCDF NN O
exposure NN O
in IN O
this DT O
cohort NN O
and CC O
whether IN O
that DT O
exposure NN O
might MD O
explain VB O
site-specific JJ O
cancer NN O
findings NNS O
in IN O
the DT O
total JJ O
cohort NN O
. . O

-DOCSTART- X X O

We PRP O
specially RB O
devised VBD O
3 CD O
types NNS O
of IN O
turbo NN O
pumps NNS O
, , O
a DT O
centrifugal JJ O
pump NN O
( -LRB- O
CFP) NNP O
, , O
a DT O
mixed JJ O
flow NN O
pump NN O
( -LRB- O
MFP) NNP O
, , O
and CC O
an DT O
axial NN O
flow NN O
pump NN O
( -LRB- O
AFP) NNP O
, , O
and CC O
analyzed VBD O
their PRP$ O
in IN O
vitro NN O
performance NN O
. . O

-DOCSTART- X X O

Two CD O
members NNS O
of IN O
the DT O
Cbl NNP B-NP
family NN I-NP
have VBP O
since IN O
been VBN O
defined VBN O
in IN O
mammals NNS O
(c-Cbl JJ O
and CC O
Cbl-b) JJ B-NP
, , O
one CD O
in IN O
C. NNP O
elegans NNS O
( -LRB- O
Sli-1 NN B-NP
) -RRB- O
and CC O
one CD O
in IN O
Drosophila NNP O
(D-Cbl NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
therapeutic JJ O
use NN O
of IN O
botulinum NN B-NP
toxin NN I-NP
( -LRB- O
Botox NN B-NP
) -RRB- O
is VBZ O
increasing VBG O
in IN O
popularity NN O
. . O

-DOCSTART- X X O

The DT O
viral JJ B-NP
oncoprotein NNP I-NP
E1A NNP I-NP
inhibits VBZ O
NFAT-dependent JJ B-NP
transactivation NN O
in IN O
a DT O
p300-dependent JJ B-NP
manner NN O
. . O

-DOCSTART- X X O

The DT O
pre-mRNA JJ O
splicing NN O
factor NN O
U2AF IN B-NP
( -LRB- O
U2 DT B-NP
small JJ I-NP
nuclear JJ I-NP
ribonucleoprotein NN I-NP
particle NN I-NP
[snRNP NNP I-NP
] SYM I-NP
auxiliary JJ I-NP
factor NN I-NP
) -RRB- O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
3' JJ O
splice NN O
site NN O
selection NN O
. . O

-DOCSTART- X X O

The DT O
second JJ O
patient NN O
had VBD O
received VBN O
pituitary-derived JJ B-NP
growth NN I-NP
hormone NN I-NP
for IN O
treatment NN O
of IN O
growth NN B-NP
hormone NN I-NP
deficiency NN O
, , O
secondary JJ O
to TO O
a DT O
third JJ O
ventricle NN O
teratoma NN O
, , O
exised VBD O
13 CD O
yr NN O
earlier JJR O
. . O

-DOCSTART- X X O

Osteoadherin NNP B-NP
is VBZ O
a DT O
recently RB O
described VBN O
bone NN O
proteoglycan NN O
containing VBG O
keratan NN O
sulfate NN O
. . O

-DOCSTART- X X O

Intron NNP O
8 CD O
harbored VBD O
a DT O
strong JJ O
erythroid-specific JJ O
enhancer NN O
activity NN O
which WDT O
was VBD O
orientation-dependent JJ O
. . O

-DOCSTART- X X O

The DT O
intron NN O
8 CD O
enhancer NN O
region NN O
was VBD O
not RB O
activated VBN O
by IN O
GATA-1 NNP B-NP
together RB O
with IN O
Sp1 NNP B-NP
in IN O
transactivation NN O
experiments NNS O
in IN O
COS-1 JJ O
cells NNS O
indicating VBG O
the DT O
involvement NN O
of IN O
a DT O
related JJ O
Sp1 JJ B-NP
protein NN I-NP
or CC O
of IN O
another DT O
unidentified JJ O
erythroid NN O
factor NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
the DT O
mass NN O
estimated VBN O
with IN O
the DT O
QCM JJ O
response NN O
through IN O
the DT O
Sauerbrey NNP O
equation NN O
and CC O
the DT O
mass NN O
which WDT O
can MD O
be VB O
measured VBN O
thanks NNS O
to TO O
other JJ O
analytical JJ O
techniques NNS O
, , O
in IN O
our PRP$ O
case NN O
an DT O
enzymatic JJ O
assay NN O
, , O
are VBP O
different JJ O
: : O
the DT O
deposited VBN O
mass NN O
is VBZ O
generally RB O
overestimated VBN O
by IN O
the DT O
QCM. NNP O

-DOCSTART- X X O

Human JJ O
isoforms NNS O
, , O
designated VBD O
1 CD O
to TO O
4 CD O
, , O
differ VBP O
from IN O
each DT O
other JJ O
by IN O
the DT O
start NN O
codon NN O
used VBN O
. . O

-DOCSTART- X X O

He PRP O
was VBD O
administered VBN O
recombinant JJ B-NP
IFN NNP I-NP
alpha-2b NN I-NP
under IN O
the DT O
diagnosis NN O
of IN O
chronic JJ O
hepatitis NN O
C. NNP O

-DOCSTART- X X O

We PRP O
then RB O
studied VBD O
four CD O
unrelated JJ O
Japanese JJ O
families NNS O
with IN O
GSD-Ib NNP O
, , O
and CC O
found VBD O
three CD O
novel JJ O
mutations NNS O
: : O
a DT O
four-base JJ O
deletion/two-base NN O
insertion NN O
, , O
a DT O
point NN O
mutation NN O
within IN O
a DT O
consensus NN O
splicing NN O
donor NN O
site NN O
, , O
and CC O
a DT O
missense NN O
mutation NN O
( -LRB- O
W118R NN O
) -RRB- O
. . O

-DOCSTART- X X O

Downregulation NN O
of IN O
FUS NNP B-NP
expression NN O
in IN O
BCR/ABL-expressing JJ B-NP
32Dcl3 JJ O
cells NNS O
was VBD O
associated VBN O
with IN O
suppression NN O
of IN O
growth NN O
factor-independent NN O
colony NN O
formation NN O
, , O
restoration NN O
of IN O
G-CSF-induced JJ B-NP
granulocytic JJ O
differentiation NN O
and CC O
reduced VBD O
tumorigenic JJ O
potential NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
with IN O
clozapine NN O
illustrate VBP O
that DT O
LI VBZ O
is VBZ O
sensitive JJ O
to TO O
antipsychotics NNS O
which WDT O
differ VBP O
in IN O
their PRP$ O
mode NN O
of IN O
action NN O
and CC O
furthermore JJR O
emphasize VBP O
the DT O
value NN O
of IN O
LI NNP O
as IN O
a DT O
test NN O
model NN O
for IN O
detecting VBG O
the DT O
antipsychotic JJ O
potential NN O
of IN O
novel JJ O
drugs NNS O
. . O

-DOCSTART- X X O

The DT O
complement NN B-NP
C3a NNP I-NP
anaphylatoxin NN I-NP
receptor NN I-NP
( -LRB- O
C3aR NN B-NP
) -RRB- O
is VBZ O
a DT O
seven-transmembrane JJ B-NP
G-protein NNP I-NP
coupled VBN I-NP
chemoattractant NN I-NP
receptor NN I-NP
that WDT O
on RP O
binding NN O
the DT O
C3a NNP B-NP
peptide NN I-NP
ligand NN I-NP
mediates NNS O
numerous JJ O
cellular JJ O
responses NNS O
, , O
including VBG O
histamine NN O
release NN O
from IN O
mast NN O
cells NNS O
. . O
smooth JJ O
muscle NN O
contraction NN O
, , O
and CC O
the DT O
directed VBN O
migration NN O
of IN O
eosinophils NNS O
. . O

-DOCSTART- X X O

The DT O
heterogeneous JJ O
nuclear JJ B-NP
ribonucleoprotein NN I-NP
C NNP I-NP
protein NN I-NP
tetramer NN I-NP
binds NNS O
U1 NNP B-NP
, , O
U2 NNP B-NP
, , O
and CC O
U6 NNP B-NP
snRNAs NNS I-NP
through IN O
its PRP$ O
high JJ O
affinity NN O
RNA NNP O
binding NN O
domain NN O
( -LRB- O
the DT O
bZIP-like JJ O
motif NN O
) -RRB- O
. . O

-DOCSTART- X X O

Acute NNP O
idiopathic JJ O
thrombocytopenic IN O
purpura NN O
presenting VBG O
a DT O
high JJ O
serum NN O
level NN O
of IN O
immunoglobulin NN B-NP
E NNP I-NP
and CC O
eosinophilia NNS O
in IN O
an DT O
elderly JJ O
patient NN O
. . O

-DOCSTART- X X O

Anesthesia NNP O
with IN O
M/K NNP O
was VBD O
reversed VBN O
after IN O
41.6 CD O
min NN O
of IN O
immobilization NN O
with IN O
atipamezole NN O
. . O

-DOCSTART- X X O

MK-801 JJ O
administration NN O
resulted VBD O
in IN O
a DT O
biphasic JJ O
response NN O
in IN O
seizure NN O
latency RB O
. . O

-DOCSTART- X X O

The DT O
binding NN O
of IN O
NF-ATp NNP B-NP
, , O
although IN O
not RB O
NF-AT4 NNP B-NP
, , O
to TO O
this DT O
enhancer NN O
also RB O
occurs VBZ O
along IN O
with IN O
HTLV-I-mediated JJ O
infection NN O
of IN O
human JJ O
peripheral NN O
blood NN O
T-cells NNS O
. . O

-DOCSTART- X X O

Peroxisome DT B-NP
proliferator-activated JJ I-NP
receptors NNS I-NP
( -LRB- O
PPAR NN B-NP
) -RRB- O
modulate VBP O
transcription NN O
by IN O
binding NN O
to TO O
specific JJ O
peroxisome JJ O
proliferator-response NN O
elements NNS O
( -LRB- O
PPRE NN O
) -RRB- O
through IN O
heterodimerization NN O
with IN O
the DT O
9-cis NNP B-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
( -LRB- O
RXR NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Co-transfection NN O
of IN O
the DT O
Sp1 NNP B-NP
expression NN O
plasmid NN O
and CC O
the DT O
-58 NNS O
promoter NN O
construct VB O
into IN O
Drosophila NNP O
Schneider NNP O
cells NNS O
revealed VBD O
that IN O
Sp1 NNP B-NP
contributed VBD O
to TO O
the DT O
kinase NN O
basal NN O
promoter NN O
activity NN O
by IN O
binding NN O
to TO O
the DT O
non-consensus JJ O
site NN O
in IN O
the DT O
-58 JJ O
region NN O
. . O

-DOCSTART- X X O

Likewise RB O
, , O
at IN O
150 CD O
degrees NNS O
C NN O
with IN O
2 CD O
% NN O
APS CC O
the DT O
surface NN O
density NN O
of IN O
NH2 JJ O
groups NNS O
reached VBD O
a DT O
maximum NN O
at IN O
24 CD O
hr NN O
and CC O
remained VBD O
relatively RB O
constant JJ O
up IN O
to TO O
96 CD O
hr NN O
. . O

-DOCSTART- X X O

Studies NNS O
using VBG O
the DT O
yeast NN O
two-hybrid JJ O
system NN O
also RB O
did VBD O
not RB O
provide VB O
evidence NN O
for IN O
the DT O
formation NN O
of IN O
a DT O
VDR-TR NNP B-NP
protein-protein NN O
interaction NN O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
either CC O
the DT O
AP-1 NN B-NP
or CC O
the DT O
ets NNS B-NP
component NN O
of IN O
this DT O
site NN O
also RB O
prevented VBD O
promoter NN O
activity NN O
in IN O
SMCs NNP O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
double JJ O
mutants NNS O
of IN O
the DT O
shy2-1D JJ B-NP
mutant NN I-NP
with IN O
the DT O
phytochrome-deficient JJ B-NP
mutants NNS O
hy2 VBP B-NP
, , O
hy3(phyB-1 JJ B-NP
) -RRB- O
and CC O
fre1-1(phyA-201 JJ B-NP
) -RRB- O
showed VBD O
reduced VBD O
photomorphogenic JJ O
response NN O
in IN O
darkness NN O
with IN O
a DT O
longer JJR O
hypocotyl NN O
, , O
a DT O
longer JJR O
inflorescence NN O
stem NN O
, , O
and CC O
a DT O
lower JJR O
level NN O
expression NN O
of IN O
the DT O
CAB NNP B-NP
gene NN I-NP
than IN O
the DT O
shy2-1D JJ B-NP
single JJ I-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

Wild-type JJ O
and CC O
mutant JJ O
MyoD NNP B-NP
were VBD O
introduced VBN O
into IN O
cells NNS O
using VBG O
an DT O
E1 NNP B-NP
, , O
E3-deleted JJ B-NP
adenoviral JJ O
vector NN O
. . O

-DOCSTART- X X O

Endoscopic NNP O
examinations NNS O
, , O
peripheral JJ O
white JJ O
blood NN O
cell NN O
( -LRB- O
WBC NNP O
) -RRB- O
counts VBZ O
, , O
and CC O
assays IN O
of IN O
myeloperoxidase NN B-NP
activity NN O
( -LRB- O
MPO NNP B-NP
) -RRB- O
in IN O
homogenates NNS O
of IN O
colon NN O
mucosa NN O
were VBD O
performed VBN O
after IN O
one CD O
week NN O
( -LRB- O
4 CD O
% NN O
DSS JJ O
model NN O
) -RRB- O
and CC O
eight CD O
weeks NNS O
( -LRB- O
1 CD O
% NN O
DSS JJ O
model NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
human JJ O
T NNP O
cell NN O
lymphotropic NN O
retrovirus NN O
type NN O
I PRP O
( -LRB- O
HTLV-I) NNP O
trans-activator NN O
, , O
Tax NNP B-NP
, , O
interacts VBZ O
specifically RB O
with IN O
the DT O
basic-domain/leucine-zipper NN B-NP
( -LRB- I-NP
bZip NN I-NP
) -RRB- I-NP
protein NN I-NP
, , O
cAMP JJ B-NP
response NN I-NP
element NN I-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
CREB) NNP B-NP
, , O
bound VBN O
to TO O
the DT O
viral JJ B-NP
Tax-responsive JJ I-NP
element NN I-NP
consisting VBG O
of IN O
three CD O
imperfect JJ O
21-base JJ O
pair NN O
repeats NNS O
, , O
each DT O
with IN O
a DT O
cAMP JJ O
response NN O
element NN O
core NN O
flanked VBN O
by IN O
G/C-rich JJ O
sequences NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
changing VBG O
the DT O
half-site JJ O
to TO O
the DT O
consensus NN O
sequence NN O
AGGTCA NNP O
( -LRB- O
IRper-1 NN O
) -RRB- O
increased VBN O
binding NN O
of IN O
AaEcR.AaUSP NNP B-NP
10-fold CC O
over IN O
IRhsp-1 NNP O
and CC O
, , O
at IN O
the DT O
same JJ O
time NN O
, , O
reduced VBD O
the DT O
stringency NN O
of IN O
the DT O
spacer NN O
length NN O
requirement NN O
, , O
with IN O
IRper-0 NNP O
to TO O
IRper-5 DT O
showing VBG O
detectable JJ O
binding NN O
. . O

-DOCSTART- X X O

Sequence NN O
comparisons NNS O
strongly RB O
suggest VBP O
that IN O
the DT O
S27a NNP B-NP
and CC O
the DT O
ubiquitin NN B-NP
coding NN O
sequences NNS O
found VBD O
in IN O
the DT O
genome NN O
of IN O
CP CD O
Rit NNP O
were VBD O
both DT O
derived VBN O
from IN O
a DT O
bovine NN O
mRNA NN O
encoding VBG O
a DT O
hybrid JJ O
protein NN O
with IN O
the DT O
structure NN O
NH2-ubiquitin-S27a-COOH. . O

-DOCSTART- X X O

J. NNP O

-DOCSTART- X X O

EGFR JJ B-NP
levels NNS O
were VBD O
found VBN O
to TO O
be VB O
elevated VBN O
5-, JJ O
3. . O

-DOCSTART- X X O

T. NNP O
, , O
Mahasneh NNP O
, , O
A. NN O
, , O
and CC O
Cote NNP O
, , O
G. NNP O

-DOCSTART- X X O

A DT O
simple JJ O
analytical JJ O
method NN O
for IN O
l-menthol JJ O
by IN O
high-performance JJ O
liquid JJ O
chromatography NN O
with IN O
a DT O
polarized JJ O
photometric JJ O
detector NN O
was VBD O
established VBN O
. . O

-DOCSTART- X X O

Although IN O
E2FBP1 NNP B-NP
lacks VBZ O
the DT O
transactivation NN O
domain NN O
, , O
it PRP O
stimulates VBZ O
E2F NNP B-NP
site-dependent NN O
transcription NN O
in IN O
cooperation NN O
with IN O
E2F-1 NN B-NP
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
chromosomal NN O
DNA NNP O
sequence NN O
immediately RB O
downstream RB O
of IN O
the DT O
transposon NN O
insertion NN O
identified VBN O
two CD O
open JJ O
reading NN O
frames NNS O
, , O
designated VBN O
csrR NN B-NP
and CC O
csrS NNS B-NP
, , O
which WDT O
exhibited VBD O
sequence NN O
similarity NN O
to TO O
bacterial JJ O
two-component JJ O
regulatory JJ O
systems NNS O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
delineated VBD O
a DT O
region NN O
in IN O
the DT O
fatty-acid JJ B-NP
synthase NN I-NP
promoter NN I-NP
, , O
which WDT O
was VBD O
responsible JJ O
for IN O
obesity-related JJ O
overexpression NN O
of IN O
the DT O
fatty-acid JJ B-NP
synthase NN I-NP
( -LRB- O
FAS NNP B-NP
) -RRB- O
gene NN O
, , O
by IN O
negatively RB O
regulating VBG O
the DT O
activity NN O
of IN O
the DT O
downstream NN O
promoter NN O
in IN O
lean JJ O
but CC O
not RB O
obese JJ O
rat NN O
fat JJ O
cells NNS O
. . O

-DOCSTART- X X O

J. NNP O

-DOCSTART- X X O

RESULTS NNS O
: : O
We PRP O
identified VBD O
a DT O
full-length JJ O
cDNA NN O
with IN O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
2883 CD O
bp NN O
corresponding JJ O
to TO O
a DT O
predicted VBD O
protein NN O
of IN O
961 CD O
amino IN O
acids NNS O
that IN O
shares NNS O
greater JJR O
than IN O
95 CD O
% NN O
homology NN O
with IN O
the DT O
rat NN B-NP
gamma-aminobutyric JJ I-NP
acid NN I-NP
B NNP I-NP
( -LRB- I-NP
GABAB) NN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

Another DT O
tentative JJ O
hotspot NN O
mutation NN O
in IN O
the DT O
third JJ O
patient NN O
, , O
a DT O
frame NN O
shift NN O
caused VBN O
by IN O
a DT O
G NNP O
nucleotide JJ O
insertion NN O
in IN O
a DT O
monotonous JJ O
repeat NN O
of IN O
six CD O
Gs NNS O
in IN O
HPRT NNP B-NP
exon NN I-NP
3 CD I-NP
, , O
has VBZ O
been VBN O
reported VBN O
previously RB O
in IN O
three CD O
other JJ O
LN NNP O
patients NNS O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
fragments NNS O
shows VBZ O
the DT O
highest JJS O
amino IN O
acid NN O
sequence NN O
homology NN O
to TO O
the DT O
insect NN O
ecdysone NN O
inducible JJ O
gene NN B-NP
E75 '' I-NP
. . O

-DOCSTART- X X O

Based VBN O
on IN O
sequence NN O
homology NN O
, , O
the DT O
genes NNS O
were VBD O
identified VBN O
as IN O
TEF NNP B-NP
, , O
encoding VBG O
translation NN B-NP
elongation NN I-NP
factor-1 NN I-NP
alpha NN I-NP
and CC O
RPS7 CD B-NP
, , O
encoding VBG O
ribosomal JJ O
protein NN O
S7. . B-NP

-DOCSTART- X X O

Fatal NN O
apneusis NN O
was VBD O
observed VBN O
under IN O
following JJ O
conditions NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
Persistent JJ O
apnea NN O
was VBD O
produced VBN O
after IN O
a DT O
single JJ O
KA NNP O
microinjection NN O
in IN O
one CD O
side NN O
of IN O
the DT O
VRG-Apa NNP O
( -LRB- O
5 CD O
animals NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Competition NN O
EMSA NNP O
established VBD O
that DT O
constitutively NN O
expressed VBN O
nuclear JJ O
proteins NNS O
bound VBN O
the DT O
KCS NNP B-NP
element NN I-NP
selectively RB O
; : O
KCS NNP B-NP
protein NN I-NP
binding NN O
activity NN O
correlated VBD O
with IN O
promoter NN O
activity NN O
in IN O
the DT O
transient NN O
transfection NN O
reporter NN O
assay NN O
. . O

-DOCSTART- X X O

Paralemmin NNP B-NP
is VBZ O
also RB O
phosphorylated VBN O
, , O
and CC O
its PRP$ O
mRNA NN O
is VBZ O
differentially RB O
spliced VBN O
in IN O
a DT O
tissue-specific JJ O
and CC O
developmentally RB O
regulated JJ O
manner NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
mechanism NN O
of IN O
activation NN O
of IN O
HIF-1alpha NNP B-NP
is VBZ O
a DT O
multi-step JJ O
process NN O
which WDT O
includes VBZ O
hypoxia-dependent JJ O
nuclear JJ O
import NN O
and CC O
activation NN O
( -LRB- O
derepression NN O
) -RRB- O
of IN O
the DT O
transactivation NN O
domain NN O
, , O
resulting VBG O
in IN O
recruitment NN O
of IN O
the DT O
CREB-binding JJ B-NP
protein NN I-NP
( -LRB- O
CBP)/p300 IN B-NP
coactivator NN B-NP
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
now RB O
well RB O
established VBN O
that IN O
progression NN O
through IN O
the DT O
eukaryotic JJ O
cell NN O
cycle NN O
is VBZ O
controlled VBN O
by IN O
oscillations NNS O
in IN O
the DT O
activity NN O
of IN O
cyclin- NNS B-NP
dependent JJ I-NP
kinases NNS I-NP
( -LRB- O
CDKs NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
hematopoietic JJ B-NP
colony-stimulating NN I-NP
factors NNS I-NP
( -LRB- O
CSF NNP B-NP
) -RRB- O
have VBP O
been VBN O
introduced VBN O
into IN O
clinical JJ O
practice NN O
as IN O
additional JJ O
supportive JJ O
measures NNS O
that WDT O
can MD O
reduce VB O
the DT O
incidence NN O
of IN O
infectious JJ O
complications NNS O
in IN O
patients NNS O
with IN O
cancer NN O
and CC O
neutropenia NN O
. . O

-DOCSTART- X X O

This DT O
model NN O
is VBZ O
supported VBN O
by IN O
experiments NNS O
showing VBG O
that IN O
Cdr2 JJ B-NP
associates NNS O
with IN O
the DT O
N-terminal JJ B-NP
regulatory JJ I-NP
domain NN I-NP
of IN I-NP
Wee1 NNP I-NP
in IN O
cell NN O
lysates NNS O
and CC O
phosphorylates NNS O
Wee1 . B-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Mean JJ O
intake NN O
of IN O
vitamin NN O
A DT O
amounted VBD O
to TO O
1.1 CD O
and CC O
0.9 CD O
mg NN O
RE/day NN O
for IN O
men NNS O
and CC O
women NNS O
, , O
respectively RB O
; : O
the DT O
contributions NNS O
of IN O
meat NN O
, , O
fats NNS O
and CC O
oils NNS O
, , O
vegetables NNS O
and CC O
dairy NN O
products NNS O
to TO O
total JJ O
intake NN O
were VBD O
35 CD O
% NN O
, , O
24 CD O
% NN O
, , O
16 CD O
% NN O
, , O
and CC O
16 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
Mig1 NNP B-NP
repressor NN I-NP
is VBZ O
a DT O
zinc NN B-NP
finger NN I-NP
protein NN I-NP
that WDT O
mediates VBZ O
glucose JJ O
repression NN O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
FCR1 NNP B-NP
gene NN I-NP
behaves VBZ O
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
drug NN O
resistance NN O
in IN O
C. NNP O
albicans NNS O
and CC O
constitute VB O
the DT O
first JJ O
evidence NN O
that IN O
FCZ NNP O
resistance NN O
can MD O
result VB O
from IN O
the DT O
inactivation NN O
of IN O
a DT O
regulatory JJ O
factor NN O
such JJ O
as IN O
Fcr1p NNP B-NP
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
late JJ O
MYO/M NNP O
is VBZ O
more RBR O
useful JJ O
than IN O
washout IN O
rate NN O
to TO O
assess VB O
the DT O
effect NN O
of IN O
treatment NN O
on IN O
heart NN O
failure NN O
due JJ O
to TO O
DCM. NNP O

-DOCSTART- X X O

With IN O
regard NN O
to TO O
the DT O
optimal JJ O
threshold NN O
values NNS O
, , O
sensitivity NN O
and CC O
specificity NN O
were VBD O
100 CD O
%/97 CD O
% NN O
and CC O
95 CD O
% NN O
/95 CD O
% NN O
with IN O
FDG NNP O
PET NNP O
, , O
compared VBN O
to TO O
86 CD O
% NN O
/92 CD O
% NN O
and CC O
77 CD O
%/8 CD O
2 CD O
% NN O
with IN O
IS NNP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Lead JJ O
fixation NN O
in IN O
dogs NNS O
achieved VBN O
with IN O
RF NNP O
energy NN O
. . O

-DOCSTART- X X O

The DT O
percutaneous JJ O
absorption NN O
of IN O
clindamycin NN O
was VBD O
studied VBN O
in IN O
healthy JJ O
male JJ O
volunteers NNS O
, , O
comparing VBG O
two CD O
investigative JJ O
clindamycin NNS O
( -LRB- O
% NN O
w/v NN O
)/tretinoin NN O
( -LRB- O
0.025 CD O
% NN O
w/v NN O
) -RRB- O
gels NNS O
, , O
containing VBG O
clindamycin NN O
phosphate NN O
ester NN O
and CC O
clindamycin VB O
HCl NNP O
, , O
respectively RB O
, , O
relative JJ O
to TO O
a DT O
clindamycin NN O
phosphate NN O
lotion NN O
( -LRB- O
1 CD O
% NN O
clindamycin NN O
; : O
Dalacin NNP O
T NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
orbitofrontal JJ O
, , O
cingulate JJ O
, , O
and CC O
anteromedial JJ O
part NN O
of IN O
the DT O
dorsal JJ O
premotor NN O
areas NNS O
were VBD O
preferentially RB O
activated VBN O
by IN O
the DT O
self-initiated JJ O
hand NN O
movement NN O
task NN O
( -LRB- O
SELF) NNP O
. . O

-DOCSTART- X X O

The DT O
active JJ O
site NN O
includes VBZ O
the DT O
acidic NN O
triad NN O
Asp53 IN O
( -LRB- O
the DT O
site NN O
of IN O
phosphorylation NN O
) -RRB- O
, , O
Asp10 NNP O
and CC O
Glu9 NNP O
. . O

-DOCSTART- X X O

Epstein-Barr NNP B-NP
virus-encoded JJ I-NP
latent JJ I-NP
membrane NN I-NP
protein NN I-NP
1 CD I-NP
activates VBZ O
the DT O
JNK NNP B-NP
pathway NN O
through IN O
its PRP$ O
extreme JJ O
C NNP O
terminus NN O
via IN O
a DT O
mechanism NN O
involving VBG O
TRADD NNP B-NP
and CC O
TRAF2 NNP B-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
using VBG O
transgenic JJ O
mouse NN O
technology NN O
we PRP O
localized VBD O
independent JJ O
cis-regulatory JJ O
elements NNS O
controlling VBG O
the DT O
tissue-specific JJ O
expression NN O
of IN O
Pax6 NNP B-NP
. . O

-DOCSTART- X X O

Interferon-alpha NNP B-NP
treatment NN O
of IN O
posttransplant NN O
lymphoproliferative NN O
disorder NN O
in IN O
recipients NNS O
of IN O
solid JJ O
organ NN O
transplants NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
the DT O
Sm-binding JJ B-NP
site NN I-NP
and CC O
stem-loop JJ O
III NNP O
structures NNS O
are VBP O
necessary JJ O
for IN O
correct JJ O
3'-end JJ O
formation NN O
. . O

-DOCSTART- X X O

Further JJ O
experiments NNS O
will MD O
be VB O
required VBN O
to TO O
highlight VB O
the DT O
in IN O
vivo JJ O
role NN O
of IN O
ELE1 NNP B-NP
in IN O
nuclear JJ O
receptor NN O
functioning NN O
. . O

-DOCSTART- X X O

A DT O
gapped JJ O
search NN O
with IN O
the DT O
C-terminal JJ O
region NN O
of IN O
CDED/LIOR NNP B-NP
revealed VBD O
a DT O
36-41 CD O
% NN O
similarity NN O
to TO O
several JJ O
proteins NNS O
related VBN O
to TO O
signal VB O
transduction NN O
and CC O
cell NN O
replication NN O
, , O
such JJ O
as IN O
ORC1 NNP B-NP
and CC O
KSR. NNP B-NP

-DOCSTART- X X O

Unitary-group NNP O
approach NN O
to TO O
spin-dependent JJ O
operators NNS O
. . O

-DOCSTART- X X O

C3 JJ B-NP
toxin NN I-NP
completely RB O
inhibited VBD O
RhoA NNP B-NP
function NN O
, , O
partially RB O
inhibited JJ O
SRE:Luc NNP O
activity NN O
, , O
but CC O
had VBD O
no DT O
effect NN O
on IN O
LPA-stimulated JJ O
c-Fos JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

Trinipatch NNP O
is VBZ O
a DT O
small JJ O
, , O
transparent JJ O
, , O
matricial JJ O
, , O
monolayer NN O
patch NN O
with IN O
an DT O
absorption NN O
promoter NN O
, , O
marketed VBD O
in IN O
two CD O
dose-strengths NNS O
( -LRB- O
5 CD O
mg/24 CD O
h NN O
and CC O
10 CD O
mg/24 JJ O
h NN O
) -RRB- O
by IN O
Laboratoires NNP O
Synthelabo NNP O
. . O

-DOCSTART- X X O

The DT O
starting VBG O
point NN O
is VBZ O
the DT O
consideration NN O
that IN O
the DT O
conceptions NNS O
underlying VBG O
the DT O
ICIDH NNP O
are VBP O
not RB O
suitable JJ O
to TO O
serve VB O
as IN O
a DT O
mainstay NN O
of IN O
a DT O
model NN O
for IN O
diagnostics NNS O
in IN O
rehabilitation NN O
because IN O
they PRP O
do VBP O
not RB O
reflect VB O
essential JJ O
characteristics NNS O
of IN O
the DT O
diagnostic JJ O
process NN O
which WDT O
is VBZ O
the DT O
basis NN O
for IN O
intervention NN O
. . O

-DOCSTART- X X O

Envelope-function NNP O
matching NN O
conditions NNS O
for IN O
GaAs/( NNP O
Al, NNP O
Ga) NNP O
As IN O
heterojunctions NNS O
. . O

-DOCSTART- X X O

NMR NNP O
of IN O
diffusing VBG O
atoms NNS O
in IN O
a DT O
periodic JJ O
porous JJ O
medium NN O
in IN O
the DT O
presence NN O
of IN O
a DT O
nonuniform JJ O
magnetic JJ O
field NN O
. . O

-DOCSTART- X X O

Microstructure NNP O
and CC O
conductivity NN O
of IN O
hierarchical JJ O
laminate JJ O
composites NNS O
. . O

-DOCSTART- X X O

Erratum NN O
: : O
Absence NN O
of IN O
precursor JJ O
effects NNS O
above IN O
the DT O
martensitic NN O
transformation NN O
in IN O
a DT O
virgin NN O
crystal NN O
of IN O
Li NNP O
metal NN O

-DOCSTART- X X O

However RB O
, , O
after IN O
PRK NNP O
at IN O
5 CD O
weeks NNS O
of IN O
age NN O
, , O
partial JJ O
retreatment NN O
may MD O
be VB O
necessary JJ O
due JJ O
to TO O
regression NN O
of IN O
the DT O
PRK NNP O
effect NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
In IN O
the DT O
ubiquitin-dependent JJ B-NP
proteolysis NN O
pathway NN O
, , O
a DT O
ubiquitin NN B-NP
ligase NN I-NP
( -LRB- O
E3 NN B-NP
) -RRB- O
is VBZ O
responsible JJ O
for IN O
substrate JJ O
selectivity NN O
and CC O
timing NN O
of IN O
degradation NN O
. . O

-DOCSTART- X X O

Quantum-statistical JJ O
theory NN O
of IN O
high-field JJ O
transport NN O
phenomena NNS O
. . O

-DOCSTART- X X O

NH3 NNP O
and CC O
NO DT O
interaction NN O
with IN O
Si( NNP O
100)-(2 CD O
x NN O
1 CD O
) -RRB- O
surfaces NNS O
. . O

-DOCSTART- X X O

Temperature NN O
dependence NN O
of IN O
the DT O
sublattice NN O
spontaneous JJ O
magnetization NN O
of IN O
YBa2Cu3O6 NNP O
. . O

-DOCSTART- X X O

Depth-controlled JJ O
grazing-incidence NN O
diffraction NN O
of IN O
synchrotron NN O
x NN O
radiation NN O
. . O

-DOCSTART- X X O

Large JJ O
scale NN O
electronic JJ O
structure NN O
calculations NNS O
. . O

-DOCSTART- X X O

Band NNP O
structure NN O
effects NNS O
of IN O
transport NN O
properties NNS O
in IN O
icosahedral JJ O
quasicrystals NNS O
. . O

-DOCSTART- X X O

Nipponbare NNP O
as RB O
well RB O
as IN O
O. NNP O
australiensis NN O
. . O

-DOCSTART- X X O

KEY NNP O
WORDS NNPS O
: : O
Melaleuca NNP O
; : O
Lake NNP O
Okeechobee NNP O
; : O
Littoral NNP O
zone NN O
; : O
Water NNP O
level NN O
; : O
Regulation NNP O
schedule NN O

-DOCSTART- X X O

These DT O
observations NNS O
of IN O
elevated JJ O
serum NN B-NP
lipase NN I-NP
and CC O
serum NN O
CA NNP B-NP
19-9 CD I-NP
in IN O
Sjogren NNP O
's POS O
syndrome NN O
without IN O
evidence NN O
of IN O
malignancy NN O
may MD O
reflect VB O
pancreatic JJ O
involvement NN O
in IN O
this DT O
disorder NN O
. . O

-DOCSTART- X X O

Calcinosis NNP O
cutis NN O
following VBG O
intravenous JJ O
infusion NN O
of IN O
calcium NN O
gluconate NN O
. . O

-DOCSTART- X X O

Medicare NNP O
SNF NNP O
benefits NNS O
revised--again NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
The DT O
MAZE-II NNP O
I PRP O
is VBZ O
the DT O
surgical JJ O
treatment NN O
of IN O
choice NN O
for IN O
medically VBG O
refractory JJ O
atrial JJ O
fibrillation NN O
. . O

-DOCSTART- X X O

This DT O
scFv NN O
was VBD O
therefore RB O
used VBN O
as IN O
control NN O
in IN O
experiments NNS O
where WRB O
another DT O
anti-Ras JJ B-NP
scFv NN I-NP
( -LRB- O
Y259 CD B-NP
scFv NN I-NP
, , O
derived VBN O
from IN O
the DT O
neutralizing JJ O
anti-Ras JJ B-NP
mAb NN I-NP
Y13-259 . I-NP
) -RRB- O
blocked VBD O
the DT O
Ras NNP B-NP
pathway NN O
in IN O
vitro NN O
and CC O
led VBD O
to TO O
tumor NN O
regression NN O
in IN O
a DT O
nude JJ O
mouse NN O
model NN O
[Cochet NN O
, , O
O. NNP O
, , O
Kenigsberg NNP O
, , O
M. NNP O
, , O
Delumeau NNP O
, , O
I. NNP O
, , O
Virone-Oddos NNP O
, , O
A. NN O
, , O
Multon NNP O
, , O
M.C. NNP O
, , O
Fridman NNP O
, , O
W.H. NNP O
, , O
Schweighoffer NNP O
, , O
F. NNP O
, , O
Teillaud NNP O
, , O
J.L. NNP O
, , O
Tocque NNP O
, , O
B. NNP O
, , O
1998 CD O
. . O

-DOCSTART- X X O

The DT O
responsive JJ O
region NN O
of IN O
the DT O
alpha NN B-NP
2(V IN I-NP
) -RRB- I-NP
collagen NN I-NP
gene NN I-NP
was VBD O
localized VBN O
to TO O
a DT O
fragment NN O
including VBG O
100 CD O
bp NN O
of IN O
basal NN O
promoter NN O
and CC O
150 CD O
bp NN O
of IN O
exon NN O
1 CD O
sequences NNS O
, , O
which WDT O
contained VBD O
two CD O
CRE-like JJ O
elements NNS O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
determine VB O
whether IN O
administration NN O
of IN O
misoprostol NN O
prevents VBZ O
gastric JJ O
hemorrhage NN O
in IN O
healthy JJ O
dogs NNS O
treated VBN O
with IN O
high JJ O
doses NNS O
of IN O
methylprednisolone NN O
sodium NN O
succinate NN O
( -LRB- O
MPSS) NNP O
. . O

-DOCSTART- X X O

( -LRB- O
i NN O
) -RRB- O
Complete NNP O
Grb10 NNP B-NP
expression NN O
from IN O
cDNA NN O
with IN O
an DT O
ecdysone-regulated JJ O
transient JJ O
expression NN O
system NN O
stimulated VBN O
PDGF-BB-, NNP B-NP
IGF-I NNP B-NP
, , O
and CC O
insulin- NNS B-NP
but CC O
not RB O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
EGF)-induced JJ B-NP
DNA NN O
synthesis NN O
in IN O
an DT O
ecdysone NN O
dose-responsive JJ O
fashion NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
In IN O
healthy JJ O
individuals NNS O
, , O
whole JJ O
body NN O
insulin NN B-NP
sensitivity NN O
is VBZ O
related VBN O
, , O
or CC O
" `` O
coupled VBN O
, , O
" '' O
to TO O
the DT O
anaerobic JJ O
threshold NN O
. . O

-DOCSTART- X X O

The DT O
intron NN O
RNA NNP O
consists VBZ O
of IN O
2492 CD O
nucleotides NNS O
which WDT O
can MD O
be VB O
folded VBN O
into IN O
a DT O
secondary JJ O
structure NN O
with IN O
all PDT O
the DT O
expected VBN O
sequence NN O
motifs NNS O
of IN O
subgroup-IIA1 JJ O
introns NNS O
( -LRB- O
Michel NNP O
et NNP O
al NN O
. . O

-DOCSTART- X X O

272 CD O
, , O
1904] CD O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
1998 CD O
Surveillance NNP O
, , O
Epidemiology NNP O
, , O
and CC O
End NN O
Results NNS O
( -LRB- O
SEER NN O
) -RRB- O
data NNS O
estimate VBP O
an DT O
83.1 CD O
% NN O
5-year JJ O
survival NN O
rate NN O
for IN O
corpus JJ O
uteri NN O
adenocarcinoma NN O
FIGO NNP O
stage NN O
II NNP O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
unstable JJ O
angina NN O
: : O
role NN O
of IN O
antithrombotic JJ O
therapy NN O
. . O

-DOCSTART- X X O

J. NNP O

-DOCSTART- X X O

Duch JJ O
, , O
and CC O
F. NNP O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
trend NN O
toward IN O
an DT O
association NN O
between IN O
IENF NNP O
and CC O
sural JJ O
nerve NN O
unmyelinated JJ O
fiber NN O
densities NNS O
( -LRB- O
r NN O
= SYM O
0.32 CD O
, , O
p NN O
= SYM O
0.054) CD O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
all DT O
three CD O
Opa NNP B-NP
proteins NNS I-NP
of IN O
C751 NNP O
bind NN O
equally RB O
well RB O
to TO O
HeLa NNP O
cells NNS O
transfected VBN O
with IN O
cDNA NN O
encoding VBG O
the DT O
carcinoembryonic JJ B-NP
antigen NN I-NP
[CEA NN O
( -LRB- O
CD66e NN B-NP
) -RRB- O
] SYM O
subgroup NN O
of IN O
the DT O
CD66 NNP B-NP
family NN I-NP
, , O
but CC O
show VBP O
distinct JJ O
tropism NN O
for IN O
CGM1- NNP B-NP
( -LRB- O
CD66d NN B-NP
) -RRB- O
and CC O
NCA NNP B-NP
( -LRB- O
CD66c)-expressing NN B-NP
cells NNS O
. . O

-DOCSTART- X X O

The DT O
proliferation-specific JJ O
HNF-3/fork NNP B-NP
head NN B-NP
homolog-11B NN I-NP
protein NN O
( -LRB- O
HFH-11B NN B-NP
; : O
also RB O
known VBN O
as IN O
Trident NNP B-NP
and CC O
Win NNP B-NP
) -RRB- O
is VBZ O
a DT O
family NN O
member NN O
of IN O
the DT O
winged JJ B-NP
helix/fork NN I-NP
head NN B-NP
transcription NN O
factors NNS O
and CC O
in IN O
regenerating VBG O
liver NN O
its PRP$ O
expression NN O
is VBZ O
reactivated VBN O
prior RB O
to TO O
hepatocyte VB O
entry NN O
into IN O
DNA NN O
replication NN O
( -LRB- O
S NNP O
phase NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
transport NN O
by IN O
sea NN O
ice NN O
from IN O
the DT O
Kara NNP O
Sea NNP O
into IN O
the DT O
Arctic NNP O
Ocean NNP O
was VBD O
assessed VBN O
by IN O
a DT O
small JJ O
subgroup NN O
at IN O
GEOMAR NNP O
. . O

-DOCSTART- X X O

Results NNS O
confirmed VBD O
that IN O
stress NN O
produced VBN O
CA3 JJ O
dendritic NN O
atrophy NN O
and CC O
tianeptine NN O
prevented VBD O
it PRP O
. . O

-DOCSTART- X X O

Studies NNS O
have VBP O
substantiated VBN O
the DT O
involvement NN O
of IN O
numerous JJ O
loci NNS O
on IN O
certain JJ O
chromosomes NNS O
; : O
in IN O
excess NN O
of IN O
10 CD O
chromosomes NNS O
are VBP O
thought VBN O
to TO O
be VB O
involved VBN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
its PRP$ O
genomic JJ O
region NN O
revealed VBD O
that IN O
the DT O
13-kb JJ O
Cdc6 NNP B-NP
gene NN I-NP
is VBZ O
divided VBN O
into IN O
12 CD O
exons NNS O
by IN O
11 CD O
introns NNS O
. . O

-DOCSTART- X X O

The DT O
availability NN O
of IN O
potent JJ O
regulatory JJ O
DNA NN O
cassettes NNS O
harboring VBG O
the DT O
murine NN B-NP
D1A DT I-NP
gene NN I-NP
promoter NN I-NP
could MD O
aid VB O
testing VBG O
the DT O
neuronal-specific JJ O
expression NN O
of IN O
transgenes NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Of IN O
these DT O
patients NNS O
, , O
46,164 CD O
were VBD O
placed VBN O
on IN O
a DT O
waiting VBG O
list NN O
for IN O
transplantation NN O
, , O
23,275 CD O
of IN O
whom WP O
received VBD O
a DT O
first JJ O
cadaveric JJ O
transplant NN O
between IN O
1991 CD O
and CC O
1997 CD O
. . O

-DOCSTART- X X O

In IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
( -LRB- O
EMSA NNP O
) -RRB- O
, , O
this DT O
GLUT4 NNP B-NP
repressor NN I-NP
element NN I-NP
( -LRB- O
G4RE NNP B-NP
) -RRB- O
generated VBD O
specific JJ O
bands NNS O
with IN O
nuclear JJ O
extracts NNS O
from IN O
preadipocytes NNS O
, , O
but CC O
not RB O
from IN O
adipocytes NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
the DT O
third JJ O
SH3 NNP B-NP
domain NN I-NP
binds NNS O
to TO O
Sos NNP B-NP
, , O
a DT O
guanine NNP B-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
for IN O
Ras NNP B-NP
and CC O
Rac NNP B-NP
, , O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

They PRP O
are VBP O
subdivided VBN O
into IN O
two CD O
types NNS O
that IN O
activate JJ O
transduction NN O
pathways NNS O
via IN O
different JJ O
cell NN O
surface NN O
receptors NNS O
. . O

-DOCSTART- X X O

Demyelinating VBG O
diseases NNS O
involving VBG O
the DT O
grey JJ O
matter NN O
were VBD O
very RB O
rare JJ O
, , O
but CC O
we PRP O
must MD O
consider VB O
the DT O
presence NN O
of IN O
symmetrical JJ O
thalamic IN O
involvement NN O
in IN O
patients NNS O
with IN O
ADEM. NNP O

-DOCSTART- X X O

In IN O
part NN O
as IN O
a DT O
result NN O
of IN O
its PRP$ O
inability NN O
to TO O
sustain VB O
radiative JJ O
loses VBZ O
, , O
the DT O
BB NNP O
resonator NN O
has VBZ O
extremely RB O
low JJ O
RF NN O
power NN O
requirements NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
the DT O
bZIP JJ B-NP
protein NN I-NP
Opaque2 NNP I-NP
( -LRB- O
O2 NN B-NP
) -RRB- O
, , O
there EX O
are VBP O
other JJ O
maize NN O
endosperm NN O
nuclear JJ O
proteins NNS O
that WDT O
recognize VBP O
the DT O
O2 NNP B-NP
box NN I-NP
in IN O
22 CD O
kDa NN O
zein NN B-NP
gene NN O
promoters NNS O
. . O

-DOCSTART- X X O

The DT O
signalling NN O
molecules NNS O
Wnt1 . B-NP
and CC O
Sonic JJ B-NP
hedgehog NN I-NP
, , O
implicated VBN O
in IN O
the DT O
activation NN O
of IN O
Myf5 CD B-NP
in IN O
myogenic JJ O
progenitor NN O
cells NNS O
in IN O
the DT O
somite NN O
, , O
are VBP O
also RB O
produced VBN O
in IN O
the DT O
viscinity NN O
of IN O
the DT O
Myf5 NNP B-NP
expression NN I-NP
domain NN I-NP
in IN O
the DT O
mesencephalon NN O
. . O

-DOCSTART- X X O

Overexpression NNP O
of IN O
CDP/cut NNP B-NP
in IN O
ROS NNP O
17/2.8 CD O
osteosarcoma NN O
cells NNS O
results NNS O
in IN O
repression NN O
of IN O
OC NNP B-NP
promoter NN I-NP
activity NN O
; : O
this DT O
repression NN O
is VBZ O
abrogated VBN O
by IN O
mutating VBG O
OC NNP B-NP
box NN I-NP
I. NN I-NP

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
the DT O
promoter NN O
region NN O
showed VBD O
no DT O
TATA NNP O
box NN O
but CC O
identified VBD O
consensus NN O
binding NN O
motifs NNS O
for IN O
Sp1 NNP B-NP
, , O
CREB NNP B-NP
, , O
and CC O
half DT O
sites NNS O
of IN O
the DT O
estrogen NN B-NP
receptor NN I-NP
binding NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Sak FW B-NP
kinase FW I-NP
gene NN O
structure NN O
and CC O
transcriptional JJ O
regulation NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
interaction NN O
of IN O
eIF4A NN B-NP
with IN O
the DT O
middle JJ O
region NN O
of IN O
eIF4GI DT B-NP
is VBZ O
necessary JJ O
for IN O
translation NN O
, , O
whereas IN O
the DT O
interaction NN O
of IN O
eIF4A NN B-NP
with IN O
the DT O
C-terminal JJ O
region NN O
plays VBZ O
a DT O
modulatory JJ O
role NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
and CC O
reverse VB O
transcription-PCR NN O
analyses NNS O
of IN O
human JJ O
mRNA NN O
samples NNS O
demonstrate VBP O
that IN O
RNR NNP B-NP
is VBZ O
expressed VBN O
exclusively RB O
in IN O
the DT O
retina NN O
, , O
with IN O
transcripts NNS O
of IN O
approximately RB O
7.5 CD O
kb NN O
, , O
approximately RB O
3.0 CD O
kb NN O
, , O
and CC O
approximately RB O
2.3 CD O
kb NN O
by IN O
Northern JJ O
blot NN O
analysis NN O
. . O

-DOCSTART- X X O

Maximum NNP O
induction NN O
of IN O
AP-1 NN B-NP
was VBD O
reached VBN O
at IN O
a DT O
concentration NN O
of IN O
250 CD O
nmol/L NN O
of IN O
CalC. NNP O

-DOCSTART- X X O

CONCLUSION NN O
: : O
In IN O
Cdks NNP B-NP
functioning NN O
throughout IN O
the DT O
cell NN O
cycle NN O
, , O
tyrosine NN O
phosphorylation NN O
is VBZ O
inhibitory JJ O
to TO O
the DT O
activation NN O
of IN O
kinase NN O
, , O
whereas IN O
the DT O
phosphorylation NN O
of IN O
threonine CD O
in IN O
the DT O
T-loop NNP O
is VBZ O
essential JJ O
for IN O
activation NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
report VBP O
that IN O
AHR NNP B-NP
interacts VBZ O
with IN O
COUP-TF NN B-NP
in IN O
transfected JJ O
CV-1 JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
single JJ O
strandedness NN O
is VBZ O
manifested VBN O
as IN O
a DT O
terminal JJ O
extension NN O
of IN O
the DT O
G-rich JJ O
strand NN O
( -LRB- O
G NNP O
tails NNS O
) -RRB- O
that WDT O
can MD O
occur VB O
independently RB O
of IN O
telomerase NN B-NP
, , O
suggesting VBG O
that IN O
cdc17/pol1 JJ B-NP
mutants NNS O
exhibit VBP O
defects NNS O
in IN O
telomeric JJ O
lagging-strand JJ O
synthesis NN O
. . O

-DOCSTART- X X O

An DT O
ASIC-chip NN O
for IN O
stereoscopic JJ O
depth NN O
analysis NN O
in IN O
video-real-time NN O
based VBN O
on IN O
visual JJ O
cortical JJ O
cell NN O
behavior NN O
. . O

-DOCSTART- X X O

The DT O
concomitant JJ O
interaction NN O
of IN O
mSTI1 NNS B-NP
with IN O
hsp70 NN B-NP
and CC O
hsp90 VBD B-NP
at IN O
its PRP$ O
N- NNP O
and CC O
C-termini NNP O
respectively RB O
is VBZ O
mediated VBN O
by IN O
the DT O
tetratricopeptide NN O
repeat NN O
( -LRB- O
TPR NNP O
) -RRB- O
motifs NNS O
in IN O
these DT O
regions NNS O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
a DT O
human JJ B-NP
alternatively NN I-NP
spliced VBD I-NP
truncated VBN I-NP
reduced VBN I-NP
folate JJ I-NP
carrier NN I-NP
increasing VBG O
folate JJ O
accumulation NN O
in IN O
parental JJ O
leukemia NN O
cells NNS O
. . O

-DOCSTART- X X O

Desmethylferrochloroquine NNP O
1a CD O
and CC O
didesmethylferrochloroquine JJ O
2 CD O
would MD O
be VB O
more RBR O
potent JJ O
against IN O
schizontocides NNS O
than IN O
CQ NNP O
in IN O
vitro NN O
against IN O
two CD O
strains NNS O
( -LRB- O
HB3 NNPS O
and CC O
Dd2 NNP O
) -RRB- O
of IN O
Plasmodium NNP O
falciparum NN O
. . O

-DOCSTART- X X O

Zebrafish JJ O
cyclops NNS B-NP
( -LRB- O
cyc NN B-NP
) -RRB- O
encodes VBZ O
a DT O
Transforming NNP B-NP
Growth NN I-NP
Factor NN I-NP
beta NN I-NP
( -LRB- O
TGFbeta NN B-NP
) -RRB- O
signaling VBG O
factor NN O
closely RB O
related VBN O
to TO O
mouse NN O
Nodal NN B-NP
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Presence NNP O
of IN O
APOE NNP B-NP
epsilon4/* NN I-NP
seems VBZ O
to TO O
increase VB O
the DT O
risk NN O
for IN O
dementia NN O
and CC O
AD NN O
independently RB O
of IN O
its PRP$ O
effect NN O
on IN O
dyslipidemia NN O
and CC O
atherogenesis NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
2.4-fold JJ O
difference NN O
in IN O
CAT NN B-NP
produced VBN O
from IN O
these DT O
transcripts NNS O
in IN O
HeLa NNP O
cells NNS O
, , O
which WDT O
contain VBP O
a DT O
greater JJR O
natural JJ O
abundance NN O
of IN O
PTB. NNP B-NP

-DOCSTART- X X O

Multiple NNP O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
signaling VBG O
pathways NNS O
connect VBP O
the DT O
cot NN B-NP
oncoprotein IN I-NP
to TO O
the DT O
c-jun NN B-NP
promoter NN I-NP
and CC O
to TO O
cellular JJ O
transformation NN O
. . O

-DOCSTART- X X O

Protein NNP O
sequence NN O
analysis NN O
reveals VBZ O
that IN O
MAN1 NNP B-NP
shares NNS O
a DT O
conserved JJ O
globular JJ O
domain NN O
of IN O
approximately RB O
40 CD O
amino IN O
acids NNS O
, , O
which WDT O
we PRP O
term VBP O
the DT O
LEM NNP B-NP
module NN I-NP
, , O
with IN O
inner JJ O
nuclear JJ O
membrane NN O
proteins VBZ O
lamina-associated JJ B-NP
polypeptide NN I-NP
2 CD I-NP
and CC O
emerin NN B-NP
. . O

-DOCSTART- X X O

In IN O
vitro NN O
expression NN O
of IN O
four CD O
different JJ O
naturally RB O
occurring VBG O
nonsense NN O
and CC O
missense NN O
mutations NNS O
revealed VBD O
a DT O
dramatically RB O
altered VBN O
subcellular JJ O
location NN O
of IN O
the DT O
protein NN O
in IN O
cultured JJ O
cells NNS O
. . O

-DOCSTART- X X O

As IN O
no DT O
complete JJ O
PPARgamma NNP B-NP
antagonists NNS O
have VBP O
been VBN O
described VBN O
hitherto PRP O
, , O
we PRP O
have VBP O
constructed VBN O
a DT O
dominant-negative JJ O
mutant NN O
receptor NN O
to TO O
inhibit VB O
wild-type JJ O
PPARgamma NNP B-NP
action NN O
. . O

-DOCSTART- X X O

EMSA NNP O
showed VBD O
that IN O
nuclear JJ O
proteins NNS O
from IN O
PC12 NN O
but CC O
not RB O
C6 NNP O
or CC O
Rat2 NNP O
cells NNS O
bind VBP O
the DT O
CRE NNP O
as IN O
a DT O
complex NN O
containing VBG O
activating JJ B-NP
transcription NN I-NP
factor NN I-NP
( -LRB- I-NP
ATF)-4 NNP I-NP
and CC O
CCAAT NNP B-NP
enhancer-binding JJ I-NP
protein NN I-NP
beta NN I-NP
, , O
while IN O
both DT O
PC12 NNP O
and CC O
C6 NNP O
cell NN O
nuclear JJ O
extracts NNS O
were VBD O
recruited VBN O
by IN O
the DT O
CCAAT-box NN O
as IN O
a DT O
complex NN O
containing VBG O
nuclear JJ B-NP
factor NN I-NP
Y PRP I-NP
. . O

-DOCSTART- X X O

National NNP O
abortion NN O
laws NNS O
usually RB O
do VBP O
not RB O
allow VB O
abortion NN O
when WRB O
a DT O
foetus NN O
is VBZ O
independently RB O
viable JJ O
, , O
i IN O
.e NN O
. . O
from IN O
a DT O
gestational JJ O
age NN O
of IN O
about IN O
24 CD O
weeks NNS O
. . O

-DOCSTART- X X O

The DT O
variations NNS O
were VBD O
caused VBN O
by IN O
opposite JJ O
shifts NNS O
in IN O
TSH NNP B-NP
frequency NN O
distribution NN O
in IN O
mothers NNS O
and CC O
neonates NNS O
. . O

-DOCSTART- X X O

Antipyretic JJ O
therapy NN O
: : O
physiologic NN O
rationale NN O
, , O
diagnostic JJ O
implications NNS O
, , O
and CC O
clinical JJ O
consequences NNS O
. . O

-DOCSTART- X X O

Cross-reaction NNP O
between IN O
a DT O
monoclonal JJ O
antibody NN O
and CC O
two CD O
alpha NN B-NP
beta NN I-NP
T NNP I-NP
cell NN I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
patients NNS O
with IN O
metastatic JJ O
melanoma NN O
are VBP O
not RB O
tolerant JJ O
to TO O
gp100 CD B-NP
Ag NNP I-NP
based VBN O
on IN O
the DT O
detection NN O
of IN O
CD8+ NNP B-NP
T NNP O
cells NNS O
specific JJ O
for IN O
multiple JJ O
HLA-A*0201-restricted JJ B-NP
, , O
gp100-derived JJ B-NP
epitopes NNS O
. . O

-DOCSTART- X X O

Following VBG O
the DT O
observation NN O
that IN O
non-organ-specific JJ O
antibodies NNS O
are VBP O
related VBN O
with IN O
pregnancy NN O
loss NN O
and CC O
preeclampsia NN O
, , O
the DT O
role NN O
of IN O
organ-specific JJ O
antibodies NNS O
is VBZ O
currently RB O
being VBG O
extensively RB O
investigated VBN O
. . O

-DOCSTART- X X O

As IN O
assessed VBN O
by IN O
a DT O
genetic JJ O
assay NN O
that WDT O
measures VBZ O
AAI-dependent JJ O
DNA NN O
binding NN O
, , O
TraM NNP B-NP
inhibited VBD O
TraR NNP B-NP
function NN O
before IN O
and CC O
after IN O
the DT O
transcription NN O
factor NN O
had VBD O
bound VBN O
to TO O
its PRP$ O
DNA NNP O
recognition NN O
site NN O
. . O

-DOCSTART- X X O

Gene NNP O
silencing NN O
associated VBN O
with IN O
repeated VBN O
DNA NNP O
sequences NNS O
has VBZ O
been VBN O
reported VBN O
for IN O
many JJ O
eukaryotes NNS O
, , O
including VBG O
plants NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
while IN O
the DT O
genomic JJ O
organization NN O
of IN O
mHuA NN B-NP
is VBZ O
similar JJ O
to TO O
the DT O
neural-restricted JJ O
members NNS O
of IN O
the DT O
Elav NNP B-NP
family NN I-NP
, , O
the DT O
promoter NN O
element NN O
differs VBZ O
substantially RB O
both DT O
by IN O
sequence NN O
analysis NN O
and CC O
transcriptional JJ O
activity NN O
in IN O
non-neural JJ O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
5' JJ O
end NN O
of IN O
the DT O
mouse NN B-NP
Elavl1 NNP I-NP
( -LRB- O
mHuA NN B-NP
) -RRB- O
gene NN O
reveals VBZ O
a DT O
transcriptional JJ O
regulatory JJ O
element NN O
and CC O
evidence NN O
for IN O
conserved VBN O
genomic JJ O
organization NN O
. . O
mHuA '' B-NP
( -LRB- O
Elavl1 NNP B-NP
) -RRB- O
belongs VBZ O
to TO O
a DT O
highly RB O
conserved VBN O
family NN O
of IN O
genes NNS O
encoding VBG O
RNA-binding JJ O
proteins NNS O
and CC O
has VBZ O
been VBN O
linked VBN O
to TO O
cell NN O
growth NN O
and CC O
proliferation NN O
through IN O
its PRP$ O
regulation NN O
of IN O
mRNA NN O
stability NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
review VB O
progress NN O
to TO O
date NN O
in IN O
this DT O
area NN O
. . O

-DOCSTART- X X O

Therefore CC O
the DT O
binding NN O
sites NNS O
for IN O
liver-enriched JJ O
factors NNS O
, , O
present JJ O
in IN O
the DT O
hamster NN B-NP
CYP7A1 IN I-NP
proximal JJ I-NP
promoter NN I-NP
in IN O
close JJ O
vicinity NN O
and CC O
conserved VBD O
between IN O
species NNS O
, , O
constitute VBP O
a DT O
regulatory JJ O
unit NN O
important JJ O
for IN O
basal NN O
hepatic JJ O
expression NN O
and CC O
tissue NN O
restriction NN O
of IN O
the DT O
action NN O
of IN O
hormones NNS O
such JJ O
as IN O
insulin NN B-NP
. . O

-DOCSTART- X X O

Molecule( JJ O
s PRP O
) -RRB- O
secreted VBN O
by IN O
neuronal JJ O
cultures NNS O
contribute VBP O
to TO O
this DT O
induction NN O
of IN O
GLT-1 JJ B-NP
, , O
but CC O
little RB O
is VBZ O
known VBN O
about IN O
the DT O
signaling VBG O
pathways NNS O
mediating VBG O
this DT O
regulation NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
icosahaedral JJ O
MVMi NNP O
capsid NN O
, , O
this DT O
sequence NN O
forms VBZ O
the DT O
carboxy JJ O
end NN O
of IN O
the DT O
amphipathic JJ O
beta-strand NN O
I PRP O
( -LRB- O
betaI IN O
) -RRB- O
, , O
and CC O
all DT O
its PRP$ O
basic JJ O
residues NNS O
are VBP O
contiguously RB O
positioned VBN O
at IN O
the DT O
face NN O
that IN O
in IN O
the DT O
unassembled JJ O
subunit NN O
would MD O
be VB O
exposed VBN O
to TO O
solvent VB O
. . O

-DOCSTART- X X O

Advanced NNP O
adenoma NN O
was VBD O
defined VBN O
as IN O
an DT O
adenoma NN O
larger JJR O
than IN O
10 CD O
mm CD O
or CC O
an DT O
adenoma NN O
of IN O
any DT O
size NN O
with IN O
villous JJ O
component NN O
, , O
high-grade JJ O
dysplasia NN O
or CC O
invasive JJ O
carcinoma NN O
. . O

-DOCSTART- X X O

In IN O
transient JJ O
assays NNS O
, , O
using VBG O
rice NN O
suspension-cultured JJ O
cells NNS O
transformed VBN O
by IN O
particle NN O
bombardment NN O
, , O
we PRP O
showed VBD O
previously RB O
that DT O
Oshox1 NNP B-NP
can MD O
transcriptionally RB O
repress VB O
the DT O
activity NN O
of IN O
reporter NN O
gene NN O
constructs NNS O
with IN O
upstream RB O
HD-Zip JJ B-NP
binding NN O
sites NNS O
. . O

-DOCSTART- X X O

Electrophile RB O
Response NN O
Elements NNS O
( -LRB- O
EpREs NNP O
) -RRB- O
, , O
located VBN O
in IN O
5'-flanking JJ O
sequences NNS O
of IN O
both DT O
the DT O
GCSh NNP B-NP
and CC O
GCSl NNP B-NP
subunit NN I-NP
genes NNS I-NP
, , O
are VBP O
hypothesized VBN O
to TO O
at IN O
least JJS O
partially RB O
mediate JJ O
gene NN O
induction NN O
following VBG O
xenobiotic JJ O
exposure NN O
. . O

-DOCSTART- X X O

TbRAB31 DT B-NP
behaviour NN O
was VBD O
also RB O
studied VBN O
during IN O
the DT O
cell NN O
cycle NN O
; : O
TbRAB31 CD B-NP
always RB O
localised VBN O
to TO O
a DT O
discrete JJ O
structure NN O
that IN O
duplicated VBN O
very RB O
early RB O
in IN O
mitosis NN O
and CC O
relocated VBD O
to TO O
daughter NN O
cells NNS O
in IN O
a DT O
coordinate VBP O
manner NN O
with IN O
the DT O
basal JJ O
body NN O
and CC O
kinetoplast NN O
, , O
suggesting VBG O
the DT O
involvement NN O
of IN O
microtubules NNS O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
T NNP I-NP
cell NN I-NP
leukemia/lymphotropic NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
Tax NNP I-NP
protein NN I-NP
represses VBZ O
MyoD-dependent JJ B-NP
transcription NN O
by IN O
inhibiting VBG O
MyoD-binding JJ B-NP
to TO O
the DT O
KIX NNP B-NP
domain NN I-NP
of IN O
p300 NN B-NP
. . O

-DOCSTART- X X O

Inhibitor-1 JJ B-NP
(I-1 NN O
) -RRB- O
and CC O
inhibitor-2 JJ B-NP
(I-2 NN O
) -RRB- O
selectively RB O
inhibit VB O
type NN B-NP
1 CD I-NP
protein NN I-NP
serine/threonine NN I-NP
phosphatases NNS I-NP
( -LRB- O
PP1 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
variety NN O
of IN O
professional JJ O
and CC O
self-applied JJ O
fluoride NN O
products NNS O
are VBP O
available JJ O
and CC O
new JJ O
fluoride NN O
delivery NN O
systems NNS O
have VBP O
recently RB O
entered VBN O
the DT O
market NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
More JJR O
than IN O
50 CD O
% NN O
of IN O
patients NNS O
with IN O
perennial JJ O
rhinitis NN O
and CC O
CRS NNP O
do VBP O
not RB O
improve VB O
after IN O
surgery NN O
, , O
a DT O
response NN O
that WDT O
may MD O
be VB O
predicted VBN O
by IN O
more JJR O
cells NNS O
expressing VBG O
IL-5 DT B-NP
mRNA NN I-NP
in IN O
the DT O
ethmoid JJ O
sinuses NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report NN O
on IN O
the DT O
isolation NN O
of IN O
ICK2 NNP B-NP
, , O
and CC O
show VB O
that IN O
it PRP O
interacts VBZ O
with IN O
Cdc2aAt JJ B-NP
, , O
but CC O
not RB O
with IN O
a DT O
second JJ O
CDK NN B-NP
from IN I-NP
Arabidopsis NNP I-NP
, , O
Cdc2bAt NNP B-NP
. . O

-DOCSTART- X X O

Recombination NNP O
, , O
replication NN O
, , O
repair NN O
: : O
from IN O
complexity NN O
to TO O
harmony NN O
. . O

-DOCSTART- X X O

The DT O
C-terminal JJ B-NP
Cdk2 NNP I-NP
truncations NNS O
, , O
however RB O
, , O
were VBD O
non-functional JJ O
in IN O
these DT O
strains NNS O
and CC O
thus RB O
dependent JJ O
for IN O
activity NN O
on IN O
the DT O
pho85 NN B-NP
coding NN I-NP
region NN I-NP
which WDT O
remained VBD O
in IN O
the DT O
mutant JJ B-NP
pho85 NN I-NP
: : O
:HIS3 CD O
chromosomal NN B-NP
locus NN I-NP
. . O

-DOCSTART- X X O

Antibodies NNS O
raised VBD O
against IN O
a DT O
C-terminal JJ O
portion NN O
of IN O
Sec31A NNP B-NP
co-precipitate NN O
Sec13 NNP B-NP
and CC O
inhibit VB O
ER-Golgi NNP O
transport NN O
of IN O
temperature-arrested JJ O
vesicular JJ O
stomatitis NN B-NP
G NNP I-NP
protein NN I-NP
in IN O
a DT O
semi-intact JJ O
cell NN O
assay NN O
. . O

-DOCSTART- X X O

This DT O
tendency NN O
is VBZ O
likely JJ O
due JJ O
to TO O
the DT O
biased VBN O
nucleotide JJ O
composition NN O
of IN O
the DT O
asparagus NN O
genome NN O
, , O
rather RB O
than IN O
to TO O
the DT O
translational JJ O
selection NN O
for IN O
specific JJ O
codons NNS O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
pituitary JJ O
vasopressin NN B-NP
V1b IN I-NP
receptors NNS I-NP
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
regulating VBG O
pituitary JJ B-NP
adrenocorticotropic NN I-NP
hormone NN I-NP
(ACTH) NN O
secretion NN O
during IN O
adaptation NN O
to TO O
stress VB O
. . O

-DOCSTART- X X O

SELECTION NNP O
CRITERIA NNP O
: : O
Randomised NNP O
trials NNS O
comparing VBG O
children NNS O
undergoing VBG O
systematic JJ O
therapy NN O
focusing VBG O
on IN O
the DT O
family NN O
in IN O
conjunction NN O
with IN O
asthma DT O
medication NN O
, , O
with IN O
children NNS O
taking VBG O
asthma DT O
medication NN O
only RB O
. . O

-DOCSTART- X X O

The DT O
models NNS O
were VBD O
tested VBN O
by IN O
studying VBG O
their PRP$ O
response NN O
to TO O
disturbances NNS O
of IN O
the DT O
afferent JJ O
signal NN O
from IN O
the DT O
bladder NN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
show VBP O
also RB O
that IN O
phagocytic JJ O
killing NN O
of IN O
meningococci NNS O
is VBZ O
probably RB O
a DT O
more RBR O
consistent JJ O
assay NN O
than IN O
antibody NN O
titer NN O
levels NNS O
for IN O
antimeningococcal JJ O
immunity NN O
, , O
especially RB O
in IN O
LCC-deficient JJ O
patients NNS O
. . O

-DOCSTART- X X O

Vancomycin NNP O
data NNS O
were VBD O
analyzed VBN O
according VBG O
to TO O
a DT O
one-compartment NN O
open JJ O
model NN O
with IN O
use NN O
of IN O
NONMEM NNP O
population NN O
pharmacokinetic JJ O
software NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
a DT O
decreased VBD O
transcription NN O
from IN O
the DT O
endogenous JJ O
c-Myb NN B-NP
promoter NN I-NP
was VBD O
observed VBN O
in IN O
several JJ O
HTLV-I JJ O
transformed VBN O
T-cell NN O
lines NNS O
. . O

-DOCSTART- X X O

H19 CD B-NP
and CC O
Igf2 NNP B-NP
monoallelic JJ O
expression NN O
is VBZ O
regulated VBN O
in IN O
two CD O
distinct JJ O
ways NNS O
by IN O
a DT O
shared VBN O
cis NN O
acting VBG O
regulatory JJ O
region NN O
upstream RB O
of IN O
H19 CD B-NP
. . O

-DOCSTART- X X O

The DT O
gene NN O
amplification NN O
model NN O
of IN O
Coquelle NNP O
et NNP O
al NN O
. . O

-DOCSTART- X X O

Up IN O
to TO O
95 CD O
% NN O
of IN O
the DT O
total JJ O
UV NN O
exposure NN O
received VBN O
is VBZ O
in IN O
the DT O
UV-A JJ O
waveband NN O
( -LRB- O
320-400 CD O
nm NN O
) -RRB- O
. . O

-DOCSTART- X X O

Among IN O
genes NNS O
induced VBN O
by IN O
added JJ O
pMesogenin1 NN B-NP
is VBZ O
Xwnt-8 CD B-NP
, , O
a DT O
signaling VBG O
factor NN O
that WDT O
induces VBZ O
a DT O
similar JJ O
repertoire NN O
of IN O
marker NN O
genes NNS O
and CC O
a DT O
similar JJ O
cellular JJ O
phenotype NN O
. . O

-DOCSTART- X X O

Accordingly RB O
, , O
no DT O
Ha-ras NNP B-NP
codon NN I-NP
12 CD I-NP
mutations NNS O
are VBP O
found VBN O
in IN O
the DT O
EtNU-induced JJ O
mammary NN O
tumors NNS O
. . O

-DOCSTART- X X O

The DT O
cellular JJ O
part NN O
of IN O
the DT O
third JJ O
chimeric JJ O
clone NN O
shows VBZ O
significant JJ O
homology NN O
to TO O
an DT O
exon NN O
of IN O
the DT O
human JJ B-NP
tyrosine NN I-NP
phosphatase NN I-NP
1 CD I-NP
gene NN I-NP
, , O
although IN O
oriented VBN O
in IN O
the DT O
antisense JJ O
direction NN O
compared VBN O
to TO O
the DT O
adjacent JJ O
LTR. NNP O

-DOCSTART- X X O

Phosphorylation NNP O
of IN O
tyrosine NN O
residues NNS O
in IN O
the DT O
kinase NN O
domain NN O
and CC O
juxtamembrane JJ O
region NN O
regulates VBZ O
the DT O
biological JJ O
and CC O
catalytic JJ O
activities NNS O
of IN O
Eph NNP B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
MAP NNP B-NP
kinase NN I-NP
stimulates VBZ O
the DT O
hPL-B NN B-NP
enhancer NN I-NP
by IN O
an DT O
NF-IL-6-dependent JJ B-NP
pathway NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
acute JJ O
, , O
mid-cervical JJ O
spinal JJ O
cord NN O
lesions NNS O
on IN O
neuronal JJ O
and CC O
reflex JJ O
activity NN O
evoked VBN O
by IN O
the DT O
noxious JJ O
visceral JJ O
stimulus NN O
, , O
colorectal NN O
distension NN O
( -LRB- O
CRD NNP O
; : O
80 CD O
mmHg JJ O
, , O
20 CD O
s PRP O
) -RRB- O
, , O
was VBD O
determined VBN O
in IN O
halothane-anesthetized JJ O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
administration NN O
of IN O
the DT O
GnRH NNP B-NP
agonist NN O
reduced VBD O
the DT O
bone NN O
mineral NN O
density NN O
in IN O
the DT O
whole JJ O
femur NN O
to TO O
91.0 CD O
% NN O
of IN O
that DT O
in IN O
the DT O
control NN O
group NN O
. . O

-DOCSTART- X X O

When WRB O
the DT O
LCx NNP O
was VBD O
partially RB O
occluded VBN O
, , O
mild JJ O
PM-induced JJ O
tachycardia NN O
resulted VBD O
in IN O
decreased VBN O
AoP NNP O
( -LRB- O
P=0.045 NNP O
) -RRB- O
as RB O
well RB O
as IN O
in IN O
decreased VBN O
SV NNP O
( -LRB- O
P=0.048 NN O
) -RRB- O
; : O
the DT O
LVEDP NNP O
remained VBD O
high JJ O
( -LRB- O
P=0.002 NN O
) -RRB- O
. . O

-DOCSTART- X X O

GAP NNP O
JUNCTIONS NNP O
IN IN O
THE DT O
BRAIN NN O
: : O
PREFACE. . O

-DOCSTART- X X O

In IN O
hemodialyzed JJ O
patients NNS O
( -LRB- O
Epo NNP B-NP
and CC O
Non-Epo JJ O
group NN O
) -RRB- O
leptin NN B-NP
levels NNS O
were VBD O
significantly RB O
higher JJR O
when WRB O
compared VBN O
to TO O
CAPD NNP O
patients NNS O
( -LRB- O
Epo NNP B-NP
and CC O
Non-Epo JJ O
group NN O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

Screening VBG O
, , O
counseling VBG O
, , O
and CC O
treatment NN O
for IN O
alcohol NN O
and CC O
illicit JJ O
drug NN O
use NN O
should MD O
be VB O
essential JJ O
components NNS O
in IN O
comprehensive JJ O
HBP NNP O
care NN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
example NN O
of IN O
a DT O
eukaryotic JJ O
transcription NN O
factor NN O
complex NN O
containing VBG O
both DT O
a DT O
MADS-box NNP B-NP
and CC O
a DT O
forkhead JJ B-NP
protein NN I-NP
, , O
and CC O
it PRP O
has VBZ O
important JJ O
implications NNS O
for IN O
the DT O
regulation NN O
of IN O
mammalian JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
was VBD O
designed VBN O
to TO O
evaluate VB O
the DT O
sensitivity NN O
and CC O
specificity NN O
of IN O
AMP NNP O
CT NNP O
( -LRB- O
Gen-Probe NNP O
Incorporated NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
on IN O
urogenital NN O
specimens NNS O
taken VBN O
from IN O
symptomatic JJ O
patients NNS O
and CC O
on IN O
first JJ O
void NN O
urine NN O
( -LRB- O
FVU) JJ O
specimens NNS O
from IN O
asymptomatic JJ O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
repetitive JJ O
ETn NNP B-NP
( -LRB- O
early JJ B-NP
transposon NN I-NP
) -RRB- O
family NN O
of IN O
sequences NNS O
represents VBZ O
an DT O
active JJ O
"mobile NN O
mutagen NN O
" '' O
in IN O
the DT O
mouse NN O
genome NN O
. . O

-DOCSTART- X X O

The DT O
two CD O
main JJ O
experimental JJ O
variables NNS O
were VBD O
the DT O
attended VBN O
hemifield NN O
( -LRB- O
left NN O
or CC O
right NN O
) -RRB- O
and CC O
the DT O
proportion NN O
of IN O
trials NNS O
requiring VBG O
a DT O
shift NN O
within IN O
that DT O
hemifield NN O
( -LRB- O
20 CD O
% NN O
or CC O
80 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Pharmacoeconomic JJ O
assessment NN O
of IN O
HMG-CoA JJ B-NP
reductase NN I-NP
inhibitor IN O
therapy NN O
: : O
an DT O
analysis NN O
based VBN O
on IN O
the DT O
CURVES NNP O
study NN O
. . O

-DOCSTART- X X O

SELECTION NN O
CRITERIA NN O
: : O
All DT O
controlled JJ O
trials NNS O
where WRB O
adults NNS O
with IN O
schizophrenia NN O
or CC O
similar JJ O
illnesses NNS O
were VBD O
randomised VBN O
to TO O
quetiapine VB O
, , O
placebo NN O
or CC O
other JJ O
neuroleptic JJ O
drugs NNS O
and CC O
where WRB O
clinically RB O
relevant JJ O
outcomes NNS O
were VBD O
reported VBN O
. . O

-DOCSTART- X X O

Twenty CD O
eligible JJ O
patients NNS O
with IN O
cirrhosis NN O
were VBD O
randomized VBN O
into IN O
two CD O
groups NNS O
: : O
10 CD O
patients NNS O
treated VBN O
with IN O
6 CD O
million CD O
units NNS O
of IN O
natural JJ O
IFN-beta NN B-NP
twice RB O
a DT O
week NN O
for IN O
36 CD O
months NNS O
and CC O
10 CD O
patients NNS O
without IN O
IFN NNP B-NP
therapy NN O
. . O

-DOCSTART- X X O

VaI NNP O
and CC O
VaII NNP O
co-immunoprecipitated VBD O
with IN O
ErbB2 NNP B-NP
, , O
but CC O
not RB O
with IN O
ErbB1 NNP B-NP
, , O
ErbB3 NNP B-NP
, , O
or CC O
ErbB4 NNP B-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
full-length JJ B-NP
E2F-3 NN I-NP
, , O
which WDT O
is VBZ O
expressed VBN O
only RB O
at IN O
the DT O
G1/S NNP O
boundary NN O
, , O
E2F-3B NNP B-NP
is VBZ O
detected VBN O
throughout IN O
the DT O
cell NN O
cycle NN O
with IN O
peak JJ O
levels NNS O
in IN O
GO NNP O
where WRB O
it PRP O
is VBZ O
associated VBN O
with IN O
Rb NNP B-NP
. . O

-DOCSTART- X X O

Five CD O
of IN O
the DT O
PDP1 NNP B-NP
isoforms NNS I-NP
differ VBP O
by IN O
the DT O
substitution NN O
or CC O
insertion NN O
of IN O
amino DT O
acids NNS O
at IN O
or CC O
near IN O
the DT O
N-terminal JJ O
of IN O
the DT O
protein NN O
. . O

-DOCSTART- X X O

To TO O
analyze VB O
the DT O
regulatory JJ O
activity NN O
of IN O
Gtx NNP B-NP
, , O
we PRP O
first RB O
identified VBD O
the DT O
optimal JJ O
Gtx-binding JJ B-NP
sequence NN I-NP
using VBG O
an DT O
in IN O
vitro NN O
DNA-binding NN O
assay NN O
. . O

-DOCSTART- X X O

The DT O
loss NN O
of IN O
avirulence NN O
activity NN O
because IN O
of IN O
mutations NNS O
in IN O
the DT O
acidic NN O
transcriptional JJ O
activation NN O
domain NN O
was VBD O
restored VBN O
by IN O
addition NN O
of IN O
the DT O
activation NN O
domain NN O
from IN O
the DT O
herpes NNS B-NP
simplex JJ I-NP
viral JJ I-NP
protein NN I-NP
VP16 NNS I-NP
. . O

-DOCSTART- X X O

Although IN O
there EX O
is VBZ O
little JJ O
evidence NN O
that IN O
diet NN O
composition NN O
plays VBZ O
a DT O
clinically RB O
important JJ O
role NN O
in IN O
the DT O
absorption NN O
or CC O
expenditure NN O
of IN O
energy NN O
, , O
it PRP O
does VBZ O
appear VB O
to TO O
play VB O
a DT O
role NN O
in IN O
food NN O
intake NN O
. . O

-DOCSTART- X X O

DATA NNP O
SYNTHESIS NNP O
: : O
Intracoronary NNP O
ultrasound NN O
has VBZ O
been VBN O
shown VBN O
to TO O
improve VB O
upon IN O
demonstrated VBN O
weaknesses NNS O
of IN O
coronary JJ O
angiography NN O
. . O

-DOCSTART- X X O

TB NNP O
bone NN O
area NN O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
, , O
height NN O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
, , O
years NNS O
in IN O
present JJ O
colony NN O
( -LRB- O
p NN O
= SYM O
0.03 CD O
) -RRB- O
, , O
and CC O
menses NNS O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
predicted VBD O
TB NNP O
BMC. NNP O

-DOCSTART- X X O

Viruses NNS O
were VBD O
isolated VBN O
from IN O
9 CD O
lungs NNS O
: : O
7 CD O
with IN O
PI-3V NNP O
, , O
1 CD O
with IN O
NCP NNP O
BVDV NNP O
type NN O
1 CD O
, , O
and CC O
1 CD O
with IN O
both DT O
BVHV-1 NNP O
and CC O
BVDV. NNP O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
ketamine-treated JJ O
rats NNS O
had VBD O
more RBR O
neurons NNS O
and CC O
glial JJ O
cells NNS O
surrounding VBG O
the DT O
ventricles NNS O
. . O

-DOCSTART- X X O

The DT O
differences NNS O
were VBD O
as IN O
follows VBZ O
: : O
for IN O
overall JJ O
response NN O
rate NN O
p NN O
= SYM O
0.004 CD O
; : O
power NN O
( -LRB- O
for IN O
p NN O
= SYM O
0.05 CD O
) -RRB- O
85 CD O
% NN O
; : O
for IN O
survival NN O
p NN O
= SYM O
0.09 CD O
; : O
for IN O
grade NN O
IV NNP O
granulocytopenia VBD O
p NN O
= SYM O
0.3 CD O
; : O
and CC O
for IN O
febrile JJ O
neutropenia NN O
p NN O
= SYM O
0.61 CD O
. . O

-DOCSTART- X X O

These DT O
regions NNS O
may MD O
be VB O
differentially RB O
involved VBN O
in IN O
tissue-specificity NN O
, , O
and/or CC O
circadian JJ O
regulation NN O
, , O
of IN O
the DT O
human JJ B-NP
hPer1 NN I-NP
gene NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

Genomic NNP O
and CC O
functional JJ O
characterization NN O
of IN O
the DT O
oas NNP B-NP
gene NN I-NP
family NN I-NP
encoding NN O
O-acetylserine NNP B-NP
( -LRB- I-NP
thiol NN I-NP
) -RRB- I-NP
lyases NNS I-NP
, , O
enzymes NNS O
catalyzing VBG O
the DT O
final JJ O
step NN O
in IN O
cysteine NN O
biosynthesis NN O
in IN O
Arabidopsis NNP O
thaliana NN O
. . O

-DOCSTART- X X O

Further JJ O
characterization NN O
of IN O
these DT O
putative JJ O
Hoxa-1 NN B-NP
target NN I-NP
genes NNS I-NP
will MD O
aid VB O
in IN O
delineating VBG O
the DT O
functions NNS O
of IN O
the DT O
Hoxa-1 JJ B-NP
protein NN I-NP
in IN O
the DT O
differentiation NN O
processes NNS O
which WDT O
occur VBP O
during IN O
embryogenesis NN O
. . O

-DOCSTART- X X O

The DT O
ability NN O
of IN O
U6-U57 DT B-NP
mutants NNS O
to TO O
influence VB O
the DT O
fidelity NN O
of IN O
both DT O
branch NN O
site NN O
and CC O
3' JJ O
splice NN O
site NN O
recognition NN O
suggests VBZ O
that IN O
this DT O
nucleotide NN O
may MD O
participate VB O
in IN O
the DT O
formation NN O
of IN O
the DT O
active JJ O
site( NN O
s VBZ O
) -RRB- O
of IN O
the DT O
spliceosome JJ O
. . O

-DOCSTART- X X O

Only RB O
two CD O
of IN O
27 CD O
participants NNS O
( -LRB- O
7.4 CD O
% NN O
) -RRB- O
with IN O
definite JJ O
POAG NNP O
had VBD O
been VBN O
previously RB O
diagnosed VBN O
and CC O
treated VBN O
, , O
and CC O
66.7 CD O
% NN O
of IN O
the DT O
previously RB O
undiagnosed VBN O
had VBD O
IOP RB O
less JJR O
than IN O
22 CD O
mmHg NN O
. . O

-DOCSTART- X X O

Because IN O
GH-induced JJ B-NP
Akt NNP B-NP
activation NN O
was VBD O
completely RB O
inhibited VBN O
in IN O
both DT O
cells NNS O
by IN O
the DT O
same JJ O
concentration NN O
of IN O
LY294002 CD O
, , O
these DT O
findings NNS O
indicate VBP O
that IN O
the DT O
wortmannin JJ O
sensitivity NN O
of IN O
both DT O
the DT O
IRS-1-independent JJ B-NP
and CC O
-dependent JJ O
GH-induced JJ B-NP
MAP NNP B-NP
kinase NN I-NP
activation NN O
may MD O
reflect VB O
the DT O
activity NN O
of IN O
another DT O
wortmannin-sensitive JJ O
target( NN O
s VBZ O
) -RRB- O
in IN O
addition NN O
to TO O
PI3K NNP B-NP
in IN O
mediation NN O
of IN O
GH-induced JJ B-NP
MAP NNP B-NP
kinase NN I-NP
activation NN O
in IN O
these DT O
cells NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
support VBP O
a DT O
model NN O
in IN O
which WDT O
p53 NN B-NP
protein NN I-NP
contributes VBZ O
to TO O
the DT O
maintenance NN O
of IN O
genomic JJ O
integrity NN O
through IN O
recombinational JJ O
repair NN O
. . O

-DOCSTART- X X O

Mutating VBG O
the DT O
Fcp1p-binding JJ B-NP
motif NN O
KEFGK NNP O
in IN O
the DT O
RAP74 NNP B-NP
( -LRB- O
Tfg1p NN B-NP
) -RRB- O
subunit NN O
of IN O
TFIIF NNP B-NP
to TO O
EEFGE NNP O
led VBD O
to TO O
both DT O
synthetic JJ O
phenotypes NNS O
in IN O
certain JJ O
fcp1 NNS B-NP
tfg1 VBP B-NP
double JJ O
mutants NNS O
and CC O
a DT O
reduced VBN O
ability NN O
of IN O
Fcp1p NNP B-NP
to TO O
activate VB O
transcription NN O
when WRB O
it PRP O
is VBZ O
artificially RB O
tethered VBN O
to TO O
a DT O
promoter NN O
. . O

-DOCSTART- X X O

Recombinant NNP O
AROM-p64 NNP B-NP
displayed VBD O
high JJ O
binding NN O
to TO O
single-stranded JJ O
DNA NNP O
and CC O
poly( JJ O
A DT O
) -RRB- O
homopolymers NNS O
suggesting VBG O
that IN O
this DT O
protein NN O
could MD O
play VB O
a DT O
role NN O
in IN O
mRNA NN O
maturation/metabolism NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
now RB O
estimated VBN O
that IN O
inactivation NN O
mutants NNS O
of IN O
PTEN NNP B-NP
exist VBP O
in IN O
60 CD O
% NN O
of IN O
all DT O
forms NNS O
of IN O
solid JJ O
tumors NNS O
. . O

-DOCSTART- X X O

Src NNP B-NP
activation NN O
induced VBN O
by IN O
FGF1 NNP B-NP
was VBD O
blocked VBN O
by IN O
the DT O
SH2 NNP B-NP
domain NN I-NP
of IN O
Src NNP B-NP
and CC O
PP2 NNP B-NP
, , O
a DT O
specific JJ O
inhibitor NN O
of IN O
Src NNP B-NP
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
the DT O
PLCgamma NNP B-NP
inhibitory NN I-NP
peptide NN I-NP
, , O
neomycin NN O
and CC O
the DT O
calcium NN O
chelator NN O
BAPTA-AM NNP O
on IN O
oocytes NNS O
expressing VBG O
FGFR1 NNP B-NP
or CC O
the DT O
stimulation NN O
by IN O
PDGF-BB NNP B-NP
of IN O
oocytes NNS O
expressing VBG O
PDGFR-FGFR1 JJ B-NP
mutated JJ O
on IN O
the DT O
PLCgamma NNP B-NP
binding NN I-NP
site NN I-NP
, , O
prevented VBD O
GVBD NNP O
and CC O
ERK2 NNP B-NP
phosphorylation NN O
. . O

-DOCSTART- X X O

HYPOTHESIS NNP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
oxidative JJ O
susceptibility NN O
of IN O
apolipoprotein NN B-NP
B-containing JJ I-NP
lipoproteins NNS I-NP
and CC O
antioxidant JJ O
status NN O
in IN O
patients NNS O
with IN O
acute JJ O
coronary JJ O
syndromes NNS O
and CC O
chronic NN O
stable JJ O
angina NN O
pectoris NN O
. . O

-DOCSTART- X X O

We PRP O
cloned VBD O
a DT O
DNA NNP O
fragment NN O
encoding VBG O
the DT O
N-terminal JJ O
part NN O
of IN O
a DT O
protein NN O
with IN O
significant JJ O
similarity NN O
to TO O
members NNS O
of IN O
the DT O
LysR NNP B-NP
family NN I-NP
of IN I-NP
transcriptional JJ I-NP
regulators NNS I-NP
( -LRB- O
LTTRs NNS B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
a DT O
dominant JJ B-NP
negative JJ I-NP
Smad2 NN I-NP
significantly RB O
reduces VBZ O
the DT O
level NN O
of IN O
luciferase JJ B-NP
reporter NN I-NP
activity NN O
induced VBN O
by IN O
nodal JJ O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
Drosophila NNP B-NP
melanogaster NN I-NP
suppressor NN I-NP
of IN I-NP
sable JJ I-NP
gene NN I-NP
, , O
su(s NNS B-NP
) -RRB- I-NP
, , O
encodes VBZ O
a DT O
novel NN O
, , O
150-kDa JJ O
nuclear JJ O
RNA NNP O
binding JJ O
protein NN O
, , O
SU(S) NNP B-NP
, , O
that WDT O
negatively RB O
regulates VBZ O
RNA NNP O
accumulation NN O
from IN O
mutant JJ O
alleles NNS O
of IN O
other JJ O
genes NNS O
that WDT O
have VBP O
transposon NN O
insertions NNS O
in IN O
the DT O
5' JJ O
transcribed JJ O
region NN O
. . O

-DOCSTART- X X O

As IN O
a DT O
result NN O
, , O
we PRP O
have VBP O
defined VBN O
two CD O
arginine-rich JJ O
motifs NNS O
( -LRB- O
ARM1 NN O
and CC O
ARM2 NN O
) -RRB- O
that WDT O
mediate VBP O
the DT O
RNA NNP O
binding NN O
activity NN O
of IN O
SU(S NNP B-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

This DT O
interaction NN O
inhibits VBZ O
the DT O
histone NN B-NP
acetyltransferase NN I-NP
activity NN O
of IN O
p300 NN B-NP
, , O
resulting VBG O
in IN O
drastic JJ O
reduction NN O
of IN O
nucleosomal JJ O
histone NN B-NP
acetylation NN O
and CC O
alteration NN O
of IN O
chromatin NN O
structure NN O
. . O

-DOCSTART- X X O

Both DT O
the DT O
Cmax NNP O
and CC O
AUC NNP O
values NNS O
were VBD O
almost RB O
doubled VBN O
with IN O
doubling VBG O
the DT O
dose NN O
. . O

-DOCSTART- X X O

Diary NNP O
. . O

-DOCSTART- X X O

In IN O
transient JJ O
analysis NN O
using VBG O
particle NN O
bombardment NN O
of IN O
tobacco NN O
leaf NN O
sections NNS O
, , O
a DT O
tetramer NN O
of IN O
the DT O
distB NN O
ABRE RB O
( -LRB- O
abscisic JJ O
acid-responsive JJ O
element NN O
) -RRB- O
mediated VBN O
transactivation NN O
by IN O
ABI3 NNP B-NP
and CC O
ABI3-dependent JJ B-NP
response NN O
to TO O
ABA NNP O
, , O
whereas IN O
a DT O
tetramer NN O
of IN O
the DT O
composite JJ O
RY/G NNP O
complex NN O
, , O
containing VBG O
RY NN O
repeats NNS O
and CC O
a DT O
G-box NN O
, , O
mediated VBN O
only RB O
ABA-independent JJ O
transactivation NN O
by IN O
ABI3 NNP B-NP
. . O

-DOCSTART- X X O

METHODS NNS O
AND CC O
RESULTS NNS O
: : O
Studies NNS O
were VBD O
undertaken VBN O
in IN O
9 CD O
isolated JJ O
guinea NN O
pig NN O
hearts NNS O
, , O
which WDT O
demonstrated VBD O
reverse NN O
use-dependent JJ O
prolongation NN O
of IN O
cardiac JJ O
repolarization NN O
by IN O
100 CD O
nmol/L JJ O
domperidone NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
LSCC NNP O
malformation NN O
, , O
like IN O
other JJ O
inner JJ O
ear NN O
malformations NNS O
such JJ O
as IN O
large JJ O
vestibular JJ O
aqueduct NN O
and CC O
X-linked JJ O
mixed JJ O
deafness NN O
with IN O
perilymph NN O
gusher NN O
, , O
can MD O
be VB O
associated VBN O
with IN O
CHL NNP O
, , O
SNHL NNP O
, , O
or CC O
normal JJ O
hearing NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
methylation NN O
of IN O
Pph21p NN B-NP
is VBZ O
important JJ O
for IN O
formation NN O
of IN O
PP2A NNP B-NP
trimeric JJ I-NP
and CC I-NP
dimeric JJ I-NP
complexes NNS I-NP
, , O
and CC O
consequently RB O
, , O
for IN O
PP2A NNP B-NP
function NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
diamide NN O
treatment NN O
of IN O
nuclear JJ O
extracts NNS O
strongly RB O
reduces VBZ O
the DT O
binding NN O
of IN O
NFI NNP B-NP
proteins NNS I-NP
, , O
and CC O
the DT O
addition NN O
of IN O
higher JJR O
concentrations NNS O
of IN O
dithiothreitol NN O
to TO O
nuclear JJ O
extracts NNS O
from IN O
TG-treated JJ B-NP
cells NNS O
restores VBZ O
NFI-DNA NNP B-NP
binding NN O
to TO O
levels NNS O
in IN O
extracts NNS O
from IN O
untreated JJ O
cells NNS O
. . O

-DOCSTART- X X O

Further RB O
, , O
Tax-mediated NNP B-NP
apoptosis NN O
was VBD O
effectively RB O
prevented VBN O
by IN O
ectopic JJ O
expression NN O
of IN O
the DT O
p300 NN B-NP
coactivator NN I-NP
. . O

-DOCSTART- X X O

There EX O
were VBD O
no DT O
instances NNS O
of IN O
major JJ O
flap NN O
necrosis NN O
although IN O
two CD O
flaps NNS O
showed VBD O
tip NN O
ischaemia NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
factors NNS O
, , O
IRF-2 NNP B-NP
, , O
was VBD O
initially RB O
cloned VBN O
as IN O
an DT O
antagonistic JJ O
counterpart NN O
to TO O
IRF-1 NNP B-NP
with IN O
oncogenic JJ O
potential NN O
. . O

-DOCSTART- X X O

Exon NNP O
A DT O
is VBZ O
located VBN O
approximately RB O
7 CD O
kb NN O
5' CD O
to TO O
the DT O
HSL NNP B-NP
translation NN I-NP
start NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Cardiovascular NNP O
risk NN O
factors NNS O
and CC O
antihypertensive JJ O
treatment NN O
. . O

-DOCSTART- X X O

These DT O
two CD O
mAbs NNS O
used VBD O
the DT O
same JJ O
V( NNP O
H) NNP O
and CC O
J( NNP O
H) NNP O
gene NN O
segments NNS O
, , O
but CC O
different JJ O
D NNP O
, , O
Vkappa NNP O
, , O
and CC O
Jkappa NNP O
genes NNS O
. . O

-DOCSTART- X X O

Patients NNS O
had VBD O
to TO O
have VB O
adequate JJ O
liver NN O
, , O
renal NNP O
, , O
and CC O
marrow JJ O
functions NNS O
. . O

-DOCSTART- X X O

In IN O
15 CD O
ventilator-dependent NN O
, , O
SB NNP O
, , O
and CC O
actively RB O
expiring VBG O
patients NNS O
, , O
we PRP O
found VBD O
that IN O
the DT O
difference NN O
PEEP(i) NN O
,dyn IN O
- : O
Pga NN O
, , O
total JJ O
decay NN O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD RB O
, , O
5.7 CD O
+/ NN O
- : O
1.9 CD O
cm NN O
H( JJ O
2)O IN O
) -RRB- O
was VBD O
quite RB O
similar JJ O
to TO O
PEEP(i) DT O
,dyn NN O
ref NN O
( -LRB- O
5.3 CD O
+/ NN O
- : O
1.9 CD O
cm NN O
H( JJ O
2)O IN O
) -RRB- O
. . O

-DOCSTART- X X O

Of IN O
208 CD O
eligible JJ O
subjects NNS O
, , O
82 CD O
received VBD O
supervised JJ O
IPT NN O
at IN O
a DT O
dose NN O
of IN O
900 CD O
mg NN O
twice RB O
weekly JJ O
for IN O
6 CD O
mo NN O
( -LRB- O
Regimen NNP O
A) NNP O
, , O
73 CD O
received VBD O
unsupervised JJ O
IPT NNP O
900 CD O
mg NN O
twice RB O
weekly JJ O
for IN O
6 CD O
mo NN O
( -LRB- O
Regimen NNP O
B) NNP O
, , O
and CC O
53 CD O
received VBD O
unsupervised JJ O
IPT NNP O
300 CD O
mg JJ O
daily JJ O
for IN O
6 CD O
mo NN O
( -LRB- O
Regimen NNP O
C NNP O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
dynamic JJ O
response NN O
strongly RB O
suggests VBZ O
that IN O
the DT O
p53 NN B-NP
and CC O
Rb NN B-NP
tumor NN O
suppressor NN O
pathways NNS O
are VBP O
intact JJ O
in IN O
HeLa NNP O
cells NNS O
and CC O
that DT O
repression NN O
of IN O
HPV NNP B-NP
E6 NNP I-NP
and CC O
E7 DT B-NP
mobilizes VBZ O
these DT O
pathways NNS O
in IN O
an DT O
orderly JJ O
fashion NN O
to TO O
deliver VB O
growth NN O
inhibitory NN O
signals NNS O
to TO O
the DT O
cells NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
blocks NNS O
in IN O
the DT O
RARalpha-specific JJ B-NP
pathway NN O
of IN O
retinoid-induced JJ O
differentiation NN O
may MD O
be VB O
bypassed VBN O
during IN O
retinoid JJ O
induction NN O
of IN O
FR-beta JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

To TO O
test VB O
whether IN O
or CC O
not RB O
SOCS-3 JJ B-NP
also RB O
binds NNS O
to TO O
the DT O
IGFIR NN B-NP
, , O
we PRP O
cloned VBD O
human JJ B-NP
SOCS-3 NN I-NP
by IN O
reverse JJ O
transcription-polymerase NN O
chain NN O
reaction NN O
from IN O
human JJ O
skeletal NN O
muscle NN O
mRNA NNS O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
this DT O
mutant JJ O
cell NN O
line NN O
lacks VBZ O
expression NN O
of IN O
the DT O
IKK NNP B-NP
regulatory JJ I-NP
protein NN I-NP
, , O
IKKgamma NNP B-NP
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
main JJ O
effect NN O
of IN O
muscle NN O
pain NN O
, , O
compared VBN O
to TO O
non-painful JJ O
stimulation NN O
, , O
was VBD O
a DT O
significant JJ O
and CC O
long-lasting JJ O
increase NN O
of IN O
delta JJ O
(1-3 JJ O
Hz NN O
) -RRB- O
power NN O
and CC O
an DT O
alpha-1 NN O
( -LRB- O
9-11 JJ O
Hz NN O
) -RRB- O
power NN O
increase NN O
over IN O
the DT O
contralateral JJ O
parietal NN O
locus NN O
. . O

-DOCSTART- X X O

This DT O
transcriptional JJ O
regulation NN O
occurs VBZ O
through IN O
modulation NN O
of IN O
the DT O
forkhead NN B-NP
transcription NN I-NP
factor NN I-NP
FKHR-L1 NNP B-NP
, , O
and CC O
IL-3 JJ B-NP
inhibited JJ O
FKHR-L1 JJ B-NP
activity NN O
in IN O
a DT O
PI3K-dependent JJ B-NP
manner NN O
. . O

-DOCSTART- X X O

Unlike IN O
the DT O
mammalian JJ O
proteins NNS O
, , O
XFGF3 NNP B-NP
is VBZ O
efficiently RB O
secreted VBN O
as IN O
a DT O
Mr NNP O
31,000 CD O
glycoprotein NN O
, , O
gp31 CD B-NP
, , O
which WDT O
undergoes VBZ O
proteolytic JJ O
cleavage NN O
to TO O
produce VB O
an DT O
NH2-terminally NNP O
truncated VBD O
product NN O
, , O
gp27 NN B-NP
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
microtubule NN O
binding JJ O
domain NN O
of IN O
microtubule JJ B-NP
actin NN I-NP
crosslinking NN I-NP
factor NN I-NP
( -LRB- O
MACF) NNP B-NP
: : O
identification NN O
of IN O
a DT O
novel JJ O
group NN O
of IN O
microtubule NN B-NP
associated VBN I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Four CD O
cases NNS O
of IN O
synovial JJ O
chondromatosis NN O
are VBP O
presented VBN O
. . O

-DOCSTART- X X O

These DT O
cells NNS O
produced VBD O
P2Y( JJ B-NP
11 CD I-NP
) -RRB- I-NP
mRNA NN I-NP
during IN O
culture NN O
. . O

-DOCSTART- X X O

Coexpression NNP O
studies NNS O
indicate VBP O
that IN O
insulin NN B-NP
and CC O
PKB NNP B-NP
suppress NN O
transactivation NN O
by IN O
C/EBPbeta NNP B-NP
, , O
but CC O
not RB O
C/EBPalpha NNP B-NP
, , O
and CC O
that IN O
N-terminal JJ O
transactivation NN O
domains VBZ O
in IN O
C/EBPbeta NNP B-NP
are VBP O
required VBN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
in IN O
our PRP$ O
in IN O
vitro NN O
model NN O
, , O
the DT O
localization NN O
of IN O
the DT O
mutation NN O
in IN O
the DT O
K-ras NNP B-NP
gene NN I-NP
predisposes VBZ O
to TO O
a DT O
different JJ O
level NN O
of IN O
aggressiveness NN O
in IN O
the DT O
transforming NN O
phenotype NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
the DT O
sequelae NNS O
of IN O
the DT O
antiphospholipid-antibodies NNS O
is VBZ O
an DT O
impaired VBN O
uteroplacental JJ O
circulation NN O
. . O

-DOCSTART- X X O

PM NNP O
12 CD O
or CC O
18 CD O
mg/kg JJ O
daily JJ O
plus CC O
a DT O
standard JJ O
dose NN O
of IN O
SB NNP O
for IN O
21 CD O
days NNS O
was VBD O
statistically RB O
more RBR O
effective JJ O
than IN O
SB NNP O
in IN O
producing VBG O
a DT O
final JJ O
cure NN O
for IN O
patients NNS O
with IN O
VL NNP O
in IN O
Bihar NNP O
, , O
India NNP O
. . O

-DOCSTART- X X O

In IN O
whole JJ O
sardine NN O
, , O
domoic JJ O
acid NN O
was VBD O
detected VBN O
in IN O
levels NNS O
exceeding VBG O
sometimes RB O
the DT O
regulatory JJ O
limit NN O
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
that IN O
the DT O
protein NN O
is VBZ O
a DT O
murine NN B-NP
homologue NN I-NP
of IN I-NP
SAF-A NNP I-NP
which WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
bind NN O
selectively RB O
to TO O
MARs NNP O
and CC O
is VBZ O
responsible JJ O
for IN O
the DT O
satMa-binding JJ B-NP
activity NN O
in IN O
the DT O
chromatographic JJ O
fractions NNS O
. . O

-DOCSTART- X X O

The DT O
molecular JJ O
associations NNS O
dictating VBG O
INCENP NNP B-NP
behavior NN O
during IN O
mitosis NN O
are VBP O
currently RB O
unknown JJ O
. . O

-DOCSTART- X X O

Termination NN O
of IN O
induced JJ O
VT NNP O
on IN O
the DT O
first JJ O
attempt NN O
was VBD O
comparable JJ O
with IN O
BV NNP O
pacing VBG O
(87.4 CD O
% NN O
) -RRB- O
versus FW O
RV NN O
pacing VBG O
(89.6 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Perfusion NNP O
technique NN O
for IN O
perfusion-assisted JJ O
direct JJ O
coronary JJ O
artery NN O
bypass NN O
( -LRB- O
PADCAB) NNP O
. . O

-DOCSTART- X X O

To TO O
account VB O
for IN O
this DT O
observation NN O
, , O
other JJ O
possible JJ O
causes NNS O
include VBP O
increased VBN O
CSF NNP O
pulsation NN O
in IN O
children NNS O
creating VBG O
motion NN O
artifact NN O
, , O
changes NNS O
in IN O
arterial NN O
oxygen NN O
concentration NN O
intrinsic JJ O
to TO O
propofol VB O
or CC O
related VBN O
to TO O
the DT O
supplemental JJ O
oxygen NN O
normally RB O
administered VBN O
, , O
or CC O
changes NNS O
in IN O
CSF NNP O
protein NN O
levels NNS O
related VBN O
to TO O
propofol VB O
binding JJ O
to TO O
proteins NNS O
for IN O
uptake NN O
into IN O
CSF. NNP O

-DOCSTART- X X O

In IN O
three CD O
cases NNS O
( -LRB- O
21.4 CD O
% NN O
) -RRB- O
, , O
the DT O
MR NNP O
imaging NN O
was VBD O
interpreted VBN O
as IN O
negative JJ O
, , O
but CC O
microscopic JJ O
tumor NN O
was VBD O
shown VBN O
around IN O
seroma NN O
on IN O
reexcision NN O
. . O

-DOCSTART- X X O

This DT O
interaction NN O
is VBZ O
reciprocal JJ O
, , O
since IN O
C/EBP NNP B-NP
dimer NN I-NP
binding NN O
to TO O
a DT O
strong JJ O
C/EBP NNP B-NP
site NN I-NP
leads VBZ O
to TO O
enhanced JJ O
CREB-1 JJ B-NP
recruitment NN O
to TO O
ATF/CREB VB B-NP
sites NNS O
that WDT O
are VBP O
weakly RB O
bound VBN O
by IN O
CREB. NNP B-NP

-DOCSTART- X X O

Quantitative JJ O
PCR NNP O
studies NNS O
indicated VBD O
that IN O
synthesis NN O
and CC O
transport NN O
of IN O
vector NN O
DNA NN O
into IN O
the DT O
nucleus NN O
were VBD O
similar JJ O
for IN O
macrophages NNS O
infected VBN O
with IN O
the DT O
clone NN O
239 CD O
and CC O
316 CD O
pseudotypes NNS O
, , O
suggesting VBG O
that IN O
the DT O
restriction NN O
for IN O
SIVmac239 NNP O
infection NN O
is VBZ O
after IN O
reverse NN O
transcription NN O
and CC O
nuclear JJ O
import NN O
of IN O
viral JJ O
DNA NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
similarities NNS O
with IN O
the DT O
endophilin JJ B-NP
proteins NNS I-NP
cover VBP O
the DT O
entire JJ O
sequence NN O
of IN O
the DT O
SH3GLB NNP B-NP
family NN I-NP
, , O
suggesting VBG O
a DT O
common JJ O
fold NN O
and CC O
presumably RB O
a DT O
common JJ O
mode NN O
of IN O
action NN O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
in IN O
vivo JJ O
role NN O
of IN O
p16.7 NN B-NP
, , O
a DT O
phi29 NN O
mutant NN O
containing VBG O
a DT O
suppressible JJ O
mutation NN O
in IN O
gene NN B-NP
16.7 CD I-NP
was VBD O
constructed VBN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
we PRP O
did VBD O
not RB O
detect VB O
a DT O
significant JJ O
correlation NN O
between IN O
plasma NN B-NP
TNFalpha NNP I-NP
and CC O
radiation NN O
pneumonitis NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Sixteen CD O
pigs NNS O
were VBD O
assigned VBN O
randomly RB O
to TO O
control NN O
and CC O
shock NN O
groups NNS O
. . O

-DOCSTART- X X O

Serial JJ O
US PRP O
images NNS O
were VBD O
obtained VBN O
before IN O
and CC O
20 CD O
, , O
30 CD O
, , O
40 CD O
, , O
50 CD O
, , O
60 CD O
, , O
90 CD O
, , O
120 CD O
, , O
150 CD O
, , O
180 CD O
, , O
240 CD O
, , O
and CC O
300 CD O
s VBZ O
after IN O
intravenous JJ O
injection NN O
of IN O
2 CD O
g NN O
of IN O
contrast NN O
agent NN O
using VBG O
conventional JJ O
and CC O
harmonic JJ O
PD NNP O
US. . O

-DOCSTART- X X O

This DT O
supports VBZ O
previous JJ O
arguments NNS O
for IN O
the DT O
improbability NN O
of IN O
biological JJ O
effects NNS O
at IN O
UHF NNP O
frequencies NNS O
unless IN O
a DT O
mechanism NN O
can MD O
be VB O
found VBN O
for IN O
accumulating VBG O
energy NN O
over IN O
time NN O
and CC O
space NN O
and CC O
focussing VBG O
it PRP O
. . O

-DOCSTART- X X O

To TO O
assess VB O
the DT O
maximum NN O
oxygen NN O
uptake NN O
( -LRB- O
V'O2 JJ O
max NN O
) -RRB- O
of IN O
Hong NNP O
Kong NNP O
Chinese NNPS O
children NNS O
and CC O
to TO O
explore VB O
its PRP$ O
association NN O
with IN O
respiratory JJ O
illnesses NNS O
, , O
we PRP O
conducted VBD O
the DT O
Multistage NNP O
Fitness NNP O
Test NNP O
( -LRB- O
MFT) NNP O
, , O
a DT O
20-m JJ O
shuttle NN O
run NN O
test NN O
, , O
in IN O
1,427 CD O
schoolchildren NNS O
aged VBN O
between IN O
8-12 CD O
years NNS O
. . O

-DOCSTART- X X O

The DT O
corresponding JJ O
genotype NN O
was VBD O
determined VBN O
with IN O
a DT O
restriction NN O
enzyme-based JJ O
assay NN O
. . O

-DOCSTART- X X O

The DT O
regulation NN O
of IN O
PGHS-2 JJ B-NP
mRNA NN I-NP
and CC O
protein NN O
was VBD O
studied VBN O
in IN O
primary JJ O
cultures NNS O
of IN O
bovine JJ O
uterine JJ O
stromal JJ O
cells NNS O
stimulated VBN O
with IN O
phorbol NN O
12-myristate JJ O
13-acetate JJ O
( -LRB- O
PMA NNP O
; : O
100 CD O
nM NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Functional JJ O
analysis NN O
of IN O
various JJ O
PTP-deficient JJ B-NP
DT40 NN O
B NNP O
cell NN O
lines NNS O
stably RB O
expressing VBG O
wild-type JJ O
chimeric JJ O
Fc NNP B-NP
gamma NN I-NP
RIIB1-PECAM-1 NN I-NP
receptor NN I-NP
indicated VBD O
that IN O
cytoplasmic JJ B-NP
Src NNP I-NP
homology NN I-NP
2-domain-containing JJ I-NP
phosphatases NNS I-NP
, , O
SHP-1 NNP B-NP
and CC O
SHP-2 NNP B-NP
, , O
were VBD O
both DT O
necessary JJ O
and CC O
sufficient JJ O
to TO O
deliver VB O
inhibitory JJ O
negative JJ O
regulation NN O
upon IN O
coligation NN O
of IN O
BCR NNP B-NP
complex NN I-NP
with IN O
inhibitory JJ O
receptor NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
failure NN O
of IN O
the DT O
QKTT NNP O
motif NN O
and CC O
TGN46 CD O
cytoplasmic JJ O
tail NN O
to TO O
induce VB O
steady-state NN O
ER NNP O
localization NN O
of IN O
vesicular JJ B-NP
stomatitis NN I-NP
virus NN I-NP
glycoprotein NN I-NP
(VSVG NN O
) -RRB- O
chimeras NNS O
in IN O
HeLa NNP O
and CC O
NRK NNP O
cells NNS O
indicates VBZ O
that IN O
significant JJ O
differences NNS O
in IN O
early JJ O
secretory NN O
trafficking NN O
also RB O
exist VBP O
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
the DT O
specificity NN O
observed VBD O
for IN O
the DT O
interaction NN O
of IN O
DmCKIIalpha NNP B-NP
with IN O
these DT O
bHLH JJ B-NP
proteins NNS I-NP
, , O
sequence NN O
alignment NN O
suggests VBZ O
that IN O
only RB O
m5 CD B-NP
, , O
m7 CD B-NP
, , O
and CC O
m8 CD B-NP
contain VBP O
a DT O
consensus NN O
site NN O
for IN O
phosphorylation NN O
by IN O
CKII NNP B-NP
within IN O
a DT O
subdomain NN O
unique JJ O
to TO O
these DT O
three CD O
proteins NNS O
. . O

-DOCSTART- X X O

Sevelamer JJ O
hydrochloride NN O
( -LRB- O
Renagel NNP O
) -RRB- O
is VBZ O
a DT O
nonabsorbed JJ O
phosphate-binding NN O
polymer NN O
marketed VBD O
for IN O
the DT O
treatment NN O
of IN O
hyperphosphatemia NN O
in IN O
adult NN O
patients NNS O
receiving VBG O
hemodialysis NN O
. . O

-DOCSTART- X X O

The DT O
Genescan NNP O
program NN O
predicted VBD O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
a DT O
novel NN O
, , O
intron-less JJ O
gene NN O
adjacent JJ O
to TO O
the DT O
B236 NNP O
spot NN O
that IN O
encodes VBZ O
a DT O
putative JJ O
493-amino JJ O
acid NN O
protein NN O
containing VBG O
the DT O
SNAG NNP O
repressor NN O
motif NN O
in IN O
the DT O
NH2-terminal JJ O
region NN O
and CC O
five CD O
C2H2-type JJ O
zinc NN O
finger NN O
motifs NNS O
in IN O
the DT O
COOH-terminal JJ O
half NN O
. . O

-DOCSTART- X X O

The DT O
BFA NNP O
System NNP O
reads VBZ O
a DT O
text NN O
file NN O
with IN O
flows NNS O
, , O
measured VBN O
with IN O
fluorescent JJ O
microsphere JJ O
technique NN O
, , O
and CC O
constructs NNS O
the DT O
lung NN O
anatomy NN O
with IN O
volumetric JJ O
pixels NNS O
showing VBG O
the DT O
flows NNS O
with IN O
a DT O
color NN O
schema NN O
. . O

-DOCSTART- X X O

Managing VBG O
HIV. PRP$ O

-DOCSTART- X X O

Cells NNP O
containing VBG O
alpha NN O
subunits NNS O
that WDT O
lacked VBD O
a DT O
distal JJ O
domain NN O
(term-3 NN O
) -RRB- O
or CC O
had VBD O
the DT O
alternatively NN O
spliced VBD O
alpha-2 DT O
distal JJ O
domain NN O
showed VBD O
markedly RB O
decreased VBN O
ability NN O
to TO O
support VB O
tyrosine NN O
phosphorylation NN O
of IN O
Jak-2 NNP B-NP
and CC O
its PRP$ O
substrates NNS O
or CC O
to TO O
up-regulate JJ O
CD86 NNP B-NP
. . O

-DOCSTART- X X O

For IN O
this DT O
purpose NN O
, , O
the DT O
immediate JJ O
and CC O
the DT O
final JJ O
( -LRB- O
after IN O
swelling VBG O
) -RRB- O
fixation NN O
strengths NNS O
of IN O
two CD O
variations NNS O
of IN O
the DT O
swellable JJ O
bone NN O
anchor NN O
designs NNS O
( -LRB- O
a DT O
smooth JJ O
anchor NN O
and CC O
a DT O
screw NN O
anchor NN O
) -RRB- O
were VBD O
measured VBN O
in IN O
two CD O
different JJ O
foams NNS O
(used VBD O
to TO O
simulate JJ O
bone NN O
) -RRB- O
with IN O
different JJ O
densities NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Within IN O
7 CD O
days NNS O
, , O
all DT O
groups NNS O
re-acquired VBD O
responding VBG O
for IN O
heroin NN O
under IN O
CRF NNP O
at IN O
rates NNS O
similar JJ O
to TO O
their PRP$ O
pre-lesion JJ O
performance NN O
. . O

-DOCSTART- X X O

A DT O
novel NN O
growth-related NNP O
nuclear JJ O
protein NN O
binds NNS O
and CC O
inhibits VBZ O
rat NN O
aldolase NN B-NP
B NNP I-NP
gene NN I-NP
promoter NN O
. . O

-DOCSTART- X X O

Mechanism NN O
in IN O
the DT O
sequential JJ O
control NN O
of IN O
cell NN O
morphology NN O
and CC O
S NNP O
phase NN O
entry NN O
by IN O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
involves VBZ O
distinct JJ O
MEK/ERK NNP B-NP
activations NNS O
. . O

-DOCSTART- X X O

3D JJ O
image-processing NN O
permits VBZ O
to TO O
analyse DT O
ultrasound JJ O
data NNS O
interactively RB O
in IN O
three CD O
orthogonal JJ O
planes NNS O
( -LRB- O
section NN O
mode NN O
) -RRB- O
or CC O
in IN O
realistic JJ O
3D JJ O
views NNS O
( -LRB- O
rendering NN O
mode NN O
) -RRB- O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
revealed VBN O
significant JJ O
differences NNS O
between IN O
the DT O
5' JJ O
region NN O
of IN O
the DT O
beta NN O
subunit NN O
gene NN O
and CC O
the DT O
corresponding JJ O
regions NNS O
of IN O
the DT O
homologous JJ B-NP
GlyR NNP I-NP
alpha NN I-NP
subunit NN I-NP
genes NNS I-NP
; : O
it PRP O
also RB O
identified VBD O
a DT O
novel NN O
exon NN O
( -LRB- O
exon NN O
0) NN O
that WDT O
encodes VBZ O
most JJS O
of IN O
the DT O
5'-untranslated JJ O
portion NN O
of IN O
the DT O
GlyR NNP B-NP
beta NN I-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Forskolin NNP O
treatment NN O
( -LRB- O
10 CD O
microM NN O
) -RRB- O
of IN O
the DT O
transfected JJ O
cells NNS O
for IN O
3--6 CD O
h NN O
maximally RB O
induced VBN O
luciferase NN B-NP
threefold NN O
. . O

-DOCSTART- X X O

B-myb NNP B-NP
is VBZ O
essential JJ O
for IN O
G1/S NNP O
transition NN O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
phosphorylated VBN O
by IN O
the DT O
cyclin NN B-NP
A2/cdk2 IN I-NP
complex NN O
. . O

-DOCSTART- X X O

The DT O
flux NN O
rates NNS O
of IN O
p-toluidine JJ O
decreased VBN O
as IN O
the DT O
pH NN O
value NN O
in IN O
the DT O
donor NN O
solution NN O
increased VBN O
. . O

-DOCSTART- X X O

The DT O
438 CD B-NP
bp NN I-NP
EcoRI NNP I-NP
fragment NN I-NP
, , O
which WDT O
was VBD O
detected VBN O
by IN O
Southern NNP O
hybridization NN O
, , O
reveals VBZ O
an DT O
open JJ O
reading NN O
frame NN O
which WDT O
encodes VBZ O
a DT O
protein NN O
of IN O
103 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

Nrf2 NN B-NP
regulates VBZ O
expression NN O
of IN O
genes NNS O
encoding VBG O
enzymes NNS O
with IN O
antioxidant JJ O
( -LRB- O
e NN O
.g NN O
. . O
heme NN B-NP
oxygenase-1 NN I-NP
( -LRB- O
HO-1 JJ B-NP
) -RRB- O
) -RRB- O
or CC O
xenobiotic JJ O
detoxification NN O
( -LRB- O
e NN O
.g NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
ATF4 NNP B-NP
regulates VBZ O
basal JJ O
and CC O
CdCl( JJ O
2)-induced JJ O
expression NN O
of IN O
the DT O
ho-1 JJ B-NP
gene NN I-NP
in IN O
a DT O
cell-specific JJ O
manner NN O
and CC O
possibly RB O
in IN O
a DT O
complex JJ O
with IN O
Nrf2 NN B-NP
. . O

-DOCSTART- X X O

This DT O
effect NN O
was VBD O
observed VBN O
in IN O
the DT O
absence NN O
of IN O
de FW O
novo FW O
protein NN O
synthesis NN O
and CC O
was VBD O
independent JJ O
of IN O
histone NN B-NP
deacetylase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Corticosteroid-mediated JJ O
transcriptional JJ O
inhibition NN O
was VBD O
greater JJR O
for IN O
MR/GR NNP B-NP
in IN O
combination NN O
than IN O
for IN O
MR NNP B-NP
or CC O
GR CD B-NP
alone RB O
. . O

-DOCSTART- X X O

SV1 NNP B-NP
has VBZ O
a DT O
33-amino JJ O
acid NN O
insert NN O
in IN O
the DT O
S1 NNP O
transmembrane NN O
domain NN O
that WDT O
does VBZ O
not RB O
alter VB O
S1 JJ O
overall JJ O
hydrophobicity NN O
, , O
but CC O
makes VBZ O
the DT O
S0-S1 JJ O
linker NN O
longer RB O
. . O

-DOCSTART- X X O

Deterministic JJ O
effects NNS O
. . O

-DOCSTART- X X O

No DT O
preferential JJ O
VH/VL-chains NNS B-NP
correlated VBN O
with IN O
any DT O
of IN O
the DT O
12 CD O
different JJ O
antigen NN O
reactivities NNS O
, , O
even RB O
for IN O
mAbs NNS O
with IN O
nearly RB O
identical JJ O
cross-reactivities NNS O
. . O

-DOCSTART- X X O

Recently RB O
, , O
it PRP O
was VBD O
shown VBN O
that IN O
purified VBN O
RAG1/2 IN B-NP
proteins NNS I-NP
can MD O
cleave VB O
DNA NNP O
hairpins NNS O
in IN O
vitro NN O
, , O
but CC O
the DT O
same JJ O
activity NN O
was VBD O
also RB O
described VBN O
for IN O
a DT O
protein NN O
complex NN O
of IN O
the DT O
DNA NNP O
repair NN O
proteins VBZ O
Nbs1/Mre11/Rad50 NNP B-NP
. . O

-DOCSTART- X X O

Instead RB O
, , O
TRPS1 NNP B-NP
potently RB O
and CC O
specifically RB O
represses VBZ O
transcriptional JJ O
activation NN O
mediated VBN O
by IN O
other JJ O
GATA NNP B-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

PABP NNP B-NP
is VBZ O
a DT O
modular JJ O
protein NN O
, , O
with IN O
four CD O
N-terminal JJ O
RNA-binding JJ O
domains NNS O
and CC O
an DT O
extensive JJ O
C NNP O
terminus NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
126 CD O
patients NNS O
with IN O
histologically RB O
confirmed VBN O
MFH NNP O
were VBD O
analyzed VBN O
. . O

-DOCSTART- X X O

Their PRP$ O
numbers NNS O
have VBP O
regularly RB O
increased VBN O
since IN O
the DT O
mid-1970s NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
ubiquitous JJ O
expression NN O
of IN O
p19(INK4d JJ B-NP
) -RRB- O
has VBZ O
not RB O
been VBN O
previously RB O
described VBN O
in IN O
human JJ O
or CC O
murine JJ O
B-lineage JJ O
cells NNS O
. . O

-DOCSTART- X X O

Cross-linking JJ O
FcalphaR NN B-NP
on IN O
wt-ITAM NN B-NP
or CC O
IIA-ITAM NNP B-NP
cells NNS O
triggered VBD O
equivalent JJ O
PI NNP B-NP
3-kinase-dependent JJ I-NP
activation NN O
of IN O
PKBalpha NNP B-NP
. . O

-DOCSTART- X X O

The DT O
UBA NNP B-NP
domains VBZ I-NP
of IN O
RAD23 NNP B-NP
and CC O
DDI1 NNP B-NP
are VBP O
required VBN O
for IN O
these DT O
interactions NNS O
. . O

-DOCSTART- X X O

Through IN O
two CD O
novel NN O
mechanisms NNS O
, , O
Arf NNP B-NP
inhibits VBZ O
the DT O
oncoprotein NNP B-NP
Hdm2 NNP I-NP
, , O
a DT O
negative JJ O
regulator NN O
of IN O
p53 NN B-NP
. . O

-DOCSTART- X X O

Srb10 PRP B-NP
is VBZ O
a DT O
physiological JJ O
regulator NN O
of IN O
Gcn4 DT B-NP
stability NN O
because IN O
both DT O
phosphorylation NN O
and CC O
turnover NN O
of IN O
Gcn4 NNP B-NP
are VBP O
diminished VBN O
in IN O
srb10 DT B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

A DT O
log-linear JJ O
dose-response NN O
was VBD O
obtained VBN O
for IN O
the DT O
average JJ O
increase NN O
in IN O
FEV1 NNP O
up IN O
to TO O
6 CD O
h NN O
( -LRB- O
AUC0-6 JJ O
h NN O
) -RRB- O
and CC O
peak NN O
FEV1 IN O
across IN O
the DT O
dose NN O
range NN O
administered VBN O
by IN O
Respimat NNP O
. . O

-DOCSTART- X X O

The DT O
COD NNP O
and CC O
color NN O
removals NNS O
were VBD O
both DT O
more JJR O
than IN O
90 CD O
% NN O
when WRB O
FeCl3 NNP O
was VBD O
used VBN O
as IN O
the DT O
coagulation NN O
( -LRB- O
dosages NNS O
of IN O
two-step JJ O
coagulation NN O
were VBD O
0.031 CD O
and CC O
0.012 CD O
mol/L JJ O
respectively RB O
) -RRB- O
after IN O
a DT O
ferrous JJ O
hydrogen NN O
peroxide NN O
oxidation NN O
pretreatment NN O
at IN O
a DT O
H2O2 NNP O
dosage NN O
of IN O
0.06 CD O
mol/L NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
useful JJ O
as IN O
an DT O
adjunct NN O
to TO O
mammography NN O
in IN O
those DT O
patients NNS O
with IN O
radiographically NNP O
dense JJ O
breasts NNS O
for IN O
the DT O
characterization NN O
of IN O
palpable JJ O
masses NNS O
. . O

-DOCSTART- X X O

Changes NNS O
of IN O
the DT O
DB NNP O
sequence NN O
without IN O
affecting VBG O
the DT O
postulated JJ O
stem NN O
structure NN O
led VBD O
to TO O
drastic JJ O
losses NNS O
of IN O
translation NN O
efficiency NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
the DT O
forkhead NN B-NP
homologue NN I-NP
in IN I-NP
rhabdomyosarcoma NN I-NP
( -LRB- O
FKHR NNP B-NP
) -RRB- O
, , O
a DT O
recently RB O
described VBN O
member NN O
of IN O
the DT O
hepatocyte NN B-NP
nuclear JJ I-NP
factor NN I-NP
3/forkhead VBD I-NP
homeotic JJ B-NP
gene NN I-NP
family NN I-NP
, , O
as IN O
a DT O
nuclear JJ B-NP
hormone NN I-NP
receptor NN I-NP
( -LRB- O
NR NNP B-NP
) -RRB- O
intermediary JJ O
protein NN O
. . O

-DOCSTART- X X O

Saccharomyces NNS O
cerevisiae NNS O
activates NNS O
a DT O
regulatory JJ O
network NN O
called VBD O
"general JJ O
control NN O
" '' O
that WDT O
provides VBZ O
the DT O
cell NN O
with IN O
sufficient JJ O
amounts NNS O
of IN O
protein NN O
precursors NNS O
during IN O
amino DT O
acid NN O
starvation NN O
. . O

-DOCSTART- X X O

Mutation NNP O
analyses NNS O
identified VBD O
the DT O
cobalt-responsive JJ O
sequences NNS O
as IN O
the DT O
stress-response NN O
elements NNS O
( -LRB- O
StREs NN O
) -RRB- O
. . O

-DOCSTART- X X O

During IN O
most JJS O
of IN O
the DT O
cell NN O
cycle NN O
, , O
separase NN B-NP
is VBZ O
kept VBN O
inactive JJ O
by IN O
binding NN O
to TO O
an DT O
inhibitory JJ O
protein NN O
called VBD O
securin NN B-NP
. . O

-DOCSTART- X X O

Mechanical NNP O
ventilation NN O
in IN O
control NN O
lungs NNS O
produced VBD O
a DT O
47 CD O
% NN O
decrease NN O
in IN O
chord NN O
compliance NN O
, , O
an DT O
increase NN O
in IN O
lung NN O
lavage NN O
levels NNS O
of IN O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
( -LRB- I-NP
TNF)-alpha NNP I-NP
( -LRB- O
722 CD O
+/ NN O
- : O
306 CD O
pg/ml NN O
) -RRB- O
, , O
interleukin FW B-NP
( -LRB- I-NP
IL)-1beta NN I-NP
(902 CD O
+/ NNS O
- : O
322 JJ O
pg/ml NN O
) -RRB- O
, , O
and CC O
macrophage NN B-NP
inflammatory NN I-NP
protein-2 NN I-NP
( -LRB- O
MIP-2 NN B-NP
) -RRB- O
( -LRB- O
363 CD O
+/ NN O
- : O
104 CD O
pg/ml NN O
) -RRB- O
as IN O
compared VBN O
with IN O
low JJ O
levels NNS O
of IN O
cytokines NNS O
detected VBN O
in IN O
preventilation NN O
data NNS O
, , O
and CC O
no DT O
change NN O
in IN O
percentage NN O
of IN O
surfactant NN O
large JJ O
aggregates NNS O
( -LRB- O
LA NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
USPIO-enhanced NNP O
MRI NNP O
data NNS O
were VBD O
capable JJ O
to TO O
characterize VB O
tumor NN O
microvessel NN O
properties NNS O
in IN O
this DT O
breast NN O
cancer NN O
model NN O
: : O
microvascular JJ O
permeability NN O
( -LRB- O
determined VBN O
using VBG O
USPIO NNP O
) -RRB- O
correlated VBN O
significantly RB O
with IN O
tumor NN O
grade NN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
constitutive JJ O
NF-kappaB NNP B-NP
activity NN O
results NNS O
in IN O
cell NN O
death NN O
of IN O
TT NNP O
cells NNS O
and CC O
blocks NNS O
focus NN O
formation NN O
induced JJ O
by IN O
oncogenic JJ O
forms NNS O
of IN O
RET NNP B-NP
in IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
described VBN O
results NNS O
show VBP O
that IN O
DTD NNP O
is VBZ O
fast RB O
, , O
simple JJ O
, , O
and CC O
easy JJ O
to TO O
automate VB O
; : O
requires VBZ O
only RB O
a DT O
small JJ O
amount NN O
of IN O
sample NN O
( -LRB- O
approximately RB O
50 CD O
mg NN O
) -RRB- O
; : O
and CC O
affords NNS O
quantitative JJ O
information NN O
about IN O
the DT O
main JJ O
groups NNS O
of IN O
compounds NNS O
present JJ O
in IN O
cheeses NNS O
. . O

-DOCSTART- X X O

Newcastle NNP B-NP
disease NN I-NP
antibody NN I-NP
titre NN O
is VBZ O
dependent JJ O
on IN O
serum NN O
calcium NN O
concentration NN O
. . O

-DOCSTART- X X O

10.0 CD O
+/ NNS O
- : O
2.0 CD O
pmol/24 NN O
h NN O
, , O
P NNP O
< JJ O
0.01 CD O
) -RRB- O
and CC O
remained VBD O
elevated JJ O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Ketamine-induced DT O
dissociative JJ O
anesthesia NN O
produces VBZ O
persistently RB O
elevated JJ O
BIS NNP O
index NN O
which WDT O
is VBZ O
different JJ O
from IN O
thiamylal NN O
and CC O
those DT O
reported VBN O
with IN O
other JJ O
conventional JJ O
anesthetic JJ O
agents NNS O
. . O

-DOCSTART- X X O

Positive NNP O
and CC O
significant JJ O
correlations NNS O
were VBD O
found VBN O
between IN O
the DT O
weeks NNS O
of IN O
pregnancy NN O
and CC O
Se NNP O
levels NNS O
in IN O
kidney NN O
( -LRB- O
r=0.433 CD O
, , O
P=0.023 CD O
) -RRB- O
and CC O
heart NN O
( -LRB- O
r=0.313 CD O
, , O
P=0.030 CD O
) -RRB- O
. . O

-DOCSTART- X X O

STAT5A NNP B-NP
mutations NNS O
in IN O
the DT O
Src NNP B-NP
homology NN I-NP
2 CD I-NP
( -LRB- O
SH2 NN B-NP
) -RRB- O
and CC O
SH3 NNP B-NP
domains VBZ I-NP
did VBD O
not RB O
alter VB O
the DT O
BTK-mediated JJ B-NP
tyrosine NN O
phosphorylation NN O
. . O

-DOCSTART- X X O

Among IN O
individuals NNS O
, , O
however RB O
, , O
changes NNS O
were VBD O
strongly RB O
correlated VBN O
with IN O
ACR NNP O
levels NNS O
at IN O
baseline NN O
. . O

-DOCSTART- X X O

The DT O
other JJ O
inhibitor NN O
was VBD O
a DT O
single JJ O
TAR NN B-NP
decoy NN O
, , O
driven VBN O
by IN O
the DT O
U6 NNP B-NP
small JJ I-NP
nuclear JJ I-NP
RNA NN I-NP
promoter NN I-NP
( -LRB- O
U6-P) JJ B-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
MPc3 NNP B-NP
, , O
data NNS O
indicate VBP O
that IN O
the DT O
Pc JJ B-NP
protein NN I-NP
M33 CC B-NP
does VBZ O
not RB O
interact VB O
with IN O
AF9 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
amount NN O
of IN O
drained VBN O
effusion NN O
was VBD O
measured VBN O
, , O
and CC O
fluid NN O
was VBD O
sent VBN O
for IN O
diagnostic JJ O
assessment NN O
. . O

-DOCSTART- X X O

A DT O
rare JJ O
case NN O
of IN O
primary JJ O
group NN O
A DT O
streptococcal JJ O
peritonitis NN O
. . O

-DOCSTART- X X O

Statistical NNP O
Analysis NNP O
included VBD O
ANOVA NNP O
, , O
the DT O
Pearson NNP O
Product NNP O
Moment NNP O
Correlation NNP O
Coefficient NNP O
, , O
Principal NNP O
Components NNP O
Analysis NNP O
and CC O
Discriminant NNP O
Function NNP O
Analysis NNP O
and CC O
the DT O
calculation NN O
of IN O
Cronbach NNP O
's POS O
alpha NN O
( -LRB- O
alpha NN O
) -RRB- O
RESULTS NNS O
: : O
Both DT O
Sensitivity NNP O
and CC O
specificity NN O
exceed VBP O
90.00 CD O
at IN O
23/24 CD O
, , O
Chronbach NNP O
's POS O
alpha NN O
for IN O
the DT O
total JJ O
scale NN O
was VBD O
equal JJ O
to TO O
0.95 CD O
. . O

-DOCSTART- X X O

The DT O
telomerase NN B-NP
RNA-protein NNP I-NP
complex JJ I-NP
responsible JJ O
for IN O
maintenance NN O
of IN O
telomeric JJ O
DNA NN O
at IN O
chromosome NN O
ends NNS O
, , O
is VBZ O
usually RB O
inactive JJ O
in IN O
most JJS O
primary JJ O
somatic JJ O
human JJ O
cells NNS O
, , O
but CC O
is VBZ O
specifically RB O
activated VBN O
with IN O
in IN O
vitro NN O
immortalization NN O
and CC O
during IN O
tumorigenesis NN O
. . O

-DOCSTART- X X O

Altogether RB O
, , O
we PRP O
confirm VBP O
that IN O
all DT O
genes NNS O
of IN O
the DT O
Rad52 NNP B-NP
recombinational NNP O
repair NN O
pathway NN O
are VBP O
required VBN O
for IN O
the DT O
survival NN O
of IN O
rad27 NN B-NP
Delta NNP I-NP
strains NNS O
at IN O
both DT O
permissive JJ O
( -LRB- O
23 CD O
degrees NNS O
C NN O
) -RRB- O
and CC O
semipermissive JJ O
( -LRB- O
30 CD O
degrees NNS O
C NN O
) -RRB- O
temperatures NNS O
for IN O
growth NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
results NNS O
of IN O
a DT O
detailed JJ O
policy NN O
analysis NN O
comparing NN O
2 CD O
CJD-related JJ O
decisions NNS O
: : O
a DT O
1995 CD O
recall NN O
of IN O
blood NN O
from IN O
a DT O
donor NN O
with IN O
classic JJ O
CJD NN O
and CC O
the DT O
1999 CD O
decision NN O
to TO O
defer VB O
donations NNS O
from IN O
individuals NNS O
with IN O
a DT O
6-month JJ O
travel NN O
history NN O
to TO O
the DT O
UK NN O
between IN O
1980 CD O
and CC O
1996 CD O
due JJ O
to TO O
concerns NNS O
related VBN O
to TO O
variant JJ O
CJD. . O

-DOCSTART- X X O

The DT O
novel JJ O
approach NN O
to TO O
insulin NN B-NP
administration NN O
known VBN O
as IN O
chronic NN O
intermittent NN O
intravenous JJ O
insulin NN B-NP
therapy NN O
( -LRB- O
CIIIT NN O
) -RRB- O
delivers VBZ O
insulin NN B-NP
in IN O
a DT O
pulsatile NN O
fashion NN O
and CC O
achieves VBZ O
physiological JJ O
insulin NN B-NP
concentration NN O
in IN O
the DT O
portal JJ O
vein NN O
. . O

-DOCSTART- X X O

Breast NN O
cancer NN O
risk NN O
assessment NN O
: : O
Who WP O
holds VBZ O
the DT O
magic JJ O
crystal NN O
ball NN O
? . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
these DT O
patients NNS O
show VBP O
both DT O
quantitative JJ O
and CC O
qualitative JJ O
differences NNS O
in IN O
their PRP$ O
infectious JJ O
microbiological JJ O
spectrum NN O
, , O
mainly RB O
in IN O
clean-contaminated JJ O
, , O
contaminated JJ O
and CC O
dirty JJ O
surgical JJ O
procedures NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
In IN O
vivo FW O
, , O
there EX O
was VBD O
a DT O
wide JJ O
distribution NN O
with IN O
the DT O
coefficient NN O
of IN O
variation NN O
( -LRB- O
SD/mean NNP O
x NNP O
100 CD O
% NN O
) -RRB- O
for IN O
different JJ O
valve NN O
sizes NNS O
ranging VBG O
from IN O
21 CD O
% NN O
to TO O
39 CD O
% NN O
in IN O
the DT O
St NNP O
Jude NNP O
Medical NNP O
valve NN O
and CC O
from IN O
25 CD O
% NN O
to TO O
33 CD O
% NN O
in IN O
the DT O
Omnicarbon NNP O
valve NN O
. . O

-DOCSTART- X X O

Even RB O
if IN O
the DT O
electrocardiographic JJ O
signs NNS O
are VBP O
subdued VBN O
, , O
the DT O
underlying VBG O
blockade NN O
of IN O
I(Kr NN O
) -RRB- O
current NN O
may MD O
precipitate VB O
the DT O
occurrence NN O
of IN O
arrhythmia NN O
. . O

-DOCSTART- X X O

The DT O
production NN O
of IN O
ceramide NN O
is VBZ O
emerging VBG O
as IN O
a DT O
fixture NN O
of IN O
programmed JJ O
cell NN O
death NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
further JJ O
development NN O
of IN O
bladder NN O
neck NN O
suspension NN O
according VBG O
to TO O
Stamey-Pereyra NNP O
, , O
the DT O
use NN O
of IN O
miniature NN O
bone NN O
anchors NNS O
received VBD O
considerable JJ O
support NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
elderly JJ O
men NNS O
with IN O
bioavailable JJ O
estradiol NN O
levels NNS O
below IN O
the DT O
median JJ O
[40 CD O
pmol/liter NN O
( -LRB- O
11 CD O
pg/ml NN O
) -RRB- O
] SYM O
had VBD O
significantly RB O
higher JJR O
rates NNS O
of IN O
bone NN O
loss NN O
and CC O
levels NNS O
of IN O
bone NN O
resorption NN O
markers NNS O
than IN O
men NNS O
with IN O
bioavailable JJ O
estradiol NN O
levels NNS O
above IN O
40 CD O
pmol/liter NN O
. . O

-DOCSTART- X X O

Forced VBN O
expression NN O
of IN O
BZAP45 NNP B-NP
strongly RB O
stimulates VBZ O
H4 CD B-NP
promoter NN I-NP
( -LRB- O
nt NN O
-215 : O
to TO O
-1 NN O
)/CAT NN O
reporter NN O
gene NN O
activity NN O
. . O

-DOCSTART- X X O

No DT O
mutation NN O
of IN O
the DT O
NRL NNP B-NP
gene NN I-NP
was VBD O
found VBN O
in IN O
any DT O
of IN O
the DT O
two CD O
families NNS O
. . O

-DOCSTART- X X O

The DT O
deubiquitinating VBG O
enzyme NN O
DUB-2 NN B-NP
is VBZ O
induced VBN O
in IN O
response NN O
to TO O
IL-2 JJ B-NP
but CC O
as RB O
yet RB O
its PRP$ O
function NN O
has VBZ O
not RB O
been VBN O
determined VBN O
. . O

-DOCSTART- X X O

Cardiac NNP O
output NN O
at IN O
anaerobic JJ O
threshold NN O
( -LRB- O
COAT NN O
) -RRB- O
< , O
or CC O
= SYM O
7.3 CD O
L/min NNP O
was VBD O
the DT O
best JJS O
cutoff NN O
value NN O
for IN O
identifying VBG O
multivessel JJ O
coronary JJ O
artery NN O
disease NN O
( -LRB- O
relative JJ O
risk NN O
, , O
3.1 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
NF-Y NNP B-NP
and CC O
Sp1 NNP B-NP
binding NN O
sites NNS O
play VBP O
a DT O
decisive JJ O
role NN O
in IN O
the DT O
basal JJ O
expression NN O
of IN O
the DT O
rat NN B-NP
mrp2 VBG I-NP
gene NN I-NP
, , O
while IN O
the DT O
human JJ B-NP
MRP2 NNP I-NP
gene NN I-NP
is VBZ O
regulated VBN O
differently RB O
. . O

-DOCSTART- X X O

NB-506 NNP O
completely RB O
inhibits VBZ O
the DT O
capacity NN O
of IN O
topoisomerase NN B-NP
I PRP I-NP
to TO O
phosphorylate VB O
, , O
in IN O
vitro NN O
, , O
the DT O
human JJ B-NP
splicing NN I-NP
factor NN I-NP
2/alternative JJ I-NP
splicing NN B-NP
factor NN I-NP
( -LRB- O
SF2/ASF) NNP B-NP
. . O

-DOCSTART- X X O

A DT O
split JJ O
motor NN O
domain NN O
in IN O
a DT O
cytoplasmic JJ B-NP
dynein NN I-NP
. . O

-DOCSTART- X X O

In IN O
hypertensive JJ O
nephrosclerosis NN O
, , O
therapy NN O
containing VBG O
an DT O
ACEI NNP O
alone RB O
or CC O
in IN O
combination NN O
significantly RB O
reduces VBZ O
the DT O
incidence NN O
of IN O
renal JJ O
events NNS O
. . O

-DOCSTART- X X O

Body NNP O
weight NN O
reduction NN O
increases VBZ O
insulin NN B-NP
sensitivity NN O
and CC O
improves VBZ O
both DT O
blood NN O
glucose NN O
and CC O
blood NN O
pressure NN O
control NN O
. . O

-DOCSTART- X X O

The DT O
best JJS O
regression NN O
model NN O
for IN O
predicting VBG O
changes NNS O
in IN O
the DT O
WCXR NNP O
included VBD O
time NN O
to TO O
first JJ O
positive JJ O
culture NN O
and CC O
antibody NN O
titer NN O
for IN O
Pa NNP B-NP
elastase NN I-NP
. . O

-DOCSTART- X X O

This DT O
paper NN O
describes VBZ O
the DT O
results NNS O
of IN O
an DT O
initial JJ O
study NN O
on IN O
the DT O
application NN O
of IN O
linear JJ O
solvation NN O
energy NN O
relationships NNS O
( -LRB- O
LSERs NN O
) -RRB- O
to TO O
the DT O
prediction NN O
of IN O
internal JJ O
standard JJ O
compounds NNS O
in IN O
reversed-phase NN O
liquid NN O
chromatographic NN O
( -LRB- O
RPLC NNP O
) -RRB- O
method NN O
development NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
TVD-patients NNS O
decreases VBZ O
in IN O
skin NN O
blood NN O
flow NN O
were VBD O
similar JJ O
compared VBN O
with IN O
the DT O
healthy JJ O
controls NNS O
. . O

-DOCSTART- X X O

In IN O
Exp NNP O
. . O

-DOCSTART- X X O

Several JJ O
distinct JJ O
apoptotic JJ O
stimuli NNS O
induce VB O
the DT O
expression NN O
and CC O
caspase-dependent JJ B-NP
cleavage NN O
of IN O
hTAF(II)80 JJ B-NP
delta NN I-NP
. . O
hTAF(II)80 JJ B-NP
delta NN I-NP
, , O
unlike IN O
hTAF(II)80 NN B-NP
, , O
forms NNS O
a DT O
TFIID-like JJ B-NP
complex JJ I-NP
lacking VBG O
hTAF(II)31 NN B-NP
. . O

-DOCSTART- X X O

Paul NNP O
Monagle NNP O
addresses VBZ O
the DT O
epidemiology NN O
of IN O
neonatal JJ O
thrombosis NN O
outside IN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
in IN O
both DT O
arterial JJ O
and CC O
venous JJ O
locations NNS O
, , O
and CC O
those DT O
that IN O
occur VBP O
in IN O
utero NN O
. . O

-DOCSTART- X X O

Saunders NNS O
Company NNP O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
activating VBG O
blood NN O
circulation NN O
to TO O
remove VB O
blood NN O
stasis NN O
on IN O
barrier NN O
action NN O
of IN O
gastric JJ O
wall NN O
in IN O
chronic JJ O
atrophic JJ O
gastritis NN O

-DOCSTART- X X O

Schistosoma NNP O
mansoni NNS O
schistosomiasis NN O
] NN O
Schistosomosis NNP O
are VBP O
parasitic JJ O
diseases NNS O
caused VBN O
by IN O
blood NN O
flukes NNS O
of IN O
the DT O
Schistosoma NNP O
genus NN O
. . O

